,Sentence,ESG BERT Topic 1,ESG BERT Topic 2,ESG BERT Topic 3,Mapped Criteria Topic 1,Mapped Criteria Topic 2,Mapped Criteria Topic 3
Line 1,"Making a   Meaningful   Difference 2020 CORPORATE    RESPONSIBILITY REPORTProduct  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Contents 3  INTRODUCTION 3 From the Chairman and CEO 4 COVID-19: Saving and Sustaining Lives    During a Global Pandemic 5 Advancing Racial Justice 6 Company Profile 7 Corporate Responsibility 11  BAXTER'S 2020 CORPORATE     RESPONSIBILITY PRIORITIES    AND GOALS 13  BAXTER'S 2030 CORPORATE     RESPONSIBILITY COMMITMENT    AND GOALS   14 PRODUCT INNOVATION 14 Patient Safety and Quality 16 Sustainable Design 17 Materials Use 19 Product End-of-Life 21 WORKPLACE CULTURE 21 Global Inclusion and Diversity 24 Employee Engagement 26 Compensation and Benefits 26 Workplace Flexibility 27 ETHICS AND COMPLIANCE   27 Companywide Accountability 28 Ethics and Compliance Training 28 Third Party Program 28 Compliance Assessments 28 Compliance Monitoring 29 Relationships With Healthcare Professionals    and Government Officials 29 Ethics and Compliance Helpline 30 Privacy and Data Protection  31 EMPLOYEE HEALTH AND SAFETY 31 Injury and Illness Performance 32 Injuries and Major Incidents 32 Driving a Culture of Safety and Engagement 32 Health and Wellness Program Management    and Initiatives33 OPERATIONS 34 Environmental, Health and Safety    Performance 34 Energy 35 Water and Wastewater 36 Waste 36 GHG Emissions Across the Value Chain 37 GHG Emissions From Operations 37 Air Emissions 38 RESPONSIBLE PROCUREMENT     AND LOGISTICS 38 Responsible Procurement 41 Green Logistics 43 INNOVATION THAT EXPANDS     ACCESS TO CARE 43 Product Donations  45 The Baxter International Foundation 46 Collaborating to Improve Healthcare 49 SERVING OUR COMMUNITIES 49 Supporting Access to Clean Water and     Community Resilience 50 Fostering Tomorrow’s Innovation Through STEM 51 #BaxterGivesBack: Employee Volunteerism     and Giving 52 Summary of 2020 Giving 53 APPENDIX 53 About This Report 54 Materiality Assessment Findings 55 Baxter Data Summary 58 Baxter Value Chain Energy Usage and    GHG Emissions 59 Baxter Facilities with ISO 14001, ISO 45001,    ISO 50001 and Green Building Certifications 60 Independent Assurance Statement 61 Sustainability Accounting Standards    Board Index 64 Global Reporting Initiative Index  67 EndnotesASSURANCE AND VERIFICATION  Apex Companies LLC (Apex) verified  Baxter’s Scope 1, 2 and 3 greenhouse  gas emissions.
","('Employee_Health_And_Safety', 0.7417070269584656)","('Access_And_Affordability', 0.06797574460506439)","('Product_Quality_And_Safety', 0.030464353039860725)","(['Operational Eco-Efficiency'], 0.7417070269584656)","('NON-ESG', 0.06797574460506439)","('NON-ESG', 0.030464353039860725)"
Line 2,"Making a   Meaningful   Difference 2020 CORPORATE    RESPONSIBILITY REPORTProduct  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Contents 3  INTRODUCTION 3 From the Chairman and CEO 4 COVID-19: Saving and Sustaining Lives    During a Global Pandemic 5 Advancing Racial Justice 6 Company Profile 7 Corporate Responsibility 11  BAXTER'S 2020 CORPORATE     RESPONSIBILITY PRIORITIES    AND GOALS 13  BAXTER'S 2030 CORPORATE     RESPONSIBILITY COMMITMENT    AND GOALS   14 PRODUCT INNOVATION 14 Patient Safety and Quality 16 Sustainable Design 17 Materials Use 19 Product End-of-Life 21 WORKPLACE CULTURE 21 Global Inclusion and Diversity 24 Employee Engagement 26 Compensation and Benefits 26 Workplace Flexibility 27 ETHICS AND COMPLIANCE   27 Companywide Accountability 28 Ethics and Compliance Training 28 Third Party Program 28 Compliance Assessments 28 Compliance Monitoring 29 Relationships With Healthcare Professionals    and Government Officials 29 Ethics and Compliance Helpline 30 Privacy and Data Protection  31 EMPLOYEE HEALTH AND SAFETY 31 Injury and Illness Performance 32 Injuries and Major Incidents 32 Driving a Culture of Safety and Engagement 32 Health and Wellness Program Management    and Initiatives33 OPERATIONS 34 Environmental, Health and Safety    Performance 34 Energy 35 Water and Wastewater 36 Waste 36 GHG Emissions Across the Value Chain 37 GHG Emissions From Operations 37 Air Emissions 38 RESPONSIBLE PROCUREMENT     AND LOGISTICS 38 Responsible Procurement 41 Green Logistics 43 INNOVATION THAT EXPANDS     ACCESS TO CARE 43 Product Donations  45 The Baxter International Foundation 46 Collaborating to Improve Healthcare 49 SERVING OUR COMMUNITIES 49 Supporting Access to Clean Water and     Community Resilience 50 Fostering Tomorrow’s Innovation Through STEM 51 #BaxterGivesBack: Employee Volunteerism     and Giving 52 Summary of 2020 Giving 53 APPENDIX 53 About This Report 54 Materiality Assessment Findings 55 Baxter Data Summary 58 Baxter Value Chain Energy Usage and    GHG Emissions 59 Baxter Facilities with ISO 14001, ISO 45001,    ISO 50001 and Green Building Certifications 60 Independent Assurance Statement 61 Sustainability Accounting Standards    Board Index 64 Global Reporting Initiative Index  67 EndnotesASSURANCE AND VERIFICATION  Apex Companies LLC (Apex) verified  Baxter’s Scope 1, 2 and 3 greenhouse  gas emissions.
","('Business_Ethics', 0.6046351790428162)","('Employee_Engagement_Inclusion_And_Diversity', 0.14860504865646362)","('Employee_Health_And_Safety', 0.03550775349140167)","(['Business Ethics'], 0.6046351790428162)","('NON-ESG', 0.14860504865646362)","('NON-ESG', 0.03550775349140167)"
Line 3,"Making a   Meaningful   Difference 2020 CORPORATE    RESPONSIBILITY REPORTProduct  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Contents 3  INTRODUCTION 3 From the Chairman and CEO 4 COVID-19: Saving and Sustaining Lives    During a Global Pandemic 5 Advancing Racial Justice 6 Company Profile 7 Corporate Responsibility 11  BAXTER'S 2020 CORPORATE     RESPONSIBILITY PRIORITIES    AND GOALS 13  BAXTER'S 2030 CORPORATE     RESPONSIBILITY COMMITMENT    AND GOALS   14 PRODUCT INNOVATION 14 Patient Safety and Quality 16 Sustainable Design 17 Materials Use 19 Product End-of-Life 21 WORKPLACE CULTURE 21 Global Inclusion and Diversity 24 Employee Engagement 26 Compensation and Benefits 26 Workplace Flexibility 27 ETHICS AND COMPLIANCE   27 Companywide Accountability 28 Ethics and Compliance Training 28 Third Party Program 28 Compliance Assessments 28 Compliance Monitoring 29 Relationships With Healthcare Professionals    and Government Officials 29 Ethics and Compliance Helpline 30 Privacy and Data Protection  31 EMPLOYEE HEALTH AND SAFETY 31 Injury and Illness Performance 32 Injuries and Major Incidents 32 Driving a Culture of Safety and Engagement 32 Health and Wellness Program Management    and Initiatives33 OPERATIONS 34 Environmental, Health and Safety    Performance 34 Energy 35 Water and Wastewater 36 Waste 36 GHG Emissions Across the Value Chain 37 GHG Emissions From Operations 37 Air Emissions 38 RESPONSIBLE PROCUREMENT     AND LOGISTICS 38 Responsible Procurement 41 Green Logistics 43 INNOVATION THAT EXPANDS     ACCESS TO CARE 43 Product Donations  45 The Baxter International Foundation 46 Collaborating to Improve Healthcare 49 SERVING OUR COMMUNITIES 49 Supporting Access to Clean Water and     Community Resilience 50 Fostering Tomorrow’s Innovation Through STEM 51 #BaxterGivesBack: Employee Volunteerism     and Giving 52 Summary of 2020 Giving 53 APPENDIX 53 About This Report 54 Materiality Assessment Findings 55 Baxter Data Summary 58 Baxter Value Chain Energy Usage and    GHG Emissions 59 Baxter Facilities with ISO 14001, ISO 45001,    ISO 50001 and Green Building Certifications 60 Independent Assurance Statement 61 Sustainability Accounting Standards    Board Index 64 Global Reporting Initiative Index  67 EndnotesASSURANCE AND VERIFICATION  Apex Companies LLC (Apex) verified  Baxter’s Scope 1, 2 and 3 greenhouse  gas emissions.
","('Employee_Health_And_Safety', 0.9838356971740723)","('Employee_Engagement_Inclusion_And_Diversity', 0.0016319724963977933)","('Critical_Incident_Risk_Management', 0.001409315038472414)","(['Operational Eco-Efficiency'], 0.9838356971740723)","('NON-ESG', 0.0016319724963977933)","('NON-ESG', 0.001409315038472414)"
Line 4,"Making a   Meaningful   Difference 2020 CORPORATE    RESPONSIBILITY REPORTProduct  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Contents 3  INTRODUCTION 3 From the Chairman and CEO 4 COVID-19: Saving and Sustaining Lives    During a Global Pandemic 5 Advancing Racial Justice 6 Company Profile 7 Corporate Responsibility 11  BAXTER'S 2020 CORPORATE     RESPONSIBILITY PRIORITIES    AND GOALS 13  BAXTER'S 2030 CORPORATE     RESPONSIBILITY COMMITMENT    AND GOALS   14 PRODUCT INNOVATION 14 Patient Safety and Quality 16 Sustainable Design 17 Materials Use 19 Product End-of-Life 21 WORKPLACE CULTURE 21 Global Inclusion and Diversity 24 Employee Engagement 26 Compensation and Benefits 26 Workplace Flexibility 27 ETHICS AND COMPLIANCE   27 Companywide Accountability 28 Ethics and Compliance Training 28 Third Party Program 28 Compliance Assessments 28 Compliance Monitoring 29 Relationships With Healthcare Professionals    and Government Officials 29 Ethics and Compliance Helpline 30 Privacy and Data Protection  31 EMPLOYEE HEALTH AND SAFETY 31 Injury and Illness Performance 32 Injuries and Major Incidents 32 Driving a Culture of Safety and Engagement 32 Health and Wellness Program Management    and Initiatives33 OPERATIONS 34 Environmental, Health and Safety    Performance 34 Energy 35 Water and Wastewater 36 Waste 36 GHG Emissions Across the Value Chain 37 GHG Emissions From Operations 37 Air Emissions 38 RESPONSIBLE PROCUREMENT     AND LOGISTICS 38 Responsible Procurement 41 Green Logistics 43 INNOVATION THAT EXPANDS     ACCESS TO CARE 43 Product Donations  45 The Baxter International Foundation 46 Collaborating to Improve Healthcare 49 SERVING OUR COMMUNITIES 49 Supporting Access to Clean Water and     Community Resilience 50 Fostering Tomorrow’s Innovation Through STEM 51 #BaxterGivesBack: Employee Volunteerism     and Giving 52 Summary of 2020 Giving 53 APPENDIX 53 About This Report 54 Materiality Assessment Findings 55 Baxter Data Summary 58 Baxter Value Chain Energy Usage and    GHG Emissions 59 Baxter Facilities with ISO 14001, ISO 45001,    ISO 50001 and Green Building Certifications 60 Independent Assurance Statement 61 Sustainability Accounting Standards    Board Index 64 Global Reporting Initiative Index  67 EndnotesASSURANCE AND VERIFICATION  Apex Companies LLC (Apex) verified  Baxter’s Scope 1, 2 and 3 greenhouse  gas emissions.
","('GHG_Emissions', 0.7559565305709839)","('Air_Quality', 0.14195187389850616)","('Energy_Management', 0.013176623731851578)","(['Climate Change'], 0.7559565305709839)","('NON-ESG', 0.14195187389850616)","('NON-ESG', 0.013176623731851578)"
Line 5,"Making a   Meaningful   Difference 2020 CORPORATE    RESPONSIBILITY REPORTProduct  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Contents 3  INTRODUCTION 3 From the Chairman and CEO 4 COVID-19: Saving and Sustaining Lives    During a Global Pandemic 5 Advancing Racial Justice 6 Company Profile 7 Corporate Responsibility 11  BAXTER'S 2020 CORPORATE     RESPONSIBILITY PRIORITIES    AND GOALS 13  BAXTER'S 2030 CORPORATE     RESPONSIBILITY COMMITMENT    AND GOALS   14 PRODUCT INNOVATION 14 Patient Safety and Quality 16 Sustainable Design 17 Materials Use 19 Product End-of-Life 21 WORKPLACE CULTURE 21 Global Inclusion and Diversity 24 Employee Engagement 26 Compensation and Benefits 26 Workplace Flexibility 27 ETHICS AND COMPLIANCE   27 Companywide Accountability 28 Ethics and Compliance Training 28 Third Party Program 28 Compliance Assessments 28 Compliance Monitoring 29 Relationships With Healthcare Professionals    and Government Officials 29 Ethics and Compliance Helpline 30 Privacy and Data Protection  31 EMPLOYEE HEALTH AND SAFETY 31 Injury and Illness Performance 32 Injuries and Major Incidents 32 Driving a Culture of Safety and Engagement 32 Health and Wellness Program Management    and Initiatives33 OPERATIONS 34 Environmental, Health and Safety    Performance 34 Energy 35 Water and Wastewater 36 Waste 36 GHG Emissions Across the Value Chain 37 GHG Emissions From Operations 37 Air Emissions 38 RESPONSIBLE PROCUREMENT     AND LOGISTICS 38 Responsible Procurement 41 Green Logistics 43 INNOVATION THAT EXPANDS     ACCESS TO CARE 43 Product Donations  45 The Baxter International Foundation 46 Collaborating to Improve Healthcare 49 SERVING OUR COMMUNITIES 49 Supporting Access to Clean Water and     Community Resilience 50 Fostering Tomorrow’s Innovation Through STEM 51 #BaxterGivesBack: Employee Volunteerism     and Giving 52 Summary of 2020 Giving 53 APPENDIX 53 About This Report 54 Materiality Assessment Findings 55 Baxter Data Summary 58 Baxter Value Chain Energy Usage and    GHG Emissions 59 Baxter Facilities with ISO 14001, ISO 45001,    ISO 50001 and Green Building Certifications 60 Independent Assurance Statement 61 Sustainability Accounting Standards    Board Index 64 Global Reporting Initiative Index  67 EndnotesASSURANCE AND VERIFICATION  Apex Companies LLC (Apex) verified  Baxter’s Scope 1, 2 and 3 greenhouse  gas emissions.
","('GHG_Emissions', 0.9633185863494873)","('Management_Of_Legal_And_Regulatory_Framework', 0.003713472280651331)","('Air_Quality', 0.0035050197038799524)","(['Climate Change'], 0.9633185863494873)","('NON-ESG', 0.003713472280651331)","('NON-ESG', 0.0035050197038799524)"
Line 6,"Making a   Meaningful   Difference 2020 CORPORATE    RESPONSIBILITY REPORTProduct  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Contents 3  INTRODUCTION 3 From the Chairman and CEO 4 COVID-19: Saving and Sustaining Lives    During a Global Pandemic 5 Advancing Racial Justice 6 Company Profile 7 Corporate Responsibility 11  BAXTER'S 2020 CORPORATE     RESPONSIBILITY PRIORITIES    AND GOALS 13  BAXTER'S 2030 CORPORATE     RESPONSIBILITY COMMITMENT    AND GOALS   14 PRODUCT INNOVATION 14 Patient Safety and Quality 16 Sustainable Design 17 Materials Use 19 Product End-of-Life 21 WORKPLACE CULTURE 21 Global Inclusion and Diversity 24 Employee Engagement 26 Compensation and Benefits 26 Workplace Flexibility 27 ETHICS AND COMPLIANCE   27 Companywide Accountability 28 Ethics and Compliance Training 28 Third Party Program 28 Compliance Assessments 28 Compliance Monitoring 29 Relationships With Healthcare Professionals    and Government Officials 29 Ethics and Compliance Helpline 30 Privacy and Data Protection  31 EMPLOYEE HEALTH AND SAFETY 31 Injury and Illness Performance 32 Injuries and Major Incidents 32 Driving a Culture of Safety and Engagement 32 Health and Wellness Program Management    and Initiatives33 OPERATIONS 34 Environmental, Health and Safety    Performance 34 Energy 35 Water and Wastewater 36 Waste 36 GHG Emissions Across the Value Chain 37 GHG Emissions From Operations 37 Air Emissions 38 RESPONSIBLE PROCUREMENT     AND LOGISTICS 38 Responsible Procurement 41 Green Logistics 43 INNOVATION THAT EXPANDS     ACCESS TO CARE 43 Product Donations  45 The Baxter International Foundation 46 Collaborating to Improve Healthcare 49 SERVING OUR COMMUNITIES 49 Supporting Access to Clean Water and     Community Resilience 50 Fostering Tomorrow’s Innovation Through STEM 51 #BaxterGivesBack: Employee Volunteerism     and Giving 52 Summary of 2020 Giving 53 APPENDIX 53 About This Report 54 Materiality Assessment Findings 55 Baxter Data Summary 58 Baxter Value Chain Energy Usage and    GHG Emissions 59 Baxter Facilities with ISO 14001, ISO 45001,    ISO 50001 and Green Building Certifications 60 Independent Assurance Statement 61 Sustainability Accounting Standards    Board Index 64 Global Reporting Initiative Index  67 EndnotesASSURANCE AND VERIFICATION  Apex Companies LLC (Apex) verified  Baxter’s Scope 1, 2 and 3 greenhouse  gas emissions.
","('GHG_Emissions', 0.9661589860916138)","('Ecological_Impacts', 0.0037670356687158346)","('Air_Quality', 0.003701118053868413)","(['Climate Change'], 0.9661589860916138)","('NON-ESG', 0.0037670356687158346)","('NON-ESG', 0.003701118053868413)"
Line 7,"See verification statement.
","('Management_Of_Legal_And_Regulatory_Framework', 0.31611311435699463)","('Human_Rights_And_Community_Relations', 0.12202560156583786)","('Competitive_Behavior', 0.07404723763465881)","('NON-ESG', 0.31611311435699463)","('NON-ESG', 0.12202560156583786)","('NON-ESG', 0.07404723763465881)"
Line 8,"Apex also assured the following sections of the report:  • Product Innovation (except Patient Safety   and Quality)  • Employee Health and Safety  • Operations  • Responsible Procurement and Logistics  • Related material in the Appendix: Baxter Data  Summary ; Baxter Value Chain Energy Usage and  GHG Emissions ; and Baxter Facilities with ISO  14001, ISO 45001, ISO 50001 and Green Building  Certifications   See assurance statements in English  and Spanish .
","('Product_Quality_And_Safety', 0.5482500195503235)","('Product_Design_And_Lifecycle_Management', 0.15670736134052277)","('GHG_Emissions', 0.0486692376434803)","(['Product Quality & Recall Management'], 0.5482500195503235)","('NON-ESG', 0.15670736134052277)","('NON-ESG', 0.0486692376434803)"
Line 9,"Most of the financial data included in the    Baxter Data Summary  are taken from the audited  consolidated financial statements contained in the  Baxter International Inc.
","('Management_Of_Legal_And_Regulatory_Framework', 0.42108649015426636)","('Systemic_Risk_Management', 0.2085205763578415)","('Business_Ethics', 0.0510159395635128)","('NON-ESG', 0.42108649015426636)","('NON-ESG', 0.2085205763578415)","('NON-ESG', 0.0510159395635128)"
Line 10,"2020 Annual Report on   Form 10-K .
","('Management_Of_Legal_And_Regulatory_Framework', 0.35881057381629944)","('Access_And_Affordability', 0.1790991574525833)","('Human_Rights_And_Community_Relations', 0.07688659429550171)","('NON-ESG', 0.35881057381629944)","('NON-ESG', 0.1790991574525833)","('NON-ESG', 0.07688659429550171)"
Line 11,"These financial statements are audited   by Baxter’s independent registered public accounting   firm, PricewaterhouseCoopers LLP.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7351343631744385)","('Systemic_Risk_Management', 0.09232522547245026)","('Business_Ethics', 0.05999944359064102)","(['Corporate Governance'], 0.7351343631744385)","('NON-ESG', 0.09232522547245026)","('NON-ESG', 0.05999944359064102)"
Line 12,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORT 2BAXTER 2020 CORPORATE RESPONSIBILITY REPORT3Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction BAXTER 2020 CORPORATE RESPONSIBILITY REPORT JOSÉ (JOE) E.
","('Business_Model_Resilience', 0.18665345013141632)","('Human_Rights_And_Community_Relations', 0.14338910579681396)","('Business_Ethics', 0.1160748302936554)","('NON-ESG', 0.18665345013141632)","('NON-ESG', 0.14338910579681396)","('NON-ESG', 0.1160748302936554)"
Line 13,"ALMEIDA    |   Chairman, President and Chief Executive Officer2020 was a year like no other, with unforeseen impact  on so many aspects of our lives—personally and  professionally.
","('Director_Removal', 0.28232523798942566)","('Business_Model_Resilience', 0.22987310588359833)","('Human_Rights_And_Community_Relations', 0.04931452125310898)","('NON-ESG', 0.28232523798942566)","('NON-ESG', 0.22987310588359833)","('NON-ESG', 0.04931452125310898)"
Line 14,"For Baxter, the global challenges  presented in 2020 also inspired a unique and powerful  year in our ongoing journey of corporate responsibility.
","('Business_Model_Resilience', 0.2802000045776367)","('Human_Rights_And_Community_Relations', 0.23057962954044342)","('Systemic_Risk_Management', 0.12044380605220795)","('NON-ESG', 0.2802000045776367)","('NON-ESG', 0.23057962954044342)","('NON-ESG', 0.12044380605220795)"
Line 15,"I write this letter against the backdrop of a public health  crisis that continues to unfold in hot spots worldwide.
","('Critical_Incident_Risk_Management', 0.34308719635009766)","('Physical_Impacts_Of_Climate_Change', 0.15959617495536804)","('Systemic_Risk_Management', 0.1405266970396042)","('NON-ESG', 0.34308719635009766)","('NON-ESG', 0.15959617495536804)","('NON-ESG', 0.1405266970396042)"
Line 16,"As  a global healthcare company manufacturing medically  essential products for patient care, Baxter rapidly  emerged on the front lines of the COVID-19 pandemic in  2020.
","('Product_Design_And_Lifecycle_Management', 0.7133020162582397)","('Energy_Management', 0.040397319942712784)","('Product_Quality_And_Safety', 0.03184543922543526)","(['Product Stewardship'], 0.7133020162582397)","('NON-ESG', 0.040397319942712784)","('NON-ESG', 0.03184543922543526)"
Line 17,"Our first priority was ensuring the health and safety  of our employees.
","('Employee_Health_And_Safety', 0.9801913499832153)","('Employee_Engagement_Inclusion_And_Diversity', 0.002729375148192048)","('Critical_Incident_Risk_Management', 0.0016792044043540955)","(['Operational Eco-Efficiency'], 0.9801913499832153)","('NON-ESG', 0.002729375148192048)","('NON-ESG', 0.0016792044043540955)"
Line 18,"They, in turn, embraced our Mission to  Save and Sustain Lives in all facets of our operations, from  manufacturing and supply chain to clinical education,  technical service, corporate philanthropy and well beyond.
","('Supply_Chain_Management', 0.9349774122238159)","('Product_Design_And_Lifecycle_Management', 0.010048934258520603)","('Employee_Health_And_Safety', 0.004242984112352133)","(['Supply Chain Management'], 0.9349774122238159)","('NON-ESG', 0.010048934258520603)","('NON-ESG', 0.004242984112352133)"
Line 19,"I remain in awe of my Baxter colleagues and their resolve  to make a difference in this relentless battle, and together  we are grateful to, and humbled by, caregivers worldwide  for their tireless commitment on behalf of their patients.
","('Access_And_Affordability', 0.5830234885215759)","('Human_Rights_And_Community_Relations', 0.13402673602104187)","('Employee_Health_And_Safety', 0.07046815007925034)","(['Health Outcome Contribution'], 0.5830234885215759)","('NON-ESG', 0.13402673602104187)","('NON-ESG', 0.07046815007925034)"
Line 20,"Our mission came to life in a different manner following  the May 2020 murder of George Floyd.
","('Business_Ethics', 0.44538697600364685)","('Employee_Health_And_Safety', 0.12587624788284302)","('Employee_Engagement_Inclusion_And_Diversity', 0.043825820088386536)","('NON-ESG', 0.44538697600364685)","('NON-ESG', 0.12587624788284302)","('NON-ESG', 0.043825820088386536)"
Line 21,"This event, and  the companywide introspection that followed, led directly to the launch of ACT: Activating Change Today, Baxter’s  multidisciplinary effort to advance racial justice in our  workplace, marketplace and the communities we serve— with an intentional focus on addressing longstanding  disparities in healthcare.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9418314099311829)","('Human_Rights_And_Community_Relations', 0.011138146743178368)","('Employee_Health_And_Safety', 0.006332413759082556)","(['Human Capital Development'], 0.9418314099311829)","('NON-ESG', 0.011138146743178368)","('NON-ESG', 0.006332413759082556)"
Line 22,"It represents a new chapter in  Baxter’s ongoing emphasis on inclusion and diversity.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9730610847473145)","('Human_Rights_And_Community_Relations', 0.002163817174732685)","('Employee_Health_And_Safety', 0.0020651472732424736)","(['Human Capital Development'], 0.9730610847473145)","('NON-ESG', 0.002163817174732685)","('NON-ESG', 0.0020651472732424736)"
Line 23,"You will find more about ACT and our response to the  ongoing COVID-19 pandemic in the following pages.
","('Physical_Impacts_Of_Climate_Change', 0.34521108865737915)","('Critical_Incident_Risk_Management', 0.19904744625091553)","('Air_Quality', 0.08352506160736084)","('NON-ESG', 0.34521108865737915)","('NON-ESG', 0.19904744625091553)","('NON-ESG', 0.08352506160736084)"
Line 24,"And  these were not the only reasons 2020 was pivotal in Baxter’s  corporate responsibility efforts.
","('Human_Rights_And_Community_Relations', 0.3158726096153259)","('Business_Model_Resilience', 0.234449103474617)","('Management_Of_Legal_And_Regulatory_Framework', 0.06889685243368149)","('NON-ESG', 0.3158726096153259)","('NON-ESG', 0.234449103474617)","('NON-ESG', 0.06889685243368149)"
Line 25,"The year also marked the  closeout of our 2020 Corporate Responsibility Priorities and  Goals.
","('Business_Model_Resilience', 0.4070222079753876)","('Human_Rights_And_Community_Relations', 0.20704428851604462)","('Physical_Impacts_Of_Climate_Change', 0.05218137800693512)","('NON-ESG', 0.4070222079753876)","('NON-ESG', 0.20704428851604462)","('NON-ESG', 0.05218137800693512)"
Line 26,"We advanced important efforts across these priorities  and made great strides even in areas where we fell short.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2621859312057495)","('Human_Rights_And_Community_Relations', 0.24300964176654816)","('Access_And_Affordability', 0.07073275744915009)","('NON-ESG', 0.2621859312057495)","('NON-ESG', 0.24300964176654816)","('NON-ESG', 0.07073275744915009)"
Line 27,"Among noteworthy accomplishments for the period: • Since 2015, Baxter reduced absolute greenhouse gas  emissions by 13.6% compared with 2015, exceeding  our goal.
","('GHG_Emissions', 0.9675021171569824)","('Air_Quality', 0.003856400493532419)","('Ecological_Impacts', 0.00379970227368176)","(['Climate Change'], 0.9675021171569824)","('NON-ESG', 0.003856400493532419)","('NON-ESG', 0.00379970227368176)"
Line 28,"• Our commitment to the circular economy continued  to advance with our PVC recovery and recycling  partnerships with more than 375 hospitals and clinics  across Australia, New Zealand, Guatemala and  Colombia, exceeding our goal.
","('Energy_Management', 0.4872574210166931)","('Access_And_Affordability', 0.10974542796611786)","('Product_Design_And_Lifecycle_Management', 0.08953756093978882)","('NON-ESG', 0.4872574210166931)","('NON-ESG', 0.10974542796611786)","('NON-ESG', 0.08953756093978882)"
Line 29,"• We launched six therapies/products that reduced  materials use by at least 15% versus those currently   on market, exceeding our goal.
","('Product_Design_And_Lifecycle_Management', 0.9334579706192017)","('Customer_Welfare', 0.010266627185046673)","('Product_Quality_And_Safety', 0.00967403594404459)","(['Product Stewardship'], 0.9334579706192017)","('NON-ESG', 0.010266627185046673)","('NON-ESG', 0.00967403594404459)"
Line 30,"•  We achieved a 19% decrease in product complaints  compared with 2015, exceeding our goal.
","('Product_Quality_And_Safety', 0.4001666307449341)","('Business_Ethics', 0.1952989101409912)","('Competitive_Behavior', 0.10254126787185669)","('NON-ESG', 0.4001666307449341)","('NON-ESG', 0.1952989101409912)","('NON-ESG', 0.10254126787185669)"
Line 31,"• The Baxter International Foundation transformed its  giving to focus on long-term strategic investments,  establishing its first six Signature Partnerships to drive  increased healthcare access around the world.
","('Access_And_Affordability', 0.8907296061515808)","('Human_Rights_And_Community_Relations', 0.009520533494651318)","('Energy_Management', 0.008723445236682892)","(['Health Outcome Contribution'], 0.8907296061515808)","('NON-ESG', 0.009520533494651318)","('NON-ESG', 0.008723445236682892)"
Line 32,"We also published our first annual Sustainability Accounting  Standards Board (SASB) Index, a voluntary public disclosure  providing transparent, relevant corporate responsibility  information to investors and other key stakeholders.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6538284420967102)","('Product_Quality_And_Safety', 0.051804203540086746)","('Business_Ethics', 0.04821915924549103)","(['Corporate Governance'], 0.6538284420967102)","('NON-ESG', 0.051804203540086746)","('NON-ESG', 0.04821915924549103)"
Line 33,"While drawing our 2020 goals to a close, we reflected on a  landscape and expectations that have evolved rapidly over  the past five years.
","('Business_Model_Resilience', 0.4437927007675171)","('Human_Rights_And_Community_Relations', 0.10274241119623184)","('Physical_Impacts_Of_Climate_Change', 0.08511868864297867)","('NON-ESG', 0.4437927007675171)","('NON-ESG', 0.10274241119623184)","('NON-ESG', 0.08511868864297867)"
Line 34,"This set the stage to establish new  goals demonstrating our multifaceted, deeply ingrained  commitment to the environmental, social and governance  issues that are a priority to Baxter and our stakeholders.
","('Human_Rights_And_Community_Relations', 0.8511518836021423)","('Business_Model_Resilience', 0.01832728087902069)","('Ecological_Impacts', 0.01613076776266098)","(['Community Relations'], 0.8511518836021423)","('NON-ESG', 0.01832728087902069)","('NON-ESG', 0.01613076776266098)"
Line 35,"Our 2030 Commitment, formally launched in this report,  reflects our responsibility to Empower our Patients,  Protect our Planet and Champion our People and  Communities.
","('Human_Rights_And_Community_Relations', 0.9126973748207092)","('Access_And_Affordability', 0.018995143473148346)","('Employee_Health_And_Safety', 0.006936581805348396)","(['Community Relations'], 0.9126973748207092)","('NON-ESG', 0.018995143473148346)","('NON-ESG', 0.006936581805348396)"
Line 36,"Among our bold goals, Baxter is committing  to the following:  •  Double the number of patients reached in underserved  markets through our peritoneal dialysis (PD) portfolio •  Achieve carbon neutrality for our direct operations by  2040 and reduce absolute Scope 1 and 2 greenhouse  gas emissions 25% by 2030, aligned with a well-below  2⁰ Celsius science-based target •  For the first time publicly, aspire to specific levels  of representation of women (globally) and ethnic  minorities (in the United States) in leadership roles Our new goals generally span a 10-year horizon.
","('Employee_Engagement_Inclusion_And_Diversity', 0.953410267829895)","('Access_And_Affordability', 0.006969316862523556)","('Human_Rights_And_Community_Relations', 0.006085248198360205)","(['Human Capital Development'], 0.953410267829895)","('NON-ESG', 0.006969316862523556)","('NON-ESG', 0.006085248198360205)"
Line 37,"Among our bold goals, Baxter is committing  to the following:  •  Double the number of patients reached in underserved  markets through our peritoneal dialysis (PD) portfolio •  Achieve carbon neutrality for our direct operations by  2040 and reduce absolute Scope 1 and 2 greenhouse  gas emissions 25% by 2030, aligned with a well-below  2⁰ Celsius science-based target •  For the first time publicly, aspire to specific levels  of representation of women (globally) and ethnic  minorities (in the United States) in leadership roles Our new goals generally span a 10-year horizon.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3000003695487976)","('Business_Model_Resilience', 0.288702130317688)","('Director_Removal', 0.0912366583943367)","('NON-ESG', 0.3000003695487976)","('NON-ESG', 0.288702130317688)","('NON-ESG', 0.0912366583943367)"
Line 38,"They are  expansive and ambitious, yet clear and attainable.
","('Employee_Engagement_Inclusion_And_Diversity', 0.24439182877540588)","('Business_Ethics', 0.1642296463251114)","('Management_Of_Legal_And_Regulatory_Framework', 0.0787225216627121)","('NON-ESG', 0.24439182877540588)","('NON-ESG', 0.1642296463251114)","('NON-ESG', 0.0787225216627121)"
Line 39,"They  reflect and advance key global frameworks, including  Baxter's inaugural alignment with several of the United  Nations Sustainable Development Goals.
","('Human_Rights_And_Community_Relations', 0.34393730759620667)","('Management_Of_Legal_And_Regulatory_Framework', 0.20207227766513824)","('Business_Model_Resilience', 0.11723321676254272)","('NON-ESG', 0.34393730759620667)","('NON-ESG', 0.20207227766513824)","('NON-ESG', 0.11723321676254272)"
Line 40,"Today’s challenges are complex and present great  promise and potential for companies like Baxter to make  an impact in our shared quest for a brighter future.
","('Business_Model_Resilience', 0.4674743711948395)","('Systemic_Risk_Management', 0.19134704768657684)","('Supply_Chain_Management', 0.07823275774717331)","('NON-ESG', 0.4674743711948395)","('NON-ESG', 0.19134704768657684)","('NON-ESG', 0.07823275774717331)"
Line 41,"I  want to thank my more than 50,000 Baxter colleagues  worldwide, whose passion fuels our progress as a leading  corporate citizen.
","('Business_Model_Resilience', 0.18368658423423767)","('Human_Rights_And_Community_Relations', 0.17670467495918274)","('Director_Removal', 0.10511089116334915)","('NON-ESG', 0.18368658423423767)","('NON-ESG', 0.17670467495918274)","('NON-ESG', 0.10511089116334915)"
Line 42,"And most importantly, the Baxter team  thanks our stakeholders across the communities we serve  for encouraging and inspiring us to reach ever higher.
","('Human_Rights_And_Community_Relations', 0.9183060526847839)","('Access_And_Affordability', 0.019358070567250252)","('Employee_Engagement_Inclusion_And_Diversity', 0.009872602298855782)","(['Community Relations'], 0.9183060526847839)","('NON-ESG', 0.019358070567250252)","('NON-ESG', 0.009872602298855782)"
Line 43,"From the Chairman and CEOBAXTER 2020 CORPORATE RESPONSIBILITY REPORT4Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction 4COVID-19: Saving and Sustaining  Lives During a Global Pandemic The ongoing COVID-19 pandemic has created a worldwide crisis unprecedented in our lifetimes.
","('Critical_Incident_Risk_Management', 0.68500816822052)","('Physical_Impacts_Of_Climate_Change', 0.08628147840499878)","('Employee_Health_And_Safety', 0.06213802844285965)","(['Risk & Crisis Management'], 0.68500816822052)","('NON-ESG', 0.08628147840499878)","('NON-ESG', 0.06213802844285965)"
Line 44,"As a global leader in healthcare, delivering on our mission to save and sustain lives became   more vital than ever.
","('Access_And_Affordability', 0.2506495416164398)","('Employee_Health_And_Safety', 0.24301786720752716)","('Human_Rights_And_Community_Relations', 0.1297311931848526)","('NON-ESG', 0.2506495416164398)","('NON-ESG', 0.24301786720752716)","('NON-ESG', 0.1297311931848526)"
Line 45,"We continue to protect the health and safety of our employees; increase   the supply of critically necessary products and therapies; share our industry expertise, including  partnering in 2021 to manufacture COVID-19 vaccines; and provide philanthropic support to  communities in need.
","('Product_Quality_And_Safety', 0.5485893487930298)","('Employee_Health_And_Safety', 0.23180164396762848)","('Product_Design_And_Lifecycle_Management', 0.05744924768805504)","(['Product Quality & Recall Management'], 0.5485893487930298)","('NON-ESG', 0.23180164396762848)","('NON-ESG', 0.05744924768805504)"
Line 46,"Learn more about our response.
","('Critical_Incident_Risk_Management', 0.13772355020046234)","('Business_Model_Resilience', 0.10628858208656311)","('Human_Rights_And_Community_Relations', 0.1026640385389328)","('NON-ESG', 0.13772355020046234)","('NON-ESG', 0.10628858208656311)","('NON-ESG', 0.1026640385389328)"
Line 47,"Of course, this COVID-19  situation is scary for us and our   loved ones, but our mission  to ‘save lives’  keeps us going.
","('Employee_Health_And_Safety', 0.48251575231552124)","('Critical_Incident_Risk_Management', 0.25156447291374207)","('Human_Rights_And_Community_Relations', 0.08136528730392456)","('NON-ESG', 0.48251575231552124)","('NON-ESG', 0.25156447291374207)","('NON-ESG', 0.08136528730392456)"
Line 48,"Today, more than ever, we feel  like ‘super heroes!’”     PIERLUIGI   FIELD SERVICE ENGINEER, ITALY“ OUR PEOPLE From our front-line workers in manufacturing to our clinical educators, service specialists and    more, Baxter colleagues have played an extraordinary role in maintaining and increasing critical   product supply to meet patient needs.
","('Product_Design_And_Lifecycle_Management', 0.9387251138687134)","('Supply_Chain_Management', 0.009685303084552288)","('Product_Quality_And_Safety', 0.00733913853764534)","(['Product Stewardship'], 0.9387251138687134)","('NON-ESG', 0.009685303084552288)","('NON-ESG', 0.00733913853764534)"
Line 49,"We also deployed a staged response plan and have  introduced new initiatives, benefits, resources and ongoing communications to support the health  and safety of all Baxter employees.
","('Employee_Health_And_Safety', 0.9820899963378906)","('Critical_Incident_Risk_Management', 0.0018963092006742954)","('Employee_Engagement_Inclusion_And_Diversity', 0.0017854477046057582)","(['Operational Eco-Efficiency'], 0.9820899963378906)","('NON-ESG', 0.0018963092006742954)","('NON-ESG', 0.0017854477046057582)"
Line 50,"See Employee Health and Safety and Workplace Culture.
","('Employee_Health_And_Safety', 0.9603980183601379)","('Employee_Engagement_Inclusion_And_Diversity', 0.006707731168717146)","('Human_Rights_And_Community_Relations', 0.004597936756908894)","(['Operational Eco-Efficiency'], 0.9603980183601379)","('NON-ESG', 0.006707731168717146)","('NON-ESG', 0.004597936756908894)"
Line 51,"OUR PRODUCTS OUR EXPERTISE Our medical team is working with global healthcare professionals to understand the unique  clinical challenges created by COVID-19.
","('Customer_Welfare', 0.15207146108150482)","('Supply_Chain_Management', 0.14203958213329315)","('Business_Model_Resilience', 0.1356004923582077)","('NON-ESG', 0.15207146108150482)","('NON-ESG', 0.14203958213329315)","('NON-ESG', 0.1356004923582077)"
Line 52,"Additionally, Baxter's BioPharma Solutions business is  providing fill/finish sterile manufacturing services and supply packaging for the Moderna COVID-19   Vaccine; sterile manufacturing services for NVX-CoV2373 , the Novavax COVID-19  recombinant  nanoparticle vaccine candidate with Matrix-M ™ adjuvant; and sterile manufacturing services as  part of a group of industry partners collaborating with BioNTech  on its COVID-19 vaccine.
","('Waste_And_Hazardous_Materials_Management', 0.3289300501346588)","('Employee_Health_And_Safety', 0.09618774801492691)","('Customer_Welfare', 0.08961480855941772)","('NON-ESG', 0.3289300501346588)","('NON-ESG', 0.09618774801492691)","('NON-ESG', 0.08961480855941772)"
Line 53,"OUR COMMUNITIES The Baxter International Foundation is providing financial support to address the needs of  patients, healthcare workers and communities.
","('Access_And_Affordability', 0.6923338770866394)","('Human_Rights_And_Community_Relations', 0.11206012219190598)","('Employee_Health_And_Safety', 0.040394242852926254)","(['Health Outcome Contribution'], 0.6923338770866394)","('NON-ESG', 0.11206012219190598)","('NON-ESG', 0.040394242852926254)"
Line 54,"In 2020, the Foundation provided $2.5 million  in COVID-19 relief grants, including $1 million to support Save the Children’s global relief  efforts.
","('Access_And_Affordability', 0.6431616544723511)","('Human_Rights_And_Community_Relations', 0.09889231622219086)","('Critical_Incident_Risk_Management', 0.05203380435705185)","(['Health Outcome Contribution'], 0.6431616544723511)","('NON-ESG', 0.09889231622219086)","('NON-ESG', 0.05203380435705185)"
Line 55,"We also implemented a 2:1 employee gift match for select organizations focused on  COVID-19 relief around the world.
","('Employee_Health_And_Safety', 0.3368362486362457)","('Labor_Practices', 0.15037694573402405)","('Employee_Engagement_Inclusion_And_Diversity', 0.1437227576971054)","('NON-ESG', 0.3368362486362457)","('NON-ESG', 0.15037694573402405)","('NON-ESG', 0.1437227576971054)"
Line 56,"See Innovation That Expands Access to Care .
","('Access_And_Affordability', 0.714725911617279)","('Customer_Welfare', 0.036916494369506836)","('Energy_Management', 0.03030308708548546)","(['Health Outcome Contribution'], 0.714725911617279)","('NON-ESG', 0.036916494369506836)","('NON-ESG', 0.03030308708548546)"
Line 57,"Photo credit:  Courtesy of Americares.We have boosted capacity and production to help address the elevated demand for our products  around the world.
","('Product_Design_And_Lifecycle_Management', 0.9581873416900635)","('Energy_Management', 0.004169782157987356)","('Customer_Welfare', 0.004117417614907026)","(['Product Stewardship'], 0.9581873416900635)","('NON-ESG', 0.004169782157987356)","('NON-ESG', 0.004117417614907026)"
Line 58,"This included creating airbridges and seabridges to expedite delivery of  supplies, increasing freight capacity, obtaining emergency use authorizations for a multitude  of products, working closely with global governments to ensure ongoing manufacturing, and  continuing our manufacture-to-donate program with humanitarian partners.
","('Critical_Incident_Risk_Management', 0.974764883518219)","('Employee_Health_And_Safety', 0.003528519533574581)","('Air_Quality', 0.002653358271345496)","(['Risk & Crisis Management'], 0.974764883518219)","('NON-ESG', 0.003528519533574581)","('NON-ESG', 0.002653358271345496)"
Line 59,"See Public Policy .
","('Management_Of_Legal_And_Regulatory_Framework', 0.7317794561386108)","('Human_Rights_And_Community_Relations', 0.040384262800216675)","('Competitive_Behavior', 0.02402694709599018)","(['Corporate Governance'], 0.7317794561386108)","('NON-ESG', 0.040384262800216675)","('NON-ESG', 0.02402694709599018)"
Line 60,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORTBAXTER 2020 CORPORATE RESPONSIBILITY REPORT5Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction 55555We are united by our mission to save and sustain lives, which rests on a strong  foundation and commitment to inclusion and diversity globally.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9654067158699036)","('Human_Rights_And_Community_Relations', 0.0037404706235975027)","('Employee_Health_And_Safety', 0.0031240792013704777)","(['Human Capital Development'], 0.9654067158699036)","('NON-ESG', 0.0037404706235975027)","('NON-ESG', 0.0031240792013704777)"
Line 61,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORTBAXTER 2020 CORPORATE RESPONSIBILITY REPORT5Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction 55555We are united by our mission to save and sustain lives, which rests on a strong  foundation and commitment to inclusion and diversity globally.
","('Customer_Privacy', 0.10236068814992905)","('Director_Removal', 0.08989939838647842)","('Labor_Practices', 0.08451154083013535)","('NON-ESG', 0.10236068814992905)","('NON-ESG', 0.08989939838647842)","('NON-ESG', 0.08451154083013535)"
Line 62,"Racism,  intolerance, marginalization and discrimination affect our colleagues, families,  friends and communities worldwide in countless forms.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8070493340492249)","('Human_Rights_And_Community_Relations', 0.041388265788555145)","('Labor_Practices', 0.036679983139038086)","(['Human Capital Development'], 0.8070493340492249)","('NON-ESG', 0.041388265788555145)","('NON-ESG', 0.036679983139038086)"
Line 63,"In 2020, working in  close collaboration with our Baxter Black Alliance business resource group, we  launched ACT: Activating Change Today , a multidimensional, multidisciplinary  and multiyear initiative to advance inclusion and racial justice within our  workplace and the communities and markets we serve.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9641835689544678)","('Human_Rights_And_Community_Relations', 0.0060031600296497345)","('Employee_Health_And_Safety', 0.0034098359756171703)","(['Human Capital Development'], 0.9641835689544678)","('NON-ESG', 0.0060031600296497345)","('NON-ESG', 0.0034098359756171703)"
Line 64,"As the name suggests, ACT is about taking action to drive results.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7224538326263428)","('Human_Rights_And_Community_Relations', 0.03710327297449112)","('Competitive_Behavior', 0.03557911142706871)","(['Corporate Governance'], 0.7224538326263428)","('NON-ESG', 0.03710327297449112)","('NON-ESG', 0.03557911142706871)"
Line 65,"We want to  achieve meaningful, sustainable change within and beyond Baxter and be part of  the solution to the complex, longstanding, multifaceted societal issue of racial  injustice.
","('Human_Rights_And_Community_Relations', 0.34263691306114197)","('Employee_Engagement_Inclusion_And_Diversity', 0.2861868143081665)","('Business_Ethics', 0.10285545140504837)","('NON-ESG', 0.34263691306114197)","('NON-ESG', 0.2861868143081665)","('NON-ESG', 0.10285545140504837)"
Line 66,"We are acting with a sense of urgency, prioritizing initiatives that we  believe will make the biggest impact.Advancing Racial Justice THE MARKETPLACE We are collaborating to promote patient advocacy work,  bolster the pipeline of Black healthcare professionals  in medicine, ensure the healthcare professionals we  engage with have experience treating diverse patient  populations and more.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9132662415504456)","('Human_Rights_And_Community_Relations', 0.014572791755199432)","('Access_And_Affordability', 0.014181858859956264)","(['Human Capital Development'], 0.9132662415504456)","('NON-ESG', 0.014572791755199432)","('NON-ESG', 0.014181858859956264)"
Line 67,"OUR COMMUNITIES We are partnering with leading nonprofit organizations  to advance racial justice in the United States, including  a new Signature Partnership with the American Diabetes  Association to address health disparities for people with  diabetes in Chicago’s underserved Black communities.
","('Access_And_Affordability', 0.9290981292724609)","('Product_Quality_And_Safety', 0.007239591795951128)","('Human_Rights_And_Community_Relations', 0.006037618033587933)","(['Health Outcome Contribution'], 0.9290981292724609)","('NON-ESG', 0.007239591795951128)","('NON-ESG', 0.006037618033587933)"
Line 68,"Additionally, we are expanding our supplier diversity  program and strengthening our healthcare disparity  advocacy efforts by supporting and deploying relevant  programming with leading policy organizations.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9539047479629517)","('Labor_Practices', 0.004738467279821634)","('Employee_Health_And_Safety', 0.0034064685460180044)","(['Human Capital Development'], 0.9539047479629517)","('NON-ESG', 0.004738467279821634)","('NON-ESG', 0.0034064685460180044)"
Line 69,"See Innovation That Expands Access to Care.We are actively working to build a more inclusive and  diverse workforce and workplace through enhanced  recruitment, engagement and development strategies,  including new listening approaches, addressing  unconscious bias in our human resources processes  and more.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9743334650993347)","('Employee_Health_And_Safety', 0.002100482815876603)","('Human_Rights_And_Community_Relations', 0.0017197972629219294)","(['Human Capital Development'], 0.9743334650993347)","('NON-ESG', 0.002100482815876603)","('NON-ESG', 0.0017197972629219294)"
Line 70,"See Workplace Culture.OUR WORKFORCE AND WORKPLACE 5“          This is a generational defining moment.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8711096048355103)","('Employee_Health_And_Safety', 0.030113104730844498)","('Human_Rights_And_Community_Relations', 0.013831127434968948)","(['Human Capital Development'], 0.8711096048355103)","('NON-ESG', 0.030113104730844498)","('NON-ESG', 0.013831127434968948)"
Line 71,"I know that the conversations are tough… conversations of race, of social injustice, of systemic   oppression.
","('Business_Ethics', 0.38670647144317627)","('Human_Rights_And_Community_Relations', 0.17747828364372253)","('Employee_Engagement_Inclusion_And_Diversity', 0.11108008027076721)","('NON-ESG', 0.38670647144317627)","('NON-ESG', 0.17747828364372253)","('NON-ESG', 0.11108008027076721)"
Line 72,"But we should have them anyway.”  NOSA, TERRITORY BUSINESS MANAGER, ADVANCED SURGERY Photo:  Employees heard from their colleague, Nosa, on his views and experiences with  institutional and systemic racism in the United States.
","('Business_Ethics', 0.7331166863441467)","('Employee_Engagement_Inclusion_And_Diversity', 0.07673702389001846)","('Labor_Practices', 0.026381177827715874)","(['Business Ethics'], 0.7331166863441467)","('NON-ESG', 0.07673702389001846)","('NON-ESG', 0.026381177827715874)"
Line 73,"As part of our ACT initiative, Baxter is  working to foster open, honest conversations.
","('Business_Ethics', 0.4223746359348297)","('Human_Rights_And_Community_Relations', 0.11434638500213623)","('Management_Of_Legal_And_Regulatory_Framework', 0.10816722363233566)","('NON-ESG', 0.4223746359348297)","('NON-ESG', 0.11434638500213623)","('NON-ESG', 0.10816722363233566)"
Line 74,"To hear from Nosa, click here.
","('Business_Ethics', 0.19837643206119537)","('Management_Of_Legal_And_Regulatory_Framework', 0.12565594911575317)","('Competitive_Behavior', 0.1116214320063591)","('NON-ESG', 0.19837643206119537)","('NON-ESG', 0.12565594911575317)","('NON-ESG', 0.1116214320063591)"
Line 75,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORTBAXTER 2020 CORPORATE RESPONSIBILITY REPORT6Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction  Company Profile Every day, millions of patients and caregivers rely on  Baxter's leading portfolio of critical care, nutrition, renal,  hospital and surgical products.
","('Access_And_Affordability', 0.5373127460479736)","('Customer_Welfare', 0.08465994149446487)","('Product_Quality_And_Safety', 0.06116494908928871)","(['Health Outcome Contribution'], 0.5373127460479736)","('NON-ESG', 0.08465994149446487)","('NON-ESG', 0.06116494908928871)"
Line 76,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORTBAXTER 2020 CORPORATE RESPONSIBILITY REPORT6Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction  Company Profile Every day, millions of patients and caregivers rely on  Baxter's leading portfolio of critical care, nutrition, renal,  hospital and surgical products.
","('Product_Design_And_Lifecycle_Management', 0.75174880027771)","('Waste_And_Hazardous_Materials_Management', 0.03857308626174927)","('Product_Quality_And_Safety', 0.021793512627482414)","(['Product Stewardship'], 0.75174880027771)","('NON-ESG', 0.03857308626174927)","('NON-ESG', 0.021793512627482414)"
Line 77,"For 90 years, we’ve been  operating at the critical intersection where innovations  that save and sustain lives meet the healthcare providers  that make it happen.
","('Product_Design_And_Lifecycle_Management', 0.29300156235694885)","('Supply_Chain_Management', 0.1289108693599701)","('Access_And_Affordability', 0.11526019871234894)","('NON-ESG', 0.29300156235694885)","('NON-ESG', 0.1289108693599701)","('NON-ESG', 0.11526019871234894)"
Line 78,"Our corporate responsibility  commitment is fundamental to our ability to deliver  on this mission as we grow our business sustainably  and strive to meet the needs of all our stakeholders,  including our employees, our shareholders, the  communities where we operate, and the patients,  clinicians and caregivers who rely on our products.
","('Product_Design_And_Lifecycle_Management', 0.3697768449783325)","('Access_And_Affordability', 0.22244824469089508)","('Customer_Welfare', 0.08722051978111267)","('NON-ESG', 0.3697768449783325)","('NON-ESG', 0.22244824469089508)","('NON-ESG', 0.08722051978111267)"
Line 79,"Baxter’s heritage and global reach provide a distinct  perspective on the needs of patients and caregivers  around the world.
","('Access_And_Affordability', 0.8635748624801636)","('Human_Rights_And_Community_Relations', 0.02596278302371502)","('Employee_Health_And_Safety', 0.01620759628713131)","(['Health Outcome Contribution'], 0.8635748624801636)","('NON-ESG', 0.02596278302371502)","('NON-ESG', 0.01620759628713131)"
Line 80,"We continue to lead by applying  those insights to deliver new and enhanced healthcare  solutions, increase access to care and expand our  presence across the continuum of care.
","('Access_And_Affordability', 0.8154455423355103)","('Customer_Welfare', 0.025196386501193047)","('Energy_Management', 0.014453255571424961)","(['Health Outcome Contribution'], 0.8154455423355103)","('NON-ESG', 0.025196386501193047)","('NON-ESG', 0.014453255571424961)"
Line 81,"We have a  longstanding commitment to research and development  (R&D) and a rich history of medical firsts, from the first  commercially manufactured IV solutions to the first  portable kidney dialysis machine, and many more.
","('Customer_Welfare', 0.19649489223957062)","('Access_And_Affordability', 0.18537777662277222)","('Product_Design_And_Lifecycle_Management', 0.14612336456775665)","('NON-ESG', 0.19649489223957062)","('NON-ESG', 0.18537777662277222)","('NON-ESG', 0.14612336456775665)"
Line 82,"Each  of our more than 50,000  employees1 is dedicated to  ensuring that Baxter is there when and where patients  need care—from hospitals to clinics and homes, in rural  areas and major cities around the world.
","('Access_And_Affordability', 0.7661204934120178)","('Employee_Health_And_Safety', 0.05744443088769913)","('Critical_Incident_Risk_Management', 0.0312082227319479)","(['Health Outcome Contribution'], 0.7661204934120178)","('NON-ESG', 0.05744443088769913)","('NON-ESG', 0.0312082227319479)"
Line 83,"We will continue to transform healthcare by supporting  educational opportunities that will cultivate the next  generation of innovators, investing in the pursuit of  new discoveries and research, and partnering with  world-renowned institutions to further our impact.
","('Access_And_Affordability', 0.17073599994182587)","('Business_Model_Resilience', 0.14535938203334808)","('Employee_Engagement_Inclusion_And_Diversity', 0.12466264516115189)","('NON-ESG', 0.17073599994182587)","('NON-ESG', 0.14535938203334808)","('NON-ESG', 0.12466264516115189)"
Line 84,"We underpin this work with a commitment to conduct  our business with integrity, attract and develop a more  diverse and inclusive workforce, increase operational  efficiency and innovate more sustainable products.
","('Employee_Engagement_Inclusion_And_Diversity', 0.877190351486206)","('Product_Design_And_Lifecycle_Management', 0.03114314004778862)","('Business_Model_Resilience', 0.01570569910109043)","(['Human Capital Development'], 0.877190351486206)","('NON-ESG', 0.03114314004778862)","('NON-ESG', 0.01570569910109043)"
Line 85,"GLOBAL PRESENCE Baxter's products, technologies and therapies are  available in more than 100 countries across three  geographic segments: the Americas (including North  and South America); Europe, Middle East and Africa  (EMEA); and Asia Pacific (APAC).
","('Product_Design_And_Lifecycle_Management', 0.7611059546470642)","('Customer_Welfare', 0.07672085613012314)","('Product_Quality_And_Safety', 0.036423541605472565)","(['Product Stewardship'], 0.7611059546470642)","('NON-ESG', 0.07672085613012314)","('NON-ESG', 0.036423541605472565)"
Line 86,"Our corporate  headquarters is located in Deerfield, Illinois, in the  United States.
","('Business_Model_Resilience', 0.37055784463882446)","('Product_Design_And_Lifecycle_Management', 0.11083148419857025)","('Competitive_Behavior', 0.06379159539937973)","('NON-ESG', 0.37055784463882446)","('NON-ESG', 0.11083148419857025)","('NON-ESG', 0.06379159539937973)"
Line 87,"R&D is conducted at centers in Belgium,  China, Germany, India, Israel, Italy, Japan, Malta,  Sweden, the UK and the United States.
","('Management_Of_Legal_And_Regulatory_Framework', 0.30277737975120544)","('Business_Model_Resilience', 0.15880520641803741)","('GHG_Emissions', 0.05857817828655243)","('NON-ESG', 0.30277737975120544)","('NON-ESG', 0.15880520641803741)","('NON-ESG', 0.05857817828655243)"
Line 88,"Our products  are manufactured in approximately 50 facilities across  more than 20 countries.
","('Product_Design_And_Lifecycle_Management', 0.9172796010971069)","('Selling_Practices_And_Product_Labeling', 0.01830054633319378)","('Product_Quality_And_Safety', 0.01363355852663517)","(['Product Stewardship'], 0.9172796010971069)","('NON-ESG', 0.01830054633319378)","('NON-ESG', 0.01363355852663517)"
Line 89,"Each of the company’s geographic segments provides  a broad portfolio of essential healthcare products,  including acute and chronic dialysis therapies; sterile  IV solutions; infusion systems and devices; parenteral  nutrition therapies; inhaled anesthetics; generic  injectable pharmaceuticals; and surgical hemostat  and sealant products.
","('Customer_Welfare', 0.43633583188056946)","('Product_Design_And_Lifecycle_Management', 0.12313574552536011)","('Selling_Practices_And_Product_Labeling', 0.08333682268857956)","('NON-ESG', 0.43633583188056946)","('NON-ESG', 0.12313574552536011)","('NON-ESG', 0.08333682268857956)"
Line 90,"Europe,  Middle East  and AfricaAmericasAsia Pacific $11.7 B21% 25%54% REVENUE BY PRODUCT CATEGORY, 2020 *  * Sales and related figures represent fiscal year 2020; other sales represent ~$0.1B.
","('Product_Design_And_Lifecycle_Management', 0.85938560962677)","('Selling_Practices_And_Product_Labeling', 0.024622676894068718)","('Customer_Welfare', 0.019510917365550995)","(['Product Stewardship'], 0.85938560962677)","('NON-ESG', 0.024622676894068718)","('NON-ESG', 0.019510917365550995)"
Line 91,"REVENUE BY GEOGRAPHIC SEGMENT, 2020COMPANY OVERVIEW, 100+Products available in countries*50 ,000+ employees worldwide* 20+Manufacturing in countries*$38 million+ in charitable giving Clinical Nutrition$0.9 B Renal Care$3.8 B Pharmaceuticals$2.1 B Advanced Surgery$0.9 B Acute Therapies$0.7 B BioPharma Solutions$0.5 B Medication Delivery$2.7 B* As of December 31, 2020.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT7Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction INNOVATION At Baxter, we innovate to bring smarter, more  personalized care to the world.
","('Business_Model_Resilience', 0.2700977325439453)","('Product_Design_And_Lifecycle_Management', 0.26928210258483887)","('Customer_Welfare', 0.1197277382016182)","('NON-ESG', 0.2700977325439453)","('NON-ESG', 0.26928210258483887)","('NON-ESG', 0.1197277382016182)"
Line 92,"REVENUE BY GEOGRAPHIC SEGMENT, 2020COMPANY OVERVIEW, 100+Products available in countries*50 ,000+ employees worldwide* 20+Manufacturing in countries*$38 million+ in charitable giving Clinical Nutrition$0.9 B Renal Care$3.8 B Pharmaceuticals$2.1 B Advanced Surgery$0.9 B Acute Therapies$0.7 B BioPharma Solutions$0.5 B Medication Delivery$2.7 B* As of December 31, 2020.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT7Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction INNOVATION At Baxter, we innovate to bring smarter, more  personalized care to the world.
","('Employee_Health_And_Safety', 0.45429471135139465)","('Access_And_Affordability', 0.23569825291633606)","('Product_Quality_And_Safety', 0.043448030948638916)","('NON-ESG', 0.45429471135139465)","('NON-ESG', 0.23569825291633606)","('NON-ESG', 0.043448030948638916)"
Line 93,"Our investments  accelerate the introduction of new technologies and  therapies for patients and providers.
","('Access_And_Affordability', 0.6656959056854248)","('Customer_Welfare', 0.041230592876672745)","('Product_Quality_And_Safety', 0.04040868952870369)","(['Health Outcome Contribution'], 0.6656959056854248)","('NON-ESG', 0.041230592876672745)","('NON-ESG', 0.04040868952870369)"
Line 94,"These efforts are  bolstered by our partnerships with clinical experts,  leaders in digital health and the broader healthcare  industry who diversify our discovery process.
","('Business_Model_Resilience', 0.2028704732656479)","('Customer_Welfare', 0.1345949023962021)","('Competitive_Behavior', 0.0836411789059639)","('NON-ESG', 0.2028704732656479)","('NON-ESG', 0.1345949023962021)","('NON-ESG', 0.0836411789059639)"
Line 95,"Baxter’s  robust product pipeline will help clinicians be more  efficient and effective as they treat patients across  multiple care settings, including the hospital bedside,  operating room and intensive care unit as well as the  dialysis clinic and at home.
","('Customer_Welfare', 0.2895258367061615)","('Access_And_Affordability', 0.2628025412559509)","('Selling_Practices_And_Product_Labeling', 0.05607391521334648)","('NON-ESG', 0.2895258367061615)","('NON-ESG', 0.2628025412559509)","('NON-ESG', 0.05607391521334648)"
Line 96,"To fuel our next chapter, we are transforming the way we  operate by empowering our people to learn and innovate  at scale using digital technology.
","('Business_Model_Resilience', 0.31049439311027527)","('Product_Design_And_Lifecycle_Management', 0.30794137716293335)","('Employee_Engagement_Inclusion_And_Diversity', 0.08552587777376175)","('NON-ESG', 0.31049439311027527)","('NON-ESG', 0.30794137716293335)","('NON-ESG', 0.08552587777376175)"
Line 97,"Our goal is a company- wide digital operating model powering our people,  processes and products.
","('Product_Design_And_Lifecycle_Management', 0.8800371885299683)","('Business_Model_Resilience', 0.021267089992761612)","('Employee_Engagement_Inclusion_And_Diversity', 0.009326068684458733)","(['Product Stewardship'], 0.8800371885299683)","('NON-ESG', 0.021267089992761612)","('NON-ESG', 0.009326068684458733)"
Line 98,"This model will help us:  • Operate more efficiently and with increased agility • Open new avenues for revenue generation through  digital solutions • Improve access to relevant, real-time data to drive  effective decision-making  • Provide increased value to customers and earn  higher customer loyalty • Equip employees with the skills and tools they need  to thrive in our digital future   We continue partnering with others to find new ways  to personalize and increase access to care, improve  patient outcomes, prevent complications before they  become life-threatening and lessen the overall cost of  care.
","('Access_And_Affordability', 0.6888417601585388)","('Customer_Welfare', 0.061405908316373825)","('Employee_Engagement_Inclusion_And_Diversity', 0.02684762515127659)","(['Health Outcome Contribution'], 0.6888417601585388)","('NON-ESG', 0.061405908316373825)","('NON-ESG', 0.02684762515127659)"
Line 99,"This model will help us:  • Operate more efficiently and with increased agility • Open new avenues for revenue generation through  digital solutions • Improve access to relevant, real-time data to drive  effective decision-making  • Provide increased value to customers and earn  higher customer loyalty • Equip employees with the skills and tools they need  to thrive in our digital future   We continue partnering with others to find new ways  to personalize and increase access to care, improve  patient outcomes, prevent complications before they  become life-threatening and lessen the overall cost of  care.
","('Employee_Health_And_Safety', 0.8104456067085266)","('Access_And_Affordability', 0.03312448784708977)","('Critical_Incident_Risk_Management', 0.026673585176467896)","(['Operational Eco-Efficiency'], 0.8104456067085266)","('NON-ESG', 0.03312448784708977)","('NON-ESG', 0.026673585176467896)"
Line 100,"In 2021 and beyond, we expect to introduce several  innovations to improve care for patients around the  world, including expanded infusion pump offerings, new  developments in home dialysis, generic injectable drug  offerings in unique delivery platforms and more.Corporate responsibility is integral to Baxter’s  business strategy.
","('Customer_Welfare', 0.45327627658843994)","('Access_And_Affordability', 0.08450229465961456)","('Product_Design_And_Lifecycle_Management', 0.06319160014390945)","('NON-ESG', 0.45327627658843994)","('NON-ESG', 0.08450229465961456)","('NON-ESG', 0.06319160014390945)"
Line 101,"Throughout our history,  employees worldwide have championed our  company’s mission to save and sustain lives.
","('Employee_Health_And_Safety', 0.8898846507072449)","('Human_Rights_And_Community_Relations', 0.019957704469561577)","('Employee_Engagement_Inclusion_And_Diversity', 0.01795930042862892)","(['Operational Eco-Efficiency'], 0.8898846507072449)","('NON-ESG', 0.019957704469561577)","('NON-ESG', 0.01795930042862892)"
Line 102,"Our approach to corporate responsibility supports  our company’s goals to achieve top quartile  results relative to industry peers and other  comparators across four dimensions:  Patient safety and Quality   Growth through innovation  Best place to work  Industry-leading performance  This annual Corporate Responsibility Report illustrates  our commitment to sound governance and balanced,  transparent disclosure.
","('Business_Ethics', 0.31876835227012634)","('Management_Of_Legal_And_Regulatory_Framework', 0.26539409160614014)","('Product_Quality_And_Safety', 0.07954112440347672)","('NON-ESG', 0.31876835227012634)","('NON-ESG', 0.26539409160614014)","('NON-ESG', 0.07954112440347672)"
Line 103,"We have reported our  environmental performance for nearly 30 years and have  consistently broadened and enhanced our reporting on  the environmental, social and governance (ESG) issues  that are a priority to Baxter and our stakeholders.
","('Human_Rights_And_Community_Relations', 0.759502649307251)","('Business_Model_Resilience', 0.03714195266366005)","('Management_Of_Legal_And_Regulatory_Framework', 0.034221768379211426)","(['Community Relations'], 0.759502649307251)","('NON-ESG', 0.03714195266366005)","('NON-ESG', 0.034221768379211426)"
Line 104,"PERFORMANCE GOALS Setting goals across a broad range of corporate  responsibility issues demonstrates our commitment,  reinforces accountability and drives ongoing  improvement .
","('Human_Rights_And_Community_Relations', 0.7240927219390869)","('Management_Of_Legal_And_Regulatory_Framework', 0.03974511846899986)","('Business_Model_Resilience', 0.031514719128608704)","(['Community Relations'], 0.7240927219390869)","('NON-ESG', 0.03974511846899986)","('NON-ESG', 0.031514719128608704)"
Line 105,"This report states final progress against  Baxter’s 2020 Corporate Responsibility Priorities and  Goals , which cover the period from 2015–2020, with  additional details in the relevant report sections.
","('Business_Model_Resilience', 0.2703050971031189)","('Management_Of_Legal_And_Regulatory_Framework', 0.20203886926174164)","('Human_Rights_And_Community_Relations', 0.16568776965141296)","('NON-ESG', 0.2703050971031189)","('NON-ESG', 0.20203886926174164)","('NON-ESG', 0.16568776965141296)"
Line 106,"Corporate Responsibility BAXTER 2020 CORPORATE RESPONSIBILITY REPORT8Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction This report also introduces Baxter’s 2030 Corporate   Responsibility Commitment and Goals .
","('Human_Rights_And_Community_Relations', 0.2422613948583603)","('Business_Model_Resilience', 0.18084193766117096)","('Management_Of_Legal_And_Regulatory_Framework', 0.1041959747672081)","('NON-ESG', 0.2422613948583603)","('NON-ESG', 0.18084193766117096)","('NON-ESG', 0.1041959747672081)"
Line 107,"Anchored  by three pillars—Empower our Patients, Protect  our Planet, and Champion our People and  Communities—this commitment features a new  set of 10 goals.
","('Human_Rights_And_Community_Relations', 0.9104180335998535)","('Access_And_Affordability', 0.013700563460588455)","('Ecological_Impacts', 0.00796960573643446)","(['Community Relations'], 0.9104180335998535)","('NON-ESG', 0.013700563460588455)","('NON-ESG', 0.00796960573643446)"
Line 108,"Given the scale and scope of the  challenges we face as a society, we chose a 10-year  timeframe for most of these goals to advance  meaningful progress against substantive issues  throughout this critical decade.
","('Business_Model_Resilience', 0.3568103611469269)","('Human_Rights_And_Community_Relations', 0.23156651854515076)","('Physical_Impacts_Of_Climate_Change', 0.07558003067970276)","('NON-ESG', 0.3568103611469269)","('NON-ESG', 0.23156651854515076)","('NON-ESG', 0.07558003067970276)"
Line 109,"To prioritize action in the areas where we can have  the greatest positive impact, our goals align with  Baxter’s material corporate responsibility issues .
","('Human_Rights_And_Community_Relations', 0.6215430498123169)","('Business_Model_Resilience', 0.10078541934490204)","('Management_Of_Legal_And_Regulatory_Framework', 0.0438692532479763)","(['Community Relations'], 0.6215430498123169)","('NON-ESG', 0.10078541934490204)","('NON-ESG', 0.0438692532479763)"
Line 110,"In the coming year, we expect to conduct a new  materiality assessment and continue to evaluate the  importance of these issues to our stakeholders and  our impact across our value chain.
","('Business_Model_Resilience', 0.5735785961151123)","('Systemic_Risk_Management', 0.09211978316307068)","('Supply_Chain_Management', 0.08793820440769196)","(['Codes of Business Conduct'], 0.5735785961151123)","('NON-ESG', 0.09211978316307068)","('NON-ESG', 0.08793820440769196)"
Line 111,"This information  will inform the evolution of our 2030 goals.
","('Human_Rights_And_Community_Relations', 0.32606059312820435)","('Business_Model_Resilience', 0.12589962780475616)","('Management_Of_Legal_And_Regulatory_Framework', 0.11356347054243088)","('NON-ESG', 0.32606059312820435)","('NON-ESG', 0.12589962780475616)","('NON-ESG', 0.11356347054243088)"
Line 112,"We developed our 2030 goals through broad  engagement with Baxter executives, our Board  of Directors, subject matter experts across the  company, investors, nongovernmental organizations  and other external stakeholders.
","('Management_Of_Legal_And_Regulatory_Framework', 0.712184727191925)","('Human_Rights_And_Community_Relations', 0.08931455761194229)","('Director_Removal', 0.026111721992492676)","(['Corporate Governance'], 0.712184727191925)","('NON-ESG', 0.08931455761194229)","('NON-ESG', 0.026111721992492676)"
Line 113,"Industry and cross- industry benchmarking also informed the process.
","('Systemic_Risk_Management', 0.29321908950805664)","('Competitive_Behavior', 0.18357796967029572)","('Business_Model_Resilience', 0.1292182207107544)","('NON-ESG', 0.29321908950805664)","('NON-ESG', 0.18357796967029572)","('NON-ESG', 0.1292182207107544)"
Line 114,"In parallel, we are proud to affirm our support for  the United Nations Sustainable Development Goals  (UN SDGs) and 2030 Agenda—a global blueprint for  achieving a more sustainable future.
","('Human_Rights_And_Community_Relations', 0.4230385720729828)","('Business_Model_Resilience', 0.15597930550575256)","('Ecological_Impacts', 0.08342739194631577)","('NON-ESG', 0.4230385720729828)","('NON-ESG', 0.15597930550575256)","('NON-ESG', 0.08342739194631577)"
Line 115,"Our business  and corporate responsibility initiatives touch various  aspects of the UN SDGs, with a critical focus on:    GOAL 3: Good Health and Well-Being     GOAL 6: Clean Water and Sanitation     GOAL 12: Responsible Consumption and Production         ESG: DRIVING BUSINESS VALUE As a mission-driven company, our corporate  responsibility strategy focuses on delivering business  value by addressing the ESG issues that matter most  to our company and stakeholders.
","('Employee_Health_And_Safety', 0.3315063714981079)","('Water_And_Wastewater_Management', 0.14699386060237885)","('Access_And_Affordability', 0.12817899882793427)","('NON-ESG', 0.3315063714981079)","('NON-ESG', 0.14699386060237885)","('NON-ESG', 0.12817899882793427)"
Line 116,"Our strategy also  addresses the key risk factors that may impact the  long-term sustainability of our business.
","('Business_Model_Resilience', 0.5387727618217468)","('Systemic_Risk_Management', 0.22421634197235107)","('Supply_Chain_Management', 0.07661610096693039)","(['Codes of Business Conduct'], 0.5387727618217468)","('NON-ESG', 0.22421634197235107)","('NON-ESG', 0.07661610096693039)"
Line 117,"Following is a  representative sample of how advancing our corporate  responsibility goals contributes to business value:  Employee attraction and retention     We foster an  environment of inclusion and engagement with our  employees and listen carefully to their feedback.
","('Employee_Engagement_Inclusion_And_Diversity', 0.967345118522644)","('Employee_Health_And_Safety', 0.0042573148384690285)","('Human_Rights_And_Community_Relations', 0.0032053350005298853)","(['Human Capital Development'], 0.967345118522644)","('NON-ESG', 0.0042573148384690285)","('NON-ESG', 0.0032053350005298853)"
Line 118,"For example, we seek employee input on critical and  timely topics on an ad hoc basis and conduct annual  Best Place to Work surveys.
","('Management_Of_Legal_And_Regulatory_Framework', 0.39250099658966064)","('Human_Rights_And_Community_Relations', 0.08350297063589096)","('Access_And_Affordability', 0.06595248728990555)","('NON-ESG', 0.39250099658966064)","('NON-ESG', 0.08350297063589096)","('NON-ESG', 0.06595248728990555)"
Line 119,"(This survey was deferred  in 2020 due to COVID-19.) In addition, twice a year we  invite employees to provide feedback about their direct  managers in the areas of ethical standards, work  flexibility, inclusion, recognition and more.
","('Business_Ethics', 0.6006436944007874)","('Labor_Practices', 0.0685376226902008)","('Employee_Engagement_Inclusion_And_Diversity', 0.06689777970314026)","(['Business Ethics'], 0.6006436944007874)","('NON-ESG', 0.0685376226902008)","('NON-ESG', 0.06689777970314026)"
Line 120,"Based on  feedback from 25,000 employees in November 2020,   our overall manager effectiveness score was 82%—eight  percentage points above the top quartile benchmark.
","('Employee_Engagement_Inclusion_And_Diversity', 0.45549240708351135)","('Business_Model_Resilience', 0.06639903038740158)","('Labor_Practices', 0.05446301028132439)","('NON-ESG', 0.45549240708351135)","('NON-ESG', 0.06639903038740158)","('NON-ESG', 0.05446301028132439)"
Line 121,"See Transforming Company Culture .
","('Business_Model_Resilience', 0.2940388321876526)","('Employee_Engagement_Inclusion_And_Diversity', 0.25292396545410156)","('Product_Design_And_Lifecycle_Management', 0.06477279961109161)","('NON-ESG', 0.2940388321876526)","('NON-ESG', 0.25292396545410156)","('NON-ESG', 0.06477279961109161)"
Line 122,"Operational efficiency    We estimate that new projects  we initiated in 2020 to reduce product packaging will save  nearly $260,000 on an annualized basis.
","('Product_Design_And_Lifecycle_Management', 0.9179332256317139)","('Energy_Management', 0.031052663922309875)","('Product_Quality_And_Safety', 0.006887844763696194)","(['Product Stewardship'], 0.9179332256317139)","('NON-ESG', 0.031052663922309875)","('NON-ESG', 0.006887844763696194)"
Line 123,"During 2019 and  2020, we also implemented 340 energy conservation  projects.
","('Energy_Management', 0.9445822238922119)","('Management_Of_Legal_And_Regulatory_Framework', 0.01606743037700653)","('GHG_Emissions', 0.004154011607170105)","(['Operational Eco-Efficiency'], 0.9445822238922119)","('NON-ESG', 0.01606743037700653)","('NON-ESG', 0.004154011607170105)"
Line 124,"We estimate these projects saved 155 trillion  joules of energy and $4.1 million and avoided 13,600 metri c  tons carbon dioxide equivalent of greenhouse gas (GHG)  emissions during 2020.2 In addition, recycling at Baxter  generated $2.3 million in net income during the year .
","('GHG_Emissions', 0.9688376188278198)","('Ecological_Impacts', 0.0038510579615831375)","('Air_Quality', 0.0034078615717589855)","(['Climate Change'], 0.9688376188278198)","('NON-ESG', 0.0038510579615831375)","('NON-ESG', 0.0034078615717589855)"
Line 125,"See Packaging , Energy  and Waste .
","('Waste_And_Hazardous_Materials_Management', 0.9713225960731506)","('Product_Design_And_Lifecycle_Management', 0.003836986841633916)","('Water_And_Wastewater_Management', 0.002501006005331874)","(['Operational Eco-Efficiency'], 0.9713225960731506)","('NON-ESG', 0.003836986841633916)","('NON-ESG', 0.002501006005331874)"
Line 126,"License to operate    Maintaining global strategies and  programs to help ensure that we meet privacy regulations  such as the EU General Data Protection Regulation;  human rights-related legislation such as the California   PROTECTING HUMAN RIGHTS Human rights are foundational to Baxter's  corporate responsibility strategy.
","('Human_Rights_And_Community_Relations', 0.9497849345207214)","('Access_And_Affordability', 0.005712227895855904)","('Ecological_Impacts', 0.0036365685518831015)","(['Community Relations'], 0.9497849345207214)","('NON-ESG', 0.005712227895855904)","('NON-ESG', 0.0036365685518831015)"
Line 127,"We have  policies and processes in place to protect human  rights across our value chain, including the  rights of our suppliers’ workers, our employees,  our customers and the patients who rely on our  products.
","('Human_Rights_And_Community_Relations', 0.46161457896232605)","('Labor_Practices', 0.3235110938549042)","('Employee_Health_And_Safety', 0.043222684413194656)","('NON-ESG', 0.46161457896232605)","('NON-ESG', 0.3235110938549042)","('NON-ESG', 0.043222684413194656)"
Line 128,"As outlined in our Global Human Rights  Policy , we respect the human rights, dignity  and diverse contributions of all individuals.
","('Human_Rights_And_Community_Relations', 0.9591660499572754)","('Access_And_Affordability', 0.004269314929842949)","('Labor_Practices', 0.003415663493797183)","(['Community Relations'], 0.9591660499572754)","('NON-ESG', 0.004269314929842949)","('NON-ESG', 0.003415663493797183)"
Line 129,"Fostering human rights takes many forms at  our company and is reflected in our policies and  initiatives in areas including workplace inclusion ,  employee safety , supply chain labor practices ,  ethical conduct , access to healthcare , and  patient, employee and customer privacy .
","('Labor_Practices', 0.5779938697814941)","('Human_Rights_And_Community_Relations', 0.12824751436710358)","('Employee_Health_And_Safety', 0.09458518773317337)","(['Labor Practice Indicators'], 0.5779938697814941)","('NON-ESG', 0.12824751436710358)","('NON-ESG', 0.09458518773317337)"
Line 130,"Also  see information about our actions during 2020  related to COVID-19  and racial justice .
","('Employee_Engagement_Inclusion_And_Diversity', 0.8959877490997314)","('Human_Rights_And_Community_Relations', 0.021527331322431564)","('Business_Ethics', 0.008767283521592617)","(['Human Capital Development'], 0.8959877490997314)","('NON-ESG', 0.021527331322431564)","('NON-ESG', 0.008767283521592617)"
Line 131,"Transparency in Supply Chains Act of 2010; and  product materials restrictions such as the EU RoHS  Directive, EU REACH Regulation and EU Medical  Devices Regulation supports our continued access to  key markets.
","('Supply_Chain_Management', 0.7405027151107788)","('Product_Design_And_Lifecycle_Management', 0.029883526265621185)","('Management_Of_Legal_And_Regulatory_Framework', 0.026881609112024307)","(['Supply Chain Management'], 0.7405027151107788)","('NON-ESG', 0.029883526265621185)","('NON-ESG', 0.026881609112024307)"
Line 132,"See Privacy and Data Protection ,  Protecting Human Rights in Our Supply Chain  and  Materials of Concern .
","('Supply_Chain_Management', 0.8672792911529541)","('Human_Rights_And_Community_Relations', 0.023038828745484352)","('Labor_Practices', 0.019147465005517006)","(['Supply Chain Management'], 0.8672792911529541)","('NON-ESG', 0.023038828745484352)","('NON-ESG', 0.019147465005517006)"
Line 133,"Risk reduction    Ongoing reduction in product  complaints (down 19% compared with 2015) as  well as improvements on other quality-related  metrics enhances patient safety and decreases  risks of regulatory actions.
","('Product_Quality_And_Safety', 0.9054856300354004)","('Product_Design_And_Lifecycle_Management', 0.021966777741909027)","('Selling_Practices_And_Product_Labeling', 0.008491798304021358)","(['Product Quality & Recall Management'], 0.9054856300354004)","('NON-ESG', 0.021966777741909027)","('NON-ESG', 0.008491798304021358)"
Line 134,"We also identify and  manage climate-related risks as part of our global  risk management activities, implement a GHG  emissions-reduction strategy and build resiliency  across our supply chain.
","('GHG_Emissions', 0.7058245539665222)","('Supply_Chain_Management', 0.09038632363080978)","('Physical_Impacts_Of_Climate_Change', 0.05152464658021927)","(['Climate Change'], 0.7058245539665222)","('NON-ESG', 0.09038632363080978)","('NON-ESG', 0.05152464658021927)"
Line 135,"See Patient Safety and Quality   and GHG Emissions Across the Value Chain .BAXTER 2020 CORPORATE RESPONSIBILITY REPORT9Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Governance    ESG matters are subject to oversight  at the highest levels of Baxter, including our Senior  Leadership Team (whose annual incentive compensation  is tied, in part, to ESG metrics beginning in 2021) and  our Board of Directors (with two committees sharing  oversight for ESG matters).
","('GHG_Emissions', 0.9354777932167053)","('Air_Quality', 0.011487078852951527)","('Physical_Impacts_Of_Climate_Change', 0.005118923727422953)","(['Climate Change'], 0.9354777932167053)","('NON-ESG', 0.011487078852951527)","('NON-ESG', 0.005118923727422953)"
Line 136,"See Patient Safety and Quality   and GHG Emissions Across the Value Chain .BAXTER 2020 CORPORATE RESPONSIBILITY REPORT9Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Governance    ESG matters are subject to oversight  at the highest levels of Baxter, including our Senior  Leadership Team (whose annual incentive compensation  is tied, in part, to ESG metrics beginning in 2021) and  our Board of Directors (with two committees sharing  oversight for ESG matters).
","('Director_Removal', 0.36345672607421875)","('Management_Of_Legal_And_Regulatory_Framework', 0.26240983605384827)","('Business_Ethics', 0.08329436182975769)","('NON-ESG', 0.36345672607421875)","('NON-ESG', 0.26240983605384827)","('NON-ESG', 0.08329436182975769)"
Line 137,"The diversity of background  and experience represented by our Board of Directors  provides key insights for corporate responsibility  and strategic initiatives, operational performance  and financial control.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3587743639945984)","('Director_Removal', 0.3012768030166626)","('Business_Model_Resilience', 0.08083005994558334)","('NON-ESG', 0.3587743639945984)","('NON-ESG', 0.3012768030166626)","('NON-ESG', 0.08083005994558334)"
Line 138,"See  Corporate Responsibility  Governance and Management and Our Leadership .
","('Business_Model_Resilience', 0.27068498730659485)","('Management_Of_Legal_And_Regulatory_Framework', 0.16754086315631866)","('Human_Rights_And_Community_Relations', 0.14871399104595184)","('NON-ESG', 0.27068498730659485)","('NON-ESG', 0.16754086315631866)","('NON-ESG', 0.14871399104595184)"
Line 139,"Reputation    Maintaining high ethical standards,  ensuring strong labor and environmental practices in  our supply chain and supporting communities where  we have an operational presence all contribute to our  reputation as a leading corporate citizen.
","('Labor_Practices', 0.566909670829773)","('Supply_Chain_Management', 0.26690152287483215)","('Employee_Health_And_Safety', 0.023633228614926338)","(['Labor Practice Indicators'], 0.566909670829773)","('NON-ESG', 0.26690152287483215)","('NON-ESG', 0.023633228614926338)"
Line 140,"See Ethics and  Compliance , Responsible Procurement and Logistics ,  Serving Our Communities  and Recognition .
","('Business_Ethics', 0.9652611613273621)","('Management_Of_Legal_And_Regulatory_Framework', 0.006300694774836302)","('Product_Quality_And_Safety', 0.002664433093741536)","(['Business Ethics'], 0.9652611613273621)","('NON-ESG', 0.006300694774836302)","('NON-ESG', 0.002664433093741536)"
Line 141,"Revenue    Innovation to enhance patient safety and  product quality drives our ability to meet patient needs  and ultimately improve health outcomes.
","('Product_Quality_And_Safety', 0.7637540102005005)","('Product_Design_And_Lifecycle_Management', 0.08643312752246857)","('Selling_Practices_And_Product_Labeling', 0.029149269685149193)","(['Product Quality & Recall Management'], 0.7637540102005005)","('NON-ESG', 0.08643312752246857)","('NON-ESG', 0.029149269685149193)"
Line 142,"Customers  increasingly consider environmental and social  performance in proposal reviews and purchasing  decisions.
","('Human_Rights_And_Community_Relations', 0.3486272394657135)","('Business_Model_Resilience', 0.2098636031150818)","('Supply_Chain_Management', 0.08915926516056061)","('NON-ESG', 0.3486272394657135)","('NON-ESG', 0.2098636031150818)","('NON-ESG', 0.08915926516056061)"
Line 143,"In addition, our efforts to expand access to  care, particularly in the renal space for underserved  markets, unlock new opportunities for revenue growth.
","('Access_And_Affordability', 0.9486674666404724)","('Critical_Incident_Risk_Management', 0.004712033551186323)","('Product_Quality_And_Safety', 0.0042726811952888966)","(['Health Outcome Contribution'], 0.9486674666404724)","('NON-ESG', 0.004712033551186323)","('NON-ESG', 0.0042726811952888966)"
Line 144,"See Product Innovation  and Innovation That Expands  Access to Care .
","('Product_Design_And_Lifecycle_Management', 0.9089166522026062)","('Customer_Welfare', 0.013532760553061962)","('Supply_Chain_Management', 0.009030284360051155)","(['Product Stewardship'], 0.9089166522026062)","('NON-ESG', 0.013532760553061962)","('NON-ESG', 0.009030284360051155)"
Line 145,"CORPORATE RESPONSIBILITY  GOVERNANCE AND MANAGEMENT CORPORATE RESPONSIBILITY COUNCIL Baxter’s Corporate Responsibility Council is composed  of executives and subject matter experts from across  the company.
","('Management_Of_Legal_And_Regulatory_Framework', 0.47582098841667175)","('Human_Rights_And_Community_Relations', 0.16472625732421875)","('Business_Ethics', 0.0627622976899147)","('NON-ESG', 0.47582098841667175)","('NON-ESG', 0.16472625732421875)","('NON-ESG', 0.0627622976899147)"
Line 146,"The Council, which meets quarterly,  leads our efforts to integrate corporate responsibility  throughout our business and ensures high standards  of accountability for the management of our corporate  responsibility priorities and goals.
","('Human_Rights_And_Community_Relations', 0.37435436248779297)","('Management_Of_Legal_And_Regulatory_Framework', 0.15892404317855835)","('Business_Model_Resilience', 0.11082414537668228)","('NON-ESG', 0.37435436248779297)","('NON-ESG', 0.15892404317855835)","('NON-ESG', 0.11082414537668228)"
Line 147,"The Council’s role is to:  • Set and advance our corporate responsibility strategy  and culture  • Establish, implement and track progress against  our corporate responsibility priorities and goals (as  reviewed by our Board of Directors) • Provide oversight and drive organizational accountability  • Deliver regular progress updates to our Board of  Directors  • Solicit and review stakeholder input on Baxter's  corporate responsibility programs, priorities, goals  and disclosure, as well as broader industry trends  BOARD OF DIRECTORS OVERSIGHT  Our Board of Directors is playing an increased role in  corporate responsibility.
","('Human_Rights_And_Community_Relations', 0.2874144911766052)","('Management_Of_Legal_And_Regulatory_Framework', 0.22205525636672974)","('Director_Removal', 0.1010979562997818)","('NON-ESG', 0.2874144911766052)","('NON-ESG', 0.22205525636672974)","('NON-ESG', 0.1010979562997818)"
Line 148,"The Council’s role is to:  • Set and advance our corporate responsibility strategy  and culture  • Establish, implement and track progress against  our corporate responsibility priorities and goals (as  reviewed by our Board of Directors) • Provide oversight and drive organizational accountability  • Deliver regular progress updates to our Board of  Directors  • Solicit and review stakeholder input on Baxter's  corporate responsibility programs, priorities, goals  and disclosure, as well as broader industry trends  BOARD OF DIRECTORS OVERSIGHT  Our Board of Directors is playing an increased role in  corporate responsibility.
","('Director_Removal', 0.7239460945129395)","('Management_Of_Legal_And_Regulatory_Framework', 0.051172252744436264)","('Business_Ethics', 0.025001684203743935)","(['Anti-Crime Policy & Measures'], 0.7239460945129395)","('NON-ESG', 0.051172252744436264)","('NON-ESG', 0.025001684203743935)"
Line 149,"As of November 2020, the Quality,  Compliance and Technology (QCT) Committee and the  Nominating, Corporate Governance and Public Policy  (NCGPP) Committee  of our Board of Directors share  oversight for ESG-related matters.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7254964113235474)","('Director_Removal', 0.06818832457065582)","('Business_Ethics', 0.04289783164858818)","(['Corporate Governance'], 0.7254964113235474)","('NON-ESG', 0.06818832457065582)","('NON-ESG', 0.04289783164858818)"
Line 150,"The QCT Committee  GOVERNANCE AND MANAGEMENT OF CORPORATE RESPONSIBILITY AT BAXTERprovides oversight for issues related to environmental  sustainability and compliance, while the NCGPP  Committee provides oversight for other areas related to  Baxter’s corporate responsibility, including charitable  contributions, public policy, access to healthcare and  other social and governance issues.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7394242882728577)","('Human_Rights_And_Community_Relations', 0.08340026438236237)","('Business_Ethics', 0.0291107427328825)","(['Corporate Governance'], 0.7394242882728577)","('NON-ESG', 0.08340026438236237)","('NON-ESG', 0.0291107427328825)"
Line 151,"SENIOR LEADER ACCOUNTABILITY Beginning in 2021, the individual performance assessment  for our Senior Leadership Team under our annual  incentive plan will be determined in connection with an  assessment of our performance against pre-established  measures for strategic 2021 priorities, including those  related to ESG.
","('Business_Model_Resilience', 0.5763160586357117)","('Systemic_Risk_Management', 0.1011105477809906)","('Human_Rights_And_Community_Relations', 0.047664932906627655)","(['Codes of Business Conduct'], 0.5763160586357117)","('NON-ESG', 0.1011105477809906)","('NON-ESG', 0.047664932906627655)"
Line 152,"For example, these measures include:    • Patient safety and quality, including product safety  and quality systems • Best place to work, including diversity in the workforce,   culture, talent, Baxter’s ACT initiative, and environmental ,  health and safety measures • Growth through innovation, including our ongoing  digital transformation Chairman and CEO Executive Co-Sponsors   SVP and President, Americas and Global Business Units            SVP, Chief Supply Chain OfficerBoard of Directors   Quality, Compliance and Technology Committee            Nominating, Corporate Governance and Public Policy Committee Co-Chairs VP, Environment, Health, Safety and Sustainability            Senior Director, Global Community Relations Corporate Responsibility Council Members Corporate Responsibility Working GroupSVP, Global  CommunicationsVP, Investor  RelationsGeneral Manager,  Medication DeliveryGeneral Manager,  Renal Care Chief Procurement  Officer VP, Global Engineering and  Manufacturing Strategy VP, Global  Patient SafetyVP, HR—Americas,  GBUs, and R&DVP, Finance—Integrated  Supply Chain and QualityDeputy General Counsel and  Chief Compliance Officer VP, National and   Strategic AccountsSenior Director,  Product QualityBAXTER 2020 CORPORATE RESPONSIBILITY REPORT10Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Communities Shareholders Patients/ Healthcare  ProvidersGovernments/ PayersEmployeesSTAKEHOLDER ENGAGEMENT Baxter collaborates with a broad range of stakeholders to  inform our corporate responsibility strategy, priorities and  goals.
","('Product_Quality_And_Safety', 0.8465652465820312)","('Employee_Health_And_Safety', 0.05364859104156494)","('Product_Design_And_Lifecycle_Management', 0.016544252634048462)","(['Product Quality & Recall Management'], 0.8465652465820312)","('NON-ESG', 0.05364859104156494)","('NON-ESG', 0.016544252634048462)"
Line 153,"For example, these measures include:    • Patient safety and quality, including product safety  and quality systems • Best place to work, including diversity in the workforce,   culture, talent, Baxter’s ACT initiative, and environmental ,  health and safety measures • Growth through innovation, including our ongoing  digital transformation Chairman and CEO Executive Co-Sponsors   SVP and President, Americas and Global Business Units            SVP, Chief Supply Chain OfficerBoard of Directors   Quality, Compliance and Technology Committee            Nominating, Corporate Governance and Public Policy Committee Co-Chairs VP, Environment, Health, Safety and Sustainability            Senior Director, Global Community Relations Corporate Responsibility Council Members Corporate Responsibility Working GroupSVP, Global  CommunicationsVP, Investor  RelationsGeneral Manager,  Medication DeliveryGeneral Manager,  Renal Care Chief Procurement  Officer VP, Global Engineering and  Manufacturing Strategy VP, Global  Patient SafetyVP, HR—Americas,  GBUs, and R&DVP, Finance—Integrated  Supply Chain and QualityDeputy General Counsel and  Chief Compliance Officer VP, National and   Strategic AccountsSenior Director,  Product QualityBAXTER 2020 CORPORATE RESPONSIBILITY REPORT10Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Communities Shareholders Patients/ Healthcare  ProvidersGovernments/ PayersEmployeesSTAKEHOLDER ENGAGEMENT Baxter collaborates with a broad range of stakeholders to  inform our corporate responsibility strategy, priorities and  goals.
","('Business_Model_Resilience', 0.3316103518009186)","('Human_Rights_And_Community_Relations', 0.14421622455120087)","('Management_Of_Legal_And_Regulatory_Framework', 0.14352960884571075)","('NON-ESG', 0.3316103518009186)","('NON-ESG', 0.14421622455120087)","('NON-ESG', 0.14352960884571075)"
Line 154,"For example, these measures include:    • Patient safety and quality, including product safety  and quality systems • Best place to work, including diversity in the workforce,   culture, talent, Baxter’s ACT initiative, and environmental ,  health and safety measures • Growth through innovation, including our ongoing  digital transformation Chairman and CEO Executive Co-Sponsors   SVP and President, Americas and Global Business Units            SVP, Chief Supply Chain OfficerBoard of Directors   Quality, Compliance and Technology Committee            Nominating, Corporate Governance and Public Policy Committee Co-Chairs VP, Environment, Health, Safety and Sustainability            Senior Director, Global Community Relations Corporate Responsibility Council Members Corporate Responsibility Working GroupSVP, Global  CommunicationsVP, Investor  RelationsGeneral Manager,  Medication DeliveryGeneral Manager,  Renal Care Chief Procurement  Officer VP, Global Engineering and  Manufacturing Strategy VP, Global  Patient SafetyVP, HR—Americas,  GBUs, and R&DVP, Finance—Integrated  Supply Chain and QualityDeputy General Counsel and  Chief Compliance Officer VP, National and   Strategic AccountsSenior Director,  Product QualityBAXTER 2020 CORPORATE RESPONSIBILITY REPORT10Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Communities Shareholders Patients/ Healthcare  ProvidersGovernments/ PayersEmployeesSTAKEHOLDER ENGAGEMENT Baxter collaborates with a broad range of stakeholders to  inform our corporate responsibility strategy, priorities and  goals.
","('Product_Design_And_Lifecycle_Management', 0.583425760269165)","('Supply_Chain_Management', 0.1345127522945404)","('Product_Quality_And_Safety', 0.11903325468301773)","(['Product Stewardship'], 0.583425760269165)","('NON-ESG', 0.1345127522945404)","('NON-ESG', 0.11903325468301773)"
Line 155,"For example, these measures include:    • Patient safety and quality, including product safety  and quality systems • Best place to work, including diversity in the workforce,   culture, talent, Baxter’s ACT initiative, and environmental ,  health and safety measures • Growth through innovation, including our ongoing  digital transformation Chairman and CEO Executive Co-Sponsors   SVP and President, Americas and Global Business Units            SVP, Chief Supply Chain OfficerBoard of Directors   Quality, Compliance and Technology Committee            Nominating, Corporate Governance and Public Policy Committee Co-Chairs VP, Environment, Health, Safety and Sustainability            Senior Director, Global Community Relations Corporate Responsibility Council Members Corporate Responsibility Working GroupSVP, Global  CommunicationsVP, Investor  RelationsGeneral Manager,  Medication DeliveryGeneral Manager,  Renal Care Chief Procurement  Officer VP, Global Engineering and  Manufacturing Strategy VP, Global  Patient SafetyVP, HR—Americas,  GBUs, and R&DVP, Finance—Integrated  Supply Chain and QualityDeputy General Counsel and  Chief Compliance Officer VP, National and   Strategic AccountsSenior Director,  Product QualityBAXTER 2020 CORPORATE RESPONSIBILITY REPORT10Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Communities Shareholders Patients/ Healthcare  ProvidersGovernments/ PayersEmployeesSTAKEHOLDER ENGAGEMENT Baxter collaborates with a broad range of stakeholders to  inform our corporate responsibility strategy, priorities and  goals.
","('Human_Rights_And_Community_Relations', 0.7430765628814697)","('Business_Model_Resilience', 0.051190465688705444)","('Management_Of_Legal_And_Regulatory_Framework', 0.027070028707385063)","(['Community Relations'], 0.7430765628814697)","('NON-ESG', 0.051190465688705444)","('NON-ESG', 0.027070028707385063)"
Line 156,"We identify and engage with stakeholders based on  their expertise, level of influence, willingness to collaborate,  impact on Baxter and our company's impact on them.
","('Employee_Engagement_Inclusion_And_Diversity', 0.2353915423154831)","('Human_Rights_And_Community_Relations', 0.18631693720817566)","('Business_Model_Resilience', 0.18355530500411987)","('NON-ESG', 0.2353915423154831)","('NON-ESG', 0.18631693720817566)","('NON-ESG', 0.18355530500411987)"
Line 157,"We continue to see increased interest in ESG matters  across our stakeholder groups.
","('Business_Model_Resilience', 0.5379689335823059)","('Systemic_Risk_Management', 0.08132335543632507)","('Management_Of_Legal_And_Regulatory_Framework', 0.0596310980618)","(['Codes of Business Conduct'], 0.5379689335823059)","('NON-ESG', 0.08132335543632507)","('NON-ESG', 0.0596310980618)"
Line 158,"With these topics  growing in importance for many audiences, we work to  consistently improve the quality of information we share  and how we provide that information.
","('Customer_Privacy', 0.24256840348243713)","('Management_Of_Legal_And_Regulatory_Framework', 0.10250076651573181)","('Access_And_Affordability', 0.09143514931201935)","('NON-ESG', 0.24256840348243713)","('NON-ESG', 0.10250076651573181)","('NON-ESG', 0.09143514931201935)"
Line 159,"During 2020, in response to interest from our investors  and other stakeholders and to further increase  transparency in our reporting, we published our first  disclosure based on the Sustainability Accounting  Standards Board (SASB) Medical Equipment and Supplies  Sustainability Accounting Standard.
","('Business_Ethics', 0.8506333827972412)","('Management_Of_Legal_And_Regulatory_Framework', 0.03204786404967308)","('Systemic_Risk_Management', 0.026237407699227333)","(['Business Ethics'], 0.8506333827972412)","('NON-ESG', 0.03204786404967308)","('NON-ESG', 0.026237407699227333)"
Line 160,"Our second SASB  disclosure  is included in this report, and we plan to  continue publishing SASB disclosures annually in future  Corporate Responsibility Reports.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5031486749649048)","('Business_Model_Resilience', 0.10054497420787811)","('Systemic_Risk_Management', 0.0525495819747448)","(['Corporate Governance'], 0.5031486749649048)","('NON-ESG', 0.10054497420787811)","('NON-ESG', 0.0525495819747448)"
Line 161,"We are assessing the potential of disclosing against additional frameworks   that are valuable to our stakeholders, such as the  Task Force on Climate-related Financial Disclosures.
","('Physical_Impacts_Of_Climate_Change', 0.9410845041275024)","('Business_Model_Resilience', 0.012557470239698887)","('GHG_Emissions', 0.007252100855112076)","(['Climate Change'], 0.9410845041275024)","('NON-ESG', 0.012557470239698887)","('NON-ESG', 0.007252100855112076)"
Line 162,"Furthermore, in early 2021, Baxter joined the Global  Reporting Initiative (GRI) Business Leadership Forum on  “Corporate Reporting as a Driver for Achieving the SDGs”  to inform our strategy and support of the SDGs. MATERIALITY To understand and prioritize issues that are critical  to the long-term sustainability of our business, we  periodically conduct assessments to identify the corporate  responsibility issues that are most relevant to Baxter  and our stakeholders.
","('Business_Model_Resilience', 0.32827407121658325)","('Human_Rights_And_Community_Relations', 0.2673836946487427)","('Systemic_Risk_Management', 0.04487524926662445)","('NON-ESG', 0.32827407121658325)","('NON-ESG', 0.2673836946487427)","('NON-ESG', 0.04487524926662445)"
Line 163,"Outcomes from these ongoing  assessments inform our corporate responsibility strategy,  commitment and goals.
","('Human_Rights_And_Community_Relations', 0.663444995880127)","('Management_Of_Legal_And_Regulatory_Framework', 0.07427053898572922)","('Business_Model_Resilience', 0.057319823652505875)","(['Community Relations'], 0.663444995880127)","('NON-ESG', 0.07427053898572922)","('NON-ESG', 0.057319823652505875)"
Line 164,"See a list of our  material corporate  responsibility issues  (as defined during our 2018  assessment) and their impacts across our value chain .
","('Human_Rights_And_Community_Relations', 0.3241809606552124)","('Business_Model_Resilience', 0.26280584931373596)","('Management_Of_Legal_And_Regulatory_Framework', 0.07131229341030121)","('NON-ESG', 0.3241809606552124)","('NON-ESG', 0.26280584931373596)","('NON-ESG', 0.07131229341030121)"
Line 165,"For more information about the process we undertook and  the key findings of that assessment, see page 6 of our   2018 Corporate Responsibility Report .
","('Management_Of_Legal_And_Regulatory_Framework', 0.3841889798641205)","('Human_Rights_And_Community_Relations', 0.2044350653886795)","('Business_Model_Resilience', 0.09489567577838898)","('NON-ESG', 0.3841889798641205)","('NON-ESG', 0.2044350653886795)","('NON-ESG', 0.09489567577838898)"
Line 166,"We expect to  conduct a new materiality assessment in the near future.BAXTER’S FIVE PRIMARY STAKEHOLDER GROUPS CORPORATE GOVERNANCE RESOURCES Visit Baxter’s Our Governance  webpage for  information and links related to:  • Corporate Governance Guidelines • Board Committees and Charters • Code of Conduct • Securities Trading Policy • Ethics and Compliance Helpline Our Ethics and Compliance  webpage includes  links to additional standards and policies for  our employees and suppliers that help us drive  a culture of integrity and ethical behavior.
","('Business_Ethics', 0.9428747892379761)","('Management_Of_Legal_And_Regulatory_Framework', 0.02143019251525402)","('Director_Removal', 0.003971824422478676)","(['Business Ethics'], 0.9428747892379761)","('NON-ESG', 0.02143019251525402)","('NON-ESG', 0.003971824422478676)"
Line 167,"We expect to  conduct a new materiality assessment in the near future.BAXTER’S FIVE PRIMARY STAKEHOLDER GROUPS CORPORATE GOVERNANCE RESOURCES Visit Baxter’s Our Governance  webpage for  information and links related to:  • Corporate Governance Guidelines • Board Committees and Charters • Code of Conduct • Securities Trading Policy • Ethics and Compliance Helpline Our Ethics and Compliance  webpage includes  links to additional standards and policies for  our employees and suppliers that help us drive  a culture of integrity and ethical behavior.
","('Business_Ethics', 0.925836443901062)","('Competitive_Behavior', 0.007452352438122034)","('Customer_Privacy', 0.006011122837662697)","(['Business Ethics'], 0.925836443901062)","('NON-ESG', 0.007452352438122034)","('NON-ESG', 0.006011122837662697)"
Line 168,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORT11Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction WORKPLACE   CULTURE Promote inclusion,   diversity and   employee engagement EMPLOYEE HEALTH  AND SAFETY  Achieve a zero-harm  workplace and improve  employee well-beingETHICS AND  COMPLIANCE   Drive a culture of  integrity and the highest  ethical behaviorPRODUCT  INNOVATION  Improve sustainability  and performance of  products and services BAXTER 2020 CORPORATE RESPONSIBILITY REPORT 11PRIORITIES GOALS PROGRESS THROUGH 2020 STATUS Our 2020 corporate responsibility priorities and goals support Baxter's top quartile goals, which include:Patient safety  and QualityGrowth through  innovationBest place  to workIndustry-leading  performanceAspire to diversity in leadership at or  above benchmarks  Achieve an employee engagement score  comparable to top quartile companies as  measured by Baxter’s Best Place to Work survey Drive highest integrity and compliance to  achieve zero government enforcement actions  over compliance issues  Achieve overall compliance culture scores in the  top quartile of general industry benchmarks  Achieve the top quartile in total recordable  incident rate among global companies across all  industries as measured by ORC HSEWe have eliminated 2,128 metric tons of packaging material from products shipped  to customers since 2016,1 including 149 metric tons in 2020.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9158480167388916)","('Employee_Health_And_Safety', 0.03199440613389015)","('Human_Rights_And_Community_Relations', 0.005996407940983772)","(['Human Capital Development'], 0.9158480167388916)","('NON-ESG', 0.03199440613389015)","('NON-ESG', 0.005996407940983772)"
Line 169,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORT11Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction WORKPLACE   CULTURE Promote inclusion,   diversity and   employee engagement EMPLOYEE HEALTH  AND SAFETY  Achieve a zero-harm  workplace and improve  employee well-beingETHICS AND  COMPLIANCE   Drive a culture of  integrity and the highest  ethical behaviorPRODUCT  INNOVATION  Improve sustainability  and performance of  products and services BAXTER 2020 CORPORATE RESPONSIBILITY REPORT 11PRIORITIES GOALS PROGRESS THROUGH 2020 STATUS Our 2020 corporate responsibility priorities and goals support Baxter's top quartile goals, which include:Patient safety  and QualityGrowth through  innovationBest place  to workIndustry-leading  performanceAspire to diversity in leadership at or  above benchmarks  Achieve an employee engagement score  comparable to top quartile companies as  measured by Baxter’s Best Place to Work survey Drive highest integrity and compliance to  achieve zero government enforcement actions  over compliance issues  Achieve overall compliance culture scores in the  top quartile of general industry benchmarks  Achieve the top quartile in total recordable  incident rate among global companies across all  industries as measured by ORC HSEWe have eliminated 2,128 metric tons of packaging material from products shipped  to customers since 2016,1 including 149 metric tons in 2020.
","('Business_Ethics', 0.3626887798309326)","('Product_Quality_And_Safety', 0.19957806169986725)","('Human_Rights_And_Community_Relations', 0.04977161064743996)","('NON-ESG', 0.3626887798309326)","('NON-ESG', 0.19957806169986725)","('NON-ESG', 0.04977161064743996)"
Line 170,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORT11Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction WORKPLACE   CULTURE Promote inclusion,   diversity and   employee engagement EMPLOYEE HEALTH  AND SAFETY  Achieve a zero-harm  workplace and improve  employee well-beingETHICS AND  COMPLIANCE   Drive a culture of  integrity and the highest  ethical behaviorPRODUCT  INNOVATION  Improve sustainability  and performance of  products and services BAXTER 2020 CORPORATE RESPONSIBILITY REPORT 11PRIORITIES GOALS PROGRESS THROUGH 2020 STATUS Our 2020 corporate responsibility priorities and goals support Baxter's top quartile goals, which include:Patient safety  and QualityGrowth through  innovationBest place  to workIndustry-leading  performanceAspire to diversity in leadership at or  above benchmarks  Achieve an employee engagement score  comparable to top quartile companies as  measured by Baxter’s Best Place to Work survey Drive highest integrity and compliance to  achieve zero government enforcement actions  over compliance issues  Achieve overall compliance culture scores in the  top quartile of general industry benchmarks  Achieve the top quartile in total recordable  incident rate among global companies across all  industries as measured by ORC HSEWe have eliminated 2,128 metric tons of packaging material from products shipped  to customers since 2016,1 including 149 metric tons in 2020.
","('Business_Ethics', 0.8430562615394592)","('Critical_Incident_Risk_Management', 0.043727319687604904)","('Employee_Health_And_Safety', 0.017873603850603104)","(['Business Ethics'], 0.8430562615394592)","('NON-ESG', 0.043727319687604904)","('NON-ESG', 0.017873603850603104)"
Line 171,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORT11Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction WORKPLACE   CULTURE Promote inclusion,   diversity and   employee engagement EMPLOYEE HEALTH  AND SAFETY  Achieve a zero-harm  workplace and improve  employee well-beingETHICS AND  COMPLIANCE   Drive a culture of  integrity and the highest  ethical behaviorPRODUCT  INNOVATION  Improve sustainability  and performance of  products and services BAXTER 2020 CORPORATE RESPONSIBILITY REPORT 11PRIORITIES GOALS PROGRESS THROUGH 2020 STATUS Our 2020 corporate responsibility priorities and goals support Baxter's top quartile goals, which include:Patient safety  and QualityGrowth through  innovationBest place  to workIndustry-leading  performanceAspire to diversity in leadership at or  above benchmarks  Achieve an employee engagement score  comparable to top quartile companies as  measured by Baxter’s Best Place to Work survey Drive highest integrity and compliance to  achieve zero government enforcement actions  over compliance issues  Achieve overall compliance culture scores in the  top quartile of general industry benchmarks  Achieve the top quartile in total recordable  incident rate among global companies across all  industries as measured by ORC HSEWe have eliminated 2,128 metric tons of packaging material from products shipped  to customers since 2016,1 including 149 metric tons in 2020.
","('Product_Design_And_Lifecycle_Management', 0.9299795627593994)","('Energy_Management', 0.011283216997981071)","('Selling_Practices_And_Product_Labeling', 0.008399546146392822)","(['Product Stewardship'], 0.9299795627593994)","('NON-ESG', 0.011283216997981071)","('NON-ESG', 0.008399546146392822)"
Line 172,"Baxter screens all new products under development and changes existing products   and processes to eliminate or reduce chemicals of concern.
","('Product_Design_And_Lifecycle_Management', 0.9405468702316284)","('Product_Quality_And_Safety', 0.012273876927793026)","('Selling_Practices_And_Product_Labeling', 0.010013172402977943)","(['Product Stewardship'], 0.9405468702316284)","('NON-ESG', 0.012273876927793026)","('NON-ESG', 0.010013172402977943)"
Line 173,"During 2020, this  included non-DEHP product launches in all regions.
","('Product_Design_And_Lifecycle_Management', 0.9140657186508179)","('Customer_Welfare', 0.01860882341861725)","('Product_Quality_And_Safety', 0.01158074289560318)","(['Product Stewardship'], 0.9140657186508179)","('NON-ESG', 0.01860882341861725)","('NON-ESG', 0.01158074289560318)"
Line 174,"As of the end of 2020, 377 hospitals and facilities had recycling programs for  some of Baxter’s products, exceeding our goal.
","('Product_Design_And_Lifecycle_Management', 0.9574182629585266)","('Product_Quality_And_Safety', 0.005421267822384834)","('Selling_Practices_And_Product_Labeling', 0.004328558221459389)","(['Product Stewardship'], 0.9574182629585266)","('NON-ESG', 0.005421267822384834)","('NON-ESG', 0.004328558221459389)"
Line 175,"During 2020, we remained at or above external benchmarks for women (globally)  and ethnic minority representation (in the United States) at most career levels.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9755427241325378)","('Human_Rights_And_Community_Relations', 0.002142552752047777)","('Labor_Practices', 0.0015705311670899391)","(['Human Capital Development'], 0.9755427241325378)","('NON-ESG', 0.002142552752047777)","('NON-ESG', 0.0015705311670899391)"
Line 176,"We  continue to work toward closing gender and ethnic minority gaps at executive levels.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9749221205711365)","('Human_Rights_And_Community_Relations', 0.002027049195021391)","('Customer_Privacy', 0.0016486708773300052)","(['Human Capital Development'], 0.9749221205711365)","('NON-ESG', 0.002027049195021391)","('NON-ESG', 0.0016486708773300052)"
Line 177,"Due to the COVID-19 pandemic, we did not conduct our annual Best Place to Work  (BPTW) survey in 2020.
","('Physical_Impacts_Of_Climate_Change', 0.3751301169395447)","('Air_Quality', 0.10569067299365997)","('Systemic_Risk_Management', 0.0848781019449234)","('NON-ESG', 0.3751301169395447)","('NON-ESG', 0.10569067299365997)","('NON-ESG', 0.0848781019449234)"
Line 178,"Results from this survey determine our employee  engagement score, which rose steadily each year from 2016 to 2019 (and was three  percentage points below the top quartile benchmark in 2019).
","('Employee_Engagement_Inclusion_And_Diversity', 0.911784827709198)","('Employee_Health_And_Safety', 0.012003125622868538)","('Human_Rights_And_Community_Relations', 0.009153746999800205)","(['Human Capital Development'], 0.911784827709198)","('NON-ESG', 0.012003125622868538)","('NON-ESG', 0.009153746999800205)"
Line 179,"We continue to  prioritize engagement with our employees.
","('Employee_Engagement_Inclusion_And_Diversity', 0.32439836859703064)","('Human_Rights_And_Community_Relations', 0.10618750005960464)","('Business_Ethics', 0.09161502122879028)","('NON-ESG', 0.32439836859703064)","('NON-ESG', 0.10618750005960464)","('NON-ESG', 0.09161502122879028)"
Line 180,"Baxter had zero corruption-related enforcement actions from 2016 through 2020 .
","('Business_Ethics', 0.9669438004493713)","('Management_Of_Legal_And_Regulatory_Framework', 0.00468163937330246)","('Data_Security', 0.002589595038443804)","(['Business Ethics'], 0.9669438004493713)","('NON-ESG', 0.00468163937330246)","('NON-ESG', 0.002589595038443804)"
Line 181,"Baxter did not conduct a BPTW survey in 2020.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7029215097427368)","('GHG_Emissions', 0.054835278540849686)","('Access_And_Affordability', 0.03062303550541401)","(['Corporate Governance'], 0.7029215097427368)","('NON-ESG', 0.054835278540849686)","('NON-ESG', 0.03062303550541401)"
Line 182,"However, BPTW survey results from 2016  to 2019 demonstrated consistent improvement in the area of ethics and compliance.
","('Business_Ethics', 0.9613335132598877)","('Management_Of_Legal_And_Regulatory_Framework', 0.005961269605904818)","('Product_Quality_And_Safety', 0.004149696324020624)","(['Business Ethics'], 0.9613335132598877)","('NON-ESG', 0.005961269605904818)","('NON-ESG', 0.004149696324020624)"
Line 183,"In 2019, the scores for the two questions related to ethics culture were one percentage  point above and two percentage points below top quartile companies, respectively.
","('Business_Ethics', 0.9406222105026245)","('Systemic_Risk_Management', 0.007263866253197193)","('Product_Quality_And_Safety', 0.00610354682430625)","(['Business Ethics'], 0.9406222105026245)","('NON-ESG', 0.007263866253197193)","('NON-ESG', 0.00610354682430625)"
Line 184,"Reduce employee health risk by increasing  participation from 35% to 45% in BeWell@Baxter  health promotion program initiatives and by  expanding family participationWe achieved 49% participation across the BeWell@Baxter initiatives, exceeding  our goal of 45%.In a comparison of 23 companies globally across all industries,2 Baxter's total recordable  incident rate during 2020 ranked thirteenth.
","('Employee_Health_And_Safety', 0.9668611288070679)","('Critical_Incident_Risk_Management', 0.010029401630163193)","('Product_Quality_And_Safety', 0.001820147386752069)","(['Operational Eco-Efficiency'], 0.9668611288070679)","('NON-ESG', 0.010029401630163193)","('NON-ESG', 0.001820147386752069)"
Line 185,"Although we did not achieve top quartile  performance in 2020, we did in 2018 and 2019.Achieved Achieved Achieved Achieved AchievedAchieve at least 15% material reduction on three  therapies/products compared to those currently  on the market, without affecting efficacy Eliminate 3,000 metric tons of packaging material  from Baxter products shipped to customers Eliminate or minimize the presence of  chemicals of concern (as defined by regulations)  in new products Partner with organizations to implement  recycling of product waste at hospitals and  increase participation from 60 hospitals to 200Since 2015, Baxter has launched six therapies/products that reduced materials  use by at least 15%, exceeding our goal.
","('Product_Design_And_Lifecycle_Management', 0.92058926820755)","('Selling_Practices_And_Product_Labeling', 0.014173374511301517)","('Product_Quality_And_Safety', 0.013752195984125137)","(['Product Stewardship'], 0.92058926820755)","('NON-ESG', 0.014173374511301517)","('NON-ESG', 0.013752195984125137)"
Line 186,"Although we did not achieve top quartile  performance in 2020, we did in 2018 and 2019.Achieved Achieved Achieved Achieved AchievedAchieve at least 15% material reduction on three  therapies/products compared to those currently  on the market, without affecting efficacy Eliminate 3,000 metric tons of packaging material  from Baxter products shipped to customers Eliminate or minimize the presence of  chemicals of concern (as defined by regulations)  in new products Partner with organizations to implement  recycling of product waste at hospitals and  increase participation from 60 hospitals to 200Since 2015, Baxter has launched six therapies/products that reduced materials  use by at least 15%, exceeding our goal.
","('Waste_And_Hazardous_Materials_Management', 0.9698851108551025)","('Product_Design_And_Lifecycle_Management', 0.004599913954734802)","('Employee_Health_And_Safety', 0.0023049490991979837)","(['Operational Eco-Efficiency'], 0.9698851108551025)","('NON-ESG', 0.004599913954734802)","('NON-ESG', 0.0023049490991979837)"
Line 187,"Not achieved Not achieved Not achievedAchievedEnhance product quality and patient safety by  achieving a 15% reduction in product complaints,  compared to 2015 (aggregate)The company achieved a 19% decrease in product complaints compared with 2015.
","('Product_Quality_And_Safety', 0.9084305763244629)","('Product_Design_And_Lifecycle_Management', 0.01404457539319992)","('Selling_Practices_And_Product_Labeling', 0.010950231924653053)","(['Product Quality & Recall Management'], 0.9084305763244629)","('NON-ESG', 0.01404457539319992)","('NON-ESG', 0.010950231924653053)"
Line 188,"Baxter's 2020 Corporate Responsibility Priorities and Goals  This table summarizes progress on our 2020 goals, which were introduced in the 2015 Baxter Corporate Responsibility Report.
","('Business_Model_Resilience', 0.3123903274536133)","('Human_Rights_And_Community_Relations', 0.2606812119483948)","('Management_Of_Legal_And_Regulatory_Framework', 0.09192731976509094)","('NON-ESG', 0.3123903274536133)","('NON-ESG', 0.2606812119483948)","('NON-ESG', 0.09192731976509094)"
Line 189,"The baseline is 2015 unless otherwise stated.
","('Management_Of_Legal_And_Regulatory_Framework', 0.253630131483078)","('GHG_Emissions', 0.23958592116832733)","('Competitive_Behavior', 0.10857483744621277)","('NON-ESG', 0.253630131483078)","('NON-ESG', 0.23958592116832733)","('NON-ESG', 0.10857483744621277)"
Line 190,"Unavailable UnavailableBAXTER 2020 CORPORATE RESPONSIBILITY REPORT12Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction OPERATIONS  Reduce environmental  footprint through  increased efficiency  and resource  conservation RESPONSIBLE  PROCUREMENT  AND LOGISTICS   Implement world- class sustainability  practices with   key partners INNOVATION  THAT EXPANDS  ACCESS TO CARE Improve access   to healthcare for   the underserved SERVING OUR  COMMUNITIES   Support communities  worldwide in  enduring waysReduce total energy and water use and total  waste generation by 15% indexed to revenue Reduce absolute greenhouse gas (GHG)  emissions by 10%Pursue zero waste-to-landfill by achieving   a landfill diversion rate of 95% or higher at all  manufacturing locations Increase Baxter’s spending with diverse  suppliers by 50%, from 4% of relevant spending  in 2015 to 6% in 20203  Expand green transport partnerships with  government agencies, nongovernmental  organizations and/or private companies from one  business region to all business regions globally Proactively pre-position Baxter’s donated  products with donor partners, which will enable  them to optimally distribute and be first on  scene to address critical medical needs Establish the Baxter International Foundation  Partnership Grant program in 2016 to drive  increased access to healthcare for an incremental  10,000 patients annually Launch two new emerging market business  models in Baxter’s renal business Complete two projects, including one by 2018,  that support access to clean water or enhance  sanitation in water-stressed areas where Baxter  has an operational presenceThrough 2020, Baxter reduced energy use, water use and waste generation by  8.2%, 10.4% and 14.7%, respectively, compared with 2015 and indexed to revenue.
","('Product_Design_And_Lifecycle_Management', 0.5534058809280396)","('Business_Model_Resilience', 0.09739966690540314)","('Supply_Chain_Management', 0.09036678820848465)","(['Product Stewardship'], 0.5534058809280396)","('NON-ESG', 0.09739966690540314)","('NON-ESG', 0.09036678820848465)"
Line 191,"Unavailable UnavailableBAXTER 2020 CORPORATE RESPONSIBILITY REPORT12Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction OPERATIONS  Reduce environmental  footprint through  increased efficiency  and resource  conservation RESPONSIBLE  PROCUREMENT  AND LOGISTICS   Implement world- class sustainability  practices with   key partners INNOVATION  THAT EXPANDS  ACCESS TO CARE Improve access   to healthcare for   the underserved SERVING OUR  COMMUNITIES   Support communities  worldwide in  enduring waysReduce total energy and water use and total  waste generation by 15% indexed to revenue Reduce absolute greenhouse gas (GHG)  emissions by 10%Pursue zero waste-to-landfill by achieving   a landfill diversion rate of 95% or higher at all  manufacturing locations Increase Baxter’s spending with diverse  suppliers by 50%, from 4% of relevant spending  in 2015 to 6% in 20203  Expand green transport partnerships with  government agencies, nongovernmental  organizations and/or private companies from one  business region to all business regions globally Proactively pre-position Baxter’s donated  products with donor partners, which will enable  them to optimally distribute and be first on  scene to address critical medical needs Establish the Baxter International Foundation  Partnership Grant program in 2016 to drive  increased access to healthcare for an incremental  10,000 patients annually Launch two new emerging market business  models in Baxter’s renal business Complete two projects, including one by 2018,  that support access to clean water or enhance  sanitation in water-stressed areas where Baxter  has an operational presenceThrough 2020, Baxter reduced energy use, water use and waste generation by  8.2%, 10.4% and 14.7%, respectively, compared with 2015 and indexed to revenue.
","('Waste_And_Hazardous_Materials_Management', 0.8713113069534302)","('Water_And_Wastewater_Management', 0.03206244856119156)","('GHG_Emissions', 0.01593783125281334)","(['Operational Eco-Efficiency'], 0.8713113069534302)","('NON-ESG', 0.03206244856119156)","('NON-ESG', 0.01593783125281334)"
Line 192,"Unavailable UnavailableBAXTER 2020 CORPORATE RESPONSIBILITY REPORT12Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction OPERATIONS  Reduce environmental  footprint through  increased efficiency  and resource  conservation RESPONSIBLE  PROCUREMENT  AND LOGISTICS   Implement world- class sustainability  practices with   key partners INNOVATION  THAT EXPANDS  ACCESS TO CARE Improve access   to healthcare for   the underserved SERVING OUR  COMMUNITIES   Support communities  worldwide in  enduring waysReduce total energy and water use and total  waste generation by 15% indexed to revenue Reduce absolute greenhouse gas (GHG)  emissions by 10%Pursue zero waste-to-landfill by achieving   a landfill diversion rate of 95% or higher at all  manufacturing locations Increase Baxter’s spending with diverse  suppliers by 50%, from 4% of relevant spending  in 2015 to 6% in 20203  Expand green transport partnerships with  government agencies, nongovernmental  organizations and/or private companies from one  business region to all business regions globally Proactively pre-position Baxter’s donated  products with donor partners, which will enable  them to optimally distribute and be first on  scene to address critical medical needs Establish the Baxter International Foundation  Partnership Grant program in 2016 to drive  increased access to healthcare for an incremental  10,000 patients annually Launch two new emerging market business  models in Baxter’s renal business Complete two projects, including one by 2018,  that support access to clean water or enhance  sanitation in water-stressed areas where Baxter  has an operational presenceThrough 2020, Baxter reduced energy use, water use and waste generation by  8.2%, 10.4% and 14.7%, respectively, compared with 2015 and indexed to revenue.
","('Product_Design_And_Lifecycle_Management', 0.49820035696029663)","('Customer_Welfare', 0.10407720506191254)","('Product_Quality_And_Safety', 0.08743331581354141)","('NON-ESG', 0.49820035696029663)","('NON-ESG', 0.10407720506191254)","('NON-ESG', 0.08743331581354141)"
Line 193,"Unavailable UnavailableBAXTER 2020 CORPORATE RESPONSIBILITY REPORT12Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction OPERATIONS  Reduce environmental  footprint through  increased efficiency  and resource  conservation RESPONSIBLE  PROCUREMENT  AND LOGISTICS   Implement world- class sustainability  practices with   key partners INNOVATION  THAT EXPANDS  ACCESS TO CARE Improve access   to healthcare for   the underserved SERVING OUR  COMMUNITIES   Support communities  worldwide in  enduring waysReduce total energy and water use and total  waste generation by 15% indexed to revenue Reduce absolute greenhouse gas (GHG)  emissions by 10%Pursue zero waste-to-landfill by achieving   a landfill diversion rate of 95% or higher at all  manufacturing locations Increase Baxter’s spending with diverse  suppliers by 50%, from 4% of relevant spending  in 2015 to 6% in 20203  Expand green transport partnerships with  government agencies, nongovernmental  organizations and/or private companies from one  business region to all business regions globally Proactively pre-position Baxter’s donated  products with donor partners, which will enable  them to optimally distribute and be first on  scene to address critical medical needs Establish the Baxter International Foundation  Partnership Grant program in 2016 to drive  increased access to healthcare for an incremental  10,000 patients annually Launch two new emerging market business  models in Baxter’s renal business Complete two projects, including one by 2018,  that support access to clean water or enhance  sanitation in water-stressed areas where Baxter  has an operational presenceThrough 2020, Baxter reduced energy use, water use and waste generation by  8.2%, 10.4% and 14.7%, respectively, compared with 2015 and indexed to revenue.
","('Water_And_Wastewater_Management', 0.9679116010665894)","('Energy_Management', 0.003945381846278906)","('GHG_Emissions', 0.0021199469920247793)","(['Operational Eco-Efficiency'], 0.9679116010665894)","('NON-ESG', 0.003945381846278906)","('NON-ESG', 0.0021199469920247793)"
Line 194,"Through 2020, we reduced our absolute GHG emissions from operations by 13.6%  compared with 2015, exceeding our goal.In 2020, 25 out of 51 manufacturing facilities achieved landfill diversion  rates of 95% or more.
","('GHG_Emissions', 0.9661662578582764)","('Air_Quality', 0.005587782710790634)","('Ecological_Impacts', 0.002983507700264454)","(['Climate Change'], 0.9661662578582764)","('NON-ESG', 0.005587782710790634)","('NON-ESG', 0.002983507700264454)"
Line 195,"Baxter increased purchases with diverse suppliers to 5.6% of relevant spending  during 2020.
","('Supply_Chain_Management', 0.7863419055938721)","('Product_Design_And_Lifecycle_Management', 0.08538015186786652)","('Customer_Welfare', 0.019546519964933395)","(['Supply Chain Management'], 0.7863419055938721)","('NON-ESG', 0.08538015186786652)","('NON-ESG', 0.019546519964933395)"
Line 196,"As of the end of 2020, Baxter was participating in green transport partnerships  in all three regions, achieving our goal.
","('Human_Rights_And_Community_Relations', 0.14623932540416718)","('Business_Model_Resilience', 0.1414225846529007)","('Management_Of_Legal_And_Regulatory_Framework', 0.11997442692518234)","('NON-ESG', 0.14623932540416718)","('NON-ESG', 0.1414225846529007)","('NON-ESG', 0.11997442692518234)"
Line 197,"In 2020, we also joined two global  initiatives focused on responsible logistics: Clean Cargo and the Global Logistics  Emissions Council.
","('Energy_Management', 0.3513641059398651)","('Product_Design_And_Lifecycle_Management', 0.0906064584851265)","('Supply_Chain_Management', 0.08930406719446182)","('NON-ESG', 0.3513641059398651)","('NON-ESG', 0.0906064584851265)","('NON-ESG', 0.08930406719446182)"
Line 198,"In 2016, Baxter launched a manufacture-to-donate program, an industry best practice,  to pre-position our products and increase our humanitarian partners’ response  capacity.
","('Product_Design_And_Lifecycle_Management', 0.9623891115188599)","('Product_Quality_And_Safety', 0.005074341781437397)","('Customer_Welfare', 0.0036609286908060312)","(['Product Stewardship'], 0.9623891115188599)","('NON-ESG', 0.005074341781437397)","('NON-ESG', 0.0036609286908060312)"
Line 199,"In 2020, Baxter donated products valued at $24 million.
","('Product_Design_And_Lifecycle_Management', 0.8704173564910889)","('Customer_Welfare', 0.027741124853491783)","('Selling_Practices_And_Product_Labeling', 0.014685512520372868)","(['Product Stewardship'], 0.8704173564910889)","('NON-ESG', 0.027741124853491783)","('NON-ESG', 0.014685512520372868)"
Line 200,"Additionally, our  partners distributed our products across 67 countries in response to natural disasters,  COVID-19 and to support ongoing humanitarian aid and medical missions.
","('Critical_Incident_Risk_Management', 0.9042012095451355)","('Physical_Impacts_Of_Climate_Change', 0.014265463687479496)","('Human_Rights_And_Community_Relations', 0.012724833562970161)","(['Risk & Crisis Management'], 0.9042012095451355)","('NON-ESG', 0.014265463687479496)","('NON-ESG', 0.012724833562970161)"
Line 201,"From 2016 through 2020, we have helped support six Signature Partnerships  benefiting hundreds of thousands of people and families globally, exceeding  our goal.
","('Access_And_Affordability', 0.5920684933662415)","('Human_Rights_And_Community_Relations', 0.21089673042297363)","('Employee_Engagement_Inclusion_And_Diversity', 0.033536914736032486)","(['Health Outcome Contribution'], 0.5920684933662415)","('NON-ESG', 0.21089673042297363)","('NON-ESG', 0.033536914736032486)"
Line 202,"From 2016 through 2020, we established three Baxter Renal Care Services  clinics  in emerging markets—one in Indonesia and two in China.
","('Access_And_Affordability', 0.4899497628211975)","('Customer_Welfare', 0.10000903904438019)","('Product_Quality_And_Safety', 0.033251240849494934)","('NON-ESG', 0.4899497628211975)","('NON-ESG', 0.10000903904438019)","('NON-ESG', 0.033251240849494934)"
Line 203,"These clinics operate  under two distinct business models.
","('Competitive_Behavior', 0.2505933344364166)","('Employee_Engagement_Inclusion_And_Diversity', 0.09218685328960419)","('Customer_Welfare', 0.0902223214507103)","('NON-ESG', 0.2505933344364166)","('NON-ESG', 0.09218685328960419)","('NON-ESG', 0.0902223214507103)"
Line 204,"We have implemented two projects in support of this goal: a partnership with  Fundación Solar in Guatemala (established 2017) and Project Srujal in Ahmedabad,  India (established 2018), achieving our goal.AchievedAchieved Achieved Achieved Achieved AchievedPRIORITIES GOALS PROGRESS THROUGH 2020 STATUS Not achievedNot achieved Not achieved BAXTER 2020 CORPORATE RESPONSIBILITY REPORT 12Our 2020 corporate responsibility priorities and goals support Baxter's top quartile goals, which include:Patient safety  and QualityGrowth through  innovationBest place  to workIndustry-leading  performanceBaxter's 2020 Corporate Responsibility Priorities and Goals  This table summarizes progress on our 2020 goals, which were introduced in the 2015 Baxter Corporate Responsibility Report.
","('Product_Quality_And_Safety', 0.796016275882721)","('Employee_Health_And_Safety', 0.04496750980615616)","('Access_And_Affordability', 0.021806340664625168)","(['Product Quality & Recall Management'], 0.796016275882721)","('NON-ESG', 0.04496750980615616)","('NON-ESG', 0.021806340664625168)"
Line 205,"We have implemented two projects in support of this goal: a partnership with  Fundación Solar in Guatemala (established 2017) and Project Srujal in Ahmedabad,  India (established 2018), achieving our goal.AchievedAchieved Achieved Achieved Achieved AchievedPRIORITIES GOALS PROGRESS THROUGH 2020 STATUS Not achievedNot achieved Not achieved BAXTER 2020 CORPORATE RESPONSIBILITY REPORT 12Our 2020 corporate responsibility priorities and goals support Baxter's top quartile goals, which include:Patient safety  and QualityGrowth through  innovationBest place  to workIndustry-leading  performanceBaxter's 2020 Corporate Responsibility Priorities and Goals  This table summarizes progress on our 2020 goals, which were introduced in the 2015 Baxter Corporate Responsibility Report.
","('Business_Model_Resilience', 0.3538984954357147)","('Human_Rights_And_Community_Relations', 0.23359991610050201)","('Management_Of_Legal_And_Regulatory_Framework', 0.0652114674448967)","('NON-ESG', 0.3538984954357147)","('NON-ESG', 0.23359991610050201)","('NON-ESG', 0.0652114674448967)"
Line 206,"The baseline is 2015 unless otherwise stated.BAXTER 2020 CORPORATE RESPONSIBILITY REPORTProduct  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Baxter's 2030 Corporate Responsibility Commitment and Goals  The baseline is 2020 unless otherwise stated.
","('Business_Model_Resilience', 0.2478400319814682)","('Human_Rights_And_Community_Relations', 0.1239316388964653)","('Management_Of_Legal_And_Regulatory_Framework', 0.1052330881357193)","('NON-ESG', 0.2478400319814682)","('NON-ESG', 0.1239316388964653)","('NON-ESG', 0.1052330881357193)"
Line 207,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORT 13Double the number of  patients reached  in underserved markets * through our  peritoneal dialysis (PD) portfolio .
","('Access_And_Affordability', 0.9429442882537842)","('Product_Quality_And_Safety', 0.005166986957192421)","('Energy_Management', 0.00503363274037838)","(['Health Outcome Contribution'], 0.9429442882537842)","('NON-ESG', 0.005166986957192421)","('NON-ESG', 0.00503363274037838)"
Line 208,"*Countries outside of the United States, Canada, Western  Europe, Japan, Korea, Australia and New Zealand.
","('Management_Of_Legal_And_Regulatory_Framework', 0.29368722438812256)","('Competitive_Behavior', 0.1466030776500702)","('Business_Model_Resilience', 0.07812844961881638)","('NON-ESG', 0.29368722438812256)","('NON-ESG', 0.1466030776500702)","('NON-ESG', 0.07812844961881638)"
Line 209,"Achieve a 10% year-over-year  improvement in manufacturing process  capability for prioritized products.
","('Product_Design_And_Lifecycle_Management', 0.9655394554138184)","('Product_Quality_And_Safety', 0.004488625563681126)","('Energy_Management', 0.00331078446470201)","(['Product Stewardship'], 0.9655394554138184)","('NON-ESG', 0.004488625563681126)","('NON-ESG', 0.00331078446470201)"
Line 210,"*  *As measured by the year-over-year decrease in defect  rate until each product’s process capability goal is met.
","('Product_Design_And_Lifecycle_Management', 0.6912478804588318)","('Product_Quality_And_Safety', 0.11656656116247177)","('Supply_Chain_Management', 0.02693643979728222)","(['Product Stewardship'], 0.6912478804588318)","('NON-ESG', 0.11656656116247177)","('NON-ESG', 0.02693643979728222)"
Line 211,"(Baseline is 2021.) EMPOWER OUR PATIENTS Invest in innovative initiatives,   products and therapies   that tackle barriers to safe   and quality healthcare SUPPORTING THE UNITED NATIONS   SUSTAINABLE DEVELOPMENT GOALS  GOAL 3: Good Health and Well-Being     GOAL 6: Clean Water and Sanitation     GOAL 12: Responsible Consumption    and Production            Invest $275 million in underserved    communities through strategic partnerships   and product donations from Baxter and  the Baxter International Foundation.
","('Access_And_Affordability', 0.9125774502754211)","('Employee_Health_And_Safety', 0.00947907380759716)","('Human_Rights_And_Community_Relations', 0.008793270215392113)","(['Health Outcome Contribution'], 0.9125774502754211)","('NON-ESG', 0.00947907380759716)","('NON-ESG', 0.008793270215392113)"
Line 212,"(Baseline is 2021.) EMPOWER OUR PATIENTS Invest in innovative initiatives,   products and therapies   that tackle barriers to safe   and quality healthcare SUPPORTING THE UNITED NATIONS   SUSTAINABLE DEVELOPMENT GOALS  GOAL 3: Good Health and Well-Being     GOAL 6: Clean Water and Sanitation     GOAL 12: Responsible Consumption    and Production            Invest $275 million in underserved    communities through strategic partnerships   and product donations from Baxter and  the Baxter International Foundation.
","('Competitive_Behavior', 0.11920864135026932)","('Business_Model_Resilience', 0.08340361714363098)","('Employee_Engagement_Inclusion_And_Diversity', 0.07986214756965637)","('NON-ESG', 0.11920864135026932)","('NON-ESG', 0.08340361714363098)","('NON-ESG', 0.07986214756965637)"
Line 213,"Achieve top quartile workplace safety  performance annually in total recordable  incident rate.
","('Employee_Health_And_Safety', 0.9479807615280151)","('Critical_Incident_Risk_Management', 0.025480547919869423)","('Air_Quality', 0.002397061325609684)","(['Operational Eco-Efficiency'], 0.9479807615280151)","('NON-ESG', 0.025480547919869423)","('NON-ESG', 0.002397061325609684)"
Line 214,"*  *Among global companies across industries as reported   by the U.S. Bureau of Labor Statistics.
","('Labor_Practices', 0.9694324731826782)","('Director_Removal', 0.0027546235360205173)","('Supply_Chain_Management', 0.0025796769186854362)","(['Labor Practice Indicators'], 0.9694324731826782)","('NON-ESG', 0.0027546235360205173)","('NON-ESG', 0.0025796769186854362)"
Line 215,"Through hiring, promotion and retention,  aspire to increase representation of women  in leadership roles globally to 40%.
","('Employee_Engagement_Inclusion_And_Diversity', 0.969190776348114)","('Labor_Practices', 0.0036087927874177694)","('Employee_Health_And_Safety', 0.002159248339012265)","(['Human Capital Development'], 0.969190776348114)","('NON-ESG', 0.0036087927874177694)","('NON-ESG', 0.002159248339012265)"
Line 216,"*  *Assuming labor market conditions continue to support   the goal.
","('Labor_Practices', 0.973861575126648)","('Supply_Chain_Management', 0.0024535618722438812)","('Director_Removal', 0.002325876150280237)","(['Labor Practice Indicators'], 0.973861575126648)","('NON-ESG', 0.0024535618722438812)","('NON-ESG', 0.002325876150280237)"
Line 217,"Leadership role is defined as director and above.
","('Director_Removal', 0.5628933310508728)","('Employee_Engagement_Inclusion_And_Diversity', 0.07572504878044128)","('Business_Model_Resilience', 0.05048665031790733)","(['Anti-Crime Policy & Measures'], 0.5628933310508728)","('NON-ESG', 0.07572504878044128)","('NON-ESG', 0.05048665031790733)"
Line 218,"Through hiring, promotion and retention,  aspire to increase representation of  ethnic minorities in leadership roles in  the United States to 25%.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9767568707466125)","('Human_Rights_And_Community_Relations', 0.0016100441571325064)","('Employee_Health_And_Safety', 0.001579509349539876)","(['Human Capital Development'], 0.9767568707466125)","('NON-ESG', 0.0016100441571325064)","('NON-ESG', 0.001579509349539876)"
Line 219,"* *Assuming labor market conditions continue to support   the goal.
","('Labor_Practices', 0.973861575126648)","('Supply_Chain_Management', 0.0024535618722438812)","('Director_Removal', 0.002325876150280237)","(['Labor Practice Indicators'], 0.973861575126648)","('NON-ESG', 0.0024535618722438812)","('NON-ESG', 0.002325876150280237)"
Line 220,"Leadership role is defined as director and above.
","('Director_Removal', 0.5628933310508728)","('Employee_Engagement_Inclusion_And_Diversity', 0.07572504878044128)","('Business_Model_Resilience', 0.05048665031790733)","(['Anti-Crime Policy & Measures'], 0.5628933310508728)","('NON-ESG', 0.07572504878044128)","('NON-ESG', 0.05048665031790733)"
Line 221,"CHAMPION OUR PEOPLE AND  COMMUNITIES Create a best place to work   for our employees and make    a meaningful difference in   communities around the world Achieve carbon neutrality for our direct  operations by 2040 and reduce absolute  Scope 1 and 2 greenhouse gas emissions  25% by 2030, aligned with a well-below   2⁰ Celsius science-based target.
","('GHG_Emissions', 0.9632822871208191)","('Air_Quality', 0.0058948202058672905)","('Ecological_Impacts', 0.003784044412896037)","(['Climate Change'], 0.9632822871208191)","('NON-ESG', 0.0058948202058672905)","('NON-ESG', 0.003784044412896037)"
Line 222,"Implement strategic water management  plans at prioritized manufacturing locations.
","('Water_And_Wastewater_Management', 0.9760580658912659)","('GHG_Emissions', 0.002498253248631954)","('Ecological_Impacts', 0.002108276356011629)","(['Operational Eco-Efficiency'], 0.9760580658912659)","('NON-ESG', 0.002498253248631954)","('NON-ESG', 0.002108276356011629)"
Line 223,"*  *Identify prioritized locations using a risk-based approach   by the end of 2023.
","('Systemic_Risk_Management', 0.8843581080436707)","('Business_Model_Resilience', 0.03747481852769852)","('Physical_Impacts_Of_Climate_Change', 0.012581915594637394)","(['Risk & Crisis Management'], 0.8843581080436707)","('NON-ESG', 0.03747481852769852)","('NON-ESG', 0.012581915594637394)"
Line 224,"Integrate Baxter's sustainable procurement  strategy across 90% of our supplier spend.
","('Supply_Chain_Management', 0.8765280246734619)","('Product_Design_And_Lifecycle_Management', 0.03881534934043884)","('Energy_Management', 0.008220926858484745)","(['Supply Chain Management'], 0.8765280246734619)","('NON-ESG', 0.03881534934043884)","('NON-ESG', 0.008220926858484745)"
Line 225,"*   *As measured by supplier commitment to Baxter's Supplier  Code of Conduct and Baxter’s completion of corporate  responsibility audits.
","('Supply_Chain_Management', 0.9391334652900696)","('Labor_Practices', 0.007077591959387064)","('Water_And_Wastewater_Management', 0.003969315439462662)","(['Supply Chain Management'], 0.9391334652900696)","('NON-ESG', 0.007077591959387064)","('NON-ESG', 0.003969315439462662)"
Line 226,"Implement prioritized waste mitigation  opportunities * in Baxter's integrated supply  chain, from procurement to distribution.
","('Waste_And_Hazardous_Materials_Management', 0.9481979012489319)","('Supply_Chain_Management', 0.01001507043838501)","('Water_And_Wastewater_Management', 0.0057762302458286285)","(['Operational Eco-Efficiency'], 0.9481979012489319)","('NON-ESG', 0.01001507043838501)","('NON-ESG', 0.0057762302458286285)"
Line 227,"*Identify prioritized waste generation sources by the   end of 2024.
","('Waste_And_Hazardous_Materials_Management', 0.9805012941360474)","('Water_And_Wastewater_Management', 0.002422333462163806)","('Air_Quality', 0.001986515009775758)","(['Operational Eco-Efficiency'], 0.9805012941360474)","('NON-ESG', 0.002422333462163806)","('NON-ESG', 0.001986515009775758)"
Line 228,"PROTECT OUR PLANET Prioritize operational excellence   and environmental stewardship   across our value chain ETHICS AND COMPLIANCE      •     HUMAN RIGHTS      •     INCLUSION AND DIVERSITY      •     PRIVACY AND DATA PROTECTIONBAXTER 2020 CORPORATE RESPONSIBILITY REPORT14Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture Apex Companies LLC has provided assurance on the content in this section (except the Patient Safety and Quality subsection).
","('Business_Ethics', 0.9231042861938477)","('Data_Security', 0.01181282103061676)","('Product_Quality_And_Safety', 0.007645456586033106)","(['Business Ethics'], 0.9231042861938477)","('NON-ESG', 0.01181282103061676)","('NON-ESG', 0.007645456586033106)"
Line 229,"PROTECT OUR PLANET Prioritize operational excellence   and environmental stewardship   across our value chain ETHICS AND COMPLIANCE      •     HUMAN RIGHTS      •     INCLUSION AND DIVERSITY      •     PRIVACY AND DATA PROTECTIONBAXTER 2020 CORPORATE RESPONSIBILITY REPORT14Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture Apex Companies LLC has provided assurance on the content in this section (except the Patient Safety and Quality subsection).
","('Product_Quality_And_Safety', 0.594189465045929)","('Employee_Health_And_Safety', 0.26447442173957825)","('Access_And_Affordability', 0.015339173376560211)","(['Product Quality & Recall Management'], 0.594189465045929)","('NON-ESG', 0.26447442173957825)","('NON-ESG', 0.015339173376560211)"
Line 230,"PATIENT SAFETY AND QUALITY Baxter’s commitment to patient safety and quality  is unwavering, and both are fundamental to  fulfilling our mission.
","('Product_Quality_And_Safety', 0.6280739307403564)","('Employee_Health_And_Safety', 0.1617911458015442)","('Access_And_Affordability', 0.023400040343403816)","(['Product Quality & Recall Management'], 0.6280739307403564)","('NON-ESG', 0.1617911458015442)","('NON-ESG', 0.023400040343403816)"
Line 231,"We have extensive policies  and processes to ensure excellence in these areas,  and we continue to innovate new products and  services that enhance patient safety and drive  improved patient outcomes.
","('Product_Quality_And_Safety', 0.7860535383224487)","('Product_Design_And_Lifecycle_Management', 0.0638640820980072)","('Customer_Welfare', 0.023224089294672012)","(['Product Quality & Recall Management'], 0.7860535383224487)","('NON-ESG', 0.0638640820980072)","('NON-ESG', 0.023224089294672012)"
Line 232,"We take a holistic,  innovative approach to quality across the product  life cycle, and our commitment to continuous  improvement builds on decades of insight.
","('Product_Design_And_Lifecycle_Management', 0.9637927412986755)","('Product_Quality_And_Safety', 0.004310435615479946)","('Business_Model_Resilience', 0.003190600546076894)","(['Product Stewardship'], 0.9637927412986755)","('NON-ESG', 0.004310435615479946)","('NON-ESG', 0.003190600546076894)"
Line 233,"Product Innovation  Improve sustainability and performance of products and services 2020 HIGHLIGHTS Baxter develops products that save and sustain lives worldwide, delivering on our  mission and representing our most important contribution to society.
","('Product_Design_And_Lifecycle_Management', 0.9690649509429932)","('Product_Quality_And_Safety', 0.0039110807701945305)","('Selling_Practices_And_Product_Labeling', 0.0023338866885751486)","(['Product Stewardship'], 0.9690649509429932)","('NON-ESG', 0.0039110807701945305)","('NON-ESG', 0.0023338866885751486)"
Line 234,"Our commitment  to patient-centered safety and quality is integral to innovations that improve the  experiences of patients and caregivers who use our products.
","('Product_Quality_And_Safety', 0.5728768110275269)","('Product_Design_And_Lifecycle_Management', 0.19946178793907166)","('Customer_Welfare', 0.05372500419616699)","(['Product Quality & Recall Management'], 0.5728768110275269)","('NON-ESG', 0.19946178793907166)","('NON-ESG', 0.05372500419616699)"
Line 235,"By integrating  sustainability into our product development approach, we consider the full life cycle  of our products from design through end-of-life.
","('Product_Design_And_Lifecycle_Management', 0.9636145830154419)","('Product_Quality_And_Safety', 0.0038103805854916573)","('Business_Model_Resilience', 0.0028888441156595945)","(['Product Stewardship'], 0.9636145830154419)","('NON-ESG', 0.0038103805854916573)","('NON-ESG', 0.0028888441156595945)"
Line 236,"INTEGRATED APPROACH TO PATIENT SAFETY AND QUALITY BAXTER 2020 CORPORATE RESPONSIBILITY REPORT 14Patient Safety and  Product QualityFacility Quality  and Control Quality Systems Performancereduction in  product  complaints*19% hospitals and facilities  with recycling programs  for some of Baxter's  productsproducts launched  since 2015 that  reduce materials  use by at least 15%*Compared with 2015.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT15Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture As of the end  of 2020, we had  reduced product  complaints by 19%  compared with  2015 (surpassing  our goal of a 15%  reduction) and made strides in several other areas  over the same timeframe (see graphic above).
","('Product_Quality_And_Safety', 0.7193690538406372)","('Product_Design_And_Lifecycle_Management', 0.16558675467967987)","('Employee_Health_And_Safety', 0.013799268752336502)","(['Product Quality & Recall Management'], 0.7193690538406372)","('NON-ESG', 0.16558675467967987)","('NON-ESG', 0.013799268752336502)"
Line 237,"INTEGRATED APPROACH TO PATIENT SAFETY AND QUALITY BAXTER 2020 CORPORATE RESPONSIBILITY REPORT 14Patient Safety and  Product QualityFacility Quality  and Control Quality Systems Performancereduction in  product  complaints*19% hospitals and facilities  with recycling programs  for some of Baxter's  productsproducts launched  since 2015 that  reduce materials  use by at least 15%*Compared with 2015.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT15Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture As of the end  of 2020, we had  reduced product  complaints by 19%  compared with  2015 (surpassing  our goal of a 15%  reduction) and made strides in several other areas  over the same timeframe (see graphic above).
","('Product_Quality_And_Safety', 0.7926772236824036)","('Employee_Health_And_Safety', 0.05418543890118599)","('Product_Design_And_Lifecycle_Management', 0.05076895281672478)","(['Product Quality & Recall Management'], 0.7926772236824036)","('NON-ESG', 0.05418543890118599)","('NON-ESG', 0.05076895281672478)"
Line 238,"With  this report, we have expanded our data summary to  include information about product recalls.
","('Selling_Practices_And_Product_Labeling', 0.4863602817058563)","('Product_Quality_And_Safety', 0.2888956069946289)","('Product_Design_And_Lifecycle_Management', 0.04513239488005638)","('NON-ESG', 0.4863602817058563)","('NON-ESG', 0.2888956069946289)","('NON-ESG', 0.04513239488005638)"
Line 239,"Collaboration within our company and with regulators  helps ensure quality across the product life cycle.
","('Product_Design_And_Lifecycle_Management', 0.9192229509353638)","('Product_Quality_And_Safety', 0.017337165772914886)","('Customer_Welfare', 0.01158818881958723)","(['Product Stewardship'], 0.9192229509353638)","('NON-ESG', 0.017337165772914886)","('NON-ESG', 0.01158818881958723)"
Line 240,"Key strategies of our multifaceted approach include:   Manufacturing standards     We established a global  initiative in 2020 to help us maintain and improve  quality standards across our manufacturing sites.
","('Product_Quality_And_Safety', 0.5281829237937927)","('Business_Ethics', 0.14453594386577606)","('Management_Of_Legal_And_Regulatory_Framework', 0.06165121868252754)","(['Product Quality & Recall Management'], 0.5281829237937927)","('NON-ESG', 0.14453594386577606)","('NON-ESG', 0.06165121868252754)"
Line 241,"This initiative focuses on three primary areas:  the physical facilities, critical systems used in the  manufacturing of our products and mechanisms to  ensure a continual state of control.
","('Product_Design_And_Lifecycle_Management', 0.9625335335731506)","('Product_Quality_And_Safety', 0.004466495476663113)","('Supply_Chain_Management', 0.0034676892682909966)","(['Product Stewardship'], 0.9625335335731506)","('NON-ESG', 0.004466495476663113)","('NON-ESG', 0.0034676892682909966)"
Line 242,"By improving  our process controls to address potential issues  upstream, we can optimize our production lines and  the effectiveness of equipment, minimize scrap and  rework, and more consistently release high-quality  products into the marketplace.Internal reviews    We employ multifunctional governing  and operating mechanisms that aid us in performing  in-depth technical evaluations, identifying necessary  improvements to individual products and implementing  those improvements across the globe.
","('Product_Design_And_Lifecycle_Management', 0.9616137742996216)","('Product_Quality_And_Safety', 0.007393332198262215)","('Selling_Practices_And_Product_Labeling', 0.0028938723262399435)","(['Product Stewardship'], 0.9616137742996216)","('NON-ESG', 0.007393332198262215)","('NON-ESG', 0.0028938723262399435)"
Line 243,"Our robust  strategic reviews provide our cross-functional  leadership  with improved visibility and a greater understanding  of product safety and quality performance across the  entire portfolio.
","('Product_Quality_And_Safety', 0.9210029244422913)","('Employee_Health_And_Safety', 0.012199641205370426)","('Product_Design_And_Lifecycle_Management', 0.008959125727415085)","(['Product Quality & Recall Management'], 0.9210029244422913)","('NON-ESG', 0.012199641205370426)","('NON-ESG', 0.008959125727415085)"
Line 244,"Resolution of Warning Letters     Since 2015, we have  worked to resolve five U.S. Food and Drug Administration  (FDA) Warning Letters covering six facilities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4159983992576599)","('Product_Quality_And_Safety', 0.1779894232749939)","('Selling_Practices_And_Product_Labeling', 0.0693880096077919)","('NON-ESG', 0.4159983992576599)","('NON-ESG', 0.1779894232749939)","('NON-ESG', 0.0693880096077919)"
Line 245,"We have  one remaining Warning Letter, issued in July 2018,  relating to the Ahmedabad, India, facility we acquired  from Claris Injectables in July 2017.
","('Product_Quality_And_Safety', 0.15958163142204285)","('Selling_Practices_And_Product_Labeling', 0.11690572649240494)","('Energy_Management', 0.1123671755194664)","('NON-ESG', 0.15958163142204285)","('NON-ESG', 0.11690572649240494)","('NON-ESG', 0.1123671755194664)"
Line 246,"We Listen Patients Healthcare providers Regulators Suppliers Manufacturing  Innovation and trendsWe Deliver Product changes  Performance Ease of use Convenience Education For patients For caregiversProduct  Development  and Innovation Existing product  improvements New productsIn 2020, drawing on a wide range of internal and external inputs and management processes and systems, we implemented  thousands of improvements to Baxter products.
","('Product_Design_And_Lifecycle_Management', 0.9645252227783203)","('Product_Quality_And_Safety', 0.005086574703454971)","('Customer_Welfare', 0.0036241442430764437)","(['Product Stewardship'], 0.9645252227783203)","('NON-ESG', 0.005086574703454971)","('NON-ESG', 0.0036241442430764437)"
Line 247,"These improvements helped enhance product performance and reliability and  increase convenience and ease of use to drive improved patient safety.
","('Product_Quality_And_Safety', 0.6619475483894348)","('Product_Design_And_Lifecycle_Management', 0.19510366022586823)","('Selling_Practices_And_Product_Labeling', 0.019421441480517387)","(['Product Quality & Recall Management'], 0.6619475483894348)","('NON-ESG', 0.19510366022586823)","('NON-ESG', 0.019421441480517387)"
Line 248,"PRODUCT QUALITY METRICS: PROGRESS FROM 2015 TO 2020 *  * ""Complaints"" are any allegations related to the identity, quality, durability, reliability, usability, safety, effectiveness or performance of a product.
","('Product_Quality_And_Safety', 0.8745095729827881)","('Product_Design_And_Lifecycle_Management', 0.03782133758068085)","('Selling_Practices_And_Product_Labeling', 0.010636418126523495)","(['Product Quality & Recall Management'], 0.8745095729827881)","('NON-ESG', 0.03782133758068085)","('NON-ESG', 0.010636418126523495)"
Line 249,"“Complaint incidents” are the number of alleged product defects globally identified within product complaints.
","('Product_Quality_And_Safety', 0.701124370098114)","('Product_Design_And_Lifecycle_Management', 0.062097132205963135)","('Selling_Practices_And_Product_Labeling', 0.045491769909858704)","(['Product Quality & Recall Management'], 0.701124370098114)","('NON-ESG', 0.062097132205963135)","('NON-ESG', 0.045491769909858704)"
Line 250,"“Medical device reports”  are reports submitted to U.S. Food and Drug Administration (FDA) of certain medical device malfunctions, serious injuries or deaths associated with the use of a medical device.
","('Employee_Health_And_Safety', 0.9726005792617798)","('Critical_Incident_Risk_Management', 0.004614328034222126)","('Product_Design_And_Lifecycle_Management', 0.0023303998168557882)","(['Operational Eco-Efficiency'], 0.9726005792617798)","('NON-ESG', 0.004614328034222126)","('NON-ESG', 0.0023303998168557882)"
Line 251,"“Field alert reports” are reports submitted to FDA for a specific drug application and defect category.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6470138430595398)","('Product_Quality_And_Safety', 0.06994441896677017)","('Selling_Practices_And_Product_Labeling', 0.04033442214131355)","(['Corporate Governance'], 0.6470138430595398)","('NON-ESG', 0.06994441896677017)","('NON-ESG', 0.04033442214131355)"
Line 252,"“Field actions” include both recalled products and nonrecall actions taken on distributed products globally.
","('Product_Design_And_Lifecycle_Management', 0.32842347025871277)","('Selling_Practices_And_Product_Labeling', 0.2688840925693512)","('Product_Quality_And_Safety', 0.17725075781345367)","('NON-ESG', 0.32842347025871277)","('NON-ESG', 0.2688840925693512)","('NON-ESG', 0.17725075781345367)"
Line 253,"All data include acquisitions and supplier-related data where integrated.Complaint  incidentsField alert  reportsField actions Medi cal device  reportsComplaint s28% reduc tion88% reduction73% reduc tion19% reduc tion53% reduction Collaboration with FDA     Through our strategic  engagement with FDA, we continue to pursue  collaborative solutions to advance patient safety  and ensure our products are of the highest quality,  presenting the lowest possible risk to patients.
","('Product_Quality_And_Safety', 0.8947774171829224)","('Selling_Practices_And_Product_Labeling', 0.018279077485203743)","('Customer_Welfare', 0.011236281134188175)","(['Product Quality & Recall Management'], 0.8947774171829224)","('NON-ESG', 0.018279077485203743)","('NON-ESG', 0.011236281134188175)"
Line 254,"We not only expanded our participation in the FDA  Case for Quality Voluntary Improvement Program  through the Center for Devices and Radiological  Health, but also expanded our collaborative  approach across FDA.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5009210705757141)","('Product_Quality_And_Safety', 0.11377950757741928)","('Access_And_Affordability', 0.0844464972615242)","(['Corporate Governance'], 0.5009210705757141)","('NON-ESG', 0.11377950757741928)","('NON-ESG', 0.0844464972615242)"
Line 255,"In 2020, we entered the Quality  Management Maturity Program through the FDA  Center for Drug Evaluation and Research.
","('Management_Of_Legal_And_Regulatory_Framework', 0.41485512256622314)","('Product_Quality_And_Safety', 0.14010319113731384)","('Competitive_Behavior', 0.054218076169490814)","('NON-ESG', 0.41485512256622314)","('NON-ESG', 0.14010319113731384)","('NON-ESG', 0.054218076169490814)"
Line 256,"Both  programs aim to measure and advance the culture   of quality at our design and manufacturing sites.
","('Product_Design_And_Lifecycle_Management', 0.8575201034545898)","('Product_Quality_And_Safety', 0.024199578911066055)","('Supply_Chain_Management', 0.017536189407110214)","(['Product Stewardship'], 0.8575201034545898)","('NON-ESG', 0.024199578911066055)","('NON-ESG', 0.017536189407110214)"
Line 257,"2020 GOALReduce  product  complaints  by 15% Achieved VIEW ALL 2020 GOALS VIEW THE DATA SUMMARY   FOR MORE DETAIL.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT16Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture SUSTAINABLE DESIGN Through the innovative, sustainable design of our  products, we minimize our environmental impacts  and capture the most value possible from the natural  resources needed to manufacture, transport, use  and recover our products.
","('Product_Design_And_Lifecycle_Management', 0.9564859867095947)","('Product_Quality_And_Safety', 0.00700005330145359)","('Customer_Welfare', 0.003514191135764122)","(['Product Stewardship'], 0.9564859867095947)","('NON-ESG', 0.00700005330145359)","('NON-ESG', 0.003514191135764122)"
Line 258,"2020 GOALReduce  product  complaints  by 15% Achieved VIEW ALL 2020 GOALS VIEW THE DATA SUMMARY   FOR MORE DETAIL.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT16Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture SUSTAINABLE DESIGN Through the innovative, sustainable design of our  products, we minimize our environmental impacts  and capture the most value possible from the natural  resources needed to manufacture, transport, use  and recover our products.
","('Product_Design_And_Lifecycle_Management', 0.9603908658027649)","('Supply_Chain_Management', 0.004260985180735588)","('Product_Quality_And_Safety', 0.0029677755665034056)","(['Product Stewardship'], 0.9603908658027649)","('NON-ESG', 0.004260985180735588)","('NON-ESG', 0.0029677755665034056)"
Line 259,"We have a long-term  objective to transition from a linear approach of “take,  make, dispose” to the circular approach illustrated  in the graphic below.
","('Business_Model_Resilience', 0.2832765281200409)","('Competitive_Behavior', 0.19724030792713165)","('Ecological_Impacts', 0.04480469226837158)","('NON-ESG', 0.2832765281200409)","('NON-ESG', 0.19724030792713165)","('NON-ESG', 0.04480469226837158)"
Line 260,"In addition to decreasing our  environmental impact and that of our customers, this  INNOVATING FOR SUSTAINABILITY ACROSS THE PRODUCT LIFE CYCLE Baxter recognizes the importance of transitioning from a linear to a circular approach that maximizes the value gained from  materials, while improving environmental performance and the customer experience.
","('Product_Design_And_Lifecycle_Management', 0.9656428694725037)","('Product_Quality_And_Safety', 0.0032605757005512714)","('Business_Model_Resilience', 0.0030629702378064394)","(['Product Stewardship'], 0.9656428694725037)","('NON-ESG', 0.0032605757005512714)","('NON-ESG', 0.0030629702378064394)"
Line 261,"We prioritize sustainability across the  life cycle of our products as we aspire to a more circular model.
","('Product_Design_And_Lifecycle_Management', 0.9669159650802612)","('Product_Quality_And_Safety', 0.0033056256361305714)","('Business_Model_Resilience', 0.0031811026856303215)","(['Product Stewardship'], 0.9669159650802612)","('NON-ESG', 0.0033056256361305714)","('NON-ESG', 0.0031811026856303215)"
Line 262,"Product Use We design products to  reduce energy demands and  waste during use by  customers, caregivers  and patients.Product End-of-Life We work to repair and reuse  electromechanical medical  products when possible and  collaborate with partners  around the world to recycle  used products.Sustainable Design We use Environmental, Health,  Safety and Sustainability reviews  and life cycle assessments to  understand product environmental  performance and requirements  and drive ongoing improvements  across the value chain.Materials Use We innovate to reduce  materials use in our  products, decrease waste in  manufacturing and  packaging, and minimize use  of materials of concern.Patient Safety and Quality We have an unrelenting  dedication to patient safety  and quality that is  foundational to our mission   and ongoing success.approach has the potential to reduce material costs  and support growth by maintaining and expanding  access to markets.
","('Product_Design_And_Lifecycle_Management', 0.9521598219871521)","('Product_Quality_And_Safety', 0.010559357702732086)","('Selling_Practices_And_Product_Labeling', 0.003575865877792239)","(['Product Stewardship'], 0.9521598219871521)","('NON-ESG', 0.010559357702732086)","('NON-ESG', 0.003575865877792239)"
Line 263,"Product Use We design products to  reduce energy demands and  waste during use by  customers, caregivers  and patients.Product End-of-Life We work to repair and reuse  electromechanical medical  products when possible and  collaborate with partners  around the world to recycle  used products.Sustainable Design We use Environmental, Health,  Safety and Sustainability reviews  and life cycle assessments to  understand product environmental  performance and requirements  and drive ongoing improvements  across the value chain.Materials Use We innovate to reduce  materials use in our  products, decrease waste in  manufacturing and  packaging, and minimize use  of materials of concern.Patient Safety and Quality We have an unrelenting  dedication to patient safety  and quality that is  foundational to our mission   and ongoing success.approach has the potential to reduce material costs  and support growth by maintaining and expanding  access to markets.
","('Product_Quality_And_Safety', 0.7789832949638367)","('Product_Design_And_Lifecycle_Management', 0.08196316659450531)","('Employee_Health_And_Safety', 0.02908387966454029)","(['Product Quality & Recall Management'], 0.7789832949638367)","('NON-ESG', 0.08196316659450531)","('NON-ESG', 0.02908387966454029)"
Line 264,"We partner with others to understand customer needs  and trends related to sustainable healthcare and help  drive the industry forward.
","('Product_Design_And_Lifecycle_Management', 0.2542685568332672)","('Supply_Chain_Management', 0.2334747463464737)","('Business_Model_Resilience', 0.22437798976898193)","('NON-ESG', 0.2542685568332672)","('NON-ESG', 0.2334747463464737)","('NON-ESG', 0.22437798976898193)"
Line 265,"We are a founding member  of the Sustainable Healthcare Coalition , and during 2020  we collaborated to produce a case study  based on the  life cycle assessment (LCA) we conducted in 2017 of  our Viaflo 1 Liter Intravenous Solution.
","('Access_And_Affordability', 0.21410560607910156)","('Customer_Welfare', 0.19650189578533173)","('Employee_Health_And_Safety', 0.08397211879491806)","('NON-ESG', 0.21410560607910156)","('NON-ESG', 0.19650189578533173)","('NON-ESG', 0.08397211879491806)"
Line 266,"PRODUCT ENVIRONMENTAL, HEALTH, SAFETY  AND SUSTAINABILITY REVIEW To support our sustainable design efforts ,   we require an Environmental, Health, Safety  and Sustainability (EHS&S) assessment during  the development process for all new products.
","('Product_Design_And_Lifecycle_Management', 0.7732175588607788)","('Product_Quality_And_Safety', 0.12871864438056946)","('Selling_Practices_And_Product_Labeling', 0.012416103854775429)","(['Product Stewardship'], 0.7732175588607788)","('NON-ESG', 0.12871864438056946)","('NON-ESG', 0.012416103854775429)"
Line 267,"This assessment evaluates EHS&S and  regulatory considerations and requirements  across our value chain.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9572765827178955)","('Competitive_Behavior', 0.003336889436468482)","('Business_Ethics', 0.002923696767538786)","(['Corporate Governance'], 0.9572765827178955)","('NON-ESG', 0.003336889436468482)","('NON-ESG', 0.002923696767538786)"
Line 268,"It also includes more  detailed LCA-based computer modeling of  proposed products and may involve comparison  with existing products.
","('Product_Design_And_Lifecycle_Management', 0.9544920921325684)","('Product_Quality_And_Safety', 0.006391268689185381)","('Selling_Practices_And_Product_Labeling', 0.005284201353788376)","(['Product Stewardship'], 0.9544920921325684)","('NON-ESG', 0.006391268689185381)","('NON-ESG', 0.005284201353788376)"
Line 269,"Key metrics from the  reviews demonstrate our progress in avoiding  materials of concern, minimizing customer  waste and reducing product carbon footprints.
","('Waste_And_Hazardous_Materials_Management', 0.8423663973808289)","('Product_Design_And_Lifecycle_Management', 0.0764331966638565)","('Product_Quality_And_Safety', 0.00960584171116352)","(['Operational Eco-Efficiency'], 0.8423663973808289)","('NON-ESG', 0.0764331966638565)","('NON-ESG', 0.00960584171116352)"
Line 270,"The EHS&S review helps us continually improve  our operations, meet customer expectations  and manage regulatory risk.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9196406602859497)","('Business_Ethics', 0.015009148046374321)","('Competitive_Behavior', 0.011569409631192684)","(['Corporate Governance'], 0.9196406602859497)","('NON-ESG', 0.015009148046374321)","('NON-ESG', 0.011569409631192684)"
Line 271,"For select new and established products, we  use full LCAs to evaluate and improve product  sustainability performance.
","('Product_Design_And_Lifecycle_Management', 0.9548150897026062)","('Product_Quality_And_Safety', 0.009296756237745285)","('Selling_Practices_And_Product_Labeling', 0.003881834214553237)","(['Product Stewardship'], 0.9548150897026062)","('NON-ESG', 0.009296756237745285)","('NON-ESG', 0.003881834214553237)"
Line 272,"See our 2018   Corporate  Responsibility Report  for information  about an LCA of our Revaclear and Theranova   dialyzers.
","('Business_Model_Resilience', 0.3585355281829834)","('Supply_Chain_Management', 0.1279972493648529)","('Management_Of_Legal_And_Regulatory_Framework', 0.07624980062246323)","('NON-ESG', 0.3585355281829834)","('NON-ESG', 0.1279972493648529)","('NON-ESG', 0.07624980062246323)"
Line 273,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORT17Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture MATERIALS USE  Materials use is a  key driver of Baxter’s  environmental  footprint, and  getting the most  value possible from  materials is central  to our transition  toward a more  circular approach.
","('Product_Design_And_Lifecycle_Management', 0.832247257232666)","('Supply_Chain_Management', 0.0431123748421669)","('Waste_And_Hazardous_Materials_Management', 0.023121973499655724)","(['Product Stewardship'], 0.832247257232666)","('NON-ESG', 0.0431123748421669)","('NON-ESG', 0.023121973499655724)"
Line 274,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORT17Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture MATERIALS USE  Materials use is a  key driver of Baxter’s  environmental  footprint, and  getting the most  value possible from  materials is central  to our transition  toward a more  circular approach.
","('Systemic_Risk_Management', 0.13038992881774902)","('Supply_Chain_Management', 0.10649295151233673)","('Business_Model_Resilience', 0.09531001001596451)","('NON-ESG', 0.13038992881774902)","('NON-ESG', 0.10649295151233673)","('NON-ESG', 0.09531001001596451)"
Line 275,"To reduce materials use in products  and packaging, we implement innovative projects and  initiatives across our value chain.
","('Product_Design_And_Lifecycle_Management', 0.9642034769058228)","('Selling_Practices_And_Product_Labeling', 0.003180823056027293)","('Supply_Chain_Management', 0.0030919797718524933)","(['Product Stewardship'], 0.9642034769058228)","('NON-ESG', 0.003180823056027293)","('NON-ESG', 0.0030919797718524933)"
Line 276,"Since 2015, we have  launched six products that reduced materials use by at  least 15% without affecting efficacy, surpassing our 2020  goal.
","('Product_Design_And_Lifecycle_Management', 0.8060311675071716)","('Product_Quality_And_Safety', 0.04572226107120514)","('Customer_Welfare', 0.04508741945028305)","(['Product Stewardship'], 0.8060311675071716)","('NON-ESG', 0.04572226107120514)","('NON-ESG', 0.04508741945028305)"
Line 277,"These include our Spectrum IQ Infusion System,  Evo IQ Infusion System, Kaguya automated peritoneal  dialysis (APD) system cycler, Amia APD system  cycler, Floseal Hemostatic Matrix and our premixed  presentation of eptifibatide (a medication used for  treatment of acute coronary syndrome).
","('Access_And_Affordability', 0.36140891909599304)","('Employee_Health_And_Safety', 0.12255676835775375)","('Customer_Welfare', 0.08461195975542068)","('NON-ESG', 0.36140891909599304)","('NON-ESG', 0.12255676835775375)","('NON-ESG', 0.08461195975542068)"
Line 278,"2020 GOALReduce  material  use by 15%  on three  therapies/ products Achieved VIEW ALL 2020 GOALS ANESTHETIC GAS CAPTURE SYSTEM REDUCES GREENHOUSE GAS (GHG ) EMISSIONS When patients receive inhaled anesthesia, they only metabolize a fraction of it.
","('GHG_Emissions', 0.9697217345237732)","('Ecological_Impacts', 0.003759726881980896)","('Air_Quality', 0.0030940580181777477)","(['Climate Change'], 0.9697217345237732)","('NON-ESG', 0.003759726881980896)","('NON-ESG', 0.0030940580181777477)"
Line 279,"The rest is exhaled,  contributing to GHG emissions in the atmosphere.
","('GHG_Emissions', 0.9662745594978333)","('Air_Quality', 0.004131557885557413)","('Ecological_Impacts', 0.0038829108234494925)","(['Climate Change'], 0.9662745594978333)","('NON-ESG', 0.004131557885557413)","('NON-ESG', 0.0038829108234494925)"
Line 280,"In 2020, Baxter announced a partnership with ZeoSys Medical to pilot the CONTRAfluranTM Anesthetic Gas  Capture system in select European countries.
","('GHG_Emissions', 0.36609065532684326)","('Water_And_Wastewater_Management', 0.2363199144601822)","('Energy_Management', 0.10415375232696533)","('NON-ESG', 0.36609065532684326)","('NON-ESG', 0.2363199144601822)","('NON-ESG', 0.10415375232696533)"
Line 281,"This innovative technology captures 99%1 of the anesthetic   gas exhaled by patients in operating rooms, preventing its release into the atmosphere and reducing hospital  GHG emissions.
","('GHG_Emissions', 0.9657118916511536)","('Ecological_Impacts', 0.004113707225769758)","('Air_Quality', 0.004067268222570419)","(['Climate Change'], 0.9657118916511536)","('NON-ESG', 0.004113707225769758)","('NON-ESG', 0.004067268222570419)"
Line 282,"Pending regulatory approval, the captured gas can then be sterilized and used as an active  pharmaceutical ingredient for new anesthetic gas—creating a circular system for inhaled anesthetics.
","('Customer_Welfare', 0.5078679919242859)","('Selling_Practices_And_Product_Labeling', 0.2805289924144745)","('Product_Quality_And_Safety', 0.036470357328653336)","(['Customer Relationship Management'], 0.5078679919242859)","('NON-ESG', 0.2805289924144745)","('NON-ESG', 0.036470357328653336)"
Line 283,"The anesthetics the system uses are packaged in lightweight, recyclable aluminum containers.
","('Product_Design_And_Lifecycle_Management', 0.6580321788787842)","('Customer_Welfare', 0.10073841363191605)","('Product_Quality_And_Safety', 0.058007288724184036)","(['Product Stewardship'], 0.6580321788787842)","('NON-ESG', 0.10073841363191605)","('NON-ESG', 0.058007288724184036)"
Line 284,"The system  also offers a measurable reduction in energy consumption and costs associated with an Anestheti c Gas  Scavenging System (AGSS).2   6Once regulatory approval is granted;  the gas will be sterilized, extracted and  separated for intended future use as an  active pharmaceutical ingredient (API)  for new anesthetic gas.
","('Customer_Welfare', 0.38671860098838806)","('Selling_Practices_And_Product_Labeling', 0.19538260996341705)","('Energy_Management', 0.15654435753822327)","('NON-ESG', 0.38671860098838806)","('NON-ESG', 0.19538260996341705)","('NON-ESG', 0.15654435753822327)"
Line 285,"5The canisters are  picked up and stored  in environmentally  safe conditions.
","('Waste_And_Hazardous_Materials_Management', 0.7185730338096619)","('Product_Design_And_Lifecycle_Management', 0.06288253515958786)","('Energy_Management', 0.018448995426297188)","(['Operational Eco-Efficiency'], 0.7185730338096619)","('NON-ESG', 0.06288253515958786)","('NON-ESG', 0.018448995426297188)"
Line 286,"4SENSOfluranTM indicates when canister is full and should be replaced.As surgeries progress, exhaled gas will  be captured in the canister.
","('Product_Quality_And_Safety', 0.15790128707885742)","('Access_And_Affordability', 0.12247199565172195)","('Customer_Welfare', 0.09136731922626495)","('NON-ESG', 0.15790128707885742)","('NON-ESG', 0.12247199565172195)","('NON-ESG', 0.09136731922626495)"
Line 287,"No longer  does the exhaled gas move through the  AGSS system into the atmosphere.CONTRAfluran™ canister is placed into sensor unit.Baxter delivers CONTRAfluran™ canisters to the hospital, along with  anesthetic gas bottles.
","('GHG_Emissions', 0.33386266231536865)","('Air_Quality', 0.3334055244922638)","('Water_And_Wastewater_Management', 0.08404892683029175)","('NON-ESG', 0.33386266231536865)","('NON-ESG', 0.3334055244922638)","('NON-ESG', 0.08404892683029175)"
Line 288,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORT18Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture PACKAGING Baxter innovates  to decrease the  environmental impact  of product packaging,  without adversely  affecting product  safety or efficacy, by  reducing the amount  of materials used  and substituting with environmentally preferable  alternatives.
","('Product_Quality_And_Safety', 0.825692355632782)","('Product_Design_And_Lifecycle_Management', 0.07031037658452988)","('Employee_Health_And_Safety', 0.019524862989783287)","(['Product Quality & Recall Management'], 0.825692355632782)","('NON-ESG', 0.07031037658452988)","('NON-ESG', 0.019524862989783287)"
Line 289,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORT18Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture PACKAGING Baxter innovates  to decrease the  environmental impact  of product packaging,  without adversely  affecting product  safety or efficacy, by  reducing the amount  of materials used  and substituting with environmentally preferable  alternatives.
","('Product_Design_And_Lifecycle_Management', 0.7661910057067871)","('Customer_Welfare', 0.07073492556810379)","('Energy_Management', 0.02360781654715538)","(['Product Stewardship'], 0.7661910057067871)","('NON-ESG', 0.07073492556810379)","('NON-ESG', 0.02360781654715538)"
Line 290,"From 2016 to 2020, we reduced packaging  globally from products shipped to customers by  2,128 metric tons,3 missing our 2020 goal.
","('Product_Design_And_Lifecycle_Management', 0.9465363025665283)","('Selling_Practices_And_Product_Labeling', 0.007105110678821802)","('Energy_Management', 0.005674845539033413)","(['Product Stewardship'], 0.9465363025665283)","('NON-ESG', 0.007105110678821802)","('NON-ESG', 0.005674845539033413)"
Line 291,"Reducing  packaging material will remain a focus of our product  sustainability strategy.
","('Product_Design_And_Lifecycle_Management', 0.9601942896842957)","('Product_Quality_And_Safety', 0.005044801160693169)","('Selling_Practices_And_Product_Labeling', 0.003280610078945756)","(['Product Stewardship'], 0.9601942896842957)","('NON-ESG', 0.005044801160693169)","('NON-ESG', 0.003280610078945756)"
Line 292,"During 2020, we initiated several projects to reduce  packaging, which we estimate will save nearly  $260,000 and 149 metric tons of packaging material on  an annualized basis.
","('Product_Design_And_Lifecycle_Management', 0.8293174505233765)","('Energy_Management', 0.050472673028707504)","('Waste_And_Hazardous_Materials_Management', 0.024771999567747116)","(['Product Stewardship'], 0.8293174505233765)","('NON-ESG', 0.050472673028707504)","('NON-ESG', 0.024771999567747116)"
Line 293,"Examples include:  • Our site in São Paulo, Brazil, reduced the  dimensions of the cardboard box needed for IV,  renal and irrigation solutions produced at the  site by 6.3% and the size of the box divider by  7.7%.
","('Energy_Management', 0.303830087184906)","('Water_And_Wastewater_Management', 0.30004703998565674)","('Product_Design_And_Lifecycle_Management', 0.11430954188108444)","('NON-ESG', 0.303830087184906)","('NON-ESG', 0.30004703998565674)","('NON-ESG', 0.11430954188108444)"
Line 294,"These changes resulted in a reduction of  116 metric tons of cardboard and approximately  $70,000 in savings in 2020.
","('Energy_Management', 0.6133955121040344)","('GHG_Emissions', 0.09151364117860794)","('Management_Of_Legal_And_Regulatory_Framework', 0.08822758495807648)","(['Operational Eco-Efficiency'], 0.6133955121040344)","('NON-ESG', 0.09151364117860794)","('NON-ESG', 0.08822758495807648)"
Line 295,"• In Cuernavaca, Mexico, the new adhesive we  use to seal the cardboard shipping boxes for our  peritoneal dialysis Twin Bag reduced packaging  materials use by 3 metric tons and saved $19,000  during the year.
","('Product_Design_And_Lifecycle_Management', 0.858287513256073)","('Waste_And_Hazardous_Materials_Management', 0.024910856038331985)","('Product_Quality_And_Safety', 0.0127639789134264)","(['Product Stewardship'], 0.858287513256073)","('NON-ESG', 0.024910856038331985)","('NON-ESG', 0.0127639789134264)"
Line 296,"• In Sabiñánigo, Spain, we reduced the size of  the Viaflo overpouch, avoiding 25 metric tons of  multilayer plastic use and saving $93,000 in 2020.MATERIALS OF CONCERN Our global strategies and programs help ensure that  we meet product materials restrictions.
","('Product_Design_And_Lifecycle_Management', 0.9221023917198181)","('Energy_Management', 0.01141132228076458)","('Product_Quality_And_Safety', 0.008558965288102627)","(['Product Stewardship'], 0.9221023917198181)","('NON-ESG', 0.01141132228076458)","('NON-ESG', 0.008558965288102627)"
Line 297,"In addition,  we work to avoid or minimize materials of concern as  part of our EHS&S product reviews and by consulting  numerous regulatory lists.
","('Product_Design_And_Lifecycle_Management', 0.7239106893539429)","('Product_Quality_And_Safety', 0.12883509695529938)","('Selling_Practices_And_Product_Labeling', 0.036670319736003876)","(['Product Stewardship'], 0.7239106893539429)","('NON-ESG', 0.12883509695529938)","('NON-ESG', 0.036670319736003876)"
Line 298,"These regulations and lists  include, but are not limited to:  • EU REACH Substances of Very High Concern • EU RoHS Directive • EU Medical Devices Regulation • U.S. Toxic Substances Control Act • U.S. SEC conflict minerals • California Proposition 65   During 2020, we  launched non-DEHP  products in all  regions.
","('Waste_And_Hazardous_Materials_Management', 0.49993985891342163)","('Product_Quality_And_Safety', 0.16948425769805908)","('Selling_Practices_And_Product_Labeling', 0.09090165793895721)","('NON-ESG', 0.49993985891342163)","('NON-ESG', 0.16948425769805908)","('NON-ESG', 0.09090165793895721)"
Line 299,"This includes  83 solution sets,  syringe sets and  accessories, and  irrigation solutions  using non-DEHP  plasticizers in the  Americas; Europe,  Middle East and Africa  (EMEA); and Asia Pacific (APAC).
","('Product_Design_And_Lifecycle_Management', 0.5407484769821167)","('Energy_Management', 0.11631834506988525)","('Waste_And_Hazardous_Materials_Management', 0.06039019674062729)","(['Product Stewardship'], 0.5407484769821167)","('NON-ESG', 0.11631834506988525)","('NON-ESG', 0.06039019674062729)"
Line 300,"We also launched the  RoHS-compliant Evo IQ Syringe Pump in EMEA and  APAC.
","('Energy_Management', 0.27006298303604126)","('Product_Design_And_Lifecycle_Management', 0.25024381279945374)","('Product_Quality_And_Safety', 0.07328999042510986)","('NON-ESG', 0.27006298303604126)","('NON-ESG', 0.25024381279945374)","('NON-ESG', 0.07328999042510986)"
Line 301,"Additionally, in EMEA, Baxter converted eight  primary solution sets to use non-DEHP plasticizers  and one accessory product to limit perfluorooctanoic  acid (PFOA) in accordance with EU regulations.
","('Product_Design_And_Lifecycle_Management', 0.29216304421424866)","('Customer_Welfare', 0.23367048799991608)","('Waste_And_Hazardous_Materials_Management', 0.07750086486339569)","('NON-ESG', 0.29216304421424866)","('NON-ESG', 0.23367048799991608)","('NON-ESG', 0.07750086486339569)"
Line 302,"REDUCING MATERIALS USE AND PLASTIC WASTE We reduce materials use when possible to  decrease our environmental impact.
","('Waste_And_Hazardous_Materials_Management', 0.970855176448822)","('Product_Design_And_Lifecycle_Management', 0.004170098342001438)","('Supply_Chain_Management', 0.0023151705972850323)","(['Operational Eco-Efficiency'], 0.970855176448822)","('NON-ESG', 0.004170098342001438)","('NON-ESG', 0.0023151705972850323)"
Line 303,"In 2020,  a project aimed at reducing materials use was  implemented at our Irvine, California, site.
","('Product_Design_And_Lifecycle_Management', 0.6112220287322998)","('Supply_Chain_Management', 0.1099773719906807)","('Waste_And_Hazardous_Materials_Management', 0.06938701868057251)","(['Product Stewardship'], 0.6112220287322998)","('NON-ESG', 0.1099773719906807)","('NON-ESG', 0.06938701868057251)"
Line 304,"The  site reduced the dispenser pouch height for  the Single Rate Infusor and Multirate Infusor  Elastomeric devices, saving 3.2 metric tons of  raw material and more than $63,000 annually.
","('Product_Design_And_Lifecycle_Management', 0.3516468107700348)","('Energy_Management', 0.21666842699050903)","('Supply_Chain_Management', 0.15698747336864471)","('NON-ESG', 0.3516468107700348)","('NON-ESG', 0.21666842699050903)","('NON-ESG', 0.15698747336864471)"
Line 305,"Plastic scrap from manufacturing is Baxter’s  largest waste stream, so we focus our efforts on  reducing plastic waste and increasing recycling.
","('Waste_And_Hazardous_Materials_Management', 0.9838235378265381)","('Data_Security', 0.001302823075093329)","('Water_And_Wastewater_Management', 0.0011326649691909552)","(['Operational Eco-Efficiency'], 0.9838235378265381)","('NON-ESG', 0.001302823075093329)","('NON-ESG', 0.0011326649691909552)"
Line 306,"In 2020, our facility in Mountain Home, Arkansas,  reduced plastic waste by approximately 400  metric tons, despite a 3% increase in production.
","('Waste_And_Hazardous_Materials_Management', 0.9833925366401672)","('Water_And_Wastewater_Management', 0.0014334588777273893)","('Data_Security', 0.0011716978624463081)","(['Operational Eco-Efficiency'], 0.9833925366401672)","('NON-ESG', 0.0014334588777273893)","('NON-ESG', 0.0011716978624463081)"
Line 307,"We accomplished this by reducing scrap in the  film extrusion lines and increasing the amount  of plastic that is reground back into the product.
","('Waste_And_Hazardous_Materials_Management', 0.6981029510498047)","('Product_Design_And_Lifecycle_Management', 0.1885777860879898)","('Employee_Health_And_Safety', 0.011982852593064308)","(['Operational Eco-Efficiency'], 0.6981029510498047)","('NON-ESG', 0.1885777860879898)","('NON-ESG', 0.011982852593064308)"
Line 308,"See Waste  for additional information about plastic  scrap reduction.
","('Waste_And_Hazardous_Materials_Management', 0.9807597994804382)","('Water_And_Wastewater_Management', 0.0016046682139858603)","('Product_Design_And_Lifecycle_Management', 0.0016001181211322546)","(['Operational Eco-Efficiency'], 0.9807597994804382)","('NON-ESG', 0.0016046682139858603)","('NON-ESG', 0.0016001181211322546)"
Line 309,"2020 GOALEliminate or minimize  the presence of  chemicals of concern  (as defined by  regulations) in new  products VIEW ALL 2020 GOALSAchieved2020 GOALEliminate 3,000   metric tons of  packaging material  from products shipped  to customers Not achieved VIEW ALL 2020 GOALSBAXTER 2020 CORPORATE RESPONSIBILITY REPORT19Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture Other substances we seek to avoid or minimize include  endocrine disrupters, latex, phthalates, volatile organic  compounds and others that might not be included in  the lists above.
","('Product_Design_And_Lifecycle_Management', 0.9121686220169067)","('Product_Quality_And_Safety', 0.031050710007548332)","('Customer_Welfare', 0.008405711501836777)","(['Product Stewardship'], 0.9121686220169067)","('NON-ESG', 0.031050710007548332)","('NON-ESG', 0.008405711501836777)"
Line 310,"2020 GOALEliminate or minimize  the presence of  chemicals of concern  (as defined by  regulations) in new  products VIEW ALL 2020 GOALSAchieved2020 GOALEliminate 3,000   metric tons of  packaging material  from products shipped  to customers Not achieved VIEW ALL 2020 GOALSBAXTER 2020 CORPORATE RESPONSIBILITY REPORT19Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture Other substances we seek to avoid or minimize include  endocrine disrupters, latex, phthalates, volatile organic  compounds and others that might not be included in  the lists above.
","('Customer_Welfare', 0.408861368894577)","('GHG_Emissions', 0.12625744938850403)","('Selling_Practices_And_Product_Labeling', 0.07952842861413956)","('NON-ESG', 0.408861368894577)","('NON-ESG', 0.12625744938850403)","('NON-ESG', 0.07952842861413956)"
Line 311,"See Baxter’s position statements on  Proposition 65 , REACH , and conflict minerals , and our  most recent Conflict Minerals Report .
","('Supply_Chain_Management', 0.4281536340713501)","('Human_Rights_And_Community_Relations', 0.09914042055606842)","('GHG_Emissions', 0.07259859889745712)","('NON-ESG', 0.4281536340713501)","('NON-ESG', 0.09914042055606842)","('NON-ESG', 0.07259859889745712)"
Line 312,"STRIVING FOR FULL MATERIALS DISCLOSURE Baxter's corporate responsibility approach prioritizes  compliance with product chemical and medical device  regulations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.45616838335990906)","('Product_Quality_And_Safety', 0.23956601321697235)","('Business_Ethics', 0.04250340163707733)","('NON-ESG', 0.45616838335990906)","('NON-ESG', 0.23956601321697235)","('NON-ESG', 0.04250340163707733)"
Line 313,"Working with a third party, we collect data  from suppliers to determine the use of substances of very  high concern (SVHC).
","('Selling_Practices_And_Product_Labeling', 0.433594673871994)","('Waste_And_Hazardous_Materials_Management', 0.13199682533740997)","('Customer_Welfare', 0.06222028657793999)","('NON-ESG', 0.433594673871994)","('NON-ESG', 0.13199682533740997)","('NON-ESG', 0.06222028657793999)"
Line 314,"This helps us to confirm compliance  with global material regulations and assists us in  proactively monitoring the impact that changes in global  legislation might have on our product portfolio.
","('Management_Of_Legal_And_Regulatory_Framework', 0.965976357460022)","('Director_Removal', 0.002651705639436841)","('Product_Quality_And_Safety', 0.002590260235592723)","(['Corporate Governance'], 0.965976357460022)","('NON-ESG', 0.002651705639436841)","('NON-ESG', 0.002590260235592723)"
Line 315,"We also  continue to leverage third-party testing, which provides  us with full material data and LCAs for many of our  devices, helps validate device compliance with chemical  legislation and provides information we need to respond to   environmental questionnaires from customers.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6755074858665466)","('Product_Quality_And_Safety', 0.1271214634180069)","('Business_Ethics', 0.04175017774105072)","(['Corporate Governance'], 0.6755074858665466)","('NON-ESG', 0.1271214634180069)","('NON-ESG', 0.04175017774105072)"
Line 316,"As of the  end of 2020, we completed testing for 127 of our products,  which covered more than 13,900 parts.
","('Product_Design_And_Lifecycle_Management', 0.9535686373710632)","('Product_Quality_And_Safety', 0.006338786333799362)","('Selling_Practices_And_Product_Labeling', 0.0050723254680633545)","(['Product Stewardship'], 0.9535686373710632)","('NON-ESG', 0.006338786333799362)","('NON-ESG', 0.0050723254680633545)"
Line 317,"This included many  of our electromechanical devices, which are the most  complex products in our portfolio in terms of number of  parts and materials.
","('Product_Design_And_Lifecycle_Management', 0.9497889280319214)","('Supply_Chain_Management', 0.005521376617252827)","('Energy_Management', 0.00536706205457449)","(['Product Stewardship'], 0.9497889280319214)","('NON-ESG', 0.005521376617252827)","('NON-ESG', 0.00536706205457449)"
Line 318,"Additionally, as a member of MedTech Europe , we   are working with other multinational pharmaceutical/ medical device companies to drive full materials  disclosure in global material compliance, and we  contribute to several working groups.
","('Product_Quality_And_Safety', 0.2894986569881439)","('Business_Ethics', 0.15200865268707275)","('Management_Of_Legal_And_Regulatory_Framework', 0.11838557571172714)","('NON-ESG', 0.2894986569881439)","('NON-ESG', 0.15200865268707275)","('NON-ESG', 0.11838557571172714)"
Line 319,"We support  greater understanding of the hazardous substances  requirements of the EU Medical Device Regulation by  sharing information within Baxter and across the industry  related to our full materials disclosure testing and  analysis program, including materials commonly used in  products that could potentially be replaced or eliminated.
","('Waste_And_Hazardous_Materials_Management', 0.7978243827819824)","('Product_Quality_And_Safety', 0.051289841532707214)","('Selling_Practices_And_Product_Labeling', 0.04011907801032066)","(['Operational Eco-Efficiency'], 0.7978243827819824)","('NON-ESG', 0.051289841532707214)","('NON-ESG', 0.04011907801032066)"
Line 320,"This supports consistent interpretation and efficient  compliance with related regulations within the industry.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9686121344566345)","('Business_Ethics', 0.002825941191986203)","('Energy_Management', 0.002316688187420368)","(['Corporate Governance'], 0.9686121344566345)","('NON-ESG', 0.002825941191986203)","('NON-ESG', 0.002316688187420368)"
Line 321,"To  inform our efforts, we also monitor ongoing developments  with the RoHS Directive and REACH Regulation.PRODUCT END-OF-LIFE DISPOSABLE  MEDICAL PRODUCTS Baxter works to  recapture valuable  materials at the end  of product life and has  introduced several  programs to facilitate  recycling for patients  and hospitals in  Australia, New Zealand, Guatemala and Colombia.
","('Product_Design_And_Lifecycle_Management', 0.9604911804199219)","('Product_Quality_And_Safety', 0.0046613761223852634)","('Waste_And_Hazardous_Materials_Management', 0.0036516764666885138)","(['Product Stewardship'], 0.9604911804199219)","('NON-ESG', 0.0046613761223852634)","('NON-ESG', 0.0036516764666885138)"
Line 322,"During  2020, we increased the number of hospitals and facilities  with recycling programs for some Baxter products to 377,  up from 349 in 2019.
","('Product_Design_And_Lifecycle_Management', 0.9547002911567688)","('Product_Quality_And_Safety', 0.005967280361801386)","('Waste_And_Hazardous_Materials_Management', 0.004603320732712746)","(['Product Stewardship'], 0.9547002911567688)","('NON-ESG', 0.005967280361801386)","('NON-ESG', 0.004603320732712746)"
Line 323,"Baxter collaborates with the Vinyl Council of Australia  to offer a program in that country for the recovery of  used Baxter PVC fluid bags.
","('Energy_Management', 0.4371403157711029)","('Product_Design_And_Lifecycle_Management', 0.17904365062713623)","('Waste_And_Hazardous_Materials_Management', 0.13413414359092712)","('NON-ESG', 0.4371403157711029)","('NON-ESG', 0.17904365062713623)","('NON-ESG', 0.13413414359092712)"
Line 324,"We also partner with waste  collection companies in New Zealand to recover used  Baxter PVC fluid bags, and with waste collection companies  in both countries to recover aluminum anesthetic gas  bottles.
","('Waste_And_Hazardous_Materials_Management', 0.983370304107666)","('Water_And_Wastewater_Management', 0.0018470223294571042)","('Data_Security', 0.001407261355780065)","(['Operational Eco-Efficiency'], 0.983370304107666)","('NON-ESG', 0.0018470223294571042)","('NON-ESG', 0.001407261355780065)"
Line 325,"While we were able to increase the number of  participating hospitals in 2020, the amounts collected  during the year decreased compared with 2019 as hospital  PVC recycling programs were suspended in New Zealand  and the state of Tasmania in Australia due to COVID-19.
","('Energy_Management', 0.5390973687171936)","('Product_Design_And_Lifecycle_Management', 0.1141456589102745)","('Waste_And_Hazardous_Materials_Management', 0.1068565770983696)","(['Operational Eco-Efficiency'], 0.5390973687171936)","('NON-ESG', 0.1141456589102745)","('NON-ESG', 0.1068565770983696)"
Line 326,"In addition to the environmental benefits, we estimate  that collection of PVC and aluminum during 2020 saved  our customers approximately $102,000 that would have  otherwise been spent on disposal.PVC AND ALUMINUM RECYCLING PROGRAMS FOR HOSPITALS AND DIALYSIS CLINICS, metric tons  PVC collected  for recycling  metric ton  aluminum  bottles recycled  hospitalshospitals66Australia metric tons  PVC recycled49.dialysis clinics45Colombia metric tons  PVC recycled16.hospitals and dialysis clinics24Guatemala  PVC collection  on hold due  to COVID-19 n/a metric ton  aluminum  bottles recycled  0.hospitalshospitals22New Zealand2020 GOALPartner to implement  recycling of product  waste at hospitals  and increase  participation to VIEW ALL 2020 GOALSAchievedBAXTER 2020 CORPORATE RESPONSIBILITY REPORT20Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture We have established a similar program in Guatemala  in partnership with Biotrash, a Central American  waste management company.
","('Waste_And_Hazardous_Materials_Management', 0.4143417477607727)","('Energy_Management', 0.2460174560546875)","('Product_Design_And_Lifecycle_Management', 0.08268473297357559)","('NON-ESG', 0.4143417477607727)","('NON-ESG', 0.2460174560546875)","('NON-ESG', 0.08268473297357559)"
Line 327,"In addition to the environmental benefits, we estimate  that collection of PVC and aluminum during 2020 saved  our customers approximately $102,000 that would have  otherwise been spent on disposal.PVC AND ALUMINUM RECYCLING PROGRAMS FOR HOSPITALS AND DIALYSIS CLINICS, metric tons  PVC collected  for recycling  metric ton  aluminum  bottles recycled  hospitalshospitals66Australia metric tons  PVC recycled49.dialysis clinics45Colombia metric tons  PVC recycled16.hospitals and dialysis clinics24Guatemala  PVC collection  on hold due  to COVID-19 n/a metric ton  aluminum  bottles recycled  0.hospitalshospitals22New Zealand2020 GOALPartner to implement  recycling of product  waste at hospitals  and increase  participation to VIEW ALL 2020 GOALSAchievedBAXTER 2020 CORPORATE RESPONSIBILITY REPORT20Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture We have established a similar program in Guatemala  in partnership with Biotrash, a Central American  waste management company.
","('Waste_And_Hazardous_Materials_Management', 0.5754449963569641)","('Product_Design_And_Lifecycle_Management', 0.2731810212135315)","('Product_Quality_And_Safety', 0.03604048863053322)","(['Operational Eco-Efficiency'], 0.5754449963569641)","('NON-ESG', 0.2731810212135315)","('NON-ESG', 0.03604048863053322)"
Line 328,"In addition to the environmental benefits, we estimate  that collection of PVC and aluminum during 2020 saved  our customers approximately $102,000 that would have  otherwise been spent on disposal.PVC AND ALUMINUM RECYCLING PROGRAMS FOR HOSPITALS AND DIALYSIS CLINICS, metric tons  PVC collected  for recycling  metric ton  aluminum  bottles recycled  hospitalshospitals66Australia metric tons  PVC recycled49.dialysis clinics45Colombia metric tons  PVC recycled16.hospitals and dialysis clinics24Guatemala  PVC collection  on hold due  to COVID-19 n/a metric ton  aluminum  bottles recycled  0.hospitalshospitals22New Zealand2020 GOALPartner to implement  recycling of product  waste at hospitals  and increase  participation to VIEW ALL 2020 GOALSAchievedBAXTER 2020 CORPORATE RESPONSIBILITY REPORT20Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture We have established a similar program in Guatemala  in partnership with Biotrash, a Central American  waste management company.
","('Waste_And_Hazardous_Materials_Management', 0.980766773223877)","('Water_And_Wastewater_Management', 0.002169579267501831)","('Employee_Health_And_Safety', 0.0016201690305024385)","(['Operational Eco-Efficiency'], 0.980766773223877)","('NON-ESG', 0.002169579267501831)","('NON-ESG', 0.0016201690305024385)"
Line 329,"Through the program,  we collect and recycle PVC and other plastics from  hospitals and dialysis clinics.
","('Waste_And_Hazardous_Materials_Management', 0.6894612312316895)","('Product_Design_And_Lifecycle_Management', 0.15996618568897247)","('Energy_Management', 0.021254608407616615)","(['Operational Eco-Efficiency'], 0.6894612312316895)","('NON-ESG', 0.15996618568897247)","('NON-ESG', 0.021254608407616615)"
Line 330,"As of the end of 2020,  24 facilities were participating in the program, and  Biotrash had recovered 16.5 metric tons of PVC  and 2.7 metric tons of polypropylene.
","('Energy_Management', 0.4384476840496063)","('Product_Design_And_Lifecycle_Management', 0.18485549092292786)","('Waste_And_Hazardous_Materials_Management', 0.09073322266340256)","('NON-ESG', 0.4384476840496063)","('NON-ESG', 0.18485549092292786)","('NON-ESG', 0.09073322266340256)"
Line 331,"Biotrash  recycles PVC to make shoe soles and uses recovered  polypropylene to manufacture bricks for use in its  own facilities.
","('Product_Design_And_Lifecycle_Management', 0.8943378329277039)","('Energy_Management', 0.017838621512055397)","('Waste_And_Hazardous_Materials_Management', 0.015116502530872822)","(['Product Stewardship'], 0.8943378329277039)","('NON-ESG', 0.017838621512055397)","('NON-ESG', 0.015116502530872822)"
Line 332,"Our Baxter Renal Care Services group in Colombia  collects PVC for recycling from dialysis clinics and  home dialysis patients.
","('Energy_Management', 0.5778956413269043)","('Waste_And_Hazardous_Materials_Management', 0.10491839796304703)","('Product_Design_And_Lifecycle_Management', 0.06969629973173141)","(['Operational Eco-Efficiency'], 0.5778956413269043)","('NON-ESG', 0.10491839796304703)","('NON-ESG', 0.06969629973173141)"
Line 333,"During 2020, we recycled  49.6 metric tons of PVC from 45 dialysis clinics and  14.7 metric tons of PVC from home dialysis patients  through this program.
","('Energy_Management', 0.7766297459602356)","('Water_And_Wastewater_Management', 0.04393120855093002)","('Waste_And_Hazardous_Materials_Management', 0.03517807647585869)","(['Operational Eco-Efficiency'], 0.7766297459602356)","('NON-ESG', 0.04393120855093002)","('NON-ESG', 0.03517807647585869)"
Line 334,"We partner with organizations  that use the recovered PVC to make chairs, water hoses,  accessories for purses, shoe soles and other items.
","('Waste_And_Hazardous_Materials_Management', 0.644946813583374)","('Product_Design_And_Lifecycle_Management', 0.09784911572933197)","('Employee_Health_And_Safety', 0.05848699435591698)","(['Operational Eco-Efficiency'], 0.644946813583374)","('NON-ESG', 0.09784911572933197)","('NON-ESG', 0.05848699435591698)"
Line 335,"In Australia and New Zealand, we also assist patients  who receive regular home deliveries of dialysis  solutions to recycle related waste.
","('Waste_And_Hazardous_Materials_Management', 0.9825658798217773)","('Water_And_Wastewater_Management', 0.0013984813122078776)","('Product_Design_And_Lifecycle_Management', 0.0013645796570926905)","(['Operational Eco-Efficiency'], 0.9825658798217773)","('NON-ESG', 0.0013984813122078776)","('NON-ESG', 0.0013645796570926905)"
Line 336,"As of the end  of 2020, approximately 33% of Baxter peritoneal  dialysis (PD) home patients in these countries (970  patients, up from 935 in 2019) participated in the  Home PD Recycling Program.
","('Access_And_Affordability', 0.5707757472991943)","('Customer_Welfare', 0.05364253744482994)","('Employee_Health_And_Safety', 0.05268997326493263)","(['Health Outcome Contribution'], 0.5707757472991943)","('NON-ESG', 0.05364253744482994)","('NON-ESG', 0.05268997326493263)"
Line 337,"Despite this increase  in participation, overall collection volumes decreased  as a result of the suspension of program collections  due to COVID-19-related concerns.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5848197340965271)","('Systemic_Risk_Management', 0.05987171456217766)","('Competitive_Behavior', 0.04305592551827431)","(['Corporate Governance'], 0.5848197340965271)","('NON-ESG', 0.05987171456217766)","('NON-ESG', 0.04305592551827431)"
Line 338,"During 2020, the  program collected approximately 8 metric tons of  plastic for recycling.
","('Waste_And_Hazardous_Materials_Management', 0.6563256978988647)","('Product_Design_And_Lifecycle_Management', 0.19319701194763184)","('Water_And_Wastewater_Management', 0.015844400972127914)","(['Operational Eco-Efficiency'], 0.6563256978988647)","('NON-ESG', 0.19319701194763184)","('NON-ESG', 0.015844400972127914)"
Line 339,"We work with customers, industry peers and  recycling and disposal vendors to facilitate the  recycling and responsible treatment of disposable  medical products.
","('Product_Design_And_Lifecycle_Management', 0.9616405963897705)","('Product_Quality_And_Safety', 0.004713996313512325)","('Waste_And_Hazardous_Materials_Management', 0.003854139242321253)","(['Product Stewardship'], 0.9616405963897705)","('NON-ESG', 0.004713996313512325)","('NON-ESG', 0.003854139242321253)"
Line 340,"For example, Baxter is a charter  member of the Healthcare Plastics Recycling   Council (HPRC) .
","('Waste_And_Hazardous_Materials_Management', 0.6629801988601685)","('Product_Design_And_Lifecycle_Management', 0.14762301743030548)","('Supply_Chain_Management', 0.023345816880464554)","(['Operational Eco-Efficiency'], 0.6629801988601685)","('NON-ESG', 0.14762301743030548)","('NON-ESG', 0.023345816880464554)"
Line 341,"During 2020, we collaborated with  other HPRC members to research the potential  of advanced recycling technologies for the plastic used in healthcare products.
","('Product_Design_And_Lifecycle_Management', 0.8679937720298767)","('Waste_And_Hazardous_Materials_Management', 0.057334184646606445)","('Selling_Practices_And_Product_Labeling', 0.007287482265383005)","(['Product Stewardship'], 0.8679937720298767)","('NON-ESG', 0.057334184646606445)","('NON-ESG', 0.007287482265383005)"
Line 342,"This research  is summarized in the white paper “ Advanced   Recycling of Healthcare Plastics—An Opportunity   for Circularity .” In 2020, HPRC launched the  HPRC recycling vendor directory —a free, public,  interactive directory designed to facilitate  geography-specific collaboration between  healthcare facilities and recycling vendors.
","('Waste_And_Hazardous_Materials_Management', 0.5516300797462463)","('Product_Design_And_Lifecycle_Management', 0.250073105096817)","('Energy_Management', 0.029599100351333618)","(['Operational Eco-Efficiency'], 0.5516300797462463)","('NON-ESG', 0.250073105096817)","('NON-ESG', 0.029599100351333618)"
Line 343,"ELECTRONIC EQUIPMENT  Some of the electromechanical medical devices we  sell, such as renal APD cyclers, support progress  toward the circular economy through serviceability,  repair and reuse.
","('Product_Design_And_Lifecycle_Management', 0.703951895236969)","('Energy_Management', 0.08856398612260818)","('Customer_Welfare', 0.026026159524917603)","(['Product Stewardship'], 0.703951895236969)","('NON-ESG', 0.08856398612260818)","('NON-ESG', 0.026026159524917603)"
Line 344,"We lease certain types of  electromechanical medical products to customers  and patients, which helps ensure they have the  technology that best meets their needs and provides  more flexibility than owning the devices.
","('Product_Design_And_Lifecycle_Management', 0.9346045851707458)","('Energy_Management', 0.010965979658067226)","('Customer_Welfare', 0.006582154426723719)","(['Product Stewardship'], 0.9346045851707458)","('NON-ESG', 0.010965979658067226)","('NON-ESG', 0.006582154426723719)"
Line 345,"This model  also ensures those products will be returned to  Baxter after use for repair and reuse.
","('Product_Design_And_Lifecycle_Management', 0.9543585181236267)","('Product_Quality_And_Safety', 0.007008089683949947)","('Selling_Practices_And_Product_Labeling', 0.004344764165580273)","(['Product Stewardship'], 0.9543585181236267)","('NON-ESG', 0.007008089683949947)","('NON-ESG', 0.004344764165580273)"
Line 346,"Regulations in many countries worldwide require  responsible recycling of electronic products when  reuse is no longer an option.
","('Product_Design_And_Lifecycle_Management', 0.9582444429397583)","('Product_Quality_And_Safety', 0.005983264651149511)","('Waste_And_Hazardous_Materials_Management', 0.0038981083780527115)","(['Product Stewardship'], 0.9582444429397583)","('NON-ESG', 0.005983264651149511)","('NON-ESG', 0.0038981083780527115)"
Line 347,"For example, the EU  Waste Electrical and Electronic Equipment (WEEE)  Directive requires manufacturers to arrange for  the take-back of electronic products at end-of-life.
","('Waste_And_Hazardous_Materials_Management', 0.9807034730911255)","('Product_Design_And_Lifecycle_Management', 0.0020600128918886185)","('Employee_Health_And_Safety', 0.0014481953112408519)","(['Operational Eco-Efficiency'], 0.9807034730911255)","('NON-ESG', 0.0020600128918886185)","('NON-ESG', 0.0014481953112408519)"
Line 348,"In 2020, our vendors recovered approximately 180  metric tons of electronic equipment in the region  on Baxter’s behalf.
","('Energy_Management', 0.4071141481399536)","('Product_Design_And_Lifecycle_Management', 0.13567517697811127)","('Supply_Chain_Management', 0.11047814041376114)","('NON-ESG', 0.4071141481399536)","('NON-ESG', 0.13567517697811127)","('NON-ESG', 0.11047814041376114)"
Line 349,"Our WEEE website  provides  customers detailed information on how to return  or dispose of Baxter products in accordance with  the directive.
","('Product_Design_And_Lifecycle_Management', 0.8706524968147278)","('Selling_Practices_And_Product_Labeling', 0.028969690203666687)","('Product_Quality_And_Safety', 0.021455567330121994)","(['Product Stewardship'], 0.8706524968147278)","('NON-ESG', 0.028969690203666687)","('NON-ESG', 0.021455567330121994)"
Line 350,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORT21Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture 2020 HIGHLIGHTS GLOBAL INCLUSION AND DIVERSITY FOCUS AREAS Workforce  Attract and build diverse and high- performing teams that are engaged and  innovative.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9742576479911804)","('Employee_Health_And_Safety', 0.0022983744274824858)","('Human_Rights_And_Community_Relations', 0.0017672281246632338)","(['Human Capital Development'], 0.9742576479911804)","('NON-ESG', 0.0022983744274824858)","('NON-ESG', 0.0017672281246632338)"
Line 351,"Workplace  Advance an inclusive culture, where  every employee feels valued, respected  and safe to be their authentic self.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7447959184646606)","('Human_Rights_And_Community_Relations', 0.10686465352773666)","('Employee_Health_And_Safety', 0.02502330020070076)","(['Human Capital Development'], 0.7447959184646606)","('NON-ESG', 0.10686465352773666)","('NON-ESG', 0.02502330020070076)"
Line 352,"Communities  Cultivate strategic and diverse supplier  and community partnerships.
","('Human_Rights_And_Community_Relations', 0.4471112787723541)","('Supply_Chain_Management', 0.2245110422372818)","('Employee_Engagement_Inclusion_And_Diversity', 0.07408317178487778)","('NON-ESG', 0.4471112787723541)","('NON-ESG', 0.2245110422372818)","('NON-ESG', 0.07408317178487778)"
Line 353,"Marketplace  Consider the needs of customers and  patients in all aspects of our business.
","('Access_And_Affordability', 0.47124871611595154)","('Customer_Welfare', 0.06295713782310486)","('Employee_Health_And_Safety', 0.049432314932346344)","('NON-ESG', 0.47124871611595154)","('NON-ESG', 0.06295713782310486)","('NON-ESG', 0.049432314932346344)"
Line 354,"These standing priority areas inform our companywide  approach to inclusion and diversity and also form the  basis of our ACT: Activating Change Today initiative.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9713920950889587)","('Human_Rights_And_Community_Relations', 0.0026601890567690134)","('Employee_Health_And_Safety', 0.0023681127931922674)","(['Human Capital Development'], 0.9713920950889587)","('NON-ESG', 0.0026601890567690134)","('NON-ESG', 0.0023681127931922674)"
Line 355,"21 BAXTER 2020 CORPORATE RESPONSIBILITY REPORToverall manager  effectiveness score,  eight percentage  points above the top  quartile benchmark82% training hours  completed, an  average of about  18 hours per  employee.*Approximately Global  mentoring  program  introduced by business  resource groups to connect  diverse employees with  company leaders 950, *These data do not represent all employee training and development, but do capture a large portion of training for most employees.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8282305598258972)","('Employee_Health_And_Safety', 0.0316920168697834)","('Access_And_Affordability', 0.027003910392522812)","(['Human Capital Development'], 0.8282305598258972)","('NON-ESG', 0.0316920168697834)","('NON-ESG', 0.027003910392522812)"
Line 356,"Baxter fosters a high-performing, inclusive and diverse organization where our more  than 50,000 employees1 worldwide are valued and pursue rewarding careers bringing  the company’s mission to life.
","('Employee_Engagement_Inclusion_And_Diversity', 0.965452253818512)","('Human_Rights_And_Community_Relations', 0.0031849138904362917)","('Business_Model_Resilience', 0.002792432438582182)","(['Human Capital Development'], 0.965452253818512)","('NON-ESG', 0.0031849138904362917)","('NON-ESG', 0.002792432438582182)"
Line 357,"We listen to our employees and help them realize their  full professional potential through our inclusion, diversity and engagement activities  plus a wide range of learning and development opportunities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9744291305541992)","('Employee_Health_And_Safety', 0.002136762486770749)","('Human_Rights_And_Community_Relations', 0.0020349917467683554)","(['Human Capital Development'], 0.9744291305541992)","('NON-ESG', 0.002136762486770749)","('NON-ESG', 0.0020349917467683554)"
Line 358,"GLOBAL INCLUSION AND DIVERSITY  We actively create a workplace where all  employees are confident that they belong  and bring value to Baxter, including women,  underrepresented minority groups, veterans,  people with disabilities, early career  professionals and the LGBTQ+ community.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9751474261283875)","('Employee_Health_And_Safety', 0.0020305197685956955)","('Human_Rights_And_Community_Relations', 0.0019367678323760629)","(['Human Capital Development'], 0.9751474261283875)","('NON-ESG', 0.0020305197685956955)","('NON-ESG', 0.0019367678323760629)"
Line 359,"Our focus on attracting, motivating, retaining  and championing an inclusive and diverse  workforce drives innovation, creates trusted  partnerships with customers, suppliers and  community partners, and contributes to the  success and sustainability of our business.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8995587229728699)","('Human_Rights_And_Community_Relations', 0.013893687166273594)","('Business_Model_Resilience', 0.012781228870153427)","(['Human Capital Development'], 0.8995587229728699)","('NON-ESG', 0.013893687166273594)","('NON-ESG', 0.012781228870153427)"
Line 360,"Workplace Culture Promote inclusion, diversity and employee engagementBAXTER 2020 CORPORATE RESPONSIBILITY REPORT22Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture The horrific actions against Black Americans in 2020  underscored the importance of our inclusion and  diversity commitment and prompted Baxter to drive  meaningful, sustainable action to address racial  injustice.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9762844443321228)","('Employee_Health_And_Safety', 0.0022903596982359886)","('Human_Rights_And_Community_Relations', 0.0017399312928318977)","(['Human Capital Development'], 0.9762844443321228)","('NON-ESG', 0.0022903596982359886)","('NON-ESG', 0.0017399312928318977)"
Line 361,"Workplace Culture Promote inclusion, diversity and employee engagementBAXTER 2020 CORPORATE RESPONSIBILITY REPORT22Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture The horrific actions against Black Americans in 2020  underscored the importance of our inclusion and  diversity commitment and prompted Baxter to drive  meaningful, sustainable action to address racial  injustice.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5348414182662964)","('Human_Rights_And_Community_Relations', 0.1608564555644989)","('Business_Ethics', 0.07784095406532288)","(['Human Capital Development'], 0.5348414182662964)","('NON-ESG', 0.1608564555644989)","('NON-ESG', 0.07784095406532288)"
Line 362,"Our ACT: Activating Change Today initiative  was conceived in partnership with our Baxter Black  Alliance business resource group to advance inclusion  and racial justice within our workplace and the  communities and markets we serve.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9537888169288635)","('Human_Rights_And_Community_Relations', 0.010217145085334778)","('Employee_Health_And_Safety', 0.00409445958212018)","(['Human Capital Development'], 0.9537888169288635)","('NON-ESG', 0.010217145085334778)","('NON-ESG', 0.00409445958212018)"
Line 363,"While prompted by  actions in the United States, the lessons and progress  we make through ACT will help us address various  forms of injustice globally.
","('Business_Ethics', 0.7332105040550232)","('Human_Rights_And_Community_Relations', 0.09834703058004379)","('Management_Of_Legal_And_Regulatory_Framework', 0.025284402072429657)","(['Business Ethics'], 0.7332105040550232)","('NON-ESG', 0.09834703058004379)","('NON-ESG', 0.025284402072429657)"
Line 364,"Through ACT, we are developing recruiting efforts in  partnership with Black professional organizations  and Historically Black Colleges and Universities and  launching an internship program.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9527449607849121)","('Labor_Practices', 0.004479325842112303)","('Employee_Health_And_Safety', 0.0034359300043433905)","(['Human Capital Development'], 0.9527449607849121)","('NON-ESG', 0.004479325842112303)","('NON-ESG', 0.0034359300043433905)"
Line 365,"We are also listening  to employees about their experiences with racism,  fostering courageous conversations about race with our leaders and working to address unconscious  biases in our global human resources processes.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9543324708938599)","('Human_Rights_And_Community_Relations', 0.004553716164082289)","('Employee_Health_And_Safety', 0.003723982721567154)","(['Human Capital Development'], 0.9543324708938599)","('NON-ESG', 0.004553716164082289)","('NON-ESG', 0.003723982721567154)"
Line 366,"In  2021, we established Martin Luther King Jr. Day as a  paid holiday for U.S. employees and encouraged our  employees to use the day for community service.
","('Employee_Health_And_Safety', 0.26459282636642456)","('Human_Rights_And_Community_Relations', 0.16268619894981384)","('Labor_Practices', 0.08115950226783752)","('NON-ESG', 0.26459282636642456)","('NON-ESG', 0.16268619894981384)","('NON-ESG', 0.08115950226783752)"
Line 367,"Find out more about ACT and related activities across  our business on our website  and in the Introduction   of this report.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8060715198516846)","('Director_Removal', 0.024454575031995773)","('Business_Ethics', 0.02092726156115532)","(['Corporate Governance'], 0.8060715198516846)","('NON-ESG', 0.024454575031995773)","('NON-ESG', 0.02092726156115532)"
Line 368,"We prioritize the engagement, retention and  advancement of women and underrepresented  minorities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9754859805107117)","('Human_Rights_And_Community_Relations', 0.002069017617031932)","('Employee_Health_And_Safety', 0.001794127281755209)","(['Human Capital Development'], 0.9754859805107117)","('NON-ESG', 0.002069017617031932)","('NON-ESG', 0.001794127281755209)"
Line 369,"One initiative designed to accelerate this  commitment is our Sponsorship Program, in which  senior leaders actively advocate for and create  opportunities for visibility and career growth for these  segments of our employee base.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9444192051887512)","('Employee_Health_And_Safety', 0.006376273464411497)","('Business_Model_Resilience', 0.0038539941888302565)","(['Human Capital Development'], 0.9444192051887512)","('NON-ESG', 0.006376273464411497)","('NON-ESG', 0.0038539941888302565)"
Line 370,"In addition, our  WoMentoring program supports women who have  been newly hired or promoted into roles at the director level and above through mentoring relationships  with other women in leadership.
","('Employee_Engagement_Inclusion_And_Diversity', 0.890648365020752)","('Director_Removal', 0.016079695895314217)","('Human_Rights_And_Community_Relations', 0.012919973582029343)","(['Human Capital Development'], 0.890648365020752)","('NON-ESG', 0.016079695895314217)","('NON-ESG', 0.012919973582029343)"
Line 371,"In 2020, we established Workforce Diversity Reviews for  all employees as part of our ongoing talent discussions  with company leaders.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9743012189865112)","('Employee_Health_And_Safety', 0.0023065952118486166)","('Labor_Practices', 0.0016627968288958073)","(['Human Capital Development'], 0.9743012189865112)","('NON-ESG', 0.0023065952118486166)","('NON-ESG', 0.0016627968288958073)"
Line 372,"Through these diversity reviews,  we accomplish the following: • Gain a better understanding of the organization’s  diversity data and metrics, including gaps and strengths  • Review development plans to ensure the right balance  of critical experiences, sponsorship and mentoring  relationships as well as networking opportunities and  increased visibility to leadership • Identify and discuss succession plans and candidate  pipelines for critical roles  • Review and discuss talent retention plans    SETTING THE TONE In addition to driving accountability and  reinforcing a commitment to inclusion and  diversity across our own organization, our CEO  has also taken the following steps to engage  outside of Baxter: • 2020:  Became a signatory of the  Disability:IN  “Are you IN?” campaign to  help advance disability inclusion efforts • 2019:  Signed the CEO Action for Diversity &   Inclusion ™ pledge—the largest CEO-driven  business commitment to advance diversity  and inclusion in the workplaceTo gain a greater understanding of Baxter’s culture of inclusion, we invited employees globally to  participate in our first annual inclusion and diversity pulse survey in February 2021.2  Baxter is effectively responding to  racial/social injustice in the workplace.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9734773635864258)","('Employee_Health_And_Safety', 0.0023178907576948404)","('Business_Model_Resilience', 0.001895242021419108)","(['Human Capital Development'], 0.9734773635864258)","('NON-ESG', 0.0023178907576948404)","('NON-ESG', 0.001895242021419108)"
Line 373,"Through these diversity reviews,  we accomplish the following: • Gain a better understanding of the organization’s  diversity data and metrics, including gaps and strengths  • Review development plans to ensure the right balance  of critical experiences, sponsorship and mentoring  relationships as well as networking opportunities and  increased visibility to leadership • Identify and discuss succession plans and candidate  pipelines for critical roles  • Review and discuss talent retention plans    SETTING THE TONE In addition to driving accountability and  reinforcing a commitment to inclusion and  diversity across our own organization, our CEO  has also taken the following steps to engage  outside of Baxter: • 2020:  Became a signatory of the  Disability:IN  “Are you IN?” campaign to  help advance disability inclusion efforts • 2019:  Signed the CEO Action for Diversity &   Inclusion ™ pledge—the largest CEO-driven  business commitment to advance diversity  and inclusion in the workplaceTo gain a greater understanding of Baxter’s culture of inclusion, we invited employees globally to  participate in our first annual inclusion and diversity pulse survey in February 2021.2  Baxter is effectively responding to  racial/social injustice in the workplace.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9753590822219849)","('Employee_Health_And_Safety', 0.0030998631846159697)","('Human_Rights_And_Community_Relations', 0.0016256239032372832)","(['Human Capital Development'], 0.9753590822219849)","('NON-ESG', 0.0030998631846159697)","('NON-ESG', 0.0016256239032372832)"
Line 374,"Through these diversity reviews,  we accomplish the following: • Gain a better understanding of the organization’s  diversity data and metrics, including gaps and strengths  • Review development plans to ensure the right balance  of critical experiences, sponsorship and mentoring  relationships as well as networking opportunities and  increased visibility to leadership • Identify and discuss succession plans and candidate  pipelines for critical roles  • Review and discuss talent retention plans    SETTING THE TONE In addition to driving accountability and  reinforcing a commitment to inclusion and  diversity across our own organization, our CEO  has also taken the following steps to engage  outside of Baxter: • 2020:  Became a signatory of the  Disability:IN  “Are you IN?” campaign to  help advance disability inclusion efforts • 2019:  Signed the CEO Action for Diversity &   Inclusion ™ pledge—the largest CEO-driven  business commitment to advance diversity  and inclusion in the workplaceTo gain a greater understanding of Baxter’s culture of inclusion, we invited employees globally to  participate in our first annual inclusion and diversity pulse survey in February 2021.2  Baxter is effectively responding to  racial/social injustice in the workplace.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9715446829795837)","('Employee_Health_And_Safety', 0.0030125936027616262)","('Human_Rights_And_Community_Relations', 0.002894933335483074)","(['Human Capital Development'], 0.9715446829795837)","('NON-ESG', 0.0030125936027616262)","('NON-ESG', 0.002894933335483074)"
Line 375,"78% Baxter is effectively responding to  racial/social injustice in the marketplace.
","('Human_Rights_And_Community_Relations', 0.7100597620010376)","('Employee_Engagement_Inclusion_And_Diversity', 0.12645481526851654)","('Labor_Practices', 0.02949298731982708)","(['Community Relations'], 0.7100597620010376)","('NON-ESG', 0.12645481526851654)","('NON-ESG', 0.02949298731982708)"
Line 376,"77% Baxter is effectively responding to  racial/social injustice in our communities.
","('Human_Rights_And_Community_Relations', 0.9337396621704102)","('Employee_Engagement_Inclusion_And_Diversity', 0.010302946902811527)","('Labor_Practices', 0.009490256197750568)","(['Community Relations'], 0.9337396621704102)","('NON-ESG', 0.010302946902811527)","('NON-ESG', 0.009490256197750568)"
Line 377,"70% I can be my authentic self with my  direct manager.
","('Customer_Privacy', 0.17118240892887115)","('Business_Model_Resilience', 0.1438002586364746)","('Director_Removal', 0.1035740002989769)","('NON-ESG', 0.17118240892887115)","('NON-ESG', 0.1438002586364746)","('NON-ESG', 0.1035740002989769)"
Line 378,"85% I feel as if I belong on my team.
","('Employee_Engagement_Inclusion_And_Diversity', 0.2601538896560669)","('Director_Removal', 0.17386242747306824)","('Business_Model_Resilience', 0.0999332070350647)","('NON-ESG', 0.2601538896560669)","('NON-ESG', 0.17386242747306824)","('NON-ESG', 0.0999332070350647)"
Line 379,"85%I regularly seek out diverse perspectives  in my work at Baxter.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9649370908737183)","('Human_Rights_And_Community_Relations', 0.003528028028085828)","('Business_Model_Resilience', 0.0026096219662576914)","(['Human Capital Development'], 0.9649370908737183)","('NON-ESG', 0.003528028028085828)","('NON-ESG', 0.0026096219662576914)"
Line 380,"81% My direct manager reinforces the  importanc e of valuing differences.
","('Competitive_Behavior', 0.7282972931861877)","('Management_Of_Legal_And_Regulatory_Framework', 0.06434541940689087)","('Systemic_Risk_Management', 0.04667281731963158)","(['Business Ethics'], 0.7282972931861877)","('NON-ESG', 0.06434541940689087)","('NON-ESG', 0.04667281731963158)"
Line 381,"79% In my work group, we check our personal  biases to make the best decisions for Baxter.
","('Competitive_Behavior', 0.29209932684898376)","('Business_Ethics', 0.2598216235637665)","('Employee_Engagement_Inclusion_And_Diversity', 0.07486928999423981)","('NON-ESG', 0.29209932684898376)","('NON-ESG', 0.2598216235637665)","('NON-ESG', 0.07486928999423981)"
Line 382,"75% I am satisfied with my access to career  advancement opportunities at Baxter.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8219943642616272)","('Access_And_Affordability', 0.03514208272099495)","('Employee_Health_And_Safety', 0.015126735903322697)","(['Human Capital Development'], 0.8219943642616272)","('NON-ESG', 0.03514208272099495)","('NON-ESG', 0.015126735903322697)"
Line 383,"62%BAXTER'S INCLUSION AND DIVE RSITY  SUR VEY RE SULTS, 2021* * Data represent the percentage of employees who responded favorably to each statement.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9454070329666138)","('Labor_Practices', 0.005359991453588009)","('Employee_Health_And_Safety', 0.0050945463590323925)","(['Human Capital Development'], 0.9454070329666138)","('NON-ESG', 0.005359991453588009)","('NON-ESG', 0.0050945463590323925)"
Line 384,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORT23Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture During 2020, we  remained at or above  external benchmarks  for women (globally)  and ethnic minority  representation (in  the United States) at  most career levels.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9765173196792603)","('Human_Rights_And_Community_Relations', 0.0019655695650726557)","('Employee_Health_And_Safety', 0.0017852223245427012)","(['Human Capital Development'], 0.9765173196792603)","('NON-ESG', 0.0019655695650726557)","('NON-ESG', 0.0017852223245427012)"
Line 385,"We continue to work  toward closing gender  and ethnic minority gaps at executive levels.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9749221205711365)","('Human_Rights_And_Community_Relations', 0.002027049195021391)","('Customer_Privacy', 0.0016486708773300052)","(['Human Capital Development'], 0.9749221205711365)","('NON-ESG', 0.002027049195021391)","('NON-ESG', 0.0016486708773300052)"
Line 386,"View our  workforce data , which we have expanded to include  additional detail about ethnic minority representation in  the United States.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9744588732719421)","('Human_Rights_And_Community_Relations', 0.0018415669910609722)","('Employee_Health_And_Safety', 0.0017681318568065763)","(['Human Capital Development'], 0.9744588732719421)","('NON-ESG', 0.0018415669910609722)","('NON-ESG', 0.0017681318568065763)"
Line 387,"BOARD DIVERSITY We are committed to further increasing the diversit y   of our Board of Directors through strategic board  refreshment efforts.
","('Director_Removal', 0.43156754970550537)","('Employee_Engagement_Inclusion_And_Diversity', 0.27994000911712646)","('Business_Model_Resilience', 0.039764441549777985)","('NON-ESG', 0.43156754970550537)","('NON-ESG', 0.27994000911712646)","('NON-ESG', 0.039764441549777985)"
Line 388,"Diversity of background, including   diversity of gender, race, ethnic or geographic origin,   age and experience (including in business, government  and education as well as healthcare, science, technology  and other areas relevant to the company’s activities) , is  a relevant factor in the selection process.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9750440120697021)","('Customer_Privacy', 0.0017180144786834717)","('Business_Model_Resilience', 0.001620783586986363)","(['Human Capital Development'], 0.9750440120697021)","('NON-ESG', 0.0017180144786834717)","('NON-ESG', 0.001620783586986363)"
Line 389,"The last four  appointments to our Board of Directors have been  women or ethnic minorities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9717369675636292)","('Human_Rights_And_Community_Relations', 0.0025634143967181444)","('Customer_Privacy', 0.0017933101626113057)","(['Human Capital Development'], 0.9717369675636292)","('NON-ESG', 0.0025634143967181444)","('NON-ESG', 0.0017933101626113057)"
Line 390,"As of the end of 2020, our  Board of Directors consisted of 25% women and 25%  ethnic minorities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9706323146820068)","('Human_Rights_And_Community_Relations', 0.0026399344205856323)","('Customer_Privacy', 0.002082995604723692)","(['Human Capital Development'], 0.9706323146820068)","('NON-ESG', 0.0026399344205856323)","('NON-ESG', 0.002082995604723692)"
Line 391,"See information regarding board  diversity on page 4 of Baxter’s 2021 Proxy Statement .
","('Employee_Engagement_Inclusion_And_Diversity', 0.9034163355827332)","('Director_Removal', 0.016304444521665573)","('Business_Model_Resilience', 0.006832851562649012)","(['Human Capital Development'], 0.9034163355827332)","('NON-ESG', 0.016304444521665573)","('NON-ESG', 0.006832851562649012)"
Line 392,"GLOBAL INCLUSION COUNCIL Baxter’s Global Inclusion Council (GIC) members  serve as inclusion and diversity champions, advocates  and thought leaders across the company.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9727688431739807)","('Employee_Health_And_Safety', 0.0025587573181837797)","('Human_Rights_And_Community_Relations', 0.002229065168648958)","(['Human Capital Development'], 0.9727688431739807)","('NON-ESG', 0.0025587573181837797)","('NON-ESG', 0.002229065168648958)"
Line 393,"The GIC's  mission is to focus on the advancement of women and  underrepresented minority groups (including people  of different races, ethnicities and sexual orientations  as well as veterans and people with disabilities) and to  drive inclusive leadership capabilities and culture.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9763969779014587)","('Human_Rights_And_Community_Relations', 0.0019686813466250896)","('Employee_Health_And_Safety', 0.0017790354322642088)","(['Human Capital Development'], 0.9763969779014587)","('NON-ESG', 0.0019686813466250896)","('NON-ESG', 0.0017790354322642088)"
Line 394,"The GIC is responsible for advocating and driving our  global inclusion and diversity priorities, as well as   developing and implementing local inclusion priorities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9737823605537415)","('Human_Rights_And_Community_Relations', 0.0023810332641005516)","('Employee_Health_And_Safety', 0.002320389961823821)","(['Human Capital Development'], 0.9737823605537415)","('NON-ESG', 0.0023810332641005516)","('NON-ESG', 0.002320389961823821)"
Line 395,"In early 2021, we formally embedded the GIC into Baxter’s  leadership structure.
","('Business_Model_Resilience', 0.22667257487773895)","('Director_Removal', 0.1904948353767395)","('Employee_Engagement_Inclusion_And_Diversity', 0.14503683149814606)","('NON-ESG', 0.22667257487773895)","('NON-ESG', 0.1904948353767395)","('NON-ESG', 0.14503683149814606)"
Line 396,"The GIC now consists of members of  our Senior Leadership Team and the executive sponsors  of our business resource groups (BRGs).
","('Director_Removal', 0.33779314160346985)","('Business_Model_Resilience', 0.17742273211479187)","('Employee_Engagement_Inclusion_And_Diversity', 0.10626291483640671)","('NON-ESG', 0.33779314160346985)","('NON-ESG', 0.17742273211479187)","('NON-ESG', 0.10626291483640671)"
Line 397,"This change  reinforces the importance of inclusion and diversity at the  highest levels of our company and will help further align  the activities of our GIC with those of our BRGs.  BUILDING CULTURAL COMPETENCE Baxter provides employees with training, tools and  resources to build cultural awareness and competence,  and engage more authentically with each other.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9710943102836609)","('Human_Rights_And_Community_Relations', 0.003241013502702117)","('Employee_Health_And_Safety', 0.0026059665251523256)","(['Human Capital Development'], 0.9710943102836609)","('NON-ESG', 0.003241013502702117)","('NON-ESG', 0.0026059665251523256)"
Line 398,"Many  employees also work on global teams, enabling them  to build cultural competence through daily interactions,  and we encourage employees to practice simple acts of  inclusiveness in their day-to-day routines.
","('Employee_Engagement_Inclusion_And_Diversity', 0.786249041557312)","('Human_Rights_And_Community_Relations', 0.05753600224852562)","('Employee_Health_And_Safety', 0.018438776955008507)","(['Human Capital Development'], 0.786249041557312)","('NON-ESG', 0.05753600224852562)","('NON-ESG', 0.018438776955008507)"
Line 399,"We work to embed awareness of unconscious bias  throughout our company and require all employees to take  a self-guided e-learning module about unconscious bias.
","('Business_Ethics', 0.41384539008140564)","('Competitive_Behavior', 0.2248689979314804)","('Employee_Engagement_Inclusion_And_Diversity', 0.07055458426475525)","('NON-ESG', 0.41384539008140564)","('NON-ESG', 0.2248689979314804)","('NON-ESG', 0.07055458426475525)"
Line 400,"In addition, we have integrated prompts in key processes,  such as talent assessment, succession planning,  feedback and hiring, to help employees think about their  biases as they undertake these activities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9710224866867065)","('Employee_Health_And_Safety', 0.0032947042491286993)","('Customer_Privacy', 0.0017321327468380332)","(['Human Capital Development'], 0.9710224866867065)","('NON-ESG', 0.0032947042491286993)","('NON-ESG', 0.0017321327468380332)"
Line 401,"In 2020, we  continued to implement “Pause and Discuss” during our  hiring process—a structured discussion to help check for  unconscious bias in the selection decision before moving  forward with an offer.
","('Competitive_Behavior', 0.43457889556884766)","('Employee_Engagement_Inclusion_And_Diversity', 0.26379936933517456)","('Business_Model_Resilience', 0.03938134014606476)","('NON-ESG', 0.43457889556884766)","('NON-ESG', 0.26379936933517456)","('NON-ESG', 0.03938134014606476)"
Line 402,"We have also established a target to  ensure that at least 30% of the candidates in the interview  slates for roles of manager or above are diverse, and we have  initiated other checks to mitigate bias in hiring, including an  automated process to collect interview feedback, guidance  for valuing differences when assessing skills, and integration  of a bias check into our global interview guide.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9570726752281189)","('Competitive_Behavior', 0.003908276092261076)","('Customer_Privacy', 0.0031149571295827627)","(['Human Capital Development'], 0.9570726752281189)","('NON-ESG', 0.003908276092261076)","('NON-ESG', 0.0031149571295827627)"
Line 403,"BUSINESS RESOURCE GROUPS Baxter’s BRGs are an important component of creating  an inclusive and diverse culture within Baxter and  advancing our priorities in the communities  where we live  and work.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8708782196044922)","('Human_Rights_And_Community_Relations', 0.05341370776295662)","('Access_And_Affordability', 0.008721265010535717)","(['Human Capital Development'], 0.8708782196044922)","('NON-ESG', 0.05341370776295662)","('NON-ESG', 0.008721265010535717)"
Line 404,"These employee-run affinity groups support the  recruitment, retention, engagement and development of  diverse employees across Baxter.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9730387330055237)","('Human_Rights_And_Community_Relations', 0.00232558511197567)","('Competitive_Behavior', 0.0020009430591017008)","(['Human Capital Development'], 0.9730387330055237)","('NON-ESG', 0.00232558511197567)","('NON-ESG', 0.0020009430591017008)"
Line 405,"We have eight established  BRGs and encourage all employees to get involved: the Asian  Leadership Network, Baxter Black Alliance, Baxter EnAbles,  Baxter Equality Network, Baxter Women Leaders, BaxVets,  Early Career Professionals and Latinos@Baxter.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9455592036247253)","('Employee_Health_And_Safety', 0.00656777061522007)","('Human_Rights_And_Community_Relations', 0.006243770942091942)","(['Human Capital Development'], 0.9455592036247253)","('NON-ESG', 0.00656777061522007)","('NON-ESG', 0.006243770942091942)"
Line 406,"During 2020, our BRGs continued to engage employees  virtually throughout the COVID-19 pandemic.
","('Employee_Health_And_Safety', 0.3054991364479065)","('Labor_Practices', 0.1414061188697815)","('Employee_Engagement_Inclusion_And_Diversity', 0.10446672886610031)","('NON-ESG', 0.3054991364479065)","('NON-ESG', 0.1414061188697815)","('NON-ESG', 0.10446672886610031)"
Line 407,"For instance,  the Baxter Equality Network organized a global virtual  pride parade and the Baxter Black Alliance hosted a  virtual Juneteenth celebration.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4304666519165039)","('Labor_Practices', 0.12253664433956146)","('Employee_Health_And_Safety', 0.08586325496435165)","('NON-ESG', 0.4304666519165039)","('NON-ESG', 0.12253664433956146)","('NON-ESG', 0.08586325496435165)"
Line 408,"Baxter EnAbles supported  Baxter’s first-ever monthly wellness day in October, which  focused on mental well-being.
","('Access_And_Affordability', 0.5076397061347961)","('Employee_Health_And_Safety', 0.187558114528656)","('Employee_Engagement_Inclusion_And_Diversity', 0.040040720254182816)","(['Health Outcome Contribution'], 0.5076397061347961)","('NON-ESG', 0.187558114528656)","('NON-ESG', 0.040040720254182816)"
Line 409,"Our BRGs also organized  a variety of virtual career panels and discussions with  executives to support employee development and elevate  multicultural awareness.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9617413282394409)","('Employee_Health_And_Safety', 0.0041985283605754375)","('Access_And_Affordability', 0.003738798899576068)","(['Human Capital Development'], 0.9617413282394409)","('NON-ESG', 0.0041985283605754375)","('NON-ESG', 0.003738798899576068)"
Line 410,"EQUAL OPPORTUNITY As an equal opportunity employer, Baxter prohibits  employment discrimination or harassment of applicants,  employees and third parties due to race, color, religion  or religious creed, gender, national origin, ancestry, age,  physical or mental disability, medical condition, genetic  information, marital status, sex, sexual orientation, gender  identity or expression, military or veteran status or any other  basis protected by law.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9747371077537537)","('Employee_Health_And_Safety', 0.0024544447660446167)","('Labor_Practices', 0.001997939310967922)","(['Human Capital Development'], 0.9747371077537537)","('NON-ESG', 0.0024544447660446167)","('NON-ESG', 0.001997939310967922)"
Line 411,"Learn more  about inclusion and diversity at Baxter.2020 GOALAspire to diversity  in leadership at or  above benchmarks Not achieved VIEW ALL 2020 GOALS A virtual celebration opened a dialogue about the relevance of Juneteenth and how  Baxter can continue to build an inclusive culture.VIEW THE DATA SUMMARY   FOR MORE DETAIL.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT24Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture EMPLOYEE ENGAGEMENT TRANSFORMING COMPANY CULTURE Baxter's four culture levers—speed, simplicity,  courage and collaboration—form the basis for our  cultural transformation.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9727774262428284)","('Employee_Health_And_Safety', 0.0023467084392905235)","('Human_Rights_And_Community_Relations', 0.0022430759854614735)","(['Human Capital Development'], 0.9727774262428284)","('NON-ESG', 0.0023467084392905235)","('NON-ESG', 0.0022430759854614735)"
Line 412,"Learn more  about inclusion and diversity at Baxter.2020 GOALAspire to diversity  in leadership at or  above benchmarks Not achieved VIEW ALL 2020 GOALS A virtual celebration opened a dialogue about the relevance of Juneteenth and how  Baxter can continue to build an inclusive culture.VIEW THE DATA SUMMARY   FOR MORE DETAIL.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT24Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture EMPLOYEE ENGAGEMENT TRANSFORMING COMPANY CULTURE Baxter's four culture levers—speed, simplicity,  courage and collaboration—form the basis for our  cultural transformation.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7137017250061035)","('Human_Rights_And_Community_Relations', 0.07641055434942245)","('Employee_Health_And_Safety', 0.053552087396383286)","(['Human Capital Development'], 0.7137017250061035)","('NON-ESG', 0.07641055434942245)","('NON-ESG', 0.053552087396383286)"
Line 413,"We’ve embedded the levers  into established processes ranging from job interviews  to new employee orientations to monthly employee- manager check-ins.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9694951176643372)","('Employee_Health_And_Safety', 0.0033187540248036385)","('Labor_Practices', 0.002896234393119812)","(['Human Capital Development'], 0.9694951176643372)","('NON-ESG', 0.0033187540248036385)","('NON-ESG', 0.002896234393119812)"
Line 414,"During 2020, we continued to  emphasize simplicity and employee safety as much  of our office-based (nonmanufacturing) staff shifted  to remote working environments due to the COVID-19   pandemic.
","('Employee_Health_And_Safety', 0.980143129825592)","('Employee_Engagement_Inclusion_And_Diversity', 0.0025233663618564606)","('Product_Quality_And_Safety', 0.001600835588760674)","(['Operational Eco-Efficiency'], 0.980143129825592)","('NON-ESG', 0.0025233663618564606)","('NON-ESG', 0.001600835588760674)"
Line 415,"We supported our employees and kept  them informed via regular communications, provided  resources to help employees work effectively in  virtual environments via our new WorkSmart Virtually  program and encouraged a sense of community with  the launch of monthly Wellness Days that empower  employees to prioritize personal wellness.
","('Employee_Health_And_Safety', 0.6419130563735962)","('Employee_Engagement_Inclusion_And_Diversity', 0.09948647767305374)","('Access_And_Affordability', 0.03961962088942528)","(['Operational Eco-Efficiency'], 0.6419130563735962)","('NON-ESG', 0.09948647767305374)","('NON-ESG', 0.03961962088942528)"
Line 416,"Between 2016 and 2019, we conducted a Best Place  to Work (BPTW) survey each year to measure the  effectiveness of our programs and practices across  several categories, including culture, professional  development, employee engagement, inclusion and  leadership, among others.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9519836902618408)","('Human_Rights_And_Community_Relations', 0.007689470425248146)","('Employee_Health_And_Safety', 0.005178578197956085)","(['Human Capital Development'], 0.9519836902618408)","('NON-ESG', 0.007689470425248146)","('NON-ESG', 0.005178578197956085)"
Line 417,"We did not administer  the survey in 2020 as we shifted our resources and  energy toward the well-being of our employees and  our company’s response to critical needs during the  COVID-19 pandemic.
","('Access_And_Affordability', 0.3701429069042206)","('Human_Rights_And_Community_Relations', 0.20084723830223083)","('Employee_Health_And_Safety', 0.07967409491539001)","('NON-ESG', 0.3701429069042206)","('NON-ESG', 0.20084723830223083)","('NON-ESG', 0.07967409491539001)"
Line 418,"During the four years we conducted the BPTW  survey, our scores held steady or increased across  the eight categories we measure.
","('Competitive_Behavior', 0.2592841684818268)","('Management_Of_Legal_And_Regulatory_Framework', 0.15762168169021606)","('Employee_Engagement_Inclusion_And_Diversity', 0.11710231751203537)","('NON-ESG', 0.2592841684818268)","('NON-ESG', 0.15762168169021606)","('NON-ESG', 0.11710231751203537)"
Line 419,"Because employee  engagement is a significant priority for Baxter, we  set a goal several years ago to achieve top quartile  scores in that area by the end of 2020.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9230929613113403)","('Employee_Health_And_Safety', 0.012998176738619804)","('Human_Rights_And_Community_Relations', 0.010598594322800636)","(['Human Capital Development'], 0.9230929613113403)","('NON-ESG', 0.012998176738619804)","('NON-ESG', 0.010598594322800636)"
Line 420,"Between 2016  and 2019, our employee engagement score rose  steadily each year.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8695802688598633)","('Employee_Health_And_Safety', 0.01840888150036335)","('Labor_Practices', 0.015443076379597187)","(['Human Capital Development'], 0.8695802688598633)","('NON-ESG', 0.01840888150036335)","('NON-ESG', 0.015443076379597187)"
Line 421,"During 2019, the last year for  which we have data from the survey, our score in the  engagement category was five percentage points BAXTER’S MANAGER EFFECTIVENESS SURVEY RESULTS, 2020 * higher than it was  in 2016.
","('Business_Model_Resilience', 0.2610345482826233)","('Human_Rights_And_Community_Relations', 0.15792155265808105)","('Management_Of_Legal_And_Regulatory_Framework', 0.11115879565477371)","('NON-ESG', 0.2610345482826233)","('NON-ESG', 0.15792155265808105)","('NON-ESG', 0.11115879565477371)"
Line 422,"It was also  five percentage  points above the  global average and  three percentage  points below the top  quartile benchmark  for that year.3  While  we had not yet  achieved top quartile  scores as of 2019, results demonstrated a positive  trajectory, and we continue to prioritize engagement  with our employees.
","('Employee_Engagement_Inclusion_And_Diversity', 0.15071429312229156)","('Competitive_Behavior', 0.139435812830925)","('Business_Model_Resilience', 0.11548622697591782)","('NON-ESG', 0.15071429312229156)","('NON-ESG', 0.139435812830925)","('NON-ESG', 0.11548622697591782)"
Line 423,"In 2020, in lieu of the BPTW survey, we conducted a  number of other employee surveys to help leadership  understand how employees were feeling about  important and timely topics.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7309651374816895)","('Employee_Health_And_Safety', 0.05168954282999039)","('Human_Rights_And_Community_Relations', 0.028256675228476524)","(['Human Capital Development'], 0.7309651374816895)","('NON-ESG', 0.05168954282999039)","('NON-ESG', 0.028256675228476524)"
Line 424,"For instance, we sent employees a pulse survey in April to find out how  they were feeling about working remotely and  another in September to gather input about various  issues related to returning to the office.
","('Labor_Practices', 0.1649617850780487)","('Director_Removal', 0.12147554010152817)","('Employee_Health_And_Safety', 0.11949402838945389)","('NON-ESG', 0.1649617850780487)","('NON-ESG', 0.12147554010152817)","('NON-ESG', 0.11949402838945389)"
Line 425,"We also invited employees to participate in two  Manager Scorecard surveys to update our people  manager effectiveness scores.
","('Employee_Engagement_Inclusion_And_Diversity', 0.2536478340625763)","('Product_Quality_And_Safety', 0.13914689421653748)","('Access_And_Affordability', 0.1251693069934845)","('NON-ESG', 0.2536478340625763)","('NON-ESG', 0.13914689421653748)","('NON-ESG', 0.1251693069934845)"
Line 426,"These scorecards  summarize anonymous feedback from employees  about the effectiveness of their direct managers.
","('Business_Ethics', 0.154737651348114)","('Employee_Engagement_Inclusion_And_Diversity', 0.12112816423177719)","('Customer_Privacy', 0.09989706426858902)","('NON-ESG', 0.154737651348114)","('NON-ESG', 0.12112816423177719)","('NON-ESG', 0.09989706426858902)"
Line 427,"Based on manager eligibility and employee  participation, we were able to provide 79% of  managers4  with an individual scorecard in June  2020, and 82% of managers with a scorecard in  November 2020.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9465787410736084)","('Employee_Health_And_Safety', 0.007169391959905624)","('Labor_Practices', 0.005134616978466511)","(['Human Capital Development'], 0.9465787410736084)","('NON-ESG', 0.007169391959905624)","('NON-ESG', 0.005134616978466511)"
Line 428,"With responses from more than  25,000 Baxter colleagues for the November survey,  Baxter’s overall manager effectiveness score was  82%, eight percentage points above the threshold  for the top quartile benchmark.
","('Product_Quality_And_Safety', 0.13777710497379303)","('Business_Ethics', 0.10692978650331497)","('Access_And_Affordability', 0.10270774364471436)","('NON-ESG', 0.13777710497379303)","('NON-ESG', 0.10692978650331497)","('NON-ESG', 0.10270774364471436)"
Line 429,"2020 GOALAchieve an employee  engagement score  comparable to top  quartile companies Unavailable VIEW ALL 2020 GOALS   My direct manager demonstrates high ethical standards in what she/he says and does.
","('Business_Ethics', 0.8537077307701111)","('Product_Quality_And_Safety', 0.022298045456409454)","('Human_Rights_And_Community_Relations', 0.01768423244357109)","(['Business Ethics'], 0.8537077307701111)","('NON-ESG', 0.022298045456409454)","('NON-ESG', 0.01768423244357109)"
Line 430,"87% 88% 78% My direct manager cares about me as a person.
","('Human_Rights_And_Community_Relations', 0.15755736827850342)","('Director_Removal', 0.12123443186283112)","('Customer_Privacy', 0.11016453057527542)","('NON-ESG', 0.15755736827850342)","('NON-ESG', 0.12123443186283112)","('NON-ESG', 0.11016453057527542)"
Line 431,"86% 86% 80% I have enough flexibility at work to accommodate the needs/demands of my personal life.
","('Labor_Practices', 0.3511201739311218)","('Employee_Engagement_Inclusion_And_Diversity', 0.12911994755268097)","('Employee_Health_And_Safety', 0.10620023310184479)","('NON-ESG', 0.3511201739311218)","('NON-ESG', 0.12911994755268097)","('NON-ESG', 0.10620023310184479)"
Line 432,"83% 83% 73% My manager gives me helpful feedback.
","('Director_Removal', 0.12757126986980438)","('Business_Model_Resilience', 0.10252375155687332)","('Customer_Privacy', 0.09725216776132584)","('NON-ESG', 0.12757126986980438)","('NON-ESG', 0.10252375155687332)","('NON-ESG', 0.09725216776132584)"
Line 433,"81% 81% 72% My direct manager gives me regular feedback.
","('Director_Removal', 0.15416653454303741)","('Data_Security', 0.09800754487514496)","('Business_Model_Resilience', 0.07766097038984299)","('NON-ESG', 0.15416653454303741)","('NON-ESG', 0.09800754487514496)","('NON-ESG', 0.07766097038984299)"
Line 434,"81% 81% 74% My direct manager does a good job of managing people from diverse backgrounds.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9731006026268005)","('Human_Rights_And_Community_Relations', 0.0022187260910868645)","('Business_Model_Resilience', 0.001852206070907414)","(['Human Capital Development'], 0.9731006026268005)","('NON-ESG', 0.0022187260910868645)","('NON-ESG', 0.001852206070907414)"
Line 435,"80% 81% 75% I am recognized when I do excellent work.
","('Employee_Engagement_Inclusion_And_Diversity', 0.15392784774303436)","('Business_Ethics', 0.10741142928600311)","('Employee_Health_And_Safety', 0.08476502448320389)","('NON-ESG', 0.15392784774303436)","('NON-ESG', 0.10741142928600311)","('NON-ESG', 0.08476502448320389)"
Line 436,"80% 80% 63% My direct manager motivates me to do the very best I can in my job.
","('Employee_Engagement_Inclusion_And_Diversity', 0.15618619322776794)","('Director_Removal', 0.11702215671539307)","('Business_Model_Resilience', 0.09452955424785614)","('NON-ESG', 0.15618619322776794)","('NON-ESG', 0.11702215671539307)","('NON-ESG', 0.09452955424785614)"
Line 437,"78% 79% 74% Overall manager effectiveness score  82% 82% 74%Baxter Results June 2020November 2020Top Quartile ** *  Baxter data represent the percentage of employees who responded favorably to each statement.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5283713936805725)","('Product_Quality_And_Safety', 0.0591190867125988)","('Business_Ethics', 0.052936624735593796)","(['Human Capital Development'], 0.5283713936805725)","('NON-ESG', 0.0591190867125988)","('NON-ESG', 0.052936624735593796)"
Line 438,"The overall manager effectiveness score is the average of the results     from the eight manager effectiveness statements.
","('Business_Ethics', 0.23102536797523499)","('Access_And_Affordability', 0.14537294209003448)","('Product_Quality_And_Safety', 0.11203285306692123)","('NON-ESG', 0.23102536797523499)","('NON-ESG', 0.14537294209003448)","('NON-ESG', 0.11203285306692123)"
Line 439,"Surveys were administered via email.
","('Customer_Privacy', 0.46379873156547546)","('Employee_Engagement_Inclusion_And_Diversity', 0.06286334991455078)","('Labor_Practices', 0.05363304913043976)","('NON-ESG', 0.46379873156547546)","('NON-ESG', 0.06286334991455078)","('NON-ESG', 0.05363304913043976)"
Line 440,"Employees without a Baxter email address, such as those in manufacturing,     did not participate.
","('Customer_Privacy', 0.9157575368881226)","('Data_Security', 0.011067148298025131)","('Labor_Practices', 0.007979780435562134)","(['Privacy Protection'], 0.9157575368881226)","('NON-ESG', 0.011067148298025131)","('NON-ESG', 0.007979780435562134)"
Line 441,"** Top quartile data are from IBM Kenexa and represent more than 400 companies and more than 19 million responses.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT25Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture PERFORMANCE AND CAREER DEVELOPMENT Instead of annual performance ratings, Baxter  embraces a continuous feedback model for  performance management, which includes monthly  check-ins between employees and their managers  that focus on constructive feedback and career  development.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4176742434501648)","('Product_Quality_And_Safety', 0.07352270931005478)","('Business_Model_Resilience', 0.07220534235239029)","('NON-ESG', 0.4176742434501648)","('NON-ESG', 0.07352270931005478)","('NON-ESG', 0.07220534235239029)"
Line 442,"** Top quartile data are from IBM Kenexa and represent more than 400 companies and more than 19 million responses.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT25Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture PERFORMANCE AND CAREER DEVELOPMENT Instead of annual performance ratings, Baxter  embraces a continuous feedback model for  performance management, which includes monthly  check-ins between employees and their managers  that focus on constructive feedback and career  development.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4098494052886963)","('Employee_Health_And_Safety', 0.1186913326382637)","('Labor_Practices', 0.06996231526136398)","('NON-ESG', 0.4098494052886963)","('NON-ESG', 0.1186913326382637)","('NON-ESG', 0.06996231526136398)"
Line 443,"We've found that employees who  take part in monthly check-ins have engagement  rates that are 19 percentage points higher than  employees who do not, based on our most recent  Best Place to Work survey.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7365268468856812)","('Labor_Practices', 0.08429516851902008)","('Employee_Health_And_Safety', 0.03277843818068504)","(['Human Capital Development'], 0.7365268468856812)","('NON-ESG', 0.08429516851902008)","('NON-ESG', 0.03277843818068504)"
Line 444,"Furthermore, to help us better understand  our global talent pipeline, we’ve expanded our  talent review and planning process in the last  several years to include not only senior leaders,  but also managers, supervisors and a subset  of our individual contributors.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9554303884506226)","('Employee_Health_And_Safety', 0.0041033802554011345)","('Business_Model_Resilience', 0.0035892848391085863)","(['Human Capital Development'], 0.9554303884506226)","('NON-ESG', 0.0041033802554011345)","('NON-ESG', 0.0035892848391085863)"
Line 445,"This expansion  helps identify high-potential employees, mitigate  retention-related risk and be more purposeful with  our employee development plans.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9649043083190918)","('Employee_Health_And_Safety', 0.0045213112607598305)","('Business_Model_Resilience', 0.002244441071525216)","(['Human Capital Development'], 0.9649043083190918)","('NON-ESG', 0.0045213112607598305)","('NON-ESG', 0.002244441071525216)"
Line 446,"In addition to regular performance feedback  and discussion, our talent development  philosophy emphasizes continuous learning,  relationship building, mentoring and enhancing  work experiences.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8449854850769043)","('Access_And_Affordability', 0.02137581817805767)","('Employee_Health_And_Safety', 0.018403135240077972)","(['Human Capital Development'], 0.8449854850769043)","('NON-ESG', 0.02137581817805767)","('NON-ESG', 0.018403135240077972)"
Line 447,"We provide virtual, online  and classroom offerings worldwide on topics  such as business/financial acumen, leadership,  management, product knowledge and a wide  range of job-specific skills.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8215363025665283)","('Business_Model_Resilience', 0.02022404782474041)","('Access_And_Affordability', 0.018962621688842773)","(['Human Capital Development'], 0.8215363025665283)","('NON-ESG', 0.02022404782474041)","('NON-ESG', 0.018962621688842773)"
Line 448,"Throughout 2020, our  SmartDevelopment program provided employees  with professional development opportunities  related to our culture lever of simplicity and  strategies for well-being and working effectively  while remote.
","('Employee_Engagement_Inclusion_And_Diversity', 0.46370500326156616)","('Human_Rights_And_Community_Relations', 0.13696542382240295)","('Access_And_Affordability', 0.10280658304691315)","('NON-ESG', 0.46370500326156616)","('NON-ESG', 0.13696542382240295)","('NON-ESG', 0.10280658304691315)"
Line 449,"For example, in line with our  SmartMeeting guidelines, we introduced the  BaxBrief to simplify meeting preparation, increase  meeting effectiveness and reduce the overall  number of meetings people attend.
","('Management_Of_Legal_And_Regulatory_Framework', 0.47094109654426575)","('Competitive_Behavior', 0.06823374330997467)","('Business_Ethics', 0.06749524176120758)","('NON-ESG', 0.47094109654426575)","('NON-ESG', 0.06823374330997467)","('NON-ESG', 0.06749524176120758)"
Line 450,"This one-page,  memo-style document is sent before a meeting begins to outline its purpose, the background of the  topic at hand and next steps for discussion or decision.
","('Management_Of_Legal_And_Regulatory_Framework', 0.39848843216896057)","('Director_Removal', 0.12511079013347626)","('Business_Model_Resilience', 0.0785130187869072)","('NON-ESG', 0.39848843216896057)","('NON-ESG', 0.12511079013347626)","('NON-ESG', 0.0785130187869072)"
Line 451,"In 2020, we recorded approximately 950,000 training  hours, with an average of about 18 hours per employee.Mentoring Baxter offers mentoring opportunities, resources  and tools to all employees, including career advice  and support, knowledge sharing and situational  engagement based on employees’ needs.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5615707039833069)","('Access_And_Affordability', 0.16078540682792664)","('Employee_Health_And_Safety', 0.049420882016420364)","(['Human Capital Development'], 0.5615707039833069)","('NON-ESG', 0.16078540682792664)","('NON-ESG', 0.049420882016420364)"
Line 452,"Any  employee can participate in more than one mentoring  relationship as a mentor or as a mentee.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4227372109889984)","('Access_And_Affordability', 0.17605207860469818)","('Human_Rights_And_Community_Relations', 0.10664757341146469)","('NON-ESG', 0.4227372109889984)","('NON-ESG', 0.17605207860469818)","('NON-ESG', 0.10664757341146469)"
Line 453,"These  engagements may include traditional, peer or reverse  mentoring as well as mentoring circles conducted in  a group setting.
","('Access_And_Affordability', 0.3245767056941986)","('Employee_Engagement_Inclusion_And_Diversity', 0.2162661999464035)","('Human_Rights_And_Community_Relations', 0.08639494329690933)","('NON-ESG', 0.3245767056941986)","('NON-ESG', 0.2162661999464035)","('NON-ESG', 0.08639494329690933)"
Line 454,"Our BRGs facilitate mentoring opportunities as well.
","('Access_And_Affordability', 0.344412624835968)","('Employee_Engagement_Inclusion_And_Diversity', 0.32054051756858826)","('Business_Ethics', 0.035230737179517746)","('NON-ESG', 0.344412624835968)","('NON-ESG', 0.32054051756858826)","('NON-ESG', 0.035230737179517746)"
Line 455,"For example, in 2020, Baxter’s eight BRGs introduced  a new global mentoring program specifically designed  to connect their diverse membership with leaders at  the company.
","('Employee_Engagement_Inclusion_And_Diversity', 0.941314697265625)","('Human_Rights_And_Community_Relations', 0.005980938207358122)","('Business_Model_Resilience', 0.005250691901892424)","(['Human Capital Development'], 0.941314697265625)","('NON-ESG', 0.005980938207358122)","('NON-ESG', 0.005250691901892424)"
Line 456,"This program provides development and  coaching opportunities for employees from a variety  of ethnic backgrounds, genders, sexual orientations,  disabilities and generations as well as those with  veteran status.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9759249687194824)","('Employee_Health_And_Safety', 0.002021871041506529)","('Human_Rights_And_Community_Relations', 0.0019117988413199782)","(['Human Capital Development'], 0.9759249687194824)","('NON-ESG', 0.002021871041506529)","('NON-ESG', 0.0019117988413199782)"
Line 457,"Learn more  about talent development at Baxter.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8958524465560913)","('Human_Rights_And_Community_Relations', 0.009910117834806442)","('Employee_Health_And_Safety', 0.008243562653660774)","(['Human Capital Development'], 0.8958524465560913)","('NON-ESG', 0.009910117834806442)","('NON-ESG', 0.008243562653660774)"
Line 458,"GLOBAL SCHOLARSHIP PROGRAM  Our employees' children can apply for merit- based scholarships, funded by the Baxter  International Foundation.
","('Access_And_Affordability', 0.22971275448799133)","('Management_Of_Legal_And_Regulatory_Framework', 0.19566111266613007)","('Employee_Engagement_Inclusion_And_Diversity', 0.13069714605808258)","('NON-ESG', 0.22971275448799133)","('NON-ESG', 0.19566111266613007)","('NON-ESG', 0.13069714605808258)"
Line 459,"A third-party agency  evaluates student applications based on  academic, extracurricular and employment  accomplishments.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5899718999862671)","('Access_And_Affordability', 0.1222730278968811)","('Labor_Practices', 0.03021829202771187)","(['Human Capital Development'], 0.5899718999862671)","('NON-ESG', 0.1222730278968811)","('NON-ESG', 0.03021829202771187)"
Line 460,"Recipients receive a cash  award, and scholarships may be renewed for  up to three additional years.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5729790925979614)","('Access_And_Affordability', 0.08982773870229721)","('Employee_Engagement_Inclusion_And_Diversity', 0.041553813964128494)","(['Corporate Governance'], 0.5729790925979614)","('NON-ESG', 0.08982773870229721)","('NON-ESG', 0.041553813964128494)"
Line 461,"new scholarshipscountries worldwiderenewed scholarships146BAXTER 2020 CORPORATE RESPONSIBILITY REPORT26Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture MANAGER AND LEADERSHIP DEVELOPMENT During 2020, Baxter continued offering a range  of programs to engage our managers and drive  effective leadership across the company.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3999730050563812)","('Business_Model_Resilience', 0.08118791878223419)","('Employee_Health_And_Safety', 0.07233782857656479)","('NON-ESG', 0.3999730050563812)","('NON-ESG', 0.08118791878223419)","('NON-ESG', 0.07233782857656479)"
Line 462,"new scholarshipscountries worldwiderenewed scholarships146BAXTER 2020 CORPORATE RESPONSIBILITY REPORT26Product  InnovationEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Workplace  Culture MANAGER AND LEADERSHIP DEVELOPMENT During 2020, Baxter continued offering a range  of programs to engage our managers and drive  effective leadership across the company.
","('Employee_Engagement_Inclusion_And_Diversity', 0.22009290754795074)","('Business_Model_Resilience', 0.1582382619380951)","('Human_Rights_And_Community_Relations', 0.08078671991825104)","('NON-ESG', 0.22009290754795074)","('NON-ESG', 0.1582382619380951)","('NON-ESG', 0.08078671991825104)"
Line 463,"This  includes programs related to change management,  quarterly calls about culture change with Baxter’s  CEO, development for mid-level leaders that show  high potential, curriculum for senior leaders  focused on driving cultural transformation through  courageous leadership and a development program  for manufacturing supervisors.
","('Employee_Engagement_Inclusion_And_Diversity', 0.34589776396751404)","('Business_Model_Resilience', 0.19266045093536377)","('Human_Rights_And_Community_Relations', 0.14077989757061005)","('NON-ESG', 0.34589776396751404)","('NON-ESG', 0.19266045093536377)","('NON-ESG', 0.14077989757061005)"
Line 464,"In addition, our  People Manager Development Program focuses  on increasing manager effectiveness by building a  culture of feedback with direct reports, managers  and peers.
","('Employee_Engagement_Inclusion_And_Diversity', 0.30840417742729187)","('Business_Model_Resilience', 0.10837813466787338)","('Human_Rights_And_Community_Relations', 0.07323072105646133)","('NON-ESG', 0.30840417742729187)","('NON-ESG', 0.10837813466787338)","('NON-ESG', 0.07323072105646133)"
Line 465,"Through this program, managers build  critical skills to increase the effectiveness of their  monthly check-ins with employees.
","('Employee_Engagement_Inclusion_And_Diversity', 0.2800056040287018)","('Labor_Practices', 0.1498071849346161)","('Employee_Health_And_Safety', 0.14562639594078064)","('NON-ESG', 0.2800056040287018)","('NON-ESG', 0.1498071849346161)","('NON-ESG', 0.14562639594078064)"
Line 466,"The program  uses a virtual learning approach that blends  structured webinars and self-paced learning with  real-world application and manager involvement.
","('Access_And_Affordability', 0.17937339842319489)","('Competitive_Behavior', 0.14627870917320251)","('Employee_Engagement_Inclusion_And_Diversity', 0.0910128504037857)","('NON-ESG', 0.17937339842319489)","('NON-ESG', 0.14627870917320251)","('NON-ESG', 0.0910128504037857)"
Line 467,"We incorporate the invaluable knowledge of our  leadership team into the webinars by showcasing  Baxter leaders sharing best practices based on their  own experiences.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3677155077457428)","('Human_Rights_And_Community_Relations', 0.09540116786956787)","('Business_Model_Resilience', 0.07780066132545471)","('NON-ESG', 0.3677155077457428)","('NON-ESG', 0.09540116786956787)","('NON-ESG', 0.07780066132545471)"
Line 468,"In 2020, 80% of leaders globally  participated in one or more of these leadership  development programs.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6564329862594604)","('Human_Rights_And_Community_Relations', 0.05317788943648338)","('Business_Model_Resilience', 0.04666121304035187)","(['Human Capital Development'], 0.6564329862594604)","('NON-ESG', 0.05317788943648338)","('NON-ESG', 0.04666121304035187)"
Line 469,"COMPENSATION AND BENEFITS Baxter's total compensation philosophy is to provide  market-competitive pay and benefits globally while  rewarding employees for strong individual and  business performance.
","('Labor_Practices', 0.9369280338287354)","('Employee_Engagement_Inclusion_And_Diversity', 0.012551436200737953)","('Business_Ethics', 0.00745033985003829)","(['Labor Practice Indicators'], 0.9369280338287354)","('NON-ESG', 0.012551436200737953)","('NON-ESG', 0.00745033985003829)"
Line 470,"A 2018 pay equity study of  our U.S. salaried workforce found no significant  pay differences among men, women and ethnic  minorities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4674846827983856)","('Labor_Practices', 0.4386005699634552)","('Employee_Health_And_Safety', 0.009891281835734844)","('NON-ESG', 0.4674846827983856)","('NON-ESG', 0.4386005699634552)","('NON-ESG', 0.009891281835734844)"
Line 471,"In addition, approximately 35% of our  employees work in positions (largely in our plant  locations) where salary levels are based solely on the  job or the job and tenure, eliminating the possibility  of pay equity discrepancies.
","('Labor_Practices', 0.9492772221565247)","('Employee_Engagement_Inclusion_And_Diversity', 0.011696191504597664)","('Director_Removal', 0.0055379848927259445)","(['Labor Practice Indicators'], 0.9492772221565247)","('NON-ESG', 0.011696191504597664)","('NON-ESG', 0.0055379848927259445)"
Line 472,"During 2020, we introduced new benefits to help  employees cope with the impacts of COVID-19.
","('Labor_Practices', 0.2957257628440857)","('Employee_Health_And_Safety', 0.2292720526456833)","('Employee_Engagement_Inclusion_And_Diversity', 0.1398647576570511)","('NON-ESG', 0.2957257628440857)","('NON-ESG', 0.2292720526456833)","('NON-ESG', 0.1398647576570511)"
Line 473,"For example, we rolled out a meditation app  globally to help our employees prioritize mental  health and well-being during this stressful time,  and we provided employees in the United States  with tutoring and childcare resources.
","('Access_And_Affordability', 0.42633065581321716)","('Employee_Health_And_Safety', 0.3456944227218628)","('Human_Rights_And_Community_Relations', 0.035728819668293)","('NON-ESG', 0.42633065581321716)","('NON-ESG', 0.3456944227218628)","('NON-ESG', 0.035728819668293)"
Line 474,"Learn more about employee compensation and   benefits  and executive compensation .
","('Labor_Practices', 0.9338638186454773)","('Employee_Engagement_Inclusion_And_Diversity', 0.01667981594800949)","('Employee_Health_And_Safety', 0.008938067592680454)","(['Labor Practice Indicators'], 0.9338638186454773)","('NON-ESG', 0.01667981594800949)","('NON-ESG', 0.008938067592680454)"
Line 475,"WORKPLACE FLEXIBILITY Baxter recognizes the increasing demands on  employees to manage their personal and work lives,  and respects the need for different approaches  to where, how and when work gets done.
","('Employee_Health_And_Safety', 0.3930054306983948)","('Labor_Practices', 0.26635605096817017)","('Employee_Engagement_Inclusion_And_Diversity', 0.06343391537666321)","('NON-ESG', 0.3930054306983948)","('NON-ESG', 0.26635605096817017)","('NON-ESG', 0.06343391537666321)"
Line 476,"With  tools and resources available for employees and  managers to navigate ad hoc or ongoing flexible  arrangements, employees are encouraged to  discuss with their managers what options might be  right for them and their jobs.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3784653842449188)","('Labor_Practices', 0.28485599160194397)","('Employee_Health_And_Safety', 0.05447101965546608)","('NON-ESG', 0.3784653842449188)","('NON-ESG', 0.28485599160194397)","('NON-ESG', 0.05447101965546608)"
Line 477,"During 2020, the majority of our office-based  (nonmanufacturing) employees shifted to working  from home due to the COVID-19 pandemic.
","('Labor_Practices', 0.6748729944229126)","('Employee_Health_And_Safety', 0.1543305367231369)","('Employee_Engagement_Inclusion_And_Diversity', 0.02122258022427559)","(['Labor Practice Indicators'], 0.6748729944229126)","('NON-ESG', 0.1543305367231369)","('NON-ESG', 0.02122258022427559)"
Line 478,"To support  this shift, we provided resources to help employees  prioritize wellness and work-life balance as well as  tips for using Baxter’s technology to stay connected  and productive.
","('Employee_Health_And_Safety', 0.3553988039493561)","('Employee_Engagement_Inclusion_And_Diversity', 0.31864017248153687)","('Labor_Practices', 0.05987270548939705)","('NON-ESG', 0.3553988039493561)","('NON-ESG', 0.31864017248153687)","('NON-ESG', 0.05987270548939705)"
Line 479,"For example, our WorkSmart Virtually  resources help employees cultivate habits to work  remotely with ease, connect with co-workers, build  team effectiveness and lead through crisis with  empathy and emotional intelligence.
","('Human_Rights_And_Community_Relations', 0.3551943600177765)","('Employee_Health_And_Safety', 0.14578887820243835)","('Employee_Engagement_Inclusion_And_Diversity', 0.11462615430355072)","('NON-ESG', 0.3551943600177765)","('NON-ESG', 0.14578887820243835)","('NON-ESG', 0.11462615430355072)"
Line 480,"Building on what we have learned and experienced  about remote working during the pandemic, we have  introduced a hybrid work arrangement, enabling  employees to combine working from home with  in-office visits to collaborate and connect in person.
","('Employee_Health_And_Safety', 0.6765159964561462)","('Labor_Practices', 0.09765058010816574)","('Employee_Engagement_Inclusion_And_Diversity', 0.03817816078662872)","(['Operational Eco-Efficiency'], 0.6765159964561462)","('NON-ESG', 0.09765058010816574)","('NON-ESG', 0.03817816078662872)"
Line 481,"Learn more  about workplace flexibility at Baxter.
","('Employee_Health_And_Safety', 0.3507176637649536)","('Employee_Engagement_Inclusion_And_Diversity', 0.18335044384002686)","('Labor_Practices', 0.12627588212490082)","('NON-ESG', 0.3507176637649536)","('NON-ESG', 0.18335044384002686)","('NON-ESG', 0.12627588212490082)"
Line 482,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORT27Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction As a global healthcare company with products sold in more than 100 countries, ethics and  compliance is critical in everything we do.
","('Business_Ethics', 0.9643344283103943)","('Product_Quality_And_Safety', 0.005102644674479961)","('Management_Of_Legal_And_Regulatory_Framework', 0.0032159562688320875)","(['Business Ethics'], 0.9643344283103943)","('NON-ESG', 0.005102644674479961)","('NON-ESG', 0.0032159562688320875)"
Line 483,"We prioritize being honest and fair, keeping  promises, encouraging questions, valuing discussion and following legal requirements— always reinforcing the importance of personal accountability and integrity.
","('Business_Ethics', 0.9425504207611084)","('Management_Of_Legal_And_Regulatory_Framework', 0.005360644776374102)","('Human_Rights_And_Community_Relations', 0.005332860164344311)","(['Business Ethics'], 0.9425504207611084)","('NON-ESG', 0.005360644776374102)","('NON-ESG', 0.005332860164344311)"
Line 484,"Patients,  doctors, customers, regulators, investors, communities and our employees count on it.
","('Management_Of_Legal_And_Regulatory_Framework', 0.31723394989967346)","('Human_Rights_And_Community_Relations', 0.1375741809606552)","('Access_And_Affordability', 0.13633005321025848)","('NON-ESG', 0.31723394989967346)","('NON-ESG', 0.1375741809606552)","('NON-ESG', 0.13633005321025848)"
Line 485,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORT 27COMPANYWIDE ACCOUNTABILITY  Baxter has compliance committees for each  country or cluster of countries where we operate  to further integrate ethics and compliance in  strategic plans and day-to-day activities.
","('Business_Ethics', 0.9634952545166016)","('Management_Of_Legal_And_Regulatory_Framework', 0.009332754649221897)","('Product_Quality_And_Safety', 0.0027873010840266943)","(['Business Ethics'], 0.9634952545166016)","('NON-ESG', 0.009332754649221897)","('NON-ESG', 0.0027873010840266943)"
Line 486,"To  ensure the local implementation of our global  ethics and compliance program, the business  lead of each country/cluster holds mandatory  quarterly meetings to facilitate discussion among  local leadership about key issues, challenges and  risks in their area.
","('Business_Ethics', 0.9546302556991577)","('Management_Of_Legal_And_Regulatory_Framework', 0.009775267913937569)","('Product_Quality_And_Safety', 0.0046597872860729694)","(['Business Ethics'], 0.9546302556991577)","('NON-ESG', 0.009775267913937569)","('NON-ESG', 0.0046597872860729694)"
Line 487,"This approach, in conjunction  with enterprise-wide established codes, policies,  trainings and monitoring and assessment  practices, enables us to more effectively target  specific needs and drive ownership of and  responsibility for ethics and compliance worldwide.DRIVING A CULTURE OF ETHICS AND COMPLIANCE Continuous  Improvement of  the Ethics and  Compliance ProgramEthics and Compliance Helpline and InvestigationsAsssessments and  AuditsMonitoring and  Data AnalyticsPROACTIVE:    Design > Implement > Guide Third  Party  Due  Diligence Training  and CommunicationGovernance  and  LeadershipPolicies  and Procedures REACTIVE:    Detect > Prevent > Learn Ethics and Compliance  Drive a culture of integrity and the highest ethical behavior 2020 HIGHLIGHTS Third Party  Program training  offered in                       corruption-related  enforcement  actionsof employees completed annual Code of Conduct training97% languagesBAXTER 2020 CORPORATE RESPONSIBILITY REPORT28Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Fostering a culture  that values ethics and  compliance is of the  utmost importance  to Baxter.
","('Business_Ethics', 0.9714378714561462)","('Management_Of_Legal_And_Regulatory_Framework', 0.0036324893590062857)","('Product_Quality_And_Safety', 0.00254169967956841)","(['Business Ethics'], 0.9714378714561462)","('NON-ESG', 0.0036324893590062857)","('NON-ESG', 0.00254169967956841)"
Line 488,"This approach, in conjunction  with enterprise-wide established codes, policies,  trainings and monitoring and assessment  practices, enables us to more effectively target  specific needs and drive ownership of and  responsibility for ethics and compliance worldwide.DRIVING A CULTURE OF ETHICS AND COMPLIANCE Continuous  Improvement of  the Ethics and  Compliance ProgramEthics and Compliance Helpline and InvestigationsAsssessments and  AuditsMonitoring and  Data AnalyticsPROACTIVE:    Design > Implement > Guide Third  Party  Due  Diligence Training  and CommunicationGovernance  and  LeadershipPolicies  and Procedures REACTIVE:    Detect > Prevent > Learn Ethics and Compliance  Drive a culture of integrity and the highest ethical behavior 2020 HIGHLIGHTS Third Party  Program training  offered in                       corruption-related  enforcement  actionsof employees completed annual Code of Conduct training97% languagesBAXTER 2020 CORPORATE RESPONSIBILITY REPORT28Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Fostering a culture  that values ethics and  compliance is of the  utmost importance  to Baxter.
","('Business_Ethics', 0.9737652540206909)","('Management_Of_Legal_And_Regulatory_Framework', 0.002102646743878722)","('Product_Quality_And_Safety', 0.002063104184344411)","(['Business Ethics'], 0.9737652540206909)","('NON-ESG', 0.002102646743878722)","('NON-ESG', 0.002063104184344411)"
Line 489,"This approach, in conjunction  with enterprise-wide established codes, policies,  trainings and monitoring and assessment  practices, enables us to more effectively target  specific needs and drive ownership of and  responsibility for ethics and compliance worldwide.DRIVING A CULTURE OF ETHICS AND COMPLIANCE Continuous  Improvement of  the Ethics and  Compliance ProgramEthics and Compliance Helpline and InvestigationsAsssessments and  AuditsMonitoring and  Data AnalyticsPROACTIVE:    Design > Implement > Guide Third  Party  Due  Diligence Training  and CommunicationGovernance  and  LeadershipPolicies  and Procedures REACTIVE:    Detect > Prevent > Learn Ethics and Compliance  Drive a culture of integrity and the highest ethical behavior 2020 HIGHLIGHTS Third Party  Program training  offered in                       corruption-related  enforcement  actionsof employees completed annual Code of Conduct training97% languagesBAXTER 2020 CORPORATE RESPONSIBILITY REPORT28Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Fostering a culture  that values ethics and  compliance is of the  utmost importance  to Baxter.
","('Business_Ethics', 0.9615451097488403)","('Product_Quality_And_Safety', 0.005330522544682026)","('Management_Of_Legal_And_Regulatory_Framework', 0.0035663419403135777)","(['Business Ethics'], 0.9615451097488403)","('NON-ESG', 0.005330522544682026)","('NON-ESG', 0.0035663419403135777)"
Line 490,"In 2015, we  established a goal to  achieve top quartile  compliance culture  scores, which we  measure through  Baxter’s annual  Best Place to Work (BPTW) survey.
","('Business_Ethics', 0.6524174809455872)","('Management_Of_Legal_And_Regulatory_Framework', 0.08682944625616074)","('Product_Quality_And_Safety', 0.07593632489442825)","(['Business Ethics'], 0.6524174809455872)","('NON-ESG', 0.08682944625616074)","('NON-ESG', 0.07593632489442825)"
Line 491,"Although we did not  conduct a BPTW survey in 2020 due to the COVID-19  pandemic, results from the BPTW surveys conducted  from 2016 through 2019 demonstrated consistent  improvement in the area of ethics and compliance.
","('Business_Ethics', 0.9642974734306335)","('Management_Of_Legal_And_Regulatory_Framework', 0.005162927322089672)","('Product_Quality_And_Safety', 0.003507862100377679)","(['Business Ethics'], 0.9642974734306335)","('NON-ESG', 0.005162927322089672)","('NON-ESG', 0.003507862100377679)"
Line 492,"During  2019, the most recent year for which we have BPTW  survey results, the scores for the two questions related  to ethics culture improved, compared with the prior year,  and were one percentage point above and two percentage  points below top quartile companies, respectively.1   While the companywide BPTW survey did not occur, we  did survey our global Ethics and Compliance team in 2020  regarding key elements of Baxter’s ethics and compliance  program, including those that are typically measured  by the BPTW survey.
","('Business_Ethics', 0.9647210240364075)","('Product_Quality_And_Safety', 0.0038067405112087727)","('Management_Of_Legal_And_Regulatory_Framework', 0.0029077883809804916)","(['Business Ethics'], 0.9647210240364075)","('NON-ESG', 0.0038067405112087727)","('NON-ESG', 0.0029077883809804916)"
Line 493,"During  2019, the most recent year for which we have BPTW  survey results, the scores for the two questions related  to ethics culture improved, compared with the prior year,  and were one percentage point above and two percentage  points below top quartile companies, respectively.1   While the companywide BPTW survey did not occur, we  did survey our global Ethics and Compliance team in 2020  regarding key elements of Baxter’s ethics and compliance  program, including those that are typically measured  by the BPTW survey.
","('Management_Of_Legal_And_Regulatory_Framework', 0.18043947219848633)","('Energy_Management', 0.10971462726593018)","('Systemic_Risk_Management', 0.10264966636896133)","('NON-ESG', 0.18043947219848633)","('NON-ESG', 0.10971462726593018)","('NON-ESG', 0.10264966636896133)"
Line 494,"The results were positive and  consistent with our expectations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.18434037268161774)","('Competitive_Behavior', 0.16349676251411438)","('Business_Ethics', 0.07791360467672348)","('NON-ESG', 0.18434037268161774)","('NON-ESG', 0.16349676251411438)","('NON-ESG', 0.07791360467672348)"
Line 495,"ETHICS AND COMPLIANCE TRAINING  All employees are required to complete Code of Conduc t  training annually.
","('Business_Ethics', 0.9599657654762268)","('Management_Of_Legal_And_Regulatory_Framework', 0.005966210272163153)","('Product_Quality_And_Safety', 0.003941399045288563)","(['Business Ethics'], 0.9599657654762268)","('NON-ESG', 0.005966210272163153)","('NON-ESG', 0.003941399045288563)"
Line 496,"In 2020, 97% of employees completed  the training.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6692971587181091)","('Labor_Practices', 0.10920029878616333)","('Employee_Health_And_Safety', 0.05628413334488869)","(['Human Capital Development'], 0.6692971587181091)","('NON-ESG', 0.10920029878616333)","('NON-ESG', 0.05628413334488869)"
Line 497,"Select employees also complete online  courses relevant to their jobs every other year on a  rotational basis.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3842583894729614)","('Labor_Practices', 0.3697223961353302)","('Customer_Welfare', 0.021535441279411316)","('NON-ESG', 0.3842583894729614)","('NON-ESG', 0.3697223961353302)","('NON-ESG', 0.021535441279411316)"
Line 498,"These courses cover topics addressed  in Baxter’s Global Interactions Policy and Third Party  Program.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8675907254219055)","('Human_Rights_And_Community_Relations', 0.030575430020689964)","('Business_Ethics', 0.012096610851585865)","(['Corporate Governance'], 0.8675907254219055)","('NON-ESG', 0.030575430020689964)","('NON-ESG', 0.012096610851585865)"
Line 499,"In addition to the anticorruption content  covered by the Code of Conduct and Global Interactions  Policy training, our sales force participates in  business-led, interactive workshops/trainings related  to ethical interactions with the medical community   and government officials, including discussion of  real-life scenarios.
","('Business_Ethics', 0.9257134795188904)","('Management_Of_Legal_And_Regulatory_Framework', 0.012020695023238659)","('Human_Rights_And_Community_Relations', 0.009125138632953167)","(['Business Ethics'], 0.9257134795188904)","('NON-ESG', 0.012020695023238659)","('NON-ESG', 0.009125138632953167)"
Line 500,"THIRD PARTY PROGRAM Baxter is committed to conducting business with  integrity and in compliance with the law wherever we  operate.
","('Business_Ethics', 0.7550166249275208)","('Management_Of_Legal_And_Regulatory_Framework', 0.15415850281715393)","('Competitive_Behavior', 0.011169707402586937)","(['Business Ethics'], 0.7550166249275208)","('NON-ESG', 0.15415850281715393)","('NON-ESG', 0.011169707402586937)"
Line 501,"Our Third Party Program policy and training  outline the standards and processes used to review,  retain and monitor new and existing third parties for  compliance with our anticorruption expectations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7013000845909119)","('Product_Quality_And_Safety', 0.09691406786441803)","('Business_Ethics', 0.04942360520362854)","(['Corporate Governance'], 0.7013000845909119)","('NON-ESG', 0.09691406786441803)","('NON-ESG', 0.04942360520362854)"
Line 502,"The program and policy apply to Baxter employees,  officers and directors involved in the review, retention  and monitoring of third parties.
","('Employee_Engagement_Inclusion_And_Diversity', 0.942487359046936)","('Labor_Practices', 0.008312314748764038)","('Director_Removal', 0.006657996214926243)","(['Human Capital Development'], 0.942487359046936)","('NON-ESG', 0.008312314748764038)","('NON-ESG', 0.006657996214926243)"
Line 503,"We offer related  training for Baxter employees in 18 languages.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3853057622909546)","('Access_And_Affordability', 0.24192191660404205)","('Human_Rights_And_Community_Relations', 0.04379284381866455)","('NON-ESG', 0.3853057622909546)","('NON-ESG', 0.24192191660404205)","('NON-ESG', 0.04379284381866455)"
Line 504,"COMPLIANCE ASSESSMENTS   Baxter completes risk-based compliance assessments  and audits each year which cover antibribery,  anticorruption and trade compliance, among other  topics.
","('Business_Ethics', 0.5796642899513245)","('Management_Of_Legal_And_Regulatory_Framework', 0.27622440457344055)","('Systemic_Risk_Management', 0.019146108999848366)","(['Business Ethics'], 0.5796642899513245)","('NON-ESG', 0.27622440457344055)","('NON-ESG', 0.019146108999848366)"
Line 505,"Our Global Ethics and Compliance function  selects locations to audit and assess based on factors  such as business complexity, size, risk of corruption,  the nature of interactions with the medical community  and third parties, enforcement trends, and the results of  compliance monitoring and investigations.
","('Business_Ethics', 0.9755050539970398)","('Management_Of_Legal_And_Regulatory_Framework', 0.0028552631847560406)","('Product_Quality_And_Safety', 0.0018725560512393713)","(['Business Ethics'], 0.9755050539970398)","('NON-ESG', 0.0028552631847560406)","('NON-ESG', 0.0018725560512393713)"
Line 506,"Compliance  assessments and audits also focus on relationships with  third parties that represent the company to customers, including the medical community, patients and  government officials and entities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.46801096200942993)","('Business_Ethics', 0.4242056906223297)","('Product_Quality_And_Safety', 0.011927321553230286)","('NON-ESG', 0.46801096200942993)","('NON-ESG', 0.4242056906223297)","('NON-ESG', 0.011927321553230286)"
Line 507,"In 2020, we conducted two compliance assessments   using Global Audit and Ethics and Compliance resources:  one in our Europe, Middle East and Africa (EMEA) region  and one in Latin America.
","('Business_Ethics', 0.9477397799491882)","('Management_Of_Legal_And_Regulatory_Framework', 0.013518066145479679)","('Product_Quality_And_Safety', 0.003862380748614669)","(['Business Ethics'], 0.9477397799491882)","('NON-ESG', 0.013518066145479679)","('NON-ESG', 0.003862380748614669)"
Line 508,"These assessments were  performed remotely as a result of COVID-19.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2709923982620239)","('GHG_Emissions', 0.2469252347946167)","('Access_And_Affordability', 0.0687207281589508)","('NON-ESG', 0.2709923982620239)","('NON-ESG', 0.2469252347946167)","('NON-ESG', 0.0687207281589508)"
Line 509,"We had also  scheduled an assessment for Asia Pacific (APAC) in 2020,  which we have deferred to 2021.
","('Business_Model_Resilience', 0.19770893454551697)","('Management_Of_Legal_And_Regulatory_Framework', 0.17520898580551147)","('Human_Rights_And_Community_Relations', 0.07413151860237122)","('NON-ESG', 0.19770893454551697)","('NON-ESG', 0.17520898580551147)","('NON-ESG', 0.07413151860237122)"
Line 510,"Additionally, we performed remote compliance audits  of 15 distributors globally during 2020.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5539055466651917)","('Business_Ethics', 0.30121612548828125)","('Product_Quality_And_Safety', 0.018188968300819397)","(['Corporate Governance'], 0.5539055466651917)","('NON-ESG', 0.30121612548828125)","('NON-ESG', 0.018188968300819397)"
Line 511,"The audits  covered six distributors in EMEA, five in Latin America  and four in APAC.
","('Systemic_Risk_Management', 0.3627097010612488)","('Management_Of_Legal_And_Regulatory_Framework', 0.2546394169330597)","('Competitive_Behavior', 0.05443364754319191)","('NON-ESG', 0.3627097010612488)","('NON-ESG', 0.2546394169330597)","('NON-ESG', 0.05443364754319191)"
Line 512,"COMPLIANCE MONITORING    Baxter has deployed a data analytics-based monitoring  system in 32 key countries around the world, including  Brazil, China, India and Russia.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7481852769851685)","('Business_Ethics', 0.0646873414516449)","('Human_Rights_And_Community_Relations', 0.022810500115156174)","(['Corporate Governance'], 0.7481852769851685)","('NON-ESG', 0.0646873414516449)","('NON-ESG', 0.022810500115156174)"
Line 513,"This system enables  us to perform near-real-time monitoring of metrics  related to travel, entertainment and interactions with  healthcare professionals and government officials.
","('Employee_Health_And_Safety', 0.30957159399986267)","('Customer_Privacy', 0.13240589201450348)","('Access_And_Affordability', 0.0818464607000351)","('NON-ESG', 0.30957159399986267)","('NON-ESG', 0.13240589201450348)","('NON-ESG', 0.0818464607000351)"
Line 514,"Transactions identified as potentially problematic are  reviewed by the Ethics and Compliance investigation  team as appropriate.
","('Business_Ethics', 0.9655729532241821)","('Management_Of_Legal_And_Regulatory_Framework', 0.00544185983017087)","('Director_Removal', 0.0027590037789195776)","(['Business Ethics'], 0.9655729532241821)","('NON-ESG', 0.00544185983017087)","('NON-ESG', 0.0027590037789195776)"
Line 515,"Moving forward, our objective is to perform more  in-depth, forensic-based monitoring on a select number  of higher risk countries.
","('Systemic_Risk_Management', 0.8892452716827393)","('Business_Ethics', 0.018376873806118965)","('Business_Model_Resilience', 0.016672903671860695)","(['Risk & Crisis Management'], 0.8892452716827393)","('NON-ESG', 0.018376873806118965)","('NON-ESG', 0.016672903671860695)"
Line 516,"This will be performed on a  rotational basis to continue to expand our risk coverage.
","('Systemic_Risk_Management', 0.848712682723999)","('Management_Of_Legal_And_Regulatory_Framework', 0.025523362681269646)","('Competitive_Behavior', 0.022010382264852524)","(['Risk & Crisis Management'], 0.848712682723999)","('NON-ESG', 0.025523362681269646)","('NON-ESG', 0.022010382264852524)"
Line 517,"Baxter had zero  corruption-related  enforcement actions  in 2020.
","('Business_Ethics', 0.9678887128829956)","('Management_Of_Legal_And_Regulatory_Framework', 0.004746874328702688)","('Data_Security', 0.0024030134081840515)","(['Business Ethics'], 0.9678887128829956)","('NON-ESG', 0.004746874328702688)","('NON-ESG', 0.0024030134081840515)"
Line 518,"2020 GOALAchieve overall  compliance culture  scores in the top  quartile of general  industry benchmarks Unavailable VIEW ALL 2020 GOALS 2020 GOALAchieve zero  government  enforcement   actions over  compliance  issues.
","('Business_Ethics', 0.6533048152923584)","('Management_Of_Legal_And_Regulatory_Framework', 0.2467697262763977)","('Product_Quality_And_Safety', 0.015326456166803837)","(['Business Ethics'], 0.6533048152923584)","('NON-ESG', 0.2467697262763977)","('NON-ESG', 0.015326456166803837)"
Line 519,"Achieved VIEW ALL 2020 GOALSBAXTER 2020 CORPORATE RESPONSIBILITY REPORT29Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction RELATIONSHIPS WITH HEALTHCARE  PROFESSIONALS AND GOVERNMENT  OFFICIALS Baxter is committed to transparent reporting about  relationships with the medical community and  government officials.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2969738245010376)","('Business_Ethics', 0.17058591544628143)","('Product_Quality_And_Safety', 0.1378510743379593)","('NON-ESG', 0.2969738245010376)","('NON-ESG', 0.17058591544628143)","('NON-ESG', 0.1378510743379593)"
Line 520,"Achieved VIEW ALL 2020 GOALSBAXTER 2020 CORPORATE RESPONSIBILITY REPORT29Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction RELATIONSHIPS WITH HEALTHCARE  PROFESSIONALS AND GOVERNMENT  OFFICIALS Baxter is committed to transparent reporting about  relationships with the medical community and  government officials.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6394684314727783)","('Director_Removal', 0.06016431748867035)","('Business_Ethics', 0.04823650047183037)","(['Corporate Governance'], 0.6394684314727783)","('NON-ESG', 0.06016431748867035)","('NON-ESG', 0.04823650047183037)"
Line 521,"This includes the continued  implementation of anticorruption programs to ensure   that those relationships and the related fair market value  payments are for necessary and genuine services.
","('Competitive_Behavior', 0.7276889085769653)","('Management_Of_Legal_And_Regulatory_Framework', 0.12053044140338898)","('Business_Ethics', 0.04667598754167557)","(['Business Ethics'], 0.7276889085769653)","('NON-ESG', 0.12053044140338898)","('NON-ESG', 0.04667598754167557)"
Line 522,"Our  Global Interactions Policy  defines the principles and rules  governing our interactions with government officials and  members of the medical community.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9008718729019165)","('Business_Ethics', 0.01972373016178608)","('Human_Rights_And_Community_Relations', 0.009747660718858242)","(['Corporate Governance'], 0.9008718729019165)","('NON-ESG', 0.01972373016178608)","('NON-ESG', 0.009747660718858242)"
Line 523,"The Global Interactions Policy also provides guidance  for corporate charitable giving to ensure compliance  with the law and with Baxter policy.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9003180265426636)","('Access_And_Affordability', 0.01750042848289013)","('Business_Ethics', 0.011096454225480556)","(['Corporate Governance'], 0.9003180265426636)","('NON-ESG', 0.01750042848289013)","('NON-ESG', 0.011096454225480556)"
Line 524,"We have Local  Contributions Management Committees in select  countries, clusters of countries or regions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7473567724227905)","('Competitive_Behavior', 0.03833162784576416)","('Human_Rights_And_Community_Relations', 0.03737452253699303)","(['Corporate Governance'], 0.7473567724227905)","('NON-ESG', 0.03833162784576416)","('NON-ESG', 0.03737452253699303)"
Line 525,"Where they exist, those local committees have decision-making  authority for charitable contribution requests from  nonprofit and for-profit healthcare and patient  organizations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6965737342834473)","('Access_And_Affordability', 0.11669515073299408)","('Human_Rights_And_Community_Relations', 0.0177778210490942)","(['Corporate Governance'], 0.6965737342834473)","('NON-ESG', 0.11669515073299408)","('NON-ESG', 0.0177778210490942)"
Line 526,"The Baxter International Foundation,  the philanthropic arm of Baxter International Inc., is  a separate legal entity governed by its own Board of  Directors and has distinct grantmaking guidelines  that outline policies for charitable contributions to  nonprofit organizations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8260574340820312)","('Access_And_Affordability', 0.02398720383644104)","('Business_Ethics', 0.01856077089905739)","(['Corporate Governance'], 0.8260574340820312)","('NON-ESG', 0.02398720383644104)","('NON-ESG', 0.01856077089905739)"
Line 527,"ETHICS AND COMPLIANCE HELPLINE  In 2020, Baxter logged 727 reports from 41 countries  into our Ethics and Compliance Helpline system  and closed 700 cases that were received through  2020.2 All reports received during the year involving  allegations of misconduct were promptly triaged for  investigation.
","('Business_Ethics', 0.9701514840126038)","('Management_Of_Legal_And_Regulatory_Framework', 0.004253032151609659)","('Product_Quality_And_Safety', 0.0026282519102096558)","(['Business Ethics'], 0.9701514840126038)","('NON-ESG', 0.004253032151609659)","('NON-ESG', 0.0026282519102096558)"
Line 528,"More than 65 of the reports logged  in 2020 raised questions or concerns relating to COVID-19 and were assigned to other teams (such  as Environment, Health, Safety and Sustainability  or Human Resources) for resolution or further  investigation.
","('Employee_Health_And_Safety', 0.957425594329834)","('Critical_Incident_Risk_Management', 0.013379555195569992)","('Human_Rights_And_Community_Relations', 0.0032964590936899185)","(['Operational Eco-Efficiency'], 0.957425594329834)","('NON-ESG', 0.013379555195569992)","('NON-ESG', 0.0032964590936899185)"
Line 529,"Of the substantiated cases closed  in 2020, appropriate remediation (e.g., training or  adoption of new or changed processes) was or is  being implemented where warranted.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4960053563117981)","('Business_Ethics', 0.21158485114574432)","('Critical_Incident_Risk_Management', 0.03799077495932579)","('NON-ESG', 0.4960053563117981)","('NON-ESG', 0.21158485114574432)","('NON-ESG', 0.03799077495932579)"
Line 530,"In substantiated  cases involving employee misconduct, employees  received appropriate disciplinary action based on  the nature of the misconduct and other factors.
","('Business_Ethics', 0.800162136554718)","('Employee_Health_And_Safety', 0.05536545068025589)","('Labor_Practices', 0.02269829995930195)","(['Business Ethics'], 0.800162136554718)","('NON-ESG', 0.05536545068025589)","('NON-ESG', 0.02269829995930195)"
Line 531,"Disciplinary action can include a range of outcomes,  including coaching and training, verbal or written  warnings, compensation reduction or termination.
","('Employee_Health_And_Safety', 0.3093681037425995)","('Employee_Engagement_Inclusion_And_Diversity', 0.21333642303943634)","('Labor_Practices', 0.2108335942029953)","('NON-ESG', 0.3093681037425995)","('NON-ESG', 0.21333642303943634)","('NON-ESG', 0.2108335942029953)"
Line 532,"Work Environment/Employee Relations 57% Manufacturing/EHS&S/R&D/Regulatory/Quality 24% Conflict of Interest  5% Interactions with Government Officials Including HCPs/HCOs (outside the United States)  4% Marketing and Sales  4% Financial Management and Reporting  3% Asset or Information Misuse or Misappropriation/Confidential Data  2% Competitive Practices <1% Payments/Gifts/Entertainment with HCPs/HCOs (United States)  <1%Category % of total*ITEMS REPORTED TO THE ETHICS AND COMPLIANCE HELPLINE IN * ""HCPs"" are healthcare professionals.
","('Business_Ethics', 0.9603111743927002)","('Data_Security', 0.006498710252344608)","('Customer_Privacy', 0.005508445203304291)","(['Business Ethics'], 0.9603111743927002)","('NON-ESG', 0.006498710252344608)","('NON-ESG', 0.005508445203304291)"
Line 533,"Work Environment/Employee Relations 57% Manufacturing/EHS&S/R&D/Regulatory/Quality 24% Conflict of Interest  5% Interactions with Government Officials Including HCPs/HCOs (outside the United States)  4% Marketing and Sales  4% Financial Management and Reporting  3% Asset or Information Misuse or Misappropriation/Confidential Data  2% Competitive Practices <1% Payments/Gifts/Entertainment with HCPs/HCOs (United States)  <1%Category % of total*ITEMS REPORTED TO THE ETHICS AND COMPLIANCE HELPLINE IN * ""HCPs"" are healthcare professionals.
","('Access_And_Affordability', 0.17388546466827393)","('Employee_Engagement_Inclusion_And_Diversity', 0.10699640959501266)","('Product_Design_And_Lifecycle_Management', 0.090329110622406)","('NON-ESG', 0.17388546466827393)","('NON-ESG', 0.10699640959501266)","('NON-ESG', 0.090329110622406)"
Line 534,"""HCOs"" are healthcare organizations.
","('Systemic_Risk_Management', 0.22353355586528778)","('Customer_Welfare', 0.08441601693630219)","('Access_And_Affordability', 0.08283170312643051)","('NON-ESG', 0.22353355586528778)","('NON-ESG', 0.08441601693630219)","('NON-ESG', 0.08283170312643051)"
Line 535,"Puerto Rico is counted as part of the United States.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT30Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction PRIVACY AND DATA PROTECTION   Baxter is committed to respecting the privacy of our  patients, employees and customers.
","('Data_Security', 0.845289409160614)","('Customer_Privacy', 0.08235401660203934)","('Business_Ethics', 0.005936382804065943)","(['Information Security/Cybersecurity & System Availability'], 0.845289409160614)","('NON-ESG', 0.08235401660203934)","('NON-ESG', 0.005936382804065943)"
Line 536,"Baxter’s Global  Privacy Policy defines our privacy standards and  guides our global operations to follow similar controls  for protecting personal information.
","('Customer_Privacy', 0.8827878832817078)","('Data_Security', 0.06459345668554306)","('Waste_And_Hazardous_Materials_Management', 0.0039193592965602875)","(['Privacy Protection'], 0.8827878832817078)","('NON-ESG', 0.06459345668554306)","('NON-ESG', 0.0039193592965602875)"
Line 537,"During 2020, we  closely followed market developments and enforcement  actions related to the EU General Data Protection  Regulation (GDPR) as we collaborated with our network  of privacy experts across the EU to successfully address  the regulation.
","('Data_Security', 0.794348955154419)","('Management_Of_Legal_And_Regulatory_Framework', 0.06802923232316971)","('Customer_Privacy', 0.027019865810871124)","(['Information Security/Cybersecurity & System Availability'], 0.794348955154419)","('NON-ESG', 0.06802923232316971)","('NON-ESG', 0.027019865810871124)"
Line 538,"In 2020, we also continued to monitor  proposed changes to privacy legislation and regulations  in other locations to assess the impact on Baxter and to  implement changes to our privacy control framework as  we prepared to comply with new privacy requirements.
","('Data_Security', 0.45901262760162354)","('Customer_Privacy', 0.3735235631465912)","('Management_Of_Legal_And_Regulatory_Framework', 0.026180751621723175)","('NON-ESG', 0.45901262760162354)","('NON-ESG', 0.3735235631465912)","('NON-ESG', 0.026180751621723175)"
Line 539,"This included the California Consumer Privacy Act, for  which additional amendments and regulations were  issued.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4538670778274536)","('Data_Security', 0.09819494932889938)","('Competitive_Behavior', 0.09603440761566162)","('NON-ESG', 0.4538670778274536)","('NON-ESG', 0.09819494932889938)","('NON-ESG', 0.09603440761566162)"
Line 540,"We also closely monitored privacy issues arising  out of the COVID-19 pandemic, including laws and  regulations addressing testing and contact tracing, to  assess the impact on Baxter as the company took steps  to address the pandemic.
","('Data_Security', 0.9117905497550964)","('Customer_Privacy', 0.02397329732775688)","('Systemic_Risk_Management', 0.007704803720116615)","(['Information Security/Cybersecurity & System Availability'], 0.9117905497550964)","('NON-ESG', 0.02397329732775688)","('NON-ESG', 0.007704803720116615)"
Line 541,"Management and oversight of IT security is a priority  for Baxter’s senior management.
","('Data_Security', 0.646692156791687)","('Systemic_Risk_Management', 0.10804746299982071)","('Business_Ethics', 0.06979209929704666)","(['Information Security/Cybersecurity & System Availability'], 0.646692156791687)","('NON-ESG', 0.10804746299982071)","('NON-ESG', 0.06979209929704666)"
Line 542,"Our Information Risk  Committee, co-led by our Chief Privacy Officer and our  Chief Information Security Officer, ensures Baxter's  privacy and security efforts are aligned with the  company's broader business initiatives and that our  business leaders are aware of changing regulatory or  technical risks.
","('Data_Security', 0.9580295085906982)","('Customer_Privacy', 0.006968815345317125)","('Business_Ethics', 0.0031663854606449604)","(['Information Security/Cybersecurity & System Availability'], 0.9580295085906982)","('NON-ESG', 0.006968815345317125)","('NON-ESG', 0.0031663854606449604)"
Line 543,"In addition, two separate committees  of our Board of Directors oversee our IT security program   strategy and efficacy and receive regular updates.
","('Director_Removal', 0.5309609174728394)","('Management_Of_Legal_And_Regulatory_Framework', 0.1852790266275406)","('Business_Model_Resilience', 0.03924263268709183)","(['Anti-Crime Policy & Measures'], 0.5309609174728394)","('NON-ESG', 0.1852790266275406)","('NON-ESG', 0.03924263268709183)"
Line 544,"The   Audit Committee provides oversight for IT security  matters generally and the Quality, Compliance and  Technology Committee provides oversight for product  cybersecurity matters.
","('Data_Security', 0.3952201306819916)","('Management_Of_Legal_And_Regulatory_Framework', 0.22827452421188354)","('Business_Ethics', 0.11769281327724457)","('NON-ESG', 0.3952201306819916)","('NON-ESG', 0.22827452421188354)","('NON-ESG', 0.11769281327724457)"
Line 545,"Baxter's Digital Security Policy outlines our approach  to information security and the standards we require  employees and suppliers to follow.
","('Data_Security', 0.9550994634628296)","('Customer_Privacy', 0.008090176619589329)","('Business_Ethics', 0.0037025632336735725)","(['Information Security/Cybersecurity & System Availability'], 0.9550994634628296)","('NON-ESG', 0.008090176619589329)","('NON-ESG', 0.0037025632336735725)"
Line 546,"We also provide an  online Product Security summary  that customers can  access to learn about security vulnerabilities that might  affect Baxter products.
","('Data_Security', 0.9426730275154114)","('Systemic_Risk_Management', 0.006916505750268698)","('Business_Ethics', 0.005633686203509569)","(['Information Security/Cybersecurity & System Availability'], 0.9426730275154114)","('NON-ESG', 0.006916505750268698)","('NON-ESG', 0.005633686203509569)"
Line 547,"In response to growing and changing cyber threats,  we consistently assess and strengthen our cyber  defenses and response capabilities.
","('Data_Security', 0.9148546457290649)","('Physical_Impacts_Of_Climate_Change', 0.010798759758472443)","('Systemic_Risk_Management', 0.008498480543494225)","(['Information Security/Cybersecurity & System Availability'], 0.9148546457290649)","('NON-ESG', 0.010798759758472443)","('NON-ESG', 0.008498480543494225)"
Line 548,"The Global IT  Security Operations team helps to protect Baxter against  cyberattacks using a range of defenses that secure our  assets, reduce detection time and improve recoverability.
","('Data_Security', 0.953795313835144)","('Systemic_Risk_Management', 0.007075759582221508)","('Business_Ethics', 0.004040732514113188)","(['Information Security/Cybersecurity & System Availability'], 0.953795313835144)","('NON-ESG', 0.007075759582221508)","('NON-ESG', 0.004040732514113188)"
Line 549,"During 2020, we implemented a new threat hunting  process to enhance the protection of our systems  against evolving security threats.
","('Data_Security', 0.9504720568656921)","('Physical_Impacts_Of_Climate_Change', 0.0045120795257389545)","('Customer_Privacy', 0.003840732155367732)","(['Information Security/Cybersecurity & System Availability'], 0.9504720568656921)","('NON-ESG', 0.0045120795257389545)","('NON-ESG', 0.003840732155367732)"
Line 550,"We also enhanced our  Governance Risk and Compliance program to include  risk-based reviews and due diligence monitoring.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6203252673149109)","('Business_Ethics', 0.21480214595794678)","('Systemic_Risk_Management', 0.04093777760863304)","(['Corporate Governance'], 0.6203252673149109)","('NON-ESG', 0.21480214595794678)","('NON-ESG', 0.04093777760863304)"
Line 551,"We continue to raise security awareness with all  Baxter users through mandatory training and recurring  reinforcement through virtual events and updated  materials.
","('Data_Security', 0.9122954607009888)","('Business_Ethics', 0.013003760948777199)","('Customer_Privacy', 0.0067970771342515945)","(['Information Security/Cybersecurity & System Availability'], 0.9122954607009888)","('NON-ESG', 0.013003760948777199)","('NON-ESG', 0.0067970771342515945)"
Line 552,"We require multifactor authentication and an  always-on virtual private network (VPN) system to provide  additional safeguards for our employees working remotely.
","('Data_Security', 0.9199730753898621)","('Business_Ethics', 0.013789676129817963)","('Customer_Privacy', 0.011084701865911484)","(['Information Security/Cybersecurity & System Availability'], 0.9199730753898621)","('NON-ESG', 0.013789676129817963)","('NON-ESG', 0.011084701865911484)"
Line 553,"In addition, during 2020, we expanded our Third Party  Risk Management program to include review of security  standards and procedures for critical external suppliers.
","('Data_Security', 0.6133370399475098)","('Business_Ethics', 0.0928267315030098)","('Systemic_Risk_Management', 0.06779229640960693)","(['Information Security/Cybersecurity & System Availability'], 0.6133370399475098)","('NON-ESG', 0.0928267315030098)","('NON-ESG', 0.06779229640960693)"
Line 554,"Baxter’s Digital Security Controls Framework has been  formally documented and conforms to the industry  standard NIST 800 and ISO27001 frameworks.
","('Data_Security', 0.9097234606742859)","('Business_Ethics', 0.011812540702521801)","('Systemic_Risk_Management', 0.010722121223807335)","(['Information Security/Cybersecurity & System Availability'], 0.9097234606742859)","('NON-ESG', 0.011812540702521801)","('NON-ESG', 0.010722121223807335)"
Line 555,"Baxter has  received ISO27001 certification and renewed the French  HDH Certification for Sharesource connectivity platform.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT31Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Apex Companies LLC has provided assurance on the content in this section.Employee Health and Safety  Achieve a zero-harm workplace and improve employee well-being 2020 HIGHLIGHTS In pursuit of Baxter’s aspiration to be a Best Place to Work, we provide a safe workplace  and the resources employees need to maintain and improve their health and wellness.
","('Product_Quality_And_Safety', 0.40127018094062805)","('Product_Design_And_Lifecycle_Management', 0.0984620451927185)","('Access_And_Affordability', 0.07811948657035828)","('NON-ESG', 0.40127018094062805)","('NON-ESG', 0.0984620451927185)","('NON-ESG', 0.07811948657035828)"
Line 556,"Baxter has  received ISO27001 certification and renewed the French  HDH Certification for Sharesource connectivity platform.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT31Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Apex Companies LLC has provided assurance on the content in this section.Employee Health and Safety  Achieve a zero-harm workplace and improve employee well-being 2020 HIGHLIGHTS In pursuit of Baxter’s aspiration to be a Best Place to Work, we provide a safe workplace  and the resources employees need to maintain and improve their health and wellness.
","('Employee_Health_And_Safety', 0.9837098121643066)","('Critical_Incident_Risk_Management', 0.0018720970256254077)","('Employee_Engagement_Inclusion_And_Diversity', 0.0017069021705538034)","(['Operational Eco-Efficiency'], 0.9837098121643066)","('NON-ESG', 0.0018720970256254077)","('NON-ESG', 0.0017069021705538034)"
Line 557,"In 2020, we focused our programs on a robust pandemic response as well as supporting  employee participation in health and wellness activities.
","('Critical_Incident_Risk_Management', 0.5979974269866943)","('Employee_Health_And_Safety', 0.22634179890155792)","('Physical_Impacts_Of_Climate_Change', 0.028100693598389626)","(['Risk & Crisis Management'], 0.5979974269866943)","('NON-ESG', 0.22634179890155792)","('NON-ESG', 0.028100693598389626)"
Line 558,"As we delivered on Baxter's  mission to save and sustain lives in facilities around the world, we also prioritized our  employees’ physical, social and mental well-being.
","('Employee_Health_And_Safety', 0.5288457870483398)","('Human_Rights_And_Community_Relations', 0.21257779002189636)","('Access_And_Affordability', 0.05975515767931938)","(['Operational Eco-Efficiency'], 0.5288457870483398)","('NON-ESG', 0.21257779002189636)","('NON-ESG', 0.05975515767931938)"
Line 559,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORT 31Baxter follows a management-systems  approach guided by our global Environmental,  Health, Safety and Sustainability (EHS&S)  requirements.
","('Employee_Health_And_Safety', 0.8924781084060669)","('Product_Quality_And_Safety', 0.026052609086036682)","('Human_Rights_And_Community_Relations', 0.010291519574820995)","(['Operational Eco-Efficiency'], 0.8924781084060669)","('NON-ESG', 0.026052609086036682)","('NON-ESG', 0.010291519574820995)"
Line 560,"For more about Baxter’s EHS&S  management system, see Operations .
","('Business_Model_Resilience', 0.2777354121208191)","('Systemic_Risk_Management', 0.20687051117420197)","('Supply_Chain_Management', 0.048749376088380814)","('NON-ESG', 0.2777354121208191)","('NON-ESG', 0.20687051117420197)","('NON-ESG', 0.048749376088380814)"
Line 561,"We clearly  define the responsibilities of corporate, regional  and facility-level occupational health and safety  professionals and hold leaders accountable  for achieving goals and targets.
","('Employee_Health_And_Safety', 0.9841521978378296)","('Critical_Incident_Risk_Management', 0.0018461538711562753)","('Employee_Engagement_Inclusion_And_Diversity', 0.0016960457433015108)","(['Operational Eco-Efficiency'], 0.9841521978378296)","('NON-ESG', 0.0018461538711562753)","('NON-ESG', 0.0016960457433015108)"
Line 562,"In 2020,  the EHS&S organization reported employee  safety performance to senior leadership and  manufacturing and supply chain management  monthly.
","('Supply_Chain_Management', 0.8860986232757568)","('Employee_Health_And_Safety', 0.025872785598039627)","('Product_Design_And_Lifecycle_Management', 0.013012470677495003)","(['Supply Chain Management'], 0.8860986232757568)","('NON-ESG', 0.025872785598039627)","('NON-ESG', 0.013012470677495003)"
Line 563,"EHS&S also communicates  performance to Baxter's Board of Directors.INJURY AND  ILLNESS  PERFORMANCE1  In 2020, due to COVID-19,    Baxter experienced  an increase in total  recordable incident  rate (TRIR) and cases  with days lost rate from  the prior year.
","('Employee_Health_And_Safety', 0.982487142086029)","('Critical_Incident_Risk_Management', 0.0033917436376214027)","('Employee_Engagement_Inclusion_And_Diversity', 0.0013583318796008825)","(['Operational Eco-Efficiency'], 0.982487142086029)","('NON-ESG', 0.0033917436376214027)","('NON-ESG', 0.0013583318796008825)"
Line 564,"In a comparison of 23 companies globally  across all industries,2 Baxter’s TRIR during the year  ranked thirteenth.
","('Systemic_Risk_Management', 0.4802015423774719)","('Supply_Chain_Management', 0.16423365473747253)","('Business_Model_Resilience', 0.15797212719917297)","('NON-ESG', 0.4802015423774719)","('NON-ESG', 0.16423365473747253)","('NON-ESG', 0.15797212719917297)"
Line 565,"Although we did not achieve top quartile   performance in 2020, we did in 2018 and 2019.*Compared with 2019.52%Restricted days rate  employees participated   in the virtual  BeWell@Baxter  Exercise Challenge14,*Introduced monthly  wellness  days emphasizing  physical, mental and  social well-being 2020 GOALAchieve the top  quartile   in total recordable  incident rate among  global companies  across all industries VIEW ALL 2020 GOALSNot achievedBAXTER 2020 CORPORATE RESPONSIBILITY REPORT32Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction INJURIES AND MAJOR INCIDENTS When a major incident occurs at Baxter, facility  management conducts a root-cause analysis and  formulates mitigation strategies.
","('Employee_Health_And_Safety', 0.6803303956985474)","('Access_And_Affordability', 0.0910160019993782)","('Employee_Engagement_Inclusion_And_Diversity', 0.04389634728431702)","(['Operational Eco-Efficiency'], 0.6803303956985474)","('NON-ESG', 0.0910160019993782)","('NON-ESG', 0.04389634728431702)"
Line 566,"Although we did not achieve top quartile   performance in 2020, we did in 2018 and 2019.*Compared with 2019.52%Restricted days rate  employees participated   in the virtual  BeWell@Baxter  Exercise Challenge14,*Introduced monthly  wellness  days emphasizing  physical, mental and  social well-being 2020 GOALAchieve the top  quartile   in total recordable  incident rate among  global companies  across all industries VIEW ALL 2020 GOALSNot achievedBAXTER 2020 CORPORATE RESPONSIBILITY REPORT32Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction INJURIES AND MAJOR INCIDENTS When a major incident occurs at Baxter, facility  management conducts a root-cause analysis and  formulates mitigation strategies.
","('Employee_Health_And_Safety', 0.9697591662406921)","('Critical_Incident_Risk_Management', 0.011240881867706776)","('Employee_Engagement_Inclusion_And_Diversity', 0.0016553900204598904)","(['Operational Eco-Efficiency'], 0.9697591662406921)","('NON-ESG', 0.011240881867706776)","('NON-ESG', 0.0016553900204598904)"
Line 567,"We review incidents  with a cross-functional team to share knowledge  across the organization.
","('Data_Security', 0.2442580759525299)","('Employee_Engagement_Inclusion_And_Diversity', 0.163379967212677)","('Business_Model_Resilience', 0.05662503466010094)","('NON-ESG', 0.2442580759525299)","('NON-ESG', 0.163379967212677)","('NON-ESG', 0.05662503466010094)"
Line 568,"Major incidents are defined as  those that result in an employee or contractor being  hospitalized overnight (for more than observation),  sustaining an amputation, or dying.
","('Employee_Health_And_Safety', 0.9752582907676697)","('Critical_Incident_Risk_Management', 0.0045559462159872055)","('Employee_Engagement_Inclusion_And_Diversity', 0.002887752838432789)","(['Operational Eco-Efficiency'], 0.9752582907676697)","('NON-ESG', 0.0045559462159872055)","('NON-ESG', 0.002887752838432789)"
Line 569,"Twelve major incidents occurred at Baxter in 2020,  compared with six in 2019.
","('Critical_Incident_Risk_Management', 0.8988962769508362)","('Employee_Health_And_Safety', 0.025662390515208244)","('Air_Quality', 0.01174996979534626)","(['Risk & Crisis Management'], 0.8988962769508362)","('NON-ESG', 0.025662390515208244)","('NON-ESG', 0.01174996979534626)"
Line 570,"Baxter attributes the  increase to hazards that had not been identified.
","('Employee_Health_And_Safety', 0.386595755815506)","('Critical_Incident_Risk_Management', 0.14416253566741943)","('Water_And_Wastewater_Management', 0.058753203600645065)","('NON-ESG', 0.386595755815506)","('NON-ESG', 0.14416253566741943)","('NON-ESG', 0.058753203600645065)"
Line 571,"The  company had no fatalities during the year.
","('Employee_Health_And_Safety', 0.8022207021713257)","('Critical_Incident_Risk_Management', 0.1281314343214035)","('Air_Quality', 0.006066851783543825)","(['Operational Eco-Efficiency'], 0.8022207021713257)","('NON-ESG', 0.1281314343214035)","('NON-ESG', 0.006066851783543825)"
Line 572,"RECORDABLE INCIDENT RATE AND CASES WITH DAYS LOST RATE * DAYS LOST RATE AND RESTRICTED DAYS RATE 2018 2019 Recordable Incident Rate  0.41 0.39 0.Cases With Days Lost Rate  0.084 0.086 0.1740.00.10.20.30.40.
","('Employee_Health_And_Safety', 0.8754420876502991)","('Critical_Incident_Risk_Management', 0.0725058764219284)","('Customer_Privacy', 0.004925629589706659)","(['Operational Eco-Efficiency'], 0.8754420876502991)","('NON-ESG', 0.0725058764219284)","('NON-ESG', 0.004925629589706659)"
Line 573,"2018 2019 Days Lost Rate  2.88 2.14 4.Restricted Days Rate  6.20 7.83 3.77DRIVING A CULTURE OF SAFETY   AND ENGAGEMENT We aspire to achieve a zero-harm-workplace.
","('Employee_Health_And_Safety', 0.951256513595581)","('Product_Quality_And_Safety', 0.014526281505823135)","('Product_Design_And_Lifecycle_Management', 0.004216501954942942)","(['Operational Eco-Efficiency'], 0.951256513595581)","('NON-ESG', 0.014526281505823135)","('NON-ESG', 0.004216501954942942)"
Line 574,"In 2020,  we continued to engage our operational workforce in  hazard identification and immediate corrective actions  where feasible.
","('Employee_Health_And_Safety', 0.7342436909675598)","('Critical_Incident_Risk_Management', 0.08579590916633606)","('Air_Quality', 0.01883799210190773)","(['Operational Eco-Efficiency'], 0.7342436909675598)","('NON-ESG', 0.08579590916633606)","('NON-ESG', 0.01883799210190773)"
Line 575,"Injury and illness metrics coupled with  internal EHS&S audits provide focus for Baxter's safety,  occupational health and industrial hygiene efforts.
","('Employee_Health_And_Safety', 0.9852324724197388)","('Critical_Incident_Risk_Management', 0.001500618876889348)","('Employee_Engagement_Inclusion_And_Diversity', 0.001348104327917099)","(['Operational Eco-Efficiency'], 0.9852324724197388)","('NON-ESG', 0.001500618876889348)","('NON-ESG', 0.001348104327917099)"
Line 576,"We  continue to target ergonomics, and slips, trips and falls— two of the primary sources of injury at the company.
","('Employee_Health_And_Safety', 0.9714293479919434)","('Critical_Incident_Risk_Management', 0.0033251976128667593)","('Waste_And_Hazardous_Materials_Management', 0.002243095077574253)","(['Operational Eco-Efficiency'], 0.9714293479919434)","('NON-ESG', 0.0033251976128667593)","('NON-ESG', 0.002243095077574253)"
Line 577,"In 2020, we continued to focus on high-hazard sources,  which are conditions or situations that could cause major  injury or death.
","('Employee_Health_And_Safety', 0.9820100665092468)","('Critical_Incident_Risk_Management', 0.00300803710706532)","('Product_Design_And_Lifecycle_Management', 0.0012528217630460858)","(['Operational Eco-Efficiency'], 0.9820100665092468)","('NON-ESG', 0.00300803710706532)","('NON-ESG', 0.0012528217630460858)"
Line 578,"We analyzed our most severe historical  incidents to identify root-cause trends and started holding  “stand down” meetings as a forum for operational leaders  to engage employees in frontline education concerning  specific risks.
","('Systemic_Risk_Management', 0.698909342288971)","('Critical_Incident_Risk_Management', 0.08267811685800552)","('Physical_Impacts_Of_Climate_Change', 0.04143458604812622)","(['Risk & Crisis Management'], 0.698909342288971)","('NON-ESG', 0.08267811685800552)","('NON-ESG', 0.04143458604812622)"
Line 579,"During these meetings, all other  operational activity stops so employees can focus on an  emerging trend or specific risk.
","('Systemic_Risk_Management', 0.8035968542098999)","('Business_Model_Resilience', 0.048786766827106476)","('Management_Of_Legal_And_Regulatory_Framework', 0.014746862463653088)","(['Risk & Crisis Management'], 0.8035968542098999)","('NON-ESG', 0.048786766827106476)","('NON-ESG', 0.014746862463653088)"
Line 580,"HEALTH AND WELLNESS PROGRAM  MANAGEMENT AND INITIATIVES Baxter’s occupational health function, in partnership  with Human Resources and Global Communications,  develops health and wellness strategies for the  company.
","('Employee_Health_And_Safety', 0.9455947279930115)","('Employee_Engagement_Inclusion_And_Diversity', 0.007900468073785305)","('Access_And_Affordability', 0.006959430407732725)","(['Operational Eco-Efficiency'], 0.9455947279930115)","('NON-ESG', 0.007900468073785305)","('NON-ESG', 0.006959430407732725)"
Line 581,"A global team of diverse health professionals  and volunteers, known as Local Champions, helps refine  and implement these approaches and set priorities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4999077022075653)","('Human_Rights_And_Community_Relations', 0.1319592148065567)","('Access_And_Affordability', 0.12529583275318146)","('NON-ESG', 0.4999077022075653)","('NON-ESG', 0.1319592148065567)","('NON-ESG', 0.12529583275318146)"
Line 582,"BEWELL@BAXTER Healthy employees are more engaged  and productive and less vulnerable  to safety incidents and injuries.
","('Employee_Health_And_Safety', 0.9831981062889099)","('Critical_Incident_Risk_Management', 0.003283747937530279)","('Employee_Engagement_Inclusion_And_Diversity', 0.001164339599199593)","(['Operational Eco-Efficiency'], 0.9831981062889099)","('NON-ESG', 0.003283747937530279)","('NON-ESG', 0.001164339599199593)"
Line 583,"Through BeWell@Baxter, our global employee health  and wellness program, we strive to create a culture that  raises awareness and promotes healthy lifestyles.
","('Employee_Health_And_Safety', 0.6851269602775574)","('Employee_Engagement_Inclusion_And_Diversity', 0.10084656625986099)","('Access_And_Affordability', 0.03086305782198906)","(['Operational Eco-Efficiency'], 0.6851269602775574)","('NON-ESG', 0.10084656625986099)","('NON-ESG', 0.03086305782198906)"
Line 584,"In response to COVID-19, BeWell@Baxter provided a  heightened focus on health and wellness and continued to  drive engagement, while complying with local regulations.
","('Employee_Health_And_Safety', 0.43686625361442566)","('Access_And_Affordability', 0.19265221059322357)","('Product_Quality_And_Safety', 0.06783886253833771)","('NON-ESG', 0.43686625361442566)","('NON-ESG', 0.19265221059322357)","('NON-ESG', 0.06783886253833771)"
Line 585,"Health and wellness during the pandemic was more  important than ever, so we transitioned our campaigns to  virtual and launched monthly wellness days to emphasize  the importance of well-being, including physical, mental  and social aspects.
","('Employee_Health_And_Safety', 0.6994172930717468)","('Access_And_Affordability', 0.08586741983890533)","('Employee_Engagement_Inclusion_And_Diversity', 0.03254672884941101)","(['Operational Eco-Efficiency'], 0.6994172930717468)","('NON-ESG', 0.08586741983890533)","('NON-ESG', 0.03254672884941101)"
Line 586,"The cornerstone of BeWell@Baxter is the Personal  Wellness Profile, an online health risk assessment  that helps employees understand how lifestyle choices,  family history and other factors influence health and  related risks.
","('Employee_Health_And_Safety', 0.826084315776825)","('Employee_Engagement_Inclusion_And_Diversity', 0.04537606239318848)","('Product_Quality_And_Safety', 0.01748235523700714)","(['Operational Eco-Efficiency'], 0.826084315776825)","('NON-ESG', 0.04537606239318848)","('NON-ESG', 0.01748235523700714)"
Line 587,"We use this data to focus our health  promotion program on the areas of highest health risk  for employees.
","('Employee_Health_And_Safety', 0.9674902558326721)","('Product_Quality_And_Safety', 0.0033596341963857412)","('Employee_Engagement_Inclusion_And_Diversity', 0.0031649908050894737)","(['Operational Eco-Efficiency'], 0.9674902558326721)","('NON-ESG', 0.0033596341963857412)","('NON-ESG', 0.0031649908050894737)"
Line 588,"As of the end of 2020, 35% of employees  worldwide had completed a Personal Wellness Profile.3   In 2020, more than 14,000 employees participated in the  virtual BeWell@Baxter Exercise Challenge.
","('Employee_Health_And_Safety', 0.6151576638221741)","('Employee_Engagement_Inclusion_And_Diversity', 0.08343388885259628)","('Product_Quality_And_Safety', 0.046641331166028976)","(['Operational Eco-Efficiency'], 0.6151576638221741)","('NON-ESG', 0.08343388885259628)","('NON-ESG', 0.046641331166028976)"
Line 589,"In addition, 83%   of facilities worldwide took part in Healthy Eating Month.
","('Customer_Welfare', 0.37899529933929443)","('Access_And_Affordability', 0.07527623325586319)","('Employee_Engagement_Inclusion_And_Diversity', 0.06389059871435165)","('NON-ESG', 0.37899529933929443)","('NON-ESG', 0.07527623325586319)","('NON-ESG', 0.06389059871435165)"
Line 590,"During the year, Baxter  recorded an average  employee participation rate  of 49% in BeWell@Baxter   health promotion initiatives ,  exceeding our 2020 goal  of 45% participation.
","('Employee_Health_And_Safety', 0.33800098299980164)","('Employee_Engagement_Inclusion_And_Diversity', 0.1488093137741089)","('Access_And_Affordability', 0.13741706311702728)","('NON-ESG', 0.33800098299980164)","('NON-ESG', 0.1488093137741089)","('NON-ESG', 0.13741706311702728)"
Line 591,"BeWell@Baxter initiatives   include the Personal  Wellness Profile, the  Exercise Challenge and Healthy Eating Month.
","('Employee_Health_And_Safety', 0.3368145823478699)","('Employee_Engagement_Inclusion_And_Diversity', 0.16422265768051147)","('Customer_Welfare', 0.09198765456676483)","('NON-ESG', 0.3368145823478699)","('NON-ESG', 0.16422265768051147)","('NON-ESG', 0.09198765456676483)"
Line 592,"ADDITIONAL PROGRAMS AND INITIATIVES   FOR EMPLOYEE HEALTH Baxter’s occupational health team also works to continually  improve the company’s performance with the following  programs and initiatives:  Flu vaccinations     In 2020, we offered free seasonal flu   vaccinations to employees working at most sites with   25 or more employees.
","('Employee_Health_And_Safety', 0.9728876352310181)","('Product_Quality_And_Safety', 0.002864234149456024)","('Employee_Engagement_Inclusion_And_Diversity', 0.0026543408166617155)","(['Operational Eco-Efficiency'], 0.9728876352310181)","('NON-ESG', 0.002864234149456024)","('NON-ESG', 0.0026543408166617155)"
Line 593,"More than 12,000 employees  worldwide received vaccinations through this program.
","('Employee_Health_And_Safety', 0.3017941415309906)","('Access_And_Affordability', 0.2600628435611725)","('Product_Quality_And_Safety', 0.0560835637152195)","('NON-ESG', 0.3017941415309906)","('NON-ESG', 0.2600628435611725)","('NON-ESG', 0.0560835637152195)"
Line 594,"Smoke-free workplaces     In 2020, in countries where  smoke-free status is allowed by law, 100% of campuses with  25 or more employees were smoke-free, the same as in 2019.
","('Air_Quality', 0.3894222676753998)","('Employee_Health_And_Safety', 0.21307340264320374)","('Waste_And_Hazardous_Materials_Management', 0.06651969999074936)","('NON-ESG', 0.3894222676753998)","('NON-ESG', 0.21307340264320374)","('NON-ESG', 0.06651969999074936)"
Line 595,"2020 GOALIncrease participation  from 35% to 45%  in BeWell@Baxter  health promotion  program initiatives VIEW ALL 2020 GOALSAchieved * Rates include COVID-19 cases.
","('Access_And_Affordability', 0.4668750762939453)","('Product_Quality_And_Safety', 0.13639138638973236)","('Customer_Welfare', 0.051507625728845596)","('NON-ESG', 0.4668750762939453)","('NON-ESG', 0.13639138638973236)","('NON-ESG', 0.051507625728845596)"
Line 596,"Public health guidance varies around the world concerning  isolation and quarantine days for COVID-19.
","('Critical_Incident_Risk_Management', 0.24844036996364594)","('Air_Quality', 0.21062321960926056)","('Employee_Health_And_Safety', 0.1066843792796135)","('NON-ESG', 0.24844036996364594)","('NON-ESG', 0.21062321960926056)","('NON-ESG', 0.1066843792796135)"
Line 597,"Probable work-related COVID-19 cases average   10 days lost per CDC guidance and account for days away from work due to the illness.
","('Employee_Health_And_Safety', 0.9462119340896606)","('Labor_Practices', 0.0167140681296587)","('Product_Quality_And_Safety', 0.003742449451237917)","(['Operational Eco-Efficiency'], 0.9462119340896606)","('NON-ESG', 0.0167140681296587)","('NON-ESG', 0.003742449451237917)"
Line 598,"VIEW THE DATA SUMMARY   FOR MORE DETAIL.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT33Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Operations  Reduce environmental footprint through increased efficiency and resource conservation Apex Companies LLC has provided assurance on the content in this section.2020 HIGHLIGHTS reduction in  energy use*8.2% reduction in  water use*10.4% reduction  in waste  generation *14.7% reduction in  absolute  greenhouse gas  emissions**13.6% *Compared with 2015 and indexed to revenue.
","('Product_Design_And_Lifecycle_Management', 0.46700161695480347)","('Business_Model_Resilience', 0.12434174865484238)","('Supply_Chain_Management', 0.09748130291700363)","('NON-ESG', 0.46700161695480347)","('NON-ESG', 0.12434174865484238)","('NON-ESG', 0.09748130291700363)"
Line 599,"VIEW THE DATA SUMMARY   FOR MORE DETAIL.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT33Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Operations  Reduce environmental footprint through increased efficiency and resource conservation Apex Companies LLC has provided assurance on the content in this section.2020 HIGHLIGHTS reduction in  energy use*8.2% reduction in  water use*10.4% reduction  in waste  generation *14.7% reduction in  absolute  greenhouse gas  emissions**13.6% *Compared with 2015 and indexed to revenue.
","('GHG_Emissions', 0.963701069355011)","('Air_Quality', 0.0037966135423630476)","('Ecological_Impacts', 0.003583623794838786)","(['Climate Change'], 0.963701069355011)","('NON-ESG', 0.0037966135423630476)","('NON-ESG', 0.003583623794838786)"
Line 600,"**Compared with 2015.
","('Management_Of_Legal_And_Regulatory_Framework', 0.31971609592437744)","('Systemic_Risk_Management', 0.1137227937579155)","('Energy_Management', 0.062252167612314224)","('NON-ESG', 0.31971609592437744)","('NON-ESG', 0.1137227937579155)","('NON-ESG', 0.062252167612314224)"
Line 601,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORT 33At Baxter, we are committed to driving sustainability throughout our global manufacturing   operations.1  We strive to use energy, water and raw materials efficiently, while reducing  waste and greenhouse gas (GHG) emissions.
","('GHG_Emissions', 0.9673823714256287)","('Ecological_Impacts', 0.003160260384902358)","('Air_Quality', 0.0028646644204854965)","(['Climate Change'], 0.9673823714256287)","('NON-ESG', 0.003160260384902358)","('NON-ESG', 0.0028646644204854965)"
Line 602,"This improves environmental performance  while saving money and demonstrating environmental leadership.
","('Human_Rights_And_Community_Relations', 0.6770246028900146)","('Business_Model_Resilience', 0.057325877249240875)","('Product_Design_And_Lifecycle_Management', 0.02924214117228985)","(['Community Relations'], 0.6770246028900146)","('NON-ESG', 0.057325877249240875)","('NON-ESG', 0.02924214117228985)"
Line 603,"Our Environmental, Health, Safety and Sustainability (EHS&S) vision is to achieve a sustainable enterprise that creates  stakeholder value by advancing superior environmental stewardship, optimum employee health and well-being,  and  a zero-harm workplace.
","('Employee_Health_And_Safety', 0.9264292120933533)","('Employee_Engagement_Inclusion_And_Diversity', 0.009220809675753117)","('Product_Design_And_Lifecycle_Management', 0.009136236272752285)","(['Operational Eco-Efficiency'], 0.9264292120933533)","('NON-ESG', 0.009220809675753117)","('NON-ESG', 0.009136236272752285)"
Line 604,"Baxter’s EHS&S Policy  outlines our commitments within operations and across the value  chain.
","('Business_Model_Resilience', 0.6229063272476196)","('Supply_Chain_Management', 0.1346287876367569)","('Product_Design_And_Lifecycle_Management', 0.037076614797115326)","(['Codes of Business Conduct'], 0.6229063272476196)","('NON-ESG', 0.1346287876367569)","('NON-ESG', 0.037076614797115326)"
Line 605,"Our EHS&S governance structure helps us achieve our goals and create long-term business value.
","('Business_Model_Resilience', 0.6293051242828369)","('Management_Of_Legal_And_Regulatory_Framework', 0.07960040122270584)","('Director_Removal', 0.03379566967487335)","(['Codes of Business Conduct'], 0.6293051242828369)","('NON-ESG', 0.07960040122270584)","('NON-ESG', 0.03379566967487335)"
Line 606,"Progress toward our 2020 environmental goals launched in 2015 is shown in the graph below.
","('Human_Rights_And_Community_Relations', 0.5720947980880737)","('Physical_Impacts_Of_Climate_Change', 0.07422416657209396)","('Management_Of_Legal_And_Regulatory_Framework', 0.06991754472255707)","(['Community Relations'], 0.5720947980880737)","('NON-ESG', 0.07422416657209396)","('NON-ESG', 0.06991754472255707)"
Line 607,"Related challenges  and opportunities are described on the pages that follow.
","('Human_Rights_And_Community_Relations', 0.2493205964565277)","('Systemic_Risk_Management', 0.17215844988822937)","('Business_Model_Resilience', 0.08792344480752945)","('NON-ESG', 0.2493205964565277)","('NON-ESG', 0.17215844988822937)","('NON-ESG', 0.08792344480752945)"
Line 608,"2016 2017 2018 2019 2020 (baseline)2016 2017 2018 2019 2020 (baseline)Metric Tons CO2e % Change, Indexed to Revenue GHG Emissions Energy Use Water Use Waste Generation -15% -20%-10%-5%0%2020 Goals: -15%2020  Goal: -10% -15-10-550,000600,000650,000700,000750,000PROGRESS TOWARD 2020 ENVIRONMENTAL GOALS * * Energy use and GHG emissions data for 2015–2019 are restated from data reported in the Baxter 2019 Corporate Responsibility Report to improve accuracy and  to reflect updated GHG emission factors.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT34Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction ENVIRONMENTAL, HEALTH AND   SAFETY PERFORMANCE   We follow a management-systems approach guided by  our global EHS&S requirements.
","('GHG_Emissions', 0.9585170745849609)","('Air_Quality', 0.01060064323246479)","('Ecological_Impacts', 0.0028620739467442036)","(['Climate Change'], 0.9585170745849609)","('NON-ESG', 0.01060064323246479)","('NON-ESG', 0.0028620739467442036)"
Line 609,"2016 2017 2018 2019 2020 (baseline)2016 2017 2018 2019 2020 (baseline)Metric Tons CO2e % Change, Indexed to Revenue GHG Emissions Energy Use Water Use Waste Generation -15% -20%-10%-5%0%2020 Goals: -15%2020  Goal: -10% -15-10-550,000600,000650,000700,000750,000PROGRESS TOWARD 2020 ENVIRONMENTAL GOALS * * Energy use and GHG emissions data for 2015–2019 are restated from data reported in the Baxter 2019 Corporate Responsibility Report to improve accuracy and  to reflect updated GHG emission factors.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT34Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction ENVIRONMENTAL, HEALTH AND   SAFETY PERFORMANCE   We follow a management-systems approach guided by  our global EHS&S requirements.
","('Employee_Health_And_Safety', 0.9659721851348877)","('Product_Quality_And_Safety', 0.0066900597885251045)","('Product_Design_And_Lifecycle_Management', 0.002585829934105277)","(['Operational Eco-Efficiency'], 0.9659721851348877)","('NON-ESG', 0.0066900597885251045)","('NON-ESG', 0.002585829934105277)"
Line 610,"We apply the ISO 14001  standard to manage our environmental aspects and the  ISO 45001 standard to manage our health and safety  hazards and risks.
","('Employee_Health_And_Safety', 0.9691521525382996)","('Product_Quality_And_Safety', 0.005916707683354616)","('Product_Design_And_Lifecycle_Management', 0.0032498801592737436)","(['Operational Eco-Efficiency'], 0.9691521525382996)","('NON-ESG', 0.005916707683354616)","('NON-ESG', 0.0032498801592737436)"
Line 611,"As of year-end 2020, 59 Baxter locations met ISO 14001  requirements, of which 44 also achieved ISO 45001.
","('Product_Quality_And_Safety', 0.49397218227386475)","('Product_Design_And_Lifecycle_Management', 0.10857796669006348)","('Management_Of_Legal_And_Regulatory_Framework', 0.06110938638448715)","('NON-ESG', 0.49397218227386475)","('NON-ESG', 0.10857796669006348)","('NON-ESG', 0.06110938638448715)"
Line 612,"Of  these 59 total certified locations, 45 are manufacturing  sites (86.5% of total Baxter manufacturing locations2).
","('Product_Design_And_Lifecycle_Management', 0.20968136191368103)","('Supply_Chain_Management', 0.18763908743858337)","('Customer_Welfare', 0.11184302717447281)","('NON-ESG', 0.20968136191368103)","('NON-ESG', 0.18763908743858337)","('NON-ESG', 0.11184302717447281)"
Line 613,"Baxter’s EHS&S audit program helps to ensure that our  facilities have programs that satisfy applicable regulatory  requirements and are consistent with our EHS&S  requirements, objectives and goals.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9672268033027649)","('Business_Ethics', 0.0044250041246414185)","('Product_Quality_And_Safety', 0.0026509519666433334)","(['Corporate Governance'], 0.9672268033027649)","('NON-ESG', 0.0044250041246414185)","('NON-ESG', 0.0026509519666433334)"
Line 614,"In 2020, third-party  EHS&S audits were conducted at 16 facilities.3   In 2020, we received six environmental Notices of Violation  (NOVs), a decrease from 22 in 2019.
","('Business_Ethics', 0.766005277633667)","('Management_Of_Legal_And_Regulatory_Framework', 0.1224706694483757)","('Product_Quality_And_Safety', 0.015405965968966484)","(['Business Ethics'], 0.766005277633667)","('NON-ESG', 0.1224706694483757)","('NON-ESG', 0.015405965968966484)"
Line 615,"All NOVs were received  at facilities in North America and Puerto Rico.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3616957366466522)","('Access_And_Affordability', 0.0910089761018753)","('Product_Quality_And_Safety', 0.08300285041332245)","('NON-ESG', 0.3616957366466522)","('NON-ESG', 0.0910089761018753)","('NON-ESG', 0.08300285041332245)"
Line 616,"A fine of  $861.16 was related to one NOV at our facility in Marion,  North Carolina.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7591213583946228)","('Business_Ethics', 0.13068585097789764)","('Director_Removal', 0.010367555543780327)","(['Corporate Governance'], 0.7591213583946228)","('NON-ESG', 0.13068585097789764)","('NON-ESG', 0.010367555543780327)"
Line 617,"We also received two health and safety  letters during the year at facilities in the United States.
","('Employee_Health_And_Safety', 0.755601167678833)","('Product_Quality_And_Safety', 0.14901278913021088)","('Product_Design_And_Lifecycle_Management', 0.00841202586889267)","(['Operational Eco-Efficiency'], 0.755601167678833)","('NON-ESG', 0.14901278913021088)","('NON-ESG', 0.00841202586889267)"
Line 618,"We paid $3,450 for a health and safety fine associated  with our Opelika, Alabama facility.
","('Employee_Health_And_Safety', 0.9060667753219604)","('Product_Quality_And_Safety', 0.03806682676076889)","('Access_And_Affordability', 0.004763963166624308)","(['Operational Eco-Efficiency'], 0.9060667753219604)","('NON-ESG', 0.03806682676076889)","('NON-ESG', 0.004763963166624308)"
Line 619,"Baxter takes incidents  of EHS&S noncompliance seriously and is working  diligently to address the root causes of these issues.
","('Business_Ethics', 0.831795334815979)","('Management_Of_Legal_And_Regulatory_Framework', 0.06749825924634933)","('Product_Quality_And_Safety', 0.013186019845306873)","(['Business Ethics'], 0.831795334815979)","('NON-ESG', 0.06749825924634933)","('NON-ESG', 0.013186019845306873)"
Line 620,"We also took significant steps during 2020 to re-affirm  our commitment to environmental compliance.
","('Management_Of_Legal_And_Regulatory_Framework', 0.79909348487854)","('Human_Rights_And_Community_Relations', 0.0413246713578701)","('Ecological_Impacts', 0.026005176827311516)","(['Corporate Governance'], 0.79909348487854)","('NON-ESG', 0.0413246713578701)","('NON-ESG', 0.026005176827311516)"
Line 621,"During  the year we filled several key EHS&S roles, including the  vice president of EHS&S, as well as other key leadership  positions in environmental programs and EHS&S  governance.
","('Management_Of_Legal_And_Regulatory_Framework', 0.23882870376110077)","('Business_Model_Resilience', 0.19223915040493011)","('Director_Removal', 0.15136383473873138)","('NON-ESG', 0.23882870376110077)","('NON-ESG', 0.19223915040493011)","('NON-ESG', 0.15136383473873138)"
Line 622,"These leaders will provide a foundation for  our next-generation transformational journey.
","('Business_Model_Resilience', 0.4095481336116791)","('Employee_Engagement_Inclusion_And_Diversity', 0.1996801644563675)","('Human_Rights_And_Community_Relations', 0.06189468130469322)","('NON-ESG', 0.4095481336116791)","('NON-ESG', 0.1996801644563675)","('NON-ESG', 0.06189468130469322)"
Line 623,"ENERGY Energy is one of our most significant manufacturing costs,  so energy conservation benefits our business as well  as the environment.
","('Energy_Management', 0.9789945483207703)","('Management_Of_Legal_And_Regulatory_Framework', 0.0029224937316030264)","('Product_Design_And_Lifecycle_Management', 0.001540852477774024)","(['Operational Eco-Efficiency'], 0.9789945483207703)","('NON-ESG', 0.0029224937316030264)","('NON-ESG', 0.001540852477774024)"
Line 624,"Using energy effectively conserves  natural resources, improves environmental performance and enhances business efficiency.
","('Energy_Management', 0.9003961086273193)","('Product_Design_And_Lifecycle_Management', 0.015002458356320858)","('Supply_Chain_Management', 0.010790284723043442)","(['Operational Eco-Efficiency'], 0.9003961086273193)","('NON-ESG', 0.015002458356320858)","('NON-ESG', 0.010790284723043442)"
Line 625,"Reducing fossil fuel  combustion decreases GHG emissions, improves air  quality and decreases fine particulates that contribute to  adverse health effects.
","('Air_Quality', 0.9534756541252136)","('GHG_Emissions', 0.015116266906261444)","('Energy_Management', 0.003130647586658597)","(['Operational Eco-Efficiency'], 0.9534756541252136)","('NON-ESG', 0.015116266906261444)","('NON-ESG', 0.003130647586658597)"
Line 626,"Renewable energy procurement  is  also integral to our overarching climate strategy.
","('Energy_Management', 0.3610999286174774)","('Physical_Impacts_Of_Climate_Change', 0.302831768989563)","('Management_Of_Legal_And_Regulatory_Framework', 0.05594676360487938)","('NON-ESG', 0.3610999286174774)","('NON-ESG', 0.302831768989563)","('NON-ESG', 0.05594676360487938)"
Line 627,"The Baxter global energy program applies the ISO 50001   standard to the company’s facility-level energy management  systems.
","('Energy_Management', 0.9794589877128601)","('Air_Quality', 0.002109288237988949)","('Water_And_Wastewater_Management', 0.001857977476902306)","(['Operational Eco-Efficiency'], 0.9794589877128601)","('NON-ESG', 0.002109288237988949)","('NON-ESG', 0.001857977476902306)"
Line 628,"By the end of 2020,19 Baxter facilities (40% of  participating locations) met ISO 50001 requirements.
","('Product_Quality_And_Safety', 0.55415940284729)","('Management_Of_Legal_And_Regulatory_Framework', 0.07882283627986908)","('Product_Design_And_Lifecycle_Management', 0.06418106704950333)","(['Product Quality & Recall Management'], 0.55415940284729)","('NON-ESG', 0.07882283627986908)","('NON-ESG', 0.06418106704950333)"
Line 629,"In 2020 , we used  10,101 trillio n  joules of energy , 8.2% less  than in 2015 indexed to  revenue, missing our 2020  goal to reduce total energy  use by 15% indexed to  revenue.
","('Energy_Management', 0.9803406000137329)","('Management_Of_Legal_And_Regulatory_Framework', 0.001770581235177815)","('Air_Quality', 0.0017400922952219844)","(['Operational Eco-Efficiency'], 0.9803406000137329)","('NON-ESG', 0.001770581235177815)","('NON-ESG', 0.0017400922952219844)"
Line 630,"Key factors for why  we did not meet the goal  included changes to  enhance resilience in manufacturing in order to mitigate  supply chain disruption from extreme weather events.
","('Supply_Chain_Management', 0.8930853605270386)","('Business_Model_Resilience', 0.03235092759132385)","('Product_Design_And_Lifecycle_Management', 0.010663626715540886)","(['Supply Chain Management'], 0.8930853605270386)","('NON-ESG', 0.03235092759132385)","('NON-ESG', 0.010663626715540886)"
Line 631,"We will continue to focus on energy efficiency as part of  Baxter’s GHG emissions reduction strategy moving forward.
","('GHG_Emissions', 0.9251059293746948)","('Energy_Management', 0.018707605078816414)","('Air_Quality', 0.013399386778473854)","(['Climate Change'], 0.9251059293746948)","('NON-ESG', 0.018707605078816414)","('NON-ESG', 0.013399386778473854)"
Line 632,"Energy use includes electricity, fuel and purchased steam  consumed by Baxter-managed and Baxter-operated  facilities; it excludes energy related to company-operated  vehicles.
","('Energy_Management', 0.9779207110404968)","('Air_Quality', 0.002649469068273902)","('Management_Of_Legal_And_Regulatory_Framework', 0.0021070775110274553)","(['Operational Eco-Efficiency'], 0.9779207110404968)","('NON-ESG', 0.002649469068273902)","('NON-ESG', 0.0021070775110274553)"
Line 633,"In 2020, we increased absolute energy use by  1% compared with 2019, due mainly to facility changes  and production increases.
","('Energy_Management', 0.9809051752090454)","('Management_Of_Legal_And_Regulatory_Framework', 0.0019222046248614788)","('Air_Quality', 0.001608668826520443)","(['Operational Eco-Efficiency'], 0.9809051752090454)","('NON-ESG', 0.0019222046248614788)","('NON-ESG', 0.001608668826520443)"
Line 634,"During that period, energy use  indexed to revenue decreased by 2%.
","('Energy_Management', 0.9784543514251709)","('Management_Of_Legal_And_Regulatory_Framework', 0.0020333838183432817)","('Water_And_Wastewater_Management', 0.0017363830702379346)","(['Operational Eco-Efficiency'], 0.9784543514251709)","('NON-ESG', 0.0020333838183432817)","('NON-ESG', 0.0017363830702379346)"
Line 635,"Our energy costs dropped 2% between 2019 and 2020,  down $3 million, due to a significant decrease in natural  gas prices, as well as energy efficiency initiatives.
","('Energy_Management', 0.9760985970497131)","('Management_Of_Legal_And_Regulatory_Framework', 0.003373044077306986)","('Air_Quality', 0.002038520062342286)","(['Operational Eco-Efficiency'], 0.9760985970497131)","('NON-ESG', 0.003373044077306986)","('NON-ESG', 0.002038520062342286)"
Line 636,"Site-specific energy assessments identify opportunities  to conserve energy and to apply and share new  technologies and best practices across the company.
","('Energy_Management', 0.9800589680671692)","('Management_Of_Legal_And_Regulatory_Framework', 0.0019132139859721065)","('Air_Quality', 0.0017824402311816812)","(['Operational Eco-Efficiency'], 0.9800589680671692)","('NON-ESG', 0.0019132139859721065)","('NON-ESG', 0.0017824402311816812)"
Line 637,"In 2020, we were unable to perform energy assessments   due to COVID-19-related travel restrictions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.19132019579410553)","('Labor_Practices', 0.10151214897632599)","('Customer_Privacy', 0.09121521562337875)","('NON-ESG', 0.19132019579410553)","('NON-ESG', 0.10151214897632599)","('NON-ESG', 0.09121521562337875)"
Line 638,"To continue   to identify potential energy projects and drive project  performance, we implemented monthly meetings with  global energy managers and regional engineering  executives, and we conducted cross-facility benchmarking  exercises focused on energy conservation opportunities  within the regions and businesses.
","('Energy_Management', 0.9765561819076538)","('Management_Of_Legal_And_Regulatory_Framework', 0.002998502692207694)","('Air_Quality', 0.002292400225996971)","(['Operational Eco-Efficiency'], 0.9765561819076538)","('NON-ESG', 0.002998502692207694)","('NON-ESG', 0.002292400225996971)"
Line 639,"During 2019 and 2020, we implemented 340 energy  conservation projects across our manufacturing sites  globally.
","('Energy_Management', 0.9749358296394348)","('Product_Design_And_Lifecycle_Management', 0.003003216814249754)","('Management_Of_Legal_And_Regulatory_Framework', 0.0027091081719845533)","(['Operational Eco-Efficiency'], 0.9749358296394348)","('NON-ESG', 0.003003216814249754)","('NON-ESG', 0.0027091081719845533)"
Line 640,"We estimate that these projects saved 155 trillion  joules of energy and $4.1 million and avoided 13,600 metric  tons carbon dioxide equivalent (CO2e) of GHG emissions  during 2020.4 This was equivalent to 2% of our net GHG  emissions from global operations during the year.
","('GHG_Emissions', 0.9687168002128601)","('Air_Quality', 0.00403974112123251)","('Ecological_Impacts', 0.0031616860069334507)","(['Climate Change'], 0.9687168002128601)","('NON-ESG', 0.00403974112123251)","('NON-ESG', 0.0031616860069334507)"
Line 641,"We have operated a Lean Energy Program for our  manufacturing facilities since 2007.
","('Energy_Management', 0.8118641972541809)","('Product_Design_And_Lifecycle_Management', 0.08097240328788757)","('Supply_Chain_Management', 0.01861797831952572)","(['Operational Eco-Efficiency'], 0.8118641972541809)","('NON-ESG', 0.08097240328788757)","('NON-ESG', 0.01861797831952572)"
Line 642,"It includes four  levels—Prerequisite, Bronze, Silver and Gold—and  facilities meet the criteria for lower levels as they   advance in pursuit of Gold.
","('Competitive_Behavior', 0.4827311933040619)","('Business_Ethics', 0.08681713789701462)","('Systemic_Risk_Management', 0.06624352186918259)","('NON-ESG', 0.4827311933040619)","('NON-ESG', 0.08681713789701462)","('NON-ESG', 0.06624352186918259)"
Line 643,"Each level includes program  requirements, standards of operational excellence and  technical requirements.
","('Management_Of_Legal_And_Regulatory_Framework', 0.35634082555770874)","('Product_Quality_And_Safety', 0.1820167899131775)","('Data_Security', 0.051938846707344055)","('NON-ESG', 0.35634082555770874)","('NON-ESG', 0.1820167899131775)","('NON-ESG', 0.051938846707344055)"
Line 644,"By year-end 2020, 38 of 47  facilities5 met prerequisite criteria.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5515600442886353)","('Access_And_Affordability', 0.08375387638807297)","('Product_Quality_And_Safety', 0.04880819097161293)","(['Corporate Governance'], 0.5515600442886353)","('NON-ESG', 0.08375387638807297)","('NON-ESG', 0.04880819097161293)"
Line 645,"Of those, 30 also met  Bronze, 19 met Silver and 4 met Gold.ENERGY CONSERVATION PROJECTS *2020 GOALReduce total energy  use by 15% indexed  to revenue VIEW ALL 2020 GOALSNot achieved VIEW THE DATA SUMMARY AND   VALUE CHAIN ENERGY USAGE AND GHG   EMISSIONS TABLE FOR MORE DETAIL.estimated CO 2e of  GHG emissions avoided 13,600During 2020 : estimated savings metric tons$4.trillion joules million 155projects implemented  2019-* Estimated energy and financial savings as well as GHG emissions avoidance are  calculated for the 12 months following project implementation.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT35Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction WATER AND WASTEWATER Water is a valuable resource, and water issues continue   to grow in importance worldwide.
","('GHG_Emissions', 0.9650759696960449)","('Air_Quality', 0.0068290079943835735)","('Ecological_Impacts', 0.0028310285415500402)","(['Climate Change'], 0.9650759696960449)","('NON-ESG', 0.0068290079943835735)","('NON-ESG', 0.0028310285415500402)"
Line 646,"Of those, 30 also met  Bronze, 19 met Silver and 4 met Gold.ENERGY CONSERVATION PROJECTS *2020 GOALReduce total energy  use by 15% indexed  to revenue VIEW ALL 2020 GOALSNot achieved VIEW THE DATA SUMMARY AND   VALUE CHAIN ENERGY USAGE AND GHG   EMISSIONS TABLE FOR MORE DETAIL.estimated CO 2e of  GHG emissions avoided 13,600During 2020 : estimated savings metric tons$4.trillion joules million 155projects implemented  2019-* Estimated energy and financial savings as well as GHG emissions avoidance are  calculated for the 12 months following project implementation.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT35Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction WATER AND WASTEWATER Water is a valuable resource, and water issues continue   to grow in importance worldwide.
","('Water_And_Wastewater_Management', 0.9767242670059204)","('Energy_Management', 0.0020663284230977297)","('GHG_Emissions', 0.0016551126027479768)","(['Operational Eco-Efficiency'], 0.9767242670059204)","('NON-ESG', 0.0020663284230977297)","('NON-ESG', 0.0016551126027479768)"
Line 647,"Although these  concerns are global, they must be addressed at the  local and regional levels.
","('Human_Rights_And_Community_Relations', 0.3526952564716339)","('Management_Of_Legal_And_Regulatory_Framework', 0.24481312930583954)","('Systemic_Risk_Management', 0.05535295978188515)","('NON-ESG', 0.3526952564716339)","('NON-ESG', 0.24481312930583954)","('NON-ESG', 0.05535295978188515)"
Line 648,"Baxter works to better  understand the impacts of water use across our value  chain and implements conservation and efficiency  projects at our manufacturing facilities.
","('Water_And_Wastewater_Management', 0.9693934917449951)","('Energy_Management', 0.003950007725507021)","('GHG_Emissions', 0.0034507266245782375)","(['Operational Eco-Efficiency'], 0.9693934917449951)","('NON-ESG', 0.003950007725507021)","('NON-ESG', 0.0034507266245782375)"
Line 649,"See our response   to CDP Water Security .
","('Water_And_Wastewater_Management', 0.9436850547790527)","('Supply_Chain_Management', 0.005996656604111195)","('Physical_Impacts_Of_Climate_Change', 0.004737874958664179)","(['Operational Eco-Efficiency'], 0.9436850547790527)","('NON-ESG', 0.005996656604111195)","('NON-ESG', 0.004737874958664179)"
Line 650,"We reduced water  consumption by 10.4%  indexed to revenue  from 2015 through  2020, missing our  2020 goal of a 15%  reduction.
","('Water_And_Wastewater_Management', 0.927715003490448)","('Energy_Management', 0.029936445876955986)","('GHG_Emissions', 0.005510818678885698)","(['Operational Eco-Efficiency'], 0.927715003490448)","('NON-ESG', 0.029936445876955986)","('NON-ESG', 0.005510818678885698)"
Line 651,"Energy use  and water processing  are closely related in  our facilities; therefore,  the changes in manufacturing that contributed to  missing our energy goal (as described previously) were  similar to those for our water goal.
","('Energy_Management', 0.7399309873580933)","('Water_And_Wastewater_Management', 0.18300403654575348)","('Air_Quality', 0.007474021520465612)","(['Operational Eco-Efficiency'], 0.7399309873580933)","('NON-ESG', 0.18300403654575348)","('NON-ESG', 0.007474021520465612)"
Line 652,"During 2020, we withdrew approximately 14 million  cubic meters of water,6 about the same as in 2019 and  a 3% decrease indexed to revenue.
","('Water_And_Wastewater_Management', 0.9712802767753601)","('GHG_Emissions', 0.0032438868656754494)","('Energy_Management', 0.003159272251650691)","(['Operational Eco-Efficiency'], 0.9712802767753601)","('NON-ESG', 0.0032438868656754494)","('NON-ESG', 0.003159272251650691)"
Line 653,"Water is a key raw material for Baxter, and we have  implemented numerous water-reduction projects since  2015.
","('Water_And_Wastewater_Management', 0.9740490913391113)","('GHG_Emissions', 0.003246757434681058)","('Energy_Management', 0.0023241164162755013)","(['Operational Eco-Efficiency'], 0.9740490913391113)","('NON-ESG', 0.003246757434681058)","('NON-ESG', 0.0023241164162755013)"
Line 654,"As part of our water management strategy going  forward, we will assess the physical, regulatory and  reputational risks associated with our water use to  continue operating successfully and responsibly.
","('Water_And_Wastewater_Management', 0.9752019047737122)","('GHG_Emissions', 0.0022847631480544806)","('Waste_And_Hazardous_Materials_Management', 0.0022634195629507303)","(['Operational Eco-Efficiency'], 0.9752019047737122)","('NON-ESG', 0.0022847631480544806)","('NON-ESG', 0.0022634195629507303)"
Line 655,"Water issues vary significantly by location.
","('Water_And_Wastewater_Management', 0.9741177558898926)","('Waste_And_Hazardous_Materials_Management', 0.0023435412440449)","('GHG_Emissions', 0.0020087193697690964)","(['Operational Eco-Efficiency'], 0.9741177558898926)","('NON-ESG', 0.0023435412440449)","('NON-ESG', 0.0020087193697690964)"
Line 656,"In 2020, we  applied the World Resources Institute (WRI) Aqueduct   Water Risk Atlas version 3.0  to map and analyze current  and future risks associated with water stress at our  most significant water-use locations.
","('Water_And_Wastewater_Management', 0.9768731594085693)","('Waste_And_Hazardous_Materials_Management', 0.002102032070979476)","('GHG_Emissions', 0.001718349871225655)","(['Operational Eco-Efficiency'], 0.9768731594085693)","('NON-ESG', 0.002102032070979476)","('NON-ESG', 0.001718349871225655)"
Line 657,"The WRI water  tool defines baseline water stress as total annual water  withdrawals (municipal, industrial and agricultural) expressed as a percent of total annual available flow.
","('Water_And_Wastewater_Management', 0.977669894695282)","('GHG_Emissions', 0.0022353818640112877)","('Energy_Management', 0.0017758632311597466)","(['Operational Eco-Efficiency'], 0.977669894695282)","('NON-ESG', 0.0022353818640112877)","('NON-ESG', 0.0017758632311597466)"
Line 658,"Higher values indicate more competition among users.7  Our 55 most significant water-use locations represented   97% of our total water use in 2020.
","('Water_And_Wastewater_Management', 0.974970817565918)","('Energy_Management', 0.0030193307902663946)","('GHG_Emissions', 0.0024350848980247974)","(['Operational Eco-Efficiency'], 0.974970817565918)","('NON-ESG', 0.0030193307902663946)","('NON-ESG', 0.0024350848980247974)"
Line 659,"Of the 55 sites,   25 are located in medium-high , high  and extremely high   water-stress areas.
","('Water_And_Wastewater_Management', 0.9679150581359863)","('Ecological_Impacts', 0.006205686368048191)","('GHG_Emissions', 0.0035053954925388098)","(['Operational Eco-Efficiency'], 0.9679150581359863)","('NON-ESG', 0.006205686368048191)","('NON-ESG', 0.0035053954925388098)"
Line 660,"During the year, facility water use  at these sites decreased by 1% in absolute terms and by  3% indexed to revenue compared with 2019.
","('Water_And_Wastewater_Management', 0.9726075530052185)","('GHG_Emissions', 0.003116545034572482)","('Energy_Management', 0.0027561469469219446)","(['Operational Eco-Efficiency'], 0.9726075530052185)","('NON-ESG', 0.003116545034572482)","('NON-ESG', 0.0027561469469219446)"
Line 661,"WASTEWATER Wastewater discharged from Baxter operations has  historically been, and remains, an important focus of  our compliance program.
","('Water_And_Wastewater_Management', 0.9612365961074829)","('Waste_And_Hazardous_Materials_Management', 0.008327222429215908)","('GHG_Emissions', 0.0033235892187803984)","(['Operational Eco-Efficiency'], 0.9612365961074829)","('NON-ESG', 0.008327222429215908)","('NON-ESG', 0.0033235892187803984)"
Line 662,"In 2020, 70% of Baxter’s self- reported environmental incidents were exceedances  of permitted wastewater discharge limits; 75% of  those were from the Americas region (North America  and Latin America) and the remaining 25% from the 2020 GOALReduce total water  use by 15% indexed  to revenue Not achieved VIEW ALL 2020 GOALSBAXTER SITES IN LOCATIONS WITH WATER STRESS RISK      Site Location Med-High High Extremely High Australia 2   Belgium   Brazil  1  China 1 2  Germany 1 3  India   Malta    Mexico   Spain 1   Thailand 1   Tunisia  1  UK  1  United States 1 1 1Europe, Middle East and Africa region.
","('Water_And_Wastewater_Management', 0.9761414527893066)","('Waste_And_Hazardous_Materials_Management', 0.0025211272295564413)","('GHG_Emissions', 0.0017706959042698145)","(['Operational Eco-Efficiency'], 0.9761414527893066)","('NON-ESG', 0.0025211272295564413)","('NON-ESG', 0.0017706959042698145)"
Line 663,"In 2020, 70% of Baxter’s self- reported environmental incidents were exceedances  of permitted wastewater discharge limits; 75% of  those were from the Americas region (North America  and Latin America) and the remaining 25% from the 2020 GOALReduce total water  use by 15% indexed  to revenue Not achieved VIEW ALL 2020 GOALSBAXTER SITES IN LOCATIONS WITH WATER STRESS RISK      Site Location Med-High High Extremely High Australia 2   Belgium   Brazil  1  China 1 2  Germany 1 3  India   Malta    Mexico   Spain 1   Thailand 1   Tunisia  1  UK  1  United States 1 1 1Europe, Middle East and Africa region.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2355610728263855)","('Business_Model_Resilience', 0.13084226846694946)","('Ecological_Impacts', 0.1060267984867096)","('NON-ESG', 0.2355610728263855)","('NON-ESG', 0.13084226846694946)","('NON-ESG', 0.1060267984867096)"
Line 664,"None of these  exceedances resulted in a fine.
","('Management_Of_Legal_And_Regulatory_Framework', 0.621935248374939)","('Business_Ethics', 0.24209338426589966)","('Director_Removal', 0.01225222647190094)","(['Corporate Governance'], 0.621935248374939)","('NON-ESG', 0.24209338426589966)","('NON-ESG', 0.01225222647190094)"
Line 665,"To manage these matters,  Baxter applied both internal and external resources  and worked to enhance internal wastewater operational  practices, training and other facility engagement  opportunities.
","('Employee_Health_And_Safety', 0.13761217892169952)","('Access_And_Affordability', 0.07650621235370636)","('Human_Rights_And_Community_Relations', 0.07263581454753876)","('NON-ESG', 0.13761217892169952)","('NON-ESG', 0.07650621235370636)","('NON-ESG', 0.07263581454753876)"
Line 666,"Baxter also upgraded wastewater  pretreatment infrastructure at several facilities in 2020.
","('Water_And_Wastewater_Management', 0.9570966958999634)","('Waste_And_Hazardous_Materials_Management', 0.0067497421987354755)","('Energy_Management', 0.0061192321591079235)","(['Operational Eco-Efficiency'], 0.9570966958999634)","('NON-ESG', 0.0067497421987354755)","('NON-ESG', 0.0061192321591079235)"
Line 667,"As part of our proactive commitment to compliance,  Baxter has adopted a more aggressive approach to  wastewater operations and enhanced how we identify,  evaluate and manage wastewater issues.
","('Water_And_Wastewater_Management', 0.9668652415275574)","('Waste_And_Hazardous_Materials_Management', 0.004525099880993366)","('Energy_Management', 0.0033044591546058655)","(['Operational Eco-Efficiency'], 0.9668652415275574)","('NON-ESG', 0.004525099880993366)","('NON-ESG', 0.0033044591546058655)"
Line 668,"Our systematic  wastewater risk management program identifies  emerging issues.
","('Water_And_Wastewater_Management', 0.9645324349403381)","('Waste_And_Hazardous_Materials_Management', 0.00410512275993824)","('GHG_Emissions', 0.0033741809893399477)","(['Operational Eco-Efficiency'], 0.9645324349403381)","('NON-ESG', 0.00410512275993824)","('NON-ESG', 0.0033741809893399477)"
Line 669,"In 2020, this involved a holistic review  of major manufacturing locations that included the  following activities:  • Engaged an expert third party to review compliance  measures at the highest priority facilities • Evaluated effectiveness of facility change management  processes for wastewater operations   • Reviewed wastewater compliance history and recent  data to identify possible trends • Assessed wastewater permit compliance procedures  and made recommendations  • Validated methods to investigate and remedy causes  of upset conditions and ensure their effectiveness • Affirmed ongoing employee awareness of wastewater  operations and roles in assuring compliance  • Conducted supplementary training at various facilities We will share best practices across our operations based  on lessons learned from our highest priority facilities.
","('Water_And_Wastewater_Management', 0.9570331573486328)","('Waste_And_Hazardous_Materials_Management', 0.004589067306369543)","('GHG_Emissions', 0.004252784885466099)","(['Operational Eco-Efficiency'], 0.9570331573486328)","('NON-ESG', 0.004589067306369543)","('NON-ESG', 0.004252784885466099)"
Line 670,"In 2020, this involved a holistic review  of major manufacturing locations that included the  following activities:  • Engaged an expert third party to review compliance  measures at the highest priority facilities • Evaluated effectiveness of facility change management  processes for wastewater operations   • Reviewed wastewater compliance history and recent  data to identify possible trends • Assessed wastewater permit compliance procedures  and made recommendations  • Validated methods to investigate and remedy causes  of upset conditions and ensure their effectiveness • Affirmed ongoing employee awareness of wastewater  operations and roles in assuring compliance  • Conducted supplementary training at various facilities We will share best practices across our operations based  on lessons learned from our highest priority facilities.
","('Water_And_Wastewater_Management', 0.43712154030799866)","('Employee_Health_And_Safety', 0.09407962113618851)","('Business_Ethics', 0.08147422969341278)","('NON-ESG', 0.43712154030799866)","('NON-ESG', 0.09407962113618851)","('NON-ESG', 0.08147422969341278)"
Line 671,"VIEW THE DATA SUMMARY   FOR MORE DETAIL.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT36Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction WASTE Baxter identifies leading waste reduction opportunities  based on our highest-volume waste streams, facilities  that produce the most waste, and sites with strong  potential to improve, among other factors.
","('Waste_And_Hazardous_Materials_Management', 0.9847515225410461)","('Water_And_Wastewater_Management', 0.001266184146516025)","('Data_Security', 0.0011826662812381983)","(['Operational Eco-Efficiency'], 0.9847515225410461)","('NON-ESG', 0.001266184146516025)","('NON-ESG', 0.0011826662812381983)"
Line 672,"VIEW THE DATA SUMMARY   FOR MORE DETAIL.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT36Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction WASTE Baxter identifies leading waste reduction opportunities  based on our highest-volume waste streams, facilities  that produce the most waste, and sites with strong  potential to improve, among other factors.
","('Access_And_Affordability', 0.14454974234104156)","('Business_Model_Resilience', 0.10348079353570938)","('Ecological_Impacts', 0.10136650502681732)","('NON-ESG', 0.14454974234104156)","('NON-ESG', 0.10348079353570938)","('NON-ESG', 0.10136650502681732)"
Line 673,"Facilities  measure waste at the point of generation to rapidly  identify significant sources.
","('Waste_And_Hazardous_Materials_Management', 0.9841362237930298)","('Water_And_Wastewater_Management', 0.0013678213581442833)","('Data_Security', 0.001270202687010169)","(['Operational Eco-Efficiency'], 0.9841362237930298)","('NON-ESG', 0.0013678213581442833)","('NON-ESG', 0.001270202687010169)"
Line 674,"We track and analyze waste  data from each major facility to assess progress toward  waste reduction goals and identify ways to improve  processes that generate waste.
","('Waste_And_Hazardous_Materials_Management', 0.9848040342330933)","('Water_And_Wastewater_Management', 0.0012739334488287568)","('Air_Quality', 0.0012062406167387962)","(['Operational Eco-Efficiency'], 0.9848040342330933)","('NON-ESG', 0.0012739334488287568)","('NON-ESG', 0.0012062406167387962)"
Line 675,"These and other  activities reduce expenses related to raw materials use,  waste handling and disposal.
","('Waste_And_Hazardous_Materials_Management', 0.9771665930747986)","('Product_Design_And_Lifecycle_Management', 0.002682637656107545)","('Water_And_Wastewater_Management', 0.0018959366716444492)","(['Operational Eco-Efficiency'], 0.9771665930747986)","('NON-ESG', 0.002682637656107545)","('NON-ESG', 0.0018959366716444492)"
Line 676,"During 2020, our  operations generated  69,700 metric tons of  total waste, similar to  2015 in absolute terms  and down 14.7% indexed  to revenue,8 just short  of our goal of a 15%  reduction.
","('Waste_And_Hazardous_Materials_Management', 0.9822558164596558)","('Water_And_Wastewater_Management', 0.0019457689486443996)","('Air_Quality', 0.0012302781688049436)","(['Operational Eco-Efficiency'], 0.9822558164596558)","('NON-ESG', 0.0019457689486443996)","('NON-ESG', 0.0012302781688049436)"
Line 677,"As part of  our future goals, we plan to further assess how waste is  generated throughout Baxter’s integrated supply chain  and to establish management plans to address impacts  internally, upstream and downstream.
","('Waste_And_Hazardous_Materials_Management', 0.9468226432800293)","('Supply_Chain_Management', 0.012945862486958504)","('Water_And_Wastewater_Management', 0.0057428982108831406)","(['Operational Eco-Efficiency'], 0.9468226432800293)","('NON-ESG', 0.012945862486958504)","('NON-ESG', 0.0057428982108831406)"
Line 678,"Our operations generated 63,500 metric tons of  nonhazardous waste during 2020, a 1% increase in  absolute terms and a 2% decrease indexed to revenue,  compared with 2019.
","('Waste_And_Hazardous_Materials_Management', 0.9837021827697754)","('Water_And_Wastewater_Management', 0.0016221428522840142)","('Air_Quality', 0.0011517528910189867)","(['Operational Eco-Efficiency'], 0.9837021827697754)","('NON-ESG', 0.0016221428522840142)","('NON-ESG', 0.0011517528910189867)"
Line 679,"Reducing plastic waste and increasing recycling is a  priority for Baxter; plastic scrap from manufacturing is  our largest waste stream, representing roughly one third  of our nonhazardous waste.
","('Waste_And_Hazardous_Materials_Management', 0.9841912984848022)","('Data_Security', 0.001413084683008492)","('Water_And_Wastewater_Management', 0.001134013058617711)","(['Operational Eco-Efficiency'], 0.9841912984848022)","('NON-ESG', 0.001413084683008492)","('NON-ESG', 0.001134013058617711)"
Line 680,"In 2020, several facilities  implemented projects to reduce plastic scrap.
","('Waste_And_Hazardous_Materials_Management', 0.9357245564460754)","('Product_Design_And_Lifecycle_Management', 0.014919830486178398)","('Employee_Health_And_Safety', 0.005781359504908323)","(['Operational Eco-Efficiency'], 0.9357245564460754)","('NON-ESG', 0.014919830486178398)","('NON-ESG', 0.005781359504908323)"
Line 681,"For  example, our facility in Cuernavaca, Mexico, reduced  PVC and HDPE plastic waste material by 78 metric tons  during the year through process improvement techniques  such as Six Sigma.
","('Waste_And_Hazardous_Materials_Management', 0.9825018644332886)","('Water_And_Wastewater_Management', 0.001997876213863492)","('Air_Quality', 0.0013107734266668558)","(['Operational Eco-Efficiency'], 0.9825018644332886)","('NON-ESG', 0.001997876213863492)","('NON-ESG', 0.0013107734266668558)"
Line 682,"See Materials Use  for an additional  example of reducing plastic scrap.
","('Waste_And_Hazardous_Materials_Management', 0.8130932450294495)","('Product_Design_And_Lifecycle_Management', 0.07163150608539581)","('Supply_Chain_Management', 0.016531700268387794)","(['Operational Eco-Efficiency'], 0.8130932450294495)","('NON-ESG', 0.07163150608539581)","('NON-ESG', 0.016531700268387794)"
Line 683,"Baxter also innovates to reduce the environmental  impact of product packaging.
","('Product_Design_And_Lifecycle_Management', 0.964072048664093)","('Product_Quality_And_Safety', 0.0038582191336899996)","('Selling_Practices_And_Product_Labeling', 0.0028729562181979418)","(['Product Stewardship'], 0.964072048664093)","('NON-ESG', 0.0038582191336899996)","('NON-ESG', 0.0028729562181979418)"
Line 684,"Read more in  Product Innovation .
","('Product_Design_And_Lifecycle_Management', 0.8878763914108276)","('Business_Model_Resilience', 0.015442727133631706)","('Supply_Chain_Management', 0.013067674823105335)","(['Product Stewardship'], 0.8878763914108276)","('NON-ESG', 0.015442727133631706)","('NON-ESG', 0.013067674823105335)"
Line 685,"Regulated waste9 represented 9% of Baxter’s total  waste during 2020.
","('Waste_And_Hazardous_Materials_Management', 0.9844421744346619)","('Data_Security', 0.0012709539150819182)","('Water_And_Wastewater_Management', 0.0012682320084422827)","(['Operational Eco-Efficiency'], 0.9844421744346619)","('NON-ESG', 0.0012709539150819182)","('NON-ESG', 0.0012682320084422827)"
Line 686,"Over the course of the year, our  operations generated 6,200 metric tons of regulated  waste, 32% lower in absolute terms than in 2019,  and 34% less indexed to revenue.
","('Waste_And_Hazardous_Materials_Management', 0.9827203750610352)","('Water_And_Wastewater_Management', 0.0017991248751059175)","('Air_Quality', 0.0014334527077153325)","(['Operational Eco-Efficiency'], 0.9827203750610352)","('NON-ESG', 0.0017991248751059175)","('NON-ESG', 0.0014334527077153325)"
Line 687,"This reduction  was mainly due to a project implemented in 2020  at our facility in Hechingen, Germany, based on a  similar project at our facility in Opelika, Alabama.
","('GHG_Emissions', 0.14244846999645233)","('Management_Of_Legal_And_Regulatory_Framework', 0.12840867042541504)","('Access_And_Affordability', 0.11876465380191803)","('NON-ESG', 0.14244846999645233)","('NON-ESG', 0.12840867042541504)","('NON-ESG', 0.11876465380191803)"
Line 688,"The project modified the solvent recovery process,  thereby eliminating the residual ultrafiltration- related waste stream.
","('Waste_And_Hazardous_Materials_Management', 0.9837114214897156)","('Water_And_Wastewater_Management', 0.0015704752877354622)","('Data_Security', 0.0011088520986959338)","(['Operational Eco-Efficiency'], 0.9837114214897156)","('NON-ESG', 0.0015704752877354622)","('NON-ESG', 0.0011088520986959338)"
Line 689,"This reduced regulated waste  by  more than 2,230 metric tons in 2020 and decreased  energy use by 14.4 trillion joules per year.
","('Waste_And_Hazardous_Materials_Management', 0.9725775718688965)","('Water_And_Wastewater_Management', 0.002916327677667141)","('Air_Quality', 0.002589427400380373)","(['Operational Eco-Efficiency'], 0.9725775718688965)","('NON-ESG', 0.002916327677667141)","('NON-ESG', 0.002589427400380373)"
Line 690,"In 2020, we recycled 79.5% of nonhazardous  waste and 49.6% of regulated waste for an overall  recycling rate of 76.8%.10 Recycling at Baxter  generated $2.3 million in net income in 2020.2020 GOALReduce total waste  generation by 15%  indexed to revenue Not achieved VIEW ALL 2020 GOALSIn 2020, 25  manufacturing sites11  (49% of the total)  achieved or exceeded  landfill diversion  rates of 95%, missing  our goal to achieve  or exceed that level  at all manufacturing  sites.
","('Waste_And_Hazardous_Materials_Management', 0.982533872127533)","('Water_And_Wastewater_Management', 0.0019094354938715696)","('Data_Security', 0.0013110486324876547)","(['Operational Eco-Efficiency'], 0.982533872127533)","('NON-ESG', 0.0019094354938715696)","('NON-ESG', 0.0013110486324876547)"
Line 691,"Twelve  additional sites (25% of the total) achieved diversion  rates of 80% or higher.
","('Water_And_Wastewater_Management', 0.7617965340614319)","('GHG_Emissions', 0.03283907473087311)","('Air_Quality', 0.031730566173791885)","(['Operational Eco-Efficiency'], 0.7617965340614319)","('NON-ESG', 0.03283907473087311)","('NON-ESG', 0.031730566173791885)"
Line 692,"We continue working with outside  experts to accelerate progress in the coming years.
","('Management_Of_Legal_And_Regulatory_Framework', 0.28705912828445435)","('Human_Rights_And_Community_Relations', 0.13981595635414124)","('Business_Model_Resilience', 0.12384176254272461)","('NON-ESG', 0.28705912828445435)","('NON-ESG', 0.13981595635414124)","('NON-ESG', 0.12384176254272461)"
Line 693,"GHG EMISSIONS ACROSS THE   VALUE CHAIN Climate change is among the most pressing global  challenges facing the world today, posing risks for  humans and natural ecosystems.
","('GHG_Emissions', 0.9562507271766663)","('Physical_Impacts_Of_Climate_Change', 0.008531320840120316)","('Ecological_Impacts', 0.005327074322849512)","(['Climate Change'], 0.9562507271766663)","('NON-ESG', 0.008531320840120316)","('NON-ESG', 0.005327074322849512)"
Line 694,"We identify, manage  and mitigate Baxter’s climate-related risks as part  of our global risk management activities.
","('Physical_Impacts_Of_Climate_Change', 0.9324507713317871)","('Business_Model_Resilience', 0.01716569997370243)","('Systemic_Risk_Management', 0.007867575623095036)","(['Climate Change'], 0.9324507713317871)","('NON-ESG', 0.01716569997370243)","('NON-ESG', 0.007867575623095036)"
Line 695,"In addition  to addressing climate change with an aggressive  GHG emissions reduction strategy, we are focused  on protecting our stakeholders by building resilience  to climate change across our supply chain.
","('GHG_Emissions', 0.6439329981803894)","('Physical_Impacts_Of_Climate_Change', 0.1967484951019287)","('Business_Model_Resilience', 0.029705189168453217)","(['Climate Change'], 0.6439329981803894)","('NON-ESG', 0.1967484951019287)","('NON-ESG', 0.029705189168453217)"
Line 696,"For more  information on our governance, strategy and risk  management as recommended by the Task Force  on Climate-related Financial Disclosures, see our  response to CDP Climate Change  and our Climate   Change & Energy Position Statement .
","('Physical_Impacts_Of_Climate_Change', 0.9504545331001282)","('Business_Model_Resilience', 0.011663288809359074)","('GHG_Emissions', 0.004441622644662857)","(['Climate Change'], 0.9504545331001282)","('NON-ESG', 0.011663288809359074)","('NON-ESG', 0.004441622644662857)"
Line 697,"We began reporting our Scope 1, Scope 2 and certain  Scope 3 GHG emissions in 1997 and contributed to the  development of the initial version of the Greenhouse   Gas Protocol .
","('GHG_Emissions', 0.9678829908370972)","('Ecological_Impacts', 0.0048239463940262794)","('Water_And_Wastewater_Management', 0.0028479434549808502)","(['Climate Change'], 0.9678829908370972)","('NON-ESG', 0.0048239463940262794)","('NON-ESG', 0.0028479434549808502)"
Line 698,"2020 RECYCLING AT BAXTER net income  generatedregulated  waste recycled$2.million49.6% nonhazardous  waste recycled79.5% overall recycling rate76.8% 2020 GOALAchieve a landfill  diversion rate of 95%   or higher at all  manufacturing locations Not achieved VIEW ALL 2020 GOALS VIEW THE DATA SUMMARY   FOR MORE DETAIL.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT37Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction We estimate our 2020 GHG emissions footprint (Scope 1,  2 and 3) at 4.5 million metric tons CO2e,12 down 7% from  2019.
","('Waste_And_Hazardous_Materials_Management', 0.9750024676322937)","('Water_And_Wastewater_Management', 0.0032101492397487164)","('Product_Design_And_Lifecycle_Management', 0.002397786360234022)","(['Operational Eco-Efficiency'], 0.9750024676322937)","('NON-ESG', 0.0032101492397487164)","('NON-ESG', 0.002397786360234022)"
Line 699,"2020 RECYCLING AT BAXTER net income  generatedregulated  waste recycled$2.million49.6% nonhazardous  waste recycled79.5% overall recycling rate76.8% 2020 GOALAchieve a landfill  diversion rate of 95%   or higher at all  manufacturing locations Not achieved VIEW ALL 2020 GOALS VIEW THE DATA SUMMARY   FOR MORE DETAIL.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT37Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction We estimate our 2020 GHG emissions footprint (Scope 1,  2 and 3) at 4.5 million metric tons CO2e,12 down 7% from  2019.
","('GHG_Emissions', 0.9668393731117249)","('Air_Quality', 0.005156173370778561)","('Ecological_Impacts', 0.003261597128584981)","(['Climate Change'], 0.9668393731117249)","('NON-ESG', 0.005156173370778561)","('NON-ESG', 0.003261597128584981)"
Line 700,"The main contributing factor to this decrease was  reduced sales and production of certain products in 2020.
","('Product_Design_And_Lifecycle_Management', 0.9387233257293701)","('Selling_Practices_And_Product_Labeling', 0.01102744322270155)","('Product_Quality_And_Safety', 0.01091056503355503)","(['Product Stewardship'], 0.9387233257293701)","('NON-ESG', 0.01102744322270155)","('NON-ESG', 0.01091056503355503)"
Line 701,"Since 2015, we have offset GHG emissions related to  global business travel with United Airlines through  the CarbonChoice program .
","('GHG_Emissions', 0.9678138494491577)","('Ecological_Impacts', 0.0046556247398257256)","('Air_Quality', 0.0032694926485419273)","(['Climate Change'], 0.9678138494491577)","('NON-ESG', 0.0046556247398257256)","('NON-ESG', 0.0032694926485419273)"
Line 702,"During 2020, this included  1,300 metric tons CO2e offset on Baxter’s behalf through  the Maísa REDD+ – Sustainable Travel International project   (reducing GHG emissions associated with deforestation  and forest degradation), a Verified Carbon Standard, and  a Climate Community & Biodiversity Standards project in  the Brazilian Amazon.
","('GHG_Emissions', 0.948488175868988)","('Ecological_Impacts', 0.019520431756973267)","('Water_And_Wastewater_Management', 0.003551253117620945)","(['Climate Change'], 0.948488175868988)","('NON-ESG', 0.019520431756973267)","('NON-ESG', 0.003551253117620945)"
Line 703,"GHG EMISSIONS FROM OPERATIONS Through 2020, we  reduced our absolute  GHG emissions from  operations by 13.6%  compared with 2015,  exceeding our goal  of a 10% reduction.
","('GHG_Emissions', 0.9657811522483826)","('Air_Quality', 0.005571967456489801)","('Ecological_Impacts', 0.0031334906816482544)","(['Climate Change'], 0.9657811522483826)","('NON-ESG', 0.005571967456489801)","('NON-ESG', 0.0031334906816482544)"
Line 704,"Total emissions from operations equaled 611,000  metric tons CO2e in 2020.
","('GHG_Emissions', 0.8766062259674072)","('Air_Quality', 0.05200902000069618)","('Energy_Management', 0.015794772654771805)","(['Climate Change'], 0.8766062259674072)","('NON-ESG', 0.05200902000069618)","('NON-ESG', 0.015794772654771805)"
Line 705,"BAXTER’S GLOBAL GHG EMISSIONS FOOTPRINT, Scope 1   Facility/Vehicle Fuel Usage  and Refrigerant Losses 6.9% Scope 2   Purchased Energy 6.7% Scope 3   Purchased Goods  and Services 18.4% Scope 3   Use of Sold Products 44.8%Scope 3   Other 13.6% Scope 3   Upstream Transportation  and Distribution 9.6%4,493 ,000  metric tons CO2e Reducing energy  use is vital to our sustainability  strategy, as energy use accounts for 99% of Baxter's  GHG emissions from operations.
","('GHG_Emissions', 0.9494931697845459)","('Energy_Management', 0.009063518606126308)","('Air_Quality', 0.007994907908141613)","(['Climate Change'], 0.9494931697845459)","('NON-ESG', 0.009063518606126308)","('NON-ESG', 0.007994907908141613)"
Line 706,"Other tactics to  decrease GHG emissions in 2020 included fuel switching,  cogeneration, on-site renewable energy systems,  renewable power procurement and green buildings .
","('GHG_Emissions', 0.9619702696800232)","('Air_Quality', 0.007109695579856634)","('Physical_Impacts_Of_Climate_Change', 0.0037080077454447746)","(['Climate Change'], 0.9619702696800232)","('NON-ESG', 0.007109695579856634)","('NON-ESG', 0.0037080077454447746)"
Line 707,"By the end of 2020, 28% of our energy use for operations  was from renewable sources.
","('Energy_Management', 0.9794451594352722)","('Management_Of_Legal_And_Regulatory_Framework', 0.002138211391866207)","('Product_Design_And_Lifecycle_Management', 0.0016604539705440402)","(['Operational Eco-Efficiency'], 0.9794451594352722)","('NON-ESG', 0.002138211391866207)","('NON-ESG', 0.0016604539705440402)"
Line 708,"Biomass fuel for boilers  at two of our locations13 accounted for 10%, and the  renewable energy component of purchased electricity and  renewable energy certificates together represented 18%.
","('Energy_Management', 0.9770887494087219)","('Management_Of_Legal_And_Regulatory_Framework', 0.004365861881524324)","('GHG_Emissions', 0.0017569339834153652)","(['Operational Eco-Efficiency'], 0.9770887494087219)","('NON-ESG', 0.004365861881524324)","('NON-ESG', 0.0017569339834153652)"
Line 709,"On-site geothermal, solar photovoltaic and solar hot  water systems contributed a small amount.
","('Water_And_Wastewater_Management', 0.9012534022331238)","('Energy_Management', 0.033013999462127686)","('GHG_Emissions', 0.012783405371010303)","(['Operational Eco-Efficiency'], 0.9012534022331238)","('NON-ESG', 0.033013999462127686)","('NON-ESG', 0.012783405371010303)"
Line 710,"Baxter's energy procurement team works with our  suppliers to source sustainable and economical energy  for our manufacturing facilities.
","('Energy_Management', 0.9742669463157654)","('Product_Design_And_Lifecycle_Management', 0.003700927132740617)","('Management_Of_Legal_And_Regulatory_Framework', 0.0022360351867973804)","(['Operational Eco-Efficiency'], 0.9742669463157654)","('NON-ESG', 0.003700927132740617)","('NON-ESG', 0.0022360351867973804)"
Line 711,"Globally in 2020,  we purchased more than 368,000 MWh of electricity  generated from 100% certified renewable power,  including all electricity purchased in Illinois.
","('Energy_Management', 0.9732821583747864)","('Management_Of_Legal_And_Regulatory_Framework', 0.004664070438593626)","('Water_And_Wastewater_Management', 0.0022841242607682943)","(['Operational Eco-Efficiency'], 0.9732821583747864)","('NON-ESG', 0.004664070438593626)","('NON-ESG', 0.0022841242607682943)"
Line 712,"We were recognized  as  the 35th largest corporate  purchaser of renewable  energy in the United States  during the year.14  Since 2007, we have maintained  carbon neutrality at our headquarters in Deerfield,  Illinois, through electricity generated from certified  renewable energy sources.
","('Energy_Management', 0.9788380861282349)","('Management_Of_Legal_And_Regulatory_Framework', 0.0029317347798496485)","('Air_Quality', 0.001722069806419313)","(['Operational Eco-Efficiency'], 0.9788380861282349)","('NON-ESG', 0.0029317347798496485)","('NON-ESG', 0.001722069806419313)"
Line 713,"We offset facility-related  emissions from purchased electricity.
","('Energy_Management', 0.5578329563140869)","('GHG_Emissions', 0.21641969680786133)","('Air_Quality', 0.07902386039495468)","(['Operational Eco-Efficiency'], 0.5578329563140869)","('NON-ESG', 0.21641969680786133)","('NON-ESG', 0.07902386039495468)"
Line 714,"During 2020, we sourced 220,000 MWh of 100% renewable  electricity for our European manufacturing sites.
","('Energy_Management', 0.9660592079162598)","('Management_Of_Legal_And_Regulatory_Framework', 0.006667050998657942)","('GHG_Emissions', 0.0031232896726578474)","(['Operational Eco-Efficiency'], 0.9660592079162598)","('NON-ESG', 0.006667050998657942)","('NON-ESG', 0.0031232896726578474)"
Line 715,"This  represented 97% of total electricity for manufacturing  in the region.
","('Energy_Management', 0.9594584703445435)","('Management_Of_Legal_And_Regulatory_Framework', 0.00798535905778408)","('Water_And_Wastewater_Management', 0.00429360568523407)","(['Operational Eco-Efficiency'], 0.9594584703445435)","('NON-ESG', 0.00798535905778408)","('NON-ESG', 0.00429360568523407)"
Line 716,"In most cases, savings from our energy  sourcing strategy in Europe finance the premium for green  electricity contracts.
","('Energy_Management', 0.9337030053138733)","('Product_Design_And_Lifecycle_Management', 0.014631830155849457)","('Supply_Chain_Management', 0.009157662279903889)","(['Operational Eco-Efficiency'], 0.9337030053138733)","('NON-ESG', 0.014631830155849457)","('NON-ESG', 0.009157662279903889)"
Line 717,"AIR EMISSIONS Baxter has reduced emissions of hazardous air pollutants  significantly during the last several decades as it has  been an area of focus since 1988.
","('Air_Quality', 0.9797911047935486)","('Critical_Incident_Risk_Management', 0.0018587005324661732)","('GHG_Emissions', 0.0015323236584663391)","(['Operational Eco-Efficiency'], 0.9797911047935486)","('NON-ESG', 0.0018587005324661732)","('NON-ESG', 0.0015323236584663391)"
Line 718,"In 2020, as part of  our continuing environmental compliance efforts, we  commenced a detailed verification process of air emissions  at our manufacturing facilities and are evaluating and  implementing upgrades to decrease emissions further.2020 GOALReduce absolute   GHG  emissions by 10% VIEW ALL 2020 GOALSAchieved GHG EMISSIONS FROM BAXTER OPERATIONS * * The regional breakdown of the data included in this graph reflects the structure  of the Environmental, Health, Safety and Sustainability (EHS&S) organization and  the categorization of data in the EHS&S global information management system  through 2020.
","('Air_Quality', 0.8320022821426392)","('GHG_Emissions', 0.10993959754705429)","('Energy_Management', 0.005789097398519516)","(['Operational Eco-Efficiency'], 0.8320022821426392)","('NON-ESG', 0.10993959754705429)","('NON-ESG', 0.005789097398519516)"
Line 719,"In 2020, as part of  our continuing environmental compliance efforts, we  commenced a detailed verification process of air emissions  at our manufacturing facilities and are evaluating and  implementing upgrades to decrease emissions further.2020 GOALReduce absolute   GHG  emissions by 10% VIEW ALL 2020 GOALSAchieved GHG EMISSIONS FROM BAXTER OPERATIONS * * The regional breakdown of the data included in this graph reflects the structure  of the Environmental, Health, Safety and Sustainability (EHS&S) organization and  the categorization of data in the EHS&S global information management system  through 2020.
","('Customer_Privacy', 0.7060526609420776)","('Data_Security', 0.15790791809558868)","('Selling_Practices_And_Product_Labeling', 0.01031432393938303)","(['Privacy Protection'], 0.7060526609420776)","('NON-ESG', 0.15790791809558868)","('NON-ESG', 0.01031432393938303)"
Line 720,"Some data for 2018 and 2019 are restated from data reported in the  Baxter 2019 Corporate Responsibility Report to improve accuracy and to reflect  updated GHG emission factors.Thousand Metric Tons CO2eMetric Tons CO2e per Million Dollars of Sales  2018 2019 North America 247       250 Latin America 68       68 EMEA 120       122 Asia Pacific 161       161 Metric tons CO2e per 54 53 Million Dollars of SalesVIEW THE DATA SUMMARY AND   VALUE CHAIN ENERGY USAGE AND GHG   EMISSIONS TABLE FOR MORE DETAIL.VIEW THE DATA SUMMARY AND   VALUE CHAIN ENERGY USAGE AND GHG   EMISSIONS TABLE FOR MORE DETAIL.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT38Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction RESPONSIBLE PROCUREMENT Baxter works to increase the diversity of our suppliers  and support sustainable practices across our supply  chain.
","('GHG_Emissions', 0.9597216248512268)","('Air_Quality', 0.010706533677875996)","('Physical_Impacts_Of_Climate_Change', 0.0027055994141846895)","(['Climate Change'], 0.9597216248512268)","('NON-ESG', 0.010706533677875996)","('NON-ESG', 0.0027055994141846895)"
Line 721,"Some data for 2018 and 2019 are restated from data reported in the  Baxter 2019 Corporate Responsibility Report to improve accuracy and to reflect  updated GHG emission factors.Thousand Metric Tons CO2eMetric Tons CO2e per Million Dollars of Sales  2018 2019 North America 247       250 Latin America 68       68 EMEA 120       122 Asia Pacific 161       161 Metric tons CO2e per 54 53 Million Dollars of SalesVIEW THE DATA SUMMARY AND   VALUE CHAIN ENERGY USAGE AND GHG   EMISSIONS TABLE FOR MORE DETAIL.VIEW THE DATA SUMMARY AND   VALUE CHAIN ENERGY USAGE AND GHG   EMISSIONS TABLE FOR MORE DETAIL.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT38Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction RESPONSIBLE PROCUREMENT Baxter works to increase the diversity of our suppliers  and support sustainable practices across our supply  chain.
","('GHG_Emissions', 0.8587702512741089)","('Supply_Chain_Management', 0.038580477237701416)","('Physical_Impacts_Of_Climate_Change', 0.01060920674353838)","(['Climate Change'], 0.8587702512741089)","('NON-ESG', 0.038580477237701416)","('NON-ESG', 0.01060920674353838)"
Line 722,"Some data for 2018 and 2019 are restated from data reported in the  Baxter 2019 Corporate Responsibility Report to improve accuracy and to reflect  updated GHG emission factors.Thousand Metric Tons CO2eMetric Tons CO2e per Million Dollars of Sales  2018 2019 North America 247       250 Latin America 68       68 EMEA 120       122 Asia Pacific 161       161 Metric tons CO2e per 54 53 Million Dollars of SalesVIEW THE DATA SUMMARY AND   VALUE CHAIN ENERGY USAGE AND GHG   EMISSIONS TABLE FOR MORE DETAIL.VIEW THE DATA SUMMARY AND   VALUE CHAIN ENERGY USAGE AND GHG   EMISSIONS TABLE FOR MORE DETAIL.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT38Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction RESPONSIBLE PROCUREMENT Baxter works to increase the diversity of our suppliers  and support sustainable practices across our supply  chain.
","('Supply_Chain_Management', 0.9353678226470947)","('Labor_Practices', 0.00938428845256567)","('Waste_And_Hazardous_Materials_Management', 0.0045160287991166115)","(['Supply Chain Management'], 0.9353678226470947)","('NON-ESG', 0.00938428845256567)","('NON-ESG', 0.0045160287991166115)"
Line 723,"In addition to traditional considerations,  such as quality and price, we integrate social and  environmental criteria into our requests for proposal  and supplier contract templates.
","('Supply_Chain_Management', 0.930820882320404)","('Labor_Practices', 0.007890223525464535)","('Product_Design_And_Lifecycle_Management', 0.007652919739484787)","(['Supply Chain Management'], 0.930820882320404)","('NON-ESG', 0.007890223525464535)","('NON-ESG', 0.007652919739484787)"
Line 724,"SUPPLIER DIVERSITY Supplier diversity is a high priority for our company.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8663192987442017)","('Labor_Practices', 0.021756136789917946)","('Supply_Chain_Management', 0.018021883442997932)","(['Human Capital Development'], 0.8663192987442017)","('NON-ESG', 0.021756136789917946)","('NON-ESG', 0.018021883442997932)"
Line 725,"Baxter develops mutually beneficial relationships with  small and diverse suppliers as we strive to increase  the diversity of our supplier base.
","('Supply_Chain_Management', 0.7731773257255554)","('Employee_Engagement_Inclusion_And_Diversity', 0.04681806638836861)","('Labor_Practices', 0.03339340537786484)","(['Supply Chain Management'], 0.7731773257255554)","('NON-ESG', 0.04681806638836861)","('NON-ESG', 0.03339340537786484)"
Line 726,"During 2020, our Responsible Procurement   and Logistics Implement world-class sustainability practices with key partners 2020 HIGHLIGHTS Baxter is committed to driving sustainable practices in our global supply chain, which extends  from the producers of the raw materials we use in manufacturing to our distribution network  for delivering products to patients and healthcare providers.
","('Product_Design_And_Lifecycle_Management', 0.8168990612030029)","('Supply_Chain_Management', 0.09024862945079803)","('Energy_Management', 0.010170918889343739)","(['Product Stewardship'], 0.8168990612030029)","('NON-ESG', 0.09024862945079803)","('NON-ESG', 0.010170918889343739)"
Line 727,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORT 38Apex Companies LLC has provided assurance on the content in this section.
","('Business_Model_Resilience', 0.3606605529785156)","('Management_Of_Legal_And_Regulatory_Framework', 0.14313291013240814)","('Human_Rights_And_Community_Relations', 0.07060142606496811)","('NON-ESG', 0.3606605529785156)","('NON-ESG', 0.14313291013240814)","('NON-ESG', 0.07060142606496811)"
Line 728,"purchases with diverse  suppliers totaled 5.6%  of relevant spending.1  Although this was an  increase from 5.2%  in 2019, we did not  achieve our goal of  6% during 2020.
","('Supply_Chain_Management', 0.85676109790802)","('Product_Design_And_Lifecycle_Management', 0.04372428357601166)","('Customer_Welfare', 0.01205829530954361)","(['Supply Chain Management'], 0.85676109790802)","('NON-ESG', 0.04372428357601166)","('NON-ESG', 0.01205829530954361)"
Line 729,"This  was largely due to the  adoption of a more  rigorous approach  to how we classify data, which only counts spend with  diversity certification confirmed by our third-party  data provider.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9693845510482788)","('Customer_Privacy', 0.0021296257618814707)","('Competitive_Behavior', 0.0020234347321093082)","(['Human Capital Development'], 0.9693845510482788)","('NON-ESG', 0.0021296257618814707)","('NON-ESG', 0.0020234347321093082)"
Line 730,"In addition, COVID-19 travel restrictions  impacted our ability to engage with diverse suppliers.
","('Supply_Chain_Management', 0.6928837299346924)","('Product_Design_And_Lifecycle_Management', 0.03857024759054184)","('Labor_Practices', 0.02901112101972103)","(['Supply Chain Management'], 0.6928837299346924)","('NON-ESG', 0.03857024759054184)","('NON-ESG', 0.02901112101972103)"
Line 731,"2020 GOALIncrease spending  with diverse  suppliers to 6% of  relevant spending Not achieved VIEW ALL 2020 GOALSin spending with minority- owned businesses* and in spending with women- owned businesses*$64.3 million $84.4 millionof UPS shipping outside  the United States offset  using carbon credits,  more than 1,300 metric  tons CO2e of greenhouse  gas emissions100% of participating suppliers  earned advanced or  moderate scores on our  Supplier Corporate  Responsibility Survey77% *Spending with suppliers that certify for multiple categories is included in the total for each category.
","('Supply_Chain_Management', 0.4890325963497162)","('GHG_Emissions', 0.3041091859340668)","('Water_And_Wastewater_Management', 0.021074868738651276)","('NON-ESG', 0.4890325963497162)","('NON-ESG', 0.3041091859340668)","('NON-ESG', 0.021074868738651276)"
Line 732,"2020 GOALIncrease spending  with diverse  suppliers to 6% of  relevant spending Not achieved VIEW ALL 2020 GOALSin spending with minority- owned businesses* and in spending with women- owned businesses*$64.3 million $84.4 millionof UPS shipping outside  the United States offset  using carbon credits,  more than 1,300 metric  tons CO2e of greenhouse  gas emissions100% of participating suppliers  earned advanced or  moderate scores on our  Supplier Corporate  Responsibility Survey77% *Spending with suppliers that certify for multiple categories is included in the total for each category.
","('Competitive_Behavior', 0.4229243993759155)","('Customer_Welfare', 0.07864872366189957)","('Employee_Engagement_Inclusion_And_Diversity', 0.07518620043992996)","('NON-ESG', 0.4229243993759155)","('NON-ESG', 0.07864872366189957)","('NON-ESG', 0.07518620043992996)"
Line 733,"United States and Puerto Rico.
","('Management_Of_Legal_And_Regulatory_Framework', 0.500128984451294)","('Competitive_Behavior', 0.11590288579463959)","('GHG_Emissions', 0.04207455739378929)","(['Corporate Governance'], 0.500128984451294)","('NON-ESG', 0.11590288579463959)","('NON-ESG', 0.04207455739378929)"
Line 734,"Fiscal year  basis (October 1 through September 30 of the year noted).BAXTER 2020 CORPORATE RESPONSIBILITY REPORT39Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction A third-party review estimates that our spending with  diverse suppliers during this same timeframe supported  more than 1,000 jobs at those suppliers and over   $57 million in associated employee income.
","('Supply_Chain_Management', 0.699309229850769)","('Product_Design_And_Lifecycle_Management', 0.156513974070549)","('Customer_Welfare', 0.018547935411334038)","(['Supply Chain Management'], 0.699309229850769)","('NON-ESG', 0.156513974070549)","('NON-ESG', 0.018547935411334038)"
Line 735,"Fiscal year  basis (October 1 through September 30 of the year noted).BAXTER 2020 CORPORATE RESPONSIBILITY REPORT39Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction A third-party review estimates that our spending with  diverse suppliers during this same timeframe supported  more than 1,000 jobs at those suppliers and over   $57 million in associated employee income.
","('Labor_Practices', 0.8371476531028748)","('Supply_Chain_Management', 0.030153069645166397)","('Employee_Health_And_Safety', 0.029202308505773544)","(['Labor Practice Indicators'], 0.8371476531028748)","('NON-ESG', 0.030153069645166397)","('NON-ESG', 0.029202308505773544)"
Line 736,"Including  estimated indirect and induced economic impacts, our  spending supported a total of more than 2,000 jobs and  $109 million in associated employee income.As part of Baxter’s ACT: Activating Change Today initiative,  we are continuing to emphasize a strategic approach  to increasing spend and deepening relationships with  diverse suppliers.
","('Supply_Chain_Management', 0.7827209234237671)","('Product_Design_And_Lifecycle_Management', 0.029906341806054115)","('Labor_Practices', 0.01910565420985222)","(['Supply Chain Management'], 0.7827209234237671)","('NON-ESG', 0.029906341806054115)","('NON-ESG', 0.01910565420985222)"
Line 737,"Consequently, in 2020, we participated  in the National Minority Supplier Development Council  (NMSDC) matchmaker event to connect Baxter team  members with minority-owned businesses.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9573071599006653)","('Business_Model_Resilience', 0.003952978178858757)","('Human_Rights_And_Community_Relations', 0.003148410702124238)","(['Human Capital Development'], 0.9573071599006653)","('NON-ESG', 0.003952978178858757)","('NON-ESG', 0.003148410702124238)"
Line 738,"We also  committed $150,000 to support minority-owned  businesses that were impacted by COVID-19 and civil  unrest.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9074788093566895)","('Labor_Practices', 0.011233237572014332)","('Human_Rights_And_Community_Relations', 0.008996857330203056)","(['Human Capital Development'], 0.9074788093566895)","('NON-ESG', 0.011233237572014332)","('NON-ESG', 0.008996857330203056)"
Line 739,"Learn more about our ACT initiative and related  activities across our business on our website  and in the  Introduction of this report.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8335683941841125)","('Human_Rights_And_Community_Relations', 0.04434336721897125)","('Business_Ethics', 0.013554410077631474)","(['Corporate Governance'], 0.8335683941841125)","('NON-ESG', 0.04434336721897125)","('NON-ESG', 0.013554410077631474)"
Line 740,"We maintain corporate memberships with many  organizations that promote and certify diverse  suppliers and have served on the NMSDC Board.
","('Supply_Chain_Management', 0.6755326986312866)","('Product_Design_And_Lifecycle_Management', 0.06851498782634735)","('Customer_Welfare', 0.03624949976801872)","(['Supply Chain Management'], 0.6755326986312866)","('NON-ESG', 0.06851498782634735)","('NON-ESG', 0.03624949976801872)"
Line 741,"During 2020, in addition to taking part in the  NMSDC matchmaking event, we participated in  meetings led by NMSDC with the National Gay and  Lesbian Chamber of Commerce and Disability:IN,  enabling us to build stronger relationships with  these organizations and increase matchmaking  opportunities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9503889679908752)","('Employee_Health_And_Safety', 0.00693560391664505)","('Human_Rights_And_Community_Relations', 0.003269574139267206)","(['Human Capital Development'], 0.9503889679908752)","('NON-ESG', 0.00693560391664505)","('NON-ESG', 0.003269574139267206)"
Line 742,"Fostering relationships with a variety  of organizations helps us identify diverse suppliers  for inclusion in our supply chain, increase our  visibility within the diverse supplier community and  advance progress in this area more broadly.
","('Supply_Chain_Management', 0.941946804523468)","('Product_Design_And_Lifecycle_Management', 0.005644107703119516)","('Labor_Practices', 0.005240615922957659)","(['Supply Chain Management'], 0.941946804523468)","('NON-ESG', 0.005644107703119516)","('NON-ESG', 0.005240615922957659)"
Line 743,"In 2020, we realigned our procurement organization  to improve collaboration with our company’s regions  and global business units.
","('Business_Model_Resilience', 0.5012628436088562)","('Management_Of_Legal_And_Regulatory_Framework', 0.07639025896787643)","('Competitive_Behavior', 0.05310739576816559)","(['Codes of Business Conduct'], 0.5012628436088562)","('NON-ESG', 0.07639025896787643)","('NON-ESG', 0.05310739576816559)"
Line 744,"This resulted in our ability  to initiate matchmaking with diverse suppliers of  specific categories toward the end of the year.
","('Supply_Chain_Management', 0.802322268486023)","('Product_Design_And_Lifecycle_Management', 0.0415274016559124)","('Customer_Welfare', 0.026398640125989914)","(['Supply Chain Management'], 0.802322268486023)","('NON-ESG', 0.0415274016559124)","('NON-ESG', 0.026398640125989914)"
Line 745,"This  new approach will help us identify opportunities  for and potentially increase our spend with diverse  suppliers moving forward.
","('Supply_Chain_Management', 0.9035231471061707)","('Product_Design_And_Lifecycle_Management', 0.021473215892910957)","('Customer_Welfare', 0.0066794464364647865)","(['Supply Chain Management'], 0.9035231471061707)","('NON-ESG', 0.021473215892910957)","('NON-ESG', 0.0066794464364647865)"
Line 746,"We also updated our supplier registration portal in  2020 to enable registration for diverse suppliers who  are looking for opportunites to work with Baxter.
","('Supply_Chain_Management', 0.9301905632019043)","('Product_Design_And_Lifecycle_Management', 0.007048638537526131)","('Labor_Practices', 0.006434828508645296)","(['Supply Chain Management'], 0.9301905632019043)","('NON-ESG', 0.007048638537526131)","('NON-ESG', 0.006434828508645296)"
Line 747,"Using the portal, diverse suppliers can upload their  certificates and answer questions that will make  them more visible to Baxter teams looking for new  suppliers through our internal search tool.
","('Supply_Chain_Management', 0.9298494458198547)","('Labor_Practices', 0.00678445165976882)","('Product_Design_And_Lifecycle_Management', 0.0063628992065787315)","(['Supply Chain Management'], 0.9298494458198547)","('NON-ESG', 0.00678445165976882)","('NON-ESG', 0.0063628992065787315)"
Line 748,"The  portal should also improve communications with  our suppliers and help us gather more information  related to spending with our Tier II suppliers so we  can track and measure it more accurately.
","('Supply_Chain_Management', 0.9242276549339294)","('Product_Design_And_Lifecycle_Management', 0.006699064746499062)","('GHG_Emissions', 0.0054466621950268745)","(['Supply Chain Management'], 0.9242276549339294)","('NON-ESG', 0.006699064746499062)","('NON-ESG', 0.0054466621950268745)"
Line 749,"Learn more  about supplier diversity at Baxter.SPENDING WITH DIVERSE SUPPLIERS, 2020* $143.million to small  businesses$64.million to minority-owned  businesses $6.million to veteran-owned  businesses $0.million to HUBZone-certified  businesses$2.million to service-disabled- veteran-owned businesses$84.million to women-owned  businesses $27.million to small  disadvantaged businesses$ * Spending with suppliers that certify for multiple categories is included in the  total for each category.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9005775451660156)","('Supply_Chain_Management', 0.01260066032409668)","('Labor_Practices', 0.009995633736252785)","(['Human Capital Development'], 0.9005775451660156)","('NON-ESG', 0.01260066032409668)","('NON-ESG', 0.009995633736252785)"
Line 750,"United States and Puerto Rico.
","('Management_Of_Legal_And_Regulatory_Framework', 0.500128984451294)","('Competitive_Behavior', 0.11590288579463959)","('GHG_Emissions', 0.04207455739378929)","(['Corporate Governance'], 0.500128984451294)","('NON-ESG', 0.11590288579463959)","('NON-ESG', 0.04207455739378929)"
Line 751,"Fiscal year basis  (October 1 through September 30 of the year noted).
","('Management_Of_Legal_And_Regulatory_Framework', 0.5398755073547363)","('Director_Removal', 0.11901940405368805)","('Physical_Impacts_Of_Climate_Change', 0.043142687529325485)","(['Corporate Governance'], 0.5398755073547363)","('NON-ESG', 0.11901940405368805)","('NON-ESG', 0.043142687529325485)"
Line 752,"PROTECTING HUMAN RIGHTS IN OUR   SUPPLY CHAIN Baxter's Global Human Rights Policy  outlines our  commitment to respect human rights across the value  chain and our expectation that suppliers do the same,  either in accordance with our policy or under their own  similar policies.
","('Human_Rights_And_Community_Relations', 0.9032282829284668)","('Supply_Chain_Management', 0.017928224056959152)","('Labor_Practices', 0.01004988607019186)","(['Community Relations'], 0.9032282829284668)","('NON-ESG', 0.017928224056959152)","('NON-ESG', 0.01004988607019186)"
Line 753,"To enable this, we make appropriate  training available to targeted suppliers and conduct  supplier assessments.
","('Supply_Chain_Management', 0.929288387298584)","('Labor_Practices', 0.01234371680766344)","('Waste_And_Hazardous_Materials_Management', 0.004067896865308285)","(['Supply Chain Management'], 0.929288387298584)","('NON-ESG', 0.01234371680766344)","('NON-ESG', 0.004067896865308285)"
Line 754,"In addition, any suppliers who  register with Baxter through our supplier registration  portal must read our Global Human Rights Policy and  indicate whether they agree with the commitments therein .
","('Supply_Chain_Management', 0.9114172458648682)","('Labor_Practices', 0.011378263123333454)","('Product_Design_And_Lifecycle_Management', 0.0072326092049479485)","(['Supply Chain Management'], 0.9114172458648682)","('NON-ESG', 0.011378263123333454)","('NON-ESG', 0.0072326092049479485)"
Line 755,"Baxter adheres to supply chain transparency requirements   where applicable, through publicly available statements.
","('Business_Ethics', 0.7188611626625061)","('Labor_Practices', 0.04538165032863617)","('Supply_Chain_Management', 0.04212944954633713)","(['Business Ethics'], 0.7188611626625061)","('NON-ESG', 0.04538165032863617)","('NON-ESG', 0.04212944954633713)"
Line 756,"In addition to our Global Human Rights Policy, Baxter’s  UK Modern Slavery Statement  declares our commitments   and approach to ensuring that our local operations and   global supply chain are free from modern slavery  practices, including child labor, forced and bonded labor,  and human trafficking.
","('Labor_Practices', 0.9447447657585144)","('Human_Rights_And_Community_Relations', 0.008042837493121624)","('Employee_Health_And_Safety', 0.007052541710436344)","(['Labor Practice Indicators'], 0.9447447657585144)","('NON-ESG', 0.008042837493121624)","('NON-ESG', 0.007052541710436344)"
Line 757,"We also have a position statement  related to the California Transparency in Supply Chains  Act of 2010 .
","('Supply_Chain_Management', 0.6614038944244385)","('Systemic_Risk_Management', 0.05307798087596893)","('Business_Ethics', 0.05075262486934662)","(['Supply Chain Management'], 0.6614038944244385)","('NON-ESG', 0.05307798087596893)","('NON-ESG', 0.05075262486934662)"
Line 758,"In addition, for specific urology products sold in the UK,   we have implemented a Labor Standards Assurance  System (LSAS).
","('Labor_Practices', 0.8254975080490112)","('Product_Quality_And_Safety', 0.04079366475343704)","('Business_Ethics', 0.02887808158993721)","(['Labor Practice Indicators'], 0.8254975080490112)","('NON-ESG', 0.04079366475343704)","('NON-ESG', 0.02887808158993721)"
Line 759,"It includes a UK LSAS Policy , a  relevant labor standards supply chain risk assessment,  management commitment, employee awareness  training and key performance indicators.
","('Labor_Practices', 0.5774893164634705)","('Supply_Chain_Management', 0.2742367684841156)","('Employee_Health_And_Safety', 0.025467339903116226)","(['Labor Practice Indicators'], 0.5774893164634705)","('NON-ESG', 0.2742367684841156)","('NON-ESG', 0.025467339903116226)"
Line 760,"This  management system provides us with a clear framework  through which to approach human rights and labor  standards and improves our ability to manage supply  chain risks in these areas.
","('Labor_Practices', 0.8814056515693665)","('Supply_Chain_Management', 0.03481075167655945)","('Human_Rights_And_Community_Relations', 0.013957285322248936)","(['Labor Practice Indicators'], 0.8814056515693665)","('NON-ESG', 0.03481075167655945)","('NON-ESG', 0.013957285322248936)"
Line 761,"Many elements of this  management system approach also help us meet the   requirements of the UK Modern Slavery Act.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7167260646820068)","('Business_Ethics', 0.17542152106761932)","('Labor_Practices', 0.015004021115601063)","(['Corporate Governance'], 0.7167260646820068)","('NON-ESG', 0.17542152106761932)","('NON-ESG', 0.015004021115601063)"
Line 762,"We have a  cross-functional team that maintains our LSAS program  and integrates it with our supplier sustainability work.
","('Supply_Chain_Management', 0.9362437129020691)","('Product_Design_And_Lifecycle_Management', 0.008723796345293522)","('Labor_Practices', 0.0061967442743480206)","(['Supply Chain Management'], 0.9362437129020691)","('NON-ESG', 0.008723796345293522)","('NON-ESG', 0.0061967442743480206)"
Line 763,"VIEW THE DATA SUMMARY   FOR MORE DETAIL.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT40Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction During 2020, in alignment with our LSAS commitments ,  we underwent a third-party audit of our management  systems by Bureau Veritas.
","('Business_Model_Resilience', 0.28770917654037476)","('Systemic_Risk_Management', 0.10940835624933243)","('Business_Ethics', 0.09294725954532623)","('NON-ESG', 0.28770917654037476)","('NON-ESG', 0.10940835624933243)","('NON-ESG', 0.09294725954532623)"
Line 764,"The results of that audit  demonstrated ongoing improvement in several audit  categories.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4459627866744995)","('Business_Ethics', 0.16859376430511475)","('Systemic_Risk_Management', 0.08797178417444229)","('NON-ESG', 0.4459627866744995)","('NON-ESG', 0.16859376430511475)","('NON-ESG', 0.08797178417444229)"
Line 765,"MANAGING PROCUREMENT RISKS Baxter takes a risk-based approach to managing  corporate responsibility issues in our supply chain.
","('Supply_Chain_Management', 0.9486584067344666)","('Labor_Practices', 0.004185964353382587)","('Product_Design_And_Lifecycle_Management', 0.004035132937133312)","(['Supply Chain Management'], 0.9486584067344666)","('NON-ESG', 0.004185964353382587)","('NON-ESG', 0.004035132937133312)"
Line 766,"Our  Supplier Quality Standard  and Ethics and Compliance  Standards for Baxter Suppliers  outline expectations and  requirements for all our suppliers.
","('Supply_Chain_Management', 0.37044212222099304)","('Labor_Practices', 0.14889630675315857)","('Business_Ethics', 0.13780848681926727)","('NON-ESG', 0.37044212222099304)","('NON-ESG', 0.14889630675315857)","('NON-ESG', 0.13780848681926727)"
Line 767,"To improve our corporate responsibility performance,  we integrate supplier sustainability into our overall  supplier management processes and conduct periodic   assessments of key suppliers to evaluate cost, delivery,  quality and risk.
","('Supply_Chain_Management', 0.939378559589386)","('Product_Design_And_Lifecycle_Management', 0.00901205837726593)","('Labor_Practices', 0.0047726938501000404)","(['Supply Chain Management'], 0.939378559589386)","('NON-ESG', 0.00901205837726593)","('NON-ESG', 0.0047726938501000404)"
Line 768,"As part of this process we also examine  the financial risk of suppliers to ensure we don’t have  SUPPLY CHAIN CORPORATE RESPONSIBILITY MANAGEMENT SYSTEMany disruptions in supply.
","('Supply_Chain_Management', 0.9497718214988708)","('Physical_Impacts_Of_Climate_Change', 0.0043958271853625774)","('Labor_Practices', 0.004304572474211454)","(['Supply Chain Management'], 0.9497718214988708)","('NON-ESG', 0.0043958271853625774)","('NON-ESG', 0.004304572474211454)"
Line 769,"We work with suppliers who  receive low scores in the areas of quality and delivery  to develop continuous improvement plans.
","('Supply_Chain_Management', 0.864250659942627)","('Product_Design_And_Lifecycle_Management', 0.036046382039785385)","('Product_Quality_And_Safety', 0.00863636378198862)","(['Supply Chain Management'], 0.864250659942627)","('NON-ESG', 0.036046382039785385)","('NON-ESG', 0.00863636378198862)"
Line 770,"Scores from  our annual Supplier Corporate Responsibility Survey  feed directly into this assessment.
","('Supply_Chain_Management', 0.9051923155784607)","('Product_Design_And_Lifecycle_Management', 0.017206329852342606)","('Energy_Management', 0.008348817005753517)","(['Supply Chain Management'], 0.9051923155784607)","('NON-ESG', 0.017206329852342606)","('NON-ESG', 0.008348817005753517)"
Line 771,"Using a trusted third-party service, we receive  notifications if disruptions occur in areas of the world  where our suppliers are located.
","('Supply_Chain_Management', 0.8726520538330078)","('Systemic_Risk_Management', 0.01603160798549652)","('Water_And_Wastewater_Management', 0.012182198464870453)","(['Supply Chain Management'], 0.8726520538330078)","('NON-ESG', 0.01603160798549652)","('NON-ESG', 0.012182198464870453)"
Line 772,"Such disruptions could  include natural disasters, fires, major weather events  or geopolitical activity.
","('Physical_Impacts_Of_Climate_Change', 0.6127325892448425)","('Critical_Incident_Risk_Management', 0.24314279854297638)","('Business_Model_Resilience', 0.028932245448231697)","(['Climate Change'], 0.6127325892448425)","('NON-ESG', 0.24314279854297638)","('NON-ESG', 0.028932245448231697)"
Line 773,"Using this information, we’re  able to respond quickly to ensure supply continuity.
","('Supply_Chain_Management', 0.5411134362220764)","('Critical_Incident_Risk_Management', 0.14152400195598602)","('Water_And_Wastewater_Management', 0.04537936672568321)","(['Supply Chain Management'], 0.5411134362220764)","('NON-ESG', 0.14152400195598602)","('NON-ESG', 0.04537936672568321)"
Line 774,"SUPPLIER CORPORATE RESPONSIBILITY SURVEY Baxter conducts an annual survey to better  understand the corporate responsibility programs and  performance of our suppliers and drive continuous  improvement.
","('Supply_Chain_Management', 0.9248849749565125)","('Product_Design_And_Lifecycle_Management', 0.007088907528668642)","('Labor_Practices', 0.005873647052794695)","(['Supply Chain Management'], 0.9248849749565125)","('NON-ESG', 0.007088907528668642)","('NON-ESG', 0.005873647052794695)"
Line 775,"In 2020, we continued partnering with  EcoVadis to use its sustainability ratings platform to survey our supplier base and validate responses in the  areas of environment, labor and human rights, ethics,  and sustainable procurement.
","('Supply_Chain_Management', 0.8274434804916382)","('Labor_Practices', 0.07533331215381622)","('Employee_Health_And_Safety', 0.009545465931296349)","(['Supply Chain Management'], 0.8274434804916382)","('NON-ESG', 0.07533331215381622)","('NON-ESG', 0.009545465931296349)"
Line 776,"The results included  data from 211 Baxter suppliers, including 136 that  already had data for 2020 in the EcoVadis platform and  75 that were invited to participate for the first time.
","('Supply_Chain_Management', 0.8250401616096497)","('Product_Design_And_Lifecycle_Management', 0.023510048165917397)","('Energy_Management', 0.018333377316594124)","(['Supply Chain Management'], 0.8250401616096497)","('NON-ESG', 0.023510048165917397)","('NON-ESG', 0.018333377316594124)"
Line 777,"Of  those 211 suppliers, 45% were from Europe, Middle  East and Africa (EMEA); 40% from the Americas; and  15% from Asia Pacific (APAC).
","('Supply_Chain_Management', 0.6274182796478271)","('GHG_Emissions', 0.052105482667684555)","('Product_Design_And_Lifecycle_Management', 0.033422552049160004)","(['Supply Chain Management'], 0.6274182796478271)","('NON-ESG', 0.052105482667684555)","('NON-ESG', 0.033422552049160004)"
Line 778,"Suppliers have access  to detailed scorecards regarding their corporate  responsibility management practices on the EcoVadis  platform, including information about strengths  and benchmark comparisons, as well as actionable  improvement areas.
","('Supply_Chain_Management', 0.2953999936580658)","('Human_Rights_And_Community_Relations', 0.16423311829566956)","('Systemic_Risk_Management', 0.08482342958450317)","('NON-ESG', 0.2953999936580658)","('NON-ESG', 0.16423311829566956)","('NON-ESG', 0.08482342958450317)"
Line 779,"We use these scorecards to drive  ongoing improvement and anticipate an increase  in participation as we expand our efforts to engage  suppliers in the coming years.
","('Supply_Chain_Management', 0.8985697031021118)","('Product_Design_And_Lifecycle_Management', 0.01175426784902811)","('GHG_Emissions', 0.009534426964819431)","(['Supply Chain Management'], 0.8985697031021118)","('NON-ESG', 0.01175426784902811)","('NON-ESG', 0.009534426964819431)"
Line 780,"In 2020, we also began  including the scores from this survey in our business  reviews with strategic suppliers for ongoing discussion  and monitoring.
","('Supply_Chain_Management', 0.899767279624939)","('Product_Design_And_Lifecycle_Management', 0.025486452504992485)","('Customer_Welfare', 0.005920823197811842)","(['Supply Chain Management'], 0.899767279624939)","('NON-ESG', 0.025486452504992485)","('NON-ESG', 0.005920823197811842)"
Line 781,"SUMMARY OF SUPPLIER CORPORATE RESPONSIBILITY SURVEY SCORES, 2018 –2020*         Environment 40% 36% 36% 45% 47% 43% 12% 17% 20% 2% 1% 2%    Labor and Human Rights  23% 23% 22% 55% 54% 54% 21% 23% 23% 1% 1% 1%    Ethics 17% 15% 19% 55% 58% 51% 26% 27% 27% 1% 1% 3%    Sustainable Procurement  18% 22% 17% 40% 43% 39% 40% 33% 36% 2% 3% 8%    Overall 25% 27% 27% 60% 55% 50% 14% 18% 23% 1% 1% 1%    Cross-Industry Average  3% 3% 4% 38% 39% 41% 55% 54% 51% 3% 4% 4%2018 2019 2020 2018 2019 2020 2018 2019 2020 2018 2019 2020Advanced Moderate Partial InsufficientPercent of Participating Suppliers * The performance categories presented in this table align with the EcoVadis methodology.
","('Supply_Chain_Management', 0.3868788182735443)","('Business_Model_Resilience', 0.10200868546962738)","('Human_Rights_And_Community_Relations', 0.08667296171188354)","('NON-ESG', 0.3868788182735443)","('NON-ESG', 0.10200868546962738)","('NON-ESG', 0.08667296171188354)"
Line 782,"SUMMARY OF SUPPLIER CORPORATE RESPONSIBILITY SURVEY SCORES, 2018 –2020*         Environment 40% 36% 36% 45% 47% 43% 12% 17% 20% 2% 1% 2%    Labor and Human Rights  23% 23% 22% 55% 54% 54% 21% 23% 23% 1% 1% 1%    Ethics 17% 15% 19% 55% 58% 51% 26% 27% 27% 1% 1% 3%    Sustainable Procurement  18% 22% 17% 40% 43% 39% 40% 33% 36% 2% 3% 8%    Overall 25% 27% 27% 60% 55% 50% 14% 18% 23% 1% 1% 1%    Cross-Industry Average  3% 3% 4% 38% 39% 41% 55% 54% 51% 3% 4% 4%2018 2019 2020 2018 2019 2020 2018 2019 2020 2018 2019 2020Advanced Moderate Partial InsufficientPercent of Participating Suppliers * The performance categories presented in this table align with the EcoVadis methodology.
","('Supply_Chain_Management', 0.8859801292419434)","('Systemic_Risk_Management', 0.014624180272221565)","('GHG_Emissions', 0.009854968637228012)","(['Supply Chain Management'], 0.8859801292419434)","('NON-ESG', 0.014624180272221565)","('NON-ESG', 0.009854968637228012)"
Line 783,"“Advanced” indicates structured and proactive corporate responsibility (CR) approach;  policies and tangible actions on major topics with significant CR reporting.
","('Management_Of_Legal_And_Regulatory_Framework', 0.751558780670166)","('Business_Ethics', 0.0529741607606411)","('Human_Rights_And_Community_Relations', 0.04212468862533569)","(['Corporate Governance'], 0.751558780670166)","('NON-ESG', 0.0529741607606411)","('NON-ESG', 0.04212468862533569)"
Line 784,"“Moderate” indicates structured and proactive CR approach; policies and tangible actions on major  topics with basic CR reporting.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9345614910125732)","('Human_Rights_And_Community_Relations', 0.012136781588196754)","('Director_Removal', 0.004930373281240463)","(['Corporate Governance'], 0.9345614910125732)","('NON-ESG', 0.012136781588196754)","('NON-ESG', 0.004930373281240463)"
Line 785,"“Partial” indicates no structured CR approach; few tangible actions on selected topics; certifications related to sites and/or products are only  partial.
","('Product_Quality_And_Safety', 0.5051252841949463)","('Product_Design_And_Lifecycle_Management', 0.17425204813480377)","('Customer_Welfare', 0.05481422692537308)","(['Product Quality & Recall Management'], 0.5051252841949463)","('NON-ESG', 0.17425204813480377)","('NON-ESG', 0.05481422692537308)"
Line 786,"“Insufficient” indicates no engagements or tangible actions regarding CR.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7945785522460938)","('Business_Ethics', 0.0996624007821083)","('Competitive_Behavior', 0.01105357613414526)","(['Corporate Governance'], 0.7945785522460938)","('NON-ESG', 0.0996624007821083)","('NON-ESG', 0.01105357613414526)"
Line 787,"Evidence in certain cases of misconduct (e.g. pollution, corruption).
","('Business_Ethics', 0.9682407975196838)","('Management_Of_Legal_And_Regulatory_Framework', 0.0032873123418539762)","('Competitive_Behavior', 0.0025183758698403835)","(['Business Ethics'], 0.9682407975196838)","('NON-ESG', 0.0032873123418539762)","('NON-ESG', 0.0025183758698403835)"
Line 788,"Data for 2020 reflect a  combination of Baxter suppliers that already had 2020 data in the EcoVadis platform, as of March 2, 2021, and those surveyed for the first time.
","('Supply_Chain_Management', 0.9046822190284729)","('Energy_Management', 0.008679189719259739)","('Systemic_Risk_Management', 0.00784264411777258)","(['Supply Chain Management'], 0.9046822190284729)","('NON-ESG', 0.008679189719259739)","('NON-ESG', 0.00784264411777258)"
Line 789,"Data from prior years are based  only on yearly surveys.
","('Management_Of_Legal_And_Regulatory_Framework', 0.27443790435791016)","('Access_And_Affordability', 0.12987284362316132)","('Energy_Management', 0.07353013753890991)","('NON-ESG', 0.27443790435791016)","('NON-ESG', 0.12987284362316132)","('NON-ESG', 0.07353013753890991)"
Line 790,"In some cases, segments do not add up to 100% due to rounding.
","('Competitive_Behavior', 0.5641286969184875)","('Systemic_Risk_Management', 0.05804404616355896)","('Management_Of_Legal_And_Regulatory_Framework', 0.046666208654642105)","(['Business Ethics'], 0.5641286969184875)","('NON-ESG', 0.05804404616355896)","('NON-ESG', 0.046666208654642105)"
Line 791,"• Supplier Quality Standards • Ethics and Compliance Standards   for Baxter Suppliers • Global Human Rights Policy • UK Labor Standards Assurance System • Identify top suppliers by annual spend • Assess comparative risk based on     geographic location, commodity type    and other factors • Conduct Supplier Corporate      Responsibility Survey • Conduct supplier audits  • Develop and confirm progress on     corrective action plansCommunicate  clear policies and  standards Identify and  prioritize suppliers  based on risk  Use established  processes and metrics  to monitor progress Regularly disclose  performance and  highlight progress• Supplier Corporate Responsibility     Survey report card • Annual Corporate Responsibility Report • Investor surveys • Ratings and rankingsEstablish Policies Assess Risk Monitor and Manage Performance Report PerformanceBAXTER 2020 CORPORATE RESPONSIBILITY REPORT41Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction SUPPLIER AUDITS In past years, the Baxter Supplier Sustainability  team has worked with our Environmental, Health,  Safety and Sustainability team to conduct supplier  audits, aligned with the Pharmaceutical Supply   Chain Initiative (PSCI)  protocol, which covers ethics;  labor; environment, health and safety; and related  management systems.
","('Labor_Practices', 0.2566886246204376)","('Supply_Chain_Management', 0.20465539395809174)","('Business_Ethics', 0.1463066041469574)","('NON-ESG', 0.2566886246204376)","('NON-ESG', 0.20465539395809174)","('NON-ESG', 0.1463066041469574)"
Line 792,"• Supplier Quality Standards • Ethics and Compliance Standards   for Baxter Suppliers • Global Human Rights Policy • UK Labor Standards Assurance System • Identify top suppliers by annual spend • Assess comparative risk based on     geographic location, commodity type    and other factors • Conduct Supplier Corporate      Responsibility Survey • Conduct supplier audits  • Develop and confirm progress on     corrective action plansCommunicate  clear policies and  standards Identify and  prioritize suppliers  based on risk  Use established  processes and metrics  to monitor progress Regularly disclose  performance and  highlight progress• Supplier Corporate Responsibility     Survey report card • Annual Corporate Responsibility Report • Investor surveys • Ratings and rankingsEstablish Policies Assess Risk Monitor and Manage Performance Report PerformanceBAXTER 2020 CORPORATE RESPONSIBILITY REPORT41Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction SUPPLIER AUDITS In past years, the Baxter Supplier Sustainability  team has worked with our Environmental, Health,  Safety and Sustainability team to conduct supplier  audits, aligned with the Pharmaceutical Supply   Chain Initiative (PSCI)  protocol, which covers ethics;  labor; environment, health and safety; and related  management systems.
","('Business_Ethics', 0.18798521161079407)","('Systemic_Risk_Management', 0.1598743051290512)","('Business_Model_Resilience', 0.13459207117557526)","('NON-ESG', 0.18798521161079407)","('NON-ESG', 0.1598743051290512)","('NON-ESG', 0.13459207117557526)"
Line 793,"• Supplier Quality Standards • Ethics and Compliance Standards   for Baxter Suppliers • Global Human Rights Policy • UK Labor Standards Assurance System • Identify top suppliers by annual spend • Assess comparative risk based on     geographic location, commodity type    and other factors • Conduct Supplier Corporate      Responsibility Survey • Conduct supplier audits  • Develop and confirm progress on     corrective action plansCommunicate  clear policies and  standards Identify and  prioritize suppliers  based on risk  Use established  processes and metrics  to monitor progress Regularly disclose  performance and  highlight progress• Supplier Corporate Responsibility     Survey report card • Annual Corporate Responsibility Report • Investor surveys • Ratings and rankingsEstablish Policies Assess Risk Monitor and Manage Performance Report PerformanceBAXTER 2020 CORPORATE RESPONSIBILITY REPORT41Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction SUPPLIER AUDITS In past years, the Baxter Supplier Sustainability  team has worked with our Environmental, Health,  Safety and Sustainability team to conduct supplier  audits, aligned with the Pharmaceutical Supply   Chain Initiative (PSCI)  protocol, which covers ethics;  labor; environment, health and safety; and related  management systems.
","('Supply_Chain_Management', 0.9333484172821045)","('Labor_Practices', 0.008193429559469223)","('Employee_Health_And_Safety', 0.006663234904408455)","(['Supply Chain Management'], 0.9333484172821045)","('NON-ESG', 0.008193429559469223)","('NON-ESG', 0.006663234904408455)"
Line 794,"During 2020, we did not  conduct any of these audits as we continued to expand  our capabilities in this area.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5137092471122742)","('Systemic_Risk_Management', 0.18430733680725098)","('Business_Ethics', 0.06148101016879082)","(['Corporate Governance'], 0.5137092471122742)","('NON-ESG', 0.18430733680725098)","('NON-ESG', 0.06148101016879082)"
Line 795,"We plan to reinstitute  these audits in future years.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5774518251419067)","('Systemic_Risk_Management', 0.18228644132614136)","('Business_Ethics', 0.04583187773823738)","(['Corporate Governance'], 0.5774518251419067)","('NON-ESG', 0.18228644132614136)","('NON-ESG', 0.04583187773823738)"
Line 796,"During 2020, 453 audits of Baxter suppliers were  conducted related to management systems for  product quality.
","('Product_Design_And_Lifecycle_Management', 0.9063423275947571)","('Product_Quality_And_Safety', 0.030390581116080284)","('Supply_Chain_Management', 0.01010479498654604)","(['Product Stewardship'], 0.9063423275947571)","('NON-ESG', 0.030390581116080284)","('NON-ESG', 0.01010479498654604)"
Line 797,"Learn more about our approach to  patient safety and quality .
","('Product_Quality_And_Safety', 0.42736342549324036)","('Employee_Health_And_Safety', 0.3238508701324463)","('Access_And_Affordability', 0.03540817275643349)","('NON-ESG', 0.42736342549324036)","('NON-ESG', 0.3238508701324463)","('NON-ESG', 0.03540817275643349)"
Line 798,"We are evaluating how   to incorporate corporate responsibility elements into  the quality audit process to more fully integrate our  sustainable procurement framework into our   supply chain.
","('Supply_Chain_Management', 0.9169170260429382)","('Product_Design_And_Lifecycle_Management', 0.02190748043358326)","('Business_Model_Resilience', 0.005082981660962105)","(['Supply Chain Management'], 0.9169170260429382)","('NON-ESG', 0.02190748043358326)","('NON-ESG', 0.005082981660962105)"
Line 799,"INDUSTRY COLLABORATION Baxter collaborates with other companies and  organizations within the healthcare industry to improve  efficiency and advance responsible procurement.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2648417055606842)","('Energy_Management', 0.26392602920532227)","('Supply_Chain_Management', 0.10005669295787811)","('NON-ESG', 0.2648417055606842)","('NON-ESG', 0.26392602920532227)","('NON-ESG', 0.10005669295787811)"
Line 800,"We are a member of PSCI and have served on the  PSCI advisory panel.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7616820931434631)","('Director_Removal', 0.04547500237822533)","('Business_Ethics', 0.028856821358203888)","(['Corporate Governance'], 0.7616820931434631)","('NON-ESG', 0.04547500237822533)","('NON-ESG', 0.028856821358203888)"
Line 801,"In addition, we have taken part in  the PSCI Supplier Capability Building Committee and  several subcommittees, including the Human Rights  and Labor subcommittee.
","('Labor_Practices', 0.6897636651992798)","('Supply_Chain_Management', 0.08704307675361633)","('Human_Rights_And_Community_Relations', 0.07601088285446167)","(['Labor Practice Indicators'], 0.6897636651992798)","('NON-ESG', 0.08704307675361633)","('NON-ESG', 0.07601088285446167)"
Line 802,"Through this work, we  have helped to establish industrywide best practices,  including those related to management systems,  human rights/labor, and ethics and compliance in the  pharmaceutical and healthcare industries.
","('Business_Ethics', 0.9261780977249146)","('Labor_Practices', 0.014704402536153793)","('Human_Rights_And_Community_Relations', 0.007244638632982969)","(['Business Ethics'], 0.9261780977249146)","('NON-ESG', 0.014704402536153793)","('NON-ESG', 0.007244638632982969)"
Line 803,"To establish a secure supply chain, we participate in  programs such as the Customs Trade Partnership  Against Terrorism (CTPAT) program, which supports a  secure and reliable supply of lifesaving medical products.
","('Supply_Chain_Management', 0.8506892323493958)","('Product_Design_And_Lifecycle_Management', 0.04163897782564163)","('Waste_And_Hazardous_Materials_Management', 0.012168082408607006)","(['Supply Chain Management'], 0.8506892323493958)","('NON-ESG', 0.04163897782564163)","('NON-ESG', 0.012168082408607006)"
Line 804,"This includes shipments of raw materials and finished  products both to and from various Baxter locations,  foreign suppliers, distributors and customers.
","('Product_Design_And_Lifecycle_Management', 0.9294824600219727)","('Supply_Chain_Management', 0.011229321360588074)","('Selling_Practices_And_Product_Labeling', 0.009102215990424156)","(['Product Stewardship'], 0.9294824600219727)","('NON-ESG', 0.011229321360588074)","('NON-ESG', 0.009102215990424156)"
Line 805,"As an  importer and exporter, Baxter has been recognized  as a Tier III Partner (the highest level possible) in the  program since 2011.
","('Management_Of_Legal_And_Regulatory_Framework', 0.17808645963668823)","('Energy_Management', 0.15641769766807556)","('Supply_Chain_Management', 0.11715182662010193)","('NON-ESG', 0.17808645963668823)","('NON-ESG', 0.15641769766807556)","('NON-ESG', 0.11715182662010193)"
Line 806,"GREEN LOGISTICS  Baxter transports more than 5 million metric tons of  raw materials and finished goods each year throughout  our global supply chain, primarily in partnership with  third-party vendors and carriers.
","('Supply_Chain_Management', 0.8296997547149658)","('Product_Design_And_Lifecycle_Management', 0.05125817656517029)","('Energy_Management', 0.017033200711011887)","(['Supply Chain Management'], 0.8296997547149658)","('NON-ESG', 0.05125817656517029)","('NON-ESG', 0.017033200711011887)"
Line 807,"We have processes  and initiatives to reduce the environmental impact of  our distribution activities and decrease greenhouse  gas (GHG) emissions related to product transport.
","('GHG_Emissions', 0.9684394598007202)","('Ecological_Impacts', 0.00529053108766675)","('Management_Of_Legal_And_Regulatory_Framework', 0.0027383198030292988)","(['Climate Change'], 0.9684394598007202)","('NON-ESG', 0.00529053108766675)","('NON-ESG', 0.0027383198030292988)"
Line 808,"To minimize emissions associated with our distribution  network, we prioritize efficiency through initiatives  such as our ocean export consolidation center in  EMEA, use of high-capacity containers and by favoring  transportation modes with fewer GHG emissions.
","('GHG_Emissions', 0.9627535343170166)","('Air_Quality', 0.007703978102654219)","('Energy_Management', 0.003336256602779031)","(['Climate Change'], 0.9627535343170166)","('NON-ESG', 0.007703978102654219)","('NON-ESG', 0.003336256602779031)"
Line 809,"We  also pilot use of nontraditional fuel sources (such as  electricity and biofuel) and transportation methods  (such as bicycle couriers) to explore the viability of  alternatives and evaluate whether we might be able  to expand any to a larger scale.
","('Energy_Management', 0.9748159646987915)","('Management_Of_Legal_And_Regulatory_Framework', 0.0024995002895593643)","('Product_Design_And_Lifecycle_Management', 0.002379675628617406)","(['Operational Eco-Efficiency'], 0.9748159646987915)","('NON-ESG', 0.0024995002895593643)","('NON-ESG', 0.002379675628617406)"
Line 810,"To better manage  emissions across our distribution network, we have  added requirements to our contracts with transport  suppliers related to the measurement of GHG  emissions, reduction targets and related initiatives.
","('GHG_Emissions', 0.9679116010665894)","('Air_Quality', 0.004348332993686199)","('Management_Of_Legal_And_Regulatory_Framework', 0.0030699046328663826)","(['Climate Change'], 0.9679116010665894)","('NON-ESG', 0.004348332993686199)","('NON-ESG', 0.0030699046328663826)"
Line 811,"Our worldwide GHG emissions from product transport  totaled 447,400 metric tons CO2e in 2020.3 This is  equivalent to 89 kilograms CO2e per metric ton of  products transported.
","('GHG_Emissions', 0.9245696067810059)","('Air_Quality', 0.01173471286892891)","('Energy_Management', 0.010818646289408207)","(['Climate Change'], 0.9245696067810059)","('NON-ESG', 0.01173471286892891)","('NON-ESG', 0.010818646289408207)"
Line 812,"During the year, our GHG emissions  related to product transport by air increased by 99%  compared with 2019.
","('GHG_Emissions', 0.8444600701332092)","('Air_Quality', 0.09689973294734955)","('Management_Of_Legal_And_Regulatory_Framework', 0.006899548694491386)","(['Climate Change'], 0.8444600701332092)","('NON-ESG', 0.09689973294734955)","('NON-ESG', 0.006899548694491386)"
Line 813,"This was primarily due to prioritizing  the quick delivery of critical, lifesaving products to  hospitals in urgent need of renal supplies and other  Baxter products as a result of the COVID-19 pandemic.In addition, during 2020 we began using EcoTransIT  methodology and software, in alignment with the  Global Logistics Emissions Council (GLEC) framework,  for calculating our GHG emissions across all product  transport modes.
","('GHG_Emissions', 0.9197770953178406)","('Air_Quality', 0.011918081901967525)","('Energy_Management', 0.009104282595217228)","(['Climate Change'], 0.9197770953178406)","('NON-ESG', 0.011918081901967525)","('NON-ESG', 0.009104282595217228)"
Line 814,"The emission factors we are  now using are more comprehensive and specific,  providing a more robust understanding of our product  transport-related GHG emissions compared with our  previous methodology.
","('GHG_Emissions', 0.921461820602417)","('Air_Quality', 0.036753106862306595)","('Management_Of_Legal_And_Regulatory_Framework', 0.004506238736212254)","(['Climate Change'], 0.921461820602417)","('NON-ESG', 0.036753106862306595)","('NON-ESG', 0.004506238736212254)"
Line 815,"WORLDWIDE GHG EMISSIONS FROM PRODUCT TRANSPORT  BY MODE, AirRoadOcean7% Rail3% 24%66% VIEW THE DATA SUMMARY   FOR MORE DETAIL.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT42Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Baxter’s approach to improving efficiency and  decreasing emissions from product transport includes:  Environmentally  responsible  partnerships Baxter is one of a  select number of  companies that  participate in the  U.S. Environmental  Protection Agency's  SmartWay program  as both a Carrier and  Shipper Partner.
","('GHG_Emissions', 0.9324490427970886)","('Air_Quality', 0.022991621866822243)","('Energy_Management', 0.00557249691337347)","(['Climate Change'], 0.9324490427970886)","('NON-ESG', 0.022991621866822243)","('NON-ESG', 0.00557249691337347)"
Line 816,"WORLDWIDE GHG EMISSIONS FROM PRODUCT TRANSPORT  BY MODE, AirRoadOcean7% Rail3% 24%66% VIEW THE DATA SUMMARY   FOR MORE DETAIL.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT42Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Baxter’s approach to improving efficiency and  decreasing emissions from product transport includes:  Environmentally  responsible  partnerships Baxter is one of a  select number of  companies that  participate in the  U.S. Environmental  Protection Agency's  SmartWay program  as both a Carrier and  Shipper Partner.
","('Product_Design_And_Lifecycle_Management', 0.9559738039970398)","('Product_Quality_And_Safety', 0.004844214301556349)","('Energy_Management', 0.004586722236126661)","(['Product Stewardship'], 0.9559738039970398)","('NON-ESG', 0.004844214301556349)","('NON-ESG', 0.004586722236126661)"
Line 817,"In addition, we continued using carbon  credits to offset our UPS shipping outside the United  States.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8834317922592163)","('GHG_Emissions', 0.01888539269566536)","('Systemic_Risk_Management', 0.012264181859791279)","(['Corporate Governance'], 0.8834317922592163)","('NON-ESG', 0.01888539269566536)","('NON-ESG', 0.012264181859791279)"
Line 818,"During 2020, we offset more than 1,300 metric  tons CO2e of GHG emissions through this program.
","('GHG_Emissions', 0.9659708738327026)","('Air_Quality', 0.005530116613954306)","('Ecological_Impacts', 0.003420440247282386)","(['Climate Change'], 0.9659708738327026)","('NON-ESG', 0.005530116613954306)","('NON-ESG', 0.003420440247282386)"
Line 819,"In 2020, we also joined two global initiatives: the  GLEC Partnership, which provides a framework for  reporting logistics-related GHG emissions, and Clean  Cargo, which focuses on environmentally responsible  ocean shipping.
","('GHG_Emissions', 0.9668257832527161)","('Ecological_Impacts', 0.004841695073992014)","('Physical_Impacts_Of_Climate_Change', 0.0036287095863372087)","(['Climate Change'], 0.9668257832527161)","('NON-ESG', 0.004841695073992014)","('NON-ESG', 0.0036287095863372087)"
Line 820,"The Clean Cargo methodology is the  industry standard for calculating emissions related to  ocean container shipping and will enable us to make  more informed purchasing decisions for our ocean  freight.
","('GHG_Emissions', 0.2991146743297577)","('Air_Quality', 0.20330414175987244)","('Energy_Management', 0.13303230702877045)","('NON-ESG', 0.2991146743297577)","('NON-ESG', 0.20330414175987244)","('NON-ESG', 0.13303230702877045)"
Line 821,"We are also using EcoTransIT software and  methodology to capture and report our emissions  data.
","('GHG_Emissions', 0.6352958083152771)","('Air_Quality', 0.22891013324260712)","('Energy_Management', 0.028832556679844856)","(['Climate Change'], 0.6352958083152771)","('NON-ESG', 0.22891013324260712)","('NON-ESG', 0.028832556679844856)"
Line 822,"These partnerships will help us better calculate  our emissions and develop greater insight into the  environmental impacts of our product transport.
","('Product_Design_And_Lifecycle_Management', 0.8621692657470703)","('Energy_Management', 0.04286513477563858)","('Product_Quality_And_Safety', 0.012590907514095306)","(['Product Stewardship'], 0.8621692657470703)","('NON-ESG', 0.04286513477563858)","('NON-ESG', 0.012590907514095306)"
Line 823,"Technology innovation    We are continuing to pilot  and implement transportation methods that decrease  emissions, with a focus on deliveries in urban areas.
","('Air_Quality', 0.368821918964386)","('Energy_Management', 0.3029722571372986)","('GHG_Emissions', 0.18126875162124634)","('NON-ESG', 0.368821918964386)","('NON-ESG', 0.3029722571372986)","('NON-ESG', 0.18126875162124634)"
Line 824,"For example, in the UK, Baxter has partnered with  Oxford University Hospitals NHS Foundation Trust  to use bicycle couriers to deliver patient-specific  chemotherapy, antibiotics and intravenous nutrition  products from our compounding facility in Oxford  to local hospitals.
","('Customer_Welfare', 0.5717121958732605)","('Selling_Practices_And_Product_Labeling', 0.18448597192764282)","('Product_Quality_And_Safety', 0.033139102160930634)","(['Customer Relationship Management'], 0.5717121958732605)","('NON-ESG', 0.18448597192764282)","('NON-ESG', 0.033139102160930634)"
Line 825,"This approach eliminates carbon  emissions associated with these deliveries and cuts the delivery time in half.
","('GHG_Emissions', 0.6452623009681702)","('Energy_Management', 0.09977400302886963)","('Air_Quality', 0.09878881275653839)","(['Climate Change'], 0.6452623009681702)","('NON-ESG', 0.09977400302886963)","('NON-ESG', 0.09878881275653839)"
Line 826,"In addition, we are piloting  electric trucks for deliveries in Belgium, and in 2020,  we laid the groundwork for a biofuel pilot program  in the UK.
","('Energy_Management', 0.9645214676856995)","('Air_Quality', 0.004063372500240803)","('Management_Of_Legal_And_Regulatory_Framework', 0.004053342621773481)","(['Operational Eco-Efficiency'], 0.9645214676856995)","('NON-ESG', 0.004063372500240803)","('NON-ESG', 0.004053342621773481)"
Line 827,"We also improve efficiency and reduce  emissions through regular fleet renewal and vehicle  improvements.
","('Energy_Management', 0.49024638533592224)","('Air_Quality', 0.2938093841075897)","('GHG_Emissions', 0.08829396963119507)","('NON-ESG', 0.49024638533592224)","('NON-ESG', 0.2938093841075897)","('NON-ESG', 0.08829396963119507)"
Line 828,"For instance, in the United States, the  vehicles we rent and lease for home deliveries are  regularly replaced to ensure we are taking advantage  of the latest features to increase fuel efficiency, such  as reduced height, aerodynamic noses, speed limiters  and idle shutdown.
","('Energy_Management', 0.9618772268295288)","('Air_Quality', 0.005594516173005104)","('Product_Design_And_Lifecycle_Management', 0.004415792878717184)","(['Operational Eco-Efficiency'], 0.9618772268295288)","('NON-ESG', 0.005594516173005104)","('NON-ESG', 0.004415792878717184)"
Line 829,"As a result, we saw a 3.5% decrease  in fuel consumption per mile for these U.S. delivery  trucks in 2020 compared with 2019.
","('Energy_Management', 0.9764446020126343)","('Product_Design_And_Lifecycle_Management', 0.002435930073261261)","('Air_Quality', 0.0019917909521609545)","(['Operational Eco-Efficiency'], 0.9764446020126343)","('NON-ESG', 0.002435930073261261)","('NON-ESG', 0.0019917909521609545)"
Line 830,"Modal shift     Combining multiple transportation modes  for a single shipment—for example, converting road to  rail for parts of a route—can decrease costs and overall  GHG emissions.
","('GHG_Emissions', 0.968103289604187)","('Air_Quality', 0.003834016155451536)","('Ecological_Impacts', 0.0034498642198741436)","(['Climate Change'], 0.968103289604187)","('NON-ESG', 0.003834016155451536)","('NON-ESG', 0.0034498642198741436)"
Line 831,"In 2020, we continued converting road  freight to rail worldwide.
","('Waste_And_Hazardous_Materials_Management', 0.2971948981285095)","('Energy_Management', 0.14009913802146912)","('Supply_Chain_Management', 0.10544958710670471)","('NON-ESG', 0.2971948981285095)","('NON-ESG', 0.14009913802146912)","('NON-ESG', 0.10544958710670471)"
Line 832,"To replace air freight with  ocean and rail wherever possible, all large, unplanned  air shipments must receive senior manager approval.
","('Air_Quality', 0.7506868243217468)","('Waste_And_Hazardous_Materials_Management', 0.08769318461418152)","('Energy_Management', 0.01928122714161873)","(['Operational Eco-Efficiency'], 0.7506868243217468)","('NON-ESG', 0.08769318461418152)","('NON-ESG', 0.01928122714161873)"
Line 833,"However, in response to the COVID-19 pandemic, we  did increase air shipments in 2020 to accelerate the  delivery of urgent, critical products.
","('Air_Quality', 0.6385195255279541)","('Energy_Management', 0.07796164602041245)","('Product_Design_And_Lifecycle_Management', 0.056152354925870895)","(['Operational Eco-Efficiency'], 0.6385195255279541)","('NON-ESG', 0.07796164602041245)","('NON-ESG', 0.056152354925870895)"
Line 834,"In some cases, we  were able to use ocean shipments, despite the longer  lead time, by initiating the customs clearance and  import process while the goods were in transit.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6757869720458984)","('Business_Ethics', 0.04134603962302208)","('Waste_And_Hazardous_Materials_Management', 0.03623241186141968)","(['Corporate Governance'], 0.6757869720458984)","('NON-ESG', 0.04134603962302208)","('NON-ESG', 0.03623241186141968)"
Line 835,"Optimizing the distribution network    The use  of innovative technologies, such as transport  management systems and route optimization tools,  saves time and money while improving environmental  performance.
","('Energy_Management', 0.44133955240249634)","('Supply_Chain_Management', 0.1227862685918808)","('Product_Design_And_Lifecycle_Management', 0.059542298316955566)","('NON-ESG', 0.44133955240249634)","('NON-ESG', 0.1227862685918808)","('NON-ESG', 0.059542298316955566)"
Line 836,"We have an ocean export consolidation  center in Antwerp, Belgium, for the majority of  our EMEA export shipments.
","('Management_Of_Legal_And_Regulatory_Framework', 0.28720521926879883)","('Competitive_Behavior', 0.10111797600984573)","('Energy_Management', 0.07410871237516403)","('NON-ESG', 0.28720521926879883)","('NON-ESG', 0.10111797600984573)","('NON-ESG', 0.07410871237516403)"
Line 837,"The center combines  shipments from different warehouse locations in  Europe and optimizes loads so that containers are less  likely to be shipped partially full.
","('Waste_And_Hazardous_Materials_Management', 0.6905936598777771)","('Product_Design_And_Lifecycle_Management', 0.06559891253709793)","('Supply_Chain_Management', 0.05389583110809326)","(['Operational Eco-Efficiency'], 0.6905936598777771)","('NON-ESG', 0.06559891253709793)","('NON-ESG', 0.05389583110809326)"
Line 838,"This reduces the total  number of containers shipped and saves money while  increasing supply frequency.
","('Product_Design_And_Lifecycle_Management', 0.37139755487442017)","('Supply_Chain_Management', 0.2293747365474701)","('Waste_And_Hazardous_Materials_Management', 0.16514421999454498)","('NON-ESG', 0.37139755487442017)","('NON-ESG', 0.2293747365474701)","('NON-ESG', 0.16514421999454498)"
Line 839,"We increased the scope  of this center in 2020 and started using higher capacity  containers for some shipments, which increases  the number of pallets per container by 30%.
","('Waste_And_Hazardous_Materials_Management', 0.482118159532547)","('Product_Design_And_Lifecycle_Management', 0.10832785069942474)","('Energy_Management', 0.0886271744966507)","('NON-ESG', 0.482118159532547)","('NON-ESG', 0.10832785069942474)","('NON-ESG', 0.0886271744966507)"
Line 840,"These  higher capacity containers enabled us to avoid the  use of 137 containers that would have otherwise been  shipped during 2020.
","('Waste_And_Hazardous_Materials_Management', 0.43305280804634094)","('Product_Design_And_Lifecycle_Management', 0.3224869668483734)","('Energy_Management', 0.03305692598223686)","('NON-ESG', 0.43305280804634094)","('NON-ESG', 0.3224869668483734)","('NON-ESG', 0.03305692598223686)"
Line 841,"We are evaluating the possibility  of expanding this consolidation center concept to our  other regions, including centers in the Americas and  Asia Pacific.
","('Business_Model_Resilience', 0.43468061089515686)","('Systemic_Risk_Management', 0.13197094202041626)","('Employee_Engagement_Inclusion_And_Diversity', 0.0682230070233345)","('NON-ESG', 0.43468061089515686)","('NON-ESG', 0.13197094202041626)","('NON-ESG', 0.0682230070233345)"
Line 842,"Conservation of resources    We conserve natural  resources at our distribution facilities, when possible.
","('Ecological_Impacts', 0.9777719974517822)","('GHG_Emissions', 0.002861388260498643)","('Water_And_Wastewater_Management', 0.002012776443734765)","(['Natural Capital'], 0.9777719974517822)","('NON-ESG', 0.002861388260498643)","('NON-ESG', 0.002012776443734765)"
Line 843,"In 2020, for example, our Marion (North Cove), North  Carolina, facility used recycled wood pallets for  outbound shipments, which reduces the use of new  wooden pallets by 101,500 annually, equivalent to  approximately 12,700 trees.4  Beginning in December  2020, we also use recycled pallets at our ocean export  consolidation center in Antwerp, Belgium, and plan to  expand this initiative to more sites in the United States  in coming years.
","('Product_Design_And_Lifecycle_Management', 0.4560306966304779)","('Waste_And_Hazardous_Materials_Management', 0.23957742750644684)","('Supply_Chain_Management', 0.05614318698644638)","('NON-ESG', 0.4560306966304779)","('NON-ESG', 0.23957742750644684)","('NON-ESG', 0.05614318698644638)"
Line 844,"2020 GOALExpand green  transport  partnerships to all  business regions  globally VIEW ALL 2020 GOALSAchievedBAXTER 2020 CORPORATE RESPONSIBILITY REPORTProduct  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction PRODUCT DONATIONS   Making sure that healthcare providers and patients around the world have access to Baxter’s lifesaving  innovations is essential.
","('Product_Design_And_Lifecycle_Management', 0.7073366045951843)","('Product_Quality_And_Safety', 0.11337477713823318)","('Customer_Welfare', 0.04783295467495918)","(['Product Stewardship'], 0.7073366045951843)","('NON-ESG', 0.11337477713823318)","('NON-ESG', 0.04783295467495918)"
Line 845,"2020 GOALExpand green  transport  partnerships to all  business regions  globally VIEW ALL 2020 GOALSAchievedBAXTER 2020 CORPORATE RESPONSIBILITY REPORTProduct  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction PRODUCT DONATIONS   Making sure that healthcare providers and patients around the world have access to Baxter’s lifesaving  innovations is essential.
","('Product_Design_And_Lifecycle_Management', 0.8122515082359314)","('Customer_Welfare', 0.02287619560956955)","('Product_Quality_And_Safety', 0.022112060338258743)","(['Product Stewardship'], 0.8122515082359314)","('NON-ESG', 0.02287619560956955)","('NON-ESG', 0.022112060338258743)"
Line 846,"Strategically investing in product donations is one way Baxter improves access to care  for vulnerable populations with unmet healthcare needs.
","('Access_And_Affordability', 0.9053835868835449)","('Human_Rights_And_Community_Relations', 0.020553505048155785)","('Critical_Incident_Risk_Management', 0.008577870205044746)","(['Health Outcome Contribution'], 0.9053835868835449)","('NON-ESG', 0.020553505048155785)","('NON-ESG', 0.008577870205044746)"
Line 847,"HUMANITARIAN ASSISTANCE: MANUFACTURE-TO-DONATE PROGRAM We manufacture products twice a year specifically for donation to our three  trusted humanitarian partners: Americares , Direct Relief  and Partners In Health .
","('Critical_Incident_Risk_Management', 0.3419804871082306)","('Access_And_Affordability', 0.2193024456501007)","('Human_Rights_And_Community_Relations', 0.08254315704107285)","('NON-ESG', 0.3419804871082306)","('NON-ESG', 0.2193024456501007)","('NON-ESG', 0.08254315704107285)"
Line 848,"This manufacture-to-donate strategy, an industry best practice, means our  partners can rely on having critically needed, long-dated products year-round—   not just during emergency situations.
","('Critical_Incident_Risk_Management', 0.9679203033447266)","('Employee_Health_And_Safety', 0.006459072232246399)","('Air_Quality', 0.002878341590985656)","(['Risk & Crisis Management'], 0.9679203033447266)","('NON-ESG', 0.006459072232246399)","('NON-ESG', 0.002878341590985656)"
Line 849,"In 2020, we donated products valued at  $24 million, enhancing access to care for patients around the world.
","('Access_And_Affordability', 0.7588870525360107)","('Customer_Welfare', 0.031696345657110214)","('Product_Design_And_Lifecycle_Management', 0.03142232075333595)","(['Health Outcome Contribution'], 0.7588870525360107)","('NON-ESG', 0.031696345657110214)","('NON-ESG', 0.03142232075333595)"
Line 850,"See Summary of 2020 Giving .
","('Management_Of_Legal_And_Regulatory_Framework', 0.5686936974525452)","('Business_Ethics', 0.0666421428322792)","('Labor_Practices', 0.0303023848682642)","(['Corporate Governance'], 0.5686936974525452)","('NON-ESG', 0.0666421428322792)","('NON-ESG', 0.0303023848682642)"
Line 851,"Innovation That Expands       Access to Care Improve access to healthcare for the underserved 2020 HIGHLIGHTS Guided by our mission and inspired by the millions of patients and caregivers who rely  on our products, we are dedicated to nurturing, developing and delivering innovative  healthcare solutions.
","('Access_And_Affordability', 0.9460828304290771)","('Critical_Incident_Risk_Management', 0.005387533456087112)","('Energy_Management', 0.004497783724218607)","(['Health Outcome Contribution'], 0.9460828304290771)","('NON-ESG', 0.005387533456087112)","('NON-ESG', 0.004497783724218607)"
Line 852,"Baxter and the Baxter International Foundation strategically invest in  new partnerships with world-renowned organizations, deploying our people, products and  grants globally to increase access to care.
","('Access_And_Affordability', 0.8125249743461609)","('Customer_Welfare', 0.02607494406402111)","('Product_Quality_And_Safety', 0.0214220117777586)","(['Health Outcome Contribution'], 0.8125249743461609)","('NON-ESG', 0.02607494406402111)","('NON-ESG', 0.0214220117777586)"
Line 853,"Additionally, our Government Affairs and Public  Policy team works with lawmakers, governments, patient organizations and policy makers  as well as entities focused on addressing healthcare disparities in minority populations.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9634368419647217)","('Human_Rights_And_Community_Relations', 0.0040205977857112885)","('Access_And_Affordability', 0.002879286417737603)","(['Human Capital Development'], 0.9634368419647217)","('NON-ESG', 0.0040205977857112885)","('NON-ESG', 0.002879286417737603)"
Line 854,"2020 GOALPre-position donated  products with donor  partners to enable  optimal distribution  and first-on-scene  response VIEW ALL 2020 GOALSAchieved BAXTER 2020 CORPORATE RESPONSIBILITY REPORT 43in products  donated$24 million patients in 9 countries served  by outpatient dialysis clinics and  centers of excellence through  Baxter Renal Care ServicesLaunched  Signature Partnerships  that expand access  to care since 201625 ,000 +BAXTER 2020 CORPORATE RESPONSIBILITY REPORTProduct  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Our manufacture-to-donate product donation  strategy aligns with the guidance established by the  World Health Organization guidelines for medicine  donations and the Partnership for Quality Medical  Donations (PQMD) guidelines .
","('Product_Design_And_Lifecycle_Management', 0.3201678395271301)","('Customer_Welfare', 0.24361683428287506)","('Access_And_Affordability', 0.1285308599472046)","('NON-ESG', 0.3201678395271301)","('NON-ESG', 0.24361683428287506)","('NON-ESG', 0.1285308599472046)"
Line 855,"2020 GOALPre-position donated  products with donor  partners to enable  optimal distribution  and first-on-scene  response VIEW ALL 2020 GOALSAchieved BAXTER 2020 CORPORATE RESPONSIBILITY REPORT 43in products  donated$24 million patients in 9 countries served  by outpatient dialysis clinics and  centers of excellence through  Baxter Renal Care ServicesLaunched  Signature Partnerships  that expand access  to care since 201625 ,000 +BAXTER 2020 CORPORATE RESPONSIBILITY REPORTProduct  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Our manufacture-to-donate product donation  strategy aligns with the guidance established by the  World Health Organization guidelines for medicine  donations and the Partnership for Quality Medical  Donations (PQMD) guidelines .
","('Product_Design_And_Lifecycle_Management', 0.4433983564376831)","('Product_Quality_And_Safety', 0.2031862735748291)","('Customer_Welfare', 0.10695308446884155)","('NON-ESG', 0.4433983564376831)","('NON-ESG', 0.2031862735748291)","('NON-ESG', 0.10695308446884155)"
Line 856,"Baxter serves on the  board of PQMD to support global best practices in  product donations.
","('Product_Design_And_Lifecycle_Management', 0.6421260833740234)","('Customer_Welfare', 0.09220707416534424)","('Product_Quality_And_Safety', 0.05688907951116562)","(['Product Stewardship'], 0.6421260833740234)","('NON-ESG', 0.09220707416534424)","('NON-ESG', 0.05688907951116562)"
Line 857,"Through our longstanding partnership with  Americares, we donate products to support U.S.  medical outreach teams that travel overseas to  provide charitable care to underserved populations.
","('Access_And_Affordability', 0.9456368088722229)","('Critical_Incident_Risk_Management', 0.005473539233207703)","('Product_Quality_And_Safety', 0.004842153750360012)","(['Health Outcome Contribution'], 0.9456368088722229)","('NON-ESG', 0.005473539233207703)","('NON-ESG', 0.004842153750360012)"
Line 858,"While fewer medical mission trips occurred in 2020  due to the COVID-19 pandemic, Baxter products  were distributed in 28 countries as part of 54 medical  mission trips during the year.
","('Selling_Practices_And_Product_Labeling', 0.22006720304489136)","('Customer_Welfare', 0.18435712158679962)","('Product_Quality_And_Safety', 0.1694028377532959)","('NON-ESG', 0.22006720304489136)","('NON-ESG', 0.18435712158679962)","('NON-ESG', 0.1694028377532959)"
Line 859,"Learn more  about  Baxter’s longstanding partnership with Americares.
","('Supply_Chain_Management', 0.1990906298160553)","('Customer_Welfare', 0.11394809186458588)","('Systemic_Risk_Management', 0.11275237798690796)","('NON-ESG', 0.1990906298160553)","('NON-ESG', 0.11394809186458588)","('NON-ESG', 0.11275237798690796)"
Line 860,"U.S. PATIENT ASSISTANCE PROGRAM Through our U.S. Patient Assistance Program, we make  chemotherapy drugs available to cancer patients who  have financial barriers to access and who lack insurance  or prescription drug coverage.
","('Access_And_Affordability', 0.8086734414100647)","('Management_Of_Legal_And_Regulatory_Framework', 0.02045176550745964)","('Product_Quality_And_Safety', 0.01759641245007515)","(['Health Outcome Contribution'], 0.8086734414100647)","('NON-ESG', 0.02045176550745964)","('NON-ESG', 0.01759641245007515)"
Line 861,"We have offered  Cyclophosphamide since the program’s inception in  2009, and in 2019, we expanded it to include Doxorubicin  (also known as Doxil).
","('Customer_Welfare', 0.48970967531204224)","('Selling_Practices_And_Product_Labeling', 0.19809590280056)","('Product_Quality_And_Safety', 0.04686705395579338)","('NON-ESG', 0.48970967531204224)","('NON-ESG', 0.19809590280056)","('NON-ESG', 0.04686705395579338)"
Line 862,"DISASTER RELIEF With several natural disasters and the onset of the  COVID-19 pandemic, 2020 was a unique and challenging  year.
","('Critical_Incident_Risk_Management', 0.9720566868782043)","('Physical_Impacts_Of_Climate_Change', 0.0031221986282616854)","('Employee_Health_And_Safety', 0.0028847581706941128)","(['Risk & Crisis Management'], 0.9720566868782043)","('NON-ESG', 0.0031221986282616854)","('NON-ESG', 0.0028847581706941128)"
Line 863,"Baxter has a longstanding history of providing  disaster relief through investments in preparedness,  immediate response and recovery efforts that expand access  to care in collaboration with our humanitarian  partners.
","('Critical_Incident_Risk_Management', 0.9721364378929138)","('Access_And_Affordability', 0.0031255607027560472)","('Employee_Health_And_Safety', 0.0030949958600103855)","(['Risk & Crisis Management'], 0.9721364378929138)","('NON-ESG', 0.0031255607027560472)","('NON-ESG', 0.0030949958600103855)"
Line 864,"In 2020, our global disaster relief partners  included the American Red Cross, Americares, the  Australian Red Cross, Direct Relief and International  Medical Corps.
","('Critical_Incident_Risk_Management', 0.9746078848838806)","('Employee_Health_And_Safety', 0.003059372305870056)","('Air_Quality', 0.002537443535402417)","(['Risk & Crisis Management'], 0.9746078848838806)","('NON-ESG', 0.003059372305870056)","('NON-ESG', 0.002537443535402417)"
Line 865,"Additionally, we provided immediate  support to more than one dozen relief organizations  working on the front lines of the COVID-19 pandemic  to address the needs of patients, health workers and  communities around the world.
","('Critical_Incident_Risk_Management', 0.5358256101608276)","('Access_And_Affordability', 0.14009836316108704)","('Employee_Health_And_Safety', 0.12261243909597397)","(['Risk & Crisis Management'], 0.5358256101608276)","('NON-ESG', 0.14009836316108704)","('NON-ESG', 0.12261243909597397)"
Line 866,"Examples of our disaster  relief efforts for the year include:  • To support a global response to COVID-19, the Baxter  International Foundation provided $2.5 million in  grants to charitable organizations.
","('Critical_Incident_Risk_Management', 0.9707760810852051)","('Employee_Health_And_Safety', 0.0032492836471647024)","('Physical_Impacts_Of_Climate_Change', 0.003142681671306491)","(['Risk & Crisis Management'], 0.9707760810852051)","('NON-ESG', 0.0032492836471647024)","('NON-ESG', 0.003142681671306491)"
Line 867,"• In response to bushfires in Australia, the Baxter  International Foundation committed $100,000 to the  Australian Red Cross.
","('Critical_Incident_Risk_Management', 0.44443950057029724)","('Physical_Impacts_Of_Climate_Change', 0.32610294222831726)","('Air_Quality', 0.05213642865419388)","('NON-ESG', 0.44443950057029724)","('NON-ESG', 0.32610294222831726)","('NON-ESG', 0.05213642865419388)"
Line 868,"In addition, our local Baxter  colleagues coordinated fundraising campaigns and  worked with emergency services personnel and  customers to reroute and reschedule deliveries and  assist patients who were displaced, evacuated or in  high-risk areas.
","('Critical_Incident_Risk_Management', 0.9719117283821106)","('Employee_Health_And_Safety', 0.005593565292656422)","('Air_Quality', 0.002922700485214591)","(['Risk & Crisis Management'], 0.9719117283821106)","('NON-ESG', 0.005593565292656422)","('NON-ESG', 0.002922700485214591)"
Line 869,"• Following a series of earthquakes and aftershocks  in Puerto Rico, Baxter implemented our emergency  preparedness process to maintain a consistent  product supply.
","('Critical_Incident_Risk_Management', 0.973194420337677)","('Air_Quality', 0.003102497663348913)","('Physical_Impacts_Of_Climate_Change', 0.00299680489115417)","(['Risk & Crisis Management'], 0.973194420337677)","('NON-ESG', 0.003102497663348913)","('NON-ESG', 0.00299680489115417)"
Line 870,"In 2020, the Baxter International  Foundation provided $175,000 through grant  commitments and disaster relief financial support  to nonprofit partners in Puerto Rico.
","('Critical_Incident_Risk_Management', 0.9667024612426758)","('Employee_Health_And_Safety', 0.004178183618932962)","('Physical_Impacts_Of_Climate_Change', 0.0040098149329423904)","(['Risk & Crisis Management'], 0.9667024612426758)","('NON-ESG', 0.004178183618932962)","('NON-ESG', 0.0040098149329423904)"
Line 871,"We also  authorized partners to deploy products that we had  pre-positioned in the area for use in times of crisis.
","('Product_Design_And_Lifecycle_Management', 0.9229573607444763)","('Product_Quality_And_Safety', 0.010925449430942535)","('Supply_Chain_Management', 0.009113293141126633)","(['Product Stewardship'], 0.9229573607444763)","('NON-ESG', 0.010925449430942535)","('NON-ESG', 0.009113293141126633)"
Line 872,"Additionally, our Baxter Employee Disaster Relief Fund  enables employees to donate funds to help co-workers  impacted by disasters globally.
","('Critical_Incident_Risk_Management', 0.9634020924568176)","('Employee_Health_And_Safety', 0.007730661891400814)","('Physical_Impacts_Of_Climate_Change', 0.0033848711755126715)","(['Risk & Crisis Management'], 0.9634020924568176)","('NON-ESG', 0.007730661891400814)","('NON-ESG', 0.0033848711755126715)"
Line 873,"The Baxter International  Foundation provided seed funding and covers all costs  related to management of the fund, which allows 100%   of employee donations to reach colleagues-in-need.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7657590508460999)","('Access_And_Affordability', 0.05897555500268936)","('Human_Rights_And_Community_Relations', 0.03061472810804844)","(['Corporate Governance'], 0.7657590508460999)","('NON-ESG', 0.05897555500268936)","('NON-ESG', 0.03061472810804844)"
Line 874,"Photo credit:  Ana María Ariza/AmericaresBAXTER 2020 CORPORATE RESPONSIBILITY REPORTProduct  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction THE BAXTER INTERNATIONAL  FOUNDATION The Baxter International Foundation , the philanthropic  arm of Baxter International Inc.
","('Business_Ethics', 0.1402244120836258)","('Product_Quality_And_Safety', 0.09714473783969879)","('Product_Design_And_Lifecycle_Management', 0.09382899850606918)","('NON-ESG', 0.1402244120836258)","('NON-ESG', 0.09714473783969879)","('NON-ESG', 0.09382899850606918)"
Line 875,"partners with  organizations around the world to increase access  to healthcare for the underserved; bolster science,  technology, engineering and math (STEM) education to  develop the next generation of healthcare innovators;  and promote community resilience where our employees  live and work.
","('Access_And_Affordability', 0.9414365291595459)","('Human_Rights_And_Community_Relations', 0.005467858165502548)","('Critical_Incident_Risk_Management', 0.004926721099764109)","(['Health Outcome Contribution'], 0.9414365291595459)","('NON-ESG', 0.005467858165502548)","('NON-ESG', 0.004926721099764109)"
Line 876,"In 2020, the Foundation provided more  than $8 million in cash contributions for programs in  40 countries.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8640058040618896)","('Access_And_Affordability', 0.02383195050060749)","('Human_Rights_And_Community_Relations', 0.013720077462494373)","(['Corporate Governance'], 0.8640058040618896)","('NON-ESG', 0.02383195050060749)","('NON-ESG', 0.013720077462494373)"
Line 877,"The grants funded programs focused on  COVID-19 relief efforts, advancing safe surgery, diabetes  prevention, nutrition, and STEM education, as well as  diversity and inclusion initiatives.SIGNATURE  PARTNERSHIPS Over the last five years  the Baxter International  Foundation has  transformed its giving  to focus on long-term  strategic investments.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9215543866157532)","('Access_And_Affordability', 0.017937853932380676)","('Employee_Health_And_Safety', 0.007318634074181318)","(['Human Capital Development'], 0.9215543866157532)","('NON-ESG', 0.017937853932380676)","('NON-ESG', 0.007318634074181318)"
Line 878,"From 2016 through 2020,  we have helped support   six Signature Partnerships  benefiting hundreds of  thousands of people and  families globally.
","('Access_And_Affordability', 0.6454092264175415)","('Human_Rights_And_Community_Relations', 0.18070027232170105)","('Employee_Engagement_Inclusion_And_Diversity', 0.026979684829711914)","(['Health Outcome Contribution'], 0.6454092264175415)","('NON-ESG', 0.18070027232170105)","('NON-ESG', 0.026979684829711914)"
Line 879,"In 2016, we established our first Signature Partnership  grant to support Driving Your Health (Manejando Tu  Salud)—a free community mobile medical program  that expanded access to healthcare in underserved  communities throughout greater Mexico City.
","('Access_And_Affordability', 0.9469591379165649)","('Critical_Incident_Risk_Management', 0.005140184424817562)","('Product_Quality_And_Safety', 0.0045636920258402824)","(['Health Outcome Contribution'], 0.9469591379165649)","('NON-ESG', 0.005140184424817562)","('NON-ESG', 0.0045636920258402824)"
Line 880,"Informed  by the success of this program, the Baxter International  Foundation launched a new strategy that emphasizes  larger-scale, multiyear partnerships to enhance quality  healthcare in underserved communities globally.
","('Access_And_Affordability', 0.9481192231178284)","('Critical_Incident_Risk_Management', 0.004962848033756018)","('Human_Rights_And_Community_Relations', 0.004445623140782118)","(['Health Outcome Contribution'], 0.9481192231178284)","('NON-ESG', 0.004962848033756018)","('NON-ESG', 0.004445623140782118)"
Line 881,"Through  these investments, we focus on increasing access to care  in the following areas: diabetes prevention, clean water  and nutrition.
","('Access_And_Affordability', 0.8007055521011353)","('Customer_Welfare', 0.02867603488266468)","('Employee_Health_And_Safety', 0.022547166794538498)","(['Health Outcome Contribution'], 0.8007055521011353)","('NON-ESG', 0.02867603488266468)","('NON-ESG', 0.022547166794538498)"
Line 882,"We accelerate progress in these areas  through digital and telehealth innovations.
","('Business_Model_Resilience', 0.2276867926120758)","('Product_Design_And_Lifecycle_Management', 0.18652145564556122)","('Customer_Welfare', 0.060598988085985184)","('NON-ESG', 0.2276867926120758)","('NON-ESG', 0.18652145564556122)","('NON-ESG', 0.060598988085985184)"
Line 883,"American Diabetes Association    As part of Baxter’s  ACT: Activating Change Today initiative , the Baxter  International Foundation established a partnership  with the American Diabetes Association (ADA) in 2020  to address health disparities for people with diabetes  in Chicago’s underserved Black communities.
","('Access_And_Affordability', 0.9126286506652832)","('Product_Quality_And_Safety', 0.009957609698176384)","('Employee_Health_And_Safety', 0.008691864088177681)","(['Health Outcome Contribution'], 0.9126286506652832)","('NON-ESG', 0.009957609698176384)","('NON-ESG', 0.008691864088177681)"
Line 884,"Made  possible with a three-year, $2 million grant from the  Foundation, the community-based program will help  remove barriers to diabetes care and promote diabetes  prevention for a population that is disproportionally  affected by the disease.
","('Access_And_Affordability', 0.5677135586738586)","('Employee_Health_And_Safety', 0.13594211637973785)","('Product_Quality_And_Safety', 0.041901811957359314)","(['Health Outcome Contribution'], 0.5677135586738586)","('NON-ESG', 0.13594211637973785)","('NON-ESG', 0.041901811957359314)"
Line 885,"The Foundation is also matching  employee donations to the ADA at a 2:1 ratio throughout  the partnership.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7710781097412109)","('Director_Removal', 0.01965433917939663)","('Labor_Practices', 0.017076294869184494)","(['Corporate Governance'], 0.7710781097412109)","('NON-ESG', 0.01965433917939663)","('NON-ESG', 0.017076294869184494)"
Line 886,"Learn more .
","('Employee_Engagement_Inclusion_And_Diversity', 0.16738976538181305)","('Access_And_Affordability', 0.09505748748779297)","('Supply_Chain_Management', 0.0712040588259697)","('NON-ESG', 0.16738976538181305)","('NON-ESG', 0.09505748748779297)","('NON-ESG', 0.0712040588259697)"
Line 887,"Across Italy, Save the Children employees and local partners distribute basic  necessities, such as food and hygiene products, directly to low-income children  and families facing increased health, education and safety risks amid COVID-19.
","('Product_Quality_And_Safety', 0.48058268427848816)","('Employee_Health_And_Safety', 0.2130545973777771)","('Access_And_Affordability', 0.06838282942771912)","('NON-ESG', 0.48058268427848816)","('NON-ESG', 0.2130545973777771)","('NON-ESG', 0.06838282942771912)"
Line 888,"Above, Save the Children colleagues prepare for distribution in the city of Sassari in  Sardinia.
","('Access_And_Affordability', 0.8500213027000427)","('Employee_Health_And_Safety', 0.019288068637251854)","('Human_Rights_And_Community_Relations', 0.015270397067070007)","(['Health Outcome Contribution'], 0.8500213027000427)","('NON-ESG', 0.019288068637251854)","('NON-ESG', 0.015270397067070007)"
Line 889,"Photo credit: Marco Sanna for Save the ChildrenUNICEF USA    The Baxter International Foundation  established a three-year, $1.5 million Signature  Partnership with UNICEF USA in 2020 to support access  to clean water and sanitation for families in La Guajira,  Colombia.
","('Water_And_Wastewater_Management', 0.7902331948280334)","('Access_And_Affordability', 0.046098947525024414)","('Human_Rights_And_Community_Relations', 0.02147177793085575)","(['Operational Eco-Efficiency'], 0.7902331948280334)","('NON-ESG', 0.046098947525024414)","('NON-ESG', 0.02147177793085575)"
Line 890,"The initiative intends to bolster the national  government’s technical expertise and capacity to provide  water and hygiene infrastructure to rural areas across  the country.
","('Water_And_Wastewater_Management', 0.9399523735046387)","('Energy_Management', 0.00904896855354309)","('Critical_Incident_Risk_Management', 0.005996671970933676)","(['Operational Eco-Efficiency'], 0.9399523735046387)","('NON-ESG', 0.00904896855354309)","('NON-ESG', 0.005996671970933676)"
Line 891,"Learn more on our UNICEF USA partner  webpage .
","('Human_Rights_And_Community_Relations', 0.49990496039390564)","('Management_Of_Legal_And_Regulatory_Framework', 0.10988502204418182)","('Competitive_Behavior', 0.0367419570684433)","('NON-ESG', 0.49990496039390564)","('NON-ESG', 0.10988502204418182)","('NON-ESG', 0.0367419570684433)"
Line 892,"For more about Baxter’s work to support  access to clean water and enhance sanitation in water- stressed areas where we have facilities, see Serving Our  Communities .
","('Water_And_Wastewater_Management', 0.9736012816429138)","('Energy_Management', 0.002379759680479765)","('GHG_Emissions', 0.002137150149792433)","(['Operational Eco-Efficiency'], 0.9736012816429138)","('NON-ESG', 0.002379759680479765)","('NON-ESG', 0.002137150149792433)"
Line 893,"Save the Children    In 2020, we made a $1 million grant  to support Save the Children’s global efforts to provide  relief to children and families during the COVID-19   pandemic.
","('Access_And_Affordability', 0.8109080195426941)","('Human_Rights_And_Community_Relations', 0.03360701724886894)","('Critical_Incident_Risk_Management', 0.0297106821089983)","(['Health Outcome Contribution'], 0.8109080195426941)","('NON-ESG', 0.03360701724886894)","('NON-ESG', 0.0297106821089983)"
Line 894,"Beyond medical supplies, the nonprofit  also provides water, sanitation and hygiene resources,  nutritional support, education and more.
","('Water_And_Wastewater_Management', 0.9201402068138123)","('Critical_Incident_Risk_Management', 0.007107580080628395)","('Energy_Management', 0.006869470700621605)","(['Operational Eco-Efficiency'], 0.9201402068138123)","('NON-ESG', 0.007107580080628395)","('NON-ESG', 0.006869470700621605)"
Line 895,"Learn more .
","('Employee_Engagement_Inclusion_And_Diversity', 0.16738976538181305)","('Access_And_Affordability', 0.09505748748779297)","('Supply_Chain_Management', 0.0712040588259697)","('NON-ESG', 0.16738976538181305)","('NON-ESG', 0.09505748748779297)","('NON-ESG', 0.0712040588259697)"
Line 896,"2020 GOALEstablish the Baxter  International  Foundation   Partnership Grant  program in 2016 to   drive increased access    to healthcare   for an incremental   10,000 patients  annually.
","('Access_And_Affordability', 0.9151316285133362)","('Critical_Incident_Risk_Management', 0.00876651518046856)","('Energy_Management', 0.007186088245362043)","(['Health Outcome Contribution'], 0.9151316285133362)","('NON-ESG', 0.00876651518046856)","('NON-ESG', 0.007186088245362043)"
Line 897,"VIEW ALL 2020 GOALSAchieved THE BAXTER INTERNATIONAL FOUNDATION:   THREE STRATEGIC PILLARS Increase Access  to Healthcare Foster  Tomorrow’s Innovation  in STEMPromote  Community ResilienceOur grant strategy focuses on accelerating change and  innovation and funding solutions across three key pillars.
","('Business_Model_Resilience', 0.8799490332603455)","('Employee_Engagement_Inclusion_And_Diversity', 0.012533904053270817)","('Supply_Chain_Management', 0.01219925470650196)","(['Codes of Business Conduct'], 0.8799490332603455)","('NON-ESG', 0.012533904053270817)","('NON-ESG', 0.01219925470650196)"
Line 898,"Our work across these pillars is discussed in detail throughout  this section and the Serving Our Communities section.
","('Human_Rights_And_Community_Relations', 0.8724846839904785)","('Access_And_Affordability', 0.02000996842980385)","('Employee_Engagement_Inclusion_And_Diversity', 0.01516474224627018)","(['Community Relations'], 0.8724846839904785)","('NON-ESG', 0.02000996842980385)","('NON-ESG', 0.01516474224627018)"
Line 899,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORTProduct  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Direct Relief    In partnership with Direct Relief, we  established the Transformative Innovation Awards for  Community Health: Incorporating Nutrition to Improve  Diabetes Health Outcomes.
","('Employee_Health_And_Safety', 0.4605300724506378)","('Access_And_Affordability', 0.15659679472446442)","('Product_Quality_And_Safety', 0.08463383466005325)","('NON-ESG', 0.4605300724506378)","('NON-ESG', 0.15659679472446442)","('NON-ESG', 0.08463383466005325)"
Line 900,"This three-year $750,000  initiative, launched in 2019, aims to advance innovation  in diabetes patient care at health centers and free  and charitable clinics.
","('Access_And_Affordability', 0.8494947552680969)","('Customer_Welfare', 0.019099436700344086)","('Product_Quality_And_Safety', 0.01226368360221386)","(['Health Outcome Contribution'], 0.8494947552680969)","('NON-ESG', 0.019099436700344086)","('NON-ESG', 0.01226368360221386)"
Line 901,"Through the end of 2020, Direct  Relief has provided more than $248,000 in awards to  six organizations, reaching nearly 3,000 people directly  and 7,500 indirectly.
","('Access_And_Affordability', 0.5404843091964722)","('Management_Of_Legal_And_Regulatory_Framework', 0.10266243666410446)","('Human_Rights_And_Community_Relations', 0.06375236809253693)","(['Health Outcome Contribution'], 0.5404843091964722)","('NON-ESG', 0.10266243666410446)","('NON-ESG', 0.06375236809253693)"
Line 902,"In 2020, the awards focused on  clinics in rural communities in Arkansas and Missouri,  providing health, nutrition, physical activity education  and evidence-based diabetes self-management  classes to help people take better control of their  diabetes.
","('Access_And_Affordability', 0.5254772305488586)","('Employee_Health_And_Safety', 0.11023538559675217)","('Customer_Welfare', 0.08050171285867691)","(['Health Outcome Contribution'], 0.5254772305488586)","('NON-ESG', 0.11023538559675217)","('NON-ESG', 0.08050171285867691)"
Line 903,"Classes are made available virtually to  address safety concerns from COVID-19.
","('Product_Quality_And_Safety', 0.8060310482978821)","('Employee_Health_And_Safety', 0.08964546024799347)","('Product_Design_And_Lifecycle_Management', 0.009173324331641197)","(['Product Quality & Recall Management'], 0.8060310482978821)","('NON-ESG', 0.08964546024799347)","('NON-ESG', 0.009173324331641197)"
Line 904,"Providers  can also access specialist support virtually through  telehealth services provided by The MAVEN Project.
","('Access_And_Affordability', 0.6648003458976746)","('Management_Of_Legal_And_Regulatory_Framework', 0.07341880351305008)","('Product_Quality_And_Safety', 0.03050224483013153)","(['Health Outcome Contribution'], 0.6648003458976746)","('NON-ESG', 0.07341880351305008)","('NON-ESG', 0.03050224483013153)"
Line 905,"Learn more .
","('Employee_Engagement_Inclusion_And_Diversity', 0.16738976538181305)","('Access_And_Affordability', 0.09505748748779297)","('Supply_Chain_Management', 0.0712040588259697)","('NON-ESG', 0.16738976538181305)","('NON-ESG', 0.09505748748779297)","('NON-ESG', 0.0712040588259697)"
Line 906,"Operation Smile    In 2019, Baxter established a three- year $2.2 million partnership with Operation Smile  to advance safe surgery in underserved communities  in India.
","('Access_And_Affordability', 0.9437800645828247)","('Product_Quality_And_Safety', 0.005123067647218704)","('Critical_Incident_Risk_Management', 0.004982151091098785)","(['Health Outcome Contribution'], 0.9437800645828247)","('NON-ESG', 0.005123067647218704)","('NON-ESG', 0.004982151091098785)"
Line 907,"The partnership supports care centers in  Durgapur, Mumbai, Srinagar and Bangalore, operated  in collaboration with Inga Health Foundation.
","('Access_And_Affordability', 0.8469021320343018)","('Critical_Incident_Risk_Management', 0.020527981221675873)","('Employee_Health_And_Safety', 0.017958225682377815)","(['Health Outcome Contribution'], 0.8469021320343018)","('NON-ESG', 0.020527981221675873)","('NON-ESG', 0.017958225682377815)"
Line 908,"The  centers treat patients of all ages with cleft conditions  and expand opportunities for education and training  of local healthcare workers.
","('Access_And_Affordability', 0.45178118348121643)","('Employee_Engagement_Inclusion_And_Diversity', 0.272295743227005)","('Employee_Health_And_Safety', 0.07509811222553253)","('NON-ESG', 0.45178118348121643)","('NON-ESG', 0.272295743227005)","('NON-ESG', 0.07509811222553253)"
Line 909,"In response to COVID-19 ,  staff and volunteers at the centers distributed food  and hygiene supplies to thousands of families and  migrant workers surrounding the Durgapur and  Mumbai centers.
","('Employee_Health_And_Safety', 0.23322801291942596)","('Labor_Practices', 0.22440680861473083)","('Access_And_Affordability', 0.12804393470287323)","('NON-ESG', 0.23322801291942596)","('NON-ESG', 0.22440680861473083)","('NON-ESG', 0.12804393470287323)"
Line 910,"The teams also continued delivering  exceptional virtual patient care and forged new  solutions to resume in-person patient care at the  centers.
","('Access_And_Affordability', 0.7070043683052063)","('Employee_Health_And_Safety', 0.04096917062997818)","('Critical_Incident_Risk_Management', 0.03207782283425331)","(['Health Outcome Contribution'], 0.7070043683052063)","('NON-ESG', 0.04096917062997818)","('NON-ESG', 0.03207782283425331)"
Line 911,"As a result of this partnership, surgery has  resumed with heightened safety protocols; in 2020,  Operation Smile directly reached 7,000 individuals,  including serving more than 4,000 patients with  surgical and multidisciplinary care.
","('Product_Quality_And_Safety', 0.7834427356719971)","('Employee_Health_And_Safety', 0.05945006012916565)","('Access_And_Affordability', 0.029438840225338936)","(['Product Quality & Recall Management'], 0.7834427356719971)","('NON-ESG', 0.05945006012916565)","('NON-ESG', 0.029438840225338936)"
Line 912,"Learn more .
","('Employee_Engagement_Inclusion_And_Diversity', 0.16738976538181305)","('Access_And_Affordability', 0.09505748748779297)","('Supply_Chain_Management', 0.0712040588259697)","('NON-ESG', 0.16738976538181305)","('NON-ESG', 0.09505748748779297)","('NON-ESG', 0.0712040588259697)"
Line 913,"BAXTER INTERNATIONAL FOUNDATION   PRIZE PROGRAMS To support ongoing advancements that benefit patients  and expand access to care, Baxter sponsors three prize  programs that recognize organizations and individuals  who have made outstanding contributions and exhibited  leadership in healthcare research and health service  delivery.
","('Access_And_Affordability', 0.877424955368042)","('Human_Rights_And_Community_Relations', 0.012621893547475338)","('Product_Quality_And_Safety', 0.010690059512853622)","(['Health Outcome Contribution'], 0.877424955368042)","('NON-ESG', 0.012621893547475338)","('NON-ESG', 0.010690059512853622)"
Line 914,"The William B.
","('Management_Of_Legal_And_Regulatory_Framework', 0.25599297881126404)","('Ecological_Impacts', 0.08314830809831619)","('Business_Ethics', 0.07603741437196732)","('NON-ESG', 0.25599297881126404)","('NON-ESG', 0.08314830809831619)","('NON-ESG', 0.07603741437196732)"
Line 915,"Graham Prize  is the highest  distinction that researchers in the health services field  can achieve, recognizing global contributions to improving  public health through research.
","('Access_And_Affordability', 0.4965532124042511)","('Management_Of_Legal_And_Regulatory_Framework', 0.06860509514808655)","('Human_Rights_And_Community_Relations', 0.053309887647628784)","('NON-ESG', 0.4965532124042511)","('NON-ESG', 0.06860509514808655)","('NON-ESG', 0.053309887647628784)"
Line 916,"The Foster G.
","('Access_And_Affordability', 0.11826533079147339)","('Management_Of_Legal_And_Regulatory_Framework', 0.11654496937990189)","('Competitive_Behavior', 0.09747294336557388)","('NON-ESG', 0.11826533079147339)","('NON-ESG', 0.11654496937990189)","('NON-ESG', 0.09747294336557388)"
Line 917,"McGaw Prize   recognizes U.S. healthcare organizations that deliver  innovative programs to improve community health and  well-being.
","('Access_And_Affordability', 0.5259072184562683)","('Employee_Health_And_Safety', 0.15398122370243073)","('Human_Rights_And_Community_Relations', 0.11945880949497223)","(['Health Outcome Contribution'], 0.5259072184562683)","('NON-ESG', 0.15398122370243073)","('NON-ESG', 0.11945880949497223)"
Line 918,"(Due to COVID-19, this prize was suspended  for 2020 as hospitals and health systems responded to the  pandemic.) The Episteme Award  is bestowed biennially  to a nurse who has contributed significantly to discovery,  practice and knowledge development in the field of nursing.
","('Access_And_Affordability', 0.4996938705444336)","('Human_Rights_And_Community_Relations', 0.055243801325559616)","('Critical_Incident_Risk_Management', 0.051437485963106155)","('NON-ESG', 0.4996938705444336)","('NON-ESG', 0.055243801325559616)","('NON-ESG', 0.051437485963106155)"
Line 919,"COLLABORATING TO IMPROVE HEALTHCARE Through partnerships, innovative solutions and  stakeholder engagement, Baxter works to tackle global  health challenges and expand the availability of our  treatments, strengthen health systems and support public  health worldwide.
","('Access_And_Affordability', 0.6007046103477478)","('Critical_Incident_Risk_Management', 0.06214681267738342)","('Employee_Health_And_Safety', 0.05681060254573822)","(['Health Outcome Contribution'], 0.6007046103477478)","('NON-ESG', 0.06214681267738342)","('NON-ESG', 0.05681060254573822)"
Line 920,"Our work includes educating patients,  training physicians and healthcare professionals, and  sharing best practices in manufacturing and treatment.
","('Access_And_Affordability', 0.5259283185005188)","('Employee_Health_And_Safety', 0.08468713611364365)","('Customer_Welfare', 0.062459610402584076)","(['Health Outcome Contribution'], 0.5259283185005188)","('NON-ESG', 0.08468713611364365)","('NON-ESG', 0.062459610402584076)"
Line 921,"Additionally, we collaborate with governments, companies  and nonprofit organizations to promote policies and  standards that enhance patient access to therapy and  products.
","('Access_And_Affordability', 0.5822963714599609)","('Product_Quality_And_Safety', 0.10019122809171677)","('Customer_Welfare', 0.06201284006237984)","(['Health Outcome Contribution'], 0.5822963714599609)","('NON-ESG', 0.10019122809171677)","('NON-ESG', 0.06201284006237984)"
Line 922,"Through these efforts we are working to provide  transformative solutions to improve healthcare.
","('Access_And_Affordability', 0.6113326549530029)","('Energy_Management', 0.063454270362854)","('Product_Design_And_Lifecycle_Management', 0.04074157401919365)","(['Health Outcome Contribution'], 0.6113326549530029)","('NON-ESG', 0.063454270362854)","('NON-ESG', 0.04074157401919365)"
Line 923,"SHARING BEST PRACTICES FOR RENAL CARE Chronic kidney disease affects 10% of the global  population.1  We estimate as many as four million people  suffer from renal failure globally, which is the last stage  of the disease progression and requires dialysis or a kidney transplant to stay alive.
","('Employee_Health_And_Safety', 0.3884096145629883)","('Access_And_Affordability', 0.1230916678905487)","('Employee_Engagement_Inclusion_And_Diversity', 0.07580816000699997)","('NON-ESG', 0.3884096145629883)","('NON-ESG', 0.1230916678905487)","('NON-ESG', 0.07580816000699997)"
Line 924,"It’s further estimated  that millions more go undiagnosed and untreated  globally.
","('Employee_Health_And_Safety', 0.37404611706733704)","('Access_And_Affordability', 0.24909864366054535)","('Critical_Incident_Risk_Management', 0.061013322323560715)","('NON-ESG', 0.37404611706733704)","('NON-ESG', 0.24909864366054535)","('NON-ESG', 0.061013322323560715)"
Line 925,"At Baxter, we seek to expand access to care  and innovate across renal care therapies to reduce  complications, improve outcomes and make dialysis  care more efficient and effective.
","('Access_And_Affordability', 0.7929328083992004)","('Employee_Health_And_Safety', 0.02542480081319809)","('Customer_Welfare', 0.025335704907774925)","(['Health Outcome Contribution'], 0.7929328083992004)","('NON-ESG', 0.02542480081319809)","('NON-ESG', 0.025335704907774925)"
Line 926,"During 2020, COVID-19 created a significant need to  focus on continuity of care for patients with kidney  failure that require lifesaving, routine therapy, with  special focus on helping them gain access to home  dialysis.
","('Access_And_Affordability', 0.6536230444908142)","('Employee_Health_And_Safety', 0.09213440120220184)","('Customer_Welfare', 0.03168874233961105)","(['Health Outcome Contribution'], 0.6536230444908142)","('NON-ESG', 0.09213440120220184)","('NON-ESG', 0.03168874233961105)"
Line 927,"The pandemic highlighted the need for  patients with kidney failure, who also have immune  dysfunction, to be able to socially distance themselves  to avoid the viral infection.
","('Employee_Health_And_Safety', 0.23098993301391602)","('Critical_Incident_Risk_Management', 0.10517153143882751)","('Access_And_Affordability', 0.09483098238706589)","('NON-ESG', 0.23098993301391602)","('NON-ESG', 0.10517153143882751)","('NON-ESG', 0.09483098238706589)"
Line 928,"Baxter assembled a global  task force to identify and advocate for solutions to  barriers resulting from the pandemic and to support  local teams as they worked to quickly address unique  country-by-country needs.
","('Critical_Incident_Risk_Management', 0.17477211356163025)","('Physical_Impacts_Of_Climate_Change', 0.17397381365299225)","('Systemic_Risk_Management', 0.13075336813926697)","('NON-ESG', 0.17477211356163025)","('NON-ESG', 0.17397381365299225)","('NON-ESG', 0.13075336813926697)"
Line 929,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORTProduct  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Our activities were broad in reach.
","('Product_Quality_And_Safety', 0.25880104303359985)","('Product_Design_And_Lifecycle_Management', 0.11109049618244171)","('Employee_Health_And_Safety', 0.09653738141059875)","('NON-ESG', 0.25880104303359985)","('NON-ESG', 0.11109049618244171)","('NON-ESG', 0.09653738141059875)"
Line 930,"Following are a few  key examples:   • New peritoneal dialysis (PD) patients must have  a catheter inserted into their abdominal area to  facilitate home treatment.
","('Employee_Health_And_Safety', 0.18861600756645203)","('Access_And_Affordability', 0.1885460466146469)","('Customer_Welfare', 0.11020765453577042)","('NON-ESG', 0.18861600756645203)","('NON-ESG', 0.1885460466146469)","('NON-ESG', 0.11020765453577042)"
Line 931,"This became challenging  during the pandemic, as some facilities deemed this  to be an elective procedure.
","('Physical_Impacts_Of_Climate_Change', 0.14547154307365417)","('Access_And_Affordability', 0.14200368523597717)","('Critical_Incident_Risk_Management', 0.1193307563662529)","('NON-ESG', 0.14547154307365417)","('NON-ESG', 0.14200368523597717)","('NON-ESG', 0.1193307563662529)"
Line 932,"To support access to  this essential procedure that enables home dialysis,  Baxter worked with healthcare professionals, medical  societies and ministries of health globally to advocate  for patients’ access to the procedure.
","('Access_And_Affordability', 0.8866578936576843)","('Critical_Incident_Risk_Management', 0.01305142231285572)","('Employee_Health_And_Safety', 0.010976488701999187)","(['Health Outcome Contribution'], 0.8866578936576843)","('NON-ESG', 0.01305142231285572)","('NON-ESG', 0.010976488701999187)"
Line 933,"For example, we  worked with the ministries of health in Australia and  India to recognize catheter insertion as a non-elective  procedure, and even an emergency procedure as  needed, removing a roadblock for patients in need of  PD care.
","('Employee_Health_And_Safety', 0.47791287302970886)","('Critical_Incident_Risk_Management', 0.35655686259269714)","('Access_And_Affordability', 0.03879490867257118)","('NON-ESG', 0.47791287302970886)","('NON-ESG', 0.35655686259269714)","('NON-ESG', 0.03879490867257118)"
Line 934,"Baxter also successfully advocated for this in  the United States, among other countries.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7228831648826599)","('Competitive_Behavior', 0.04508707672357559)","('Access_And_Affordability', 0.030313968658447266)","(['Corporate Governance'], 0.7228831648826599)","('NON-ESG', 0.04508707672357559)","('NON-ESG', 0.030313968658447266)"
Line 935,"• In response to the pandemic many healthcare  professionals rapidly adjusted practices in their  clinics and began supporting an increased number  of home patients.
","('Critical_Incident_Risk_Management', 0.47812017798423767)","('Physical_Impacts_Of_Climate_Change', 0.19411714375019073)","('Air_Quality', 0.06396085023880005)","('NON-ESG', 0.47812017798423767)","('NON-ESG', 0.19411714375019073)","('NON-ESG', 0.06396085023880005)"
Line 936,"As home dialysis rates continue  to rise, so does the demand for nurses who have  the expertise to successfully manage a PD program.
","('Access_And_Affordability', 0.4849529266357422)","('Customer_Welfare', 0.06058325618505478)","('Critical_Incident_Risk_Management', 0.057701922953128815)","('NON-ESG', 0.4849529266357422)","('NON-ESG', 0.06058325618505478)","('NON-ESG', 0.057701922953128815)"
Line 937,"In response, we created programs such as  the PD  Excellence Academy, a virtual training platform and  educational resource center to help nurses develop  PD skills for optimal patient care.
","('Access_And_Affordability', 0.6294015645980835)","('Employee_Engagement_Inclusion_And_Diversity', 0.06266902387142181)","('Employee_Health_And_Safety', 0.0442759171128273)","(['Health Outcome Contribution'], 0.6294015645980835)","('NON-ESG', 0.06266902387142181)","('NON-ESG', 0.0442759171128273)"
Line 938,"Baxter designed the PD Excellence Academy training resources  to provide standardized, evidence-based and  actionable curriculum in a convenient and easily  accessible virtual format.
","('Access_And_Affordability', 0.6593358516693115)","('Product_Quality_And_Safety', 0.0532572939991951)","('Employee_Engagement_Inclusion_And_Diversity', 0.04459696635603905)","(['Health Outcome Contribution'], 0.6593358516693115)","('NON-ESG', 0.0532572939991951)","('NON-ESG', 0.04459696635603905)"
Line 939,"• Around the world, local teams actively engaged  with policy makers to support healthcare  professionals’ ability to adopt and implement digital  health tools to remotely manage patient care.
","('Access_And_Affordability', 0.6926740407943726)","('Energy_Management', 0.04136913642287254)","('Customer_Welfare', 0.030312562361359596)","(['Health Outcome Contribution'], 0.6926740407943726)","('NON-ESG', 0.04136913642287254)","('NON-ESG', 0.030312562361359596)"
Line 940,"For  example, the Baxter team in South Korea worked  with the ministry of health to gain temporary  approval to provide reimbursement for dialysis  providers that use Baxter’s Sharesource remote  patient management platform, which enables  healthcare providers to remotely monitor their  home patients’ treatments.
","('Access_And_Affordability', 0.28423845767974854)","('Management_Of_Legal_And_Regulatory_Framework', 0.22120094299316406)","('Energy_Management', 0.1269892454147339)","('NON-ESG', 0.28423845767974854)","('NON-ESG', 0.22120094299316406)","('NON-ESG', 0.1269892454147339)"
Line 941,"About half the hospitals  in South Korea that treat PD patients (54 hospitals  in total) were included in the first phase of this  program during 2020.
","('Access_And_Affordability', 0.5398939847946167)","('Customer_Welfare', 0.05499827489256859)","('Critical_Incident_Risk_Management', 0.04683347046375275)","(['Health Outcome Contribution'], 0.5398939847946167)","('NON-ESG', 0.05499827489256859)","('NON-ESG', 0.04683347046375275)"
Line 942,"• To further foster global support of patients’ access  to home care during the pandemic, we hosted the  first International Home Dialysis Roundtable.
","('Access_And_Affordability', 0.8676232695579529)","('Critical_Incident_Risk_Management', 0.016405019909143448)","('Product_Quality_And_Safety', 0.013150213286280632)","(['Health Outcome Contribution'], 0.8676232695579529)","('NON-ESG', 0.016405019909143448)","('NON-ESG', 0.013150213286280632)"
Line 943,"The  two-day meeting was the first global gathering  of all the major nephrology societies, patient  organizations and key opinion leaders on the topic  of how to help dialysis patients during this time.
","('Access_And_Affordability', 0.7874963283538818)","('Critical_Incident_Risk_Management', 0.023979460820555687)","('Employee_Health_And_Safety', 0.018751176074147224)","(['Health Outcome Contribution'], 0.7874963283538818)","('NON-ESG', 0.023979460820555687)","('NON-ESG', 0.018751176074147224)"
Line 944,"The initial output from this meeting resulted in a  white paper roadmap and consensus paper.
","('Management_Of_Legal_And_Regulatory_Framework', 0.56444251537323)","('Ecological_Impacts', 0.05466654524207115)","('GHG_Emissions', 0.053346749395132065)","(['Corporate Governance'], 0.56444251537323)","('NON-ESG', 0.05466654524207115)","('NON-ESG', 0.053346749395132065)"
Line 945,"• We initiated a global Safer at Home awareness campaign  to help educate patients and key stakeholders  about  home care as an important therapy  option during this time and to  discourage slow starts on therapy   or patients opting out of therapy for   fear of contracting the virus.
","('Access_And_Affordability', 0.6005598902702332)","('Product_Quality_And_Safety', 0.07372347265481949)","('Employee_Health_And_Safety', 0.07072257995605469)","(['Health Outcome Contribution'], 0.6005598902702332)","('NON-ESG', 0.07372347265481949)","('NON-ESG', 0.07072257995605469)"
Line 946,"During 2020, we also  continued to provide patient  care through our Baxter  Renal Care Services.
","('Access_And_Affordability', 0.8434903025627136)","('Customer_Welfare', 0.014783935621380806)","('Employee_Health_And_Safety', 0.013461323454976082)","(['Health Outcome Contribution'], 0.8434903025627136)","('NON-ESG', 0.014783935621380806)","('NON-ESG', 0.013461323454976082)"
Line 947,"These  facilities, located in nine  countries, function as  dialysis clinics and centers  of excellence to support  patients with chronic kidney  disease management, PD   or hemodialysis therapies.
","('Access_And_Affordability', 0.3172694146633148)","('Customer_Welfare', 0.10767501592636108)","('Employee_Health_And_Safety', 0.1004166305065155)","('NON-ESG', 0.3172694146633148)","('NON-ESG', 0.10767501592636108)","('NON-ESG', 0.1004166305065155)"
Line 948,"This includes the three clinics we opened in recent years in  emerging markets, one in Indonesia and two in China.
","('Systemic_Risk_Management', 0.251010537147522)","('Business_Model_Resilience', 0.17980752885341644)","('Competitive_Behavior', 0.126055508852005)","('NON-ESG', 0.251010537147522)","('NON-ESG', 0.17980752885341644)","('NON-ESG', 0.126055508852005)"
Line 949,"These clinics operate under two distinct business models.
","('Competitive_Behavior', 0.2505933344364166)","('Employee_Engagement_Inclusion_And_Diversity', 0.09218685328960419)","('Customer_Welfare', 0.0902223214507103)","('NON-ESG', 0.2505933344364166)","('NON-ESG', 0.09218685328960419)","('NON-ESG', 0.0902223214507103)"
Line 950,"During 2020, in partnership with the Indonesian Ministry of  Health and Lampung Province, Baxter Renal Care Services,  with the assistance of Menggala District Hospital, hosted  three events to provide education and free testing an d  diagnostics for patients with chronic kidney disease.
","('Employee_Health_And_Safety', 0.2664255201816559)","('Access_And_Affordability', 0.21847932040691376)","('Customer_Welfare', 0.06821837276220322)","('NON-ESG', 0.2664255201816559)","('NON-ESG', 0.21847932040691376)","('NON-ESG', 0.06821837276220322)"
Line 951,"We   are currently caring for more than 25,000 patients in our  Baxter Renal Care Services clinics globally.
","('Access_And_Affordability', 0.6877259612083435)","('Customer_Welfare', 0.03928261250257492)","('Critical_Incident_Risk_Management', 0.03435477986931801)","(['Health Outcome Contribution'], 0.6877259612083435)","('NON-ESG', 0.03928261250257492)","('NON-ESG', 0.03435477986931801)"
Line 952,"“          Freedom is the big thing about being on PD.
","('Labor_Practices', 0.20917630195617676)","('Human_Rights_And_Community_Relations', 0.17852118611335754)","('Competitive_Behavior', 0.1258593201637268)","('NON-ESG', 0.20917630195617676)","('NON-ESG', 0.17852118611335754)","('NON-ESG', 0.1258593201637268)"
Line 953,"You don't have  to drive for miles, three times a week for in-center hemodialysis   treatments.
","('Access_And_Affordability', 0.3602297604084015)","('Customer_Welfare', 0.07141300290822983)","('Employee_Health_And_Safety', 0.06557303667068481)","('NON-ESG', 0.3602297604084015)","('NON-ESG', 0.07141300290822983)","('NON-ESG', 0.06557303667068481)"
Line 954,"My days are free, so I can do whatever I want;   I only do therapy while sleeping.
","('Access_And_Affordability', 0.16370049118995667)","('Labor_Practices', 0.08812869340181351)","('Employee_Health_And_Safety', 0.0878746435046196)","('NON-ESG', 0.16370049118995667)","('NON-ESG', 0.08812869340181351)","('NON-ESG', 0.0878746435046196)"
Line 955,"If I keep feeling the way I do  now,  I plan to do a lot of fishing this summer at the lake.” TOM from Canada           The transition  from hemodialysis to  PD was good for me.
","('Access_And_Affordability', 0.16102725267410278)","('Ecological_Impacts', 0.1339317262172699)","('Customer_Welfare', 0.12963047623634338)","('NON-ESG', 0.16102725267410278)","('NON-ESG', 0.1339317262172699)","('NON-ESG', 0.12963047623634338)"
Line 956,"It is milder and I feel  better, which puts me in  a better position to get  tested for a transplant.” ANIA from Poland “ 2020 GOALLaunch two new  emerging market  business models  in Baxter’s renal  business VIEW ALL 2020 GOALSAchievedBAXTER 2020 CORPORATE RESPONSIBILITY REPORTProduct  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Additionally, we continue our work to advocate broadly  for renal patients who need access to lifesaving  therapies but encounter barriers due to cost or other  challenges.
","('Business_Model_Resilience', 0.22913441061973572)","('Product_Design_And_Lifecycle_Management', 0.13201794028282166)","('Product_Quality_And_Safety', 0.10385505110025406)","('NON-ESG', 0.22913441061973572)","('NON-ESG', 0.13201794028282166)","('NON-ESG', 0.10385505110025406)"
Line 957,"It is milder and I feel  better, which puts me in  a better position to get  tested for a transplant.” ANIA from Poland “ 2020 GOALLaunch two new  emerging market  business models  in Baxter’s renal  business VIEW ALL 2020 GOALSAchievedBAXTER 2020 CORPORATE RESPONSIBILITY REPORTProduct  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Additionally, we continue our work to advocate broadly  for renal patients who need access to lifesaving  therapies but encounter barriers due to cost or other  challenges.
","('Access_And_Affordability', 0.9214449524879456)","('Product_Quality_And_Safety', 0.008154566399753094)","('Critical_Incident_Risk_Management', 0.006145470775663853)","(['Health Outcome Contribution'], 0.9214449524879456)","('NON-ESG', 0.008154566399753094)","('NON-ESG', 0.006145470775663853)"
Line 958,"For example, Baxter is working to advance  the Prime Minister’s National Dialysis Program  (PMNDP), which is driven by the National Health  Mission of India’s Ministry of Health and Family Welfare .
","('Access_And_Affordability', 0.611127495765686)","('Employee_Health_And_Safety', 0.1801472306251526)","('Critical_Incident_Risk_Management', 0.023588525131344795)","(['Health Outcome Contribution'], 0.611127495765686)","('NON-ESG', 0.1801472306251526)","('NON-ESG', 0.023588525131344795)"
Line 959,"This policy, announced in 2016, encourages increased  access to PD care for those living below the poverty line.
","('Access_And_Affordability', 0.8377698659896851)","('Human_Rights_And_Community_Relations', 0.03194845840334892)","('Product_Quality_And_Safety', 0.01312192715704441)","(['Health Outcome Contribution'], 0.8377698659896851)","('NON-ESG', 0.03194845840334892)","('NON-ESG', 0.01312192715704441)"
Line 960,"In late 2019, the Ministry of Health and Family Welfare  established guidelines for inclusion of PD in the PMNDP  and made funding available that will increase access to  care for this economically vulnerable group, which  includes approximately 100 million families.
","('Access_And_Affordability', 0.8530072569847107)","('Human_Rights_And_Community_Relations', 0.04786503687500954)","('Employee_Engagement_Inclusion_And_Diversity', 0.010252846404910088)","(['Health Outcome Contribution'], 0.8530072569847107)","('NON-ESG', 0.04786503687500954)","('NON-ESG', 0.010252846404910088)"
Line 961,"By the   end of 2020, 21 states and union territories in India  had shown interest in implementing the plan and   have received approval for funding from the National  Health Mission.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8343920707702637)","('Access_And_Affordability', 0.04057936742901802)","('Human_Rights_And_Community_Relations', 0.02389870025217533)","(['Corporate Governance'], 0.8343920707702637)","('NON-ESG', 0.04057936742901802)","('NON-ESG', 0.02389870025217533)"
Line 962,"PUBLIC POLICY To deliver on Baxter’s mission of saving and sustaining  lives, we advocate for issues related to reimbursement,  tax, trade and a variety of regulatory concerns.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9758815169334412)","('Business_Ethics', 0.0023210991639643908)","('Director_Removal', 0.002116565592586994)","(['Corporate Governance'], 0.9758815169334412)","('NON-ESG', 0.0023210991639643908)","('NON-ESG', 0.002116565592586994)"
Line 963,"Baxter's  Government Affairs and Public Policy team works with  lawmakers, governments and policy makers worldwide  to support patient access to Baxter’s lifesaving therapies ,  improve the regulatory environment and reimbursement  structure for our therapies, and increase understanding  of the benefits of those therapies.
","('Management_Of_Legal_And_Regulatory_Framework', 0.47558116912841797)","('Access_And_Affordability', 0.3167107403278351)","('Product_Quality_And_Safety', 0.027110515162348747)","('NON-ESG', 0.47558116912841797)","('NON-ESG', 0.3167107403278351)","('NON-ESG', 0.027110515162348747)"
Line 964,"We also collaborate  with clinicians, nongovernmental organizations and  patient groups to improve access to healthcare for  millions of people worldwide.
","('Access_And_Affordability', 0.9277442693710327)","('Critical_Incident_Risk_Management', 0.008366871625185013)","('Human_Rights_And_Community_Relations', 0.006745306309312582)","(['Health Outcome Contribution'], 0.9277442693710327)","('NON-ESG', 0.008366871625185013)","('NON-ESG', 0.006745306309312582)"
Line 965,"See Baxter’s 2020 Political Contributions Report  for  details about our political contributions as well as our  membership in certain trade and industry groups.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7383618950843811)","('Director_Removal', 0.04126007854938507)","('Competitive_Behavior', 0.040328435599803925)","(['Corporate Governance'], 0.7383618950843811)","('NON-ESG', 0.04126007854938507)","('NON-ESG', 0.040328435599803925)"
Line 966,"During 2020, our key public policy focus areas included:  COVID-19 pandemic response     Beginning in March  2020, Baxter engaged directly with governments  throughout the world to provide pharmaceuticals  and  medical devices needed in the response to COVID-19.
","('Physical_Impacts_Of_Climate_Change', 0.4219614863395691)","('Critical_Incident_Risk_Management', 0.24912917613983154)","('Systemic_Risk_Management', 0.05420902743935585)","('NON-ESG', 0.4219614863395691)","('NON-ESG', 0.24912917613983154)","('NON-ESG', 0.05420902743935585)"
Line 967,"Baxter worked with multiple agencies and ministries   in relevant countries to ensure that our lifesaving and   life-sustaining products remained available for  healthcare providers treating all patients, both with   and without COVID-19.
","('Product_Design_And_Lifecycle_Management', 0.5969155430793762)","('Customer_Welfare', 0.10676538944244385)","('Access_And_Affordability', 0.05743500590324402)","(['Product Stewardship'], 0.5969155430793762)","('NON-ESG', 0.10676538944244385)","('NON-ESG', 0.05743500590324402)"
Line 968,"For example, during the early days of the pandemic,   Baxter worked directly with multiple governments to  ensure our employees could continue to work in our  manufacturing facilities.
","('Employee_Health_And_Safety', 0.33672642707824707)","('Access_And_Affordability', 0.08973059058189392)","('Labor_Practices', 0.07733937352895737)","('NON-ESG', 0.33672642707824707)","('NON-ESG', 0.08973059058189392)","('NON-ESG', 0.07733937352895737)"
Line 969,"In the United States that  meant ensuring our employees were deemed essential  and could travel to multiple manufacturing facilities  within the United States to ensure manufacturing  continued throughout the pandemic.
","('Employee_Engagement_Inclusion_And_Diversity', 0.30138158798217773)","('Employee_Health_And_Safety', 0.2112015336751938)","('Labor_Practices', 0.2107376754283905)","('NON-ESG', 0.30138158798217773)","('NON-ESG', 0.2112015336751938)","('NON-ESG', 0.2107376754283905)"
Line 970,"In Malaysia and  Singapore, Baxter worked with both governments to  ensure Malaysian employees could continue to reside  in Singapore to ensure our Singapore manufacturing  facility could continue manufacturing.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5372199416160583)","('Labor_Practices', 0.06465233117341995)","('Product_Design_And_Lifecycle_Management', 0.056254222989082336)","(['Human Capital Development'], 0.5372199416160583)","('NON-ESG', 0.06465233117341995)","('NON-ESG', 0.056254222989082336)"
Line 971,"Furthermore,  Baxter found accommodations for our Malaysian  employees in Singapore to ensure they could safely  contribute to the pandemic response.
","('Critical_Incident_Risk_Management', 0.2900204658508301)","('Employee_Health_And_Safety', 0.2595510184764862)","('Access_And_Affordability', 0.12825439870357513)","('NON-ESG', 0.2900204658508301)","('NON-ESG', 0.2595510184764862)","('NON-ESG', 0.12825439870357513)"
Line 972,"As a result,  Baxter was able to continue manufacturing critical  pharmaceuticals and medical devices and products  without disruption in the fight against the global pandemic.
","('Product_Design_And_Lifecycle_Management', 0.2833259105682373)","('Supply_Chain_Management', 0.14299969375133514)","('Product_Quality_And_Safety', 0.08490140736103058)","('NON-ESG', 0.2833259105682373)","('NON-ESG', 0.14299969375133514)","('NON-ESG', 0.08490140736103058)"
Line 973,"Baxter also worked with multiple governments around  the globe to communicate which Baxter products were  available for government stakeholders and hospitals  that were mobilizing to treat COVID-19 patients.
","('Customer_Welfare', 0.2756025195121765)","('Product_Design_And_Lifecycle_Management', 0.1388663500547409)","('Access_And_Affordability', 0.1280108392238617)","('NON-ESG', 0.2756025195121765)","('NON-ESG', 0.1388663500547409)","('NON-ESG', 0.1280108392238617)"
Line 974,"Additionally, we advocated for certain governments  around the world to move dialysis patients home,  where appropriate, in order to better protect them from  COVID-19.
","('Access_And_Affordability', 0.3449556231498718)","('Customer_Welfare', 0.1167418584227562)","('Product_Quality_And_Safety', 0.0528675876557827)","('NON-ESG', 0.3449556231498718)","('NON-ESG', 0.1167418584227562)","('NON-ESG', 0.0528675876557827)"
Line 975,"Working with multiple governmental health  agencies and ministries, Baxter obtained emergency use  authorizations for a multitude of products around the  world.
","('Critical_Incident_Risk_Management', 0.9724271893501282)","('Air_Quality', 0.0038656822871416807)","('Employee_Health_And_Safety', 0.002566392533481121)","(['Risk & Crisis Management'], 0.9724271893501282)","('NON-ESG', 0.0038656822871416807)","('NON-ESG', 0.002566392533481121)"
Line 976,"Furthermore, we used our global manufacturing  footprint to increase production, in some cases, creating  our own airbridges and seabridges to expedite delivery  of supplies needed to treat COVID-19 patients.
","('Customer_Welfare', 0.18001875281333923)","('Access_And_Affordability', 0.1771106719970703)","('Supply_Chain_Management', 0.09048966318368912)","('NON-ESG', 0.18001875281333923)","('NON-ESG', 0.1771106719970703)","('NON-ESG', 0.09048966318368912)"
Line 977,"Since 2018 and throughout this pandemic, Baxter has  advocated to key governments for increased resources  to bolster public health pandemic preparedness, and will  continue this advocacy going forward.
","('Physical_Impacts_Of_Climate_Change', 0.430163711309433)","('Critical_Incident_Risk_Management', 0.35507264733314514)","('Air_Quality', 0.03389577567577362)","('NON-ESG', 0.430163711309433)","('NON-ESG', 0.35507264733314514)","('NON-ESG', 0.03389577567577362)"
Line 978,"Advancing American Kidney Health Initiative       In 2020, the U.S. Department of Health and Human  Services finalized an initiative aimed at increasing  home dialysis and transplantation in the United States  called the Advancing American Kidney Health Initiative  (AAKHI).
","('Employee_Health_And_Safety', 0.16270431876182556)","('Customer_Welfare', 0.13590718805789948)","('Access_And_Affordability', 0.13255463540554047)","('NON-ESG', 0.16270431876182556)","('NON-ESG', 0.13590718805789948)","('NON-ESG', 0.13255463540554047)"
Line 979,"The centerpiece of AAKHI is the End-Stage  Renal Disease Treatment Choices Model, a mandatory  payment model that provides financial incentives to  dialysis clinics for achieving higher rates of home  dialysis and transplantation.
","('Access_And_Affordability', 0.5585951209068298)","('Customer_Welfare', 0.06894667446613312)","('Management_Of_Legal_And_Regulatory_Framework', 0.04228532686829567)","(['Health Outcome Contribution'], 0.5585951209068298)","('NON-ESG', 0.06894667446613312)","('NON-ESG', 0.04228532686829567)"
Line 980,"Currently, nearly 90% of  U.S. renal patients2 receive dialysis in a center, even  though a home dialysis therapy option, such as PD,  offers the convenience of therapy at home, provides  equal or better outcomes for many patients and is a less  costly alternative.
","('Access_And_Affordability', 0.42986762523651123)","('Employee_Health_And_Safety', 0.09938640892505646)","('Customer_Welfare', 0.07875572890043259)","('NON-ESG', 0.42986762523651123)","('NON-ESG', 0.09938640892505646)","('NON-ESG', 0.07875572890043259)"
Line 981,"Baxter is committed to supporting  AAKHI by increasing PD supply for home dialysis in the  United States.
","('Energy_Management', 0.28762856125831604)","('Access_And_Affordability', 0.19858302175998688)","('Supply_Chain_Management', 0.11153104156255722)","('NON-ESG', 0.28762856125831604)","('NON-ESG', 0.19858302175998688)","('NON-ESG', 0.11153104156255722)"
Line 982,"Promoting innovation in products for chronic kidney care    We continued to support U.S. legislation that provides  incentives to develop new, innovative devices for patients  with kidney disease.
","('Product_Design_And_Lifecycle_Management', 0.4577023684978485)","('Customer_Welfare', 0.17353996634483337)","('Access_And_Affordability', 0.05807418003678322)","('NON-ESG', 0.4577023684978485)","('NON-ESG', 0.17353996634483337)","('NON-ESG', 0.05807418003678322)"
Line 983,"Supporting diverse populations    Baxter representatives  attended the National Minority Quality Forum annual  conference (held virtually in 2020) to learn more about  health disparities affecting diverse populations and  engaged key leaders in our efforts to serve patients  with kidney failure and COVID-19, both of which  disproportionally impact minority populations.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9744200706481934)","('Human_Rights_And_Community_Relations', 0.001887883641757071)","('Employee_Health_And_Safety', 0.0016975469188764691)","(['Human Capital Development'], 0.9744200706481934)","('NON-ESG', 0.001887883641757071)","('NON-ESG', 0.0016975469188764691)"
Line 984,"A Baxter  representative participated on a panel discussing the  need to ensure equitable access to new innovations in  dialysis therapy.
","('Access_And_Affordability', 0.8340005874633789)","('Product_Quality_And_Safety', 0.01727355271577835)","('Customer_Welfare', 0.016945552080869675)","(['Health Outcome Contribution'], 0.8340005874633789)","('NON-ESG', 0.01727355271577835)","('NON-ESG', 0.016945552080869675)"
Line 985,"Home delivery of renal products    In the United States,  each state has its own laws and regulations that govern  the dispensing of pharmaceuticals.
","('Selling_Practices_And_Product_Labeling', 0.3131362795829773)","('Customer_Welfare', 0.16629000008106232)","('Product_Quality_And_Safety', 0.12771597504615784)","('NON-ESG', 0.3131362795829773)","('NON-ESG', 0.16629000008106232)","('NON-ESG', 0.12771597504615784)"
Line 986,"We work across the  states to help shape state policies that better align with  our Renal HomeCare Services distribution and delivery  model which provides a more efficient and cost effective  delivery of home-based renal devices and supplies.
","('Access_And_Affordability', 0.694780707359314)","('Product_Design_And_Lifecycle_Management', 0.04589438810944557)","('Customer_Welfare', 0.03914068266749382)","(['Health Outcome Contribution'], 0.694780707359314)","('NON-ESG', 0.04589438810944557)","('NON-ESG', 0.03914068266749382)"
Line 987,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORT49Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction BAXTER 2020 CORPORATE RESPONSIBILITY REPORT 49Serving Our Communities  Support communities worldwide in enduring ways    2020 HIGHLIGHTS in cash and   products contributed  to communities  worldwide*$38 million+ contributed by the  Baxter International  Foundation to support  COVID-19 response  $2.5 million countries reached  through  philanthropic  giving*100+ *By Baxter and the Baxter International Foundation.
","('Human_Rights_And_Community_Relations', 0.33810749650001526)","('Access_And_Affordability', 0.10380688309669495)","('Product_Design_And_Lifecycle_Management', 0.09476692229509354)","('NON-ESG', 0.33810749650001526)","('NON-ESG', 0.10380688309669495)","('NON-ESG', 0.09476692229509354)"
Line 988,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORT49Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction BAXTER 2020 CORPORATE RESPONSIBILITY REPORT 49Serving Our Communities  Support communities worldwide in enduring ways    2020 HIGHLIGHTS in cash and   products contributed  to communities  worldwide*$38 million+ contributed by the  Baxter International  Foundation to support  COVID-19 response  $2.5 million countries reached  through  philanthropic  giving*100+ *By Baxter and the Baxter International Foundation.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5821208953857422)","('Access_And_Affordability', 0.1215304508805275)","('Human_Rights_And_Community_Relations', 0.039226748049259186)","(['Corporate Governance'], 0.5821208953857422)","('NON-ESG', 0.1215304508805275)","('NON-ESG', 0.039226748049259186)"
Line 989,"The work Baxter and the Baxter International Foundation do to make a meaningful  difference  around the world is a key component of our corporate responsibility commitment.
","('Human_Rights_And_Community_Relations', 0.5553964376449585)","('Business_Model_Resilience', 0.09176415205001831)","('Management_Of_Legal_And_Regulatory_Framework', 0.056912098079919815)","(['Community Relations'], 0.5553964376449585)","('NON-ESG', 0.09176415205001831)","('NON-ESG', 0.056912098079919815)"
Line 990,"While 2020 was uniquely challenging, our dedication to social investments globally never  wavered.
","('Human_Rights_And_Community_Relations', 0.4218688905239105)","('Management_Of_Legal_And_Regulatory_Framework', 0.1456819623708725)","('Business_Model_Resilience', 0.1158248782157898)","('NON-ESG', 0.4218688905239105)","('NON-ESG', 0.1456819623708725)","('NON-ESG', 0.1158248782157898)"
Line 991,"We supported COVID-19 response efforts by providing financial support to groups  on the front lines of the pandemic—addressing the needs of patients, health workers and  communities.
","('Access_And_Affordability', 0.32063108682632446)","('Critical_Incident_Risk_Management', 0.2742929458618164)","('Employee_Health_And_Safety', 0.17464396357536316)","('NON-ESG', 0.32063108682632446)","('NON-ESG', 0.2742929458618164)","('NON-ESG', 0.17464396357536316)"
Line 992,"Throughout the year, we also continued and, in some cases, expanded our  programs to increase access to healthcare for the underserved ; bolster science, technology,  engineering and math (STEM) education to develop the next generation of healthcare  innovators; and promote community resilience where our employees live, work and give.
","('Access_And_Affordability', 0.9315347075462341)","('Human_Rights_And_Community_Relations', 0.007335949689149857)","('Product_Quality_And_Safety', 0.00593434926122427)","(['Health Outcome Contribution'], 0.9315347075462341)","('NON-ESG', 0.007335949689149857)","('NON-ESG', 0.00593434926122427)"
Line 993,"2020 GOALComplete two  projects that support  access to clean  water or enhance  sanitation in water- stressed areas VIEW ALL 2020 GOALSAchievedSUPPORTING ACCESS TO CLEAN WATER AND   COMMUNITY RESILIENCE Access to clean water is crucial for good health and well-being, proper  sanitation and hygiene, and disease prevention.
","('Water_And_Wastewater_Management', 0.9722727537155151)","('Ecological_Impacts', 0.0021925854962319136)","('Energy_Management', 0.002080797916278243)","(['Operational Eco-Efficiency'], 0.9722727537155151)","('NON-ESG', 0.0021925854962319136)","('NON-ESG', 0.002080797916278243)"
Line 994,"Unfortunately, this vital natural  resource is limited in many areas of the world, disproportionately affecting  communities with already constrained health infrastructure.
","('Ecological_Impacts', 0.29722172021865845)","('Supply_Chain_Management', 0.24116529524326324)","('Water_And_Wastewater_Management', 0.14318594336509705)","('NON-ESG', 0.29722172021865845)","('NON-ESG', 0.24116529524326324)","('NON-ESG', 0.14318594336509705)"
Line 995,"To improve  the health of people in underserved communities, Baxter and the Baxter  International Foundation invest in projects that support access to clean water  and enhance sanitation in water-stressed areas where we have facilities.
","('Water_And_Wastewater_Management', 0.7889465093612671)","('Access_And_Affordability', 0.05917259678244591)","('Energy_Management', 0.016920434311032295)","(['Operational Eco-Efficiency'], 0.7889465093612671)","('NON-ESG', 0.05917259678244591)","('NON-ESG', 0.016920434311032295)"
Line 996,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORT50Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction During 2020, we continued our work with Fundación  Solar, a nonprofit in Guatemala, to reduce natural  resource use, provide access to clean drinking water,  improve community health and empower women in  Aguacatán, Huehuetenango.
","('Water_And_Wastewater_Management', 0.4297443628311157)","('Employee_Health_And_Safety', 0.12452876567840576)","('Access_And_Affordability', 0.09216469526290894)","('NON-ESG', 0.4297443628311157)","('NON-ESG', 0.12452876567840576)","('NON-ESG', 0.09216469526290894)"
Line 997,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORT50Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction During 2020, we continued our work with Fundación  Solar, a nonprofit in Guatemala, to reduce natural  resource use, provide access to clean drinking water,  improve community health and empower women in  Aguacatán, Huehuetenango.
","('Employee_Engagement_Inclusion_And_Diversity', 0.34321272373199463)","('Human_Rights_And_Community_Relations', 0.13573233783245087)","('Labor_Practices', 0.08294114470481873)","('NON-ESG', 0.34321272373199463)","('NON-ESG', 0.13573233783245087)","('NON-ESG', 0.08294114470481873)"
Line 998,"Throughout the year,  Fundación Solar provided 257 families in the Aguacatán  community with water filters and wood-burning stoves  that are safer and more energy-efficient than the  traditional method of open-fire cooking.
","('Energy_Management', 0.9097515344619751)","('Product_Design_And_Lifecycle_Management', 0.012143086642026901)","('Water_And_Wastewater_Management', 0.009304826147854328)","(['Operational Eco-Efficiency'], 0.9097515344619751)","('NON-ESG', 0.012143086642026901)","('NON-ESG', 0.009304826147854328)"
Line 999,"A Universidad  del Valle de Guatemala study estimates that use of  these wood-burning stoves reduces CO2 emissions by  44% compared with open-fire cooking.
","('GHG_Emissions', 0.7528089284896851)","('Energy_Management', 0.08633268624544144)","('Air_Quality', 0.0662076473236084)","(['Climate Change'], 0.7528089284896851)","('NON-ESG', 0.08633268624544144)","('NON-ESG', 0.0662076473236084)"
Line 1000,"We have now  supported 507 families since distribution of these  stoves and water filters began, avoiding approximately  1,140 metric tons of CO2 emissions since the project's  initiation in 2018.
","('GHG_Emissions', 0.8887484073638916)","('Air_Quality', 0.031936585903167725)","('Water_And_Wastewater_Management', 0.01352884154766798)","(['Climate Change'], 0.8887484073638916)","('NON-ESG', 0.031936585903167725)","('NON-ESG', 0.01352884154766798)"
Line 1001,"In addition, the solar-powered  rainwater capture system established by Fundación  Solar at the Oficial Rural Mixta school in Llano del  Coyote collected and treated approximately 380 cubic  meters of water during the year, which was then  used throughout the facility for handwashing and  cleaning.
","('Water_And_Wastewater_Management', 0.9734695553779602)","('Waste_And_Hazardous_Materials_Management', 0.0031498477328568697)","('Energy_Management', 0.0021453595254570246)","(['Operational Eco-Efficiency'], 0.9734695553779602)","('NON-ESG', 0.0031498477328568697)","('NON-ESG', 0.0021453595254570246)"
Line 1002,"As part of this initiative, 7,500 trees1 have  been planted to promote sustainable reforestation.
","('Ecological_Impacts', 0.9288206100463867)","('Human_Rights_And_Community_Relations', 0.008539197966456413)","('GHG_Emissions', 0.007327998522669077)","(['Natural Capital'], 0.9288206100463867)","('NON-ESG', 0.008539197966456413)","('NON-ESG', 0.007327998522669077)"
Line 1003,"Other partners engaged in this initiative include the Guatemalan Ministry of the Environment, Universidad  del Valle de Guatemala and the United Nations.
","('Ecological_Impacts', 0.9129066467285156)","('GHG_Emissions', 0.023266250267624855)","('Management_Of_Legal_And_Regulatory_Framework', 0.012838411144912243)","(['Natural Capital'], 0.9129066467285156)","('NON-ESG', 0.023266250267624855)","('NON-ESG', 0.012838411144912243)"
Line 1004,"We also continued our work on Project Srujal, a  program that will provide clean water to 11 villages  near Baxter’s manufacturing site in Ahmedabad,  India—home to 1,500 of our employees.
","('Water_And_Wastewater_Management', 0.9323440194129944)","('Energy_Management', 0.010342738591134548)","('Human_Rights_And_Community_Relations', 0.004860800225287676)","(['Operational Eco-Efficiency'], 0.9323440194129944)","('NON-ESG', 0.010342738591134548)","('NON-ESG', 0.004860800225287676)"
Line 1005,"This  multimillion-dollar initiative aims to benefit  25,000 community members by the end of 2021  through establishing water-related infrastructure,  strengthening the villages’ ability to sustainably  manage water resources, educating local  communities about water safety and security,  and building capacity to manage resources.
","('Water_And_Wastewater_Management', 0.9711598753929138)","('Energy_Management', 0.002841559937223792)","('GHG_Emissions', 0.00232351734302938)","(['Operational Eco-Efficiency'], 0.9711598753929138)","('NON-ESG', 0.002841559937223792)","('NON-ESG', 0.00232351734302938)"
Line 1006,"While  we experienced some project delays in 2020 due  to the COVID-19 pandemic, as of the end of the  year, Project Srujal had completed multiple water  infrastructure projects, including construction of  water tanks, bore wells, water meters, pipeline  networks, rooftop rainwater harvesting structures  and a cattle trough.
","('Water_And_Wastewater_Management', 0.9746243953704834)","('GHG_Emissions', 0.002462412230670452)","('Energy_Management', 0.002401019213721156)","(['Operational Eco-Efficiency'], 0.9746243953704834)","('NON-ESG', 0.002462412230670452)","('NON-ESG', 0.002401019213721156)"
Line 1007,"Additionally, in 2020, the Foundation established a   Signature Partnership  with UNICEF USA  to increase access   to clean water, sanitation and hygiene in Colombia.
","('Water_And_Wastewater_Management', 0.9400837421417236)","('Energy_Management', 0.0062058959156274796)","('Critical_Incident_Risk_Management', 0.0043872445821762085)","(['Operational Eco-Efficiency'], 0.9400837421417236)","('NON-ESG', 0.0062058959156274796)","('NON-ESG', 0.0043872445821762085)"
Line 1008,"FOSTERING TOMORROW’S  INNOVATION THROUGH STEM As a business, Baxter is committed to growth through   innovation.
","('Product_Design_And_Lifecycle_Management', 0.47781041264533997)","('Business_Model_Resilience', 0.09914886951446533)","('Employee_Engagement_Inclusion_And_Diversity', 0.07434006035327911)","('NON-ESG', 0.47781041264533997)","('NON-ESG', 0.09914886951446533)","('NON-ESG', 0.07434006035327911)"
Line 1009,"Cultivating an innovative ecosystem  is ingrained in who we are and what we do as a  company—which is why we take a hands-on approach   to help develop the next generation of scientists,  engineers and healthcare professionals who will  lead the way in defining tomorrow’s healthcare  breakthroughs.
","('Business_Model_Resilience', 0.2785649001598358)","('Employee_Engagement_Inclusion_And_Diversity', 0.21372054517269135)","('Product_Design_And_Lifecycle_Management', 0.0741283968091011)","('NON-ESG', 0.2785649001598358)","('NON-ESG', 0.21372054517269135)","('NON-ESG', 0.0741283968091011)"
Line 1010,"To achieve this, we develop  partnerships that support diverse STEM learning  opportunities and encourage employees to serve as  mentors in communities worldwide.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8194526433944702)","('Access_And_Affordability', 0.05672479420900345)","('Customer_Welfare', 0.012199833057820797)","(['Human Capital Development'], 0.8194526433944702)","('NON-ESG', 0.05672479420900345)","('NON-ESG', 0.012199833057820797)"
Line 1011,"The Baxter Center for Science Education  is a  partnership between the Baxter International  Foundation, Northwestern University, Lindblom Math  & Science Academy and Round Lake High School.
","('Access_And_Affordability', 0.6380589008331299)","('Employee_Engagement_Inclusion_And_Diversity', 0.08796688169240952)","('Ecological_Impacts', 0.03438885882496834)","(['Health Outcome Contribution'], 0.6380589008331299)","('NON-ESG', 0.08796688169240952)","('NON-ESG', 0.03438885882496834)"
Line 1012,"During 2020, the Baxter Center quickly transitioned  to a virtual environment in response to COVID-19  to continue supporting educators and students and  ensure STEM education could happen at home.
","('Access_And_Affordability', 0.6563849449157715)","('Employee_Engagement_Inclusion_And_Diversity', 0.11538723856210709)","('Customer_Welfare', 0.018644925206899643)","(['Health Outcome Contribution'], 0.6563849449157715)","('NON-ESG', 0.11538723856210709)","('NON-ESG', 0.018644925206899643)"
Line 1013,"The  Baxter Center’s ongoing virtual offerings include live  and on-demand workshops, meetups for teachers  to collaborate on planning, opportunities to hear  from and ask questions of scientists and educational  researchers, and remote curriculum support.
","('Access_And_Affordability', 0.6701073050498962)","('Employee_Engagement_Inclusion_And_Diversity', 0.05175667628645897)","('Product_Quality_And_Safety', 0.02519753761589527)","(['Health Outcome Contribution'], 0.6701073050498962)","('NON-ESG', 0.05175667628645897)","('NON-ESG', 0.02519753761589527)"
Line 1014,"For  example, through the Baxter Box@Home Program,  teachers receive a demo lab kit and participate in  virtual training and planning sessions with other  educators to explore creative ways of bringing  engaging science experiences to virtual, hybrid or  in-person classrooms.
","('Access_And_Affordability', 0.6188694834709167)","('Employee_Engagement_Inclusion_And_Diversity', 0.05969942361116409)","('Product_Quality_And_Safety', 0.03721025958657265)","(['Health Outcome Contribution'], 0.6188694834709167)","('NON-ESG', 0.05969942361116409)","('NON-ESG', 0.03721025958657265)"
Line 1015,"Through this partnership we  have reached 164,000 students since 2009.2    Learn more about our 10+ year partnership .
","('Access_And_Affordability', 0.6723484396934509)","('Employee_Engagement_Inclusion_And_Diversity', 0.11124547570943832)","('Human_Rights_And_Community_Relations', 0.020180711522698402)","(['Health Outcome Contribution'], 0.6723484396934509)","('NON-ESG', 0.11124547570943832)","('NON-ESG', 0.020180711522698402)"
Line 1016,"Photo left:  Fundación Solar provides efficient, wood-burning stoves to families in Guatemala.
","('Energy_Management', 0.91936194896698)","('Product_Design_And_Lifecycle_Management', 0.009740052744746208)","('Access_And_Affordability', 0.007966591976583004)","(['Operational Eco-Efficiency'], 0.91936194896698)","('NON-ESG', 0.009740052744746208)","('NON-ESG', 0.007966591976583004)"
Line 1017,"Photo right: Eighty individual rooftop rainwater harvesting structures have been   constructed through Project Srujal, providing households with direct access to clean drinking water.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT51Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction The Baxter International Foundation also supports  the Illinois Science and Technology Institute’s (ISTI)  annual STEM Challenge.
","('Water_And_Wastewater_Management', 0.9679492115974426)","('Energy_Management', 0.003213518299162388)","('GHG_Emissions', 0.003018970601260662)","(['Operational Eco-Efficiency'], 0.9679492115974426)","('NON-ESG', 0.003213518299162388)","('NON-ESG', 0.003018970601260662)"
Line 1018,"Photo right: Eighty individual rooftop rainwater harvesting structures have been   constructed through Project Srujal, providing households with direct access to clean drinking water.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT51Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction The Baxter International Foundation also supports  the Illinois Science and Technology Institute’s (ISTI)  annual STEM Challenge.
","('Access_And_Affordability', 0.22373050451278687)","('Management_Of_Legal_And_Regulatory_Framework', 0.2022390216588974)","('Ecological_Impacts', 0.0858231857419014)","('NON-ESG', 0.22373050451278687)","('NON-ESG', 0.2022390216588974)","('NON-ESG', 0.0858231857419014)"
Line 1019,"Through this initiative,  Baxter employees act as mentors for high school  students participating in the six-month program to  develop innovative solutions for real-world business  challenges in STEM fields.
","('Employee_Engagement_Inclusion_And_Diversity', 0.20079371333122253)","('Access_And_Affordability', 0.1603040248155594)","('Business_Model_Resilience', 0.12881556153297424)","('NON-ESG', 0.20079371333122253)","('NON-ESG', 0.1603040248155594)","('NON-ESG', 0.12881556153297424)"
Line 1020,"During 2020, students were  able to continue engaging with mentors through the  ISTI virtual Mentor Match Engine.
","('Access_And_Affordability', 0.656670331954956)","('Employee_Engagement_Inclusion_And_Diversity', 0.08102326095104218)","('Management_Of_Legal_And_Regulatory_Framework', 0.030884603038430214)","(['Health Outcome Contribution'], 0.656670331954956)","('NON-ESG', 0.08102326095104218)","('NON-ESG', 0.030884603038430214)"
Line 1021,"Additionally, ISTI  conducted dedicated training for mentors focused on  diversity, equity and inclusion as well as implicit bias  and trauma-informed mentorship.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9737581610679626)","('Access_And_Affordability', 0.002069031586870551)","('Employee_Health_And_Safety', 0.0019994897302240133)","(['Human Capital Development'], 0.9737581610679626)","('NON-ESG', 0.002069031586870551)","('NON-ESG', 0.0019994897302240133)"
Line 1022,"For more than 20 years, Baxter and the Baxter  International Foundation have supported FIRST (For  Inspiration and Recognition of Science and Technology)   Robotics’ STEM mission, to inspire young people to  be science and technology leaders and innovators.
","('Employee_Engagement_Inclusion_And_Diversity', 0.241592675447464)","('Business_Model_Resilience', 0.16848772764205933)","('Product_Design_And_Lifecycle_Management', 0.15092800557613373)","('NON-ESG', 0.241592675447464)","('NON-ESG', 0.16848772764205933)","('NON-ESG', 0.15092800557613373)"
Line 1023,"Through a progression of team-based robotics  challenges and backed by a global network of mentors,  coaches, volunteers, alumni and sponsors, FIRST  Robotics helps young people discover a passion for  STEM and develop the skills they'll need to succeed in  today's competitive workforce.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6764987111091614)","('Access_And_Affordability', 0.07181958854198456)","('Employee_Health_And_Safety', 0.03625159338116646)","(['Human Capital Development'], 0.6764987111091614)","('NON-ESG', 0.07181958854198456)","('NON-ESG', 0.03625159338116646)"
Line 1024,"As a founding member,  we’ve provided more than $3 million in funding for local  teams and regional competitions since 1998.
","('Management_Of_Legal_And_Regulatory_Framework', 0.38601064682006836)","('Employee_Engagement_Inclusion_And_Diversity', 0.1002497524023056)","('Competitive_Behavior', 0.07679316401481628)","('NON-ESG', 0.38601064682006836)","('NON-ESG', 0.1002497524023056)","('NON-ESG', 0.07679316401481628)"
Line 1025,"In 2020,  Baxter supported teams in Arkansas, Colorado, Illinois,  Indiana, New York and Wisconsin.#BAXTERGIVESBACK: EMPLOYEE  VOLUNTEERISM AND GIVING Each year, our employees donate thousands of dollars  and hours to help make a meaningful difference  in communities globally.
","('Human_Rights_And_Community_Relations', 0.2740606963634491)","('Employee_Health_And_Safety', 0.20966991782188416)","('Employee_Engagement_Inclusion_And_Diversity', 0.14355947077274323)","('NON-ESG', 0.2740606963634491)","('NON-ESG', 0.20966991782188416)","('NON-ESG', 0.14355947077274323)"
Line 1026,"The Baxter International  Foundation supports and amplifies the giving and  volunteer efforts of our employees through our  Matching Gift and Dollars for Doers Programs.
","('Access_And_Affordability', 0.1853344589471817)","('Management_Of_Legal_And_Regulatory_Framework', 0.13215330243110657)","('Human_Rights_And_Community_Relations', 0.11673610657453537)","('NON-ESG', 0.1853344589471817)","('NON-ESG', 0.13215330243110657)","('NON-ESG', 0.11673610657453537)"
Line 1027,"The Baxter International Foundation Matching Gift  Program matches employee donations,3 up to $5,000  per year per employee.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7138409614562988)","('Labor_Practices', 0.028473133221268654)","('Director_Removal', 0.027169790118932724)","(['Corporate Governance'], 0.7138409614562988)","('NON-ESG', 0.028473133221268654)","('NON-ESG', 0.027169790118932724)"
Line 1028,"During 2020, we increased  our support for two key areas by offering a 2:1  match for employee gifts to select organizations  providing COVID-19 relief efforts around the world and   advancing racial justice in the United States.
","('Human_Rights_And_Community_Relations', 0.3562573790550232)","('Access_And_Affordability', 0.1783011108636856)","('Employee_Health_And_Safety', 0.16037718951702118)","('NON-ESG', 0.3562573790550232)","('NON-ESG', 0.1783011108636856)","('NON-ESG', 0.16037718951702118)"
Line 1029,"In 2020,  the Foundation provided nearly $780,000 to match  employee giving.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4449297785758972)","('Access_And_Affordability', 0.12106528878211975)","('Human_Rights_And_Community_Relations', 0.05828452110290527)","('NON-ESG', 0.4449297785758972)","('NON-ESG', 0.12106528878211975)","('NON-ESG', 0.05828452110290527)"
Line 1030,"Employees are also eligible for the Foundation’s  Dollars for Doers Program, translating their time  into volunteer grants for eligible organizations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.21064066886901855)","('Access_And_Affordability', 0.20942802727222443)","('Labor_Practices', 0.11922478675842285)","('NON-ESG', 0.21064066886901855)","('NON-ESG', 0.20942802727222443)","('NON-ESG', 0.11922478675842285)"
Line 1031,"In  2020, 142 Dollars for Doers grants provided more  than $52,500 to community organizations.
","('Human_Rights_And_Community_Relations', 0.42647308111190796)","('Access_And_Affordability', 0.28929412364959717)","('Management_Of_Legal_And_Regulatory_Framework', 0.1123397946357727)","('NON-ESG', 0.42647308111190796)","('NON-ESG', 0.28929412364959717)","('NON-ESG', 0.1123397946357727)"
Line 1032,"Despite  the impact of COVID-19, by the end of the year,  employees had volunteered 16,875 hours in 17  countries worldwide.To further encourage local community engagement,  the Baxter International Foundation provides each  of our eight business resource groups with a grant  to extend to a nonprofit that supports diversity and  inclusion initiatives.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9685251116752625)","('Human_Rights_And_Community_Relations', 0.004167839419096708)","('Employee_Health_And_Safety', 0.0027973451651632786)","(['Human Capital Development'], 0.9685251116752625)","('NON-ESG', 0.004167839419096708)","('NON-ESG', 0.0027973451651632786)"
Line 1033,"Organizations selected in 2020  focus on a range of priorities, including healthcare,  girls in STEM, disability inclusion, women’s career  empowerment and LGBTQ+ initiatives.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9576807022094727)","('Human_Rights_And_Community_Relations', 0.004946961533278227)","('Access_And_Affordability', 0.004732271656394005)","(['Human Capital Development'], 0.9576807022094727)","('NON-ESG', 0.004946961533278227)","('NON-ESG', 0.004732271656394005)"
Line 1034,"Since 2009, we have encouraged our facilities to host  activities for Baxter World Environment Week, an  annual global event that corresponds to the United  Nations World Environment Day in June.
","('Ecological_Impacts', 0.8094871044158936)","('Human_Rights_And_Community_Relations', 0.041646894067525864)","('GHG_Emissions', 0.039240237325429916)","(['Natural Capital'], 0.8094871044158936)","('NON-ESG', 0.041646894067525864)","('NON-ESG', 0.039240237325429916)"
Line 1035,"These events  include activities such as refuse cleanups, habitat  restoration and educational visits to local nature  preserves with employees and their families.
","('Ecological_Impacts', 0.9771013855934143)","('GHG_Emissions', 0.0028076074086129665)","('Water_And_Wastewater_Management', 0.0018417261308059096)","(['Natural Capital'], 0.9771013855934143)","('NON-ESG', 0.0028076074086129665)","('NON-ESG', 0.0018417261308059096)"
Line 1036,"In 2020,  we did not sponsor any events due to COVID-19.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5927777290344238)","('Competitive_Behavior', 0.06740061938762665)","('Business_Model_Resilience', 0.06398940086364746)","(['Corporate Governance'], 0.5927777290344238)","('NON-ESG', 0.06740061938762665)","('NON-ESG', 0.06398940086364746)"
Line 1037,"We  look forward to celebrating Baxter World Environment  Week again in the future.
","('Ecological_Impacts', 0.4034385085105896)","('Human_Rights_And_Community_Relations', 0.17454512417316437)","('Physical_Impacts_Of_Climate_Change', 0.11863434314727783)","('NON-ESG', 0.4034385085105896)","('NON-ESG', 0.17454512417316437)","('NON-ESG', 0.11863434314727783)"
Line 1038,"“          I loved being able to ask questions that prompted our group to  think about the project in a different way—how an engineer would.
","('Business_Model_Resilience', 0.20068466663360596)","('Product_Design_And_Lifecycle_Management', 0.15608680248260498)","('Employee_Engagement_Inclusion_And_Diversity', 0.09757280349731445)","('NON-ESG', 0.20068466663360596)","('NON-ESG', 0.15608680248260498)","('NON-ESG', 0.09757280349731445)"
Line 1039,"I could see the wheels turning in their minds as we encouraged them  to see the challenge from a different perspective.
","('Business_Model_Resilience', 0.2486073076725006)","('Human_Rights_And_Community_Relations', 0.16847282648086548)","('Competitive_Behavior', 0.06792708486318588)","('NON-ESG', 0.2486073076725006)","('NON-ESG', 0.16847282648086548)","('NON-ESG', 0.06792708486318588)"
Line 1040,"I hope I helped  them learn more about the engineering process, and how engineers   approach problems or situations in a unique way.” SARAH,  BAXTER MANAGER OF ENGINEERING AND STEM MENTOR BAXTER 2020 CORPORATE RESPONSIBILITY REPORT52Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction SUMMARY OF 2020 GIVING During 2020, Baxter and the Baxter International Foundation donated cash and products valued at more than  $38 million to organizations working to increase access to healthcare, foster innovation in STEM education  and promote community resilience around the world.
","('Business_Model_Resilience', 0.12584485113620758)","('Product_Design_And_Lifecycle_Management', 0.1200554147362709)","('Business_Ethics', 0.11683432757854462)","('NON-ESG', 0.12584485113620758)","('NON-ESG', 0.1200554147362709)","('NON-ESG', 0.11683432757854462)"
Line 1041,"I hope I helped  them learn more about the engineering process, and how engineers   approach problems or situations in a unique way.” SARAH,  BAXTER MANAGER OF ENGINEERING AND STEM MENTOR BAXTER 2020 CORPORATE RESPONSIBILITY REPORT52Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction SUMMARY OF 2020 GIVING During 2020, Baxter and the Baxter International Foundation donated cash and products valued at more than  $38 million to organizations working to increase access to healthcare, foster innovation in STEM education  and promote community resilience around the world.
","('Access_And_Affordability', 0.3076230585575104)","('Business_Model_Resilience', 0.17042824625968933)","('Employee_Engagement_Inclusion_And_Diversity', 0.13730746507644653)","('NON-ESG', 0.3076230585575104)","('NON-ESG', 0.17042824625968933)","('NON-ESG', 0.13730746507644653)"
Line 1042,"BAXTER GLOBAL GIVING, 2020BAXTER AND THE BAXTER INTERNATIONAL FOUNDATION  CHARITABLE GIVING (DOLLARS IN MILLIONS )  2018      2019 Baxter Product Donations to Aid Organizations*   Products/Patient Assistance Programs $5.60 $16.81 $24.Business and Facility Cash Donations Within the United States  $1.55 $1.21 $2.Outside the United States  $3.81 $3.56 $3.Total  $5.36 $4.77 $5.The Baxter International Foundation Contributions Within the United States (including Puerto Rico)   Grants**  $4.64 $4.77 $6.Matching Gifts and Dollars for Doers $0.83 $0.81 $0.83  Scholarships  $0.20 $0.15 $0.Prize Programs  $0.41 $0.33 $0.Subtotal  $6.08  $6.06 $7.Outside the United States   Grants  $0.43 $0.66 $0.Scholarships  $0.15  $0.11 $0.Subtotal  $0.58  $0.77 $0.Total Foundation Contributions  $6.66 $6.83 $8.Total Charitable Giving  $17.62 $28.41 $38.*Variations in Baxter's annual product donations are due to fluctuations in  community needs, the need and volume of disaster relief response, the regulatory  environment, manufacturing processes and changes in product mix and marketing.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7718480825424194)","('Access_And_Affordability', 0.05438576266169548)","('Human_Rights_And_Community_Relations', 0.018877128139138222)","(['Corporate Governance'], 0.7718480825424194)","('NON-ESG', 0.05438576266169548)","('NON-ESG', 0.018877128139138222)"
Line 1043,"BAXTER GLOBAL GIVING, 2020BAXTER AND THE BAXTER INTERNATIONAL FOUNDATION  CHARITABLE GIVING (DOLLARS IN MILLIONS )  2018      2019 Baxter Product Donations to Aid Organizations*   Products/Patient Assistance Programs $5.60 $16.81 $24.Business and Facility Cash Donations Within the United States  $1.55 $1.21 $2.Outside the United States  $3.81 $3.56 $3.Total  $5.36 $4.77 $5.The Baxter International Foundation Contributions Within the United States (including Puerto Rico)   Grants**  $4.64 $4.77 $6.Matching Gifts and Dollars for Doers $0.83 $0.81 $0.83  Scholarships  $0.20 $0.15 $0.Prize Programs  $0.41 $0.33 $0.Subtotal  $6.08  $6.06 $7.Outside the United States   Grants  $0.43 $0.66 $0.Scholarships  $0.15  $0.11 $0.Subtotal  $0.58  $0.77 $0.Total Foundation Contributions  $6.66 $6.83 $8.Total Charitable Giving  $17.62 $28.41 $38.*Variations in Baxter's annual product donations are due to fluctuations in  community needs, the need and volume of disaster relief response, the regulatory  environment, manufacturing processes and changes in product mix and marketing.
","('Critical_Incident_Risk_Management', 0.7349064350128174)","('Human_Rights_And_Community_Relations', 0.056007564067840576)","('Access_And_Affordability', 0.03954700753092766)","(['Risk & Crisis Management'], 0.7349064350128174)","('NON-ESG', 0.056007564067840576)","('NON-ESG', 0.03954700753092766)"
Line 1044,"BAXTER GLOBAL GIVING, 2020BAXTER AND THE BAXTER INTERNATIONAL FOUNDATION  CHARITABLE GIVING (DOLLARS IN MILLIONS )  2018      2019 Baxter Product Donations to Aid Organizations*   Products/Patient Assistance Programs $5.60 $16.81 $24.Business and Facility Cash Donations Within the United States  $1.55 $1.21 $2.Outside the United States  $3.81 $3.56 $3.Total  $5.36 $4.77 $5.The Baxter International Foundation Contributions Within the United States (including Puerto Rico)   Grants**  $4.64 $4.77 $6.Matching Gifts and Dollars for Doers $0.83 $0.81 $0.83  Scholarships  $0.20 $0.15 $0.Prize Programs  $0.41 $0.33 $0.Subtotal  $6.08  $6.06 $7.Outside the United States   Grants  $0.43 $0.66 $0.Scholarships  $0.15  $0.11 $0.Subtotal  $0.58  $0.77 $0.Total Foundation Contributions  $6.66 $6.83 $8.Total Charitable Giving  $17.62 $28.41 $38.*Variations in Baxter's annual product donations are due to fluctuations in  community needs, the need and volume of disaster relief response, the regulatory  environment, manufacturing processes and changes in product mix and marketing.
","('Product_Design_And_Lifecycle_Management', 0.8542693257331848)","('Selling_Practices_And_Product_Labeling', 0.05317600443959236)","('Customer_Welfare', 0.01809346303343773)","(['Product Stewardship'], 0.8542693257331848)","('NON-ESG', 0.05317600443959236)","('NON-ESG', 0.01809346303343773)"
Line 1045,"We identify opportunities to donate and respond to community and humanitarian  aid partners as appropriate.
","('Human_Rights_And_Community_Relations', 0.39101576805114746)","('Critical_Incident_Risk_Management', 0.3053238093852997)","('Access_And_Affordability', 0.07941839843988419)","('NON-ESG', 0.39101576805114746)","('NON-ESG', 0.3053238093852997)","('NON-ESG', 0.07941839843988419)"
Line 1046,"Value of products donated (provided at no cost) is  provided by partners based on wholesale acquisition cost at the time of donation.
","('Product_Design_And_Lifecycle_Management', 0.9040402770042419)","('Selling_Practices_And_Product_Labeling', 0.01703040301799774)","('Energy_Management', 0.011351626366376877)","(['Product Stewardship'], 0.9040402770042419)","('NON-ESG', 0.01703040301799774)","('NON-ESG', 0.011351626366376877)"
Line 1047,"This number may be greater or less than the value of Baxter products distributed  during the year by our relief partners.
","('Product_Design_And_Lifecycle_Management', 0.8909574747085571)","('Selling_Practices_And_Product_Labeling', 0.028602631762623787)","('Product_Quality_And_Safety', 0.017488844692707062)","(['Product Stewardship'], 0.8909574747085571)","('NON-ESG', 0.028602631762623787)","('NON-ESG', 0.017488844692707062)"
Line 1048,"See Innovation That Expands Access to Care.
","('Access_And_Affordability', 0.714725911617279)","('Customer_Welfare', 0.036916494369506836)","('Energy_Management', 0.03030308708548546)","(['Health Outcome Contribution'], 0.714725911617279)","('NON-ESG', 0.036916494369506836)","('NON-ESG', 0.03030308708548546)"
Line 1049,"Contributions to U.S.-based 501(c)(3) organizations for programs within and  outside of the United States.*** Reflects programmatic location of Baxter International Foundation grants and scholarships and business and facility cash donations  mapped by location of Baxter office outside the United States.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8123412728309631)","('Access_And_Affordability', 0.02997707389295101)","('Ecological_Impacts', 0.018894264474511147)","(['Corporate Governance'], 0.8123412728309631)","('NON-ESG', 0.02997707389295101)","('NON-ESG', 0.018894264474511147)"
Line 1050,"#BAXTERGIVESBACK THROUGH EMPLOYEE VOLUNTEERISM AND GIVING, * Total volunteer hours include personal time and Baxter paid time.
","('Employee_Health_And_Safety', 0.22834758460521698)","('Labor_Practices', 0.1948491632938385)","('Employee_Engagement_Inclusion_And_Diversity', 0.14163367450237274)","('NON-ESG', 0.22834758460521698)","('NON-ESG', 0.1948491632938385)","('NON-ESG', 0.14163367450237274)"
Line 1051,"Baxter offers U.S. employees two days of paid time off per year to volunteer.Baxter Product Distributed Cash Contributions* Both101 countries  reached through: employees  participated 1,contributed by the Foundation  for Matching Gifts and  Dollars for Doers Programs$832 ,employee  volunteer hours*16 ,countries  reached organizations  received gifts of time  and/or money826BAXTER 2020 CORPORATE RESPONSIBILITY REPORT53Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction EXTERNAL REPORTING STANDARDS To develop our corporate responsibility reporting approach ,  we have considered the disclosure frameworks and  guidance of leading sustainability standards and reporting  organizations, including the Global Reporting Initiative  (GRI), the Sustainability Accounting Standards Board  (SASB), the United Nations Sustainable Development  Goals (UN SDGs) and third-party raters and rankers  focused on environmental, social and governance issues.
","('Employee_Health_And_Safety', 0.27984777092933655)","('Employee_Engagement_Inclusion_And_Diversity', 0.13337846100330353)","('Access_And_Affordability', 0.09505782276391983)","('NON-ESG', 0.27984777092933655)","('NON-ESG', 0.13337846100330353)","('NON-ESG', 0.09505782276391983)"
Line 1052,"Baxter offers U.S. employees two days of paid time off per year to volunteer.Baxter Product Distributed Cash Contributions* Both101 countries  reached through: employees  participated 1,contributed by the Foundation  for Matching Gifts and  Dollars for Doers Programs$832 ,employee  volunteer hours*16 ,countries  reached organizations  received gifts of time  and/or money826BAXTER 2020 CORPORATE RESPONSIBILITY REPORT53Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction EXTERNAL REPORTING STANDARDS To develop our corporate responsibility reporting approach ,  we have considered the disclosure frameworks and  guidance of leading sustainability standards and reporting  organizations, including the Global Reporting Initiative  (GRI), the Sustainability Accounting Standards Board  (SASB), the United Nations Sustainable Development  Goals (UN SDGs) and third-party raters and rankers  focused on environmental, social and governance issues.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6395214200019836)","('Product_Quality_And_Safety', 0.08189327269792557)","('Systemic_Risk_Management', 0.043488260358572006)","(['Corporate Governance'], 0.6395214200019836)","('NON-ESG', 0.08189327269792557)","('NON-ESG', 0.043488260358572006)"
Line 1053,"Baxter offers U.S. employees two days of paid time off per year to volunteer.Baxter Product Distributed Cash Contributions* Both101 countries  reached through: employees  participated 1,contributed by the Foundation  for Matching Gifts and  Dollars for Doers Programs$832 ,employee  volunteer hours*16 ,countries  reached organizations  received gifts of time  and/or money826BAXTER 2020 CORPORATE RESPONSIBILITY REPORT53Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction EXTERNAL REPORTING STANDARDS To develop our corporate responsibility reporting approach ,  we have considered the disclosure frameworks and  guidance of leading sustainability standards and reporting  organizations, including the Global Reporting Initiative  (GRI), the Sustainability Accounting Standards Board  (SASB), the United Nations Sustainable Development  Goals (UN SDGs) and third-party raters and rankers  focused on environmental, social and governance issues.
","('Human_Rights_And_Community_Relations', 0.7645412683486938)","('Management_Of_Legal_And_Regulatory_Framework', 0.04738941788673401)","('Ecological_Impacts', 0.031126312911510468)","(['Community Relations'], 0.7645412683486938)","('NON-ESG', 0.04738941788673401)","('NON-ESG', 0.031126312911510468)"
Line 1054,"We were one of the first  companies to pilot the   GRI Sustainability  Reporting Guidelines, in 1999, and belong to the GRI  Community.
","('Management_Of_Legal_And_Regulatory_Framework', 0.18151986598968506)","('Business_Model_Resilience', 0.15211312472820282)","('Human_Rights_And_Community_Relations', 0.12122222781181335)","('NON-ESG', 0.18151986598968506)","('NON-ESG', 0.15211312472820282)","('NON-ESG', 0.12122222781181335)"
Line 1055,"We referenced the GRI 2016 Sustainability  Reporting Standards  in the development of this report.
","('Management_Of_Legal_And_Regulatory_Framework', 0.34802111983299255)","('Product_Quality_And_Safety', 0.20323753356933594)","('Business_Model_Resilience', 0.04558925703167915)","('NON-ESG', 0.34802111983299255)","('NON-ESG', 0.20323753356933594)","('NON-ESG', 0.04558925703167915)"
Line 1056,"See the GRI Index  for detail.
","('Systemic_Risk_Management', 0.25475361943244934)","('Management_Of_Legal_And_Regulatory_Framework', 0.15157081186771393)","('Human_Rights_And_Community_Relations', 0.12765172123908997)","('NON-ESG', 0.25475361943244934)","('NON-ESG', 0.15157081186771393)","('NON-ESG', 0.12765172123908997)"
Line 1057,"In addition, this report includes our SASB disclosure ,  based on the SASB Medical Equipment and Supplies  Sustainability Accounting Standard.
","('Supply_Chain_Management', 0.24924536049365997)","('Product_Design_And_Lifecycle_Management', 0.24098022282123566)","('Energy_Management', 0.08759744465351105)","('NON-ESG', 0.24924536049365997)","('NON-ESG', 0.24098022282123566)","('NON-ESG', 0.08759744465351105)"
Line 1058,"FEEDBACK Readers of this report can provide comments and  suggestions to us via email:   corporate_responsibility_report@baxter.com .
","('Management_Of_Legal_And_Regulatory_Framework', 0.5333787202835083)","('Human_Rights_And_Community_Relations', 0.15556156635284424)","('Business_Model_Resilience', 0.04058608040213585)","(['Corporate Governance'], 0.5333787202835083)","('NON-ESG', 0.15556156635284424)","('NON-ESG', 0.04058608040213585)"
Line 1059,"SCOPE OF THIS REPORT The performance and other data in this report are from  calendar year 2020 unless stated otherwise.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5692227482795715)","('Physical_Impacts_Of_Climate_Change', 0.06976328045129776)","('Systemic_Risk_Management', 0.06107686460018158)","(['Corporate Governance'], 0.5692227482795715)","('NON-ESG', 0.06976328045129776)","('NON-ESG', 0.06107686460018158)"
Line 1060,"Some  examples and program descriptions include information  from 2021.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7274600267410278)","('Access_And_Affordability', 0.03462150692939758)","('Product_Quality_And_Safety', 0.023579545319080353)","(['Corporate Governance'], 0.7274600267410278)","('NON-ESG', 0.03462150692939758)","('NON-ESG', 0.023579545319080353)"
Line 1061,"• This report covers Baxter’s global operations,  including subsidiaries, unless stated otherwise.
","('Business_Model_Resilience', 0.405117392539978)","('Director_Removal', 0.11583027243614197)","('Systemic_Risk_Management', 0.07341917604207993)","('NON-ESG', 0.405117392539978)","('NON-ESG', 0.11583027243614197)","('NON-ESG', 0.07341917604207993)"
Line 1062,"Environmental, health and safety data include joint  ventures where we have a controlling interest.
","('Employee_Health_And_Safety', 0.9556803107261658)","('Critical_Incident_Risk_Management', 0.00733174616470933)","('Product_Quality_And_Safety', 0.006372331641614437)","(['Operational Eco-Efficiency'], 0.9556803107261658)","('NON-ESG', 0.00733174616470933)","('NON-ESG', 0.006372331641614437)"
Line 1063,"• The performance data in this report do not include  parts of Baxter that became Baxalta on July 1, 2015,  unless stated otherwise.
","('Systemic_Risk_Management', 0.3381703794002533)","('Business_Model_Resilience', 0.1443844735622406)","('Management_Of_Legal_And_Regulatory_Framework', 0.10298258811235428)","('NON-ESG', 0.3381703794002533)","('NON-ESG', 0.1443844735622406)","('NON-ESG', 0.10298258811235428)"
Line 1064,"• All currency in this report is in U.S. dollars unless  stated otherwise.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6914989352226257)","('Systemic_Risk_Management', 0.06481266021728516)","('Data_Security', 0.027165744453668594)","(['Corporate Governance'], 0.6914989352226257)","('NON-ESG', 0.06481266021728516)","('NON-ESG', 0.027165744453668594)"
Line 1065,"• Significant restatements of data compared with prior  years are noted in the sections where they appear.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3566654324531555)","('Systemic_Risk_Management', 0.14860287308692932)","('Energy_Management', 0.06482265889644623)","('NON-ESG', 0.3566654324531555)","('NON-ESG', 0.14860287308692932)","('NON-ESG', 0.06482265889644623)"
Line 1066,"• All references to “new product launches” in this report  include new product launches and line extensions,  unless otherwise noted.
","('Product_Design_And_Lifecycle_Management', 0.9212962985038757)","('Customer_Welfare', 0.01391508523374796)","('Product_Quality_And_Safety', 0.009976932778954506)","(['Product Stewardship'], 0.9212962985038757)","('NON-ESG', 0.01391508523374796)","('NON-ESG', 0.009976932778954506)"
Line 1067,"• This report is intended for global use.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6511866450309753)","('Access_And_Affordability', 0.0681052878499031)","('Ecological_Impacts', 0.03315431997179985)","(['Corporate Governance'], 0.6511866450309753)","('NON-ESG', 0.0681052878499031)","('NON-ESG', 0.03315431997179985)"
Line 1068,"Please consult  the appropriate country-specific Baxter website for  information regarding activities in that country.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4557649791240692)","('Human_Rights_And_Community_Relations', 0.08561674505472183)","('Selling_Practices_And_Product_Labeling', 0.04376013204455376)","('NON-ESG', 0.4557649791240692)","('NON-ESG', 0.08561674505472183)","('NON-ESG', 0.04376013204455376)"
Line 1069,"• Some statements in this report about products or  procedures may differ from the licensed indications in   specific countries.
","('Selling_Practices_And_Product_Labeling', 0.7262714505195618)","('Customer_Welfare', 0.07635356485843658)","('Product_Design_And_Lifecycle_Management', 0.06607648730278015)","(['Marketing Practices'], 0.7262714505195618)","('NON-ESG', 0.07635356485843658)","('NON-ESG', 0.06607648730278015)"
Line 1070,"Therefore, always consult the country- specific summary of product characteristics, package  leaflets or instructions for use.
","('Product_Design_And_Lifecycle_Management', 0.588283360004425)","('Selling_Practices_And_Product_Labeling', 0.23127195239067078)","('Product_Quality_And_Safety', 0.058216288685798645)","(['Product Stewardship'], 0.588283360004425)","('NON-ESG', 0.23127195239067078)","('NON-ESG', 0.058216288685798645)"
Line 1071,"For more information,  please contact a local Baxter representative.
","('Management_Of_Legal_And_Regulatory_Framework', 0.297320157289505)","('Human_Rights_And_Community_Relations', 0.14029954373836517)","('Selling_Practices_And_Product_Labeling', 0.05204889550805092)","('NON-ESG', 0.297320157289505)","('NON-ESG', 0.14029954373836517)","('NON-ESG', 0.05204889550805092)"
Line 1072,"FORWARD-LOOKING STATEMENTS This report contains forward-looking statements  concerning Baxter, including with respect to compliance,  future performance, our 2030 Corporate Responsibility  Commitment and other plans and initiatives.
","('Management_Of_Legal_And_Regulatory_Framework', 0.31163087487220764)","('Business_Model_Resilience', 0.21386852860450745)","('Human_Rights_And_Community_Relations', 0.14543592929840088)","('NON-ESG', 0.31163087487220764)","('NON-ESG', 0.21386852860450745)","('NON-ESG', 0.14543592929840088)"
Line 1073,"These  statements are based on assumptions about many  important factors, including the following, which could  cause actual results to differ materially from those in  the forward-looking statements: demand for and market  acceptance of risks for new and existing products; product  development risks; product quality or patient safety  concerns; continuity, availability and pricing of acceptable  raw materials and component supply; inability to create  additional production capacity in a timely manner or the  occurrence of other manufacturing or supply difficulties  (including as a result of natural disasters, public health  crises and epidemics/pandemics, regulatory actions or  otherwise); the impact of global economic conditions  (including potential trade wars) and public health crises  and epidemics, such as the ongoing coronavirus (COVID- 19) pandemic, on us and our customers and suppliers,  including foreign governments in countries in which  we operate; breaches or failures of our information  technology systems or products, including by cyberattack,  unauthorized access or theft; the adequacy of our cash  flows from operations (which may be negatively impacted  by collectability concerns as a result of the ongoing  COVID-19 pandemic or otherwise) and other sources of APPENDIX:   About This Report liquidity to meet our ongoing cash obligations and fund  our investment program; loss of key employees or inability  to identify and recruit new employees; future actions of  regulatory bodies and other governmental authorities,  including FDA, the Department of Justice, the SEC, the New  York Attorney General and foreign regulatory agencies,  including the continued delay in lifting the warning letter  at our Ahmedabad facility or proceedings related to the  investigation related to foreign exchange gains and losses;  the outcome of pending or future litigation, including  the opioid litigation and litigation related to our internal  investigation of foreign exchange gains and losses; proposed  regulatory changes of the U.S. Department of Health and  Human Services in kidney health policy and reimbursement,  which may substantially change the U.S. end-stage renal  disease market and demand for our peritoneal dialysis  products, necessitating significant multiyear capital  expenditures, which are difficult to estimate in advance;  failures with respect to compliance programs; accurate  identification of and execution on business development and  R&D opportunities and realization of anticipated benefits  (including the acquisitions of Cheetah Medical; Seprafilm  Adhesion Barrier; specified outside the United States (OUS)  rights to Caelyx/Doxil; and full U.S. and specified OUS  rights to Transderm Scop); future actions of third parties,  including payers; U.S. healthcare reform and other global  austerity measures; pricing, reimbursement, taxation and  rebate policies of government agencies and private payers;  the impact of competitive products and pricing, including  generic competition, drug reimportation and disruptive  technologies; fluctuations in foreign exchange and interest  rates; the ability to enforce owned or in-licensed patents  or the prevention or restriction of the manufacture, sale or  use of products or technology affected by patents of third  parties; global trade and tax policies; any change in laws  concerning the taxation of income (including current or  future tax reform), including income earned outside the  United States and potential taxes associated with the Base  Erosion and Anti-Abuse Tax; actions taken by tax authorities  in connection with ongoing tax audits; and other risks  identified in Baxter’s most recent filings on Form 10-K and  Form 10-Q and other SEC filings, all of which are available  on Baxter’s website.
","('Product_Quality_And_Safety', 0.4676491320133209)","('Product_Design_And_Lifecycle_Management', 0.36897900700569153)","('Selling_Practices_And_Product_Labeling', 0.04653361812233925)","('NON-ESG', 0.4676491320133209)","('NON-ESG', 0.36897900700569153)","('NON-ESG', 0.04653361812233925)"
Line 1074,"These  statements are based on assumptions about many  important factors, including the following, which could  cause actual results to differ materially from those in  the forward-looking statements: demand for and market  acceptance of risks for new and existing products; product  development risks; product quality or patient safety  concerns; continuity, availability and pricing of acceptable  raw materials and component supply; inability to create  additional production capacity in a timely manner or the  occurrence of other manufacturing or supply difficulties  (including as a result of natural disasters, public health  crises and epidemics/pandemics, regulatory actions or  otherwise); the impact of global economic conditions  (including potential trade wars) and public health crises  and epidemics, such as the ongoing coronavirus (COVID- 19) pandemic, on us and our customers and suppliers,  including foreign governments in countries in which  we operate; breaches or failures of our information  technology systems or products, including by cyberattack,  unauthorized access or theft; the adequacy of our cash  flows from operations (which may be negatively impacted  by collectability concerns as a result of the ongoing  COVID-19 pandemic or otherwise) and other sources of APPENDIX:   About This Report liquidity to meet our ongoing cash obligations and fund  our investment program; loss of key employees or inability  to identify and recruit new employees; future actions of  regulatory bodies and other governmental authorities,  including FDA, the Department of Justice, the SEC, the New  York Attorney General and foreign regulatory agencies,  including the continued delay in lifting the warning letter  at our Ahmedabad facility or proceedings related to the  investigation related to foreign exchange gains and losses;  the outcome of pending or future litigation, including  the opioid litigation and litigation related to our internal  investigation of foreign exchange gains and losses; proposed  regulatory changes of the U.S. Department of Health and  Human Services in kidney health policy and reimbursement,  which may substantially change the U.S. end-stage renal  disease market and demand for our peritoneal dialysis  products, necessitating significant multiyear capital  expenditures, which are difficult to estimate in advance;  failures with respect to compliance programs; accurate  identification of and execution on business development and  R&D opportunities and realization of anticipated benefits  (including the acquisitions of Cheetah Medical; Seprafilm  Adhesion Barrier; specified outside the United States (OUS)  rights to Caelyx/Doxil; and full U.S. and specified OUS  rights to Transderm Scop); future actions of third parties,  including payers; U.S. healthcare reform and other global  austerity measures; pricing, reimbursement, taxation and  rebate policies of government agencies and private payers;  the impact of competitive products and pricing, including  generic competition, drug reimportation and disruptive  technologies; fluctuations in foreign exchange and interest  rates; the ability to enforce owned or in-licensed patents  or the prevention or restriction of the manufacture, sale or  use of products or technology affected by patents of third  parties; global trade and tax policies; any change in laws  concerning the taxation of income (including current or  future tax reform), including income earned outside the  United States and potential taxes associated with the Base  Erosion and Anti-Abuse Tax; actions taken by tax authorities  in connection with ongoing tax audits; and other risks  identified in Baxter’s most recent filings on Form 10-K and  Form 10-Q and other SEC filings, all of which are available  on Baxter’s website.
","('Supply_Chain_Management', 0.7642689943313599)","('Systemic_Risk_Management', 0.075596384704113)","('Physical_Impacts_Of_Climate_Change', 0.028624698519706726)","(['Supply Chain Management'], 0.7642689943313599)","('NON-ESG', 0.075596384704113)","('NON-ESG', 0.028624698519706726)"
Line 1075,"These  statements are based on assumptions about many  important factors, including the following, which could  cause actual results to differ materially from those in  the forward-looking statements: demand for and market  acceptance of risks for new and existing products; product  development risks; product quality or patient safety  concerns; continuity, availability and pricing of acceptable  raw materials and component supply; inability to create  additional production capacity in a timely manner or the  occurrence of other manufacturing or supply difficulties  (including as a result of natural disasters, public health  crises and epidemics/pandemics, regulatory actions or  otherwise); the impact of global economic conditions  (including potential trade wars) and public health crises  and epidemics, such as the ongoing coronavirus (COVID- 19) pandemic, on us and our customers and suppliers,  including foreign governments in countries in which  we operate; breaches or failures of our information  technology systems or products, including by cyberattack,  unauthorized access or theft; the adequacy of our cash  flows from operations (which may be negatively impacted  by collectability concerns as a result of the ongoing  COVID-19 pandemic or otherwise) and other sources of APPENDIX:   About This Report liquidity to meet our ongoing cash obligations and fund  our investment program; loss of key employees or inability  to identify and recruit new employees; future actions of  regulatory bodies and other governmental authorities,  including FDA, the Department of Justice, the SEC, the New  York Attorney General and foreign regulatory agencies,  including the continued delay in lifting the warning letter  at our Ahmedabad facility or proceedings related to the  investigation related to foreign exchange gains and losses;  the outcome of pending or future litigation, including  the opioid litigation and litigation related to our internal  investigation of foreign exchange gains and losses; proposed  regulatory changes of the U.S. Department of Health and  Human Services in kidney health policy and reimbursement,  which may substantially change the U.S. end-stage renal  disease market and demand for our peritoneal dialysis  products, necessitating significant multiyear capital  expenditures, which are difficult to estimate in advance;  failures with respect to compliance programs; accurate  identification of and execution on business development and  R&D opportunities and realization of anticipated benefits  (including the acquisitions of Cheetah Medical; Seprafilm  Adhesion Barrier; specified outside the United States (OUS)  rights to Caelyx/Doxil; and full U.S. and specified OUS  rights to Transderm Scop); future actions of third parties,  including payers; U.S. healthcare reform and other global  austerity measures; pricing, reimbursement, taxation and  rebate policies of government agencies and private payers;  the impact of competitive products and pricing, including  generic competition, drug reimportation and disruptive  technologies; fluctuations in foreign exchange and interest  rates; the ability to enforce owned or in-licensed patents  or the prevention or restriction of the manufacture, sale or  use of products or technology affected by patents of third  parties; global trade and tax policies; any change in laws  concerning the taxation of income (including current or  future tax reform), including income earned outside the  United States and potential taxes associated with the Base  Erosion and Anti-Abuse Tax; actions taken by tax authorities  in connection with ongoing tax audits; and other risks  identified in Baxter’s most recent filings on Form 10-K and  Form 10-Q and other SEC filings, all of which are available  on Baxter’s website.
","('Data_Security', 0.656622588634491)","('Business_Ethics', 0.2290269285440445)","('Systemic_Risk_Management', 0.023796800523996353)","(['Information Security/Cybersecurity & System Availability'], 0.656622588634491)","('NON-ESG', 0.2290269285440445)","('NON-ESG', 0.023796800523996353)"
Line 1076,"These  statements are based on assumptions about many  important factors, including the following, which could  cause actual results to differ materially from those in  the forward-looking statements: demand for and market  acceptance of risks for new and existing products; product  development risks; product quality or patient safety  concerns; continuity, availability and pricing of acceptable  raw materials and component supply; inability to create  additional production capacity in a timely manner or the  occurrence of other manufacturing or supply difficulties  (including as a result of natural disasters, public health  crises and epidemics/pandemics, regulatory actions or  otherwise); the impact of global economic conditions  (including potential trade wars) and public health crises  and epidemics, such as the ongoing coronavirus (COVID- 19) pandemic, on us and our customers and suppliers,  including foreign governments in countries in which  we operate; breaches or failures of our information  technology systems or products, including by cyberattack,  unauthorized access or theft; the adequacy of our cash  flows from operations (which may be negatively impacted  by collectability concerns as a result of the ongoing  COVID-19 pandemic or otherwise) and other sources of APPENDIX:   About This Report liquidity to meet our ongoing cash obligations and fund  our investment program; loss of key employees or inability  to identify and recruit new employees; future actions of  regulatory bodies and other governmental authorities,  including FDA, the Department of Justice, the SEC, the New  York Attorney General and foreign regulatory agencies,  including the continued delay in lifting the warning letter  at our Ahmedabad facility or proceedings related to the  investigation related to foreign exchange gains and losses;  the outcome of pending or future litigation, including  the opioid litigation and litigation related to our internal  investigation of foreign exchange gains and losses; proposed  regulatory changes of the U.S. Department of Health and  Human Services in kidney health policy and reimbursement,  which may substantially change the U.S. end-stage renal  disease market and demand for our peritoneal dialysis  products, necessitating significant multiyear capital  expenditures, which are difficult to estimate in advance;  failures with respect to compliance programs; accurate  identification of and execution on business development and  R&D opportunities and realization of anticipated benefits  (including the acquisitions of Cheetah Medical; Seprafilm  Adhesion Barrier; specified outside the United States (OUS)  rights to Caelyx/Doxil; and full U.S. and specified OUS  rights to Transderm Scop); future actions of third parties,  including payers; U.S. healthcare reform and other global  austerity measures; pricing, reimbursement, taxation and  rebate policies of government agencies and private payers;  the impact of competitive products and pricing, including  generic competition, drug reimportation and disruptive  technologies; fluctuations in foreign exchange and interest  rates; the ability to enforce owned or in-licensed patents  or the prevention or restriction of the manufacture, sale or  use of products or technology affected by patents of third  parties; global trade and tax policies; any change in laws  concerning the taxation of income (including current or  future tax reform), including income earned outside the  United States and potential taxes associated with the Base  Erosion and Anti-Abuse Tax; actions taken by tax authorities  in connection with ongoing tax audits; and other risks  identified in Baxter’s most recent filings on Form 10-K and  Form 10-Q and other SEC filings, all of which are available  on Baxter’s website.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9574141502380371)","('Business_Ethics', 0.008157527074217796)","('Competitive_Behavior', 0.004442165140062571)","(['Corporate Governance'], 0.9574141502380371)","('NON-ESG', 0.008157527074217796)","('NON-ESG', 0.004442165140062571)"
Line 1077,"These  statements are based on assumptions about many  important factors, including the following, which could  cause actual results to differ materially from those in  the forward-looking statements: demand for and market  acceptance of risks for new and existing products; product  development risks; product quality or patient safety  concerns; continuity, availability and pricing of acceptable  raw materials and component supply; inability to create  additional production capacity in a timely manner or the  occurrence of other manufacturing or supply difficulties  (including as a result of natural disasters, public health  crises and epidemics/pandemics, regulatory actions or  otherwise); the impact of global economic conditions  (including potential trade wars) and public health crises  and epidemics, such as the ongoing coronavirus (COVID- 19) pandemic, on us and our customers and suppliers,  including foreign governments in countries in which  we operate; breaches or failures of our information  technology systems or products, including by cyberattack,  unauthorized access or theft; the adequacy of our cash  flows from operations (which may be negatively impacted  by collectability concerns as a result of the ongoing  COVID-19 pandemic or otherwise) and other sources of APPENDIX:   About This Report liquidity to meet our ongoing cash obligations and fund  our investment program; loss of key employees or inability  to identify and recruit new employees; future actions of  regulatory bodies and other governmental authorities,  including FDA, the Department of Justice, the SEC, the New  York Attorney General and foreign regulatory agencies,  including the continued delay in lifting the warning letter  at our Ahmedabad facility or proceedings related to the  investigation related to foreign exchange gains and losses;  the outcome of pending or future litigation, including  the opioid litigation and litigation related to our internal  investigation of foreign exchange gains and losses; proposed  regulatory changes of the U.S. Department of Health and  Human Services in kidney health policy and reimbursement,  which may substantially change the U.S. end-stage renal  disease market and demand for our peritoneal dialysis  products, necessitating significant multiyear capital  expenditures, which are difficult to estimate in advance;  failures with respect to compliance programs; accurate  identification of and execution on business development and  R&D opportunities and realization of anticipated benefits  (including the acquisitions of Cheetah Medical; Seprafilm  Adhesion Barrier; specified outside the United States (OUS)  rights to Caelyx/Doxil; and full U.S. and specified OUS  rights to Transderm Scop); future actions of third parties,  including payers; U.S. healthcare reform and other global  austerity measures; pricing, reimbursement, taxation and  rebate policies of government agencies and private payers;  the impact of competitive products and pricing, including  generic competition, drug reimportation and disruptive  technologies; fluctuations in foreign exchange and interest  rates; the ability to enforce owned or in-licensed patents  or the prevention or restriction of the manufacture, sale or  use of products or technology affected by patents of third  parties; global trade and tax policies; any change in laws  concerning the taxation of income (including current or  future tax reform), including income earned outside the  United States and potential taxes associated with the Base  Erosion and Anti-Abuse Tax; actions taken by tax authorities  in connection with ongoing tax audits; and other risks  identified in Baxter’s most recent filings on Form 10-K and  Form 10-Q and other SEC filings, all of which are available  on Baxter’s website.
","('Management_Of_Legal_And_Regulatory_Framework', 0.22310318052768707)","('Product_Quality_And_Safety', 0.14735299348831177)","('Customer_Welfare', 0.08689854294061661)","('NON-ESG', 0.22310318052768707)","('NON-ESG', 0.14735299348831177)","('NON-ESG', 0.08689854294061661)"
Line 1078,"These  statements are based on assumptions about many  important factors, including the following, which could  cause actual results to differ materially from those in  the forward-looking statements: demand for and market  acceptance of risks for new and existing products; product  development risks; product quality or patient safety  concerns; continuity, availability and pricing of acceptable  raw materials and component supply; inability to create  additional production capacity in a timely manner or the  occurrence of other manufacturing or supply difficulties  (including as a result of natural disasters, public health  crises and epidemics/pandemics, regulatory actions or  otherwise); the impact of global economic conditions  (including potential trade wars) and public health crises  and epidemics, such as the ongoing coronavirus (COVID- 19) pandemic, on us and our customers and suppliers,  including foreign governments in countries in which  we operate; breaches or failures of our information  technology systems or products, including by cyberattack,  unauthorized access or theft; the adequacy of our cash  flows from operations (which may be negatively impacted  by collectability concerns as a result of the ongoing  COVID-19 pandemic or otherwise) and other sources of APPENDIX:   About This Report liquidity to meet our ongoing cash obligations and fund  our investment program; loss of key employees or inability  to identify and recruit new employees; future actions of  regulatory bodies and other governmental authorities,  including FDA, the Department of Justice, the SEC, the New  York Attorney General and foreign regulatory agencies,  including the continued delay in lifting the warning letter  at our Ahmedabad facility or proceedings related to the  investigation related to foreign exchange gains and losses;  the outcome of pending or future litigation, including  the opioid litigation and litigation related to our internal  investigation of foreign exchange gains and losses; proposed  regulatory changes of the U.S. Department of Health and  Human Services in kidney health policy and reimbursement,  which may substantially change the U.S. end-stage renal  disease market and demand for our peritoneal dialysis  products, necessitating significant multiyear capital  expenditures, which are difficult to estimate in advance;  failures with respect to compliance programs; accurate  identification of and execution on business development and  R&D opportunities and realization of anticipated benefits  (including the acquisitions of Cheetah Medical; Seprafilm  Adhesion Barrier; specified outside the United States (OUS)  rights to Caelyx/Doxil; and full U.S. and specified OUS  rights to Transderm Scop); future actions of third parties,  including payers; U.S. healthcare reform and other global  austerity measures; pricing, reimbursement, taxation and  rebate policies of government agencies and private payers;  the impact of competitive products and pricing, including  generic competition, drug reimportation and disruptive  technologies; fluctuations in foreign exchange and interest  rates; the ability to enforce owned or in-licensed patents  or the prevention or restriction of the manufacture, sale or  use of products or technology affected by patents of third  parties; global trade and tax policies; any change in laws  concerning the taxation of income (including current or  future tax reform), including income earned outside the  United States and potential taxes associated with the Base  Erosion and Anti-Abuse Tax; actions taken by tax authorities  in connection with ongoing tax audits; and other risks  identified in Baxter’s most recent filings on Form 10-K and  Form 10-Q and other SEC filings, all of which are available  on Baxter’s website.
","('Competitive_Behavior', 0.9539769887924194)","('Management_Of_Legal_And_Regulatory_Framework', 0.010804254561662674)","('Business_Ethics', 0.004562925081700087)","(['Business Ethics'], 0.9539769887924194)","('NON-ESG', 0.010804254561662674)","('NON-ESG', 0.004562925081700087)"
Line 1079,"These  statements are based on assumptions about many  important factors, including the following, which could  cause actual results to differ materially from those in  the forward-looking statements: demand for and market  acceptance of risks for new and existing products; product  development risks; product quality or patient safety  concerns; continuity, availability and pricing of acceptable  raw materials and component supply; inability to create  additional production capacity in a timely manner or the  occurrence of other manufacturing or supply difficulties  (including as a result of natural disasters, public health  crises and epidemics/pandemics, regulatory actions or  otherwise); the impact of global economic conditions  (including potential trade wars) and public health crises  and epidemics, such as the ongoing coronavirus (COVID- 19) pandemic, on us and our customers and suppliers,  including foreign governments in countries in which  we operate; breaches or failures of our information  technology systems or products, including by cyberattack,  unauthorized access or theft; the adequacy of our cash  flows from operations (which may be negatively impacted  by collectability concerns as a result of the ongoing  COVID-19 pandemic or otherwise) and other sources of APPENDIX:   About This Report liquidity to meet our ongoing cash obligations and fund  our investment program; loss of key employees or inability  to identify and recruit new employees; future actions of  regulatory bodies and other governmental authorities,  including FDA, the Department of Justice, the SEC, the New  York Attorney General and foreign regulatory agencies,  including the continued delay in lifting the warning letter  at our Ahmedabad facility or proceedings related to the  investigation related to foreign exchange gains and losses;  the outcome of pending or future litigation, including  the opioid litigation and litigation related to our internal  investigation of foreign exchange gains and losses; proposed  regulatory changes of the U.S. Department of Health and  Human Services in kidney health policy and reimbursement,  which may substantially change the U.S. end-stage renal  disease market and demand for our peritoneal dialysis  products, necessitating significant multiyear capital  expenditures, which are difficult to estimate in advance;  failures with respect to compliance programs; accurate  identification of and execution on business development and  R&D opportunities and realization of anticipated benefits  (including the acquisitions of Cheetah Medical; Seprafilm  Adhesion Barrier; specified outside the United States (OUS)  rights to Caelyx/Doxil; and full U.S. and specified OUS  rights to Transderm Scop); future actions of third parties,  including payers; U.S. healthcare reform and other global  austerity measures; pricing, reimbursement, taxation and  rebate policies of government agencies and private payers;  the impact of competitive products and pricing, including  generic competition, drug reimportation and disruptive  technologies; fluctuations in foreign exchange and interest  rates; the ability to enforce owned or in-licensed patents  or the prevention or restriction of the manufacture, sale or  use of products or technology affected by patents of third  parties; global trade and tax policies; any change in laws  concerning the taxation of income (including current or  future tax reform), including income earned outside the  United States and potential taxes associated with the Base  Erosion and Anti-Abuse Tax; actions taken by tax authorities  in connection with ongoing tax audits; and other risks  identified in Baxter’s most recent filings on Form 10-K and  Form 10-Q and other SEC filings, all of which are available  on Baxter’s website.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8919023871421814)","('Competitive_Behavior', 0.0288395918905735)","('Business_Ethics', 0.008151725865900517)","(['Corporate Governance'], 0.8919023871421814)","('NON-ESG', 0.0288395918905735)","('NON-ESG', 0.008151725865900517)"
Line 1080,"These  statements are based on assumptions about many  important factors, including the following, which could  cause actual results to differ materially from those in  the forward-looking statements: demand for and market  acceptance of risks for new and existing products; product  development risks; product quality or patient safety  concerns; continuity, availability and pricing of acceptable  raw materials and component supply; inability to create  additional production capacity in a timely manner or the  occurrence of other manufacturing or supply difficulties  (including as a result of natural disasters, public health  crises and epidemics/pandemics, regulatory actions or  otherwise); the impact of global economic conditions  (including potential trade wars) and public health crises  and epidemics, such as the ongoing coronavirus (COVID- 19) pandemic, on us and our customers and suppliers,  including foreign governments in countries in which  we operate; breaches or failures of our information  technology systems or products, including by cyberattack,  unauthorized access or theft; the adequacy of our cash  flows from operations (which may be negatively impacted  by collectability concerns as a result of the ongoing  COVID-19 pandemic or otherwise) and other sources of APPENDIX:   About This Report liquidity to meet our ongoing cash obligations and fund  our investment program; loss of key employees or inability  to identify and recruit new employees; future actions of  regulatory bodies and other governmental authorities,  including FDA, the Department of Justice, the SEC, the New  York Attorney General and foreign regulatory agencies,  including the continued delay in lifting the warning letter  at our Ahmedabad facility or proceedings related to the  investigation related to foreign exchange gains and losses;  the outcome of pending or future litigation, including  the opioid litigation and litigation related to our internal  investigation of foreign exchange gains and losses; proposed  regulatory changes of the U.S. Department of Health and  Human Services in kidney health policy and reimbursement,  which may substantially change the U.S. end-stage renal  disease market and demand for our peritoneal dialysis  products, necessitating significant multiyear capital  expenditures, which are difficult to estimate in advance;  failures with respect to compliance programs; accurate  identification of and execution on business development and  R&D opportunities and realization of anticipated benefits  (including the acquisitions of Cheetah Medical; Seprafilm  Adhesion Barrier; specified outside the United States (OUS)  rights to Caelyx/Doxil; and full U.S. and specified OUS  rights to Transderm Scop); future actions of third parties,  including payers; U.S. healthcare reform and other global  austerity measures; pricing, reimbursement, taxation and  rebate policies of government agencies and private payers;  the impact of competitive products and pricing, including  generic competition, drug reimportation and disruptive  technologies; fluctuations in foreign exchange and interest  rates; the ability to enforce owned or in-licensed patents  or the prevention or restriction of the manufacture, sale or  use of products or technology affected by patents of third  parties; global trade and tax policies; any change in laws  concerning the taxation of income (including current or  future tax reform), including income earned outside the  United States and potential taxes associated with the Base  Erosion and Anti-Abuse Tax; actions taken by tax authorities  in connection with ongoing tax audits; and other risks  identified in Baxter’s most recent filings on Form 10-K and  Form 10-Q and other SEC filings, all of which are available  on Baxter’s website.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9495485424995422)","('Systemic_Risk_Management', 0.007801671512424946)","('Business_Ethics', 0.005638989619910717)","(['Corporate Governance'], 0.9495485424995422)","('NON-ESG', 0.007801671512424946)","('NON-ESG', 0.005638989619910717)"
Line 1081,"Baxter does not undertake to update its  forward-looking statements unless otherwise required by  the federal securities laws.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT54Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Climate ChangeReducing energy consumption and expanding use of renewable energy in Baxter’s operations and reducing greenhouse   gas emissions across our value chain; incorporating climate change strategy, including adaptation and resilience planning,  into relevant business decisions.
","('Physical_Impacts_Of_Climate_Change', 0.8945618271827698)","('Business_Model_Resilience', 0.016027439385652542)","('Energy_Management', 0.014800759963691235)","(['Climate Change'], 0.8945618271827698)","('NON-ESG', 0.016027439385652542)","('NON-ESG', 0.014800759963691235)"
Line 1082,"Baxter does not undertake to update its  forward-looking statements unless otherwise required by  the federal securities laws.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT54Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Climate ChangeReducing energy consumption and expanding use of renewable energy in Baxter’s operations and reducing greenhouse   gas emissions across our value chain; incorporating climate change strategy, including adaptation and resilience planning,  into relevant business decisions.
","('GHG_Emissions', 0.5703758001327515)","('Physical_Impacts_Of_Climate_Change', 0.21407295763492584)","('Business_Model_Resilience', 0.08129019290208817)","(['Climate Change'], 0.5703758001327515)","('NON-ESG', 0.21407295763492584)","('NON-ESG', 0.08129019290208817)"
Line 1083,"Learn more.
","('Employee_Engagement_Inclusion_And_Diversity', 0.16738976538181305)","('Access_And_Affordability', 0.09505748748779297)","('Supply_Chain_Management', 0.0712040588259697)","('NON-ESG', 0.16738976538181305)","('NON-ESG', 0.09505748748779297)","('NON-ESG', 0.0712040588259697)"
Line 1084,"Community Support   and VolunteerismSupporting communities in need where Baxter has a presence, with partnerships aimed at addressing economic,   environmental and social needs, including through financial contributions and employee volunteerism.
","('Human_Rights_And_Community_Relations', 0.888105571269989)","('Access_And_Affordability', 0.03849898651242256)","('Employee_Health_And_Safety', 0.008994238451123238)","(['Community Relations'], 0.888105571269989)","('NON-ESG', 0.03849898651242256)","('NON-ESG', 0.008994238451123238)"
Line 1085,"Learn more.
","('Employee_Engagement_Inclusion_And_Diversity', 0.16738976538181305)","('Access_And_Affordability', 0.09505748748779297)","('Supply_Chain_Management', 0.0712040588259697)","('NON-ESG', 0.16738976538181305)","('NON-ESG', 0.09505748748779297)","('NON-ESG', 0.0712040588259697)"
Line 1086,"Diversity and InclusionMaintaining an inclusive, nondiscriminatory hiring process and culture; providing employees equal pay for equal work  regardless of gender, race, sexual orientation or disability; welcoming, leveraging and appreciating the uniqueness of every  Baxter employee; and supporting supplier diversity.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9756171703338623)","('Employee_Health_And_Safety', 0.002248329808935523)","('Labor_Practices', 0.001742460415698588)","(['Human Capital Development'], 0.9756171703338623)","('NON-ESG', 0.002248329808935523)","('NON-ESG', 0.001742460415698588)"
Line 1087,"Learn more.
","('Employee_Engagement_Inclusion_And_Diversity', 0.16738976538181305)","('Access_And_Affordability', 0.09505748748779297)","('Supply_Chain_Management', 0.0712040588259697)","('NON-ESG', 0.16738976538181305)","('NON-ESG', 0.09505748748779297)","('NON-ESG', 0.0712040588259697)"
Line 1088,"Employee Attraction,  Development and RetentionAttracting, engaging and retaining top talent by providing employees career and personal training and development  opportunities, and designing succession plans to ensure there are qualified Baxter candidates for critical positions;   upholding labor rights and ensuring that labor concerns can be reported.
","('Labor_Practices', 0.9056283235549927)","('Employee_Engagement_Inclusion_And_Diversity', 0.0444527193903923)","('Employee_Health_And_Safety', 0.006863123271614313)","(['Labor Practice Indicators'], 0.9056283235549927)","('NON-ESG', 0.0444527193903923)","('NON-ESG', 0.006863123271614313)"
Line 1089,"Learn more.
","('Employee_Engagement_Inclusion_And_Diversity', 0.16738976538181305)","('Access_And_Affordability', 0.09505748748779297)","('Supply_Chain_Management', 0.0712040588259697)","('NON-ESG', 0.16738976538181305)","('NON-ESG', 0.09505748748779297)","('NON-ESG', 0.0712040588259697)"
Line 1090,"Ethics and ComplianceProviding an effective corporate governance structure, business processes, marketing standards, and reporting   mechanisms, and fostering an open culture that demonstrates the highest ethics and anticorruption standards.
","('Business_Ethics', 0.9719685912132263)","('Management_Of_Legal_And_Regulatory_Framework', 0.0037839740980416536)","('Product_Quality_And_Safety', 0.0024425301235169172)","(['Business Ethics'], 0.9719685912132263)","('NON-ESG', 0.0037839740980416536)","('NON-ESG', 0.0024425301235169172)"
Line 1091,"Learn more.
","('Employee_Engagement_Inclusion_And_Diversity', 0.16738976538181305)","('Access_And_Affordability', 0.09505748748779297)","('Supply_Chain_Management', 0.0712040588259697)","('NON-ESG', 0.16738976538181305)","('NON-ESG', 0.09505748748779297)","('NON-ESG', 0.0712040588259697)"
Line 1092,"Health, Safety and Well-BeingProviding employees with a zero-harm workplace, an environment that encourages healthy choices, and resources to   maintain and improve their health and safety and that of their families.
","('Employee_Health_And_Safety', 0.9812284111976624)","('Employee_Engagement_Inclusion_And_Diversity', 0.0021660716738551855)","('Critical_Incident_Risk_Management', 0.001612801686860621)","(['Operational Eco-Efficiency'], 0.9812284111976624)","('NON-ESG', 0.0021660716738551855)","('NON-ESG', 0.001612801686860621)"
Line 1093,"Learn more.
","('Employee_Engagement_Inclusion_And_Diversity', 0.16738976538181305)","('Access_And_Affordability', 0.09505748748779297)","('Supply_Chain_Management', 0.0712040588259697)","('NON-ESG', 0.16738976538181305)","('NON-ESG', 0.09505748748779297)","('NON-ESG', 0.0712040588259697)"
Line 1094,"Healthcare Access and  AffordabilityImproving access to, and affordability of, Baxter products and services for populations in need through product innovation,   public health initiatives, public policy efforts, business model innovation and strategic giving, which includes product   donations and grants from the Baxter International Foundation.
","('Product_Design_And_Lifecycle_Management', 0.363761842250824)","('Access_And_Affordability', 0.20213988423347473)","('Customer_Welfare', 0.10962843149900436)","('NON-ESG', 0.363761842250824)","('NON-ESG', 0.20213988423347473)","('NON-ESG', 0.10962843149900436)"
Line 1095,"Learn more.
","('Employee_Engagement_Inclusion_And_Diversity', 0.16738976538181305)","('Access_And_Affordability', 0.09505748748779297)","('Supply_Chain_Management', 0.0712040588259697)","('NON-ESG', 0.16738976538181305)","('NON-ESG', 0.09505748748779297)","('NON-ESG', 0.0712040588259697)"
Line 1096,"Human Rights Ensuring workers across Baxter’s value chain are treated in accordance with international standards of human rights.
","('Human_Rights_And_Community_Relations', 0.8678994178771973)","('Labor_Practices', 0.04112289845943451)","('Employee_Health_And_Safety', 0.016670335084199905)","(['Community Relations'], 0.8678994178771973)","('NON-ESG', 0.04112289845943451)","('NON-ESG', 0.016670335084199905)"
Line 1097,"Learn more.
","('Employee_Engagement_Inclusion_And_Diversity', 0.16738976538181305)","('Access_And_Affordability', 0.09505748748779297)","('Supply_Chain_Management', 0.0712040588259697)","('NON-ESG', 0.16738976538181305)","('NON-ESG', 0.09505748748779297)","('NON-ESG', 0.0712040588259697)"
Line 1098,"Innovation Investing in innovation that solves for unmet needs and improves patient outcomes and standards of care.
","('Access_And_Affordability', 0.5384837985038757)","('Customer_Welfare', 0.05077964439988136)","('Product_Design_And_Lifecycle_Management', 0.037297509610652924)","(['Health Outcome Contribution'], 0.5384837985038757)","('NON-ESG', 0.05077964439988136)","('NON-ESG', 0.037297509610652924)"
Line 1099,"Learn more.
","('Employee_Engagement_Inclusion_And_Diversity', 0.16738976538181305)","('Access_And_Affordability', 0.09505748748779297)","('Supply_Chain_Management', 0.0712040588259697)","('NON-ESG', 0.16738976538181305)","('NON-ESG', 0.09505748748779297)","('NON-ESG', 0.0712040588259697)"
Line 1100,"Patient Safety and QualityHelping to ensure quality and patient safety across the product life cycle through leading practices in design,   materials use, manufacturing, communications, surveillance and reporting.
","('Product_Quality_And_Safety', 0.739707887172699)","('Product_Design_And_Lifecycle_Management', 0.13305404782295227)","('Employee_Health_And_Safety', 0.019048383459448814)","(['Product Quality & Recall Management'], 0.739707887172699)","('NON-ESG', 0.13305404782295227)","('NON-ESG', 0.019048383459448814)"
Line 1101,"Learn more.
","('Employee_Engagement_Inclusion_And_Diversity', 0.16738976538181305)","('Access_And_Affordability', 0.09505748748779297)","('Supply_Chain_Management', 0.0712040588259697)","('NON-ESG', 0.16738976538181305)","('NON-ESG', 0.09505748748779297)","('NON-ESG', 0.0712040588259697)"
Line 1102,"Privacy and Data ProtectionProtecting personal information from unauthorized or inappropriate collection, processing and disclosure, and protecting  information resources from threats, whether internal or external, deliberate or accidental.
","('Data_Security', 0.7024044394493103)","('Customer_Privacy', 0.21755129098892212)","('Business_Ethics', 0.006995599251240492)","(['Information Security/Cybersecurity & System Availability'], 0.7024044394493103)","('NON-ESG', 0.21755129098892212)","('NON-ESG', 0.006995599251240492)"
Line 1103,"Learn more.
","('Employee_Engagement_Inclusion_And_Diversity', 0.16738976538181305)","('Access_And_Affordability', 0.09505748748779297)","('Supply_Chain_Management', 0.0712040588259697)","('NON-ESG', 0.16738976538181305)","('NON-ESG', 0.09505748748779297)","('NON-ESG', 0.0712040588259697)"
Line 1104,"Product SustainabilityIncorporating and managing sustainability across the product life cycle (R&D and design, materials use including chemicals   of concern, manufacturing, product transport, packaging, product use and end-of-life), and communicating sustainable   product attributes to customers.
","('Product_Design_And_Lifecycle_Management', 0.9648750424385071)","('Selling_Practices_And_Product_Labeling', 0.0041899168863892555)","('Product_Quality_And_Safety', 0.003733209101483226)","(['Product Stewardship'], 0.9648750424385071)","('NON-ESG', 0.0041899168863892555)","('NON-ESG', 0.003733209101483226)"
Line 1105,"Learn more.
","('Employee_Engagement_Inclusion_And_Diversity', 0.16738976538181305)","('Access_And_Affordability', 0.09505748748779297)","('Supply_Chain_Management', 0.0712040588259697)","('NON-ESG', 0.16738976538181305)","('NON-ESG', 0.09505748748779297)","('NON-ESG', 0.0712040588259697)"
Line 1106,"Supply Chain Sustainability Working with suppliers to improve their own sustainability programs and performance, as well as Baxter’s.
","('Supply_Chain_Management', 0.9481483697891235)","('Product_Design_And_Lifecycle_Management', 0.005428674630820751)","('Physical_Impacts_Of_Climate_Change', 0.003781297942623496)","(['Supply Chain Management'], 0.9481483697891235)","('NON-ESG', 0.005428674630820751)","('NON-ESG', 0.003781297942623496)"
Line 1107,"Learn more.
","('Employee_Engagement_Inclusion_And_Diversity', 0.16738976538181305)","('Access_And_Affordability', 0.09505748748779297)","('Supply_Chain_Management', 0.0712040588259697)","('NON-ESG', 0.16738976538181305)","('NON-ESG', 0.09505748748779297)","('NON-ESG', 0.0712040588259697)"
Line 1108,"WasteMinimizing disposal of manufacturing waste from Baxter’s operations, first through source reduction and reuse and then  through recycling and energy recovery.
","('Waste_And_Hazardous_Materials_Management', 0.9838790893554688)","('Data_Security', 0.0012921146117150784)","('Water_And_Wastewater_Management', 0.0012890590587630868)","(['Operational Eco-Efficiency'], 0.9838790893554688)","('NON-ESG', 0.0012921146117150784)","('NON-ESG', 0.0012890590587630868)"
Line 1109,"Learn more.
","('Employee_Engagement_Inclusion_And_Diversity', 0.16738976538181305)","('Access_And_Affordability', 0.09505748748779297)","('Supply_Chain_Management', 0.0712040588259697)","('NON-ESG', 0.16738976538181305)","('NON-ESG', 0.09505748748779297)","('NON-ESG', 0.0712040588259697)"
Line 1110,"Water UseReducing water use in Baxter’s operations, increasing reuse, managing water discharge quality and protecting local water  sources, especially in water-scarce areas.
","('Water_And_Wastewater_Management', 0.9782422184944153)","('GHG_Emissions', 0.0019391474779695272)","('Waste_And_Hazardous_Materials_Management', 0.0016065507661551237)","(['Operational Eco-Efficiency'], 0.9782422184944153)","('NON-ESG', 0.0019391474779695272)","('NON-ESG', 0.0016065507661551237)"
Line 1111,"Learn more.ISSUE DESCRIPTION Upstream DownstreamBaxter  OperationsIMPACT WITHIN VALUE CHAINFor more information about the process we undertook and the key findings of our 2018 assessment,   see page 6 of our 2018 Corporate Responsibility Report.APPENDIX:   Materiality Assessment Findings1 BAXTER 2020 CORPORATE RESPONSIBILITY REPORT55Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Data Summary  Apex Companies LLC has provided assurance on the Employee Health and Safety, Operations, and Responsible Procurement and Logistics content in this section.
","('Business_Model_Resilience', 0.3180479109287262)","('Business_Ethics', 0.09996026009321213)","('Systemic_Risk_Management', 0.09884005784988403)","('NON-ESG', 0.3180479109287262)","('NON-ESG', 0.09996026009321213)","('NON-ESG', 0.09884005784988403)"
Line 1112,"Learn more.ISSUE DESCRIPTION Upstream DownstreamBaxter  OperationsIMPACT WITHIN VALUE CHAINFor more information about the process we undertook and the key findings of our 2018 assessment,   see page 6 of our 2018 Corporate Responsibility Report.APPENDIX:   Materiality Assessment Findings1 BAXTER 2020 CORPORATE RESPONSIBILITY REPORT55Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Data Summary  Apex Companies LLC has provided assurance on the Employee Health and Safety, Operations, and Responsible Procurement and Logistics content in this section.
","('Employee_Health_And_Safety', 0.9817264676094055)","('Employee_Engagement_Inclusion_And_Diversity', 0.0026298267766833305)","('Critical_Incident_Risk_Management', 0.0018217007163912058)","(['Operational Eco-Efficiency'], 0.9817264676094055)","('NON-ESG', 0.0026298267766833305)","('NON-ESG', 0.0018217007163912058)"
Line 1113,"Financial Performance Net Sales ($ millions)   $11,099 $11,362 $11,U.S. Net Sales ($ millions)   $4,723 $4,826 $4,878  International Net Sales ($ millions)   $6,376 $6,536 $6,Net Income ($ millions)   $1,546 $1,011 $1,110  Stock Price ($ at year end)   $65.82 $83.62 $80.Dividend ($ per share)   $0.73 $0.85 $0.Research and Development ($ millions)   $654 $595 $Product Safety and Quality   Total Recalls: Medical Device and Drug    Within the United States1   16 9  Outside the United States   29 33 Recalls: Medical Device Only     Within the United States1   12 6 11    U.S. Food and Drug Administration (FDA) Class I Recalls1  0 0  Outside the United States   9 16 Recalls: Drug Only    /uniFEFF  Within the United States1   4 3 1    FDA Class I Recalls1   0 0 0/uniFEFF   Outside the United States   20 17 Product Recall Rate2 (% of Product Codes Sold)   0.8% 0.7% 0.5% FDA Inspections and Enforcement Actions3      Form 483s Received   10 5 0   Warning Letters Open   2 1 1  /uniFEFF Warning Letters Resolved   0 1  Warning Letters Received   1 0  Product Seizure   0 0  Consent Decree   0 0 Workforce  Global Workforce by Job Level (as a % of total)    Vice President and Above   0.3% 0.3% 0.3%  Director   -- --  1.6%  Manager   -- --  9.2%  Professional4   24.8% 25.6% 26.2%   Technical/Clerical5   63.8% 63.1% 62.7% Global Workforce by Region (as a % of total)    Americas6   49.8% 48.2% 48.2%   /uniFEFFEurope, Middle East and Africa (EMEA)   26.6% 27.2% 27.4%   /uniFEFFAsia Pacific   23.6% 24.6% 24.3%     Workforce (continued) Global Workforce by Gender (as a % of total)    Women   48.0% 47.8% 48.0%   Men   52.0% 52.2% 52.0% Representation of Women by Region (as a % of total)       Americas6   49.9% 49.6% 49.5%   EMEA   48.2% 47.2% 48.1%  /uniFEFF Asia Pacific   43.7% 44.9% 44.9% Representation of Women by Job Level (as a % of total)       Vice President and Above   33.3% 31.9% 28.7%  Director   -- -- 34.3%  Manager   -- -- 42.5%   Professional4   /uniFEFF48.7% 47.3% 47.2% Ethnic Minority Representation (as a % of total, U.S. only)       Asian   -- -- 8.6%  Black/African American   -- -- 9.7%  Hispanic/Latino   -- -- 18.0%   White   /uniFEFF -- -- 61.9%  Other7   /uniFEFF -- -- 1.8% Ethnic Minority Representation by Job Level (as a % of total, U.S. only) 38.5% 38.5% 38.1%  Vice President and Above   19.3% 18.4% 18.0%  Director   -- -- 23.2%  Manager   -- -- 27.7%   Professional4   30.4% 30.0% 30.9%  Vice President and Above        Asian   -- -- 10.1%   Black/African American   -- -- 2.2%   Hispanic/Latino   -- -- 3.4%   White   /uniFEFF -- -- 82.0%   Other7   /uniFEFF -- -- 2.3%  Director        Asian   -- -- 9.9%   Black/African American   -- -- 2.8%   Hispanic/Latino   -- -- 8.8%   White   /uniFEFF -- -- 76.8%    Other7   /uniFEFF -- -- 1.7%        SECTION AND INDICATOR   2018 2019 2020 SECTION AND INDICATOR  2018 2019 2020BAXTER 2020 CORPORATE RESPONSIBILITY REPORT56Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Data Summary (continued)       Workforce (continued) Ethnic Minority Representation by Job Level (as a % of total, U.S. only)  (continued)   Manager        Asian   -- -- 15.1%   Black/African American   -- -- 3.0%   Hispanic/Latino   -- -- 8.1%   White   /uniFEFF -- -- 72.3%    Other7   /uniFEFF -- -- 1.5%  Professional4        Asian   -- -- 8.6%   Black/African American   -- -- 5.6%   Hispanic/Latino   -- -- 14.6%   White   /uniFEFF -- -- 69.1%    Other7   /uniFEFF -- -- 2.1% Employee Health and Safety8   Recordable Incident Rate9   0.41 0.39 0.
","('Product_Quality_And_Safety', 0.8821226358413696)","('Selling_Practices_And_Product_Labeling', 0.014941908419132233)","('Employee_Health_And_Safety', 0.009707944467663765)","(['Product Quality & Recall Management'], 0.8821226358413696)","('NON-ESG', 0.014941908419132233)","('NON-ESG', 0.009707944467663765)"
Line 1114,"Financial Performance Net Sales ($ millions)   $11,099 $11,362 $11,U.S. Net Sales ($ millions)   $4,723 $4,826 $4,878  International Net Sales ($ millions)   $6,376 $6,536 $6,Net Income ($ millions)   $1,546 $1,011 $1,110  Stock Price ($ at year end)   $65.82 $83.62 $80.Dividend ($ per share)   $0.73 $0.85 $0.Research and Development ($ millions)   $654 $595 $Product Safety and Quality   Total Recalls: Medical Device and Drug    Within the United States1   16 9  Outside the United States   29 33 Recalls: Medical Device Only     Within the United States1   12 6 11    U.S. Food and Drug Administration (FDA) Class I Recalls1  0 0  Outside the United States   9 16 Recalls: Drug Only    /uniFEFF  Within the United States1   4 3 1    FDA Class I Recalls1   0 0 0/uniFEFF   Outside the United States   20 17 Product Recall Rate2 (% of Product Codes Sold)   0.8% 0.7% 0.5% FDA Inspections and Enforcement Actions3      Form 483s Received   10 5 0   Warning Letters Open   2 1 1  /uniFEFF Warning Letters Resolved   0 1  Warning Letters Received   1 0  Product Seizure   0 0  Consent Decree   0 0 Workforce  Global Workforce by Job Level (as a % of total)    Vice President and Above   0.3% 0.3% 0.3%  Director   -- --  1.6%  Manager   -- --  9.2%  Professional4   24.8% 25.6% 26.2%   Technical/Clerical5   63.8% 63.1% 62.7% Global Workforce by Region (as a % of total)    Americas6   49.8% 48.2% 48.2%   /uniFEFFEurope, Middle East and Africa (EMEA)   26.6% 27.2% 27.4%   /uniFEFFAsia Pacific   23.6% 24.6% 24.3%     Workforce (continued) Global Workforce by Gender (as a % of total)    Women   48.0% 47.8% 48.0%   Men   52.0% 52.2% 52.0% Representation of Women by Region (as a % of total)       Americas6   49.9% 49.6% 49.5%   EMEA   48.2% 47.2% 48.1%  /uniFEFF Asia Pacific   43.7% 44.9% 44.9% Representation of Women by Job Level (as a % of total)       Vice President and Above   33.3% 31.9% 28.7%  Director   -- -- 34.3%  Manager   -- -- 42.5%   Professional4   /uniFEFF48.7% 47.3% 47.2% Ethnic Minority Representation (as a % of total, U.S. only)       Asian   -- -- 8.6%  Black/African American   -- -- 9.7%  Hispanic/Latino   -- -- 18.0%   White   /uniFEFF -- -- 61.9%  Other7   /uniFEFF -- -- 1.8% Ethnic Minority Representation by Job Level (as a % of total, U.S. only) 38.5% 38.5% 38.1%  Vice President and Above   19.3% 18.4% 18.0%  Director   -- -- 23.2%  Manager   -- -- 27.7%   Professional4   30.4% 30.0% 30.9%  Vice President and Above        Asian   -- -- 10.1%   Black/African American   -- -- 2.2%   Hispanic/Latino   -- -- 3.4%   White   /uniFEFF -- -- 82.0%   Other7   /uniFEFF -- -- 2.3%  Director        Asian   -- -- 9.9%   Black/African American   -- -- 2.8%   Hispanic/Latino   -- -- 8.8%   White   /uniFEFF -- -- 76.8%    Other7   /uniFEFF -- -- 1.7%        SECTION AND INDICATOR   2018 2019 2020 SECTION AND INDICATOR  2018 2019 2020BAXTER 2020 CORPORATE RESPONSIBILITY REPORT56Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Data Summary (continued)       Workforce (continued) Ethnic Minority Representation by Job Level (as a % of total, U.S. only)  (continued)   Manager        Asian   -- -- 15.1%   Black/African American   -- -- 3.0%   Hispanic/Latino   -- -- 8.1%   White   /uniFEFF -- -- 72.3%    Other7   /uniFEFF -- -- 1.5%  Professional4        Asian   -- -- 8.6%   Black/African American   -- -- 5.6%   Hispanic/Latino   -- -- 14.6%   White   /uniFEFF -- -- 69.1%    Other7   /uniFEFF -- -- 2.1% Employee Health and Safety8   Recordable Incident Rate9   0.41 0.39 0.
","('Product_Quality_And_Safety', 0.6438122391700745)","('Selling_Practices_And_Product_Labeling', 0.05743590369820595)","('Business_Ethics', 0.03822055086493492)","(['Product Quality & Recall Management'], 0.6438122391700745)","('NON-ESG', 0.05743590369820595)","('NON-ESG', 0.03822055086493492)"
Line 1115,"Financial Performance Net Sales ($ millions)   $11,099 $11,362 $11,U.S. Net Sales ($ millions)   $4,723 $4,826 $4,878  International Net Sales ($ millions)   $6,376 $6,536 $6,Net Income ($ millions)   $1,546 $1,011 $1,110  Stock Price ($ at year end)   $65.82 $83.62 $80.Dividend ($ per share)   $0.73 $0.85 $0.Research and Development ($ millions)   $654 $595 $Product Safety and Quality   Total Recalls: Medical Device and Drug    Within the United States1   16 9  Outside the United States   29 33 Recalls: Medical Device Only     Within the United States1   12 6 11    U.S. Food and Drug Administration (FDA) Class I Recalls1  0 0  Outside the United States   9 16 Recalls: Drug Only    /uniFEFF  Within the United States1   4 3 1    FDA Class I Recalls1   0 0 0/uniFEFF   Outside the United States   20 17 Product Recall Rate2 (% of Product Codes Sold)   0.8% 0.7% 0.5% FDA Inspections and Enforcement Actions3      Form 483s Received   10 5 0   Warning Letters Open   2 1 1  /uniFEFF Warning Letters Resolved   0 1  Warning Letters Received   1 0  Product Seizure   0 0  Consent Decree   0 0 Workforce  Global Workforce by Job Level (as a % of total)    Vice President and Above   0.3% 0.3% 0.3%  Director   -- --  1.6%  Manager   -- --  9.2%  Professional4   24.8% 25.6% 26.2%   Technical/Clerical5   63.8% 63.1% 62.7% Global Workforce by Region (as a % of total)    Americas6   49.8% 48.2% 48.2%   /uniFEFFEurope, Middle East and Africa (EMEA)   26.6% 27.2% 27.4%   /uniFEFFAsia Pacific   23.6% 24.6% 24.3%     Workforce (continued) Global Workforce by Gender (as a % of total)    Women   48.0% 47.8% 48.0%   Men   52.0% 52.2% 52.0% Representation of Women by Region (as a % of total)       Americas6   49.9% 49.6% 49.5%   EMEA   48.2% 47.2% 48.1%  /uniFEFF Asia Pacific   43.7% 44.9% 44.9% Representation of Women by Job Level (as a % of total)       Vice President and Above   33.3% 31.9% 28.7%  Director   -- -- 34.3%  Manager   -- -- 42.5%   Professional4   /uniFEFF48.7% 47.3% 47.2% Ethnic Minority Representation (as a % of total, U.S. only)       Asian   -- -- 8.6%  Black/African American   -- -- 9.7%  Hispanic/Latino   -- -- 18.0%   White   /uniFEFF -- -- 61.9%  Other7   /uniFEFF -- -- 1.8% Ethnic Minority Representation by Job Level (as a % of total, U.S. only) 38.5% 38.5% 38.1%  Vice President and Above   19.3% 18.4% 18.0%  Director   -- -- 23.2%  Manager   -- -- 27.7%   Professional4   30.4% 30.0% 30.9%  Vice President and Above        Asian   -- -- 10.1%   Black/African American   -- -- 2.2%   Hispanic/Latino   -- -- 3.4%   White   /uniFEFF -- -- 82.0%   Other7   /uniFEFF -- -- 2.3%  Director        Asian   -- -- 9.9%   Black/African American   -- -- 2.8%   Hispanic/Latino   -- -- 8.8%   White   /uniFEFF -- -- 76.8%    Other7   /uniFEFF -- -- 1.7%        SECTION AND INDICATOR   2018 2019 2020 SECTION AND INDICATOR  2018 2019 2020BAXTER 2020 CORPORATE RESPONSIBILITY REPORT56Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Data Summary (continued)       Workforce (continued) Ethnic Minority Representation by Job Level (as a % of total, U.S. only)  (continued)   Manager        Asian   -- -- 15.1%   Black/African American   -- -- 3.0%   Hispanic/Latino   -- -- 8.1%   White   /uniFEFF -- -- 72.3%    Other7   /uniFEFF -- -- 1.5%  Professional4        Asian   -- -- 8.6%   Black/African American   -- -- 5.6%   Hispanic/Latino   -- -- 14.6%   White   /uniFEFF -- -- 69.1%    Other7   /uniFEFF -- -- 2.1% Employee Health and Safety8   Recordable Incident Rate9   0.41 0.39 0.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8583800196647644)","('Business_Model_Resilience', 0.018355395644903183)","('Employee_Health_And_Safety', 0.014301619492471218)","(['Human Capital Development'], 0.8583800196647644)","('NON-ESG', 0.018355395644903183)","('NON-ESG', 0.014301619492471218)"
Line 1116,"Financial Performance Net Sales ($ millions)   $11,099 $11,362 $11,U.S. Net Sales ($ millions)   $4,723 $4,826 $4,878  International Net Sales ($ millions)   $6,376 $6,536 $6,Net Income ($ millions)   $1,546 $1,011 $1,110  Stock Price ($ at year end)   $65.82 $83.62 $80.Dividend ($ per share)   $0.73 $0.85 $0.Research and Development ($ millions)   $654 $595 $Product Safety and Quality   Total Recalls: Medical Device and Drug    Within the United States1   16 9  Outside the United States   29 33 Recalls: Medical Device Only     Within the United States1   12 6 11    U.S. Food and Drug Administration (FDA) Class I Recalls1  0 0  Outside the United States   9 16 Recalls: Drug Only    /uniFEFF  Within the United States1   4 3 1    FDA Class I Recalls1   0 0 0/uniFEFF   Outside the United States   20 17 Product Recall Rate2 (% of Product Codes Sold)   0.8% 0.7% 0.5% FDA Inspections and Enforcement Actions3      Form 483s Received   10 5 0   Warning Letters Open   2 1 1  /uniFEFF Warning Letters Resolved   0 1  Warning Letters Received   1 0  Product Seizure   0 0  Consent Decree   0 0 Workforce  Global Workforce by Job Level (as a % of total)    Vice President and Above   0.3% 0.3% 0.3%  Director   -- --  1.6%  Manager   -- --  9.2%  Professional4   24.8% 25.6% 26.2%   Technical/Clerical5   63.8% 63.1% 62.7% Global Workforce by Region (as a % of total)    Americas6   49.8% 48.2% 48.2%   /uniFEFFEurope, Middle East and Africa (EMEA)   26.6% 27.2% 27.4%   /uniFEFFAsia Pacific   23.6% 24.6% 24.3%     Workforce (continued) Global Workforce by Gender (as a % of total)    Women   48.0% 47.8% 48.0%   Men   52.0% 52.2% 52.0% Representation of Women by Region (as a % of total)       Americas6   49.9% 49.6% 49.5%   EMEA   48.2% 47.2% 48.1%  /uniFEFF Asia Pacific   43.7% 44.9% 44.9% Representation of Women by Job Level (as a % of total)       Vice President and Above   33.3% 31.9% 28.7%  Director   -- -- 34.3%  Manager   -- -- 42.5%   Professional4   /uniFEFF48.7% 47.3% 47.2% Ethnic Minority Representation (as a % of total, U.S. only)       Asian   -- -- 8.6%  Black/African American   -- -- 9.7%  Hispanic/Latino   -- -- 18.0%   White   /uniFEFF -- -- 61.9%  Other7   /uniFEFF -- -- 1.8% Ethnic Minority Representation by Job Level (as a % of total, U.S. only) 38.5% 38.5% 38.1%  Vice President and Above   19.3% 18.4% 18.0%  Director   -- -- 23.2%  Manager   -- -- 27.7%   Professional4   30.4% 30.0% 30.9%  Vice President and Above        Asian   -- -- 10.1%   Black/African American   -- -- 2.2%   Hispanic/Latino   -- -- 3.4%   White   /uniFEFF -- -- 82.0%   Other7   /uniFEFF -- -- 2.3%  Director        Asian   -- -- 9.9%   Black/African American   -- -- 2.8%   Hispanic/Latino   -- -- 8.8%   White   /uniFEFF -- -- 76.8%    Other7   /uniFEFF -- -- 1.7%        SECTION AND INDICATOR   2018 2019 2020 SECTION AND INDICATOR  2018 2019 2020BAXTER 2020 CORPORATE RESPONSIBILITY REPORT56Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Data Summary (continued)       Workforce (continued) Ethnic Minority Representation by Job Level (as a % of total, U.S. only)  (continued)   Manager        Asian   -- -- 15.1%   Black/African American   -- -- 3.0%   Hispanic/Latino   -- -- 8.1%   White   /uniFEFF -- -- 72.3%    Other7   /uniFEFF -- -- 1.5%  Professional4        Asian   -- -- 8.6%   Black/African American   -- -- 5.6%   Hispanic/Latino   -- -- 14.6%   White   /uniFEFF -- -- 69.1%    Other7   /uniFEFF -- -- 2.1% Employee Health and Safety8   Recordable Incident Rate9   0.41 0.39 0.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9726461172103882)","('Employee_Health_And_Safety', 0.00211914861574769)","('Human_Rights_And_Community_Relations', 0.0020947305019944906)","(['Human Capital Development'], 0.9726461172103882)","('NON-ESG', 0.00211914861574769)","('NON-ESG', 0.0020947305019944906)"
Line 1117,"Financial Performance Net Sales ($ millions)   $11,099 $11,362 $11,U.S. Net Sales ($ millions)   $4,723 $4,826 $4,878  International Net Sales ($ millions)   $6,376 $6,536 $6,Net Income ($ millions)   $1,546 $1,011 $1,110  Stock Price ($ at year end)   $65.82 $83.62 $80.Dividend ($ per share)   $0.73 $0.85 $0.Research and Development ($ millions)   $654 $595 $Product Safety and Quality   Total Recalls: Medical Device and Drug    Within the United States1   16 9  Outside the United States   29 33 Recalls: Medical Device Only     Within the United States1   12 6 11    U.S. Food and Drug Administration (FDA) Class I Recalls1  0 0  Outside the United States   9 16 Recalls: Drug Only    /uniFEFF  Within the United States1   4 3 1    FDA Class I Recalls1   0 0 0/uniFEFF   Outside the United States   20 17 Product Recall Rate2 (% of Product Codes Sold)   0.8% 0.7% 0.5% FDA Inspections and Enforcement Actions3      Form 483s Received   10 5 0   Warning Letters Open   2 1 1  /uniFEFF Warning Letters Resolved   0 1  Warning Letters Received   1 0  Product Seizure   0 0  Consent Decree   0 0 Workforce  Global Workforce by Job Level (as a % of total)    Vice President and Above   0.3% 0.3% 0.3%  Director   -- --  1.6%  Manager   -- --  9.2%  Professional4   24.8% 25.6% 26.2%   Technical/Clerical5   63.8% 63.1% 62.7% Global Workforce by Region (as a % of total)    Americas6   49.8% 48.2% 48.2%   /uniFEFFEurope, Middle East and Africa (EMEA)   26.6% 27.2% 27.4%   /uniFEFFAsia Pacific   23.6% 24.6% 24.3%     Workforce (continued) Global Workforce by Gender (as a % of total)    Women   48.0% 47.8% 48.0%   Men   52.0% 52.2% 52.0% Representation of Women by Region (as a % of total)       Americas6   49.9% 49.6% 49.5%   EMEA   48.2% 47.2% 48.1%  /uniFEFF Asia Pacific   43.7% 44.9% 44.9% Representation of Women by Job Level (as a % of total)       Vice President and Above   33.3% 31.9% 28.7%  Director   -- -- 34.3%  Manager   -- -- 42.5%   Professional4   /uniFEFF48.7% 47.3% 47.2% Ethnic Minority Representation (as a % of total, U.S. only)       Asian   -- -- 8.6%  Black/African American   -- -- 9.7%  Hispanic/Latino   -- -- 18.0%   White   /uniFEFF -- -- 61.9%  Other7   /uniFEFF -- -- 1.8% Ethnic Minority Representation by Job Level (as a % of total, U.S. only) 38.5% 38.5% 38.1%  Vice President and Above   19.3% 18.4% 18.0%  Director   -- -- 23.2%  Manager   -- -- 27.7%   Professional4   30.4% 30.0% 30.9%  Vice President and Above        Asian   -- -- 10.1%   Black/African American   -- -- 2.2%   Hispanic/Latino   -- -- 3.4%   White   /uniFEFF -- -- 82.0%   Other7   /uniFEFF -- -- 2.3%  Director        Asian   -- -- 9.9%   Black/African American   -- -- 2.8%   Hispanic/Latino   -- -- 8.8%   White   /uniFEFF -- -- 76.8%    Other7   /uniFEFF -- -- 1.7%        SECTION AND INDICATOR   2018 2019 2020 SECTION AND INDICATOR  2018 2019 2020BAXTER 2020 CORPORATE RESPONSIBILITY REPORT56Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Data Summary (continued)       Workforce (continued) Ethnic Minority Representation by Job Level (as a % of total, U.S. only)  (continued)   Manager        Asian   -- -- 15.1%   Black/African American   -- -- 3.0%   Hispanic/Latino   -- -- 8.1%   White   /uniFEFF -- -- 72.3%    Other7   /uniFEFF -- -- 1.5%  Professional4        Asian   -- -- 8.6%   Black/African American   -- -- 5.6%   Hispanic/Latino   -- -- 14.6%   White   /uniFEFF -- -- 69.1%    Other7   /uniFEFF -- -- 2.1% Employee Health and Safety8   Recordable Incident Rate9   0.41 0.39 0.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9665701389312744)","('Business_Model_Resilience', 0.002232953207567334)","('Employee_Health_And_Safety', 0.0021877882536500692)","(['Human Capital Development'], 0.9665701389312744)","('NON-ESG', 0.002232953207567334)","('NON-ESG', 0.0021877882536500692)"
Line 1118,"Financial Performance Net Sales ($ millions)   $11,099 $11,362 $11,U.S. Net Sales ($ millions)   $4,723 $4,826 $4,878  International Net Sales ($ millions)   $6,376 $6,536 $6,Net Income ($ millions)   $1,546 $1,011 $1,110  Stock Price ($ at year end)   $65.82 $83.62 $80.Dividend ($ per share)   $0.73 $0.85 $0.Research and Development ($ millions)   $654 $595 $Product Safety and Quality   Total Recalls: Medical Device and Drug    Within the United States1   16 9  Outside the United States   29 33 Recalls: Medical Device Only     Within the United States1   12 6 11    U.S. Food and Drug Administration (FDA) Class I Recalls1  0 0  Outside the United States   9 16 Recalls: Drug Only    /uniFEFF  Within the United States1   4 3 1    FDA Class I Recalls1   0 0 0/uniFEFF   Outside the United States   20 17 Product Recall Rate2 (% of Product Codes Sold)   0.8% 0.7% 0.5% FDA Inspections and Enforcement Actions3      Form 483s Received   10 5 0   Warning Letters Open   2 1 1  /uniFEFF Warning Letters Resolved   0 1  Warning Letters Received   1 0  Product Seizure   0 0  Consent Decree   0 0 Workforce  Global Workforce by Job Level (as a % of total)    Vice President and Above   0.3% 0.3% 0.3%  Director   -- --  1.6%  Manager   -- --  9.2%  Professional4   24.8% 25.6% 26.2%   Technical/Clerical5   63.8% 63.1% 62.7% Global Workforce by Region (as a % of total)    Americas6   49.8% 48.2% 48.2%   /uniFEFFEurope, Middle East and Africa (EMEA)   26.6% 27.2% 27.4%   /uniFEFFAsia Pacific   23.6% 24.6% 24.3%     Workforce (continued) Global Workforce by Gender (as a % of total)    Women   48.0% 47.8% 48.0%   Men   52.0% 52.2% 52.0% Representation of Women by Region (as a % of total)       Americas6   49.9% 49.6% 49.5%   EMEA   48.2% 47.2% 48.1%  /uniFEFF Asia Pacific   43.7% 44.9% 44.9% Representation of Women by Job Level (as a % of total)       Vice President and Above   33.3% 31.9% 28.7%  Director   -- -- 34.3%  Manager   -- -- 42.5%   Professional4   /uniFEFF48.7% 47.3% 47.2% Ethnic Minority Representation (as a % of total, U.S. only)       Asian   -- -- 8.6%  Black/African American   -- -- 9.7%  Hispanic/Latino   -- -- 18.0%   White   /uniFEFF -- -- 61.9%  Other7   /uniFEFF -- -- 1.8% Ethnic Minority Representation by Job Level (as a % of total, U.S. only) 38.5% 38.5% 38.1%  Vice President and Above   19.3% 18.4% 18.0%  Director   -- -- 23.2%  Manager   -- -- 27.7%   Professional4   30.4% 30.0% 30.9%  Vice President and Above        Asian   -- -- 10.1%   Black/African American   -- -- 2.2%   Hispanic/Latino   -- -- 3.4%   White   /uniFEFF -- -- 82.0%   Other7   /uniFEFF -- -- 2.3%  Director        Asian   -- -- 9.9%   Black/African American   -- -- 2.8%   Hispanic/Latino   -- -- 8.8%   White   /uniFEFF -- -- 76.8%    Other7   /uniFEFF -- -- 1.7%        SECTION AND INDICATOR   2018 2019 2020 SECTION AND INDICATOR  2018 2019 2020BAXTER 2020 CORPORATE RESPONSIBILITY REPORT56Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Data Summary (continued)       Workforce (continued) Ethnic Minority Representation by Job Level (as a % of total, U.S. only)  (continued)   Manager        Asian   -- -- 15.1%   Black/African American   -- -- 3.0%   Hispanic/Latino   -- -- 8.1%   White   /uniFEFF -- -- 72.3%    Other7   /uniFEFF -- -- 1.5%  Professional4        Asian   -- -- 8.6%   Black/African American   -- -- 5.6%   Hispanic/Latino   -- -- 14.6%   White   /uniFEFF -- -- 69.1%    Other7   /uniFEFF -- -- 2.1% Employee Health and Safety8   Recordable Incident Rate9   0.41 0.39 0.
","('Product_Quality_And_Safety', 0.44909703731536865)","('Employee_Health_And_Safety', 0.206787109375)","('Employee_Engagement_Inclusion_And_Diversity', 0.0752415806055069)","('NON-ESG', 0.44909703731536865)","('NON-ESG', 0.206787109375)","('NON-ESG', 0.0752415806055069)"
Line 1119,"Financial Performance Net Sales ($ millions)   $11,099 $11,362 $11,U.S. Net Sales ($ millions)   $4,723 $4,826 $4,878  International Net Sales ($ millions)   $6,376 $6,536 $6,Net Income ($ millions)   $1,546 $1,011 $1,110  Stock Price ($ at year end)   $65.82 $83.62 $80.Dividend ($ per share)   $0.73 $0.85 $0.Research and Development ($ millions)   $654 $595 $Product Safety and Quality   Total Recalls: Medical Device and Drug    Within the United States1   16 9  Outside the United States   29 33 Recalls: Medical Device Only     Within the United States1   12 6 11    U.S. Food and Drug Administration (FDA) Class I Recalls1  0 0  Outside the United States   9 16 Recalls: Drug Only    /uniFEFF  Within the United States1   4 3 1    FDA Class I Recalls1   0 0 0/uniFEFF   Outside the United States   20 17 Product Recall Rate2 (% of Product Codes Sold)   0.8% 0.7% 0.5% FDA Inspections and Enforcement Actions3      Form 483s Received   10 5 0   Warning Letters Open   2 1 1  /uniFEFF Warning Letters Resolved   0 1  Warning Letters Received   1 0  Product Seizure   0 0  Consent Decree   0 0 Workforce  Global Workforce by Job Level (as a % of total)    Vice President and Above   0.3% 0.3% 0.3%  Director   -- --  1.6%  Manager   -- --  9.2%  Professional4   24.8% 25.6% 26.2%   Technical/Clerical5   63.8% 63.1% 62.7% Global Workforce by Region (as a % of total)    Americas6   49.8% 48.2% 48.2%   /uniFEFFEurope, Middle East and Africa (EMEA)   26.6% 27.2% 27.4%   /uniFEFFAsia Pacific   23.6% 24.6% 24.3%     Workforce (continued) Global Workforce by Gender (as a % of total)    Women   48.0% 47.8% 48.0%   Men   52.0% 52.2% 52.0% Representation of Women by Region (as a % of total)       Americas6   49.9% 49.6% 49.5%   EMEA   48.2% 47.2% 48.1%  /uniFEFF Asia Pacific   43.7% 44.9% 44.9% Representation of Women by Job Level (as a % of total)       Vice President and Above   33.3% 31.9% 28.7%  Director   -- -- 34.3%  Manager   -- -- 42.5%   Professional4   /uniFEFF48.7% 47.3% 47.2% Ethnic Minority Representation (as a % of total, U.S. only)       Asian   -- -- 8.6%  Black/African American   -- -- 9.7%  Hispanic/Latino   -- -- 18.0%   White   /uniFEFF -- -- 61.9%  Other7   /uniFEFF -- -- 1.8% Ethnic Minority Representation by Job Level (as a % of total, U.S. only) 38.5% 38.5% 38.1%  Vice President and Above   19.3% 18.4% 18.0%  Director   -- -- 23.2%  Manager   -- -- 27.7%   Professional4   30.4% 30.0% 30.9%  Vice President and Above        Asian   -- -- 10.1%   Black/African American   -- -- 2.2%   Hispanic/Latino   -- -- 3.4%   White   /uniFEFF -- -- 82.0%   Other7   /uniFEFF -- -- 2.3%  Director        Asian   -- -- 9.9%   Black/African American   -- -- 2.8%   Hispanic/Latino   -- -- 8.8%   White   /uniFEFF -- -- 76.8%    Other7   /uniFEFF -- -- 1.7%        SECTION AND INDICATOR   2018 2019 2020 SECTION AND INDICATOR  2018 2019 2020BAXTER 2020 CORPORATE RESPONSIBILITY REPORT56Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Data Summary (continued)       Workforce (continued) Ethnic Minority Representation by Job Level (as a % of total, U.S. only)  (continued)   Manager        Asian   -- -- 15.1%   Black/African American   -- -- 3.0%   Hispanic/Latino   -- -- 8.1%   White   /uniFEFF -- -- 72.3%    Other7   /uniFEFF -- -- 1.5%  Professional4        Asian   -- -- 8.6%   Black/African American   -- -- 5.6%   Hispanic/Latino   -- -- 14.6%   White   /uniFEFF -- -- 69.1%    Other7   /uniFEFF -- -- 2.1% Employee Health and Safety8   Recordable Incident Rate9   0.41 0.39 0.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9735668301582336)","('Employee_Health_And_Safety', 0.0017822673544287682)","('Customer_Privacy', 0.0017141238786280155)","(['Human Capital Development'], 0.9735668301582336)","('NON-ESG', 0.0017822673544287682)","('NON-ESG', 0.0017141238786280155)"
Line 1120,"Financial Performance Net Sales ($ millions)   $11,099 $11,362 $11,U.S. Net Sales ($ millions)   $4,723 $4,826 $4,878  International Net Sales ($ millions)   $6,376 $6,536 $6,Net Income ($ millions)   $1,546 $1,011 $1,110  Stock Price ($ at year end)   $65.82 $83.62 $80.Dividend ($ per share)   $0.73 $0.85 $0.Research and Development ($ millions)   $654 $595 $Product Safety and Quality   Total Recalls: Medical Device and Drug    Within the United States1   16 9  Outside the United States   29 33 Recalls: Medical Device Only     Within the United States1   12 6 11    U.S. Food and Drug Administration (FDA) Class I Recalls1  0 0  Outside the United States   9 16 Recalls: Drug Only    /uniFEFF  Within the United States1   4 3 1    FDA Class I Recalls1   0 0 0/uniFEFF   Outside the United States   20 17 Product Recall Rate2 (% of Product Codes Sold)   0.8% 0.7% 0.5% FDA Inspections and Enforcement Actions3      Form 483s Received   10 5 0   Warning Letters Open   2 1 1  /uniFEFF Warning Letters Resolved   0 1  Warning Letters Received   1 0  Product Seizure   0 0  Consent Decree   0 0 Workforce  Global Workforce by Job Level (as a % of total)    Vice President and Above   0.3% 0.3% 0.3%  Director   -- --  1.6%  Manager   -- --  9.2%  Professional4   24.8% 25.6% 26.2%   Technical/Clerical5   63.8% 63.1% 62.7% Global Workforce by Region (as a % of total)    Americas6   49.8% 48.2% 48.2%   /uniFEFFEurope, Middle East and Africa (EMEA)   26.6% 27.2% 27.4%   /uniFEFFAsia Pacific   23.6% 24.6% 24.3%     Workforce (continued) Global Workforce by Gender (as a % of total)    Women   48.0% 47.8% 48.0%   Men   52.0% 52.2% 52.0% Representation of Women by Region (as a % of total)       Americas6   49.9% 49.6% 49.5%   EMEA   48.2% 47.2% 48.1%  /uniFEFF Asia Pacific   43.7% 44.9% 44.9% Representation of Women by Job Level (as a % of total)       Vice President and Above   33.3% 31.9% 28.7%  Director   -- -- 34.3%  Manager   -- -- 42.5%   Professional4   /uniFEFF48.7% 47.3% 47.2% Ethnic Minority Representation (as a % of total, U.S. only)       Asian   -- -- 8.6%  Black/African American   -- -- 9.7%  Hispanic/Latino   -- -- 18.0%   White   /uniFEFF -- -- 61.9%  Other7   /uniFEFF -- -- 1.8% Ethnic Minority Representation by Job Level (as a % of total, U.S. only) 38.5% 38.5% 38.1%  Vice President and Above   19.3% 18.4% 18.0%  Director   -- -- 23.2%  Manager   -- -- 27.7%   Professional4   30.4% 30.0% 30.9%  Vice President and Above        Asian   -- -- 10.1%   Black/African American   -- -- 2.2%   Hispanic/Latino   -- -- 3.4%   White   /uniFEFF -- -- 82.0%   Other7   /uniFEFF -- -- 2.3%  Director        Asian   -- -- 9.9%   Black/African American   -- -- 2.8%   Hispanic/Latino   -- -- 8.8%   White   /uniFEFF -- -- 76.8%    Other7   /uniFEFF -- -- 1.7%        SECTION AND INDICATOR   2018 2019 2020 SECTION AND INDICATOR  2018 2019 2020BAXTER 2020 CORPORATE RESPONSIBILITY REPORT56Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Data Summary (continued)       Workforce (continued) Ethnic Minority Representation by Job Level (as a % of total, U.S. only)  (continued)   Manager        Asian   -- -- 15.1%   Black/African American   -- -- 3.0%   Hispanic/Latino   -- -- 8.1%   White   /uniFEFF -- -- 72.3%    Other7   /uniFEFF -- -- 1.5%  Professional4        Asian   -- -- 8.6%   Black/African American   -- -- 5.6%   Hispanic/Latino   -- -- 14.6%   White   /uniFEFF -- -- 69.1%    Other7   /uniFEFF -- -- 2.1% Employee Health and Safety8   Recordable Incident Rate9   0.41 0.39 0.
","('Employee_Health_And_Safety', 0.9746235013008118)","('Critical_Incident_Risk_Management', 0.0061353761702775955)","('Employee_Engagement_Inclusion_And_Diversity', 0.002036606427282095)","(['Operational Eco-Efficiency'], 0.9746235013008118)","('NON-ESG', 0.0061353761702775955)","('NON-ESG', 0.002036606427282095)"
Line 1121,"North America   0.72 0.82 0.
","('Business_Model_Resilience', 0.15781888365745544)","('Systemic_Risk_Management', 0.11107472330331802)","('Competitive_Behavior', 0.10180997848510742)","('NON-ESG', 0.15781888365745544)","('NON-ESG', 0.11107472330331802)","('NON-ESG', 0.10180997848510742)"
Line 1122,"Latin America   0.26 0.24 0.46    EMEA   0.44 0.32 0.
","('Business_Model_Resilience', 0.18285582959651947)","('Competitive_Behavior', 0.1443815529346466)","('Management_Of_Legal_And_Regulatory_Framework', 0.11079001426696777)","('NON-ESG', 0.18285582959651947)","('NON-ESG', 0.1443815529346466)","('NON-ESG', 0.11079001426696777)"
Line 1123,"Asia Pacific   0.08 0.07 0.Cases with Days Lost Rate10   0.084 0.086 0.
","('Labor_Practices', 0.2077832669019699)","('Systemic_Risk_Management', 0.12932397425174713)","('Employee_Health_And_Safety', 0.12068429589271545)","('NON-ESG', 0.2077832669019699)","('NON-ESG', 0.12932397425174713)","('NON-ESG', 0.12068429589271545)"
Line 1124,"North America   0.112 0.165 0.
","('Competitive_Behavior', 0.12620136141777039)","('Business_Model_Resilience', 0.10751157999038696)","('Management_Of_Legal_And_Regulatory_Framework', 0.08811759948730469)","('NON-ESG', 0.12620136141777039)","('NON-ESG', 0.10751157999038696)","('NON-ESG', 0.08811759948730469)"
Line 1125,"Latin America   0.043 0.000 0.
","('Business_Model_Resilience', 0.14899620413780212)","('Competitive_Behavior', 0.09943106025457382)","('Ecological_Impacts', 0.0888667106628418)","('NON-ESG', 0.14899620413780212)","('NON-ESG', 0.09943106025457382)","('NON-ESG', 0.0888667106628418)"
Line 1126,"EMEA   0.168 0.148 0.
","('Competitive_Behavior', 0.12955184280872345)","('Energy_Management', 0.12728005647659302)","('Management_Of_Legal_And_Regulatory_Framework', 0.11000191420316696)","('NON-ESG', 0.12955184280872345)","('NON-ESG', 0.12728005647659302)","('NON-ESG', 0.11000191420316696)"
Line 1127,"Asia Pacific   0.000 0.008 0.Days Lost Rate11   2.88 2.14 4.
","('Systemic_Risk_Management', 0.2613508701324463)","('Employee_Health_And_Safety', 0.08051673322916031)","('Critical_Incident_Risk_Management', 0.05831453204154968)","('NON-ESG', 0.2613508701324463)","('NON-ESG', 0.08051673322916031)","('NON-ESG', 0.05831453204154968)"
Line 1128,"North America   6.54 5.88 7.
","('Business_Model_Resilience', 0.15470783412456512)","('Director_Removal', 0.0803564116358757)","('Selling_Practices_And_Product_Labeling', 0.0734972134232521)","('NON-ESG', 0.15470783412456512)","('NON-ESG', 0.0803564116358757)","('NON-ESG', 0.0734972134232521)"
Line 1129,"Latin America   1.02 0.00 2.
","('Competitive_Behavior', 0.1856127381324768)","('Business_Model_Resilience', 0.1294582039117813)","('Management_Of_Legal_And_Regulatory_Framework', 0.065613754093647)","('NON-ESG', 0.1856127381324768)","('NON-ESG', 0.1294582039117813)","('NON-ESG', 0.065613754093647)"
Line 1130,"EMEA   2.36 1.47 7.
","('Business_Model_Resilience', 0.21470299363136292)","('Systemic_Risk_Management', 0.16447192430496216)","('Management_Of_Legal_And_Regulatory_Framework', 0.09190137684345245)","('NON-ESG', 0.21470299363136292)","('NON-ESG', 0.16447192430496216)","('NON-ESG', 0.09190137684345245)"
Line 1131,"Asia Pacific   0.00 0.01 1.Restricted Days Rate12   6.20 7.83 3.
","('Management_Of_Legal_And_Regulatory_Framework', 0.421845942735672)","('Physical_Impacts_Of_Climate_Change', 0.09281431883573532)","('Labor_Practices', 0.0747411698102951)","('NON-ESG', 0.421845942735672)","('NON-ESG', 0.09281431883573532)","('NON-ESG', 0.0747411698102951)"
Line 1132,"North America   15.23 21.16 9.80   Latin America   0.56 0.55 1.
","('Business_Model_Resilience', 0.22938182950019836)","('Competitive_Behavior', 0.12577500939369202)","('Employee_Engagement_Inclusion_And_Diversity', 0.0636252835392952)","('NON-ESG', 0.22938182950019836)","('NON-ESG', 0.12577500939369202)","('NON-ESG', 0.0636252835392952)"
Line 1133,"EMEA   4.05 3.79 1.
","('Management_Of_Legal_And_Regulatory_Framework', 0.1476520448923111)","('Systemic_Risk_Management', 0.13770078122615814)","('Business_Model_Resilience', 0.13357555866241455)","('NON-ESG', 0.1476520448923111)","('NON-ESG', 0.13770078122615814)","('NON-ESG', 0.13357555866241455)"
Line 1134,"Asia Pacific   1.00 1.43 0.Days Away (Lost), Restricted or Transferred Rate (DART)   9.08 9.97 8.Employee/Contractor Major Incidents (total number)   6/1 5/1 12/Employee/Contractor Fatalities (total number)   1/1 0/0 0/Health and Safety Notices of Violation Settled   4 3 Health and Safety Fines Paid (in dollars)   $7,130 $9,382 $3,Sources of Recordable Injury and Serious Incidents (as a % of total)    Ergonomic   22% 24% 14%  Illness   -- -- 18%  Involving the Body (nonergonomic)   6% 6% 5%   Punctures   12% 13% 9%     Employee Health and Safety8  (continued)   Sources of Recordable Injury and Serious Incidents (as a % of total) (continued)    Struck by Object   16% 15% 13%  Slips, Trips and Falls    24% 22% 18%   Caught In, On or Between   13% 13% 13%   Forklifts and Other Vehicles   4% 3% 4%   Other   4% 4% 5% OperationsBaxter Toxics Release Inventory Air Releases14 (metric tons)   27 30 -- NOx and SOx Emissions15 (metric tons)   543 554  NOx   412 428   SOx    131 126  Kg NOx and SOx Emissions per Million Dollars of Sales   49 49  Energy Usage from Baxter Operations16 (trillions of joules)    9,644 9,916 10, North America   4,036 4,247 4, Latin America   996 972 1, EMEA   2,989 3,078 3, Asia Pacific   1,624 1,619 1,Billions of Joules per Million Dollars of Sales   869 873 Renewable Energy Usage (trillions of joules)   2,807 2,850 2,Facility Usage of Renewable Energy (as a % of total energy use)  /uniFEFF29% 29% 28% Lean Energy Program Performance17 (% of program criteria implemented across all manufacturing facilities, at year-end)  Prerequisite   99% 91% 96%   Bronze    96% 85% 90%   Silver    85% 74% 82%  Gold    /uniFEFF66% 56% 64% Baxter's Global Greenhouse Gas (GHG) Emissions Footprint  (Scope 1, 2, and 3) (metric tons CO2e).
","('Employee_Health_And_Safety', 0.9849148988723755)","('Critical_Incident_Risk_Management', 0.0018654133891686797)","('Employee_Engagement_Inclusion_And_Diversity', 0.0013420592295005918)","(['Operational Eco-Efficiency'], 0.9849148988723755)","('NON-ESG', 0.0018654133891686797)","('NON-ESG', 0.0013420592295005918)"
Line 1135,"Asia Pacific   1.00 1.43 0.Days Away (Lost), Restricted or Transferred Rate (DART)   9.08 9.97 8.Employee/Contractor Major Incidents (total number)   6/1 5/1 12/Employee/Contractor Fatalities (total number)   1/1 0/0 0/Health and Safety Notices of Violation Settled   4 3 Health and Safety Fines Paid (in dollars)   $7,130 $9,382 $3,Sources of Recordable Injury and Serious Incidents (as a % of total)    Ergonomic   22% 24% 14%  Illness   -- -- 18%  Involving the Body (nonergonomic)   6% 6% 5%   Punctures   12% 13% 9%     Employee Health and Safety8  (continued)   Sources of Recordable Injury and Serious Incidents (as a % of total) (continued)    Struck by Object   16% 15% 13%  Slips, Trips and Falls    24% 22% 18%   Caught In, On or Between   13% 13% 13%   Forklifts and Other Vehicles   4% 3% 4%   Other   4% 4% 5% OperationsBaxter Toxics Release Inventory Air Releases14 (metric tons)   27 30 -- NOx and SOx Emissions15 (metric tons)   543 554  NOx   412 428   SOx    131 126  Kg NOx and SOx Emissions per Million Dollars of Sales   49 49  Energy Usage from Baxter Operations16 (trillions of joules)    9,644 9,916 10, North America   4,036 4,247 4, Latin America   996 972 1, EMEA   2,989 3,078 3, Asia Pacific   1,624 1,619 1,Billions of Joules per Million Dollars of Sales   869 873 Renewable Energy Usage (trillions of joules)   2,807 2,850 2,Facility Usage of Renewable Energy (as a % of total energy use)  /uniFEFF29% 29% 28% Lean Energy Program Performance17 (% of program criteria implemented across all manufacturing facilities, at year-end)  Prerequisite   99% 91% 96%   Bronze    96% 85% 90%   Silver    85% 74% 82%  Gold    /uniFEFF66% 56% 64% Baxter's Global Greenhouse Gas (GHG) Emissions Footprint  (Scope 1, 2, and 3) (metric tons CO2e).
","('Air_Quality', 0.93680739402771)","('Employee_Health_And_Safety', 0.015142195858061314)","('Critical_Incident_Risk_Management', 0.006479223724454641)","(['Operational Eco-Efficiency'], 0.93680739402771)","('NON-ESG', 0.015142195858061314)","('NON-ESG', 0.006479223724454641)"
Line 1136,"Asia Pacific   1.00 1.43 0.Days Away (Lost), Restricted or Transferred Rate (DART)   9.08 9.97 8.Employee/Contractor Major Incidents (total number)   6/1 5/1 12/Employee/Contractor Fatalities (total number)   1/1 0/0 0/Health and Safety Notices of Violation Settled   4 3 Health and Safety Fines Paid (in dollars)   $7,130 $9,382 $3,Sources of Recordable Injury and Serious Incidents (as a % of total)    Ergonomic   22% 24% 14%  Illness   -- -- 18%  Involving the Body (nonergonomic)   6% 6% 5%   Punctures   12% 13% 9%     Employee Health and Safety8  (continued)   Sources of Recordable Injury and Serious Incidents (as a % of total) (continued)    Struck by Object   16% 15% 13%  Slips, Trips and Falls    24% 22% 18%   Caught In, On or Between   13% 13% 13%   Forklifts and Other Vehicles   4% 3% 4%   Other   4% 4% 5% OperationsBaxter Toxics Release Inventory Air Releases14 (metric tons)   27 30 -- NOx and SOx Emissions15 (metric tons)   543 554  NOx   412 428   SOx    131 126  Kg NOx and SOx Emissions per Million Dollars of Sales   49 49  Energy Usage from Baxter Operations16 (trillions of joules)    9,644 9,916 10, North America   4,036 4,247 4, Latin America   996 972 1, EMEA   2,989 3,078 3, Asia Pacific   1,624 1,619 1,Billions of Joules per Million Dollars of Sales   869 873 Renewable Energy Usage (trillions of joules)   2,807 2,850 2,Facility Usage of Renewable Energy (as a % of total energy use)  /uniFEFF29% 29% 28% Lean Energy Program Performance17 (% of program criteria implemented across all manufacturing facilities, at year-end)  Prerequisite   99% 91% 96%   Bronze    96% 85% 90%   Silver    85% 74% 82%  Gold    /uniFEFF66% 56% 64% Baxter's Global Greenhouse Gas (GHG) Emissions Footprint  (Scope 1, 2, and 3) (metric tons CO2e).
","('Energy_Management', 0.9802315831184387)","('Air_Quality', 0.001912448089569807)","('Management_Of_Legal_And_Regulatory_Framework', 0.001852087676525116)","(['Operational Eco-Efficiency'], 0.9802315831184387)","('NON-ESG', 0.001912448089569807)","('NON-ESG', 0.001852087676525116)"
Line 1137,"Asia Pacific   1.00 1.43 0.Days Away (Lost), Restricted or Transferred Rate (DART)   9.08 9.97 8.Employee/Contractor Major Incidents (total number)   6/1 5/1 12/Employee/Contractor Fatalities (total number)   1/1 0/0 0/Health and Safety Notices of Violation Settled   4 3 Health and Safety Fines Paid (in dollars)   $7,130 $9,382 $3,Sources of Recordable Injury and Serious Incidents (as a % of total)    Ergonomic   22% 24% 14%  Illness   -- -- 18%  Involving the Body (nonergonomic)   6% 6% 5%   Punctures   12% 13% 9%     Employee Health and Safety8  (continued)   Sources of Recordable Injury and Serious Incidents (as a % of total) (continued)    Struck by Object   16% 15% 13%  Slips, Trips and Falls    24% 22% 18%   Caught In, On or Between   13% 13% 13%   Forklifts and Other Vehicles   4% 3% 4%   Other   4% 4% 5% OperationsBaxter Toxics Release Inventory Air Releases14 (metric tons)   27 30 -- NOx and SOx Emissions15 (metric tons)   543 554  NOx   412 428   SOx    131 126  Kg NOx and SOx Emissions per Million Dollars of Sales   49 49  Energy Usage from Baxter Operations16 (trillions of joules)    9,644 9,916 10, North America   4,036 4,247 4, Latin America   996 972 1, EMEA   2,989 3,078 3, Asia Pacific   1,624 1,619 1,Billions of Joules per Million Dollars of Sales   869 873 Renewable Energy Usage (trillions of joules)   2,807 2,850 2,Facility Usage of Renewable Energy (as a % of total energy use)  /uniFEFF29% 29% 28% Lean Energy Program Performance17 (% of program criteria implemented across all manufacturing facilities, at year-end)  Prerequisite   99% 91% 96%   Bronze    96% 85% 90%   Silver    85% 74% 82%  Gold    /uniFEFF66% 56% 64% Baxter's Global Greenhouse Gas (GHG) Emissions Footprint  (Scope 1, 2, and 3) (metric tons CO2e).
","('GHG_Emissions', 0.9687204957008362)","('Ecological_Impacts', 0.004216301254928112)","('Air_Quality', 0.002963607432320714)","(['Climate Change'], 0.9687204957008362)","('NON-ESG', 0.004216301254928112)","('NON-ESG', 0.002963607432320714)"
Line 1138,"See Baxter Value Chain    Energy Usage and GHG Emissions for detail.
","('GHG_Emissions', 0.9622400999069214)","('Air_Quality', 0.005180243402719498)","('Energy_Management', 0.0040509458631277084)","(['Climate Change'], 0.9622400999069214)","('NON-ESG', 0.005180243402719498)","('NON-ESG', 0.0040509458631277084)"
Line 1139,"5,205,000 4,854,000 4,493,GHG Emissions from Baxter Operations18 (metric tons CO2e)   596,000 601,000 611,000   North America   247,000 250,000 253, Latin America   68,000 68,000 69, EMEA   120,000 122,000 128, Asia Pacific   161,000 161,000 161,GHG Emissions from Operations per Million Dollars of Sales   (metric tons CO2e)   54 53 Total Waste19 (metric tons)   71,300 71,900 69, North America   27,700 28,500 28, Latin America   8,200 8,000 8, EMEA   27,300 25,800 23, Asia Pacific   8,100 9,600 9,Metric Tons of Total Waste per Million Dollars of Sales   6.42 6.33 5.97SECTION AND INDICATOR  2018 2019 2020 SECTION AND INDICATOR  2018 2019 2020BAXTER 2020 CORPORATE RESPONSIBILITY REPORT57Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Data Summary (continued)       Operations13  (continued) Nonhazardous Waste20 (metric tons)   62,800 62,800 63, North America   25,700 26,100 27, Latin America   6,900 6,600 6, EMEA   22,400 20,800 19,900   Asia Pacific   7,800 9,300 9,Metric Tons of Nonhazardous Waste per Million Dollars of Sales  5.66 5.52 5.Regulated Waste21 (metric tons)   8,500 9,100 6,200   North America   2,000 2,400 1, Latin America   1,300 1,400 1, EMEA   4,900 5,000 3, Asia Pacific   300 300 Metric Tons of Regulated Waste per Million Dollars of Sales   0.76 0.80 0.Waste Management at Baxter (% of total)    Recycled (on-site or off-site)   61.4% 56.8% 57.2%   Incinerated with Energy Recovery   18.8% 18.1% 19.2%   Incinerated   5.1% 5.1% 5.3%  Sent to Landfill   12.3% 17.0% 16.3%  Other Disposal   2.4% 3.0% 2.0% Water Usage (thousand cubic meters)   14,258 14,471 14, North America   5,071 5,204 5, Latin America   1,793 1,734 1, EMEA   /uniFEFF4,278 4,387 4, Asia Pacific   3,116 3,146 3,Thousand Cubic Meters Water Usage per Million Dollars of Sales  1.28 1.27 1.Water Usage, by Availability22 (thousand cubic meters)   13,820 14,021 13,966   Extremely High Water Stress   1,149 1,158 1, High Water Stress   2,855 2,929 2,868   Medium-High Water Stress   1,336 1,216 1,141   Low-Medium Water Stress   985 2,089 2, Low Water Stress   7,494 6,629 6,Wastewater Flow23 (total direct discharge, thousand cubic meters)   3,414 3,514 3,449   BOD5 (metric tons)   24 33 20    BOD5 (mg/L)   7 9 6   COD (metric tons)   61 86  COD (mg/L)   18 24 15   TSS (metric tons)   24 44  TSS (mg/L)   7 12 Environmental Compliance    Environmental Notices of Violation   11 22 6   Environmental Fines Paid24 (in dollars)   $79,500 $0 $   SECTION AND INDICATOR  2018 2019 2020 SECTION AND INDICATOR  2018 2019 Responsible Procurement and Logistics Spend with Suppliers25 (United States and Puerto Rico)    (approximate, dollars in billions)    $2.8 $2.9 $2.Supplier Diversity26 (dollars in millions)      Spend with Small Businesses   $378 $167 $144   Spend with Minority-Owned Businesses   $94 $102 $64   Spend with Women-Owned Businesses   $80 $96 $ Spend with Veteran-Owned Businesses   $13 $4 $Worldwide GHG Emissions from Product Transport, by Mode(metric tons CO2e)   516,700 440,000  447,400    Air   80,400 53,100 105,800     Ocean    62,300 51,900 33,200   Rail   21,100 21,800 12, Road    352,800 313,200 295,Worldwide GHG Emissions from Product Transport, by Region27  (metric tons CO2e)   516,700 440,000 447,400   North America   197,000 164,600 201, Latin America   50,800 64,200 59, EMEA    185,400 164,100 90, Asia Pacific    83,400 47,100  96,Baxter and the Baxter International Foundation Charitable Giving (dollars in millions) Total Charitable Giving   $17.62 $28.41 $38.Baxter Product Donations to Aid Organizations Products/Patient Assistance Programs   $5.60 $16.81 $24.Business and Facility Cash Donations   $5.36 $4.77 $5.
","('GHG_Emissions', 0.9658827781677246)","('Air_Quality', 0.005332409869879484)","('Ecological_Impacts', 0.0041699581779539585)","(['Climate Change'], 0.9658827781677246)","('NON-ESG', 0.005332409869879484)","('NON-ESG', 0.0041699581779539585)"
Line 1140,"5,205,000 4,854,000 4,493,GHG Emissions from Baxter Operations18 (metric tons CO2e)   596,000 601,000 611,000   North America   247,000 250,000 253, Latin America   68,000 68,000 69, EMEA   120,000 122,000 128, Asia Pacific   161,000 161,000 161,GHG Emissions from Operations per Million Dollars of Sales   (metric tons CO2e)   54 53 Total Waste19 (metric tons)   71,300 71,900 69, North America   27,700 28,500 28, Latin America   8,200 8,000 8, EMEA   27,300 25,800 23, Asia Pacific   8,100 9,600 9,Metric Tons of Total Waste per Million Dollars of Sales   6.42 6.33 5.97SECTION AND INDICATOR  2018 2019 2020 SECTION AND INDICATOR  2018 2019 2020BAXTER 2020 CORPORATE RESPONSIBILITY REPORT57Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Data Summary (continued)       Operations13  (continued) Nonhazardous Waste20 (metric tons)   62,800 62,800 63, North America   25,700 26,100 27, Latin America   6,900 6,600 6, EMEA   22,400 20,800 19,900   Asia Pacific   7,800 9,300 9,Metric Tons of Nonhazardous Waste per Million Dollars of Sales  5.66 5.52 5.Regulated Waste21 (metric tons)   8,500 9,100 6,200   North America   2,000 2,400 1, Latin America   1,300 1,400 1, EMEA   4,900 5,000 3, Asia Pacific   300 300 Metric Tons of Regulated Waste per Million Dollars of Sales   0.76 0.80 0.Waste Management at Baxter (% of total)    Recycled (on-site or off-site)   61.4% 56.8% 57.2%   Incinerated with Energy Recovery   18.8% 18.1% 19.2%   Incinerated   5.1% 5.1% 5.3%  Sent to Landfill   12.3% 17.0% 16.3%  Other Disposal   2.4% 3.0% 2.0% Water Usage (thousand cubic meters)   14,258 14,471 14, North America   5,071 5,204 5, Latin America   1,793 1,734 1, EMEA   /uniFEFF4,278 4,387 4, Asia Pacific   3,116 3,146 3,Thousand Cubic Meters Water Usage per Million Dollars of Sales  1.28 1.27 1.Water Usage, by Availability22 (thousand cubic meters)   13,820 14,021 13,966   Extremely High Water Stress   1,149 1,158 1, High Water Stress   2,855 2,929 2,868   Medium-High Water Stress   1,336 1,216 1,141   Low-Medium Water Stress   985 2,089 2, Low Water Stress   7,494 6,629 6,Wastewater Flow23 (total direct discharge, thousand cubic meters)   3,414 3,514 3,449   BOD5 (metric tons)   24 33 20    BOD5 (mg/L)   7 9 6   COD (metric tons)   61 86  COD (mg/L)   18 24 15   TSS (metric tons)   24 44  TSS (mg/L)   7 12 Environmental Compliance    Environmental Notices of Violation   11 22 6   Environmental Fines Paid24 (in dollars)   $79,500 $0 $   SECTION AND INDICATOR  2018 2019 2020 SECTION AND INDICATOR  2018 2019 Responsible Procurement and Logistics Spend with Suppliers25 (United States and Puerto Rico)    (approximate, dollars in billions)    $2.8 $2.9 $2.Supplier Diversity26 (dollars in millions)      Spend with Small Businesses   $378 $167 $144   Spend with Minority-Owned Businesses   $94 $102 $64   Spend with Women-Owned Businesses   $80 $96 $ Spend with Veteran-Owned Businesses   $13 $4 $Worldwide GHG Emissions from Product Transport, by Mode(metric tons CO2e)   516,700 440,000  447,400    Air   80,400 53,100 105,800     Ocean    62,300 51,900 33,200   Rail   21,100 21,800 12, Road    352,800 313,200 295,Worldwide GHG Emissions from Product Transport, by Region27  (metric tons CO2e)   516,700 440,000 447,400   North America   197,000 164,600 201, Latin America   50,800 64,200 59, EMEA    185,400 164,100 90, Asia Pacific    83,400 47,100  96,Baxter and the Baxter International Foundation Charitable Giving (dollars in millions) Total Charitable Giving   $17.62 $28.41 $38.Baxter Product Donations to Aid Organizations Products/Patient Assistance Programs   $5.60 $16.81 $24.Business and Facility Cash Donations   $5.36 $4.77 $5.
","('Waste_And_Hazardous_Materials_Management', 0.9605847597122192)","('Water_And_Wastewater_Management', 0.00436795549467206)","('Product_Design_And_Lifecycle_Management', 0.004098961595445871)","(['Operational Eco-Efficiency'], 0.9605847597122192)","('NON-ESG', 0.00436795549467206)","('NON-ESG', 0.004098961595445871)"
Line 1141,"5,205,000 4,854,000 4,493,GHG Emissions from Baxter Operations18 (metric tons CO2e)   596,000 601,000 611,000   North America   247,000 250,000 253, Latin America   68,000 68,000 69, EMEA   120,000 122,000 128, Asia Pacific   161,000 161,000 161,GHG Emissions from Operations per Million Dollars of Sales   (metric tons CO2e)   54 53 Total Waste19 (metric tons)   71,300 71,900 69, North America   27,700 28,500 28, Latin America   8,200 8,000 8, EMEA   27,300 25,800 23, Asia Pacific   8,100 9,600 9,Metric Tons of Total Waste per Million Dollars of Sales   6.42 6.33 5.97SECTION AND INDICATOR  2018 2019 2020 SECTION AND INDICATOR  2018 2019 2020BAXTER 2020 CORPORATE RESPONSIBILITY REPORT57Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Data Summary (continued)       Operations13  (continued) Nonhazardous Waste20 (metric tons)   62,800 62,800 63, North America   25,700 26,100 27, Latin America   6,900 6,600 6, EMEA   22,400 20,800 19,900   Asia Pacific   7,800 9,300 9,Metric Tons of Nonhazardous Waste per Million Dollars of Sales  5.66 5.52 5.Regulated Waste21 (metric tons)   8,500 9,100 6,200   North America   2,000 2,400 1, Latin America   1,300 1,400 1, EMEA   4,900 5,000 3, Asia Pacific   300 300 Metric Tons of Regulated Waste per Million Dollars of Sales   0.76 0.80 0.Waste Management at Baxter (% of total)    Recycled (on-site or off-site)   61.4% 56.8% 57.2%   Incinerated with Energy Recovery   18.8% 18.1% 19.2%   Incinerated   5.1% 5.1% 5.3%  Sent to Landfill   12.3% 17.0% 16.3%  Other Disposal   2.4% 3.0% 2.0% Water Usage (thousand cubic meters)   14,258 14,471 14, North America   5,071 5,204 5, Latin America   1,793 1,734 1, EMEA   /uniFEFF4,278 4,387 4, Asia Pacific   3,116 3,146 3,Thousand Cubic Meters Water Usage per Million Dollars of Sales  1.28 1.27 1.Water Usage, by Availability22 (thousand cubic meters)   13,820 14,021 13,966   Extremely High Water Stress   1,149 1,158 1, High Water Stress   2,855 2,929 2,868   Medium-High Water Stress   1,336 1,216 1,141   Low-Medium Water Stress   985 2,089 2, Low Water Stress   7,494 6,629 6,Wastewater Flow23 (total direct discharge, thousand cubic meters)   3,414 3,514 3,449   BOD5 (metric tons)   24 33 20    BOD5 (mg/L)   7 9 6   COD (metric tons)   61 86  COD (mg/L)   18 24 15   TSS (metric tons)   24 44  TSS (mg/L)   7 12 Environmental Compliance    Environmental Notices of Violation   11 22 6   Environmental Fines Paid24 (in dollars)   $79,500 $0 $   SECTION AND INDICATOR  2018 2019 2020 SECTION AND INDICATOR  2018 2019 Responsible Procurement and Logistics Spend with Suppliers25 (United States and Puerto Rico)    (approximate, dollars in billions)    $2.8 $2.9 $2.Supplier Diversity26 (dollars in millions)      Spend with Small Businesses   $378 $167 $144   Spend with Minority-Owned Businesses   $94 $102 $64   Spend with Women-Owned Businesses   $80 $96 $ Spend with Veteran-Owned Businesses   $13 $4 $Worldwide GHG Emissions from Product Transport, by Mode(metric tons CO2e)   516,700 440,000  447,400    Air   80,400 53,100 105,800     Ocean    62,300 51,900 33,200   Rail   21,100 21,800 12, Road    352,800 313,200 295,Worldwide GHG Emissions from Product Transport, by Region27  (metric tons CO2e)   516,700 440,000 447,400   North America   197,000 164,600 201, Latin America   50,800 64,200 59, EMEA    185,400 164,100 90, Asia Pacific    83,400 47,100  96,Baxter and the Baxter International Foundation Charitable Giving (dollars in millions) Total Charitable Giving   $17.62 $28.41 $38.Baxter Product Donations to Aid Organizations Products/Patient Assistance Programs   $5.60 $16.81 $24.Business and Facility Cash Donations   $5.36 $4.77 $5.
","('Waste_And_Hazardous_Materials_Management', 0.9839901924133301)","('Water_And_Wastewater_Management', 0.0016021691262722015)","('Data_Security', 0.0011958775576204062)","(['Operational Eco-Efficiency'], 0.9839901924133301)","('NON-ESG', 0.0016021691262722015)","('NON-ESG', 0.0011958775576204062)"
Line 1142,"5,205,000 4,854,000 4,493,GHG Emissions from Baxter Operations18 (metric tons CO2e)   596,000 601,000 611,000   North America   247,000 250,000 253, Latin America   68,000 68,000 69, EMEA   120,000 122,000 128, Asia Pacific   161,000 161,000 161,GHG Emissions from Operations per Million Dollars of Sales   (metric tons CO2e)   54 53 Total Waste19 (metric tons)   71,300 71,900 69, North America   27,700 28,500 28, Latin America   8,200 8,000 8, EMEA   27,300 25,800 23, Asia Pacific   8,100 9,600 9,Metric Tons of Total Waste per Million Dollars of Sales   6.42 6.33 5.97SECTION AND INDICATOR  2018 2019 2020 SECTION AND INDICATOR  2018 2019 2020BAXTER 2020 CORPORATE RESPONSIBILITY REPORT57Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Data Summary (continued)       Operations13  (continued) Nonhazardous Waste20 (metric tons)   62,800 62,800 63, North America   25,700 26,100 27, Latin America   6,900 6,600 6, EMEA   22,400 20,800 19,900   Asia Pacific   7,800 9,300 9,Metric Tons of Nonhazardous Waste per Million Dollars of Sales  5.66 5.52 5.Regulated Waste21 (metric tons)   8,500 9,100 6,200   North America   2,000 2,400 1, Latin America   1,300 1,400 1, EMEA   4,900 5,000 3, Asia Pacific   300 300 Metric Tons of Regulated Waste per Million Dollars of Sales   0.76 0.80 0.Waste Management at Baxter (% of total)    Recycled (on-site or off-site)   61.4% 56.8% 57.2%   Incinerated with Energy Recovery   18.8% 18.1% 19.2%   Incinerated   5.1% 5.1% 5.3%  Sent to Landfill   12.3% 17.0% 16.3%  Other Disposal   2.4% 3.0% 2.0% Water Usage (thousand cubic meters)   14,258 14,471 14, North America   5,071 5,204 5, Latin America   1,793 1,734 1, EMEA   /uniFEFF4,278 4,387 4, Asia Pacific   3,116 3,146 3,Thousand Cubic Meters Water Usage per Million Dollars of Sales  1.28 1.27 1.Water Usage, by Availability22 (thousand cubic meters)   13,820 14,021 13,966   Extremely High Water Stress   1,149 1,158 1, High Water Stress   2,855 2,929 2,868   Medium-High Water Stress   1,336 1,216 1,141   Low-Medium Water Stress   985 2,089 2, Low Water Stress   7,494 6,629 6,Wastewater Flow23 (total direct discharge, thousand cubic meters)   3,414 3,514 3,449   BOD5 (metric tons)   24 33 20    BOD5 (mg/L)   7 9 6   COD (metric tons)   61 86  COD (mg/L)   18 24 15   TSS (metric tons)   24 44  TSS (mg/L)   7 12 Environmental Compliance    Environmental Notices of Violation   11 22 6   Environmental Fines Paid24 (in dollars)   $79,500 $0 $   SECTION AND INDICATOR  2018 2019 2020 SECTION AND INDICATOR  2018 2019 Responsible Procurement and Logistics Spend with Suppliers25 (United States and Puerto Rico)    (approximate, dollars in billions)    $2.8 $2.9 $2.Supplier Diversity26 (dollars in millions)      Spend with Small Businesses   $378 $167 $144   Spend with Minority-Owned Businesses   $94 $102 $64   Spend with Women-Owned Businesses   $80 $96 $ Spend with Veteran-Owned Businesses   $13 $4 $Worldwide GHG Emissions from Product Transport, by Mode(metric tons CO2e)   516,700 440,000  447,400    Air   80,400 53,100 105,800     Ocean    62,300 51,900 33,200   Rail   21,100 21,800 12, Road    352,800 313,200 295,Worldwide GHG Emissions from Product Transport, by Region27  (metric tons CO2e)   516,700 440,000 447,400   North America   197,000 164,600 201, Latin America   50,800 64,200 59, EMEA    185,400 164,100 90, Asia Pacific    83,400 47,100  96,Baxter and the Baxter International Foundation Charitable Giving (dollars in millions) Total Charitable Giving   $17.62 $28.41 $38.Baxter Product Donations to Aid Organizations Products/Patient Assistance Programs   $5.60 $16.81 $24.Business and Facility Cash Donations   $5.36 $4.77 $5.
","('Water_And_Wastewater_Management', 0.8430872559547424)","('Waste_And_Hazardous_Materials_Management', 0.09238319098949432)","('Air_Quality', 0.00801230687648058)","(['Operational Eco-Efficiency'], 0.8430872559547424)","('NON-ESG', 0.09238319098949432)","('NON-ESG', 0.00801230687648058)"
Line 1143,"5,205,000 4,854,000 4,493,GHG Emissions from Baxter Operations18 (metric tons CO2e)   596,000 601,000 611,000   North America   247,000 250,000 253, Latin America   68,000 68,000 69, EMEA   120,000 122,000 128, Asia Pacific   161,000 161,000 161,GHG Emissions from Operations per Million Dollars of Sales   (metric tons CO2e)   54 53 Total Waste19 (metric tons)   71,300 71,900 69, North America   27,700 28,500 28, Latin America   8,200 8,000 8, EMEA   27,300 25,800 23, Asia Pacific   8,100 9,600 9,Metric Tons of Total Waste per Million Dollars of Sales   6.42 6.33 5.97SECTION AND INDICATOR  2018 2019 2020 SECTION AND INDICATOR  2018 2019 2020BAXTER 2020 CORPORATE RESPONSIBILITY REPORT57Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Data Summary (continued)       Operations13  (continued) Nonhazardous Waste20 (metric tons)   62,800 62,800 63, North America   25,700 26,100 27, Latin America   6,900 6,600 6, EMEA   22,400 20,800 19,900   Asia Pacific   7,800 9,300 9,Metric Tons of Nonhazardous Waste per Million Dollars of Sales  5.66 5.52 5.Regulated Waste21 (metric tons)   8,500 9,100 6,200   North America   2,000 2,400 1, Latin America   1,300 1,400 1, EMEA   4,900 5,000 3, Asia Pacific   300 300 Metric Tons of Regulated Waste per Million Dollars of Sales   0.76 0.80 0.Waste Management at Baxter (% of total)    Recycled (on-site or off-site)   61.4% 56.8% 57.2%   Incinerated with Energy Recovery   18.8% 18.1% 19.2%   Incinerated   5.1% 5.1% 5.3%  Sent to Landfill   12.3% 17.0% 16.3%  Other Disposal   2.4% 3.0% 2.0% Water Usage (thousand cubic meters)   14,258 14,471 14, North America   5,071 5,204 5, Latin America   1,793 1,734 1, EMEA   /uniFEFF4,278 4,387 4, Asia Pacific   3,116 3,146 3,Thousand Cubic Meters Water Usage per Million Dollars of Sales  1.28 1.27 1.Water Usage, by Availability22 (thousand cubic meters)   13,820 14,021 13,966   Extremely High Water Stress   1,149 1,158 1, High Water Stress   2,855 2,929 2,868   Medium-High Water Stress   1,336 1,216 1,141   Low-Medium Water Stress   985 2,089 2, Low Water Stress   7,494 6,629 6,Wastewater Flow23 (total direct discharge, thousand cubic meters)   3,414 3,514 3,449   BOD5 (metric tons)   24 33 20    BOD5 (mg/L)   7 9 6   COD (metric tons)   61 86  COD (mg/L)   18 24 15   TSS (metric tons)   24 44  TSS (mg/L)   7 12 Environmental Compliance    Environmental Notices of Violation   11 22 6   Environmental Fines Paid24 (in dollars)   $79,500 $0 $   SECTION AND INDICATOR  2018 2019 2020 SECTION AND INDICATOR  2018 2019 Responsible Procurement and Logistics Spend with Suppliers25 (United States and Puerto Rico)    (approximate, dollars in billions)    $2.8 $2.9 $2.Supplier Diversity26 (dollars in millions)      Spend with Small Businesses   $378 $167 $144   Spend with Minority-Owned Businesses   $94 $102 $64   Spend with Women-Owned Businesses   $80 $96 $ Spend with Veteran-Owned Businesses   $13 $4 $Worldwide GHG Emissions from Product Transport, by Mode(metric tons CO2e)   516,700 440,000  447,400    Air   80,400 53,100 105,800     Ocean    62,300 51,900 33,200   Rail   21,100 21,800 12, Road    352,800 313,200 295,Worldwide GHG Emissions from Product Transport, by Region27  (metric tons CO2e)   516,700 440,000 447,400   North America   197,000 164,600 201, Latin America   50,800 64,200 59, EMEA    185,400 164,100 90, Asia Pacific    83,400 47,100  96,Baxter and the Baxter International Foundation Charitable Giving (dollars in millions) Total Charitable Giving   $17.62 $28.41 $38.Baxter Product Donations to Aid Organizations Products/Patient Assistance Programs   $5.60 $16.81 $24.Business and Facility Cash Donations   $5.36 $4.77 $5.
","('Water_And_Wastewater_Management', 0.9675248861312866)","('GHG_Emissions', 0.004332022275775671)","('Waste_And_Hazardous_Materials_Management', 0.0029235922265797853)","(['Operational Eco-Efficiency'], 0.9675248861312866)","('NON-ESG', 0.004332022275775671)","('NON-ESG', 0.0029235922265797853)"
Line 1144,"5,205,000 4,854,000 4,493,GHG Emissions from Baxter Operations18 (metric tons CO2e)   596,000 601,000 611,000   North America   247,000 250,000 253, Latin America   68,000 68,000 69, EMEA   120,000 122,000 128, Asia Pacific   161,000 161,000 161,GHG Emissions from Operations per Million Dollars of Sales   (metric tons CO2e)   54 53 Total Waste19 (metric tons)   71,300 71,900 69, North America   27,700 28,500 28, Latin America   8,200 8,000 8, EMEA   27,300 25,800 23, Asia Pacific   8,100 9,600 9,Metric Tons of Total Waste per Million Dollars of Sales   6.42 6.33 5.97SECTION AND INDICATOR  2018 2019 2020 SECTION AND INDICATOR  2018 2019 2020BAXTER 2020 CORPORATE RESPONSIBILITY REPORT57Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Data Summary (continued)       Operations13  (continued) Nonhazardous Waste20 (metric tons)   62,800 62,800 63, North America   25,700 26,100 27, Latin America   6,900 6,600 6, EMEA   22,400 20,800 19,900   Asia Pacific   7,800 9,300 9,Metric Tons of Nonhazardous Waste per Million Dollars of Sales  5.66 5.52 5.Regulated Waste21 (metric tons)   8,500 9,100 6,200   North America   2,000 2,400 1, Latin America   1,300 1,400 1, EMEA   4,900 5,000 3, Asia Pacific   300 300 Metric Tons of Regulated Waste per Million Dollars of Sales   0.76 0.80 0.Waste Management at Baxter (% of total)    Recycled (on-site or off-site)   61.4% 56.8% 57.2%   Incinerated with Energy Recovery   18.8% 18.1% 19.2%   Incinerated   5.1% 5.1% 5.3%  Sent to Landfill   12.3% 17.0% 16.3%  Other Disposal   2.4% 3.0% 2.0% Water Usage (thousand cubic meters)   14,258 14,471 14, North America   5,071 5,204 5, Latin America   1,793 1,734 1, EMEA   /uniFEFF4,278 4,387 4, Asia Pacific   3,116 3,146 3,Thousand Cubic Meters Water Usage per Million Dollars of Sales  1.28 1.27 1.Water Usage, by Availability22 (thousand cubic meters)   13,820 14,021 13,966   Extremely High Water Stress   1,149 1,158 1, High Water Stress   2,855 2,929 2,868   Medium-High Water Stress   1,336 1,216 1,141   Low-Medium Water Stress   985 2,089 2, Low Water Stress   7,494 6,629 6,Wastewater Flow23 (total direct discharge, thousand cubic meters)   3,414 3,514 3,449   BOD5 (metric tons)   24 33 20    BOD5 (mg/L)   7 9 6   COD (metric tons)   61 86  COD (mg/L)   18 24 15   TSS (metric tons)   24 44  TSS (mg/L)   7 12 Environmental Compliance    Environmental Notices of Violation   11 22 6   Environmental Fines Paid24 (in dollars)   $79,500 $0 $   SECTION AND INDICATOR  2018 2019 2020 SECTION AND INDICATOR  2018 2019 Responsible Procurement and Logistics Spend with Suppliers25 (United States and Puerto Rico)    (approximate, dollars in billions)    $2.8 $2.9 $2.Supplier Diversity26 (dollars in millions)      Spend with Small Businesses   $378 $167 $144   Spend with Minority-Owned Businesses   $94 $102 $64   Spend with Women-Owned Businesses   $80 $96 $ Spend with Veteran-Owned Businesses   $13 $4 $Worldwide GHG Emissions from Product Transport, by Mode(metric tons CO2e)   516,700 440,000  447,400    Air   80,400 53,100 105,800     Ocean    62,300 51,900 33,200   Rail   21,100 21,800 12, Road    352,800 313,200 295,Worldwide GHG Emissions from Product Transport, by Region27  (metric tons CO2e)   516,700 440,000 447,400   North America   197,000 164,600 201, Latin America   50,800 64,200 59, EMEA    185,400 164,100 90, Asia Pacific    83,400 47,100  96,Baxter and the Baxter International Foundation Charitable Giving (dollars in millions) Total Charitable Giving   $17.62 $28.41 $38.Baxter Product Donations to Aid Organizations Products/Patient Assistance Programs   $5.60 $16.81 $24.Business and Facility Cash Donations   $5.36 $4.77 $5.
","('Employee_Engagement_Inclusion_And_Diversity', 0.636181116104126)","('Business_Ethics', 0.04274015128612518)","('Labor_Practices', 0.037133317440748215)","(['Human Capital Development'], 0.636181116104126)","('NON-ESG', 0.04274015128612518)","('NON-ESG', 0.037133317440748215)"
Line 1145,"5,205,000 4,854,000 4,493,GHG Emissions from Baxter Operations18 (metric tons CO2e)   596,000 601,000 611,000   North America   247,000 250,000 253, Latin America   68,000 68,000 69, EMEA   120,000 122,000 128, Asia Pacific   161,000 161,000 161,GHG Emissions from Operations per Million Dollars of Sales   (metric tons CO2e)   54 53 Total Waste19 (metric tons)   71,300 71,900 69, North America   27,700 28,500 28, Latin America   8,200 8,000 8, EMEA   27,300 25,800 23, Asia Pacific   8,100 9,600 9,Metric Tons of Total Waste per Million Dollars of Sales   6.42 6.33 5.97SECTION AND INDICATOR  2018 2019 2020 SECTION AND INDICATOR  2018 2019 2020BAXTER 2020 CORPORATE RESPONSIBILITY REPORT57Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Data Summary (continued)       Operations13  (continued) Nonhazardous Waste20 (metric tons)   62,800 62,800 63, North America   25,700 26,100 27, Latin America   6,900 6,600 6, EMEA   22,400 20,800 19,900   Asia Pacific   7,800 9,300 9,Metric Tons of Nonhazardous Waste per Million Dollars of Sales  5.66 5.52 5.Regulated Waste21 (metric tons)   8,500 9,100 6,200   North America   2,000 2,400 1, Latin America   1,300 1,400 1, EMEA   4,900 5,000 3, Asia Pacific   300 300 Metric Tons of Regulated Waste per Million Dollars of Sales   0.76 0.80 0.Waste Management at Baxter (% of total)    Recycled (on-site or off-site)   61.4% 56.8% 57.2%   Incinerated with Energy Recovery   18.8% 18.1% 19.2%   Incinerated   5.1% 5.1% 5.3%  Sent to Landfill   12.3% 17.0% 16.3%  Other Disposal   2.4% 3.0% 2.0% Water Usage (thousand cubic meters)   14,258 14,471 14, North America   5,071 5,204 5, Latin America   1,793 1,734 1, EMEA   /uniFEFF4,278 4,387 4, Asia Pacific   3,116 3,146 3,Thousand Cubic Meters Water Usage per Million Dollars of Sales  1.28 1.27 1.Water Usage, by Availability22 (thousand cubic meters)   13,820 14,021 13,966   Extremely High Water Stress   1,149 1,158 1, High Water Stress   2,855 2,929 2,868   Medium-High Water Stress   1,336 1,216 1,141   Low-Medium Water Stress   985 2,089 2, Low Water Stress   7,494 6,629 6,Wastewater Flow23 (total direct discharge, thousand cubic meters)   3,414 3,514 3,449   BOD5 (metric tons)   24 33 20    BOD5 (mg/L)   7 9 6   COD (metric tons)   61 86  COD (mg/L)   18 24 15   TSS (metric tons)   24 44  TSS (mg/L)   7 12 Environmental Compliance    Environmental Notices of Violation   11 22 6   Environmental Fines Paid24 (in dollars)   $79,500 $0 $   SECTION AND INDICATOR  2018 2019 2020 SECTION AND INDICATOR  2018 2019 Responsible Procurement and Logistics Spend with Suppliers25 (United States and Puerto Rico)    (approximate, dollars in billions)    $2.8 $2.9 $2.Supplier Diversity26 (dollars in millions)      Spend with Small Businesses   $378 $167 $144   Spend with Minority-Owned Businesses   $94 $102 $64   Spend with Women-Owned Businesses   $80 $96 $ Spend with Veteran-Owned Businesses   $13 $4 $Worldwide GHG Emissions from Product Transport, by Mode(metric tons CO2e)   516,700 440,000  447,400    Air   80,400 53,100 105,800     Ocean    62,300 51,900 33,200   Rail   21,100 21,800 12, Road    352,800 313,200 295,Worldwide GHG Emissions from Product Transport, by Region27  (metric tons CO2e)   516,700 440,000 447,400   North America   197,000 164,600 201, Latin America   50,800 64,200 59, EMEA    185,400 164,100 90, Asia Pacific    83,400 47,100  96,Baxter and the Baxter International Foundation Charitable Giving (dollars in millions) Total Charitable Giving   $17.62 $28.41 $38.Baxter Product Donations to Aid Organizations Products/Patient Assistance Programs   $5.60 $16.81 $24.Business and Facility Cash Donations   $5.36 $4.77 $5.
","('GHG_Emissions', 0.9618371725082397)","('Air_Quality', 0.007796960882842541)","('Ecological_Impacts', 0.003450110787525773)","(['Climate Change'], 0.9618371725082397)","('NON-ESG', 0.007796960882842541)","('NON-ESG', 0.003450110787525773)"
Line 1146,"5,205,000 4,854,000 4,493,GHG Emissions from Baxter Operations18 (metric tons CO2e)   596,000 601,000 611,000   North America   247,000 250,000 253, Latin America   68,000 68,000 69, EMEA   120,000 122,000 128, Asia Pacific   161,000 161,000 161,GHG Emissions from Operations per Million Dollars of Sales   (metric tons CO2e)   54 53 Total Waste19 (metric tons)   71,300 71,900 69, North America   27,700 28,500 28, Latin America   8,200 8,000 8, EMEA   27,300 25,800 23, Asia Pacific   8,100 9,600 9,Metric Tons of Total Waste per Million Dollars of Sales   6.42 6.33 5.97SECTION AND INDICATOR  2018 2019 2020 SECTION AND INDICATOR  2018 2019 2020BAXTER 2020 CORPORATE RESPONSIBILITY REPORT57Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Data Summary (continued)       Operations13  (continued) Nonhazardous Waste20 (metric tons)   62,800 62,800 63, North America   25,700 26,100 27, Latin America   6,900 6,600 6, EMEA   22,400 20,800 19,900   Asia Pacific   7,800 9,300 9,Metric Tons of Nonhazardous Waste per Million Dollars of Sales  5.66 5.52 5.Regulated Waste21 (metric tons)   8,500 9,100 6,200   North America   2,000 2,400 1, Latin America   1,300 1,400 1, EMEA   4,900 5,000 3, Asia Pacific   300 300 Metric Tons of Regulated Waste per Million Dollars of Sales   0.76 0.80 0.Waste Management at Baxter (% of total)    Recycled (on-site or off-site)   61.4% 56.8% 57.2%   Incinerated with Energy Recovery   18.8% 18.1% 19.2%   Incinerated   5.1% 5.1% 5.3%  Sent to Landfill   12.3% 17.0% 16.3%  Other Disposal   2.4% 3.0% 2.0% Water Usage (thousand cubic meters)   14,258 14,471 14, North America   5,071 5,204 5, Latin America   1,793 1,734 1, EMEA   /uniFEFF4,278 4,387 4, Asia Pacific   3,116 3,146 3,Thousand Cubic Meters Water Usage per Million Dollars of Sales  1.28 1.27 1.Water Usage, by Availability22 (thousand cubic meters)   13,820 14,021 13,966   Extremely High Water Stress   1,149 1,158 1, High Water Stress   2,855 2,929 2,868   Medium-High Water Stress   1,336 1,216 1,141   Low-Medium Water Stress   985 2,089 2, Low Water Stress   7,494 6,629 6,Wastewater Flow23 (total direct discharge, thousand cubic meters)   3,414 3,514 3,449   BOD5 (metric tons)   24 33 20    BOD5 (mg/L)   7 9 6   COD (metric tons)   61 86  COD (mg/L)   18 24 15   TSS (metric tons)   24 44  TSS (mg/L)   7 12 Environmental Compliance    Environmental Notices of Violation   11 22 6   Environmental Fines Paid24 (in dollars)   $79,500 $0 $   SECTION AND INDICATOR  2018 2019 2020 SECTION AND INDICATOR  2018 2019 Responsible Procurement and Logistics Spend with Suppliers25 (United States and Puerto Rico)    (approximate, dollars in billions)    $2.8 $2.9 $2.Supplier Diversity26 (dollars in millions)      Spend with Small Businesses   $378 $167 $144   Spend with Minority-Owned Businesses   $94 $102 $64   Spend with Women-Owned Businesses   $80 $96 $ Spend with Veteran-Owned Businesses   $13 $4 $Worldwide GHG Emissions from Product Transport, by Mode(metric tons CO2e)   516,700 440,000  447,400    Air   80,400 53,100 105,800     Ocean    62,300 51,900 33,200   Rail   21,100 21,800 12, Road    352,800 313,200 295,Worldwide GHG Emissions from Product Transport, by Region27  (metric tons CO2e)   516,700 440,000 447,400   North America   197,000 164,600 201, Latin America   50,800 64,200 59, EMEA    185,400 164,100 90, Asia Pacific    83,400 47,100  96,Baxter and the Baxter International Foundation Charitable Giving (dollars in millions) Total Charitable Giving   $17.62 $28.41 $38.Baxter Product Donations to Aid Organizations Products/Patient Assistance Programs   $5.60 $16.81 $24.Business and Facility Cash Donations   $5.36 $4.77 $5.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4743267893791199)","('Access_And_Affordability', 0.22086377441883087)","('Human_Rights_And_Community_Relations', 0.041548583656549454)","('NON-ESG', 0.4743267893791199)","('NON-ESG', 0.22086377441883087)","('NON-ESG', 0.041548583656549454)"
Line 1147,"Within the United States    $1.55 $1.21 $2.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5985021591186523)","('Energy_Management', 0.09622424095869064)","('Systemic_Risk_Management', 0.06421352177858353)","(['Corporate Governance'], 0.5985021591186523)","('NON-ESG', 0.09622424095869064)","('NON-ESG', 0.06421352177858353)"
Line 1148,"Outside the United States   $3.81 $3.56 $3.The Baxter International Foundation Contributions   $6.66 $6.83 $8.
","('Management_Of_Legal_And_Regulatory_Framework', 0.721534013748169)","('Ecological_Impacts', 0.03968792036175728)","('Director_Removal', 0.026464352384209633)","(['Corporate Governance'], 0.721534013748169)","('NON-ESG', 0.03968792036175728)","('NON-ESG', 0.026464352384209633)"
Line 1149,"Within the United States (including Puerto Rico)   $6.08 $6.06 $7.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7748327851295471)","('Competitive_Behavior', 0.05589762702584267)","('Energy_Management', 0.024799002334475517)","(['Corporate Governance'], 0.7748327851295471)","('NON-ESG', 0.05589762702584267)","('NON-ESG', 0.024799002334475517)"
Line 1150,"Grants29   $4.64 $4.77 $6.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9079264998435974)","('Director_Removal', 0.009190458804368973)","('Energy_Management', 0.008737840689718723)","(['Corporate Governance'], 0.9079264998435974)","('NON-ESG', 0.009190458804368973)","('NON-ESG', 0.008737840689718723)"
Line 1151,"Matching Gifts and Dollars for Doers   $0.83 $0.81 $0.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5761572122573853)","('Labor_Practices', 0.06834924221038818)","('Business_Ethics', 0.0569307766854763)","(['Corporate Governance'], 0.5761572122573853)","('NON-ESG', 0.06834924221038818)","('NON-ESG', 0.0569307766854763)"
Line 1152,"Scholarships   $0.20 $0.15 $0.
","('Management_Of_Legal_And_Regulatory_Framework', 0.644866943359375)","('Business_Ethics', 0.05272511765360832)","('Access_And_Affordability', 0.05248378962278366)","(['Corporate Governance'], 0.644866943359375)","('NON-ESG', 0.05272511765360832)","('NON-ESG', 0.05248378962278366)"
Line 1153,"Prize Programs   $0.41 $0.33 $0.
","('Management_Of_Legal_And_Regulatory_Framework', 0.436538428068161)","('Competitive_Behavior', 0.1487566977739334)","('Business_Ethics', 0.10981200635433197)","('NON-ESG', 0.436538428068161)","('NON-ESG', 0.1487566977739334)","('NON-ESG', 0.10981200635433197)"
Line 1154,"Outside the United States   $0.58 $0.77 $0.
","('Management_Of_Legal_And_Regulatory_Framework', 0.632627546787262)","('Competitive_Behavior', 0.07544650882482529)","('Energy_Management', 0.0588681697845459)","(['Corporate Governance'], 0.632627546787262)","('NON-ESG', 0.07544650882482529)","('NON-ESG', 0.0588681697845459)"
Line 1155,"Grants   $0.43 $0.66 $0.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9123247265815735)","('Director_Removal', 0.008794503286480904)","('Energy_Management', 0.008098515681922436)","(['Corporate Governance'], 0.9123247265815735)","('NON-ESG', 0.008794503286480904)","('NON-ESG', 0.008098515681922436)"
Line 1156,"Scholarships   $0.15 $0.11 $0.Political Contributions See Baxter ’s 2020 Political Contributions Report for detailed data.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7194460034370422)","('Director_Removal', 0.052035216242074966)","('Labor_Practices', 0.041438374668359756)","(['Corporate Governance'], 0.7194460034370422)","('NON-ESG', 0.052035216242074966)","('NON-ESG', 0.041438374668359756)"
Line 1157,"BAXTER 2020 CORPORATE RESPONSIBILITY REPORT58Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Value Chain Energy Usage and GHG Emissions  Apex Companies LLC has provided assurance on the content in this section.
","('GHG_Emissions', 0.9628450274467468)","('Air_Quality', 0.0050308192148804665)","('Physical_Impacts_Of_Climate_Change', 0.004047912545502186)","(['Climate Change'], 0.9628450274467468)","('NON-ESG', 0.0050308192148804665)","('NON-ESG', 0.004047912545502186)"
Line 1158,"Units 2018 2019 2020 2018 2019 2020 2018 2019 2020 2018 2019 Baxter OperationsScope 1 - Stationary Sources (facilities) Natural Gas  Million Cubic Meters 111 114 121 4,263 4,384 4,631 $32.8 $34.7 $33.0 214 221 Fuel Oil Million Liters 6 5 6 248 208 235 $3.5 $3.1 $3.3 17 15 Propane and LPG Million Kilograms 7 7 8 341 359 363 $5.7 $5.1 $4.6 21 22 Biomass4 Million Kilograms 135 144 138 940 986 966 $3.2 $4.4 $5.6  2 2 Subtotal  /uniFEFFn/a n/a n/a 5,792 5,937 6,195 $45.2 $47.3 $46.5 254 260 Scope 1 - Mobile Sources (Baxter-operated vehicles)Aviation Fuel Million Liters 0.4 0.4 0.3 13 14 9 $0.2 $0.3 $0.2 1 1 Gasoline  Million Liters 5.2 6.8 4.4 189 245 158 $6.0 $8.7 $4.8 12 15 Diesel Fuel   Million Liters 6.5 7.2 6.7 252 275 258 $5.9 $6.6 $4.1 18 19 Subtotal Million Liters  12.1 14.4 11.4 454 534 425 $12.1 $15.6 $9.1 31 35 RefrigerantsRefrigerant Losses (facilities) Metric Tons /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 9 8 Scope 1 Total    /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 294 303 Scope 2 - Electricity and Purchased Steam     Electricity (purchased)7 Million Kilowatt-Hours 988 995 983 3,578 3,599 3,555 $107.6 $112.0 $109.7 274 268 Electricity (on-site renewable) Million  Kilowatt-Hours 4 3 2 13 12 7 n/a n/a n/a n/a n/a n/a Cogen Losses Million  Kilowatt-Hours 46 68 61 166 245 220 n/a n/a n/a n/a n/a n/a Purchased Steam Million Kilograms 48 54 54 113 124 126 $1.5 $1.7 $1.4 30 30 Scope 2 Total (market-based)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 304 298 Scope 2 Total (location-based)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 430 412 Baxter Operations Total  /uniFEFFn/a n/a n/a 10,116 10,451 10,528 $166.4 $176.6 $166.7 598 601 Scope 3 Emissions   Purchased Goods and Services (Category 1)8  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 787 805 Capital Goods (Category 2)9  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 82 87 Fuel and Energy-related Activities (Category 3)10  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 147 148 Upstream Transportation and Distribution (Category 4)11  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 517 440 Waste Generated in Operations (Category 5)12  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 13 15 Business Travel (Category 6)13  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 54 51 Employee Commuting (Category 7)14  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 29 29 Upstream Leased Assets (Category 8)15  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Downstream Transportation and Distribution (Category 9)16  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 132 131 Processing of Sold Products (Category 10)17  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 17 16 Use of Sold Products (Category 11)18  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 2,658 2,366 2,End-of-life Treatment of Sold Products (Category 12)18  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 171 165 Downstream Leased Assets (Category 13)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Franchises (Category 14)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Investments (Category 15)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Scope 3 Emissions Total  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 4,607 4,253 3,Total  GHG E missions19 /uniFEFF n/a n/a n/a n/a n/a n/a n/a n/a n/a 5,205 4,854 4,493ENERGY USAGE JOULES (TRILLIONS)ENERGY COSTS (DOLLARS IN MILLIONS)CARBON DIOXIDE EQUIVALENTS1,(THOUSAND METRIC TONS)BAXTER 2020 CORPORATE RESPONSIBILITY REPORT59Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Facilities with ISO 14001, ISO 45001, ISO 50001 and Green Building Certifications1  Apex Companies LLC has provided assurance on the content in this section.
","('Energy_Management', 0.34385058283805847)","('GHG_Emissions', 0.30878254771232605)","('Management_Of_Legal_And_Regulatory_Framework', 0.09556949138641357)","('NON-ESG', 0.34385058283805847)","('NON-ESG', 0.30878254771232605)","('NON-ESG', 0.09556949138641357)"
Line 1159,"Units 2018 2019 2020 2018 2019 2020 2018 2019 2020 2018 2019 Baxter OperationsScope 1 - Stationary Sources (facilities) Natural Gas  Million Cubic Meters 111 114 121 4,263 4,384 4,631 $32.8 $34.7 $33.0 214 221 Fuel Oil Million Liters 6 5 6 248 208 235 $3.5 $3.1 $3.3 17 15 Propane and LPG Million Kilograms 7 7 8 341 359 363 $5.7 $5.1 $4.6 21 22 Biomass4 Million Kilograms 135 144 138 940 986 966 $3.2 $4.4 $5.6  2 2 Subtotal  /uniFEFFn/a n/a n/a 5,792 5,937 6,195 $45.2 $47.3 $46.5 254 260 Scope 1 - Mobile Sources (Baxter-operated vehicles)Aviation Fuel Million Liters 0.4 0.4 0.3 13 14 9 $0.2 $0.3 $0.2 1 1 Gasoline  Million Liters 5.2 6.8 4.4 189 245 158 $6.0 $8.7 $4.8 12 15 Diesel Fuel   Million Liters 6.5 7.2 6.7 252 275 258 $5.9 $6.6 $4.1 18 19 Subtotal Million Liters  12.1 14.4 11.4 454 534 425 $12.1 $15.6 $9.1 31 35 RefrigerantsRefrigerant Losses (facilities) Metric Tons /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 9 8 Scope 1 Total    /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 294 303 Scope 2 - Electricity and Purchased Steam     Electricity (purchased)7 Million Kilowatt-Hours 988 995 983 3,578 3,599 3,555 $107.6 $112.0 $109.7 274 268 Electricity (on-site renewable) Million  Kilowatt-Hours 4 3 2 13 12 7 n/a n/a n/a n/a n/a n/a Cogen Losses Million  Kilowatt-Hours 46 68 61 166 245 220 n/a n/a n/a n/a n/a n/a Purchased Steam Million Kilograms 48 54 54 113 124 126 $1.5 $1.7 $1.4 30 30 Scope 2 Total (market-based)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 304 298 Scope 2 Total (location-based)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 430 412 Baxter Operations Total  /uniFEFFn/a n/a n/a 10,116 10,451 10,528 $166.4 $176.6 $166.7 598 601 Scope 3 Emissions   Purchased Goods and Services (Category 1)8  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 787 805 Capital Goods (Category 2)9  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 82 87 Fuel and Energy-related Activities (Category 3)10  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 147 148 Upstream Transportation and Distribution (Category 4)11  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 517 440 Waste Generated in Operations (Category 5)12  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 13 15 Business Travel (Category 6)13  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 54 51 Employee Commuting (Category 7)14  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 29 29 Upstream Leased Assets (Category 8)15  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Downstream Transportation and Distribution (Category 9)16  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 132 131 Processing of Sold Products (Category 10)17  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 17 16 Use of Sold Products (Category 11)18  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 2,658 2,366 2,End-of-life Treatment of Sold Products (Category 12)18  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 171 165 Downstream Leased Assets (Category 13)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Franchises (Category 14)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Investments (Category 15)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Scope 3 Emissions Total  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 4,607 4,253 3,Total  GHG E missions19 /uniFEFF n/a n/a n/a n/a n/a n/a n/a n/a n/a 5,205 4,854 4,493ENERGY USAGE JOULES (TRILLIONS)ENERGY COSTS (DOLLARS IN MILLIONS)CARBON DIOXIDE EQUIVALENTS1,(THOUSAND METRIC TONS)BAXTER 2020 CORPORATE RESPONSIBILITY REPORT59Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Facilities with ISO 14001, ISO 45001, ISO 50001 and Green Building Certifications1  Apex Companies LLC has provided assurance on the content in this section.
","('Energy_Management', 0.8087137341499329)","('GHG_Emissions', 0.03637895733118057)","('Management_Of_Legal_And_Regulatory_Framework', 0.028684785589575768)","(['Operational Eco-Efficiency'], 0.8087137341499329)","('NON-ESG', 0.03637895733118057)","('NON-ESG', 0.028684785589575768)"
Line 1160,"Units 2018 2019 2020 2018 2019 2020 2018 2019 2020 2018 2019 Baxter OperationsScope 1 - Stationary Sources (facilities) Natural Gas  Million Cubic Meters 111 114 121 4,263 4,384 4,631 $32.8 $34.7 $33.0 214 221 Fuel Oil Million Liters 6 5 6 248 208 235 $3.5 $3.1 $3.3 17 15 Propane and LPG Million Kilograms 7 7 8 341 359 363 $5.7 $5.1 $4.6 21 22 Biomass4 Million Kilograms 135 144 138 940 986 966 $3.2 $4.4 $5.6  2 2 Subtotal  /uniFEFFn/a n/a n/a 5,792 5,937 6,195 $45.2 $47.3 $46.5 254 260 Scope 1 - Mobile Sources (Baxter-operated vehicles)Aviation Fuel Million Liters 0.4 0.4 0.3 13 14 9 $0.2 $0.3 $0.2 1 1 Gasoline  Million Liters 5.2 6.8 4.4 189 245 158 $6.0 $8.7 $4.8 12 15 Diesel Fuel   Million Liters 6.5 7.2 6.7 252 275 258 $5.9 $6.6 $4.1 18 19 Subtotal Million Liters  12.1 14.4 11.4 454 534 425 $12.1 $15.6 $9.1 31 35 RefrigerantsRefrigerant Losses (facilities) Metric Tons /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 9 8 Scope 1 Total    /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 294 303 Scope 2 - Electricity and Purchased Steam     Electricity (purchased)7 Million Kilowatt-Hours 988 995 983 3,578 3,599 3,555 $107.6 $112.0 $109.7 274 268 Electricity (on-site renewable) Million  Kilowatt-Hours 4 3 2 13 12 7 n/a n/a n/a n/a n/a n/a Cogen Losses Million  Kilowatt-Hours 46 68 61 166 245 220 n/a n/a n/a n/a n/a n/a Purchased Steam Million Kilograms 48 54 54 113 124 126 $1.5 $1.7 $1.4 30 30 Scope 2 Total (market-based)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 304 298 Scope 2 Total (location-based)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 430 412 Baxter Operations Total  /uniFEFFn/a n/a n/a 10,116 10,451 10,528 $166.4 $176.6 $166.7 598 601 Scope 3 Emissions   Purchased Goods and Services (Category 1)8  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 787 805 Capital Goods (Category 2)9  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 82 87 Fuel and Energy-related Activities (Category 3)10  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 147 148 Upstream Transportation and Distribution (Category 4)11  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 517 440 Waste Generated in Operations (Category 5)12  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 13 15 Business Travel (Category 6)13  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 54 51 Employee Commuting (Category 7)14  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 29 29 Upstream Leased Assets (Category 8)15  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Downstream Transportation and Distribution (Category 9)16  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 132 131 Processing of Sold Products (Category 10)17  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 17 16 Use of Sold Products (Category 11)18  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 2,658 2,366 2,End-of-life Treatment of Sold Products (Category 12)18  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 171 165 Downstream Leased Assets (Category 13)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Franchises (Category 14)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Investments (Category 15)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Scope 3 Emissions Total  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 4,607 4,253 3,Total  GHG E missions19 /uniFEFF n/a n/a n/a n/a n/a n/a n/a n/a n/a 5,205 4,854 4,493ENERGY USAGE JOULES (TRILLIONS)ENERGY COSTS (DOLLARS IN MILLIONS)CARBON DIOXIDE EQUIVALENTS1,(THOUSAND METRIC TONS)BAXTER 2020 CORPORATE RESPONSIBILITY REPORT59Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Facilities with ISO 14001, ISO 45001, ISO 50001 and Green Building Certifications1  Apex Companies LLC has provided assurance on the content in this section.
","('Energy_Management', 0.96479332447052)","('Management_Of_Legal_And_Regulatory_Framework', 0.00574059784412384)","('Water_And_Wastewater_Management', 0.0036310616414994)","(['Operational Eco-Efficiency'], 0.96479332447052)","('NON-ESG', 0.00574059784412384)","('NON-ESG', 0.0036310616414994)"
Line 1161,"Units 2018 2019 2020 2018 2019 2020 2018 2019 2020 2018 2019 Baxter OperationsScope 1 - Stationary Sources (facilities) Natural Gas  Million Cubic Meters 111 114 121 4,263 4,384 4,631 $32.8 $34.7 $33.0 214 221 Fuel Oil Million Liters 6 5 6 248 208 235 $3.5 $3.1 $3.3 17 15 Propane and LPG Million Kilograms 7 7 8 341 359 363 $5.7 $5.1 $4.6 21 22 Biomass4 Million Kilograms 135 144 138 940 986 966 $3.2 $4.4 $5.6  2 2 Subtotal  /uniFEFFn/a n/a n/a 5,792 5,937 6,195 $45.2 $47.3 $46.5 254 260 Scope 1 - Mobile Sources (Baxter-operated vehicles)Aviation Fuel Million Liters 0.4 0.4 0.3 13 14 9 $0.2 $0.3 $0.2 1 1 Gasoline  Million Liters 5.2 6.8 4.4 189 245 158 $6.0 $8.7 $4.8 12 15 Diesel Fuel   Million Liters 6.5 7.2 6.7 252 275 258 $5.9 $6.6 $4.1 18 19 Subtotal Million Liters  12.1 14.4 11.4 454 534 425 $12.1 $15.6 $9.1 31 35 RefrigerantsRefrigerant Losses (facilities) Metric Tons /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 9 8 Scope 1 Total    /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 294 303 Scope 2 - Electricity and Purchased Steam     Electricity (purchased)7 Million Kilowatt-Hours 988 995 983 3,578 3,599 3,555 $107.6 $112.0 $109.7 274 268 Electricity (on-site renewable) Million  Kilowatt-Hours 4 3 2 13 12 7 n/a n/a n/a n/a n/a n/a Cogen Losses Million  Kilowatt-Hours 46 68 61 166 245 220 n/a n/a n/a n/a n/a n/a Purchased Steam Million Kilograms 48 54 54 113 124 126 $1.5 $1.7 $1.4 30 30 Scope 2 Total (market-based)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 304 298 Scope 2 Total (location-based)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 430 412 Baxter Operations Total  /uniFEFFn/a n/a n/a 10,116 10,451 10,528 $166.4 $176.6 $166.7 598 601 Scope 3 Emissions   Purchased Goods and Services (Category 1)8  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 787 805 Capital Goods (Category 2)9  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 82 87 Fuel and Energy-related Activities (Category 3)10  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 147 148 Upstream Transportation and Distribution (Category 4)11  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 517 440 Waste Generated in Operations (Category 5)12  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 13 15 Business Travel (Category 6)13  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 54 51 Employee Commuting (Category 7)14  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 29 29 Upstream Leased Assets (Category 8)15  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Downstream Transportation and Distribution (Category 9)16  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 132 131 Processing of Sold Products (Category 10)17  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 17 16 Use of Sold Products (Category 11)18  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 2,658 2,366 2,End-of-life Treatment of Sold Products (Category 12)18  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 171 165 Downstream Leased Assets (Category 13)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Franchises (Category 14)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Investments (Category 15)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Scope 3 Emissions Total  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 4,607 4,253 3,Total  GHG E missions19 /uniFEFF n/a n/a n/a n/a n/a n/a n/a n/a n/a 5,205 4,854 4,493ENERGY USAGE JOULES (TRILLIONS)ENERGY COSTS (DOLLARS IN MILLIONS)CARBON DIOXIDE EQUIVALENTS1,(THOUSAND METRIC TONS)BAXTER 2020 CORPORATE RESPONSIBILITY REPORT59Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Facilities with ISO 14001, ISO 45001, ISO 50001 and Green Building Certifications1  Apex Companies LLC has provided assurance on the content in this section.
","('Product_Design_And_Lifecycle_Management', 0.3450894355773926)","('Supply_Chain_Management', 0.1488552689552307)","('Energy_Management', 0.14623242616653442)","('NON-ESG', 0.3450894355773926)","('NON-ESG', 0.1488552689552307)","('NON-ESG', 0.14623242616653442)"
Line 1162,"Units 2018 2019 2020 2018 2019 2020 2018 2019 2020 2018 2019 Baxter OperationsScope 1 - Stationary Sources (facilities) Natural Gas  Million Cubic Meters 111 114 121 4,263 4,384 4,631 $32.8 $34.7 $33.0 214 221 Fuel Oil Million Liters 6 5 6 248 208 235 $3.5 $3.1 $3.3 17 15 Propane and LPG Million Kilograms 7 7 8 341 359 363 $5.7 $5.1 $4.6 21 22 Biomass4 Million Kilograms 135 144 138 940 986 966 $3.2 $4.4 $5.6  2 2 Subtotal  /uniFEFFn/a n/a n/a 5,792 5,937 6,195 $45.2 $47.3 $46.5 254 260 Scope 1 - Mobile Sources (Baxter-operated vehicles)Aviation Fuel Million Liters 0.4 0.4 0.3 13 14 9 $0.2 $0.3 $0.2 1 1 Gasoline  Million Liters 5.2 6.8 4.4 189 245 158 $6.0 $8.7 $4.8 12 15 Diesel Fuel   Million Liters 6.5 7.2 6.7 252 275 258 $5.9 $6.6 $4.1 18 19 Subtotal Million Liters  12.1 14.4 11.4 454 534 425 $12.1 $15.6 $9.1 31 35 RefrigerantsRefrigerant Losses (facilities) Metric Tons /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 9 8 Scope 1 Total    /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 294 303 Scope 2 - Electricity and Purchased Steam     Electricity (purchased)7 Million Kilowatt-Hours 988 995 983 3,578 3,599 3,555 $107.6 $112.0 $109.7 274 268 Electricity (on-site renewable) Million  Kilowatt-Hours 4 3 2 13 12 7 n/a n/a n/a n/a n/a n/a Cogen Losses Million  Kilowatt-Hours 46 68 61 166 245 220 n/a n/a n/a n/a n/a n/a Purchased Steam Million Kilograms 48 54 54 113 124 126 $1.5 $1.7 $1.4 30 30 Scope 2 Total (market-based)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 304 298 Scope 2 Total (location-based)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 430 412 Baxter Operations Total  /uniFEFFn/a n/a n/a 10,116 10,451 10,528 $166.4 $176.6 $166.7 598 601 Scope 3 Emissions   Purchased Goods and Services (Category 1)8  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 787 805 Capital Goods (Category 2)9  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 82 87 Fuel and Energy-related Activities (Category 3)10  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 147 148 Upstream Transportation and Distribution (Category 4)11  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 517 440 Waste Generated in Operations (Category 5)12  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 13 15 Business Travel (Category 6)13  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 54 51 Employee Commuting (Category 7)14  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 29 29 Upstream Leased Assets (Category 8)15  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Downstream Transportation and Distribution (Category 9)16  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 132 131 Processing of Sold Products (Category 10)17  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 17 16 Use of Sold Products (Category 11)18  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 2,658 2,366 2,End-of-life Treatment of Sold Products (Category 12)18  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 171 165 Downstream Leased Assets (Category 13)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Franchises (Category 14)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Investments (Category 15)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Scope 3 Emissions Total  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 4,607 4,253 3,Total  GHG E missions19 /uniFEFF n/a n/a n/a n/a n/a n/a n/a n/a n/a 5,205 4,854 4,493ENERGY USAGE JOULES (TRILLIONS)ENERGY COSTS (DOLLARS IN MILLIONS)CARBON DIOXIDE EQUIVALENTS1,(THOUSAND METRIC TONS)BAXTER 2020 CORPORATE RESPONSIBILITY REPORT59Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Facilities with ISO 14001, ISO 45001, ISO 50001 and Green Building Certifications1  Apex Companies LLC has provided assurance on the content in this section.
","('Waste_And_Hazardous_Materials_Management', 0.9804983139038086)","('Water_And_Wastewater_Management', 0.0024667277466505766)","('Air_Quality', 0.001350617385469377)","(['Operational Eco-Efficiency'], 0.9804983139038086)","('NON-ESG', 0.0024667277466505766)","('NON-ESG', 0.001350617385469377)"
Line 1163,"Units 2018 2019 2020 2018 2019 2020 2018 2019 2020 2018 2019 Baxter OperationsScope 1 - Stationary Sources (facilities) Natural Gas  Million Cubic Meters 111 114 121 4,263 4,384 4,631 $32.8 $34.7 $33.0 214 221 Fuel Oil Million Liters 6 5 6 248 208 235 $3.5 $3.1 $3.3 17 15 Propane and LPG Million Kilograms 7 7 8 341 359 363 $5.7 $5.1 $4.6 21 22 Biomass4 Million Kilograms 135 144 138 940 986 966 $3.2 $4.4 $5.6  2 2 Subtotal  /uniFEFFn/a n/a n/a 5,792 5,937 6,195 $45.2 $47.3 $46.5 254 260 Scope 1 - Mobile Sources (Baxter-operated vehicles)Aviation Fuel Million Liters 0.4 0.4 0.3 13 14 9 $0.2 $0.3 $0.2 1 1 Gasoline  Million Liters 5.2 6.8 4.4 189 245 158 $6.0 $8.7 $4.8 12 15 Diesel Fuel   Million Liters 6.5 7.2 6.7 252 275 258 $5.9 $6.6 $4.1 18 19 Subtotal Million Liters  12.1 14.4 11.4 454 534 425 $12.1 $15.6 $9.1 31 35 RefrigerantsRefrigerant Losses (facilities) Metric Tons /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 9 8 Scope 1 Total    /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 294 303 Scope 2 - Electricity and Purchased Steam     Electricity (purchased)7 Million Kilowatt-Hours 988 995 983 3,578 3,599 3,555 $107.6 $112.0 $109.7 274 268 Electricity (on-site renewable) Million  Kilowatt-Hours 4 3 2 13 12 7 n/a n/a n/a n/a n/a n/a Cogen Losses Million  Kilowatt-Hours 46 68 61 166 245 220 n/a n/a n/a n/a n/a n/a Purchased Steam Million Kilograms 48 54 54 113 124 126 $1.5 $1.7 $1.4 30 30 Scope 2 Total (market-based)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 304 298 Scope 2 Total (location-based)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 430 412 Baxter Operations Total  /uniFEFFn/a n/a n/a 10,116 10,451 10,528 $166.4 $176.6 $166.7 598 601 Scope 3 Emissions   Purchased Goods and Services (Category 1)8  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 787 805 Capital Goods (Category 2)9  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 82 87 Fuel and Energy-related Activities (Category 3)10  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 147 148 Upstream Transportation and Distribution (Category 4)11  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 517 440 Waste Generated in Operations (Category 5)12  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 13 15 Business Travel (Category 6)13  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 54 51 Employee Commuting (Category 7)14  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 29 29 Upstream Leased Assets (Category 8)15  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Downstream Transportation and Distribution (Category 9)16  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 132 131 Processing of Sold Products (Category 10)17  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 17 16 Use of Sold Products (Category 11)18  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 2,658 2,366 2,End-of-life Treatment of Sold Products (Category 12)18  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 171 165 Downstream Leased Assets (Category 13)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Franchises (Category 14)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Investments (Category 15)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Scope 3 Emissions Total  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 4,607 4,253 3,Total  GHG E missions19 /uniFEFF n/a n/a n/a n/a n/a n/a n/a n/a n/a 5,205 4,854 4,493ENERGY USAGE JOULES (TRILLIONS)ENERGY COSTS (DOLLARS IN MILLIONS)CARBON DIOXIDE EQUIVALENTS1,(THOUSAND METRIC TONS)BAXTER 2020 CORPORATE RESPONSIBILITY REPORT59Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Facilities with ISO 14001, ISO 45001, ISO 50001 and Green Building Certifications1  Apex Companies LLC has provided assurance on the content in this section.
","('Product_Design_And_Lifecycle_Management', 0.9298084378242493)","('Selling_Practices_And_Product_Labeling', 0.011144386604428291)","('Customer_Welfare', 0.010441388003528118)","(['Product Stewardship'], 0.9298084378242493)","('NON-ESG', 0.011144386604428291)","('NON-ESG', 0.010441388003528118)"
Line 1164,"Units 2018 2019 2020 2018 2019 2020 2018 2019 2020 2018 2019 Baxter OperationsScope 1 - Stationary Sources (facilities) Natural Gas  Million Cubic Meters 111 114 121 4,263 4,384 4,631 $32.8 $34.7 $33.0 214 221 Fuel Oil Million Liters 6 5 6 248 208 235 $3.5 $3.1 $3.3 17 15 Propane and LPG Million Kilograms 7 7 8 341 359 363 $5.7 $5.1 $4.6 21 22 Biomass4 Million Kilograms 135 144 138 940 986 966 $3.2 $4.4 $5.6  2 2 Subtotal  /uniFEFFn/a n/a n/a 5,792 5,937 6,195 $45.2 $47.3 $46.5 254 260 Scope 1 - Mobile Sources (Baxter-operated vehicles)Aviation Fuel Million Liters 0.4 0.4 0.3 13 14 9 $0.2 $0.3 $0.2 1 1 Gasoline  Million Liters 5.2 6.8 4.4 189 245 158 $6.0 $8.7 $4.8 12 15 Diesel Fuel   Million Liters 6.5 7.2 6.7 252 275 258 $5.9 $6.6 $4.1 18 19 Subtotal Million Liters  12.1 14.4 11.4 454 534 425 $12.1 $15.6 $9.1 31 35 RefrigerantsRefrigerant Losses (facilities) Metric Tons /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 9 8 Scope 1 Total    /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 294 303 Scope 2 - Electricity and Purchased Steam     Electricity (purchased)7 Million Kilowatt-Hours 988 995 983 3,578 3,599 3,555 $107.6 $112.0 $109.7 274 268 Electricity (on-site renewable) Million  Kilowatt-Hours 4 3 2 13 12 7 n/a n/a n/a n/a n/a n/a Cogen Losses Million  Kilowatt-Hours 46 68 61 166 245 220 n/a n/a n/a n/a n/a n/a Purchased Steam Million Kilograms 48 54 54 113 124 126 $1.5 $1.7 $1.4 30 30 Scope 2 Total (market-based)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 304 298 Scope 2 Total (location-based)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 430 412 Baxter Operations Total  /uniFEFFn/a n/a n/a 10,116 10,451 10,528 $166.4 $176.6 $166.7 598 601 Scope 3 Emissions   Purchased Goods and Services (Category 1)8  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 787 805 Capital Goods (Category 2)9  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 82 87 Fuel and Energy-related Activities (Category 3)10  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 147 148 Upstream Transportation and Distribution (Category 4)11  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 517 440 Waste Generated in Operations (Category 5)12  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 13 15 Business Travel (Category 6)13  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 54 51 Employee Commuting (Category 7)14  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 29 29 Upstream Leased Assets (Category 8)15  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Downstream Transportation and Distribution (Category 9)16  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 132 131 Processing of Sold Products (Category 10)17  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 17 16 Use of Sold Products (Category 11)18  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 2,658 2,366 2,End-of-life Treatment of Sold Products (Category 12)18  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 171 165 Downstream Leased Assets (Category 13)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Franchises (Category 14)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Investments (Category 15)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Scope 3 Emissions Total  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 4,607 4,253 3,Total  GHG E missions19 /uniFEFF n/a n/a n/a n/a n/a n/a n/a n/a n/a 5,205 4,854 4,493ENERGY USAGE JOULES (TRILLIONS)ENERGY COSTS (DOLLARS IN MILLIONS)CARBON DIOXIDE EQUIVALENTS1,(THOUSAND METRIC TONS)BAXTER 2020 CORPORATE RESPONSIBILITY REPORT59Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Facilities with ISO 14001, ISO 45001, ISO 50001 and Green Building Certifications1  Apex Companies LLC has provided assurance on the content in this section.
","('GHG_Emissions', 0.9542809724807739)","('Air_Quality', 0.008579812943935394)","('Management_Of_Legal_And_Regulatory_Framework', 0.004130376037210226)","(['Climate Change'], 0.9542809724807739)","('NON-ESG', 0.008579812943935394)","('NON-ESG', 0.004130376037210226)"
Line 1165,"Units 2018 2019 2020 2018 2019 2020 2018 2019 2020 2018 2019 Baxter OperationsScope 1 - Stationary Sources (facilities) Natural Gas  Million Cubic Meters 111 114 121 4,263 4,384 4,631 $32.8 $34.7 $33.0 214 221 Fuel Oil Million Liters 6 5 6 248 208 235 $3.5 $3.1 $3.3 17 15 Propane and LPG Million Kilograms 7 7 8 341 359 363 $5.7 $5.1 $4.6 21 22 Biomass4 Million Kilograms 135 144 138 940 986 966 $3.2 $4.4 $5.6  2 2 Subtotal  /uniFEFFn/a n/a n/a 5,792 5,937 6,195 $45.2 $47.3 $46.5 254 260 Scope 1 - Mobile Sources (Baxter-operated vehicles)Aviation Fuel Million Liters 0.4 0.4 0.3 13 14 9 $0.2 $0.3 $0.2 1 1 Gasoline  Million Liters 5.2 6.8 4.4 189 245 158 $6.0 $8.7 $4.8 12 15 Diesel Fuel   Million Liters 6.5 7.2 6.7 252 275 258 $5.9 $6.6 $4.1 18 19 Subtotal Million Liters  12.1 14.4 11.4 454 534 425 $12.1 $15.6 $9.1 31 35 RefrigerantsRefrigerant Losses (facilities) Metric Tons /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 9 8 Scope 1 Total    /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 294 303 Scope 2 - Electricity and Purchased Steam     Electricity (purchased)7 Million Kilowatt-Hours 988 995 983 3,578 3,599 3,555 $107.6 $112.0 $109.7 274 268 Electricity (on-site renewable) Million  Kilowatt-Hours 4 3 2 13 12 7 n/a n/a n/a n/a n/a n/a Cogen Losses Million  Kilowatt-Hours 46 68 61 166 245 220 n/a n/a n/a n/a n/a n/a Purchased Steam Million Kilograms 48 54 54 113 124 126 $1.5 $1.7 $1.4 30 30 Scope 2 Total (market-based)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 304 298 Scope 2 Total (location-based)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 430 412 Baxter Operations Total  /uniFEFFn/a n/a n/a 10,116 10,451 10,528 $166.4 $176.6 $166.7 598 601 Scope 3 Emissions   Purchased Goods and Services (Category 1)8  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 787 805 Capital Goods (Category 2)9  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 82 87 Fuel and Energy-related Activities (Category 3)10  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 147 148 Upstream Transportation and Distribution (Category 4)11  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 517 440 Waste Generated in Operations (Category 5)12  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 13 15 Business Travel (Category 6)13  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 54 51 Employee Commuting (Category 7)14  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 29 29 Upstream Leased Assets (Category 8)15  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Downstream Transportation and Distribution (Category 9)16  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 132 131 Processing of Sold Products (Category 10)17  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 17 16 Use of Sold Products (Category 11)18  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 2,658 2,366 2,End-of-life Treatment of Sold Products (Category 12)18  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 171 165 Downstream Leased Assets (Category 13)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Franchises (Category 14)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Investments (Category 15)  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 Scope 3 Emissions Total  /uniFEFFn/a n/a n/a n/a n/a n/a n/a n/a n/a 4,607 4,253 3,Total  GHG E missions19 /uniFEFF n/a n/a n/a n/a n/a n/a n/a n/a n/a 5,205 4,854 4,493ENERGY USAGE JOULES (TRILLIONS)ENERGY COSTS (DOLLARS IN MILLIONS)CARBON DIOXIDE EQUIVALENTS1,(THOUSAND METRIC TONS)BAXTER 2020 CORPORATE RESPONSIBILITY REPORT59Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Baxter Facilities with ISO 14001, ISO 45001, ISO 50001 and Green Building Certifications1  Apex Companies LLC has provided assurance on the content in this section.
","('Product_Quality_And_Safety', 0.32169586420059204)","('Management_Of_Legal_And_Regulatory_Framework', 0.12759536504745483)","('Product_Design_And_Lifecycle_Management', 0.12193270772695541)","('NON-ESG', 0.32169586420059204)","('NON-ESG', 0.12759536504745483)","('NON-ESG', 0.12193270772695541)"
Line 1166,"North America Canada, Ontario Alliston X X  Canada, Ontario Mississauga    Canada LEED Silver (2014)  United States, Alabama Opelika X X  United States, Arkansas Mountain Home/Midway  X X X  United States, California Hayward X X  United States, California Irvine X   United States, Illinois Round Lake , Manufacturing  X  X  United States, Illinois Round Lake, R&D    LEED Silver (2013)United States, Indiana Bloomington X X United States, Minnesota St. Paul X  United States, Mississippi Cleveland X X X United States, New York Medina X  United States, North Carolina Marion (North Cove) X X Latin America     Brazil São Paulo X X X  Colombia Cali X X X Dominican Republic Haina X X    Costa Rica Cartago X X X  Mexico Atlacomulco X X  Mexico Cuernavaca X X Mexico Tijuana X    Puerto Rico Aibonito X X Puerto Rico Guayama X   Puerto Rico Jayuya X Europe, Middle East and Africa Belgium Lessines X X X Belgium Lessines BDCE X X X France Jonage-Lyon X   BREEAM Good (2011) France Meyzieu X  X   Germany Bielefeld X X X Germany Halle Westfalen X X X Germany Hechingen X X X Greece Athens (Herakleio) X Ireland Castlebar X X X Ireland Swinford X X Region/Country/ City ISO ISO ISO Green Building State/Province  14001 450012 50001 CertificationRegion/Country/ City ISO ISO ISO Green Building State/Province  14001 450012 50001 Certification Europe, Middle East and Africa (continued) Ireland Dublin/Blackrock X Ireland Dublin/Sandyford X   Italy Grosotto X X X  Italy Medolla X X   Italy Rome X X  Italia LEED Gold (2015 ) Italy Sesto Fiorentino X X  Italy Sondalo X X X Malta Marsa X X X  Portugal Sintra X X Spain Sabiñánigo X X X Spain Valencia X X Sweden Lund X   Sweden Rosersberg    EU GreenBuilding (2011) Switzerland Zurich    Minergie Plus (2010) Tunisia Oued Ellil X X  United Kingdom Elstree X   United Kingdom Croydon  X   United Kingdom Northampton X X  United Kingdom Stockport X X  United Kingdom Oxford X X  United Kingdom Thetford X X Asia Pacific Australia Toongabbie X X X China Guangzhou X X China Shanghai X X China Suzhou X X China Tianjin X X India Ahmedabad, Office    LEED Gold (2018) Japan Miyazaki X New Zealand Auckland X X Philippines Canlubang X X Singapore Woodlands X X X  Thailand Amata XBAXTER 2020 CORPORATE RESPONSIBILITY REPORT60Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Independent Assurance Statement To: The Stakeholders of Baxter International Inc.
","('Competitive_Behavior', 0.5050158500671387)","('Customer_Welfare', 0.0775105357170105)","('Management_Of_Legal_And_Regulatory_Framework', 0.07103791832923889)","(['Business Ethics'], 0.5050158500671387)","('NON-ESG', 0.0775105357170105)","('NON-ESG', 0.07103791832923889)"
Line 1167,"North America Canada, Ontario Alliston X X  Canada, Ontario Mississauga    Canada LEED Silver (2014)  United States, Alabama Opelika X X  United States, Arkansas Mountain Home/Midway  X X X  United States, California Hayward X X  United States, California Irvine X   United States, Illinois Round Lake , Manufacturing  X  X  United States, Illinois Round Lake, R&D    LEED Silver (2013)United States, Indiana Bloomington X X United States, Minnesota St. Paul X  United States, Mississippi Cleveland X X X United States, New York Medina X  United States, North Carolina Marion (North Cove) X X Latin America     Brazil São Paulo X X X  Colombia Cali X X X Dominican Republic Haina X X    Costa Rica Cartago X X X  Mexico Atlacomulco X X  Mexico Cuernavaca X X Mexico Tijuana X    Puerto Rico Aibonito X X Puerto Rico Guayama X   Puerto Rico Jayuya X Europe, Middle East and Africa Belgium Lessines X X X Belgium Lessines BDCE X X X France Jonage-Lyon X   BREEAM Good (2011) France Meyzieu X  X   Germany Bielefeld X X X Germany Halle Westfalen X X X Germany Hechingen X X X Greece Athens (Herakleio) X Ireland Castlebar X X X Ireland Swinford X X Region/Country/ City ISO ISO ISO Green Building State/Province  14001 450012 50001 CertificationRegion/Country/ City ISO ISO ISO Green Building State/Province  14001 450012 50001 Certification Europe, Middle East and Africa (continued) Ireland Dublin/Blackrock X Ireland Dublin/Sandyford X   Italy Grosotto X X X  Italy Medolla X X   Italy Rome X X  Italia LEED Gold (2015 ) Italy Sesto Fiorentino X X  Italy Sondalo X X X Malta Marsa X X X  Portugal Sintra X X Spain Sabiñánigo X X X Spain Valencia X X Sweden Lund X   Sweden Rosersberg    EU GreenBuilding (2011) Switzerland Zurich    Minergie Plus (2010) Tunisia Oued Ellil X X  United Kingdom Elstree X   United Kingdom Croydon  X   United Kingdom Northampton X X  United Kingdom Stockport X X  United Kingdom Oxford X X  United Kingdom Thetford X X Asia Pacific Australia Toongabbie X X X China Guangzhou X X China Shanghai X X China Suzhou X X China Tianjin X X India Ahmedabad, Office    LEED Gold (2018) Japan Miyazaki X New Zealand Auckland X X Philippines Canlubang X X Singapore Woodlands X X X  Thailand Amata XBAXTER 2020 CORPORATE RESPONSIBILITY REPORT60Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Independent Assurance Statement To: The Stakeholders of Baxter International Inc.
","('Competitive_Behavior', 0.23404642939567566)","('Management_Of_Legal_And_Regulatory_Framework', 0.14868199825286865)","('Customer_Welfare', 0.07896159589290619)","('NON-ESG', 0.23404642939567566)","('NON-ESG', 0.14868199825286865)","('NON-ESG', 0.07896159589290619)"
Line 1168,"North America Canada, Ontario Alliston X X  Canada, Ontario Mississauga    Canada LEED Silver (2014)  United States, Alabama Opelika X X  United States, Arkansas Mountain Home/Midway  X X X  United States, California Hayward X X  United States, California Irvine X   United States, Illinois Round Lake , Manufacturing  X  X  United States, Illinois Round Lake, R&D    LEED Silver (2013)United States, Indiana Bloomington X X United States, Minnesota St. Paul X  United States, Mississippi Cleveland X X X United States, New York Medina X  United States, North Carolina Marion (North Cove) X X Latin America     Brazil São Paulo X X X  Colombia Cali X X X Dominican Republic Haina X X    Costa Rica Cartago X X X  Mexico Atlacomulco X X  Mexico Cuernavaca X X Mexico Tijuana X    Puerto Rico Aibonito X X Puerto Rico Guayama X   Puerto Rico Jayuya X Europe, Middle East and Africa Belgium Lessines X X X Belgium Lessines BDCE X X X France Jonage-Lyon X   BREEAM Good (2011) France Meyzieu X  X   Germany Bielefeld X X X Germany Halle Westfalen X X X Germany Hechingen X X X Greece Athens (Herakleio) X Ireland Castlebar X X X Ireland Swinford X X Region/Country/ City ISO ISO ISO Green Building State/Province  14001 450012 50001 CertificationRegion/Country/ City ISO ISO ISO Green Building State/Province  14001 450012 50001 Certification Europe, Middle East and Africa (continued) Ireland Dublin/Blackrock X Ireland Dublin/Sandyford X   Italy Grosotto X X X  Italy Medolla X X   Italy Rome X X  Italia LEED Gold (2015 ) Italy Sesto Fiorentino X X  Italy Sondalo X X X Malta Marsa X X X  Portugal Sintra X X Spain Sabiñánigo X X X Spain Valencia X X Sweden Lund X   Sweden Rosersberg    EU GreenBuilding (2011) Switzerland Zurich    Minergie Plus (2010) Tunisia Oued Ellil X X  United Kingdom Elstree X   United Kingdom Croydon  X   United Kingdom Northampton X X  United Kingdom Stockport X X  United Kingdom Oxford X X  United Kingdom Thetford X X Asia Pacific Australia Toongabbie X X X China Guangzhou X X China Shanghai X X China Suzhou X X China Tianjin X X India Ahmedabad, Office    LEED Gold (2018) Japan Miyazaki X New Zealand Auckland X X Philippines Canlubang X X Singapore Woodlands X X X  Thailand Amata XBAXTER 2020 CORPORATE RESPONSIBILITY REPORT60Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Independent Assurance Statement To: The Stakeholders of Baxter International Inc.
","('Product_Quality_And_Safety', 0.3472318947315216)","('Product_Design_And_Lifecycle_Management', 0.1752346307039261)","('Management_Of_Legal_And_Regulatory_Framework', 0.08039423823356628)","('NON-ESG', 0.3472318947315216)","('NON-ESG', 0.1752346307039261)","('NON-ESG', 0.08039423823356628)"
Line 1169,"North America Canada, Ontario Alliston X X  Canada, Ontario Mississauga    Canada LEED Silver (2014)  United States, Alabama Opelika X X  United States, Arkansas Mountain Home/Midway  X X X  United States, California Hayward X X  United States, California Irvine X   United States, Illinois Round Lake , Manufacturing  X  X  United States, Illinois Round Lake, R&D    LEED Silver (2013)United States, Indiana Bloomington X X United States, Minnesota St. Paul X  United States, Mississippi Cleveland X X X United States, New York Medina X  United States, North Carolina Marion (North Cove) X X Latin America     Brazil São Paulo X X X  Colombia Cali X X X Dominican Republic Haina X X    Costa Rica Cartago X X X  Mexico Atlacomulco X X  Mexico Cuernavaca X X Mexico Tijuana X    Puerto Rico Aibonito X X Puerto Rico Guayama X   Puerto Rico Jayuya X Europe, Middle East and Africa Belgium Lessines X X X Belgium Lessines BDCE X X X France Jonage-Lyon X   BREEAM Good (2011) France Meyzieu X  X   Germany Bielefeld X X X Germany Halle Westfalen X X X Germany Hechingen X X X Greece Athens (Herakleio) X Ireland Castlebar X X X Ireland Swinford X X Region/Country/ City ISO ISO ISO Green Building State/Province  14001 450012 50001 CertificationRegion/Country/ City ISO ISO ISO Green Building State/Province  14001 450012 50001 Certification Europe, Middle East and Africa (continued) Ireland Dublin/Blackrock X Ireland Dublin/Sandyford X   Italy Grosotto X X X  Italy Medolla X X   Italy Rome X X  Italia LEED Gold (2015 ) Italy Sesto Fiorentino X X  Italy Sondalo X X X Malta Marsa X X X  Portugal Sintra X X Spain Sabiñánigo X X X Spain Valencia X X Sweden Lund X   Sweden Rosersberg    EU GreenBuilding (2011) Switzerland Zurich    Minergie Plus (2010) Tunisia Oued Ellil X X  United Kingdom Elstree X   United Kingdom Croydon  X   United Kingdom Northampton X X  United Kingdom Stockport X X  United Kingdom Oxford X X  United Kingdom Thetford X X Asia Pacific Australia Toongabbie X X X China Guangzhou X X China Shanghai X X China Suzhou X X China Tianjin X X India Ahmedabad, Office    LEED Gold (2018) Japan Miyazaki X New Zealand Auckland X X Philippines Canlubang X X Singapore Woodlands X X X  Thailand Amata XBAXTER 2020 CORPORATE RESPONSIBILITY REPORT60Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Independent Assurance Statement To: The Stakeholders of Baxter International Inc.
","('Competitive_Behavior', 0.23401977121829987)","('Business_Model_Resilience', 0.14799083769321442)","('Management_Of_Legal_And_Regulatory_Framework', 0.1023314818739891)","('NON-ESG', 0.23401977121829987)","('NON-ESG', 0.14799083769321442)","('NON-ESG', 0.1023314818739891)"
Line 1170,"North America Canada, Ontario Alliston X X  Canada, Ontario Mississauga    Canada LEED Silver (2014)  United States, Alabama Opelika X X  United States, Arkansas Mountain Home/Midway  X X X  United States, California Hayward X X  United States, California Irvine X   United States, Illinois Round Lake , Manufacturing  X  X  United States, Illinois Round Lake, R&D    LEED Silver (2013)United States, Indiana Bloomington X X United States, Minnesota St. Paul X  United States, Mississippi Cleveland X X X United States, New York Medina X  United States, North Carolina Marion (North Cove) X X Latin America     Brazil São Paulo X X X  Colombia Cali X X X Dominican Republic Haina X X    Costa Rica Cartago X X X  Mexico Atlacomulco X X  Mexico Cuernavaca X X Mexico Tijuana X    Puerto Rico Aibonito X X Puerto Rico Guayama X   Puerto Rico Jayuya X Europe, Middle East and Africa Belgium Lessines X X X Belgium Lessines BDCE X X X France Jonage-Lyon X   BREEAM Good (2011) France Meyzieu X  X   Germany Bielefeld X X X Germany Halle Westfalen X X X Germany Hechingen X X X Greece Athens (Herakleio) X Ireland Castlebar X X X Ireland Swinford X X Region/Country/ City ISO ISO ISO Green Building State/Province  14001 450012 50001 CertificationRegion/Country/ City ISO ISO ISO Green Building State/Province  14001 450012 50001 Certification Europe, Middle East and Africa (continued) Ireland Dublin/Blackrock X Ireland Dublin/Sandyford X   Italy Grosotto X X X  Italy Medolla X X   Italy Rome X X  Italia LEED Gold (2015 ) Italy Sesto Fiorentino X X  Italy Sondalo X X X Malta Marsa X X X  Portugal Sintra X X Spain Sabiñánigo X X X Spain Valencia X X Sweden Lund X   Sweden Rosersberg    EU GreenBuilding (2011) Switzerland Zurich    Minergie Plus (2010) Tunisia Oued Ellil X X  United Kingdom Elstree X   United Kingdom Croydon  X   United Kingdom Northampton X X  United Kingdom Stockport X X  United Kingdom Oxford X X  United Kingdom Thetford X X Asia Pacific Australia Toongabbie X X X China Guangzhou X X China Shanghai X X China Suzhou X X China Tianjin X X India Ahmedabad, Office    LEED Gold (2018) Japan Miyazaki X New Zealand Auckland X X Philippines Canlubang X X Singapore Woodlands X X X  Thailand Amata XBAXTER 2020 CORPORATE RESPONSIBILITY REPORT60Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Independent Assurance Statement To: The Stakeholders of Baxter International Inc.
","('Business_Model_Resilience', 0.21674448251724243)","('Business_Ethics', 0.10881342738866806)","('Product_Design_And_Lifecycle_Management', 0.08635248988866806)","('NON-ESG', 0.21674448251724243)","('NON-ESG', 0.10881342738866806)","('NON-ESG', 0.08635248988866806)"
Line 1171,"North America Canada, Ontario Alliston X X  Canada, Ontario Mississauga    Canada LEED Silver (2014)  United States, Alabama Opelika X X  United States, Arkansas Mountain Home/Midway  X X X  United States, California Hayward X X  United States, California Irvine X   United States, Illinois Round Lake , Manufacturing  X  X  United States, Illinois Round Lake, R&D    LEED Silver (2013)United States, Indiana Bloomington X X United States, Minnesota St. Paul X  United States, Mississippi Cleveland X X X United States, New York Medina X  United States, North Carolina Marion (North Cove) X X Latin America     Brazil São Paulo X X X  Colombia Cali X X X Dominican Republic Haina X X    Costa Rica Cartago X X X  Mexico Atlacomulco X X  Mexico Cuernavaca X X Mexico Tijuana X    Puerto Rico Aibonito X X Puerto Rico Guayama X   Puerto Rico Jayuya X Europe, Middle East and Africa Belgium Lessines X X X Belgium Lessines BDCE X X X France Jonage-Lyon X   BREEAM Good (2011) France Meyzieu X  X   Germany Bielefeld X X X Germany Halle Westfalen X X X Germany Hechingen X X X Greece Athens (Herakleio) X Ireland Castlebar X X X Ireland Swinford X X Region/Country/ City ISO ISO ISO Green Building State/Province  14001 450012 50001 CertificationRegion/Country/ City ISO ISO ISO Green Building State/Province  14001 450012 50001 Certification Europe, Middle East and Africa (continued) Ireland Dublin/Blackrock X Ireland Dublin/Sandyford X   Italy Grosotto X X X  Italy Medolla X X   Italy Rome X X  Italia LEED Gold (2015 ) Italy Sesto Fiorentino X X  Italy Sondalo X X X Malta Marsa X X X  Portugal Sintra X X Spain Sabiñánigo X X X Spain Valencia X X Sweden Lund X   Sweden Rosersberg    EU GreenBuilding (2011) Switzerland Zurich    Minergie Plus (2010) Tunisia Oued Ellil X X  United Kingdom Elstree X   United Kingdom Croydon  X   United Kingdom Northampton X X  United Kingdom Stockport X X  United Kingdom Oxford X X  United Kingdom Thetford X X Asia Pacific Australia Toongabbie X X X China Guangzhou X X China Shanghai X X China Suzhou X X China Tianjin X X India Ahmedabad, Office    LEED Gold (2018) Japan Miyazaki X New Zealand Auckland X X Philippines Canlubang X X Singapore Woodlands X X X  Thailand Amata XBAXTER 2020 CORPORATE RESPONSIBILITY REPORT60Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Independent Assurance Statement To: The Stakeholders of Baxter International Inc.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2701603174209595)","('Business_Ethics', 0.1312464326620102)","('Business_Model_Resilience', 0.09999717772006989)","('NON-ESG', 0.2701603174209595)","('NON-ESG', 0.1312464326620102)","('NON-ESG', 0.09999717772006989)"
Line 1172,"Introduction and Objectives of Work Baxter International Inc.
","('Management_Of_Legal_And_Regulatory_Framework', 0.35237497091293335)","('Business_Ethics', 0.11659809947013855)","('Business_Model_Resilience', 0.06854298710823059)","('NON-ESG', 0.35237497091293335)","('NON-ESG', 0.11659809947013855)","('NON-ESG', 0.06854298710823059)"
Line 1173,"(Baxter) engaged Apex  Companies, LLC (Apex) to provide assurance of  selected sections of Baxter’s 2020 Corporate Responsibility Report.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5559390187263489)","('Business_Model_Resilience', 0.07819881290197372)","('Business_Ethics', 0.056112974882125854)","(['Corporate Governance'], 0.5559390187263489)","('NON-ESG', 0.07819881290197372)","('NON-ESG', 0.056112974882125854)"
Line 1174,"This Assurance Statement applies to the Subject Matter included  within the scope of work described below.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7037213444709778)","('Access_And_Affordability', 0.03671944886445999)","('Ecological_Impacts', 0.029633184894919395)","(['Corporate Governance'], 0.7037213444709778)","('NON-ESG', 0.03671944886445999)","('NON-ESG', 0.029633184894919395)"
Line 1175,"This information and its presentation in Baxter’s 2020 Corporate  Responsibility Report (“the Report”) are the sole responsibility of the  management of Baxter.
","('Management_Of_Legal_And_Regulatory_Framework', 0.29369229078292847)","('Business_Model_Resilience', 0.1836589276790619)","('Director_Removal', 0.07213260978460312)","('NON-ESG', 0.29369229078292847)","('NON-ESG', 0.1836589276790619)","('NON-ESG', 0.07213260978460312)"
Line 1176,"Apex was not involved in the drafting of the  Report.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7340564727783203)","('GHG_Emissions', 0.03141134977340698)","('Business_Ethics', 0.02468164451420307)","(['Corporate Governance'], 0.7340564727783203)","('NON-ESG', 0.03141134977340698)","('NON-ESG', 0.02468164451420307)"
Line 1177,"Our sole responsibility was to provide independent assurance  on the accuracy of the Subject Matter.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5594208240509033)","('Business_Ethics', 0.20349186658859253)","('Competitive_Behavior', 0.03748936951160431)","(['Corporate Governance'], 0.5594208240509033)","('NON-ESG', 0.20349186658859253)","('NON-ESG', 0.03748936951160431)"
Line 1178,"Baxter’s 2020 Corporate  Responsibility Report marks the 12th year for which we have provided  assurance.
","('Business_Model_Resilience', 0.4891144335269928)","('Human_Rights_And_Community_Relations', 0.059555426239967346)","('Management_Of_Legal_And_Regulatory_Framework', 0.05710509046912193)","('NON-ESG', 0.4891144335269928)","('NON-ESG', 0.059555426239967346)","('NON-ESG', 0.05710509046912193)"
Line 1179,"Scope of Work The scope of our work was reasonable-level assurance of the following  information included within the Report for the period January 1, 2020   to December 31, 2020 (the “Subject Matter”).
","('Management_Of_Legal_And_Regulatory_Framework', 0.8425070643424988)","('Access_And_Affordability', 0.020888473838567734)","('GHG_Emissions', 0.016389204189181328)","(['Corporate Governance'], 0.8425070643424988)","('NON-ESG', 0.020888473838567734)","('NON-ESG', 0.016389204189181328)"
Line 1180,"Data and information included in the following sections of the Report: • Product Innovation (except the Patient Safety and Quality subsection) • Employee Health and Safety • Operations > Greenhouse gas (GHG) emissions verification is documented   under a separate verification opinion declaration Related material in the Report Appendix, including: • Baxter Data Summary—Employee Health and Safety and Operations  subsections • Baxter Value Chain Energy Usage and GHG Emissions • Facilities with ISO 14001, ISO 45001, ISO 50001 and Green Building  Certifications The scope of work also included limited-level assurance of the   following Subject Matter: • Data and information included in the following section of the Report: > Responsible Procurement and Logistics • Related material in the Report Appendix: > Baxter Data Summary—Responsible Procurement and Logistics  subsection Our assurance does not extend to any other information included   in the Report.
","('GHG_Emissions', 0.945227861404419)","('Air_Quality', 0.011740506626665592)","('Ecological_Impacts', 0.0035833544097840786)","(['Climate Change'], 0.945227861404419)","('NON-ESG', 0.011740506626665592)","('NON-ESG', 0.0035833544097840786)"
Line 1181,"Data and information included in the following sections of the Report: • Product Innovation (except the Patient Safety and Quality subsection) • Employee Health and Safety • Operations > Greenhouse gas (GHG) emissions verification is documented   under a separate verification opinion declaration Related material in the Report Appendix, including: • Baxter Data Summary—Employee Health and Safety and Operations  subsections • Baxter Value Chain Energy Usage and GHG Emissions • Facilities with ISO 14001, ISO 45001, ISO 50001 and Green Building  Certifications The scope of work also included limited-level assurance of the   following Subject Matter: • Data and information included in the following section of the Report: > Responsible Procurement and Logistics • Related material in the Report Appendix: > Baxter Data Summary—Responsible Procurement and Logistics  subsection Our assurance does not extend to any other information included   in the Report.
","('Product_Design_And_Lifecycle_Management', 0.5853701829910278)","('Supply_Chain_Management', 0.13116969168186188)","('Product_Quality_And_Safety', 0.04216296225786209)","(['Product Stewardship'], 0.5853701829910278)","('NON-ESG', 0.13116969168186188)","('NON-ESG', 0.04216296225786209)"
Line 1182,"Reporting Boundaries The following are the boundaries Baxter used for reporting  sustainability data: • Operational control • Worldwide Reporting Criteria The Subject Matter needs to be read and understood together with  Baxter’s internal reporting requirements for facility environmental,  health, safety and sustainability performance, as well as information  described in the text, appendix, data tables and notes of the Report.
","('Employee_Health_And_Safety', 0.36176514625549316)","('Product_Quality_And_Safety', 0.13148392736911774)","('Human_Rights_And_Community_Relations', 0.07280047982931137)","('NON-ESG', 0.36176514625549316)","('NON-ESG', 0.13148392736911774)","('NON-ESG', 0.07280047982931137)"
Line 1183,"Limitations and Exclusions Excluded from the scope of our work is any verification of information  relating to: • Activities outside the defined assurance period, which is the   2020 calendar year• Positional statements (expressions of opinion, belief, aim or   future intention) by Baxter and statements of future commitment • Any financial data previously audited by an external third party • Data and information included in sections of the Report not listed in  the scope of work above This assurance engagement relies on a risk-based selected sample   of sustainability data and the associated limitations that this entails.
","('Customer_Privacy', 0.6862692832946777)","('Data_Security', 0.07025972753763199)","('Management_Of_Legal_And_Regulatory_Framework', 0.056836262345314026)","(['Privacy Protection'], 0.6862692832946777)","('NON-ESG', 0.07025972753763199)","('NON-ESG', 0.056836262345314026)"
Line 1184,"Limitations and Exclusions Excluded from the scope of our work is any verification of information  relating to: • Activities outside the defined assurance period, which is the   2020 calendar year• Positional statements (expressions of opinion, belief, aim or   future intention) by Baxter and statements of future commitment • Any financial data previously audited by an external third party • Data and information included in sections of the Report not listed in  the scope of work above This assurance engagement relies on a risk-based selected sample   of sustainability data and the associated limitations that this entails.
","('Systemic_Risk_Management', 0.7583696842193604)","('Business_Model_Resilience', 0.05710488557815552)","('Supply_Chain_Management', 0.03249695524573326)","(['Risk & Crisis Management'], 0.7583696842193604)","('NON-ESG', 0.05710488557815552)","('NON-ESG', 0.03249695524573326)"
Line 1185,"This independent statement should not be relied upon to detect all  errors, omissions or misstatements that may exist.
","('Business_Ethics', 0.9567157626152039)","('Product_Quality_And_Safety', 0.004227639175951481)","('Systemic_Risk_Management', 0.003733548102900386)","(['Business Ethics'], 0.9567157626152039)","('NON-ESG', 0.004227639175951481)","('NON-ESG', 0.003733548102900386)"
Line 1186,"Responsibilities The preparation and presentation of the Subject Matter in the Report  are the sole responsibility of the management of Baxter.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7324671745300293)","('Ecological_Impacts', 0.053527530282735825)","('Director_Removal', 0.020741041749715805)","(['Corporate Governance'], 0.7324671745300293)","('NON-ESG', 0.053527530282735825)","('NON-ESG', 0.020741041749715805)"
Line 1187,"Apex was not  involved in the drafting of the Report or of the Reporting Criteria.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8697689771652222)","('GHG_Emissions', 0.01472181174904108)","('Human_Rights_And_Community_Relations', 0.011706515215337276)","(['Corporate Governance'], 0.8697689771652222)","('NON-ESG', 0.01472181174904108)","('NON-ESG', 0.011706515215337276)"
Line 1188,"Our  responsibilities were to: • Provide independent assurance about whether the Subject Matter   has been prepared in accordance with the Reporting Criteria • Form an independent conclusion based on the assurance procedures  performed and evidence obtained • Report our conclusions to the stakeholders of Baxter Assessment Standards We performed our work in accordance with Apex’s standard  procedures and guidelines for external Assurance of Sustainability  Reports and the International Standard on Assurance Engagements  (ISAE) 3000 Revised, Assurance Engagements Other than Audits or  Reviews of Historical Financial Information (effective for assurance  reports dated on or after Dec.
","('Management_Of_Legal_And_Regulatory_Framework', 0.601494312286377)","('Product_Quality_And_Safety', 0.15025341510772705)","('Business_Ethics', 0.050650645047426224)","(['Corporate Governance'], 0.601494312286377)","('NON-ESG', 0.15025341510772705)","('NON-ESG', 0.050650645047426224)"
Line 1189,"Our  responsibilities were to: • Provide independent assurance about whether the Subject Matter   has been prepared in accordance with the Reporting Criteria • Form an independent conclusion based on the assurance procedures  performed and evidence obtained • Report our conclusions to the stakeholders of Baxter Assessment Standards We performed our work in accordance with Apex’s standard  procedures and guidelines for external Assurance of Sustainability  Reports and the International Standard on Assurance Engagements  (ISAE) 3000 Revised, Assurance Engagements Other than Audits or  Reviews of Historical Financial Information (effective for assurance  reports dated on or after Dec.
","('Management_Of_Legal_And_Regulatory_Framework', 0.805533230304718)","('Business_Ethics', 0.07075084745883942)","('Director_Removal', 0.01573042944073677)","(['Corporate Governance'], 0.805533230304718)","('NON-ESG', 0.07075084745883942)","('NON-ESG', 0.01573042944073677)"
Line 1190,"15, 2015), issued by the International  Auditing and Assurance Standards Board.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7461057901382446)","('Product_Quality_And_Safety', 0.060040198266506195)","('Business_Ethics', 0.046343907713890076)","(['Corporate Governance'], 0.7461057901382446)","('NON-ESG', 0.060040198266506195)","('NON-ESG', 0.046343907713890076)"
Line 1191,"A materiality threshold of  ±5% was set for the assurance process.
","('Supply_Chain_Management', 0.17701658606529236)","('Product_Design_And_Lifecycle_Management', 0.11924131214618683)","('Management_Of_Legal_And_Regulatory_Framework', 0.10330437868833542)","('NON-ESG', 0.17701658606529236)","('NON-ESG', 0.11924131214618683)","('NON-ESG', 0.10330437868833542)"
Line 1192,"The work was planned and carried out to provide reasonable, rather  than absolute, assurance of the Subject Matter except for the  Responsible Procurement and Logistics section of the Report, which  was carried out to provide limited assurance.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9096288084983826)","('Ecological_Impacts', 0.010802737437188625)","('Business_Ethics', 0.008338714018464088)","(['Corporate Governance'], 0.9096288084983826)","('NON-ESG', 0.010802737437188625)","('NON-ESG', 0.008338714018464088)"
Line 1193,"We believe that our  work provides an appropriate basis for our conclusions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6988307237625122)","('Business_Ethics', 0.05227448046207428)","('Competitive_Behavior', 0.044328466057777405)","(['Corporate Governance'], 0.6988307237625122)","('NON-ESG', 0.05227448046207428)","('NON-ESG', 0.044328466057777405)"
Line 1194,"Summary of Work Performed As part of our independent verification, our work included: • Assessing the appropriateness of the Reporting Criteria for the  Subject Matter • Conducting interviews with relevant Baxter personnel who are  responsible for collecting and reporting performance data and  other Subject Matter • Reviewing documentary evidence provided by Baxter • Reviewing Baxter’s systems for quantitative data aggregation and  analysis during remote meetings with personnel from Baxter’s  offices in Round Lake and Deerfield, Illinois • Assessing assumptions made and the data scope and reporting  boundaries.
","('Customer_Privacy', 0.2789955735206604)","('Management_Of_Legal_And_Regulatory_Framework', 0.20495648682117462)","('Access_And_Affordability', 0.05188526213169098)","('NON-ESG', 0.2789955735206604)","('NON-ESG', 0.20495648682117462)","('NON-ESG', 0.05188526213169098)"
Line 1195,"Summary of Work Performed As part of our independent verification, our work included: • Assessing the appropriateness of the Reporting Criteria for the  Subject Matter • Conducting interviews with relevant Baxter personnel who are  responsible for collecting and reporting performance data and  other Subject Matter • Reviewing documentary evidence provided by Baxter • Reviewing Baxter’s systems for quantitative data aggregation and  analysis during remote meetings with personnel from Baxter’s  offices in Round Lake and Deerfield, Illinois • Assessing assumptions made and the data scope and reporting  boundaries.
","('Ecological_Impacts', 0.6584173440933228)","('GHG_Emissions', 0.0538870245218277)","('Management_Of_Legal_And_Regulatory_Framework', 0.05158138647675514)","(['Natural Capital'], 0.6584173440933228)","('NON-ESG', 0.0538870245218277)","('NON-ESG', 0.05158138647675514)"
Line 1196,"Auditing consolidated performance data, including  review of a sample of data-to-source documentation • Auditing a selection of the Subject Matter to the corresponding  source documentation • Auditing performance data during virtual assessments to  operating sites located in: Castlebar, Ireland; Cuernavaca,  Mexico; Halle, Germany; Hayward, California; Tianjin, China; and  Toongabbie, Australia • Assessing the disclosure and presentation of the Subject Matter  with emphasis on principles of accuracy, accessibility, balance,  clarity, comparability, reliability and timeliness and to ensure  consistency with the Reporting CriteriaConclusion On the basis of our methodology and the activities described  above, it is our opinion that the Subject Matter within the Product  Innovation (except the Patient Safety and Quality subsection),  Employee Health and Safety, and Operations sections of the Report,  as well as related material in the Report Appendix: • Is presented in accordance with the Reporting Criteria and is, in all  material respects, fairly stated • Is presented in a clear, understandable and accessible manner • Allows readers to form a balanced opinion of Baxter’s activities  and performance during calendar year Also, on the basis of our methodology and the activities described  above: • Nothing has come to our attention to indicate that the data  and information in the Responsible Procurement and Logistics  section of the Report are inaccurate or that the information is  not fairly stated.
","('Business_Ethics', 0.3125659227371216)","('Management_Of_Legal_And_Regulatory_Framework', 0.1146499365568161)","('Data_Security', 0.10974926501512527)","('NON-ESG', 0.3125659227371216)","('NON-ESG', 0.1146499365568161)","('NON-ESG', 0.10974926501512527)"
Line 1197,"Auditing consolidated performance data, including  review of a sample of data-to-source documentation • Auditing a selection of the Subject Matter to the corresponding  source documentation • Auditing performance data during virtual assessments to  operating sites located in: Castlebar, Ireland; Cuernavaca,  Mexico; Halle, Germany; Hayward, California; Tianjin, China; and  Toongabbie, Australia • Assessing the disclosure and presentation of the Subject Matter  with emphasis on principles of accuracy, accessibility, balance,  clarity, comparability, reliability and timeliness and to ensure  consistency with the Reporting CriteriaConclusion On the basis of our methodology and the activities described  above, it is our opinion that the Subject Matter within the Product  Innovation (except the Patient Safety and Quality subsection),  Employee Health and Safety, and Operations sections of the Report,  as well as related material in the Report Appendix: • Is presented in accordance with the Reporting Criteria and is, in all  material respects, fairly stated • Is presented in a clear, understandable and accessible manner • Allows readers to form a balanced opinion of Baxter’s activities  and performance during calendar year Also, on the basis of our methodology and the activities described  above: • Nothing has come to our attention to indicate that the data  and information in the Responsible Procurement and Logistics  section of the Report are inaccurate or that the information is  not fairly stated.
","('Product_Quality_And_Safety', 0.8798507452011108)","('Product_Design_And_Lifecycle_Management', 0.030083350837230682)","('Employee_Health_And_Safety', 0.01690642163157463)","(['Product Quality & Recall Management'], 0.8798507452011108)","('NON-ESG', 0.030083350837230682)","('NON-ESG', 0.01690642163157463)"
Line 1198,"Auditing consolidated performance data, including  review of a sample of data-to-source documentation • Auditing a selection of the Subject Matter to the corresponding  source documentation • Auditing performance data during virtual assessments to  operating sites located in: Castlebar, Ireland; Cuernavaca,  Mexico; Halle, Germany; Hayward, California; Tianjin, China; and  Toongabbie, Australia • Assessing the disclosure and presentation of the Subject Matter  with emphasis on principles of accuracy, accessibility, balance,  clarity, comparability, reliability and timeliness and to ensure  consistency with the Reporting CriteriaConclusion On the basis of our methodology and the activities described  above, it is our opinion that the Subject Matter within the Product  Innovation (except the Patient Safety and Quality subsection),  Employee Health and Safety, and Operations sections of the Report,  as well as related material in the Report Appendix: • Is presented in accordance with the Reporting Criteria and is, in all  material respects, fairly stated • Is presented in a clear, understandable and accessible manner • Allows readers to form a balanced opinion of Baxter’s activities  and performance during calendar year Also, on the basis of our methodology and the activities described  above: • Nothing has come to our attention to indicate that the data  and information in the Responsible Procurement and Logistics  section of the Report are inaccurate or that the information is  not fairly stated.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2908245623111725)","('Customer_Privacy', 0.22737832367420197)","('Data_Security', 0.05473213270306587)","('NON-ESG', 0.2908245623111725)","('NON-ESG', 0.22737832367420197)","('NON-ESG', 0.05473213270306587)"
Line 1199,"• It is also our opinion that Baxter has established appropriate  systems for the collection, aggregation, analysis and review of the  Subject Matter.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8284545540809631)","('Ecological_Impacts', 0.027052927762269974)","('Access_And_Affordability', 0.014459489844739437)","(['Corporate Governance'], 0.8284545540809631)","('NON-ESG', 0.027052927762269974)","('NON-ESG', 0.014459489844739437)"
Line 1200,"Additional Commentary During the assurance process, Apex observed that Baxter  continues to improve its overall data collection and reporting  processes at the site and corporate level.
","('Customer_Privacy', 0.5247258543968201)","('Data_Security', 0.15278230607509613)","('Management_Of_Legal_And_Regulatory_Framework', 0.03638245910406113)","(['Privacy Protection'], 0.5247258543968201)","('NON-ESG', 0.15278230607509613)","('NON-ESG', 0.03638245910406113)"
Line 1201,"Opportunities for  improving facility-level data collection, reporting and procedural  documentation at some facilities were noted.
","('Customer_Privacy', 0.6282765865325928)","('Data_Security', 0.06464539468288422)","('Waste_And_Hazardous_Materials_Management', 0.030964482575654984)","(['Privacy Protection'], 0.6282765865325928)","('NON-ESG', 0.06464539468288422)","('NON-ESG', 0.030964482575654984)"
Line 1202,"We recommend that Baxter corporate personnel continue to support  individual facility personnel with collection and consolidation of site- specific metrics that are included in reporting.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4523349106311798)","('Employee_Health_And_Safety', 0.06848734617233276)","('Director_Removal', 0.06342648714780807)","('NON-ESG', 0.4523349106311798)","('NON-ESG', 0.06848734617233276)","('NON-ESG', 0.06342648714780807)"
Line 1203,"Statement of Independence, Integrity and Competence Apex is an independent professional services company that  specializes in health, safety, social and environmental management  services, including assurance, with more than 30 years history in  providing these services.
","('Employee_Health_And_Safety', 0.5731322765350342)","('Business_Ethics', 0.10767485946416855)","('Human_Rights_And_Community_Relations', 0.07871505618095398)","(['Operational Eco-Efficiency'], 0.5731322765350342)","('NON-ESG', 0.10767485946416855)","('NON-ESG', 0.07871505618095398)"
Line 1204,"Apex has implemented a Code of Ethics across the business to  maintain high ethical standards among staff in their day-to-day  business activities.
","('Business_Ethics', 0.9595322608947754)","('Product_Quality_And_Safety', 0.003026869846507907)","('Customer_Privacy', 0.0029485009144991636)","(['Business Ethics'], 0.9595322608947754)","('NON-ESG', 0.003026869846507907)","('NON-ESG', 0.0029485009144991636)"
Line 1205,"No member of the assurance team has a business relationship with  Baxter International Inc., or its directors or managers, beyond that  required of this assignment.
","('Director_Removal', 0.7356469035148621)","('Business_Model_Resilience', 0.028230713680386543)","('Employee_Engagement_Inclusion_And_Diversity', 0.02665765956044197)","(['Anti-Crime Policy & Measures'], 0.7356469035148621)","('NON-ESG', 0.028230713680386543)","('NON-ESG', 0.02665765956044197)"
Line 1206,"We have conducted this verification  independently, and there has been no conflict of interest.
","('Management_Of_Legal_And_Regulatory_Framework', 0.34251564741134644)","('Competitive_Behavior', 0.30822256207466125)","('Business_Ethics', 0.09753146767616272)","('NON-ESG', 0.34251564741134644)","('NON-ESG', 0.30822256207466125)","('NON-ESG', 0.09753146767616272)"
Line 1207,"The assurance team has extensive experience in conducting  assurance on health, safety, social, environmental and ethical  information, systems and processes.
","('Business_Ethics', 0.4608469009399414)","('Employee_Health_And_Safety', 0.25848388671875)","('Human_Rights_And_Community_Relations', 0.06534752249717712)","('NON-ESG', 0.4608469009399414)","('NON-ESG', 0.25848388671875)","('NON-ESG', 0.06534752249717712)"
Line 1208,"The team has more than  20 years combined experience in this field and an excellent  understanding of Apex’s standard methodology for the assurance of  sustainability-related assertions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2575486898422241)","('Business_Model_Resilience', 0.21653519570827484)","('Systemic_Risk_Management', 0.06914319097995758)","('NON-ESG', 0.2575486898422241)","('NON-ESG', 0.21653519570827484)","('NON-ESG', 0.06914319097995758)"
Line 1209,"JOHN A.
","('Business_Ethics', 0.12237881869077682)","('Employee_Engagement_Inclusion_And_Diversity', 0.06794557720422745)","('Management_Of_Legal_And_Regulatory_Framework', 0.06727104634046555)","('NON-ESG', 0.12237881869077682)","('NON-ESG', 0.06794557720422745)","('NON-ESG', 0.06727104634046555)"
Line 1210,"ROHDE   Apex Companies LLC   |   Lakewood, COTREVOR DONAGHU   Apex Companies LLC   |   Pleasant Hill, CA May 20, 2021 BAXTER 2020 CORPORATE RESPONSIBILITY REPORT61Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction This index includes and references information related to the Sustainability Accounting Standards Board (SASB) Medical Equipment and Supplies Sustainability Accounting  Standard.
","('Business_Model_Resilience', 0.15571796894073486)","('Product_Design_And_Lifecycle_Management', 0.15070503950119019)","('Product_Quality_And_Safety', 0.13899031281471252)","('NON-ESG', 0.15571796894073486)","('NON-ESG', 0.15070503950119019)","('NON-ESG', 0.13899031281471252)"
Line 1211,"ROHDE   Apex Companies LLC   |   Lakewood, COTREVOR DONAGHU   Apex Companies LLC   |   Pleasant Hill, CA May 20, 2021 BAXTER 2020 CORPORATE RESPONSIBILITY REPORT61Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction This index includes and references information related to the Sustainability Accounting Standards Board (SASB) Medical Equipment and Supplies Sustainability Accounting  Standard.
","('Management_Of_Legal_And_Regulatory_Framework', 0.23944538831710815)","('Systemic_Risk_Management', 0.16548503935337067)","('Product_Quality_And_Safety', 0.08299164474010468)","('NON-ESG', 0.23944538831710815)","('NON-ESG', 0.16548503935337067)","('NON-ESG', 0.08299164474010468)"
Line 1212,"Data are calendar year 2020, unless stated otherwise.APPENDIX:   Sustainability Accounting Standards Board Index  TOPIC CODE SASB METRIC 2020 REPORTING Affordability   & PricingHC-MS-240a.1 Ratio of weighted average rate of  net price increases (for all products)  to the annual increase in the U.S.  Consumer Price IndexBaxter does not disclose this data.
","('Product_Design_And_Lifecycle_Management', 0.40574973821640015)","('Competitive_Behavior', 0.12956592440605164)","('Customer_Welfare', 0.12556584179401398)","('NON-ESG', 0.40574973821640015)","('NON-ESG', 0.12956592440605164)","('NON-ESG', 0.12556584179401398)"
Line 1213,"See Contractual Arrangements in Baxter’s  2020 Annual Report on Form 10-K (page 2) for information about some factors that  impact product pricing.
","('Product_Design_And_Lifecycle_Management', 0.5839563012123108)","('Competitive_Behavior', 0.07501165568828583)","('Selling_Practices_And_Product_Labeling', 0.07447806745767593)","(['Product Stewardship'], 0.5839563012123108)","('NON-ESG', 0.07501165568828583)","('NON-ESG', 0.07447806745767593)"
Line 1214,"HC-MS-240a.2 Description of how price information  for each product is disclosed to  customers or to their agentsBaxter products are sold through contracts with customers, both within and outside  the United States.
","('Selling_Practices_And_Product_Labeling', 0.5875523090362549)","('Product_Design_And_Lifecycle_Management', 0.21651193499565125)","('Product_Quality_And_Safety', 0.04270114004611969)","(['Marketing Practices'], 0.5875523090362549)","('NON-ESG', 0.21651193499565125)","('NON-ESG', 0.04270114004611969)"
Line 1215,"Some of these contracts have terms of more than one year and  place limits on our ability to increase prices; some contracts also specify minimum  quantities to be purchased by the customer; and some contracts may include  variable consideration related to rebates, sales discounts and/or wholesaler  chargebacks.
","('Competitive_Behavior', 0.8202467560768127)","('Management_Of_Legal_And_Regulatory_Framework', 0.05485215783119202)","('Energy_Management', 0.014323219656944275)","(['Business Ethics'], 0.8202467560768127)","('NON-ESG', 0.05485215783119202)","('NON-ESG', 0.014323219656944275)"
Line 1216,"Our customers include hospitals, governments, kidney dialysis  centers and other organizations.
","('Customer_Welfare', 0.2372514307498932)","('Access_And_Affordability', 0.12782256305217743)","('Competitive_Behavior', 0.09091945737600327)","('NON-ESG', 0.2372514307498932)","('NON-ESG', 0.12782256305217743)","('NON-ESG', 0.09091945737600327)"
Line 1217,"Both in the United States and outside, hospitals  and other customers have joined purchasing entities, such as group purchasing  organizations, integrated delivery networks and public contracting authorities, to  enhance purchasing power.
","('Energy_Management', 0.327144980430603)","('Competitive_Behavior', 0.1437951624393463)","('Customer_Welfare', 0.11474042385816574)","('NON-ESG', 0.327144980430603)","('NON-ESG', 0.1437951624393463)","('NON-ESG', 0.11474042385816574)"
Line 1218,"See the Contractual Arrangements, Competition and Healthcare Cost Containment,  and Revenue Recognition sections in Baxter's 2020 Annual Report on Form 10-K.
","('Competitive_Behavior', 0.9611074328422546)","('Management_Of_Legal_And_Regulatory_Framework', 0.005323012359440327)","('Systemic_Risk_Management', 0.0032246005721390247)","(['Business Ethics'], 0.9611074328422546)","('NON-ESG', 0.005323012359440327)","('NON-ESG', 0.0032246005721390247)"
Line 1219,"Product Safety HC-MS-250a.1 Number of recalls issued,   total units recalledDuring 2020, Baxter issued • Eleven medical device product recalls that were reported to FDA and removed from  the market or corrected1  • Zero medical device product recalls that were not reported to FDA  • Sixteen medical device product recalls that were reported to non-U.S.   national regulatory authorities and removed from the market or corrected  See Patient Safety and Quality and Baxter Data Summary for information about the  company’s product improvements and recall data, inclusive of drug-related recalls.
","('Product_Quality_And_Safety', 0.8762532472610474)","('Selling_Practices_And_Product_Labeling', 0.02836277149617672)","('Product_Design_And_Lifecycle_Management', 0.00995053630322218)","(['Product Quality & Recall Management'], 0.8762532472610474)","('NON-ESG', 0.02836277149617672)","('NON-ESG', 0.00995053630322218)"
Line 1220,"Product Safety HC-MS-250a.1 Number of recalls issued,   total units recalledDuring 2020, Baxter issued • Eleven medical device product recalls that were reported to FDA and removed from  the market or corrected1  • Zero medical device product recalls that were not reported to FDA  • Sixteen medical device product recalls that were reported to non-U.S.   national regulatory authorities and removed from the market or corrected  See Patient Safety and Quality and Baxter Data Summary for information about the  company’s product improvements and recall data, inclusive of drug-related recalls.
","('Product_Quality_And_Safety', 0.6771544814109802)","('Selling_Practices_And_Product_Labeling', 0.08900605142116547)","('Product_Design_And_Lifecycle_Management', 0.04046565666794777)","(['Product Quality & Recall Management'], 0.6771544814109802)","('NON-ESG', 0.08900605142116547)","('NON-ESG', 0.04046565666794777)"
Line 1221,"HC-MS-250a.2 List of products listed in the FDA’s  MedWatch Safety Alerts for Human  Medical Products databaseAs of December 31, 2020, the MedWatch Safety Alerts for Human Medical Products  database included the following Baxter medical device product:   Sigma Spectrum Infusion Pumps (V6, V8 and IQ).
","('Product_Quality_And_Safety', 0.8748341798782349)","('Product_Design_And_Lifecycle_Management', 0.023590603843331337)","('Selling_Practices_And_Product_Labeling', 0.017124729230999947)","(['Product Quality & Recall Management'], 0.8748341798782349)","('NON-ESG', 0.023590603843331337)","('NON-ESG', 0.017124729230999947)"
Line 1222,"Baxter issued an Urgent Device Correction to reinforce important safety information  regarding cleaning practices and communicated that Spectrum Instructions for  Use would be clarified to emphasize that deviations from the specified cleaning  methods may impair pump functionality and performance.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT62Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction TOPIC CODE SASB METRIC 2020 REPORTING Product Safety   (continued)HC-MS-250a.3 Number of fatalities related to  products as reported in the FDA  Manufacturer and User Facility  Device ExperienceUnder FDA regulations, manufacturers and device user facilities must report  information that reasonably suggests a medical device may have caused or  contributed to a fatality or serious injury.
","('Product_Quality_And_Safety', 0.8176302313804626)","('Employee_Health_And_Safety', 0.08419106900691986)","('Product_Design_And_Lifecycle_Management', 0.017323896288871765)","(['Product Quality & Recall Management'], 0.8176302313804626)","('NON-ESG', 0.08419106900691986)","('NON-ESG', 0.017323896288871765)"
Line 1223,"Baxter issued an Urgent Device Correction to reinforce important safety information  regarding cleaning practices and communicated that Spectrum Instructions for  Use would be clarified to emphasize that deviations from the specified cleaning  methods may impair pump functionality and performance.BAXTER 2020 CORPORATE RESPONSIBILITY REPORT62Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction TOPIC CODE SASB METRIC 2020 REPORTING Product Safety   (continued)HC-MS-250a.3 Number of fatalities related to  products as reported in the FDA  Manufacturer and User Facility  Device ExperienceUnder FDA regulations, manufacturers and device user facilities must report  information that reasonably suggests a medical device may have caused or  contributed to a fatality or serious injury.
","('Product_Quality_And_Safety', 0.4706028699874878)","('Employee_Health_And_Safety', 0.37648963928222656)","('Product_Design_And_Lifecycle_Management', 0.031868722289800644)","('NON-ESG', 0.4706028699874878)","('NON-ESG', 0.37648963928222656)","('NON-ESG', 0.031868722289800644)"
Line 1224,"Manufacturers must also submit to FDA  reports of certain malfunctions.
","('Product_Quality_And_Safety', 0.25247442722320557)","('Product_Design_And_Lifecycle_Management', 0.10882052034139633)","('Waste_And_Hazardous_Materials_Management', 0.06012783572077751)","('NON-ESG', 0.25247442722320557)","('NON-ESG', 0.10882052034139633)","('NON-ESG', 0.06012783572077751)"
Line 1225,"Such reports for Baxter’s medical devices are  available here: Manufacturer and User Facility Device Experience.
","('Product_Design_And_Lifecycle_Management', 0.5524678826332092)","('Product_Quality_And_Safety', 0.07624737173318863)","('Customer_Welfare', 0.06078537926077843)","(['Product Stewardship'], 0.5524678826332092)","('NON-ESG', 0.07624737173318863)","('NON-ESG', 0.06078537926077843)"
Line 1226,"HC-MS-250a.4 Number of FDA enforcement   actions taken in response to  violations of current Good  Manufacturing Practices (cGMP),   by typeIn 2020, Baxter received  • Zero Form 483s • Zero warning letters • Zero seizures  • Zero consent decrees See Patient Safety and Quality as well as Certain Regulatory Matters in Baxter’s  2020 Annual Report on Form 10-K for related information.
","('Product_Quality_And_Safety', 0.8921363949775696)","('Selling_Practices_And_Product_Labeling', 0.011019150726497173)","('Business_Ethics', 0.010924450121819973)","(['Product Quality & Recall Management'], 0.8921363949775696)","('NON-ESG', 0.011019150726497173)","('NON-ESG', 0.010924450121819973)"
Line 1227,"Ethical  MarketingHC-MS-270a.1 Total amount of monetary   losses as a result of legal  proceedings associated with false  marketing claimsIn 2020, Baxter had no monetary losses due to legal proceedings associated with  false marketing claims that were previously reported in any company Exchange  Act filing s.
","('Business_Ethics', 0.7560259103775024)","('Competitive_Behavior', 0.059130411595106125)","('Selling_Practices_And_Product_Labeling', 0.03502562642097473)","(['Business Ethics'], 0.7560259103775024)","('NON-ESG', 0.059130411595106125)","('NON-ESG', 0.03502562642097473)"
Line 1228,"HC-MS-270a.2 Description of code of ethics  governing promotion of off-label use  of productsOff-label promotion is strictly prohibited at Baxter.
","('Selling_Practices_And_Product_Labeling', 0.763246476650238)","('Customer_Welfare', 0.0610840879380703)","('Product_Quality_And_Safety', 0.043652456253767014)","(['Marketing Practices'], 0.763246476650238)","('NON-ESG', 0.0610840879380703)","('NON-ESG', 0.043652456253767014)"
Line 1229,"See the Baxter Code of Conduct  and the Baxter Global Interactions Policy .
","('Management_Of_Legal_And_Regulatory_Framework', 0.42649218440055847)","('Business_Ethics', 0.41627463698387146)","('Human_Rights_And_Community_Relations', 0.022549040615558624)","('NON-ESG', 0.42649218440055847)","('NON-ESG', 0.41627463698387146)","('NON-ESG', 0.022549040615558624)"
Line 1230,"See Ethics and Compliance for information  about the company's approach in this area.
","('Business_Ethics', 0.9624679684638977)","('Management_Of_Legal_And_Regulatory_Framework', 0.0055328235030174255)","('Competitive_Behavior', 0.0029950335156172514)","(['Business Ethics'], 0.9624679684638977)","('NON-ESG', 0.0055328235030174255)","('NON-ESG', 0.0029950335156172514)"
Line 1231,"Product Design  & Lifecycle  ManagementHC-MS-410a.1 Discussion of process to assess and  manage environmental and human  health considerations associated  with chemicals in products, and meet  demand for sustainable productsSee Sustainable Design and Materials Use for information about the company's  approach in this area.
","('Product_Design_And_Lifecycle_Management', 0.9623811841011047)","('Product_Quality_And_Safety', 0.00557129830121994)","('Selling_Practices_And_Product_Labeling', 0.0034733437933027744)","(['Product Stewardship'], 0.9623811841011047)","('NON-ESG', 0.00557129830121994)","('NON-ESG', 0.0034733437933027744)"
Line 1232,"HC-MS-410a.2 Total amount of products accepted  for takeback and reused, recycled, or  donated, broken down by: (1) devices  and equipment and (2) suppliesSee Product End-of-Life for product recovery data and information about the  company's approach in this area.APPENDIX:   Sustainability Accounting Standards Board Index (continued) BAXTER 2020 CORPORATE RESPONSIBILITY REPORT63Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction TOPIC CODE SASB METRIC 2020 REPORTING Supply Chain  ManagementHC-MS-430a.1 Percentage of (1) entity's facilities  and (2) Tier I suppliers' facilities  participating in third-party audit  programs for manufacturing and  product qualityBetween 2018 and 2020, approximately 36% of Baxter's total facilities worldwide  completed third-party audits based on ISO 13485 or ISO 9001 (including through the  Medical Device Single Audit Program), approximately 55%2 completed ministry of  health or equivalent audits (depending on location) related to manufacturing and  product quality, and nearly 10% completed safety marking (such as CE marking) audits.
","('Product_Design_And_Lifecycle_Management', 0.96271151304245)","('Product_Quality_And_Safety', 0.005986685398966074)","('Selling_Practices_And_Product_Labeling', 0.0035983796697109938)","(['Product Stewardship'], 0.96271151304245)","('NON-ESG', 0.005986685398966074)","('NON-ESG', 0.0035983796697109938)"
Line 1233,"HC-MS-410a.2 Total amount of products accepted  for takeback and reused, recycled, or  donated, broken down by: (1) devices  and equipment and (2) suppliesSee Product End-of-Life for product recovery data and information about the  company's approach in this area.APPENDIX:   Sustainability Accounting Standards Board Index (continued) BAXTER 2020 CORPORATE RESPONSIBILITY REPORT63Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction TOPIC CODE SASB METRIC 2020 REPORTING Supply Chain  ManagementHC-MS-430a.1 Percentage of (1) entity's facilities  and (2) Tier I suppliers' facilities  participating in third-party audit  programs for manufacturing and  product qualityBetween 2018 and 2020, approximately 36% of Baxter's total facilities worldwide  completed third-party audits based on ISO 13485 or ISO 9001 (including through the  Medical Device Single Audit Program), approximately 55%2 completed ministry of  health or equivalent audits (depending on location) related to manufacturing and  product quality, and nearly 10% completed safety marking (such as CE marking) audits.
","('Supply_Chain_Management', 0.40045878291130066)","('Product_Design_And_Lifecycle_Management', 0.37021464109420776)","('Product_Quality_And_Safety', 0.06056838482618332)","('NON-ESG', 0.40045878291130066)","('NON-ESG', 0.37021464109420776)","('NON-ESG', 0.06056838482618332)"
Line 1234,"HC-MS-410a.2 Total amount of products accepted  for takeback and reused, recycled, or  donated, broken down by: (1) devices  and equipment and (2) suppliesSee Product End-of-Life for product recovery data and information about the  company's approach in this area.APPENDIX:   Sustainability Accounting Standards Board Index (continued) BAXTER 2020 CORPORATE RESPONSIBILITY REPORT63Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction TOPIC CODE SASB METRIC 2020 REPORTING Supply Chain  ManagementHC-MS-430a.1 Percentage of (1) entity's facilities  and (2) Tier I suppliers' facilities  participating in third-party audit  programs for manufacturing and  product qualityBetween 2018 and 2020, approximately 36% of Baxter's total facilities worldwide  completed third-party audits based on ISO 13485 or ISO 9001 (including through the  Medical Device Single Audit Program), approximately 55%2 completed ministry of  health or equivalent audits (depending on location) related to manufacturing and  product quality, and nearly 10% completed safety marking (such as CE marking) audits.
","('Product_Quality_And_Safety', 0.9164347052574158)","('Product_Design_And_Lifecycle_Management', 0.011970408260822296)","('Employee_Health_And_Safety', 0.009912310168147087)","(['Product Quality & Recall Management'], 0.9164347052574158)","('NON-ESG', 0.011970408260822296)","('NON-ESG', 0.009912310168147087)"
Line 1235,"As of December 31, 2020, 28% of Baxter's Tier I suppliers had obtained third-party  certification.
","('Supply_Chain_Management', 0.8764705061912537)","('Product_Design_And_Lifecycle_Management', 0.024530837312340736)","('Product_Quality_And_Safety', 0.009164839051663876)","(['Supply Chain Management'], 0.8764705061912537)","('NON-ESG', 0.024530837312340736)","('NON-ESG', 0.009164839051663876)"
Line 1236,"See Patient Safety and Quality and Supplier Audits for related information.
","('Product_Quality_And_Safety', 0.39477527141571045)","('Employee_Health_And_Safety', 0.16931723058223724)","('Supply_Chain_Management', 0.16172869503498077)","('NON-ESG', 0.39477527141571045)","('NON-ESG', 0.16931723058223724)","('NON-ESG', 0.16172869503498077)"
Line 1237,"HC-MS-430a.2 Description of efforts to   maintain traceability within the  distribution chainBaxter has a range of systems and processes to maintain traceability of materials  throughout the product supply and distribution chain:  • Traceability of materials from suppliers to Baxter, and throughout the  manufacturing process, is maintained utilizing electronic systems.
","('Product_Design_And_Lifecycle_Management', 0.687972903251648)","('Supply_Chain_Management', 0.1336311399936676)","('Product_Quality_And_Safety', 0.03240203857421875)","(['Product Stewardship'], 0.687972903251648)","('NON-ESG', 0.1336311399936676)","('NON-ESG', 0.03240203857421875)"
Line 1238,"• Products manufactured by Baxter are labeled with an identifier that is traceable  from the manufacturing process to the customer and may utilize barcoding  and sterilization technology to facilitate electronic track-and-trace capability.
","('Product_Design_And_Lifecycle_Management', 0.359009325504303)","('Product_Quality_And_Safety', 0.28331437706947327)","('Selling_Practices_And_Product_Labeling', 0.13778524100780487)","('NON-ESG', 0.359009325504303)","('NON-ESG', 0.28331437706947327)","('NON-ESG', 0.13778524100780487)"
Line 1239,"Enterprise resource planning (ERP) systems are used to manage traceability to  the point of sale.
","('Systemic_Risk_Management', 0.3459087610244751)","('Data_Security', 0.12908576428890228)","('Competitive_Behavior', 0.09825877100229263)","('NON-ESG', 0.3459087610244751)","('NON-ESG', 0.12908576428890228)","('NON-ESG', 0.09825877100229263)"
Line 1240,"Baxter has business agreements with our wholesalers to ensure  traceability is maintained within their distribution chains, and we can access  related information if needed.
","('Data_Security', 0.3849734961986542)","('Customer_Privacy', 0.21421469748020172)","('Business_Ethics', 0.09214033931493759)","('NON-ESG', 0.3849734961986542)","('NON-ESG', 0.21421469748020172)","('NON-ESG', 0.09214033931493759)"
Line 1241,"• Baxter maintains a range of compliance-focused initiatives to help ensure all products  are labeled as required by local and regional regulations to enable traceability.
","('Product_Quality_And_Safety', 0.5166899561882019)","('Product_Design_And_Lifecycle_Management', 0.10746505856513977)","('Selling_Practices_And_Product_Labeling', 0.10443300753831863)","(['Product Quality & Recall Management'], 0.5166899561882019)","('NON-ESG', 0.10746505856513977)","('NON-ESG', 0.10443300753831863)"
Line 1242,"See section 7.11, Product Identification and Traceability of the Baxter Supplier  Quality Standard and Customs Trade Partnership Against Terrorism program  content in Industry Collaboration  for more information.
","('Product_Design_And_Lifecycle_Management', 0.6026440262794495)","('Supply_Chain_Management', 0.12408475577831268)","('Product_Quality_And_Safety', 0.07842252403497696)","(['Product Stewardship'], 0.6026440262794495)","('NON-ESG', 0.12408475577831268)","('NON-ESG', 0.07842252403497696)"
Line 1243,"HC-MS-430a.3 Description of the management   of risks associated with the use of   critical materialsSee Baxter’s Position Statement on Conflict Minerals and our most recent Conflict  Minerals Report.
","('Supply_Chain_Management', 0.7243700623512268)","('Waste_And_Hazardous_Materials_Management', 0.030846986919641495)","('Employee_Health_And_Safety', 0.024368206039071083)","(['Supply Chain Management'], 0.7243700623512268)","('NON-ESG', 0.030846986919641495)","('NON-ESG', 0.024368206039071083)"
Line 1244,"Baxter does not currently disclose its management of risks for other  critical materials.
","('Supply_Chain_Management', 0.6514691710472107)","('Waste_And_Hazardous_Materials_Management', 0.10697010904550552)","('Systemic_Risk_Management', 0.04449218139052391)","(['Supply Chain Management'], 0.6514691710472107)","('NON-ESG', 0.10697010904550552)","('NON-ESG', 0.04449218139052391)"
Line 1245,"Business  EthicsHC-MS-510a.1 Total amount of monetary losses as   a result of legal proceedings associated  with bribery or corruptionIn 2020, Baxter had no monetary losses due to legal proceedings associated with  bribery or corruption that were previously reported in any company Exchange Act filings.
","('Business_Ethics', 0.974170446395874)","('Management_Of_Legal_And_Regulatory_Framework', 0.0021822419948875904)","('Product_Quality_And_Safety', 0.0020191411022096872)","(['Business Ethics'], 0.974170446395874)","('NON-ESG', 0.0021822419948875904)","('NON-ESG', 0.0020191411022096872)"
Line 1246,"See Ethics and Compliance for information about the company's approach in this area.
","('Business_Ethics', 0.9624679684638977)","('Management_Of_Legal_And_Regulatory_Framework', 0.0055328235030174255)","('Competitive_Behavior', 0.0029950335156172514)","(['Business Ethics'], 0.9624679684638977)","('NON-ESG', 0.0055328235030174255)","('NON-ESG', 0.0029950335156172514)"
Line 1247,"HC-MS-510a.2 Description of code of ethics governing  interactions with health care  professionalsSee Baxter’s Global Interactions Policy and Ethics and Compliance  for information  about the company's approach in this area.
","('Business_Ethics', 0.9670854210853577)","('Management_Of_Legal_And_Regulatory_Framework', 0.005717002786695957)","('Product_Quality_And_Safety', 0.0028254452627152205)","(['Business Ethics'], 0.9670854210853577)","('NON-ESG', 0.005717002786695957)","('NON-ESG', 0.0028254452627152205)"
Line 1248,"Baxter has adopted the AdvaMed Code of Ethics and also belongs to similar industry  and professional associations around the world.
","('Business_Ethics', 0.9592050909996033)","('Management_Of_Legal_And_Regulatory_Framework', 0.008927660994231701)","('Director_Removal', 0.0034377833362668753)","(['Business Ethics'], 0.9592050909996033)","('NON-ESG', 0.008927660994231701)","('NON-ESG', 0.0034377833362668753)"
Line 1249,"See Professional Codes of Ethics  and Industry Standards on Baxter's Ethics and Compliance  page for information.APPENDIX:   Sustainability Accounting Standards Board Index (continued) BAXTER 2020 CORPORATE RESPONSIBILITY REPORT64Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction This index references information related to disclosures from the Global Reporting Initiative Sustainability Reporting Standards 2016.
","('Business_Ethics', 0.9693557620048523)","('Management_Of_Legal_And_Regulatory_Framework', 0.004208380822092295)","('Product_Quality_And_Safety', 0.003128223353996873)","(['Business Ethics'], 0.9693557620048523)","('NON-ESG', 0.004208380822092295)","('NON-ESG', 0.003128223353996873)"
Line 1250,"See Professional Codes of Ethics  and Industry Standards on Baxter's Ethics and Compliance  page for information.APPENDIX:   Sustainability Accounting Standards Board Index (continued) BAXTER 2020 CORPORATE RESPONSIBILITY REPORT64Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction This index references information related to disclosures from the Global Reporting Initiative Sustainability Reporting Standards 2016.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5178568363189697)","('Business_Model_Resilience', 0.0809013769030571)","('Product_Quality_And_Safety', 0.04147665575146675)","(['Corporate Governance'], 0.5178568363189697)","('NON-ESG', 0.0809013769030571)","('NON-ESG', 0.04147665575146675)"
Line 1251,"The reported information may meet in part  or in full the requirements of each GRI disclosure listed.
","('Management_Of_Legal_And_Regulatory_Framework', 0.33695876598358154)","('Customer_Privacy', 0.2547161877155304)","('Data_Security', 0.05499834194779396)","('NON-ESG', 0.33695876598358154)","('NON-ESG', 0.2547161877155304)","('NON-ESG', 0.05499834194779396)"
Line 1252,"APPENDIX:   Global Reporting Initiative (GRI) Index  Disclosure Disclosure GRI 102: General Disclosures Organizational Profile 102-1 Name of the organization Company Profile 102-2 Activities, brands, products and services Baxter 2020 Annual Report on Form 10-K 102-3 Location of headquarters Baxter's corporate headquarters is in   Deerfield, Illinois.
","('Product_Design_And_Lifecycle_Management', 0.700076162815094)","('Business_Model_Resilience', 0.09251844882965088)","('Customer_Welfare', 0.028452452272176743)","(['Product Stewardship'], 0.700076162815094)","('NON-ESG', 0.09251844882965088)","('NON-ESG', 0.028452452272176743)"
Line 1253,"102-4 Location of operations Baxter 2020 Annual Report on Form 10-K 102-5 Ownership and legal form Baxter International Inc.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3165169954299927)","('Business_Model_Resilience', 0.1432153433561325)","('Director_Removal', 0.04780479893088341)","('NON-ESG', 0.3165169954299927)","('NON-ESG', 0.1432153433561325)","('NON-ESG', 0.04780479893088341)"
Line 1254,"(BAX) is a publicly   traded company listed on the New York   Stock Exchange.
","('Management_Of_Legal_And_Regulatory_Framework', 0.32693031430244446)","('Systemic_Risk_Management', 0.18786045908927917)","('Competitive_Behavior', 0.10426473617553711)","('NON-ESG', 0.32693031430244446)","('NON-ESG', 0.18786045908927917)","('NON-ESG', 0.10426473617553711)"
Line 1255,"102-6 Markets served Baxter 2020 Annual Report on Form 10-K 102-7 Scale of the organization Operations; Baxter 2020 Annual Report   on Form 10-K 102-8 Information on employees and other workers Baxter Data Summary 102-9 Supply chain Responsible Procurement and Logistics;   Baxter Data Summary 102-10 Significant changes to the organization and   its supply chainBaxter 2020 Annual Report on Form 10-K 102-11 Precautionary Principle or approach Patient Safety and Quality ; Sustainable Design;  Materials Use 102-12 External initiatives Examples are included throughout this report.
","('Supply_Chain_Management', 0.7669566869735718)","('Product_Design_And_Lifecycle_Management', 0.09787172824144363)","('Employee_Health_And_Safety', 0.01677691377699375)","(['Supply Chain Management'], 0.7669566869735718)","('NON-ESG', 0.09787172824144363)","('NON-ESG', 0.01677691377699375)"
Line 1256,"102-6 Markets served Baxter 2020 Annual Report on Form 10-K 102-7 Scale of the organization Operations; Baxter 2020 Annual Report   on Form 10-K 102-8 Information on employees and other workers Baxter Data Summary 102-9 Supply chain Responsible Procurement and Logistics;   Baxter Data Summary 102-10 Significant changes to the organization and   its supply chainBaxter 2020 Annual Report on Form 10-K 102-11 Precautionary Principle or approach Patient Safety and Quality ; Sustainable Design;  Materials Use 102-12 External initiatives Examples are included throughout this report.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4084598124027252)","('Human_Rights_And_Community_Relations', 0.16368141770362854)","('Access_And_Affordability', 0.07958419620990753)","('NON-ESG', 0.4084598124027252)","('NON-ESG', 0.16368141770362854)","('NON-ESG', 0.07958419620990753)"
Line 1257,"102-13 Membership of associations We engage with external organizations to help  drive progress on a broad range of corporate  responsibility issues.
","('Human_Rights_And_Community_Relations', 0.6416385173797607)","('Management_Of_Legal_And_Regulatory_Framework', 0.13642485439777374)","('Business_Ethics', 0.035031095147132874)","(['Community Relations'], 0.6416385173797607)","('NON-ESG', 0.13642485439777374)","('NON-ESG', 0.035031095147132874)"
Line 1258,"Examples include Advanced  Medical Technology Association, Clean Cargo, the  Ceres Company Network, Global Logistics Emissions  Council Partnership, the Global Reporting Initiative  (GRI) Community, Healthcare Plastics Recycling  Council, MedTech Europe, National Association for  EHS&S Management, National Minority Supplier  Development Council, ORC HSE, Partnership for  Quality Medical Donations, Pharmaceutical Supply  Chain Initiative, Sustainable Healthcare Coalition,  Vinyl Council of Australia and others .
","('Supply_Chain_Management', 0.9367613792419434)","('Product_Design_And_Lifecycle_Management', 0.007731263060122728)","('Labor_Practices', 0.004733875393867493)","(['Supply Chain Management'], 0.9367613792419434)","('NON-ESG', 0.007731263060122728)","('NON-ESG', 0.004733875393867493)"
Line 1259,"Examples include Advanced  Medical Technology Association, Clean Cargo, the  Ceres Company Network, Global Logistics Emissions  Council Partnership, the Global Reporting Initiative  (GRI) Community, Healthcare Plastics Recycling  Council, MedTech Europe, National Association for  EHS&S Management, National Minority Supplier  Development Council, ORC HSE, Partnership for  Quality Medical Donations, Pharmaceutical Supply  Chain Initiative, Sustainable Healthcare Coalition,  Vinyl Council of Australia and others .
","('Management_Of_Legal_And_Regulatory_Framework', 0.30321651697158813)","('Energy_Management', 0.1013161689043045)","('Data_Security', 0.06391458213329315)","('NON-ESG', 0.30321651697158813)","('NON-ESG', 0.1013161689043045)","('NON-ESG', 0.06391458213329315)"
Line 1260,"Strategy  102-14 Statement from senior decision-maker From the Chairman and CEO Ethics and Integrity 102-16 Values, principles, standards and norms   of behaviorProtecting Human Rights; Ethics and Compliance;   Responsible Procurement 102-17 Mechanisms for advice and concerns   about ethicsEthics and Compliance HelplineGRI 102: General Disclosures 2016 (continued) Governance  102-18 Governance structure Our Governance 102-19 Delegating authority Corporate Responsibility Governance   and Management 102-20 Executive-level responsibility for economic,  environmental and social topicsCorporate Responsibility Governance   and Management 102-22 Composition of the highest governance body   and its committeesOur Governance 102-23 Chair of the highest governance body Our Governance Organizational Profile 102-24 Nominating and selecting the highest   governance bodyCorporate Governance Guidelines 102-25 Conflicts of interest Corporate Governance Guidelines 102-31 Review of economic, environmental and   social topicsCorporate Responsibility 102-33 Communicating critical concerns Baxter 2021 Proxy Statement 102-35 Remuneration policies Corporate Governance Guidelines;   Baxter 2021 Proxy Statement 102-36 Process for determining remuneration Corporate Governance Guidelines Stakeholder Engagement 102-40 List of stakeholder groups Stakeholder Engagement 102-42 Identifying and selecting stakeholders Stakeholder Engagement 102-43 Approach to stakeholder engagement Stakeholder Engagement Reporting Practice  102-45 Entities included in the consolidated   financial statementsBaxter 2020 Annual Report on Form 10-K 102-46 Defining report content and topic Boundaries Materiality 102-47 List of material topics Materiality 102-50 Reporting period Calendar year 102-51 Date of most recent report June 102-52 Reporting cycle Yearly 102-53 Contact point for questions regarding the report corporate_responsibility_report@baxter.com 102-55 GRI content index This section 102-56 External assurance Assurance and Verification2020 Reporting 2020 ReportingBAXTER 2020 CORPORATE RESPONSIBILITY REPORT65Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Disclosure Disclosure GRI 200 Economic Standard Series GRI 201: Economic Performance Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 201-1 Direct economic value generated and  distributedServing Our Communities ; Baxter Data Summary ;  Baxter 2020 Annual Report on Form 10-K 201-2 Financial implications and other risks and  opportunities due to climate changeBaxter CDP submission GRI 203: Indirect Economic Impacts Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 203-1 Infrastructure investments and   services supportedInnovation That Expands Access to Care;   Serving Our Communities 203-2 Significant indirect economic impacts Innovation That Expands Access to Care;   Serving Our Communities GRI 205: Anticorruption Management approach Ethics and Compliance; Materiality   Assessment Findings 205-1 Operations assessed for risks related   to corruptionEthics and Compliance 205-2 Communication and training about   anticorruption policies and proceduresEthics and Compliance GRI 300 Environmental Standards Series GRI 301: Materials Management approach Sustainable Design; Materials Use;   Product End-of-Life; Materiality   Assessment Findings 301-3 Reclaimed products and their   packaging materialsProduct End-of-Life GRI 302: Energy Management approach Operations; Energy ; Materiality   Assessment Findings 302-1 Energy consumption within the organization Energy ; Baxter Data Summary ; Baxter Value   Chain Energy Usage and GHG Emissions 302-3 Energy intensity Energy ; Baxter Data Summary 302-4 Reduction of energy consumption EnergyGRI 300 Environmental Standards Series (continued) GRI 303: Water Management approach Operations; Water and Wastewater ;   Materiality Assessment Findings 303-1 Water withdrawal by source Water and Wastewater ; Baxter Data Summary 303-2 Water sources significantly affected by   withdrawal of waterWater and Wastewater ; Baxter Data Summary GRI 305: Emissions Management approach Operations; GHG Emissions Across the Value   Chain; GHG Emissions from Operations;   Materiality Assessment Findings 305-1 Direct (Scope 1) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-2 Energy indirect (Scope 2) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-3 Other indirect (Scope 3) GHG emissions GHG Emissions Across the Value Chain;   Baxter Data Summary ; Baxter Value Chain Energy  Usage and GHG Emissions 305-4 GHG emissions intensity GHG Emissions from Operations; Baxter Data Summary 305-5 Reduction of GHG emissions GHG Emissions from Operations 305-7 Nitrogen oxides (NOX), sulfur oxides (SOX)   and other significant air emissionsBaxter Data Summary GRI 306: Effluents and Waste Management approach Operations; Waste ; Materiality    Assessment Findings 306-1 Water discharge by quality and destination Baxter Data Summary 306-2 Waste by type and disposal method Waste ; Baxter Data Summary GRI 307: Environmental Compliance Management approach Operations 307-1 Non-compliance with environmental laws   and regulationsEnvironmental, Health and Safety Performance;   Baxter Data Summary GRI 308: Supplier Environmental Assessment Management approach Managing Procurement Risks; Supplier   Corporate Responsibility Survey ; Supplier Audits;   Materiality Assessment Findings  308-2 Negative environmental impacts in the   supply chain and actions takenSupplier Corporate Responsibility Survey ;   Green Logistics; Baxter Value Chain Energy Usage  and GHG Emissions2020 Reporting 2020 ReportingAPPENDIX:   Global Reporting Initiative (GRI) Index (continued)BAXTER 2020 CORPORATE RESPONSIBILITY REPORT66Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Global Reporting Initiative (GRI) Index (continued) Disclosure Disclosure 2020 Reporting 2020 Reporting GRI 400 Social Standards Series GRI 401: Employment Management approach Workplace Culture; Materiality    Assessment Findings 401-1 New employee hires and employee turnover Voluntary employee turnover was 9.2% in 2020.
","('Business_Ethics', 0.9724799394607544)","('Management_Of_Legal_And_Regulatory_Framework', 0.0035296697169542313)","('Product_Quality_And_Safety', 0.0019100857898592949)","(['Business Ethics'], 0.9724799394607544)","('NON-ESG', 0.0035296697169542313)","('NON-ESG', 0.0019100857898592949)"
Line 1261,"Strategy  102-14 Statement from senior decision-maker From the Chairman and CEO Ethics and Integrity 102-16 Values, principles, standards and norms   of behaviorProtecting Human Rights; Ethics and Compliance;   Responsible Procurement 102-17 Mechanisms for advice and concerns   about ethicsEthics and Compliance HelplineGRI 102: General Disclosures 2016 (continued) Governance  102-18 Governance structure Our Governance 102-19 Delegating authority Corporate Responsibility Governance   and Management 102-20 Executive-level responsibility for economic,  environmental and social topicsCorporate Responsibility Governance   and Management 102-22 Composition of the highest governance body   and its committeesOur Governance 102-23 Chair of the highest governance body Our Governance Organizational Profile 102-24 Nominating and selecting the highest   governance bodyCorporate Governance Guidelines 102-25 Conflicts of interest Corporate Governance Guidelines 102-31 Review of economic, environmental and   social topicsCorporate Responsibility 102-33 Communicating critical concerns Baxter 2021 Proxy Statement 102-35 Remuneration policies Corporate Governance Guidelines;   Baxter 2021 Proxy Statement 102-36 Process for determining remuneration Corporate Governance Guidelines Stakeholder Engagement 102-40 List of stakeholder groups Stakeholder Engagement 102-42 Identifying and selecting stakeholders Stakeholder Engagement 102-43 Approach to stakeholder engagement Stakeholder Engagement Reporting Practice  102-45 Entities included in the consolidated   financial statementsBaxter 2020 Annual Report on Form 10-K 102-46 Defining report content and topic Boundaries Materiality 102-47 List of material topics Materiality 102-50 Reporting period Calendar year 102-51 Date of most recent report June 102-52 Reporting cycle Yearly 102-53 Contact point for questions regarding the report corporate_responsibility_report@baxter.com 102-55 GRI content index This section 102-56 External assurance Assurance and Verification2020 Reporting 2020 ReportingBAXTER 2020 CORPORATE RESPONSIBILITY REPORT65Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Disclosure Disclosure GRI 200 Economic Standard Series GRI 201: Economic Performance Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 201-1 Direct economic value generated and  distributedServing Our Communities ; Baxter Data Summary ;  Baxter 2020 Annual Report on Form 10-K 201-2 Financial implications and other risks and  opportunities due to climate changeBaxter CDP submission GRI 203: Indirect Economic Impacts Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 203-1 Infrastructure investments and   services supportedInnovation That Expands Access to Care;   Serving Our Communities 203-2 Significant indirect economic impacts Innovation That Expands Access to Care;   Serving Our Communities GRI 205: Anticorruption Management approach Ethics and Compliance; Materiality   Assessment Findings 205-1 Operations assessed for risks related   to corruptionEthics and Compliance 205-2 Communication and training about   anticorruption policies and proceduresEthics and Compliance GRI 300 Environmental Standards Series GRI 301: Materials Management approach Sustainable Design; Materials Use;   Product End-of-Life; Materiality   Assessment Findings 301-3 Reclaimed products and their   packaging materialsProduct End-of-Life GRI 302: Energy Management approach Operations; Energy ; Materiality   Assessment Findings 302-1 Energy consumption within the organization Energy ; Baxter Data Summary ; Baxter Value   Chain Energy Usage and GHG Emissions 302-3 Energy intensity Energy ; Baxter Data Summary 302-4 Reduction of energy consumption EnergyGRI 300 Environmental Standards Series (continued) GRI 303: Water Management approach Operations; Water and Wastewater ;   Materiality Assessment Findings 303-1 Water withdrawal by source Water and Wastewater ; Baxter Data Summary 303-2 Water sources significantly affected by   withdrawal of waterWater and Wastewater ; Baxter Data Summary GRI 305: Emissions Management approach Operations; GHG Emissions Across the Value   Chain; GHG Emissions from Operations;   Materiality Assessment Findings 305-1 Direct (Scope 1) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-2 Energy indirect (Scope 2) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-3 Other indirect (Scope 3) GHG emissions GHG Emissions Across the Value Chain;   Baxter Data Summary ; Baxter Value Chain Energy  Usage and GHG Emissions 305-4 GHG emissions intensity GHG Emissions from Operations; Baxter Data Summary 305-5 Reduction of GHG emissions GHG Emissions from Operations 305-7 Nitrogen oxides (NOX), sulfur oxides (SOX)   and other significant air emissionsBaxter Data Summary GRI 306: Effluents and Waste Management approach Operations; Waste ; Materiality    Assessment Findings 306-1 Water discharge by quality and destination Baxter Data Summary 306-2 Waste by type and disposal method Waste ; Baxter Data Summary GRI 307: Environmental Compliance Management approach Operations 307-1 Non-compliance with environmental laws   and regulationsEnvironmental, Health and Safety Performance;   Baxter Data Summary GRI 308: Supplier Environmental Assessment Management approach Managing Procurement Risks; Supplier   Corporate Responsibility Survey ; Supplier Audits;   Materiality Assessment Findings  308-2 Negative environmental impacts in the   supply chain and actions takenSupplier Corporate Responsibility Survey ;   Green Logistics; Baxter Value Chain Energy Usage  and GHG Emissions2020 Reporting 2020 ReportingAPPENDIX:   Global Reporting Initiative (GRI) Index (continued)BAXTER 2020 CORPORATE RESPONSIBILITY REPORT66Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Global Reporting Initiative (GRI) Index (continued) Disclosure Disclosure 2020 Reporting 2020 Reporting GRI 400 Social Standards Series GRI 401: Employment Management approach Workplace Culture; Materiality    Assessment Findings 401-1 New employee hires and employee turnover Voluntary employee turnover was 9.2% in 2020.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6869077682495117)","('Business_Ethics', 0.05726775527000427)","('Human_Rights_And_Community_Relations', 0.05709848180413246)","(['Corporate Governance'], 0.6869077682495117)","('NON-ESG', 0.05726775527000427)","('NON-ESG', 0.05709848180413246)"
Line 1262,"Strategy  102-14 Statement from senior decision-maker From the Chairman and CEO Ethics and Integrity 102-16 Values, principles, standards and norms   of behaviorProtecting Human Rights; Ethics and Compliance;   Responsible Procurement 102-17 Mechanisms for advice and concerns   about ethicsEthics and Compliance HelplineGRI 102: General Disclosures 2016 (continued) Governance  102-18 Governance structure Our Governance 102-19 Delegating authority Corporate Responsibility Governance   and Management 102-20 Executive-level responsibility for economic,  environmental and social topicsCorporate Responsibility Governance   and Management 102-22 Composition of the highest governance body   and its committeesOur Governance 102-23 Chair of the highest governance body Our Governance Organizational Profile 102-24 Nominating and selecting the highest   governance bodyCorporate Governance Guidelines 102-25 Conflicts of interest Corporate Governance Guidelines 102-31 Review of economic, environmental and   social topicsCorporate Responsibility 102-33 Communicating critical concerns Baxter 2021 Proxy Statement 102-35 Remuneration policies Corporate Governance Guidelines;   Baxter 2021 Proxy Statement 102-36 Process for determining remuneration Corporate Governance Guidelines Stakeholder Engagement 102-40 List of stakeholder groups Stakeholder Engagement 102-42 Identifying and selecting stakeholders Stakeholder Engagement 102-43 Approach to stakeholder engagement Stakeholder Engagement Reporting Practice  102-45 Entities included in the consolidated   financial statementsBaxter 2020 Annual Report on Form 10-K 102-46 Defining report content and topic Boundaries Materiality 102-47 List of material topics Materiality 102-50 Reporting period Calendar year 102-51 Date of most recent report June 102-52 Reporting cycle Yearly 102-53 Contact point for questions regarding the report corporate_responsibility_report@baxter.com 102-55 GRI content index This section 102-56 External assurance Assurance and Verification2020 Reporting 2020 ReportingBAXTER 2020 CORPORATE RESPONSIBILITY REPORT65Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Disclosure Disclosure GRI 200 Economic Standard Series GRI 201: Economic Performance Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 201-1 Direct economic value generated and  distributedServing Our Communities ; Baxter Data Summary ;  Baxter 2020 Annual Report on Form 10-K 201-2 Financial implications and other risks and  opportunities due to climate changeBaxter CDP submission GRI 203: Indirect Economic Impacts Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 203-1 Infrastructure investments and   services supportedInnovation That Expands Access to Care;   Serving Our Communities 203-2 Significant indirect economic impacts Innovation That Expands Access to Care;   Serving Our Communities GRI 205: Anticorruption Management approach Ethics and Compliance; Materiality   Assessment Findings 205-1 Operations assessed for risks related   to corruptionEthics and Compliance 205-2 Communication and training about   anticorruption policies and proceduresEthics and Compliance GRI 300 Environmental Standards Series GRI 301: Materials Management approach Sustainable Design; Materials Use;   Product End-of-Life; Materiality   Assessment Findings 301-3 Reclaimed products and their   packaging materialsProduct End-of-Life GRI 302: Energy Management approach Operations; Energy ; Materiality   Assessment Findings 302-1 Energy consumption within the organization Energy ; Baxter Data Summary ; Baxter Value   Chain Energy Usage and GHG Emissions 302-3 Energy intensity Energy ; Baxter Data Summary 302-4 Reduction of energy consumption EnergyGRI 300 Environmental Standards Series (continued) GRI 303: Water Management approach Operations; Water and Wastewater ;   Materiality Assessment Findings 303-1 Water withdrawal by source Water and Wastewater ; Baxter Data Summary 303-2 Water sources significantly affected by   withdrawal of waterWater and Wastewater ; Baxter Data Summary GRI 305: Emissions Management approach Operations; GHG Emissions Across the Value   Chain; GHG Emissions from Operations;   Materiality Assessment Findings 305-1 Direct (Scope 1) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-2 Energy indirect (Scope 2) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-3 Other indirect (Scope 3) GHG emissions GHG Emissions Across the Value Chain;   Baxter Data Summary ; Baxter Value Chain Energy  Usage and GHG Emissions 305-4 GHG emissions intensity GHG Emissions from Operations; Baxter Data Summary 305-5 Reduction of GHG emissions GHG Emissions from Operations 305-7 Nitrogen oxides (NOX), sulfur oxides (SOX)   and other significant air emissionsBaxter Data Summary GRI 306: Effluents and Waste Management approach Operations; Waste ; Materiality    Assessment Findings 306-1 Water discharge by quality and destination Baxter Data Summary 306-2 Waste by type and disposal method Waste ; Baxter Data Summary GRI 307: Environmental Compliance Management approach Operations 307-1 Non-compliance with environmental laws   and regulationsEnvironmental, Health and Safety Performance;   Baxter Data Summary GRI 308: Supplier Environmental Assessment Management approach Managing Procurement Risks; Supplier   Corporate Responsibility Survey ; Supplier Audits;   Materiality Assessment Findings  308-2 Negative environmental impacts in the   supply chain and actions takenSupplier Corporate Responsibility Survey ;   Green Logistics; Baxter Value Chain Energy Usage  and GHG Emissions2020 Reporting 2020 ReportingAPPENDIX:   Global Reporting Initiative (GRI) Index (continued)BAXTER 2020 CORPORATE RESPONSIBILITY REPORT66Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Global Reporting Initiative (GRI) Index (continued) Disclosure Disclosure 2020 Reporting 2020 Reporting GRI 400 Social Standards Series GRI 401: Employment Management approach Workplace Culture; Materiality    Assessment Findings 401-1 New employee hires and employee turnover Voluntary employee turnover was 9.2% in 2020.
","('Management_Of_Legal_And_Regulatory_Framework', 0.22704117000102997)","('Business_Ethics', 0.19562846422195435)","('Human_Rights_And_Community_Relations', 0.15689055621623993)","('NON-ESG', 0.22704117000102997)","('NON-ESG', 0.19562846422195435)","('NON-ESG', 0.15689055621623993)"
Line 1263,"Strategy  102-14 Statement from senior decision-maker From the Chairman and CEO Ethics and Integrity 102-16 Values, principles, standards and norms   of behaviorProtecting Human Rights; Ethics and Compliance;   Responsible Procurement 102-17 Mechanisms for advice and concerns   about ethicsEthics and Compliance HelplineGRI 102: General Disclosures 2016 (continued) Governance  102-18 Governance structure Our Governance 102-19 Delegating authority Corporate Responsibility Governance   and Management 102-20 Executive-level responsibility for economic,  environmental and social topicsCorporate Responsibility Governance   and Management 102-22 Composition of the highest governance body   and its committeesOur Governance 102-23 Chair of the highest governance body Our Governance Organizational Profile 102-24 Nominating and selecting the highest   governance bodyCorporate Governance Guidelines 102-25 Conflicts of interest Corporate Governance Guidelines 102-31 Review of economic, environmental and   social topicsCorporate Responsibility 102-33 Communicating critical concerns Baxter 2021 Proxy Statement 102-35 Remuneration policies Corporate Governance Guidelines;   Baxter 2021 Proxy Statement 102-36 Process for determining remuneration Corporate Governance Guidelines Stakeholder Engagement 102-40 List of stakeholder groups Stakeholder Engagement 102-42 Identifying and selecting stakeholders Stakeholder Engagement 102-43 Approach to stakeholder engagement Stakeholder Engagement Reporting Practice  102-45 Entities included in the consolidated   financial statementsBaxter 2020 Annual Report on Form 10-K 102-46 Defining report content and topic Boundaries Materiality 102-47 List of material topics Materiality 102-50 Reporting period Calendar year 102-51 Date of most recent report June 102-52 Reporting cycle Yearly 102-53 Contact point for questions regarding the report corporate_responsibility_report@baxter.com 102-55 GRI content index This section 102-56 External assurance Assurance and Verification2020 Reporting 2020 ReportingBAXTER 2020 CORPORATE RESPONSIBILITY REPORT65Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Disclosure Disclosure GRI 200 Economic Standard Series GRI 201: Economic Performance Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 201-1 Direct economic value generated and  distributedServing Our Communities ; Baxter Data Summary ;  Baxter 2020 Annual Report on Form 10-K 201-2 Financial implications and other risks and  opportunities due to climate changeBaxter CDP submission GRI 203: Indirect Economic Impacts Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 203-1 Infrastructure investments and   services supportedInnovation That Expands Access to Care;   Serving Our Communities 203-2 Significant indirect economic impacts Innovation That Expands Access to Care;   Serving Our Communities GRI 205: Anticorruption Management approach Ethics and Compliance; Materiality   Assessment Findings 205-1 Operations assessed for risks related   to corruptionEthics and Compliance 205-2 Communication and training about   anticorruption policies and proceduresEthics and Compliance GRI 300 Environmental Standards Series GRI 301: Materials Management approach Sustainable Design; Materials Use;   Product End-of-Life; Materiality   Assessment Findings 301-3 Reclaimed products and their   packaging materialsProduct End-of-Life GRI 302: Energy Management approach Operations; Energy ; Materiality   Assessment Findings 302-1 Energy consumption within the organization Energy ; Baxter Data Summary ; Baxter Value   Chain Energy Usage and GHG Emissions 302-3 Energy intensity Energy ; Baxter Data Summary 302-4 Reduction of energy consumption EnergyGRI 300 Environmental Standards Series (continued) GRI 303: Water Management approach Operations; Water and Wastewater ;   Materiality Assessment Findings 303-1 Water withdrawal by source Water and Wastewater ; Baxter Data Summary 303-2 Water sources significantly affected by   withdrawal of waterWater and Wastewater ; Baxter Data Summary GRI 305: Emissions Management approach Operations; GHG Emissions Across the Value   Chain; GHG Emissions from Operations;   Materiality Assessment Findings 305-1 Direct (Scope 1) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-2 Energy indirect (Scope 2) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-3 Other indirect (Scope 3) GHG emissions GHG Emissions Across the Value Chain;   Baxter Data Summary ; Baxter Value Chain Energy  Usage and GHG Emissions 305-4 GHG emissions intensity GHG Emissions from Operations; Baxter Data Summary 305-5 Reduction of GHG emissions GHG Emissions from Operations 305-7 Nitrogen oxides (NOX), sulfur oxides (SOX)   and other significant air emissionsBaxter Data Summary GRI 306: Effluents and Waste Management approach Operations; Waste ; Materiality    Assessment Findings 306-1 Water discharge by quality and destination Baxter Data Summary 306-2 Waste by type and disposal method Waste ; Baxter Data Summary GRI 307: Environmental Compliance Management approach Operations 307-1 Non-compliance with environmental laws   and regulationsEnvironmental, Health and Safety Performance;   Baxter Data Summary GRI 308: Supplier Environmental Assessment Management approach Managing Procurement Risks; Supplier   Corporate Responsibility Survey ; Supplier Audits;   Materiality Assessment Findings  308-2 Negative environmental impacts in the   supply chain and actions takenSupplier Corporate Responsibility Survey ;   Green Logistics; Baxter Value Chain Energy Usage  and GHG Emissions2020 Reporting 2020 ReportingAPPENDIX:   Global Reporting Initiative (GRI) Index (continued)BAXTER 2020 CORPORATE RESPONSIBILITY REPORT66Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Global Reporting Initiative (GRI) Index (continued) Disclosure Disclosure 2020 Reporting 2020 Reporting GRI 400 Social Standards Series GRI 401: Employment Management approach Workplace Culture; Materiality    Assessment Findings 401-1 New employee hires and employee turnover Voluntary employee turnover was 9.2% in 2020.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5839000940322876)","('Business_Model_Resilience', 0.09927785396575928)","('Systemic_Risk_Management', 0.07500740140676498)","(['Corporate Governance'], 0.5839000940322876)","('NON-ESG', 0.09927785396575928)","('NON-ESG', 0.07500740140676498)"
Line 1264,"Strategy  102-14 Statement from senior decision-maker From the Chairman and CEO Ethics and Integrity 102-16 Values, principles, standards and norms   of behaviorProtecting Human Rights; Ethics and Compliance;   Responsible Procurement 102-17 Mechanisms for advice and concerns   about ethicsEthics and Compliance HelplineGRI 102: General Disclosures 2016 (continued) Governance  102-18 Governance structure Our Governance 102-19 Delegating authority Corporate Responsibility Governance   and Management 102-20 Executive-level responsibility for economic,  environmental and social topicsCorporate Responsibility Governance   and Management 102-22 Composition of the highest governance body   and its committeesOur Governance 102-23 Chair of the highest governance body Our Governance Organizational Profile 102-24 Nominating and selecting the highest   governance bodyCorporate Governance Guidelines 102-25 Conflicts of interest Corporate Governance Guidelines 102-31 Review of economic, environmental and   social topicsCorporate Responsibility 102-33 Communicating critical concerns Baxter 2021 Proxy Statement 102-35 Remuneration policies Corporate Governance Guidelines;   Baxter 2021 Proxy Statement 102-36 Process for determining remuneration Corporate Governance Guidelines Stakeholder Engagement 102-40 List of stakeholder groups Stakeholder Engagement 102-42 Identifying and selecting stakeholders Stakeholder Engagement 102-43 Approach to stakeholder engagement Stakeholder Engagement Reporting Practice  102-45 Entities included in the consolidated   financial statementsBaxter 2020 Annual Report on Form 10-K 102-46 Defining report content and topic Boundaries Materiality 102-47 List of material topics Materiality 102-50 Reporting period Calendar year 102-51 Date of most recent report June 102-52 Reporting cycle Yearly 102-53 Contact point for questions regarding the report corporate_responsibility_report@baxter.com 102-55 GRI content index This section 102-56 External assurance Assurance and Verification2020 Reporting 2020 ReportingBAXTER 2020 CORPORATE RESPONSIBILITY REPORT65Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Disclosure Disclosure GRI 200 Economic Standard Series GRI 201: Economic Performance Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 201-1 Direct economic value generated and  distributedServing Our Communities ; Baxter Data Summary ;  Baxter 2020 Annual Report on Form 10-K 201-2 Financial implications and other risks and  opportunities due to climate changeBaxter CDP submission GRI 203: Indirect Economic Impacts Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 203-1 Infrastructure investments and   services supportedInnovation That Expands Access to Care;   Serving Our Communities 203-2 Significant indirect economic impacts Innovation That Expands Access to Care;   Serving Our Communities GRI 205: Anticorruption Management approach Ethics and Compliance; Materiality   Assessment Findings 205-1 Operations assessed for risks related   to corruptionEthics and Compliance 205-2 Communication and training about   anticorruption policies and proceduresEthics and Compliance GRI 300 Environmental Standards Series GRI 301: Materials Management approach Sustainable Design; Materials Use;   Product End-of-Life; Materiality   Assessment Findings 301-3 Reclaimed products and their   packaging materialsProduct End-of-Life GRI 302: Energy Management approach Operations; Energy ; Materiality   Assessment Findings 302-1 Energy consumption within the organization Energy ; Baxter Data Summary ; Baxter Value   Chain Energy Usage and GHG Emissions 302-3 Energy intensity Energy ; Baxter Data Summary 302-4 Reduction of energy consumption EnergyGRI 300 Environmental Standards Series (continued) GRI 303: Water Management approach Operations; Water and Wastewater ;   Materiality Assessment Findings 303-1 Water withdrawal by source Water and Wastewater ; Baxter Data Summary 303-2 Water sources significantly affected by   withdrawal of waterWater and Wastewater ; Baxter Data Summary GRI 305: Emissions Management approach Operations; GHG Emissions Across the Value   Chain; GHG Emissions from Operations;   Materiality Assessment Findings 305-1 Direct (Scope 1) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-2 Energy indirect (Scope 2) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-3 Other indirect (Scope 3) GHG emissions GHG Emissions Across the Value Chain;   Baxter Data Summary ; Baxter Value Chain Energy  Usage and GHG Emissions 305-4 GHG emissions intensity GHG Emissions from Operations; Baxter Data Summary 305-5 Reduction of GHG emissions GHG Emissions from Operations 305-7 Nitrogen oxides (NOX), sulfur oxides (SOX)   and other significant air emissionsBaxter Data Summary GRI 306: Effluents and Waste Management approach Operations; Waste ; Materiality    Assessment Findings 306-1 Water discharge by quality and destination Baxter Data Summary 306-2 Waste by type and disposal method Waste ; Baxter Data Summary GRI 307: Environmental Compliance Management approach Operations 307-1 Non-compliance with environmental laws   and regulationsEnvironmental, Health and Safety Performance;   Baxter Data Summary GRI 308: Supplier Environmental Assessment Management approach Managing Procurement Risks; Supplier   Corporate Responsibility Survey ; Supplier Audits;   Materiality Assessment Findings  308-2 Negative environmental impacts in the   supply chain and actions takenSupplier Corporate Responsibility Survey ;   Green Logistics; Baxter Value Chain Energy Usage  and GHG Emissions2020 Reporting 2020 ReportingAPPENDIX:   Global Reporting Initiative (GRI) Index (continued)BAXTER 2020 CORPORATE RESPONSIBILITY REPORT66Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Global Reporting Initiative (GRI) Index (continued) Disclosure Disclosure 2020 Reporting 2020 Reporting GRI 400 Social Standards Series GRI 401: Employment Management approach Workplace Culture; Materiality    Assessment Findings 401-1 New employee hires and employee turnover Voluntary employee turnover was 9.2% in 2020.
","('Access_And_Affordability', 0.8113729357719421)","('Employee_Health_And_Safety', 0.04003476724028587)","('Human_Rights_And_Community_Relations', 0.022692544385790825)","(['Health Outcome Contribution'], 0.8113729357719421)","('NON-ESG', 0.04003476724028587)","('NON-ESG', 0.022692544385790825)"
Line 1265,"Strategy  102-14 Statement from senior decision-maker From the Chairman and CEO Ethics and Integrity 102-16 Values, principles, standards and norms   of behaviorProtecting Human Rights; Ethics and Compliance;   Responsible Procurement 102-17 Mechanisms for advice and concerns   about ethicsEthics and Compliance HelplineGRI 102: General Disclosures 2016 (continued) Governance  102-18 Governance structure Our Governance 102-19 Delegating authority Corporate Responsibility Governance   and Management 102-20 Executive-level responsibility for economic,  environmental and social topicsCorporate Responsibility Governance   and Management 102-22 Composition of the highest governance body   and its committeesOur Governance 102-23 Chair of the highest governance body Our Governance Organizational Profile 102-24 Nominating and selecting the highest   governance bodyCorporate Governance Guidelines 102-25 Conflicts of interest Corporate Governance Guidelines 102-31 Review of economic, environmental and   social topicsCorporate Responsibility 102-33 Communicating critical concerns Baxter 2021 Proxy Statement 102-35 Remuneration policies Corporate Governance Guidelines;   Baxter 2021 Proxy Statement 102-36 Process for determining remuneration Corporate Governance Guidelines Stakeholder Engagement 102-40 List of stakeholder groups Stakeholder Engagement 102-42 Identifying and selecting stakeholders Stakeholder Engagement 102-43 Approach to stakeholder engagement Stakeholder Engagement Reporting Practice  102-45 Entities included in the consolidated   financial statementsBaxter 2020 Annual Report on Form 10-K 102-46 Defining report content and topic Boundaries Materiality 102-47 List of material topics Materiality 102-50 Reporting period Calendar year 102-51 Date of most recent report June 102-52 Reporting cycle Yearly 102-53 Contact point for questions regarding the report corporate_responsibility_report@baxter.com 102-55 GRI content index This section 102-56 External assurance Assurance and Verification2020 Reporting 2020 ReportingBAXTER 2020 CORPORATE RESPONSIBILITY REPORT65Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Disclosure Disclosure GRI 200 Economic Standard Series GRI 201: Economic Performance Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 201-1 Direct economic value generated and  distributedServing Our Communities ; Baxter Data Summary ;  Baxter 2020 Annual Report on Form 10-K 201-2 Financial implications and other risks and  opportunities due to climate changeBaxter CDP submission GRI 203: Indirect Economic Impacts Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 203-1 Infrastructure investments and   services supportedInnovation That Expands Access to Care;   Serving Our Communities 203-2 Significant indirect economic impacts Innovation That Expands Access to Care;   Serving Our Communities GRI 205: Anticorruption Management approach Ethics and Compliance; Materiality   Assessment Findings 205-1 Operations assessed for risks related   to corruptionEthics and Compliance 205-2 Communication and training about   anticorruption policies and proceduresEthics and Compliance GRI 300 Environmental Standards Series GRI 301: Materials Management approach Sustainable Design; Materials Use;   Product End-of-Life; Materiality   Assessment Findings 301-3 Reclaimed products and their   packaging materialsProduct End-of-Life GRI 302: Energy Management approach Operations; Energy ; Materiality   Assessment Findings 302-1 Energy consumption within the organization Energy ; Baxter Data Summary ; Baxter Value   Chain Energy Usage and GHG Emissions 302-3 Energy intensity Energy ; Baxter Data Summary 302-4 Reduction of energy consumption EnergyGRI 300 Environmental Standards Series (continued) GRI 303: Water Management approach Operations; Water and Wastewater ;   Materiality Assessment Findings 303-1 Water withdrawal by source Water and Wastewater ; Baxter Data Summary 303-2 Water sources significantly affected by   withdrawal of waterWater and Wastewater ; Baxter Data Summary GRI 305: Emissions Management approach Operations; GHG Emissions Across the Value   Chain; GHG Emissions from Operations;   Materiality Assessment Findings 305-1 Direct (Scope 1) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-2 Energy indirect (Scope 2) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-3 Other indirect (Scope 3) GHG emissions GHG Emissions Across the Value Chain;   Baxter Data Summary ; Baxter Value Chain Energy  Usage and GHG Emissions 305-4 GHG emissions intensity GHG Emissions from Operations; Baxter Data Summary 305-5 Reduction of GHG emissions GHG Emissions from Operations 305-7 Nitrogen oxides (NOX), sulfur oxides (SOX)   and other significant air emissionsBaxter Data Summary GRI 306: Effluents and Waste Management approach Operations; Waste ; Materiality    Assessment Findings 306-1 Water discharge by quality and destination Baxter Data Summary 306-2 Waste by type and disposal method Waste ; Baxter Data Summary GRI 307: Environmental Compliance Management approach Operations 307-1 Non-compliance with environmental laws   and regulationsEnvironmental, Health and Safety Performance;   Baxter Data Summary GRI 308: Supplier Environmental Assessment Management approach Managing Procurement Risks; Supplier   Corporate Responsibility Survey ; Supplier Audits;   Materiality Assessment Findings  308-2 Negative environmental impacts in the   supply chain and actions takenSupplier Corporate Responsibility Survey ;   Green Logistics; Baxter Value Chain Energy Usage  and GHG Emissions2020 Reporting 2020 ReportingAPPENDIX:   Global Reporting Initiative (GRI) Index (continued)BAXTER 2020 CORPORATE RESPONSIBILITY REPORT66Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Global Reporting Initiative (GRI) Index (continued) Disclosure Disclosure 2020 Reporting 2020 Reporting GRI 400 Social Standards Series GRI 401: Employment Management approach Workplace Culture; Materiality    Assessment Findings 401-1 New employee hires and employee turnover Voluntary employee turnover was 9.2% in 2020.
","('Physical_Impacts_Of_Climate_Change', 0.9397920966148376)","('Business_Model_Resilience', 0.013706251978874207)","('Human_Rights_And_Community_Relations', 0.0057855634950101376)","(['Climate Change'], 0.9397920966148376)","('NON-ESG', 0.013706251978874207)","('NON-ESG', 0.0057855634950101376)"
Line 1266,"Strategy  102-14 Statement from senior decision-maker From the Chairman and CEO Ethics and Integrity 102-16 Values, principles, standards and norms   of behaviorProtecting Human Rights; Ethics and Compliance;   Responsible Procurement 102-17 Mechanisms for advice and concerns   about ethicsEthics and Compliance HelplineGRI 102: General Disclosures 2016 (continued) Governance  102-18 Governance structure Our Governance 102-19 Delegating authority Corporate Responsibility Governance   and Management 102-20 Executive-level responsibility for economic,  environmental and social topicsCorporate Responsibility Governance   and Management 102-22 Composition of the highest governance body   and its committeesOur Governance 102-23 Chair of the highest governance body Our Governance Organizational Profile 102-24 Nominating and selecting the highest   governance bodyCorporate Governance Guidelines 102-25 Conflicts of interest Corporate Governance Guidelines 102-31 Review of economic, environmental and   social topicsCorporate Responsibility 102-33 Communicating critical concerns Baxter 2021 Proxy Statement 102-35 Remuneration policies Corporate Governance Guidelines;   Baxter 2021 Proxy Statement 102-36 Process for determining remuneration Corporate Governance Guidelines Stakeholder Engagement 102-40 List of stakeholder groups Stakeholder Engagement 102-42 Identifying and selecting stakeholders Stakeholder Engagement 102-43 Approach to stakeholder engagement Stakeholder Engagement Reporting Practice  102-45 Entities included in the consolidated   financial statementsBaxter 2020 Annual Report on Form 10-K 102-46 Defining report content and topic Boundaries Materiality 102-47 List of material topics Materiality 102-50 Reporting period Calendar year 102-51 Date of most recent report June 102-52 Reporting cycle Yearly 102-53 Contact point for questions regarding the report corporate_responsibility_report@baxter.com 102-55 GRI content index This section 102-56 External assurance Assurance and Verification2020 Reporting 2020 ReportingBAXTER 2020 CORPORATE RESPONSIBILITY REPORT65Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Disclosure Disclosure GRI 200 Economic Standard Series GRI 201: Economic Performance Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 201-1 Direct economic value generated and  distributedServing Our Communities ; Baxter Data Summary ;  Baxter 2020 Annual Report on Form 10-K 201-2 Financial implications and other risks and  opportunities due to climate changeBaxter CDP submission GRI 203: Indirect Economic Impacts Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 203-1 Infrastructure investments and   services supportedInnovation That Expands Access to Care;   Serving Our Communities 203-2 Significant indirect economic impacts Innovation That Expands Access to Care;   Serving Our Communities GRI 205: Anticorruption Management approach Ethics and Compliance; Materiality   Assessment Findings 205-1 Operations assessed for risks related   to corruptionEthics and Compliance 205-2 Communication and training about   anticorruption policies and proceduresEthics and Compliance GRI 300 Environmental Standards Series GRI 301: Materials Management approach Sustainable Design; Materials Use;   Product End-of-Life; Materiality   Assessment Findings 301-3 Reclaimed products and their   packaging materialsProduct End-of-Life GRI 302: Energy Management approach Operations; Energy ; Materiality   Assessment Findings 302-1 Energy consumption within the organization Energy ; Baxter Data Summary ; Baxter Value   Chain Energy Usage and GHG Emissions 302-3 Energy intensity Energy ; Baxter Data Summary 302-4 Reduction of energy consumption EnergyGRI 300 Environmental Standards Series (continued) GRI 303: Water Management approach Operations; Water and Wastewater ;   Materiality Assessment Findings 303-1 Water withdrawal by source Water and Wastewater ; Baxter Data Summary 303-2 Water sources significantly affected by   withdrawal of waterWater and Wastewater ; Baxter Data Summary GRI 305: Emissions Management approach Operations; GHG Emissions Across the Value   Chain; GHG Emissions from Operations;   Materiality Assessment Findings 305-1 Direct (Scope 1) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-2 Energy indirect (Scope 2) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-3 Other indirect (Scope 3) GHG emissions GHG Emissions Across the Value Chain;   Baxter Data Summary ; Baxter Value Chain Energy  Usage and GHG Emissions 305-4 GHG emissions intensity GHG Emissions from Operations; Baxter Data Summary 305-5 Reduction of GHG emissions GHG Emissions from Operations 305-7 Nitrogen oxides (NOX), sulfur oxides (SOX)   and other significant air emissionsBaxter Data Summary GRI 306: Effluents and Waste Management approach Operations; Waste ; Materiality    Assessment Findings 306-1 Water discharge by quality and destination Baxter Data Summary 306-2 Waste by type and disposal method Waste ; Baxter Data Summary GRI 307: Environmental Compliance Management approach Operations 307-1 Non-compliance with environmental laws   and regulationsEnvironmental, Health and Safety Performance;   Baxter Data Summary GRI 308: Supplier Environmental Assessment Management approach Managing Procurement Risks; Supplier   Corporate Responsibility Survey ; Supplier Audits;   Materiality Assessment Findings  308-2 Negative environmental impacts in the   supply chain and actions takenSupplier Corporate Responsibility Survey ;   Green Logistics; Baxter Value Chain Energy Usage  and GHG Emissions2020 Reporting 2020 ReportingAPPENDIX:   Global Reporting Initiative (GRI) Index (continued)BAXTER 2020 CORPORATE RESPONSIBILITY REPORT66Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Global Reporting Initiative (GRI) Index (continued) Disclosure Disclosure 2020 Reporting 2020 Reporting GRI 400 Social Standards Series GRI 401: Employment Management approach Workplace Culture; Materiality    Assessment Findings 401-1 New employee hires and employee turnover Voluntary employee turnover was 9.2% in 2020.
","('Business_Ethics', 0.8944131731987)","('Management_Of_Legal_And_Regulatory_Framework', 0.032231975346803665)","('Access_And_Affordability', 0.009585344232618809)","(['Business Ethics'], 0.8944131731987)","('NON-ESG', 0.032231975346803665)","('NON-ESG', 0.009585344232618809)"
Line 1267,"Strategy  102-14 Statement from senior decision-maker From the Chairman and CEO Ethics and Integrity 102-16 Values, principles, standards and norms   of behaviorProtecting Human Rights; Ethics and Compliance;   Responsible Procurement 102-17 Mechanisms for advice and concerns   about ethicsEthics and Compliance HelplineGRI 102: General Disclosures 2016 (continued) Governance  102-18 Governance structure Our Governance 102-19 Delegating authority Corporate Responsibility Governance   and Management 102-20 Executive-level responsibility for economic,  environmental and social topicsCorporate Responsibility Governance   and Management 102-22 Composition of the highest governance body   and its committeesOur Governance 102-23 Chair of the highest governance body Our Governance Organizational Profile 102-24 Nominating and selecting the highest   governance bodyCorporate Governance Guidelines 102-25 Conflicts of interest Corporate Governance Guidelines 102-31 Review of economic, environmental and   social topicsCorporate Responsibility 102-33 Communicating critical concerns Baxter 2021 Proxy Statement 102-35 Remuneration policies Corporate Governance Guidelines;   Baxter 2021 Proxy Statement 102-36 Process for determining remuneration Corporate Governance Guidelines Stakeholder Engagement 102-40 List of stakeholder groups Stakeholder Engagement 102-42 Identifying and selecting stakeholders Stakeholder Engagement 102-43 Approach to stakeholder engagement Stakeholder Engagement Reporting Practice  102-45 Entities included in the consolidated   financial statementsBaxter 2020 Annual Report on Form 10-K 102-46 Defining report content and topic Boundaries Materiality 102-47 List of material topics Materiality 102-50 Reporting period Calendar year 102-51 Date of most recent report June 102-52 Reporting cycle Yearly 102-53 Contact point for questions regarding the report corporate_responsibility_report@baxter.com 102-55 GRI content index This section 102-56 External assurance Assurance and Verification2020 Reporting 2020 ReportingBAXTER 2020 CORPORATE RESPONSIBILITY REPORT65Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Disclosure Disclosure GRI 200 Economic Standard Series GRI 201: Economic Performance Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 201-1 Direct economic value generated and  distributedServing Our Communities ; Baxter Data Summary ;  Baxter 2020 Annual Report on Form 10-K 201-2 Financial implications and other risks and  opportunities due to climate changeBaxter CDP submission GRI 203: Indirect Economic Impacts Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 203-1 Infrastructure investments and   services supportedInnovation That Expands Access to Care;   Serving Our Communities 203-2 Significant indirect economic impacts Innovation That Expands Access to Care;   Serving Our Communities GRI 205: Anticorruption Management approach Ethics and Compliance; Materiality   Assessment Findings 205-1 Operations assessed for risks related   to corruptionEthics and Compliance 205-2 Communication and training about   anticorruption policies and proceduresEthics and Compliance GRI 300 Environmental Standards Series GRI 301: Materials Management approach Sustainable Design; Materials Use;   Product End-of-Life; Materiality   Assessment Findings 301-3 Reclaimed products and their   packaging materialsProduct End-of-Life GRI 302: Energy Management approach Operations; Energy ; Materiality   Assessment Findings 302-1 Energy consumption within the organization Energy ; Baxter Data Summary ; Baxter Value   Chain Energy Usage and GHG Emissions 302-3 Energy intensity Energy ; Baxter Data Summary 302-4 Reduction of energy consumption EnergyGRI 300 Environmental Standards Series (continued) GRI 303: Water Management approach Operations; Water and Wastewater ;   Materiality Assessment Findings 303-1 Water withdrawal by source Water and Wastewater ; Baxter Data Summary 303-2 Water sources significantly affected by   withdrawal of waterWater and Wastewater ; Baxter Data Summary GRI 305: Emissions Management approach Operations; GHG Emissions Across the Value   Chain; GHG Emissions from Operations;   Materiality Assessment Findings 305-1 Direct (Scope 1) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-2 Energy indirect (Scope 2) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-3 Other indirect (Scope 3) GHG emissions GHG Emissions Across the Value Chain;   Baxter Data Summary ; Baxter Value Chain Energy  Usage and GHG Emissions 305-4 GHG emissions intensity GHG Emissions from Operations; Baxter Data Summary 305-5 Reduction of GHG emissions GHG Emissions from Operations 305-7 Nitrogen oxides (NOX), sulfur oxides (SOX)   and other significant air emissionsBaxter Data Summary GRI 306: Effluents and Waste Management approach Operations; Waste ; Materiality    Assessment Findings 306-1 Water discharge by quality and destination Baxter Data Summary 306-2 Waste by type and disposal method Waste ; Baxter Data Summary GRI 307: Environmental Compliance Management approach Operations 307-1 Non-compliance with environmental laws   and regulationsEnvironmental, Health and Safety Performance;   Baxter Data Summary GRI 308: Supplier Environmental Assessment Management approach Managing Procurement Risks; Supplier   Corporate Responsibility Survey ; Supplier Audits;   Materiality Assessment Findings  308-2 Negative environmental impacts in the   supply chain and actions takenSupplier Corporate Responsibility Survey ;   Green Logistics; Baxter Value Chain Energy Usage  and GHG Emissions2020 Reporting 2020 ReportingAPPENDIX:   Global Reporting Initiative (GRI) Index (continued)BAXTER 2020 CORPORATE RESPONSIBILITY REPORT66Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Global Reporting Initiative (GRI) Index (continued) Disclosure Disclosure 2020 Reporting 2020 Reporting GRI 400 Social Standards Series GRI 401: Employment Management approach Workplace Culture; Materiality    Assessment Findings 401-1 New employee hires and employee turnover Voluntary employee turnover was 9.2% in 2020.
","('Energy_Management', 0.9480989575386047)","('Product_Design_And_Lifecycle_Management', 0.01883968710899353)","('Management_Of_Legal_And_Regulatory_Framework', 0.003034470370039344)","(['Operational Eco-Efficiency'], 0.9480989575386047)","('NON-ESG', 0.01883968710899353)","('NON-ESG', 0.003034470370039344)"
Line 1268,"Strategy  102-14 Statement from senior decision-maker From the Chairman and CEO Ethics and Integrity 102-16 Values, principles, standards and norms   of behaviorProtecting Human Rights; Ethics and Compliance;   Responsible Procurement 102-17 Mechanisms for advice and concerns   about ethicsEthics and Compliance HelplineGRI 102: General Disclosures 2016 (continued) Governance  102-18 Governance structure Our Governance 102-19 Delegating authority Corporate Responsibility Governance   and Management 102-20 Executive-level responsibility for economic,  environmental and social topicsCorporate Responsibility Governance   and Management 102-22 Composition of the highest governance body   and its committeesOur Governance 102-23 Chair of the highest governance body Our Governance Organizational Profile 102-24 Nominating and selecting the highest   governance bodyCorporate Governance Guidelines 102-25 Conflicts of interest Corporate Governance Guidelines 102-31 Review of economic, environmental and   social topicsCorporate Responsibility 102-33 Communicating critical concerns Baxter 2021 Proxy Statement 102-35 Remuneration policies Corporate Governance Guidelines;   Baxter 2021 Proxy Statement 102-36 Process for determining remuneration Corporate Governance Guidelines Stakeholder Engagement 102-40 List of stakeholder groups Stakeholder Engagement 102-42 Identifying and selecting stakeholders Stakeholder Engagement 102-43 Approach to stakeholder engagement Stakeholder Engagement Reporting Practice  102-45 Entities included in the consolidated   financial statementsBaxter 2020 Annual Report on Form 10-K 102-46 Defining report content and topic Boundaries Materiality 102-47 List of material topics Materiality 102-50 Reporting period Calendar year 102-51 Date of most recent report June 102-52 Reporting cycle Yearly 102-53 Contact point for questions regarding the report corporate_responsibility_report@baxter.com 102-55 GRI content index This section 102-56 External assurance Assurance and Verification2020 Reporting 2020 ReportingBAXTER 2020 CORPORATE RESPONSIBILITY REPORT65Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Disclosure Disclosure GRI 200 Economic Standard Series GRI 201: Economic Performance Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 201-1 Direct economic value generated and  distributedServing Our Communities ; Baxter Data Summary ;  Baxter 2020 Annual Report on Form 10-K 201-2 Financial implications and other risks and  opportunities due to climate changeBaxter CDP submission GRI 203: Indirect Economic Impacts Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 203-1 Infrastructure investments and   services supportedInnovation That Expands Access to Care;   Serving Our Communities 203-2 Significant indirect economic impacts Innovation That Expands Access to Care;   Serving Our Communities GRI 205: Anticorruption Management approach Ethics and Compliance; Materiality   Assessment Findings 205-1 Operations assessed for risks related   to corruptionEthics and Compliance 205-2 Communication and training about   anticorruption policies and proceduresEthics and Compliance GRI 300 Environmental Standards Series GRI 301: Materials Management approach Sustainable Design; Materials Use;   Product End-of-Life; Materiality   Assessment Findings 301-3 Reclaimed products and their   packaging materialsProduct End-of-Life GRI 302: Energy Management approach Operations; Energy ; Materiality   Assessment Findings 302-1 Energy consumption within the organization Energy ; Baxter Data Summary ; Baxter Value   Chain Energy Usage and GHG Emissions 302-3 Energy intensity Energy ; Baxter Data Summary 302-4 Reduction of energy consumption EnergyGRI 300 Environmental Standards Series (continued) GRI 303: Water Management approach Operations; Water and Wastewater ;   Materiality Assessment Findings 303-1 Water withdrawal by source Water and Wastewater ; Baxter Data Summary 303-2 Water sources significantly affected by   withdrawal of waterWater and Wastewater ; Baxter Data Summary GRI 305: Emissions Management approach Operations; GHG Emissions Across the Value   Chain; GHG Emissions from Operations;   Materiality Assessment Findings 305-1 Direct (Scope 1) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-2 Energy indirect (Scope 2) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-3 Other indirect (Scope 3) GHG emissions GHG Emissions Across the Value Chain;   Baxter Data Summary ; Baxter Value Chain Energy  Usage and GHG Emissions 305-4 GHG emissions intensity GHG Emissions from Operations; Baxter Data Summary 305-5 Reduction of GHG emissions GHG Emissions from Operations 305-7 Nitrogen oxides (NOX), sulfur oxides (SOX)   and other significant air emissionsBaxter Data Summary GRI 306: Effluents and Waste Management approach Operations; Waste ; Materiality    Assessment Findings 306-1 Water discharge by quality and destination Baxter Data Summary 306-2 Waste by type and disposal method Waste ; Baxter Data Summary GRI 307: Environmental Compliance Management approach Operations 307-1 Non-compliance with environmental laws   and regulationsEnvironmental, Health and Safety Performance;   Baxter Data Summary GRI 308: Supplier Environmental Assessment Management approach Managing Procurement Risks; Supplier   Corporate Responsibility Survey ; Supplier Audits;   Materiality Assessment Findings  308-2 Negative environmental impacts in the   supply chain and actions takenSupplier Corporate Responsibility Survey ;   Green Logistics; Baxter Value Chain Energy Usage  and GHG Emissions2020 Reporting 2020 ReportingAPPENDIX:   Global Reporting Initiative (GRI) Index (continued)BAXTER 2020 CORPORATE RESPONSIBILITY REPORT66Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Global Reporting Initiative (GRI) Index (continued) Disclosure Disclosure 2020 Reporting 2020 Reporting GRI 400 Social Standards Series GRI 401: Employment Management approach Workplace Culture; Materiality    Assessment Findings 401-1 New employee hires and employee turnover Voluntary employee turnover was 9.2% in 2020.
","('GHG_Emissions', 0.9557032585144043)","('Water_And_Wastewater_Management', 0.0066460371017456055)","('Ecological_Impacts', 0.004944094456732273)","(['Climate Change'], 0.9557032585144043)","('NON-ESG', 0.0066460371017456055)","('NON-ESG', 0.004944094456732273)"
Line 1269,"Strategy  102-14 Statement from senior decision-maker From the Chairman and CEO Ethics and Integrity 102-16 Values, principles, standards and norms   of behaviorProtecting Human Rights; Ethics and Compliance;   Responsible Procurement 102-17 Mechanisms for advice and concerns   about ethicsEthics and Compliance HelplineGRI 102: General Disclosures 2016 (continued) Governance  102-18 Governance structure Our Governance 102-19 Delegating authority Corporate Responsibility Governance   and Management 102-20 Executive-level responsibility for economic,  environmental and social topicsCorporate Responsibility Governance   and Management 102-22 Composition of the highest governance body   and its committeesOur Governance 102-23 Chair of the highest governance body Our Governance Organizational Profile 102-24 Nominating and selecting the highest   governance bodyCorporate Governance Guidelines 102-25 Conflicts of interest Corporate Governance Guidelines 102-31 Review of economic, environmental and   social topicsCorporate Responsibility 102-33 Communicating critical concerns Baxter 2021 Proxy Statement 102-35 Remuneration policies Corporate Governance Guidelines;   Baxter 2021 Proxy Statement 102-36 Process for determining remuneration Corporate Governance Guidelines Stakeholder Engagement 102-40 List of stakeholder groups Stakeholder Engagement 102-42 Identifying and selecting stakeholders Stakeholder Engagement 102-43 Approach to stakeholder engagement Stakeholder Engagement Reporting Practice  102-45 Entities included in the consolidated   financial statementsBaxter 2020 Annual Report on Form 10-K 102-46 Defining report content and topic Boundaries Materiality 102-47 List of material topics Materiality 102-50 Reporting period Calendar year 102-51 Date of most recent report June 102-52 Reporting cycle Yearly 102-53 Contact point for questions regarding the report corporate_responsibility_report@baxter.com 102-55 GRI content index This section 102-56 External assurance Assurance and Verification2020 Reporting 2020 ReportingBAXTER 2020 CORPORATE RESPONSIBILITY REPORT65Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Disclosure Disclosure GRI 200 Economic Standard Series GRI 201: Economic Performance Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 201-1 Direct economic value generated and  distributedServing Our Communities ; Baxter Data Summary ;  Baxter 2020 Annual Report on Form 10-K 201-2 Financial implications and other risks and  opportunities due to climate changeBaxter CDP submission GRI 203: Indirect Economic Impacts Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 203-1 Infrastructure investments and   services supportedInnovation That Expands Access to Care;   Serving Our Communities 203-2 Significant indirect economic impacts Innovation That Expands Access to Care;   Serving Our Communities GRI 205: Anticorruption Management approach Ethics and Compliance; Materiality   Assessment Findings 205-1 Operations assessed for risks related   to corruptionEthics and Compliance 205-2 Communication and training about   anticorruption policies and proceduresEthics and Compliance GRI 300 Environmental Standards Series GRI 301: Materials Management approach Sustainable Design; Materials Use;   Product End-of-Life; Materiality   Assessment Findings 301-3 Reclaimed products and their   packaging materialsProduct End-of-Life GRI 302: Energy Management approach Operations; Energy ; Materiality   Assessment Findings 302-1 Energy consumption within the organization Energy ; Baxter Data Summary ; Baxter Value   Chain Energy Usage and GHG Emissions 302-3 Energy intensity Energy ; Baxter Data Summary 302-4 Reduction of energy consumption EnergyGRI 300 Environmental Standards Series (continued) GRI 303: Water Management approach Operations; Water and Wastewater ;   Materiality Assessment Findings 303-1 Water withdrawal by source Water and Wastewater ; Baxter Data Summary 303-2 Water sources significantly affected by   withdrawal of waterWater and Wastewater ; Baxter Data Summary GRI 305: Emissions Management approach Operations; GHG Emissions Across the Value   Chain; GHG Emissions from Operations;   Materiality Assessment Findings 305-1 Direct (Scope 1) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-2 Energy indirect (Scope 2) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-3 Other indirect (Scope 3) GHG emissions GHG Emissions Across the Value Chain;   Baxter Data Summary ; Baxter Value Chain Energy  Usage and GHG Emissions 305-4 GHG emissions intensity GHG Emissions from Operations; Baxter Data Summary 305-5 Reduction of GHG emissions GHG Emissions from Operations 305-7 Nitrogen oxides (NOX), sulfur oxides (SOX)   and other significant air emissionsBaxter Data Summary GRI 306: Effluents and Waste Management approach Operations; Waste ; Materiality    Assessment Findings 306-1 Water discharge by quality and destination Baxter Data Summary 306-2 Waste by type and disposal method Waste ; Baxter Data Summary GRI 307: Environmental Compliance Management approach Operations 307-1 Non-compliance with environmental laws   and regulationsEnvironmental, Health and Safety Performance;   Baxter Data Summary GRI 308: Supplier Environmental Assessment Management approach Managing Procurement Risks; Supplier   Corporate Responsibility Survey ; Supplier Audits;   Materiality Assessment Findings  308-2 Negative environmental impacts in the   supply chain and actions takenSupplier Corporate Responsibility Survey ;   Green Logistics; Baxter Value Chain Energy Usage  and GHG Emissions2020 Reporting 2020 ReportingAPPENDIX:   Global Reporting Initiative (GRI) Index (continued)BAXTER 2020 CORPORATE RESPONSIBILITY REPORT66Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Global Reporting Initiative (GRI) Index (continued) Disclosure Disclosure 2020 Reporting 2020 Reporting GRI 400 Social Standards Series GRI 401: Employment Management approach Workplace Culture; Materiality    Assessment Findings 401-1 New employee hires and employee turnover Voluntary employee turnover was 9.2% in 2020.
","('GHG_Emissions', 0.9641660451889038)","('Air_Quality', 0.0069431038573384285)","('Ecological_Impacts', 0.003470259252935648)","(['Climate Change'], 0.9641660451889038)","('NON-ESG', 0.0069431038573384285)","('NON-ESG', 0.003470259252935648)"
Line 1270,"Strategy  102-14 Statement from senior decision-maker From the Chairman and CEO Ethics and Integrity 102-16 Values, principles, standards and norms   of behaviorProtecting Human Rights; Ethics and Compliance;   Responsible Procurement 102-17 Mechanisms for advice and concerns   about ethicsEthics and Compliance HelplineGRI 102: General Disclosures 2016 (continued) Governance  102-18 Governance structure Our Governance 102-19 Delegating authority Corporate Responsibility Governance   and Management 102-20 Executive-level responsibility for economic,  environmental and social topicsCorporate Responsibility Governance   and Management 102-22 Composition of the highest governance body   and its committeesOur Governance 102-23 Chair of the highest governance body Our Governance Organizational Profile 102-24 Nominating and selecting the highest   governance bodyCorporate Governance Guidelines 102-25 Conflicts of interest Corporate Governance Guidelines 102-31 Review of economic, environmental and   social topicsCorporate Responsibility 102-33 Communicating critical concerns Baxter 2021 Proxy Statement 102-35 Remuneration policies Corporate Governance Guidelines;   Baxter 2021 Proxy Statement 102-36 Process for determining remuneration Corporate Governance Guidelines Stakeholder Engagement 102-40 List of stakeholder groups Stakeholder Engagement 102-42 Identifying and selecting stakeholders Stakeholder Engagement 102-43 Approach to stakeholder engagement Stakeholder Engagement Reporting Practice  102-45 Entities included in the consolidated   financial statementsBaxter 2020 Annual Report on Form 10-K 102-46 Defining report content and topic Boundaries Materiality 102-47 List of material topics Materiality 102-50 Reporting period Calendar year 102-51 Date of most recent report June 102-52 Reporting cycle Yearly 102-53 Contact point for questions regarding the report corporate_responsibility_report@baxter.com 102-55 GRI content index This section 102-56 External assurance Assurance and Verification2020 Reporting 2020 ReportingBAXTER 2020 CORPORATE RESPONSIBILITY REPORT65Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Disclosure Disclosure GRI 200 Economic Standard Series GRI 201: Economic Performance Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 201-1 Direct economic value generated and  distributedServing Our Communities ; Baxter Data Summary ;  Baxter 2020 Annual Report on Form 10-K 201-2 Financial implications and other risks and  opportunities due to climate changeBaxter CDP submission GRI 203: Indirect Economic Impacts Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 203-1 Infrastructure investments and   services supportedInnovation That Expands Access to Care;   Serving Our Communities 203-2 Significant indirect economic impacts Innovation That Expands Access to Care;   Serving Our Communities GRI 205: Anticorruption Management approach Ethics and Compliance; Materiality   Assessment Findings 205-1 Operations assessed for risks related   to corruptionEthics and Compliance 205-2 Communication and training about   anticorruption policies and proceduresEthics and Compliance GRI 300 Environmental Standards Series GRI 301: Materials Management approach Sustainable Design; Materials Use;   Product End-of-Life; Materiality   Assessment Findings 301-3 Reclaimed products and their   packaging materialsProduct End-of-Life GRI 302: Energy Management approach Operations; Energy ; Materiality   Assessment Findings 302-1 Energy consumption within the organization Energy ; Baxter Data Summary ; Baxter Value   Chain Energy Usage and GHG Emissions 302-3 Energy intensity Energy ; Baxter Data Summary 302-4 Reduction of energy consumption EnergyGRI 300 Environmental Standards Series (continued) GRI 303: Water Management approach Operations; Water and Wastewater ;   Materiality Assessment Findings 303-1 Water withdrawal by source Water and Wastewater ; Baxter Data Summary 303-2 Water sources significantly affected by   withdrawal of waterWater and Wastewater ; Baxter Data Summary GRI 305: Emissions Management approach Operations; GHG Emissions Across the Value   Chain; GHG Emissions from Operations;   Materiality Assessment Findings 305-1 Direct (Scope 1) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-2 Energy indirect (Scope 2) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-3 Other indirect (Scope 3) GHG emissions GHG Emissions Across the Value Chain;   Baxter Data Summary ; Baxter Value Chain Energy  Usage and GHG Emissions 305-4 GHG emissions intensity GHG Emissions from Operations; Baxter Data Summary 305-5 Reduction of GHG emissions GHG Emissions from Operations 305-7 Nitrogen oxides (NOX), sulfur oxides (SOX)   and other significant air emissionsBaxter Data Summary GRI 306: Effluents and Waste Management approach Operations; Waste ; Materiality    Assessment Findings 306-1 Water discharge by quality and destination Baxter Data Summary 306-2 Waste by type and disposal method Waste ; Baxter Data Summary GRI 307: Environmental Compliance Management approach Operations 307-1 Non-compliance with environmental laws   and regulationsEnvironmental, Health and Safety Performance;   Baxter Data Summary GRI 308: Supplier Environmental Assessment Management approach Managing Procurement Risks; Supplier   Corporate Responsibility Survey ; Supplier Audits;   Materiality Assessment Findings  308-2 Negative environmental impacts in the   supply chain and actions takenSupplier Corporate Responsibility Survey ;   Green Logistics; Baxter Value Chain Energy Usage  and GHG Emissions2020 Reporting 2020 ReportingAPPENDIX:   Global Reporting Initiative (GRI) Index (continued)BAXTER 2020 CORPORATE RESPONSIBILITY REPORT66Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Global Reporting Initiative (GRI) Index (continued) Disclosure Disclosure 2020 Reporting 2020 Reporting GRI 400 Social Standards Series GRI 401: Employment Management approach Workplace Culture; Materiality    Assessment Findings 401-1 New employee hires and employee turnover Voluntary employee turnover was 9.2% in 2020.
","('Waste_And_Hazardous_Materials_Management', 0.9724164605140686)","('Water_And_Wastewater_Management', 0.0044960882514715195)","('Air_Quality', 0.002667343243956566)","(['Operational Eco-Efficiency'], 0.9724164605140686)","('NON-ESG', 0.0044960882514715195)","('NON-ESG', 0.002667343243956566)"
Line 1271,"Strategy  102-14 Statement from senior decision-maker From the Chairman and CEO Ethics and Integrity 102-16 Values, principles, standards and norms   of behaviorProtecting Human Rights; Ethics and Compliance;   Responsible Procurement 102-17 Mechanisms for advice and concerns   about ethicsEthics and Compliance HelplineGRI 102: General Disclosures 2016 (continued) Governance  102-18 Governance structure Our Governance 102-19 Delegating authority Corporate Responsibility Governance   and Management 102-20 Executive-level responsibility for economic,  environmental and social topicsCorporate Responsibility Governance   and Management 102-22 Composition of the highest governance body   and its committeesOur Governance 102-23 Chair of the highest governance body Our Governance Organizational Profile 102-24 Nominating and selecting the highest   governance bodyCorporate Governance Guidelines 102-25 Conflicts of interest Corporate Governance Guidelines 102-31 Review of economic, environmental and   social topicsCorporate Responsibility 102-33 Communicating critical concerns Baxter 2021 Proxy Statement 102-35 Remuneration policies Corporate Governance Guidelines;   Baxter 2021 Proxy Statement 102-36 Process for determining remuneration Corporate Governance Guidelines Stakeholder Engagement 102-40 List of stakeholder groups Stakeholder Engagement 102-42 Identifying and selecting stakeholders Stakeholder Engagement 102-43 Approach to stakeholder engagement Stakeholder Engagement Reporting Practice  102-45 Entities included in the consolidated   financial statementsBaxter 2020 Annual Report on Form 10-K 102-46 Defining report content and topic Boundaries Materiality 102-47 List of material topics Materiality 102-50 Reporting period Calendar year 102-51 Date of most recent report June 102-52 Reporting cycle Yearly 102-53 Contact point for questions regarding the report corporate_responsibility_report@baxter.com 102-55 GRI content index This section 102-56 External assurance Assurance and Verification2020 Reporting 2020 ReportingBAXTER 2020 CORPORATE RESPONSIBILITY REPORT65Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Disclosure Disclosure GRI 200 Economic Standard Series GRI 201: Economic Performance Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 201-1 Direct economic value generated and  distributedServing Our Communities ; Baxter Data Summary ;  Baxter 2020 Annual Report on Form 10-K 201-2 Financial implications and other risks and  opportunities due to climate changeBaxter CDP submission GRI 203: Indirect Economic Impacts Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 203-1 Infrastructure investments and   services supportedInnovation That Expands Access to Care;   Serving Our Communities 203-2 Significant indirect economic impacts Innovation That Expands Access to Care;   Serving Our Communities GRI 205: Anticorruption Management approach Ethics and Compliance; Materiality   Assessment Findings 205-1 Operations assessed for risks related   to corruptionEthics and Compliance 205-2 Communication and training about   anticorruption policies and proceduresEthics and Compliance GRI 300 Environmental Standards Series GRI 301: Materials Management approach Sustainable Design; Materials Use;   Product End-of-Life; Materiality   Assessment Findings 301-3 Reclaimed products and their   packaging materialsProduct End-of-Life GRI 302: Energy Management approach Operations; Energy ; Materiality   Assessment Findings 302-1 Energy consumption within the organization Energy ; Baxter Data Summary ; Baxter Value   Chain Energy Usage and GHG Emissions 302-3 Energy intensity Energy ; Baxter Data Summary 302-4 Reduction of energy consumption EnergyGRI 300 Environmental Standards Series (continued) GRI 303: Water Management approach Operations; Water and Wastewater ;   Materiality Assessment Findings 303-1 Water withdrawal by source Water and Wastewater ; Baxter Data Summary 303-2 Water sources significantly affected by   withdrawal of waterWater and Wastewater ; Baxter Data Summary GRI 305: Emissions Management approach Operations; GHG Emissions Across the Value   Chain; GHG Emissions from Operations;   Materiality Assessment Findings 305-1 Direct (Scope 1) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-2 Energy indirect (Scope 2) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-3 Other indirect (Scope 3) GHG emissions GHG Emissions Across the Value Chain;   Baxter Data Summary ; Baxter Value Chain Energy  Usage and GHG Emissions 305-4 GHG emissions intensity GHG Emissions from Operations; Baxter Data Summary 305-5 Reduction of GHG emissions GHG Emissions from Operations 305-7 Nitrogen oxides (NOX), sulfur oxides (SOX)   and other significant air emissionsBaxter Data Summary GRI 306: Effluents and Waste Management approach Operations; Waste ; Materiality    Assessment Findings 306-1 Water discharge by quality and destination Baxter Data Summary 306-2 Waste by type and disposal method Waste ; Baxter Data Summary GRI 307: Environmental Compliance Management approach Operations 307-1 Non-compliance with environmental laws   and regulationsEnvironmental, Health and Safety Performance;   Baxter Data Summary GRI 308: Supplier Environmental Assessment Management approach Managing Procurement Risks; Supplier   Corporate Responsibility Survey ; Supplier Audits;   Materiality Assessment Findings  308-2 Negative environmental impacts in the   supply chain and actions takenSupplier Corporate Responsibility Survey ;   Green Logistics; Baxter Value Chain Energy Usage  and GHG Emissions2020 Reporting 2020 ReportingAPPENDIX:   Global Reporting Initiative (GRI) Index (continued)BAXTER 2020 CORPORATE RESPONSIBILITY REPORT66Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Global Reporting Initiative (GRI) Index (continued) Disclosure Disclosure 2020 Reporting 2020 Reporting GRI 400 Social Standards Series GRI 401: Employment Management approach Workplace Culture; Materiality    Assessment Findings 401-1 New employee hires and employee turnover Voluntary employee turnover was 9.2% in 2020.
","('Supply_Chain_Management', 0.9484416842460632)","('Product_Design_And_Lifecycle_Management', 0.005421525798738003)","('Labor_Practices', 0.00447080796584487)","(['Supply Chain Management'], 0.9484416842460632)","('NON-ESG', 0.005421525798738003)","('NON-ESG', 0.00447080796584487)"
Line 1272,"Strategy  102-14 Statement from senior decision-maker From the Chairman and CEO Ethics and Integrity 102-16 Values, principles, standards and norms   of behaviorProtecting Human Rights; Ethics and Compliance;   Responsible Procurement 102-17 Mechanisms for advice and concerns   about ethicsEthics and Compliance HelplineGRI 102: General Disclosures 2016 (continued) Governance  102-18 Governance structure Our Governance 102-19 Delegating authority Corporate Responsibility Governance   and Management 102-20 Executive-level responsibility for economic,  environmental and social topicsCorporate Responsibility Governance   and Management 102-22 Composition of the highest governance body   and its committeesOur Governance 102-23 Chair of the highest governance body Our Governance Organizational Profile 102-24 Nominating and selecting the highest   governance bodyCorporate Governance Guidelines 102-25 Conflicts of interest Corporate Governance Guidelines 102-31 Review of economic, environmental and   social topicsCorporate Responsibility 102-33 Communicating critical concerns Baxter 2021 Proxy Statement 102-35 Remuneration policies Corporate Governance Guidelines;   Baxter 2021 Proxy Statement 102-36 Process for determining remuneration Corporate Governance Guidelines Stakeholder Engagement 102-40 List of stakeholder groups Stakeholder Engagement 102-42 Identifying and selecting stakeholders Stakeholder Engagement 102-43 Approach to stakeholder engagement Stakeholder Engagement Reporting Practice  102-45 Entities included in the consolidated   financial statementsBaxter 2020 Annual Report on Form 10-K 102-46 Defining report content and topic Boundaries Materiality 102-47 List of material topics Materiality 102-50 Reporting period Calendar year 102-51 Date of most recent report June 102-52 Reporting cycle Yearly 102-53 Contact point for questions regarding the report corporate_responsibility_report@baxter.com 102-55 GRI content index This section 102-56 External assurance Assurance and Verification2020 Reporting 2020 ReportingBAXTER 2020 CORPORATE RESPONSIBILITY REPORT65Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Disclosure Disclosure GRI 200 Economic Standard Series GRI 201: Economic Performance Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 201-1 Direct economic value generated and  distributedServing Our Communities ; Baxter Data Summary ;  Baxter 2020 Annual Report on Form 10-K 201-2 Financial implications and other risks and  opportunities due to climate changeBaxter CDP submission GRI 203: Indirect Economic Impacts Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 203-1 Infrastructure investments and   services supportedInnovation That Expands Access to Care;   Serving Our Communities 203-2 Significant indirect economic impacts Innovation That Expands Access to Care;   Serving Our Communities GRI 205: Anticorruption Management approach Ethics and Compliance; Materiality   Assessment Findings 205-1 Operations assessed for risks related   to corruptionEthics and Compliance 205-2 Communication and training about   anticorruption policies and proceduresEthics and Compliance GRI 300 Environmental Standards Series GRI 301: Materials Management approach Sustainable Design; Materials Use;   Product End-of-Life; Materiality   Assessment Findings 301-3 Reclaimed products and their   packaging materialsProduct End-of-Life GRI 302: Energy Management approach Operations; Energy ; Materiality   Assessment Findings 302-1 Energy consumption within the organization Energy ; Baxter Data Summary ; Baxter Value   Chain Energy Usage and GHG Emissions 302-3 Energy intensity Energy ; Baxter Data Summary 302-4 Reduction of energy consumption EnergyGRI 300 Environmental Standards Series (continued) GRI 303: Water Management approach Operations; Water and Wastewater ;   Materiality Assessment Findings 303-1 Water withdrawal by source Water and Wastewater ; Baxter Data Summary 303-2 Water sources significantly affected by   withdrawal of waterWater and Wastewater ; Baxter Data Summary GRI 305: Emissions Management approach Operations; GHG Emissions Across the Value   Chain; GHG Emissions from Operations;   Materiality Assessment Findings 305-1 Direct (Scope 1) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-2 Energy indirect (Scope 2) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-3 Other indirect (Scope 3) GHG emissions GHG Emissions Across the Value Chain;   Baxter Data Summary ; Baxter Value Chain Energy  Usage and GHG Emissions 305-4 GHG emissions intensity GHG Emissions from Operations; Baxter Data Summary 305-5 Reduction of GHG emissions GHG Emissions from Operations 305-7 Nitrogen oxides (NOX), sulfur oxides (SOX)   and other significant air emissionsBaxter Data Summary GRI 306: Effluents and Waste Management approach Operations; Waste ; Materiality    Assessment Findings 306-1 Water discharge by quality and destination Baxter Data Summary 306-2 Waste by type and disposal method Waste ; Baxter Data Summary GRI 307: Environmental Compliance Management approach Operations 307-1 Non-compliance with environmental laws   and regulationsEnvironmental, Health and Safety Performance;   Baxter Data Summary GRI 308: Supplier Environmental Assessment Management approach Managing Procurement Risks; Supplier   Corporate Responsibility Survey ; Supplier Audits;   Materiality Assessment Findings  308-2 Negative environmental impacts in the   supply chain and actions takenSupplier Corporate Responsibility Survey ;   Green Logistics; Baxter Value Chain Energy Usage  and GHG Emissions2020 Reporting 2020 ReportingAPPENDIX:   Global Reporting Initiative (GRI) Index (continued)BAXTER 2020 CORPORATE RESPONSIBILITY REPORT66Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Global Reporting Initiative (GRI) Index (continued) Disclosure Disclosure 2020 Reporting 2020 Reporting GRI 400 Social Standards Series GRI 401: Employment Management approach Workplace Culture; Materiality    Assessment Findings 401-1 New employee hires and employee turnover Voluntary employee turnover was 9.2% in 2020.
","('Management_Of_Legal_And_Regulatory_Framework', 0.26606762409210205)","('Business_Model_Resilience', 0.1046481803059578)","('Product_Quality_And_Safety', 0.09512648731470108)","('NON-ESG', 0.26606762409210205)","('NON-ESG', 0.1046481803059578)","('NON-ESG', 0.09512648731470108)"
Line 1273,"Strategy  102-14 Statement from senior decision-maker From the Chairman and CEO Ethics and Integrity 102-16 Values, principles, standards and norms   of behaviorProtecting Human Rights; Ethics and Compliance;   Responsible Procurement 102-17 Mechanisms for advice and concerns   about ethicsEthics and Compliance HelplineGRI 102: General Disclosures 2016 (continued) Governance  102-18 Governance structure Our Governance 102-19 Delegating authority Corporate Responsibility Governance   and Management 102-20 Executive-level responsibility for economic,  environmental and social topicsCorporate Responsibility Governance   and Management 102-22 Composition of the highest governance body   and its committeesOur Governance 102-23 Chair of the highest governance body Our Governance Organizational Profile 102-24 Nominating and selecting the highest   governance bodyCorporate Governance Guidelines 102-25 Conflicts of interest Corporate Governance Guidelines 102-31 Review of economic, environmental and   social topicsCorporate Responsibility 102-33 Communicating critical concerns Baxter 2021 Proxy Statement 102-35 Remuneration policies Corporate Governance Guidelines;   Baxter 2021 Proxy Statement 102-36 Process for determining remuneration Corporate Governance Guidelines Stakeholder Engagement 102-40 List of stakeholder groups Stakeholder Engagement 102-42 Identifying and selecting stakeholders Stakeholder Engagement 102-43 Approach to stakeholder engagement Stakeholder Engagement Reporting Practice  102-45 Entities included in the consolidated   financial statementsBaxter 2020 Annual Report on Form 10-K 102-46 Defining report content and topic Boundaries Materiality 102-47 List of material topics Materiality 102-50 Reporting period Calendar year 102-51 Date of most recent report June 102-52 Reporting cycle Yearly 102-53 Contact point for questions regarding the report corporate_responsibility_report@baxter.com 102-55 GRI content index This section 102-56 External assurance Assurance and Verification2020 Reporting 2020 ReportingBAXTER 2020 CORPORATE RESPONSIBILITY REPORT65Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction Disclosure Disclosure GRI 200 Economic Standard Series GRI 201: Economic Performance Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 201-1 Direct economic value generated and  distributedServing Our Communities ; Baxter Data Summary ;  Baxter 2020 Annual Report on Form 10-K 201-2 Financial implications and other risks and  opportunities due to climate changeBaxter CDP submission GRI 203: Indirect Economic Impacts Management approach Innovation That Expands Access to Care;   Serving Our Communities; Materiality   Assessment Findings 203-1 Infrastructure investments and   services supportedInnovation That Expands Access to Care;   Serving Our Communities 203-2 Significant indirect economic impacts Innovation That Expands Access to Care;   Serving Our Communities GRI 205: Anticorruption Management approach Ethics and Compliance; Materiality   Assessment Findings 205-1 Operations assessed for risks related   to corruptionEthics and Compliance 205-2 Communication and training about   anticorruption policies and proceduresEthics and Compliance GRI 300 Environmental Standards Series GRI 301: Materials Management approach Sustainable Design; Materials Use;   Product End-of-Life; Materiality   Assessment Findings 301-3 Reclaimed products and their   packaging materialsProduct End-of-Life GRI 302: Energy Management approach Operations; Energy ; Materiality   Assessment Findings 302-1 Energy consumption within the organization Energy ; Baxter Data Summary ; Baxter Value   Chain Energy Usage and GHG Emissions 302-3 Energy intensity Energy ; Baxter Data Summary 302-4 Reduction of energy consumption EnergyGRI 300 Environmental Standards Series (continued) GRI 303: Water Management approach Operations; Water and Wastewater ;   Materiality Assessment Findings 303-1 Water withdrawal by source Water and Wastewater ; Baxter Data Summary 303-2 Water sources significantly affected by   withdrawal of waterWater and Wastewater ; Baxter Data Summary GRI 305: Emissions Management approach Operations; GHG Emissions Across the Value   Chain; GHG Emissions from Operations;   Materiality Assessment Findings 305-1 Direct (Scope 1) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-2 Energy indirect (Scope 2) GHG emissions GHG Emissions Across the Value Chain; GHG   Emissions from Operations; Baxter Data Summary ;  Baxter Value Chain Energy Usage and GHG Emissions 305-3 Other indirect (Scope 3) GHG emissions GHG Emissions Across the Value Chain;   Baxter Data Summary ; Baxter Value Chain Energy  Usage and GHG Emissions 305-4 GHG emissions intensity GHG Emissions from Operations; Baxter Data Summary 305-5 Reduction of GHG emissions GHG Emissions from Operations 305-7 Nitrogen oxides (NOX), sulfur oxides (SOX)   and other significant air emissionsBaxter Data Summary GRI 306: Effluents and Waste Management approach Operations; Waste ; Materiality    Assessment Findings 306-1 Water discharge by quality and destination Baxter Data Summary 306-2 Waste by type and disposal method Waste ; Baxter Data Summary GRI 307: Environmental Compliance Management approach Operations 307-1 Non-compliance with environmental laws   and regulationsEnvironmental, Health and Safety Performance;   Baxter Data Summary GRI 308: Supplier Environmental Assessment Management approach Managing Procurement Risks; Supplier   Corporate Responsibility Survey ; Supplier Audits;   Materiality Assessment Findings  308-2 Negative environmental impacts in the   supply chain and actions takenSupplier Corporate Responsibility Survey ;   Green Logistics; Baxter Value Chain Energy Usage  and GHG Emissions2020 Reporting 2020 ReportingAPPENDIX:   Global Reporting Initiative (GRI) Index (continued)BAXTER 2020 CORPORATE RESPONSIBILITY REPORT66Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction APPENDIX:   Global Reporting Initiative (GRI) Index (continued) Disclosure Disclosure 2020 Reporting 2020 Reporting GRI 400 Social Standards Series GRI 401: Employment Management approach Workplace Culture; Materiality    Assessment Findings 401-1 New employee hires and employee turnover Voluntary employee turnover was 9.2% in 2020.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7195935845375061)","('Labor_Practices', 0.1476725935935974)","('Employee_Health_And_Safety', 0.033769574016332626)","(['Human Capital Development'], 0.7195935845375061)","('NON-ESG', 0.1476725935935974)","('NON-ESG', 0.033769574016332626)"
Line 1274,"401-2 Benefits provided to full-time employees   that are not provided to temporary or   part-time employeesCompensation and Benefits   All benefits are generally provided to full-time   and part-time employees.
","('Labor_Practices', 0.9204337000846863)","('Employee_Engagement_Inclusion_And_Diversity', 0.023087507113814354)","('Employee_Health_And_Safety', 0.006997630465775728)","(['Labor Practice Indicators'], 0.9204337000846863)","('NON-ESG', 0.023087507113814354)","('NON-ESG', 0.006997630465775728)"
Line 1275,"GRI 402: Labor/Management Relations 402-1 Minimum notice periods regarding   operational changesMinimum notice period varies by country.
","('Labor_Practices', 0.9419893026351929)","('Employee_Health_And_Safety', 0.006966869346797466)","('Business_Ethics', 0.006732170470058918)","(['Labor Practice Indicators'], 0.9419893026351929)","('NON-ESG', 0.006966869346797466)","('NON-ESG', 0.006732170470058918)"
Line 1276,"The  length of the notice period is dependent on the   type of change being made.
","('Management_Of_Legal_And_Regulatory_Framework', 0.501004695892334)","('Director_Removal', 0.09917163103818893)","('Business_Model_Resilience', 0.06515944004058838)","(['Corporate Governance'], 0.501004695892334)","('NON-ESG', 0.09917163103818893)","('NON-ESG', 0.06515944004058838)"
Line 1277,"Baxter is committed   to providing appropriate notice and follows all  relevant consultation and notice requirements.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9331628680229187)","('Business_Ethics', 0.01032315380871296)","('Director_Removal', 0.007451118901371956)","(['Corporate Governance'], 0.9331628680229187)","('NON-ESG', 0.01032315380871296)","('NON-ESG', 0.007451118901371956)"
Line 1278,"GRI 403: Occupational Health and Safety Management approach Employee Health and Safety ; Materiality  Assessment Findings 403-2 Types of injury and rates of injury, occupational  diseases, lost days and absenteeism, and  number of work-related fatalitiesEmployee Health and Safety ; Baxter Data Summary GRI 404: Training and Education Management approach Performance and Career Development;   Manager and Leadership Development;   Materiality Assessment Findings 404-1 Average hours of training per year   per employeePerformance and Career Development 404-2 Programs for upgrading employee skills   and transition assistance programsPerformance and Career Development;   Manager and Leadership Development GRI 405: Diversity and Equal Opportunity Management approach Global Inclusion and Diversity ; Materiality  Assessment Findings 405-1 Diversity of governance bodies and employees Baxter Data Summary ; Our Leadership GRI 408: Child Labor Management approach Responsible Procurement; Materiality Assessment  Findings; Baxter Global Human Rights Policy ;  Baxter Code of Conduct; Baxter Supplier Quality  Standard; Ethics and Compliance Standards for  Baxter Suppliers 408-1 Operations and suppliers at significant risk   for incidents of child laborSupplier Corporate Responsibility Survey ;   Supplier AuditsGRI 400 Social Standards Series (continued) GRI 409: Forced or Compulsory Labor Management approach Responsible Procurement; Materiality Assessment  Findings; Baxter Global Human Rights Policy ;  Baxter Code of Conduct; Baxter Supplier Quality  Standard; Ethics and Compliance Standards for  Baxter Suppliers; Baxter California Transparency  in Supply Chains Act Position Statement; Baxter UK  Modern Slavery Statement; Baxter Conflict Minerals  Position Statement 409-1 Operations and suppliers at significant risk   for incidents of forced or compulsory laborSupplier Corporate Responsibility Survey ;   Supplier Audits GRI 414: Supplier Social Assessment Management approach Managing Procurement Risks; Supplier   Corporate Responsibility Survey ; Supplier Audits;   Materiality Assessment Findings 414-2 Negative social impacts in the supply chain  and actions takenSupplier Corporate Responsibility Survey ;   Supplier Audits GRI 415: Public Policy Management approach Public Policy 415-1 Political contributions Baxter 2020 Political Contributions Report GRI 416: Customer Health and Safety Management approach Patient Safety and Quality ; Sustainable Design;  Materials Use; Materiality Assessment Findings 416-1 Assessment of the health and safety impacts   of product and service categoriesPatient Safety and Quality ; Sustainable Design 416-2 Incidents of non-compliance concerning   the health and safety impacts of products   and servicesBaxter 2020 Annual Report on Form 10-K GRI 418: Customer Privacy Management approach Privacy and Data Protection; Materiality  Assessment Findings GRI 419: Socioeconomic Compliance Management approach Ethics and Compliance 419-1 Non-compliance with laws and regulations in   the social and economic areaBaxter 2020 Annual Report on Form 10-KBAXTER 2020 CORPORATE RESPONSIBILITY REPORT67Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction INTRODUCTION 1 As of December 31, 2020.
","('Employee_Health_And_Safety', 0.9848760366439819)","('Employee_Engagement_Inclusion_And_Diversity', 0.0017031733877956867)","('Critical_Incident_Risk_Management', 0.0011309828842058778)","(['Operational Eco-Efficiency'], 0.9848760366439819)","('NON-ESG', 0.0017031733877956867)","('NON-ESG', 0.0011309828842058778)"
Line 1279,"GRI 403: Occupational Health and Safety Management approach Employee Health and Safety ; Materiality  Assessment Findings 403-2 Types of injury and rates of injury, occupational  diseases, lost days and absenteeism, and  number of work-related fatalitiesEmployee Health and Safety ; Baxter Data Summary GRI 404: Training and Education Management approach Performance and Career Development;   Manager and Leadership Development;   Materiality Assessment Findings 404-1 Average hours of training per year   per employeePerformance and Career Development 404-2 Programs for upgrading employee skills   and transition assistance programsPerformance and Career Development;   Manager and Leadership Development GRI 405: Diversity and Equal Opportunity Management approach Global Inclusion and Diversity ; Materiality  Assessment Findings 405-1 Diversity of governance bodies and employees Baxter Data Summary ; Our Leadership GRI 408: Child Labor Management approach Responsible Procurement; Materiality Assessment  Findings; Baxter Global Human Rights Policy ;  Baxter Code of Conduct; Baxter Supplier Quality  Standard; Ethics and Compliance Standards for  Baxter Suppliers 408-1 Operations and suppliers at significant risk   for incidents of child laborSupplier Corporate Responsibility Survey ;   Supplier AuditsGRI 400 Social Standards Series (continued) GRI 409: Forced or Compulsory Labor Management approach Responsible Procurement; Materiality Assessment  Findings; Baxter Global Human Rights Policy ;  Baxter Code of Conduct; Baxter Supplier Quality  Standard; Ethics and Compliance Standards for  Baxter Suppliers; Baxter California Transparency  in Supply Chains Act Position Statement; Baxter UK  Modern Slavery Statement; Baxter Conflict Minerals  Position Statement 409-1 Operations and suppliers at significant risk   for incidents of forced or compulsory laborSupplier Corporate Responsibility Survey ;   Supplier Audits GRI 414: Supplier Social Assessment Management approach Managing Procurement Risks; Supplier   Corporate Responsibility Survey ; Supplier Audits;   Materiality Assessment Findings 414-2 Negative social impacts in the supply chain  and actions takenSupplier Corporate Responsibility Survey ;   Supplier Audits GRI 415: Public Policy Management approach Public Policy 415-1 Political contributions Baxter 2020 Political Contributions Report GRI 416: Customer Health and Safety Management approach Patient Safety and Quality ; Sustainable Design;  Materials Use; Materiality Assessment Findings 416-1 Assessment of the health and safety impacts   of product and service categoriesPatient Safety and Quality ; Sustainable Design 416-2 Incidents of non-compliance concerning   the health and safety impacts of products   and servicesBaxter 2020 Annual Report on Form 10-K GRI 418: Customer Privacy Management approach Privacy and Data Protection; Materiality  Assessment Findings GRI 419: Socioeconomic Compliance Management approach Ethics and Compliance 419-1 Non-compliance with laws and regulations in   the social and economic areaBaxter 2020 Annual Report on Form 10-KBAXTER 2020 CORPORATE RESPONSIBILITY REPORT67Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction INTRODUCTION 1 As of December 31, 2020.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9767025113105774)","('Employee_Health_And_Safety', 0.0018143549095839262)","('Human_Rights_And_Community_Relations', 0.0015872075455263257)","(['Human Capital Development'], 0.9767025113105774)","('NON-ESG', 0.0018143549095839262)","('NON-ESG', 0.0015872075455263257)"
Line 1280,"GRI 403: Occupational Health and Safety Management approach Employee Health and Safety ; Materiality  Assessment Findings 403-2 Types of injury and rates of injury, occupational  diseases, lost days and absenteeism, and  number of work-related fatalitiesEmployee Health and Safety ; Baxter Data Summary GRI 404: Training and Education Management approach Performance and Career Development;   Manager and Leadership Development;   Materiality Assessment Findings 404-1 Average hours of training per year   per employeePerformance and Career Development 404-2 Programs for upgrading employee skills   and transition assistance programsPerformance and Career Development;   Manager and Leadership Development GRI 405: Diversity and Equal Opportunity Management approach Global Inclusion and Diversity ; Materiality  Assessment Findings 405-1 Diversity of governance bodies and employees Baxter Data Summary ; Our Leadership GRI 408: Child Labor Management approach Responsible Procurement; Materiality Assessment  Findings; Baxter Global Human Rights Policy ;  Baxter Code of Conduct; Baxter Supplier Quality  Standard; Ethics and Compliance Standards for  Baxter Suppliers 408-1 Operations and suppliers at significant risk   for incidents of child laborSupplier Corporate Responsibility Survey ;   Supplier AuditsGRI 400 Social Standards Series (continued) GRI 409: Forced or Compulsory Labor Management approach Responsible Procurement; Materiality Assessment  Findings; Baxter Global Human Rights Policy ;  Baxter Code of Conduct; Baxter Supplier Quality  Standard; Ethics and Compliance Standards for  Baxter Suppliers; Baxter California Transparency  in Supply Chains Act Position Statement; Baxter UK  Modern Slavery Statement; Baxter Conflict Minerals  Position Statement 409-1 Operations and suppliers at significant risk   for incidents of forced or compulsory laborSupplier Corporate Responsibility Survey ;   Supplier Audits GRI 414: Supplier Social Assessment Management approach Managing Procurement Risks; Supplier   Corporate Responsibility Survey ; Supplier Audits;   Materiality Assessment Findings 414-2 Negative social impacts in the supply chain  and actions takenSupplier Corporate Responsibility Survey ;   Supplier Audits GRI 415: Public Policy Management approach Public Policy 415-1 Political contributions Baxter 2020 Political Contributions Report GRI 416: Customer Health and Safety Management approach Patient Safety and Quality ; Sustainable Design;  Materials Use; Materiality Assessment Findings 416-1 Assessment of the health and safety impacts   of product and service categoriesPatient Safety and Quality ; Sustainable Design 416-2 Incidents of non-compliance concerning   the health and safety impacts of products   and servicesBaxter 2020 Annual Report on Form 10-K GRI 418: Customer Privacy Management approach Privacy and Data Protection; Materiality  Assessment Findings GRI 419: Socioeconomic Compliance Management approach Ethics and Compliance 419-1 Non-compliance with laws and regulations in   the social and economic areaBaxter 2020 Annual Report on Form 10-KBAXTER 2020 CORPORATE RESPONSIBILITY REPORT67Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction INTRODUCTION 1 As of December 31, 2020.
","('Labor_Practices', 0.9389463663101196)","('Employee_Health_And_Safety', 0.010317453183233738)","('Human_Rights_And_Community_Relations', 0.008469214662909508)","(['Labor Practice Indicators'], 0.9389463663101196)","('NON-ESG', 0.010317453183233738)","('NON-ESG', 0.008469214662909508)"
Line 1281,"GRI 403: Occupational Health and Safety Management approach Employee Health and Safety ; Materiality  Assessment Findings 403-2 Types of injury and rates of injury, occupational  diseases, lost days and absenteeism, and  number of work-related fatalitiesEmployee Health and Safety ; Baxter Data Summary GRI 404: Training and Education Management approach Performance and Career Development;   Manager and Leadership Development;   Materiality Assessment Findings 404-1 Average hours of training per year   per employeePerformance and Career Development 404-2 Programs for upgrading employee skills   and transition assistance programsPerformance and Career Development;   Manager and Leadership Development GRI 405: Diversity and Equal Opportunity Management approach Global Inclusion and Diversity ; Materiality  Assessment Findings 405-1 Diversity of governance bodies and employees Baxter Data Summary ; Our Leadership GRI 408: Child Labor Management approach Responsible Procurement; Materiality Assessment  Findings; Baxter Global Human Rights Policy ;  Baxter Code of Conduct; Baxter Supplier Quality  Standard; Ethics and Compliance Standards for  Baxter Suppliers 408-1 Operations and suppliers at significant risk   for incidents of child laborSupplier Corporate Responsibility Survey ;   Supplier AuditsGRI 400 Social Standards Series (continued) GRI 409: Forced or Compulsory Labor Management approach Responsible Procurement; Materiality Assessment  Findings; Baxter Global Human Rights Policy ;  Baxter Code of Conduct; Baxter Supplier Quality  Standard; Ethics and Compliance Standards for  Baxter Suppliers; Baxter California Transparency  in Supply Chains Act Position Statement; Baxter UK  Modern Slavery Statement; Baxter Conflict Minerals  Position Statement 409-1 Operations and suppliers at significant risk   for incidents of forced or compulsory laborSupplier Corporate Responsibility Survey ;   Supplier Audits GRI 414: Supplier Social Assessment Management approach Managing Procurement Risks; Supplier   Corporate Responsibility Survey ; Supplier Audits;   Materiality Assessment Findings 414-2 Negative social impacts in the supply chain  and actions takenSupplier Corporate Responsibility Survey ;   Supplier Audits GRI 415: Public Policy Management approach Public Policy 415-1 Political contributions Baxter 2020 Political Contributions Report GRI 416: Customer Health and Safety Management approach Patient Safety and Quality ; Sustainable Design;  Materials Use; Materiality Assessment Findings 416-1 Assessment of the health and safety impacts   of product and service categoriesPatient Safety and Quality ; Sustainable Design 416-2 Incidents of non-compliance concerning   the health and safety impacts of products   and servicesBaxter 2020 Annual Report on Form 10-K GRI 418: Customer Privacy Management approach Privacy and Data Protection; Materiality  Assessment Findings GRI 419: Socioeconomic Compliance Management approach Ethics and Compliance 419-1 Non-compliance with laws and regulations in   the social and economic areaBaxter 2020 Annual Report on Form 10-KBAXTER 2020 CORPORATE RESPONSIBILITY REPORT67Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction INTRODUCTION 1 As of December 31, 2020.
","('Supply_Chain_Management', 0.6320396065711975)","('Labor_Practices', 0.18394584953784943)","('Business_Ethics', 0.01976318284869194)","(['Supply Chain Management'], 0.6320396065711975)","('NON-ESG', 0.18394584953784943)","('NON-ESG', 0.01976318284869194)"
Line 1282,"GRI 403: Occupational Health and Safety Management approach Employee Health and Safety ; Materiality  Assessment Findings 403-2 Types of injury and rates of injury, occupational  diseases, lost days and absenteeism, and  number of work-related fatalitiesEmployee Health and Safety ; Baxter Data Summary GRI 404: Training and Education Management approach Performance and Career Development;   Manager and Leadership Development;   Materiality Assessment Findings 404-1 Average hours of training per year   per employeePerformance and Career Development 404-2 Programs for upgrading employee skills   and transition assistance programsPerformance and Career Development;   Manager and Leadership Development GRI 405: Diversity and Equal Opportunity Management approach Global Inclusion and Diversity ; Materiality  Assessment Findings 405-1 Diversity of governance bodies and employees Baxter Data Summary ; Our Leadership GRI 408: Child Labor Management approach Responsible Procurement; Materiality Assessment  Findings; Baxter Global Human Rights Policy ;  Baxter Code of Conduct; Baxter Supplier Quality  Standard; Ethics and Compliance Standards for  Baxter Suppliers 408-1 Operations and suppliers at significant risk   for incidents of child laborSupplier Corporate Responsibility Survey ;   Supplier AuditsGRI 400 Social Standards Series (continued) GRI 409: Forced or Compulsory Labor Management approach Responsible Procurement; Materiality Assessment  Findings; Baxter Global Human Rights Policy ;  Baxter Code of Conduct; Baxter Supplier Quality  Standard; Ethics and Compliance Standards for  Baxter Suppliers; Baxter California Transparency  in Supply Chains Act Position Statement; Baxter UK  Modern Slavery Statement; Baxter Conflict Minerals  Position Statement 409-1 Operations and suppliers at significant risk   for incidents of forced or compulsory laborSupplier Corporate Responsibility Survey ;   Supplier Audits GRI 414: Supplier Social Assessment Management approach Managing Procurement Risks; Supplier   Corporate Responsibility Survey ; Supplier Audits;   Materiality Assessment Findings 414-2 Negative social impacts in the supply chain  and actions takenSupplier Corporate Responsibility Survey ;   Supplier Audits GRI 415: Public Policy Management approach Public Policy 415-1 Political contributions Baxter 2020 Political Contributions Report GRI 416: Customer Health and Safety Management approach Patient Safety and Quality ; Sustainable Design;  Materials Use; Materiality Assessment Findings 416-1 Assessment of the health and safety impacts   of product and service categoriesPatient Safety and Quality ; Sustainable Design 416-2 Incidents of non-compliance concerning   the health and safety impacts of products   and servicesBaxter 2020 Annual Report on Form 10-K GRI 418: Customer Privacy Management approach Privacy and Data Protection; Materiality  Assessment Findings GRI 419: Socioeconomic Compliance Management approach Ethics and Compliance 419-1 Non-compliance with laws and regulations in   the social and economic areaBaxter 2020 Annual Report on Form 10-KBAXTER 2020 CORPORATE RESPONSIBILITY REPORT67Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction INTRODUCTION 1 As of December 31, 2020.
","('Supply_Chain_Management', 0.8424568176269531)","('Product_Design_And_Lifecycle_Management', 0.04264770820736885)","('Employee_Health_And_Safety', 0.017854230478405952)","(['Supply Chain Management'], 0.8424568176269531)","('NON-ESG', 0.04264770820736885)","('NON-ESG', 0.017854230478405952)"
Line 1283,"GRI 403: Occupational Health and Safety Management approach Employee Health and Safety ; Materiality  Assessment Findings 403-2 Types of injury and rates of injury, occupational  diseases, lost days and absenteeism, and  number of work-related fatalitiesEmployee Health and Safety ; Baxter Data Summary GRI 404: Training and Education Management approach Performance and Career Development;   Manager and Leadership Development;   Materiality Assessment Findings 404-1 Average hours of training per year   per employeePerformance and Career Development 404-2 Programs for upgrading employee skills   and transition assistance programsPerformance and Career Development;   Manager and Leadership Development GRI 405: Diversity and Equal Opportunity Management approach Global Inclusion and Diversity ; Materiality  Assessment Findings 405-1 Diversity of governance bodies and employees Baxter Data Summary ; Our Leadership GRI 408: Child Labor Management approach Responsible Procurement; Materiality Assessment  Findings; Baxter Global Human Rights Policy ;  Baxter Code of Conduct; Baxter Supplier Quality  Standard; Ethics and Compliance Standards for  Baxter Suppliers 408-1 Operations and suppliers at significant risk   for incidents of child laborSupplier Corporate Responsibility Survey ;   Supplier AuditsGRI 400 Social Standards Series (continued) GRI 409: Forced or Compulsory Labor Management approach Responsible Procurement; Materiality Assessment  Findings; Baxter Global Human Rights Policy ;  Baxter Code of Conduct; Baxter Supplier Quality  Standard; Ethics and Compliance Standards for  Baxter Suppliers; Baxter California Transparency  in Supply Chains Act Position Statement; Baxter UK  Modern Slavery Statement; Baxter Conflict Minerals  Position Statement 409-1 Operations and suppliers at significant risk   for incidents of forced or compulsory laborSupplier Corporate Responsibility Survey ;   Supplier Audits GRI 414: Supplier Social Assessment Management approach Managing Procurement Risks; Supplier   Corporate Responsibility Survey ; Supplier Audits;   Materiality Assessment Findings 414-2 Negative social impacts in the supply chain  and actions takenSupplier Corporate Responsibility Survey ;   Supplier Audits GRI 415: Public Policy Management approach Public Policy 415-1 Political contributions Baxter 2020 Political Contributions Report GRI 416: Customer Health and Safety Management approach Patient Safety and Quality ; Sustainable Design;  Materials Use; Materiality Assessment Findings 416-1 Assessment of the health and safety impacts   of product and service categoriesPatient Safety and Quality ; Sustainable Design 416-2 Incidents of non-compliance concerning   the health and safety impacts of products   and servicesBaxter 2020 Annual Report on Form 10-K GRI 418: Customer Privacy Management approach Privacy and Data Protection; Materiality  Assessment Findings GRI 419: Socioeconomic Compliance Management approach Ethics and Compliance 419-1 Non-compliance with laws and regulations in   the social and economic areaBaxter 2020 Annual Report on Form 10-KBAXTER 2020 CORPORATE RESPONSIBILITY REPORT67Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction INTRODUCTION 1 As of December 31, 2020.
","('Product_Quality_And_Safety', 0.8846310973167419)","('Product_Design_And_Lifecycle_Management', 0.028880013152956963)","('Employee_Health_And_Safety', 0.01602870598435402)","(['Product Quality & Recall Management'], 0.8846310973167419)","('NON-ESG', 0.028880013152956963)","('NON-ESG', 0.01602870598435402)"
Line 1284,"GRI 403: Occupational Health and Safety Management approach Employee Health and Safety ; Materiality  Assessment Findings 403-2 Types of injury and rates of injury, occupational  diseases, lost days and absenteeism, and  number of work-related fatalitiesEmployee Health and Safety ; Baxter Data Summary GRI 404: Training and Education Management approach Performance and Career Development;   Manager and Leadership Development;   Materiality Assessment Findings 404-1 Average hours of training per year   per employeePerformance and Career Development 404-2 Programs for upgrading employee skills   and transition assistance programsPerformance and Career Development;   Manager and Leadership Development GRI 405: Diversity and Equal Opportunity Management approach Global Inclusion and Diversity ; Materiality  Assessment Findings 405-1 Diversity of governance bodies and employees Baxter Data Summary ; Our Leadership GRI 408: Child Labor Management approach Responsible Procurement; Materiality Assessment  Findings; Baxter Global Human Rights Policy ;  Baxter Code of Conduct; Baxter Supplier Quality  Standard; Ethics and Compliance Standards for  Baxter Suppliers 408-1 Operations and suppliers at significant risk   for incidents of child laborSupplier Corporate Responsibility Survey ;   Supplier AuditsGRI 400 Social Standards Series (continued) GRI 409: Forced or Compulsory Labor Management approach Responsible Procurement; Materiality Assessment  Findings; Baxter Global Human Rights Policy ;  Baxter Code of Conduct; Baxter Supplier Quality  Standard; Ethics and Compliance Standards for  Baxter Suppliers; Baxter California Transparency  in Supply Chains Act Position Statement; Baxter UK  Modern Slavery Statement; Baxter Conflict Minerals  Position Statement 409-1 Operations and suppliers at significant risk   for incidents of forced or compulsory laborSupplier Corporate Responsibility Survey ;   Supplier Audits GRI 414: Supplier Social Assessment Management approach Managing Procurement Risks; Supplier   Corporate Responsibility Survey ; Supplier Audits;   Materiality Assessment Findings 414-2 Negative social impacts in the supply chain  and actions takenSupplier Corporate Responsibility Survey ;   Supplier Audits GRI 415: Public Policy Management approach Public Policy 415-1 Political contributions Baxter 2020 Political Contributions Report GRI 416: Customer Health and Safety Management approach Patient Safety and Quality ; Sustainable Design;  Materials Use; Materiality Assessment Findings 416-1 Assessment of the health and safety impacts   of product and service categoriesPatient Safety and Quality ; Sustainable Design 416-2 Incidents of non-compliance concerning   the health and safety impacts of products   and servicesBaxter 2020 Annual Report on Form 10-K GRI 418: Customer Privacy Management approach Privacy and Data Protection; Materiality  Assessment Findings GRI 419: Socioeconomic Compliance Management approach Ethics and Compliance 419-1 Non-compliance with laws and regulations in   the social and economic areaBaxter 2020 Annual Report on Form 10-KBAXTER 2020 CORPORATE RESPONSIBILITY REPORT67Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction INTRODUCTION 1 As of December 31, 2020.
","('Product_Quality_And_Safety', 0.3124849200248718)","('Product_Design_And_Lifecycle_Management', 0.16513970494270325)","('Employee_Health_And_Safety', 0.05925728753209114)","('NON-ESG', 0.3124849200248718)","('NON-ESG', 0.16513970494270325)","('NON-ESG', 0.05925728753209114)"
Line 1285,"2 Estimated energy and financial savings as well as GHG emissions avoidance are calculated for the 12 months following project implementation.
","('GHG_Emissions', 0.9649415016174316)","('Air_Quality', 0.006089014001190662)","('Ecological_Impacts', 0.0032369426917284727)","(['Climate Change'], 0.9649415016174316)","('NON-ESG', 0.006089014001190662)","('NON-ESG', 0.0032369426917284727)"
Line 1286,"2020 PRIORITIES AND GOALS 1 This represents the total savings attributable to identified projects across the company, counted only for the first year the packaging  innovation was implemented.
","('Product_Design_And_Lifecycle_Management', 0.6697117686271667)","('Business_Model_Resilience', 0.0818263590335846)","('Supply_Chain_Management', 0.03696822002530098)","(['Product Stewardship'], 0.6697117686271667)","('NON-ESG', 0.0818263590335846)","('NON-ESG', 0.03696822002530098)"
Line 1287,"2 Comparison based on global safety data reported by 23 global companies across industries.
","('Employee_Health_And_Safety', 0.8899003863334656)","('Product_Quality_And_Safety', 0.03688090294599533)","('Critical_Incident_Risk_Management', 0.01628023386001587)","(['Operational Eco-Efficiency'], 0.8899003863334656)","('NON-ESG', 0.03688090294599533)","('NON-ESG', 0.01628023386001587)"
Line 1288,"Data are reported through ORC HSE or on  the companies' public websites.
","('Customer_Privacy', 0.8113280534744263)","('Data_Security', 0.03197794035077095)","('Labor_Practices', 0.013560598716139793)","(['Privacy Protection'], 0.8113280534744263)","('NON-ESG', 0.03197794035077095)","('NON-ESG', 0.013560598716139793)"
Line 1289,"3 Includes spending with women-owned businesses and minority-owned businesses.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9329358339309692)","('Labor_Practices', 0.012992496602237225)","('Human_Rights_And_Community_Relations', 0.005511557217687368)","(['Human Capital Development'], 0.9329358339309692)","('NON-ESG', 0.012992496602237225)","('NON-ESG', 0.005511557217687368)"
Line 1290,"Spending with suppliers that certify for more than one  classification is counted only once.
","('Supply_Chain_Management', 0.779487669467926)","('Management_Of_Legal_And_Regulatory_Framework', 0.03517536446452141)","('GHG_Emissions', 0.0210046898573637)","(['Supply Chain Management'], 0.779487669467926)","('NON-ESG', 0.03517536446452141)","('NON-ESG', 0.0210046898573637)"
Line 1291,"United States and Puerto Rico.
","('Management_Of_Legal_And_Regulatory_Framework', 0.500128984451294)","('Competitive_Behavior', 0.11590288579463959)","('GHG_Emissions', 0.04207455739378929)","(['Corporate Governance'], 0.500128984451294)","('NON-ESG', 0.11590288579463959)","('NON-ESG', 0.04207455739378929)"
Line 1292,"Fiscal year basis (October 1 through September 30 of the year noted).
","('Management_Of_Legal_And_Regulatory_Framework', 0.5398755073547363)","('Director_Removal', 0.11901940405368805)","('Physical_Impacts_Of_Climate_Change', 0.043142687529325485)","(['Corporate Governance'], 0.5398755073547363)","('NON-ESG', 0.11901940405368805)","('NON-ESG', 0.043142687529325485)"
Line 1293,"PRODUCT INNOVATION 1 Data on file.
","('Product_Design_And_Lifecycle_Management', 0.9295304417610168)","('Business_Model_Resilience', 0.008134960196912289)","('Supply_Chain_Management', 0.007963071577250957)","(['Product Stewardship'], 0.9295304417610168)","('NON-ESG', 0.008134960196912289)","('NON-ESG', 0.007963071577250957)"
Line 1294,"Efficiency Test Canister .
","('Energy_Management', 0.6636095643043518)","('Product_Design_And_Lifecycle_Management', 0.09299622476100922)","('Product_Quality_And_Safety', 0.0504075363278389)","(['Operational Eco-Efficiency'], 0.6636095643043518)","('NON-ESG', 0.09299622476100922)","('NON-ESG', 0.0504075363278389)"
Line 1295,"Berlin: ZeoSys Medical; 2020.
","('Access_And_Affordability', 0.15521769225597382)","('Management_Of_Legal_And_Regulatory_Framework', 0.0945638120174408)","('Business_Model_Resilience', 0.09138931334018707)","('NON-ESG', 0.15521769225597382)","('NON-ESG', 0.0945638120174408)","('NON-ESG', 0.09138931334018707)"
Line 1296,"2 Morris, G., Parker, B.
","('Management_Of_Legal_And_Regulatory_Framework', 0.21824811398983002)","('Competitive_Behavior', 0.14245466887950897)","('Ecological_Impacts', 0.12640824913978577)","('NON-ESG', 0.21824811398983002)","('NON-ESG', 0.14245466887950897)","('NON-ESG', 0.12640824913978577)"
Line 1297,"and Pierce, J., ""Reducing theatre energy consumption,"" Health Estate Journal , March 2014, 58–62.
","('Energy_Management', 0.9796843528747559)","('Water_And_Wastewater_Management', 0.0017637218115851283)","('Critical_Incident_Risk_Management', 0.001610447303391993)","(['Operational Eco-Efficiency'], 0.9796843528747559)","('NON-ESG', 0.0017637218115851283)","('NON-ESG', 0.001610447303391993)"
Line 1298,"3 This represents the total savings attributable to identified projects across the company, counted only for the first year the packaging  innovation was implemented.
","('Product_Design_And_Lifecycle_Management', 0.746126651763916)","('Energy_Management', 0.041837308555841446)","('Supply_Chain_Management', 0.03195129334926605)","(['Product Stewardship'], 0.746126651763916)","('NON-ESG', 0.041837308555841446)","('NON-ESG', 0.03195129334926605)"
Line 1299,"WORKPLACE CULTURE 1 As of December 31, 2020.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6631731390953064)","('Employee_Health_And_Safety', 0.07652679085731506)","('Human_Rights_And_Community_Relations', 0.03859756141901016)","(['Human Capital Development'], 0.6631731390953064)","('NON-ESG', 0.07652679085731506)","('NON-ESG', 0.03859756141901016)"
Line 1300,"2 The survey was administered via email.
","('Customer_Privacy', 0.49085673689842224)","('Data_Security', 0.10229010879993439)","('Business_Ethics', 0.05019227787852287)","('NON-ESG', 0.49085673689842224)","('NON-ESG', 0.10229010879993439)","('NON-ESG', 0.05019227787852287)"
Line 1301,"Employees without a Baxter email address, such as those in manufacturing, did not participate.
","('Customer_Privacy', 0.9157575368881226)","('Data_Security', 0.011067148298025131)","('Labor_Practices', 0.007979780435562134)","(['Privacy Protection'], 0.9157575368881226)","('NON-ESG', 0.011067148298025131)","('NON-ESG', 0.007979780435562134)"
Line 1302,"3 Data are from Aon Hewitt and IBM Kenexa.
","('Data_Security', 0.6399087309837341)","('Customer_Privacy', 0.08133604377508163)","('Systemic_Risk_Management', 0.0683705285191536)","(['Information Security/Cybersecurity & System Availability'], 0.6399087309837341)","('NON-ESG', 0.08133604377508163)","('NON-ESG', 0.0683705285191536)"
Line 1303,"The global average database includes more than 400 companies and more than 19 million  responses.
","('Systemic_Risk_Management', 0.3241026699542999)","('Business_Model_Resilience', 0.16206222772598267)","('Competitive_Behavior', 0.13289059698581696)","('NON-ESG', 0.3241026699542999)","('NON-ESG', 0.16206222772598267)","('NON-ESG', 0.13289059698581696)"
Line 1304,"Top quartile is a subset of the global average.
","('Competitive_Behavior', 0.5128926634788513)","('Systemic_Risk_Management', 0.12410381436347961)","('Energy_Management', 0.04870112985372543)","(['Business Ethics'], 0.5128926634788513)","('NON-ESG', 0.12410381436347961)","('NON-ESG', 0.04870112985372543)"
Line 1305,"4 Managers are eligible to receive the scorecard if they have five or more direct reports and at least five of their direct reports  responded to the survey.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3937048614025116)","('Access_And_Affordability', 0.14547798037528992)","('Business_Ethics', 0.06562694907188416)","('NON-ESG', 0.3937048614025116)","('NON-ESG', 0.14547798037528992)","('NON-ESG', 0.06562694907188416)"
Line 1306,"The surveys were administered via email.
","('Customer_Privacy', 0.5793317556381226)","('Data_Security', 0.043211013078689575)","('Business_Ethics', 0.038802314549684525)","(['Privacy Protection'], 0.5793317556381226)","('NON-ESG', 0.043211013078689575)","('NON-ESG', 0.038802314549684525)"
Line 1307,"Employees without a Baxter email address, such as those in  manufacturing, did not participate.
","('Customer_Privacy', 0.9157575368881226)","('Data_Security', 0.011067148298025131)","('Labor_Practices', 0.007979780435562134)","(['Privacy Protection'], 0.9157575368881226)","('NON-ESG', 0.011067148298025131)","('NON-ESG', 0.007979780435562134)"
Line 1308,"5 These data do not represent all employee training and development, but do capture a large portion of training for most employees.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5460968613624573)","('Employee_Health_And_Safety', 0.15306346118450165)","('Labor_Practices', 0.050340812653303146)","(['Human Capital Development'], 0.5460968613624573)","('NON-ESG', 0.15306346118450165)","('NON-ESG', 0.050340812653303146)"
Line 1309,"ETHICS AND COMPLIANCE 1 Data are from Aon Hewitt and IBM Kenexa.
","('Business_Ethics', 0.9655361771583557)","('Management_Of_Legal_And_Regulatory_Framework', 0.005229718517512083)","('Product_Quality_And_Safety', 0.002948131412267685)","(['Business Ethics'], 0.9655361771583557)","('NON-ESG', 0.005229718517512083)","('NON-ESG', 0.002948131412267685)"
Line 1310,"The global average database includes more than 400 companies and more than 19 million  responses.
","('Systemic_Risk_Management', 0.3241026699542999)","('Business_Model_Resilience', 0.16206222772598267)","('Competitive_Behavior', 0.13289059698581696)","('NON-ESG', 0.3241026699542999)","('NON-ESG', 0.16206222772598267)","('NON-ESG', 0.13289059698581696)"
Line 1311,"Top quartile is a subset of the global average.
","('Competitive_Behavior', 0.5128926634788513)","('Systemic_Risk_Management', 0.12410381436347961)","('Energy_Management', 0.04870112985372543)","(['Business Ethics'], 0.5128926634788513)","('NON-ESG', 0.12410381436347961)","('NON-ESG', 0.04870112985372543)"
Line 1312,"2 The number of cases closed during any given year typically includes some cases opened before the beginning of the year.
","('Systemic_Risk_Management', 0.27493956685066223)","('Management_Of_Legal_And_Regulatory_Framework', 0.1010754406452179)","('Director_Removal', 0.0617562010884285)","('NON-ESG', 0.27493956685066223)","('NON-ESG', 0.1010754406452179)","('NON-ESG', 0.0617562010884285)"
Line 1313,"EMPLOYEE HEALTH AND SAFETY 1 See Baxter Data Summary endnotes 9 –12 for definitions of the injury and illness metrics used in this section.
","('Employee_Health_And_Safety', 0.9845667481422424)","('Employee_Engagement_Inclusion_And_Diversity', 0.0016316089313477278)","('Critical_Incident_Risk_Management', 0.0013469725381582975)","(['Operational Eco-Efficiency'], 0.9845667481422424)","('NON-ESG', 0.0016316089313477278)","('NON-ESG', 0.0013469725381582975)"
Line 1314,"2 Comparison based on global safety data reported by 23 global companies across industries.
","('Employee_Health_And_Safety', 0.8899003863334656)","('Product_Quality_And_Safety', 0.03688090294599533)","('Critical_Incident_Risk_Management', 0.01628023386001587)","(['Operational Eco-Efficiency'], 0.8899003863334656)","('NON-ESG', 0.03688090294599533)","('NON-ESG', 0.01628023386001587)"
Line 1315,"Data are reported through ORC HSE or on  the companies' public websites.
","('Customer_Privacy', 0.8113280534744263)","('Data_Security', 0.03197794035077095)","('Labor_Practices', 0.013560598716139793)","(['Privacy Protection'], 0.8113280534744263)","('NON-ESG', 0.03197794035077095)","('NON-ESG', 0.013560598716139793)"
Line 1316,"3 Each year, profiles untouched for the previous three years are removed from the active database.
","('Director_Removal', 0.1290542483329773)","('Business_Model_Resilience', 0.0958121195435524)","('Data_Security', 0.09445935487747192)","('NON-ESG', 0.1290542483329773)","('NON-ESG', 0.0958121195435524)","('NON-ESG', 0.09445935487747192)"
Line 1317,"OPERATIONS 1 The environmental data included in this report are based on 117 reporting locations, of which 51 are manufacturing, 19 are  warehouse, and 47 are pharmacies, administrative, clerical or other.
","('Customer_Welfare', 0.3641226589679718)","('Supply_Chain_Management', 0.0958876833319664)","('Selling_Practices_And_Product_Labeling', 0.0863354429602623)","('NON-ESG', 0.3641226589679718)","('NON-ESG', 0.0958876833319664)","('NON-ESG', 0.0863354429602623)"
Line 1318,"Several of the reporting units comprise multiple locations that  report as a single entity.
","('Management_Of_Legal_And_Regulatory_Framework', 0.37498146295547485)","('Director_Removal', 0.08776631206274033)","('Systemic_Risk_Management', 0.07580052316188812)","('NON-ESG', 0.37498146295547485)","('NON-ESG', 0.08776631206274033)","('NON-ESG', 0.07580052316188812)"
Line 1319,"For example, in 2020, Baxter’s 46 renal therapy sites in Colombia reported as a single entity.
","('Customer_Welfare', 0.3027031123638153)","('Access_And_Affordability', 0.08257802575826645)","('Competitive_Behavior', 0.06731212139129639)","('NON-ESG', 0.3027031123638153)","('NON-ESG', 0.08257802575826645)","('NON-ESG', 0.06731212139129639)"
Line 1320,"The reporting  scope excludes certain leased facilities for which environmental performance data are not available or are not material to Baxter’s  overall environmental performance.
","('Energy_Management', 0.21015480160713196)","('Supply_Chain_Management', 0.17962871491909027)","('Business_Model_Resilience', 0.14716996252536774)","('NON-ESG', 0.21015480160713196)","('NON-ESG', 0.17962871491909027)","('NON-ESG', 0.14716996252536774)"
Line 1321,"The health and safety data included in this report are based on 179 reporting locations.
","('Employee_Health_And_Safety', 0.9450740814208984)","('Product_Quality_And_Safety', 0.015163039788603783)","('Critical_Incident_Risk_Management', 0.005645671393722296)","(['Operational Eco-Efficiency'], 0.9450740814208984)","('NON-ESG', 0.015163039788603783)","('NON-ESG', 0.005645671393722296)"
Line 1322,"The  Environmental, Health, Safety and Sustainability (EHS&S) information reported covers 100% of Baxter’s operations unless noted  otherwise.
","('Employee_Health_And_Safety', 0.9100130796432495)","('Product_Quality_And_Safety', 0.026711268350481987)","('Product_Design_And_Lifecycle_Management', 0.007566194981336594)","(['Operational Eco-Efficiency'], 0.9100130796432495)","('NON-ESG', 0.026711268350481987)","('NON-ESG', 0.007566194981336594)"
Line 1323,"EHS&S data are revised to reflect acquisitions, divestitures and plant closings as well as to incorporate any corrections  necessary due to additional data verification activities (such as EHS&S audits).
","('Systemic_Risk_Management', 0.333524614572525)","('Management_Of_Legal_And_Regulatory_Framework', 0.22215129435062408)","('Business_Model_Resilience', 0.11108629405498505)","('NON-ESG', 0.333524614572525)","('NON-ESG', 0.22215129435062408)","('NON-ESG', 0.11108629405498505)"
Line 1324,"See the Baxter Data Summary for additional detail.
","('Systemic_Risk_Management', 0.2258208841085434)","('Data_Security', 0.1367543786764145)","('Management_Of_Legal_And_Regulatory_Framework', 0.08384472876787186)","('NON-ESG', 0.2258208841085434)","('NON-ESG', 0.1367543786764145)","('NON-ESG', 0.08384472876787186)"
Line 1325,"2 For the purpose of this calculation, our sites in Sondalo, Italy, and Grosotto, Italy, are counted separately.
","('Ecological_Impacts', 0.1772991269826889)","('Supply_Chain_Management', 0.07666026800870895)","('Competitive_Behavior', 0.07409308850765228)","('NON-ESG', 0.1772991269826889)","('NON-ESG', 0.07666026800870895)","('NON-ESG', 0.07409308850765228)"
Line 1326,"3 COVID-19 pandemic and related business and governmental travel restrictions resulted in a 27% decrease in overall corporate and  external assurance audits conducted in 2020.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6816232204437256)","('Business_Ethics', 0.08741531521081924)","('Systemic_Risk_Management', 0.04251931980252266)","(['Corporate Governance'], 0.6816232204437256)","('NON-ESG', 0.08741531521081924)","('NON-ESG', 0.04251931980252266)"
Line 1327,"4 Estimated energy and financial savings as well as GHG emissions avoidance are calculated for the 12 months following project implementation.
","('GHG_Emissions', 0.9646131992340088)","('Air_Quality', 0.006128452252596617)","('Management_Of_Legal_And_Regulatory_Framework', 0.0032906841952353716)","(['Climate Change'], 0.9646131992340088)","('NON-ESG', 0.006128452252596617)","('NON-ESG', 0.0032906841952353716)"
Line 1328,"5 Includes manufacturing facilities with energy costs that exceed $200,000 per year and excludes two sites that underwent significant  change or expansion in production during the reporting year.
","('Energy_Management', 0.9685415625572205)","('Product_Design_And_Lifecycle_Management', 0.005423706956207752)","('Supply_Chain_Management', 0.0028291207272559404)","(['Operational Eco-Efficiency'], 0.9685415625572205)","('NON-ESG', 0.005423706956207752)","('NON-ESG', 0.0028291207272559404)"
Line 1329,"6 One cubic meter equals 1,000 liters or 264 gallons.
","('Water_And_Wastewater_Management', 0.4393254220485687)","('Energy_Management', 0.2669186294078827)","('GHG_Emissions', 0.053926531225442886)","('NON-ESG', 0.4393254220485687)","('NON-ESG', 0.2669186294078827)","('NON-ESG', 0.053926531225442886)"
Line 1330,"7  Low―Less than 10% of the water available to agricultural, domestic and industrial users is withdrawn annually.
","('Water_And_Wastewater_Management', 0.9751467108726501)","('Energy_Management', 0.002649744041264057)","('GHG_Emissions', 0.0024666939862072468)","(['Operational Eco-Efficiency'], 0.9751467108726501)","('NON-ESG', 0.002649744041264057)","('NON-ESG', 0.0024666939862072468)"
Line 1331,"Low-Med―Between 10 and 20% of the water available to agricultural, domestic and industrial users is withdrawn annually.
","('Water_And_Wastewater_Management', 0.9751467108726501)","('Energy_Management', 0.0026916395872831345)","('GHG_Emissions', 0.00239472440443933)","(['Operational Eco-Efficiency'], 0.9751467108726501)","('NON-ESG', 0.0026916395872831345)","('NON-ESG', 0.00239472440443933)"
Line 1332,"Med-High―Between 20 and 40% of the water available to agricultural, domestic and industrial users is withdrawn annually.
","('Water_And_Wastewater_Management', 0.9755120873451233)","('Energy_Management', 0.0025588376447558403)","('GHG_Emissions', 0.002283047651872039)","(['Operational Eco-Efficiency'], 0.9755120873451233)","('NON-ESG', 0.0025588376447558403)","('NON-ESG', 0.002283047651872039)"
Line 1333,"High―Between 40 and 80% of the water available to agricultural, domestic and industrial users is withdrawn annually.
","('Water_And_Wastewater_Management', 0.9749159812927246)","('Energy_Management', 0.002570662647485733)","('GHG_Emissions', 0.0024912983644753695)","(['Operational Eco-Efficiency'], 0.9749159812927246)","('NON-ESG', 0.002570662647485733)","('NON-ESG', 0.0024912983644753695)"
Line 1334,"Extremely High―More than 80% of the water available to agricultural, domestic, and industrial users is withdrawn annually.
","('Water_And_Wastewater_Management', 0.9759045243263245)","('Energy_Management', 0.0023934824857860804)","('GHG_Emissions', 0.0023642678279429674)","(['Operational Eco-Efficiency'], 0.9759045243263245)","('NON-ESG', 0.0023934824857860804)","('NON-ESG', 0.0023642678279429674)"
Line 1335,"8 To more closely reflect production efficiency and support consistent evaluation of facility performance and trends, we exclude certain  nonroutine, nonproduction-related waste streams from our total waste performance data and progress against our 2020 waste goal.
","('Waste_And_Hazardous_Materials_Management', 0.9834716320037842)","('Water_And_Wastewater_Management', 0.001523741171695292)","('Air_Quality', 0.0012732725590467453)","(['Operational Eco-Efficiency'], 0.9834716320037842)","('NON-ESG', 0.001523741171695292)","('NON-ESG', 0.0012732725590467453)"
Line 1336,"These waste streams are construction and demolition debris, remediation waste and wastewater treatment sludge.OPERATIONS  (CONTINUED ) 9 We report “regulated waste” rather than “hazardous waste.” This term includes some materials that would otherwise be classified as  nonhazardous waste in some countries, which helps Baxter harmonize waste reporting across locations.
","('Waste_And_Hazardous_Materials_Management', 0.9848514199256897)","('Data_Security', 0.0012241171207278967)","('Water_And_Wastewater_Management', 0.0011793181765824556)","(['Operational Eco-Efficiency'], 0.9848514199256897)","('NON-ESG', 0.0012241171207278967)","('NON-ESG', 0.0011793181765824556)"
Line 1337,"In addition to wastes typically  considered hazardous (such as toxics and corrosives), we also include oils, biohazardous or infectious materials, batteries, fluorescent  lamps, asbestos and other materials that may not be defined as hazardous waste by national legislation at the point of origin.
","('Waste_And_Hazardous_Materials_Management', 0.9842991828918457)","('Employee_Health_And_Safety', 0.001134473830461502)","('Data_Security', 0.001129539217799902)","(['Operational Eco-Efficiency'], 0.9842991828918457)","('NON-ESG', 0.001134473830461502)","('NON-ESG', 0.001129539217799902)"
Line 1338,"10 Incineration with energy recovery is considered recycling.
","('Energy_Management', 0.9188992381095886)","('Waste_And_Hazardous_Materials_Management', 0.013339731842279434)","('Air_Quality', 0.010113690979778767)","(['Operational Eco-Efficiency'], 0.9188992381095886)","('NON-ESG', 0.013339731842279434)","('NON-ESG', 0.010113690979778767)"
Line 1339,"11 Certain waste streams at two facilities in Europe have government-mandated requirements.
","('Waste_And_Hazardous_Materials_Management', 0.982331395149231)","('Water_And_Wastewater_Management', 0.0020177641417831182)","('Air_Quality', 0.0017926959553733468)","(['Operational Eco-Efficiency'], 0.982331395149231)","('NON-ESG', 0.0020177641417831182)","('NON-ESG', 0.0017926959553733468)"
Line 1340,"These waste streams are excluded  from the total.
","('Waste_And_Hazardous_Materials_Management', 0.9817713499069214)","('Water_And_Wastewater_Management', 0.0019751538056880236)","('Data_Security', 0.001338587375357747)","(['Operational Eco-Efficiency'], 0.9817713499069214)","('NON-ESG', 0.0019751538056880236)","('NON-ESG', 0.001338587375357747)"
Line 1341,"12 Our Scope 1 and Scope 2 emissions have a high level of certainty and have been verified for the past nine years to a reasonable  assurance level by Apex Companies LLC.
","('GHG_Emissions', 0.9104620814323425)","('Air_Quality', 0.03145910054445267)","('Physical_Impacts_Of_Climate_Change', 0.008030631579458714)","(['Climate Change'], 0.9104620814323425)","('NON-ESG', 0.03145910054445267)","('NON-ESG', 0.008030631579458714)"
Line 1342,"Scope 3 categories are based on various assumptions and estimates.
","('Management_Of_Legal_And_Regulatory_Framework', 0.23641078174114227)","('Competitive_Behavior', 0.14637066423892975)","('Systemic_Risk_Management', 0.07356501370668411)","('NON-ESG', 0.23641078174114227)","('NON-ESG', 0.14637066423892975)","('NON-ESG', 0.07356501370668411)"
Line 1343,"For the past  eight years, Apex Companies LLC has verified to a limited assurance level Baxter’s methodology and emission factors for  calculating Scope 3 GHG emissions.
","('GHG_Emissions', 0.9452094435691833)","('Air_Quality', 0.019286666065454483)","('Management_Of_Legal_And_Regulatory_Framework', 0.004073421470820904)","(['Climate Change'], 0.9452094435691833)","('NON-ESG', 0.019286666065454483)","('NON-ESG', 0.004073421470820904)"
Line 1344,"The market-based method is used for Scope 2 unless otherwise stated.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2599915564060211)","('Competitive_Behavior', 0.25104907155036926)","('Systemic_Risk_Management', 0.11435277760028839)","('NON-ESG', 0.2599915564060211)","('NON-ESG', 0.25104907155036926)","('NON-ESG', 0.11435277760028839)"
Line 1345,"Data in this report  are presented in accordance with the GHG Protocol (Scope 1 and Scope 2) and the Corporate Value Chain (Scope 3) Accounting  and Reporting Standard.
","('GHG_Emissions', 0.9600946307182312)","('Water_And_Wastewater_Management', 0.004315566271543503)","('Ecological_Impacts', 0.0038765384815633297)","(['Climate Change'], 0.9600946307182312)","('NON-ESG', 0.004315566271543503)","('NON-ESG', 0.0038765384815633297)"
Line 1346,"13 In 2020, we used biomass fuels to generate energy in boilers at two Baxter locations, one in the United States and one in Italy.
","('Energy_Management', 0.9758847951889038)","('Air_Quality', 0.002665293402969837)","('Management_Of_Legal_And_Regulatory_Framework', 0.002275012666359544)","(['Operational Eco-Efficiency'], 0.9758847951889038)","('NON-ESG', 0.002665293402969837)","('NON-ESG', 0.002275012666359544)"
Line 1347,"During the year, emissions from the Baxter-operated biomass boilers equaled 149,000 metric tons CO2.
","('GHG_Emissions', 0.7858231067657471)","('Air_Quality', 0.10439776629209518)","('Energy_Management', 0.028268802911043167)","(['Climate Change'], 0.7858231067657471)","('NON-ESG', 0.10439776629209518)","('NON-ESG', 0.028268802911043167)"
Line 1348,"In accordance with the  GHG Protocol, these are not included in reported Scope 1 and Scope 2 emissions.
","('GHG_Emissions', 0.9661720395088196)","('Ecological_Impacts', 0.00414656475186348)","('Water_And_Wastewater_Management', 0.003433173755183816)","(['Climate Change'], 0.9661720395088196)","('NON-ESG', 0.00414656475186348)","('NON-ESG', 0.003433173755183816)"
Line 1349,"However, also in accordance with the GHG  Protocol, we include CO2e emissions from the CH4 and N2O components of biomass combustion in our reported Scope 1 emissions.
","('GHG_Emissions', 0.9675992131233215)","('Ecological_Impacts', 0.0038759445305913687)","('Air_Quality', 0.0031958341132849455)","(['Climate Change'], 0.9675992131233215)","('NON-ESG', 0.0038759445305913687)","('NON-ESG', 0.0031958341132849455)"
Line 1350,"14 U.S. Environmental Protection Agency Green Power Partnership Fortune 500 Partners List.
","('Ecological_Impacts', 0.34708577394485474)","('GHG_Emissions', 0.13663066923618317)","('Management_Of_Legal_And_Regulatory_Framework', 0.11976928263902664)","('NON-ESG', 0.34708577394485474)","('NON-ESG', 0.13663066923618317)","('NON-ESG', 0.11976928263902664)"
Line 1351,"As of October 19, 2020.
","('Systemic_Risk_Management', 0.13367976248264313)","('Business_Model_Resilience', 0.12876774370670319)","('Director_Removal', 0.0735124945640564)","('NON-ESG', 0.13367976248264313)","('NON-ESG', 0.12876774370670319)","('NON-ESG', 0.0735124945640564)"
Line 1352,"RESPONSIBLE PROCUREMENT AND LOGISTICS 1 Includes spending with women-owned businesses and minority-owned businesses.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9134080410003662)","('Labor_Practices', 0.012897576205432415)","('Human_Rights_And_Community_Relations', 0.010801207274198532)","(['Human Capital Development'], 0.9134080410003662)","('NON-ESG', 0.012897576205432415)","('NON-ESG', 0.010801207274198532)"
Line 1353,"Spending with suppliers that certify  for more than one classification is counted only once.
","('Supply_Chain_Management', 0.779487669467926)","('Management_Of_Legal_And_Regulatory_Framework', 0.03517536446452141)","('GHG_Emissions', 0.0210046898573637)","(['Supply Chain Management'], 0.779487669467926)","('NON-ESG', 0.03517536446452141)","('NON-ESG', 0.0210046898573637)"
Line 1354,"United States and Puerto Rico.
","('Management_Of_Legal_And_Regulatory_Framework', 0.500128984451294)","('Competitive_Behavior', 0.11590288579463959)","('GHG_Emissions', 0.04207455739378929)","(['Corporate Governance'], 0.500128984451294)","('NON-ESG', 0.11590288579463959)","('NON-ESG', 0.04207455739378929)"
Line 1355,"Fiscal year basis (October 1 through  September 30 of the year noted).
","('Management_Of_Legal_And_Regulatory_Framework', 0.5398755073547363)","('Director_Removal', 0.11901940405368805)","('Physical_Impacts_Of_Climate_Change', 0.043142687529325485)","(['Corporate Governance'], 0.5398755073547363)","('NON-ESG', 0.11901940405368805)","('NON-ESG', 0.043142687529325485)"
Line 1356,"2 October 1, 2019 through September 30, 2020.
","('Management_Of_Legal_And_Regulatory_Framework', 0.1801459789276123)","('Business_Model_Resilience', 0.1469021737575531)","('Director_Removal', 0.09209577739238739)","('NON-ESG', 0.1801459789276123)","('NON-ESG', 0.1469021737575531)","('NON-ESG', 0.09209577739238739)"
Line 1357,"“Indirect” includes impacts at the businesses from which suppliers (and their suppliers)  purchase goods and services.
","('Supply_Chain_Management', 0.43254968523979187)","('Product_Design_And_Lifecycle_Management', 0.3823363780975342)","('Energy_Management', 0.029288912191987038)","('NON-ESG', 0.43254968523979187)","('NON-ESG', 0.3823363780975342)","('NON-ESG', 0.029288912191987038)"
Line 1358,"“Induced” includes impacts generated in the communities of the suppliers’ employees associated with  purchases made by these employees and jobs supported through those purchases.
","('Labor_Practices', 0.573924720287323)","('Employee_Engagement_Inclusion_And_Diversity', 0.21628008782863617)","('Employee_Health_And_Safety', 0.04040805622935295)","(['Labor Practice Indicators'], 0.573924720287323)","('NON-ESG', 0.21628008782863617)","('NON-ESG', 0.04040805622935295)"
Line 1359,"3 Includes Scope 1 and Scope 3 GHG emissions for product transport.
","('GHG_Emissions', 0.9638959169387817)","('Air_Quality', 0.004627101588994265)","('Management_Of_Legal_And_Regulatory_Framework', 0.0035709873773157597)","(['Climate Change'], 0.9638959169387817)","('NON-ESG', 0.004627101588994265)","('NON-ESG', 0.0035709873773157597)"
Line 1360,"4 Based on https://associated-pallets.co.uk/blog/environmental-impact-recycling-wooden-pallets/ .
","('Product_Design_And_Lifecycle_Management', 0.8351216912269592)","('Energy_Management', 0.03264201432466507)","('Waste_And_Hazardous_Materials_Management', 0.030647888779640198)","(['Product Stewardship'], 0.8351216912269592)","('NON-ESG', 0.03264201432466507)","('NON-ESG', 0.030647888779640198)"
Line 1361,"Last accessed February, 2021.
","('Management_Of_Legal_And_Regulatory_Framework', 0.1837991327047348)","('Business_Model_Resilience', 0.10687733441591263)","('Director_Removal', 0.10495389252901077)","('NON-ESG', 0.1837991327047348)","('NON-ESG', 0.10687733441591263)","('NON-ESG', 0.10495389252901077)"
Line 1362,"INNOVATION THAT EXPANDS ACCESS TO CARE 1 Source: https://www.kidney.org/kidneydisease/global-facts-about-kidney-disease.
","('Access_And_Affordability', 0.41931283473968506)","('Customer_Welfare', 0.12483765184879303)","('Employee_Health_And_Safety', 0.06280624121427536)","('NON-ESG', 0.41931283473968506)","('NON-ESG', 0.12483765184879303)","('NON-ESG', 0.06280624121427536)"
Line 1363,"Last accessed June, 2021.
","('Management_Of_Legal_And_Regulatory_Framework', 0.33258187770843506)","('Director_Removal', 0.08585675805807114)","('GHG_Emissions', 0.0802314430475235)","('NON-ESG', 0.33258187770843506)","('NON-ESG', 0.08585675805807114)","('NON-ESG', 0.0802314430475235)"
Line 1364,"2 United States Renal Data System (USRDS), 2020 Annual Data Report: Epidemiology of Kidney Disease in the United States, available  at https://adr.usrds.org/2020/end-stage-renal-disease/1-incidence-prevalence-patient-characteristics-and-treatment-modalities.
","('Employee_Health_And_Safety', 0.19782985746860504)","('Access_And_Affordability', 0.14072096347808838)","('Customer_Welfare', 0.08657862991094589)","('NON-ESG', 0.19782985746860504)","('NON-ESG', 0.14072096347808838)","('NON-ESG', 0.08657862991094589)"
Line 1365,"Last accessed June, 2021.
","('Management_Of_Legal_And_Regulatory_Framework', 0.33258187770843506)","('Director_Removal', 0.08585675805807114)","('GHG_Emissions', 0.0802314430475235)","('NON-ESG', 0.33258187770843506)","('NON-ESG', 0.08585675805807114)","('NON-ESG', 0.0802314430475235)"
Line 1366,"SERVING OUR COMMUNITIES 1 5,000 in 2019 and 2,500 in 2020.
","('Human_Rights_And_Community_Relations', 0.48778003454208374)","('Access_And_Affordability', 0.2248121052980423)","('Employee_Engagement_Inclusion_And_Diversity', 0.07523777335882187)","('NON-ESG', 0.48778003454208374)","('NON-ESG', 0.2248121052980423)","('NON-ESG', 0.07523777335882187)"
Line 1367,"2 This figure is lower than reported in 2019 due to a difference in the calculation methodology.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8185509443283081)","('Energy_Management', 0.018205121159553528)","('Director_Removal', 0.01337205059826374)","(['Corporate Governance'], 0.8185509443283081)","('NON-ESG', 0.018205121159553528)","('NON-ESG', 0.01337205059826374)"
Line 1368,"3 For employee donations to qualifying U.S. public charities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8199467658996582)","('Human_Rights_And_Community_Relations', 0.015373390167951584)","('Access_And_Affordability', 0.014287855476140976)","(['Corporate Governance'], 0.8199467658996582)","('NON-ESG', 0.015373390167951584)","('NON-ESG', 0.014287855476140976)"
Line 1369,"Houses of worship and political organizations are not eligible for the  Foundation Matching Gift Program.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8162963390350342)","('Director_Removal', 0.018947940319776535)","('Ecological_Impacts', 0.017061332240700722)","(['Corporate Governance'], 0.8162963390350342)","('NON-ESG', 0.018947940319776535)","('NON-ESG', 0.017061332240700722)"
Line 1370,"MATERIALITY ASSESSMENT FINDINGS 1 In this report, we are not using the terms “material” and “materiality” as defined for the purposes of financial and SEC reporting  in the United States.
","('Systemic_Risk_Management', 0.34925025701522827)","('Business_Ethics', 0.10471843928098679)","('Business_Model_Resilience', 0.0674644187092781)","('NON-ESG', 0.34925025701522827)","('NON-ESG', 0.10471843928098679)","('NON-ESG', 0.0674644187092781)"
Line 1371,"Instead, the terms refer to environmental, social and economic issues that are of significant importance to  our stakeholders and to the company.
","('Human_Rights_And_Community_Relations', 0.9330004453659058)","('Management_Of_Legal_And_Regulatory_Framework', 0.0070749688893556595)","('Ecological_Impacts', 0.005831335671246052)","(['Community Relations'], 0.9330004453659058)","('NON-ESG', 0.0070749688893556595)","('NON-ESG', 0.005831335671246052)"
Line 1372,"These “material” issues inform our corporate responsibility strategy, priorities and goals,  and reporting.
","('Human_Rights_And_Community_Relations', 0.6938844323158264)","('Management_Of_Legal_And_Regulatory_Framework', 0.0602370984852314)","('Business_Model_Resilience', 0.056804366409778595)","(['Community Relations'], 0.6938844323158264)","('NON-ESG', 0.0602370984852314)","('NON-ESG', 0.056804366409778595)"
Line 1373,"The issues in this table are listed in alphabetical order.
","('Systemic_Risk_Management', 0.16708198189735413)","('Business_Ethics', 0.16297869384288788)","('Director_Removal', 0.06436845660209656)","('NON-ESG', 0.16708198189735413)","('NON-ESG', 0.16297869384288788)","('NON-ESG', 0.06436845660209656)"
Line 1374,"The listing does not reflect the presumed importance or  “materiality” of any particular issue to Baxter or our stakeholders.
","('Business_Model_Resilience', 0.21905861794948578)","('Systemic_Risk_Management', 0.1977980136871338)","('Management_Of_Legal_And_Regulatory_Framework', 0.14125484228134155)","('NON-ESG', 0.21905861794948578)","('NON-ESG', 0.1977980136871338)","('NON-ESG', 0.14125484228134155)"
Line 1375,"BAXTER DATA SUMMARY 1 Differences compared with data on FDA websites may be due to timeframe (the date Baxter takes an action may differ from the date  FDA classifies that action), definition of “recall” (FDA data includes actions taken even if the product is not removed or corrected), and  classification by product group vs.
","('Product_Quality_And_Safety', 0.37890395522117615)","('Selling_Practices_And_Product_Labeling', 0.3408293128013611)","('Product_Design_And_Lifecycle_Management', 0.04781928285956383)","('NON-ESG', 0.37890395522117615)","('NON-ESG', 0.3408293128013611)","('NON-ESG', 0.04781928285956383)"
Line 1376,"product code (FDA counts each impacted product code within a product family as a distinct recall).
","('Product_Quality_And_Safety', 0.6788889169692993)","('Selling_Practices_And_Product_Labeling', 0.11353560537099838)","('Product_Design_And_Lifecycle_Management', 0.024341657757759094)","(['Product Quality & Recall Management'], 0.6788889169692993)","('NON-ESG', 0.11353560537099838)","('NON-ESG', 0.024341657757759094)"
Line 1377,"2 Product Recall Rate is defined as the number of unique product codes corrected or removed from the market per total Baxter  owned unique product codes sold globally.
","('Product_Quality_And_Safety', 0.7565874457359314)","('Selling_Practices_And_Product_Labeling', 0.07969978451728821)","('Product_Design_And_Lifecycle_Management', 0.04538295045495033)","(['Product Quality & Recall Management'], 0.7565874457359314)","('NON-ESG', 0.07969978451728821)","('NON-ESG', 0.04538295045495033)"
Line 1378,"3 As of 2020, Baxter had 56 FDA-registered establishments available for inspection.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7129771709442139)","('Product_Quality_And_Safety', 0.06727124005556107)","('Competitive_Behavior', 0.03567774221301079)","(['Corporate Governance'], 0.7129771709442139)","('NON-ESG', 0.06727124005556107)","('NON-ESG', 0.03567774221301079)"
Line 1379,"4 “Professional” includes individual contributors.
","('Labor_Practices', 0.22472548484802246)","('Director_Removal', 0.09344501793384552)","('Competitive_Behavior', 0.06888555735349655)","('NON-ESG', 0.22472548484802246)","('NON-ESG', 0.09344501793384552)","('NON-ESG', 0.06888555735349655)"
Line 1380,"5 “Technical/Clerical” includes employees in operational and administrative/clerical roles.
","('Labor_Practices', 0.5372006297111511)","('Employee_Engagement_Inclusion_And_Diversity', 0.11221957951784134)","('Director_Removal', 0.07759451121091843)","(['Labor Practice Indicators'], 0.5372006297111511)","('NON-ESG', 0.11221957951784134)","('NON-ESG', 0.07759451121091843)"
Line 1381,"6  Americas includes the United States (with Puerto Rico), Canada and Latin America.
","('Competitive_Behavior', 0.24176432192325592)","('Management_Of_Legal_And_Regulatory_Framework', 0.1653909981250763)","('Business_Model_Resilience', 0.11155644804239273)","('NON-ESG', 0.24176432192325592)","('NON-ESG', 0.1653909981250763)","('NON-ESG', 0.11155644804239273)"
Line 1382,"7 ""Other"" includes American Indian/Alaska Native, Native Hawaiian/Other Pacific Islander and two or more races.
","('Employee_Engagement_Inclusion_And_Diversity', 0.965957760810852)","('Human_Rights_And_Community_Relations', 0.003938768059015274)","('Labor_Practices', 0.002285434165969491)","(['Human Capital Development'], 0.965957760810852)","('NON-ESG', 0.003938768059015274)","('NON-ESG', 0.002285434165969491)"
Line 1383,"8 The regional breakdown of the data included in this section reflects the structure of the Environmental, Health, Safety and  Sustainability (EHS&S) organization and the categorization of data in the EHS&S global information management system through 2020.APPENDIX:   EndnotesBAXTER 2020 CORPORATE RESPONSIBILITY REPORT68Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction BAXTER DATA SUMMARY (CONTINUED ) 9 Work-related injuries or illnesses requiring medical attention beyond first aid, including cases with days lost.
","('Employee_Health_And_Safety', 0.8404666185379028)","('Product_Quality_And_Safety', 0.07485125213861465)","('Product_Design_And_Lifecycle_Management', 0.009702583774924278)","(['Operational Eco-Efficiency'], 0.8404666185379028)","('NON-ESG', 0.07485125213861465)","('NON-ESG', 0.009702583774924278)"
Line 1384,"8 The regional breakdown of the data included in this section reflects the structure of the Environmental, Health, Safety and  Sustainability (EHS&S) organization and the categorization of data in the EHS&S global information management system through 2020.APPENDIX:   EndnotesBAXTER 2020 CORPORATE RESPONSIBILITY REPORT68Product  InnovationWorkplace  CultureEthics and  ComplianceAppendix Innovation  That Expands  Access to CareServing Our  CommunitiesEmployee  Health and  SafetyResponsible  Procurement  and LogisticsOperations 2030  Commitment  and Goals2020  Priorities  and GoalsIntroduction BAXTER DATA SUMMARY (CONTINUED ) 9 Work-related injuries or illnesses requiring medical attention beyond first aid, including cases with days lost.
","('Employee_Health_And_Safety', 0.9824695587158203)","('Critical_Incident_Risk_Management', 0.0020741464104503393)","('Employee_Engagement_Inclusion_And_Diversity', 0.001297451090067625)","(['Operational Eco-Efficiency'], 0.9824695587158203)","('NON-ESG', 0.0020741464104503393)","('NON-ESG', 0.001297451090067625)"
Line 1385,"All rates based on 100  full-time employees working one year, which equals 200,000 work hours.
","('Labor_Practices', 0.9581542611122131)","('Employee_Health_And_Safety', 0.005200245883315802)","('Waste_And_Hazardous_Materials_Management', 0.0030637241434305906)","(['Labor Practice Indicators'], 0.9581542611122131)","('NON-ESG', 0.005200245883315802)","('NON-ESG', 0.0030637241434305906)"
Line 1386,"For tracking purposes, Baxter follows U.S. Occupational  Safety and Health Administration recordkeeping requirements worldwide.
","('Employee_Health_And_Safety', 0.9410921335220337)","('Product_Quality_And_Safety', 0.0173133984208107)","('Critical_Incident_Risk_Management', 0.0037004572805017233)","(['Operational Eco-Efficiency'], 0.9410921335220337)","('NON-ESG', 0.0173133984208107)","('NON-ESG', 0.0037004572805017233)"
Line 1387,"Thus, in cases where an injury occurs and conflicting  medical opinions arise as to the number of days away and/or restricted days that should be recorded, we record on the basis of the  most authoritative physician’s opinion.
","('Employee_Health_And_Safety', 0.979259729385376)","('Critical_Incident_Risk_Management', 0.0027339626103639603)","('Employee_Engagement_Inclusion_And_Diversity', 0.001357089844532311)","(['Operational Eco-Efficiency'], 0.979259729385376)","('NON-ESG', 0.0027339626103639603)","('NON-ESG', 0.001357089844532311)"
Line 1388,"We include occupational diseases and illnesses, such as hearing loss and ergonomic disorders,  within our broader categories of cases, but do not track or report those items separately.
","('Employee_Health_And_Safety', 0.9436519145965576)","('Employee_Engagement_Inclusion_And_Diversity', 0.016406657174229622)","('Product_Quality_And_Safety', 0.004235143773257732)","(['Operational Eco-Efficiency'], 0.9436519145965576)","('NON-ESG', 0.016406657174229622)","('NON-ESG', 0.004235143773257732)"
Line 1389,"Due to privacy regulations in our Europe,  Middle East and Africa region, we do not classify or report injuries by gender.
","('Employee_Health_And_Safety', 0.7426334619522095)","('Employee_Engagement_Inclusion_And_Diversity', 0.06131342425942421)","('Customer_Privacy', 0.034269388765096664)","(['Operational Eco-Efficiency'], 0.7426334619522095)","('NON-ESG', 0.06131342425942421)","('NON-ESG', 0.034269388765096664)"
Line 1390,"Supervised contracted employees are included in the  injury statistics reported below and are not tracked separately.
","('Employee_Health_And_Safety', 0.9445620179176331)","('Labor_Practices', 0.01876126043498516)","('Employee_Engagement_Inclusion_And_Diversity', 0.005547434091567993)","(['Operational Eco-Efficiency'], 0.9445620179176331)","('NON-ESG', 0.01876126043498516)","('NON-ESG', 0.005547434091567993)"
Line 1391,"Independent contractors are not included in Baxter’s injury data,  because they are supervised by other organizations.
","('Employee_Health_And_Safety', 0.9791252017021179)","('Labor_Practices', 0.0023243334144353867)","('Critical_Incident_Risk_Management', 0.0021133488044142723)","(['Operational Eco-Efficiency'], 0.9791252017021179)","('NON-ESG', 0.0023243334144353867)","('NON-ESG', 0.0021133488044142723)"
Line 1392,"10 Work-related injuries or illnesses that cause an employee to lose at least one full day after the date of the incident.
","('Employee_Health_And_Safety', 0.98399817943573)","('Critical_Incident_Risk_Management', 0.0022793509997427464)","('Employee_Engagement_Inclusion_And_Diversity', 0.0014175755204632878)","(['Operational Eco-Efficiency'], 0.98399817943573)","('NON-ESG', 0.0022793509997427464)","('NON-ESG', 0.0014175755204632878)"
Line 1393,"11 The number of days lost (including weekends and holidays) recommended by the most authoritative physician’s opinion due to  work-related injuries or illnesses.
","('Employee_Health_And_Safety', 0.9778771996498108)","('Labor_Practices', 0.003098119981586933)","('Employee_Engagement_Inclusion_And_Diversity', 0.0016903816722333431)","(['Operational Eco-Efficiency'], 0.9778771996498108)","('NON-ESG', 0.003098119981586933)","('NON-ESG', 0.0016903816722333431)"
Line 1394,"We do not count the date of injury and date of return to full duty as lost days.
","('Employee_Health_And_Safety', 0.9783905148506165)","('Critical_Incident_Risk_Management', 0.0021616823505610228)","('Employee_Engagement_Inclusion_And_Diversity', 0.0016564545221626759)","(['Operational Eco-Efficiency'], 0.9783905148506165)","('NON-ESG', 0.0021616823505610228)","('NON-ESG', 0.0016564545221626759)"
Line 1395,"12 The number of days recommended by the most authoritative physician’s opinion that an employee or supervised contractor is  unable to work full duty (including weekends and holidays) due to a work-related injury or illness.
","('Employee_Health_And_Safety', 0.9785354733467102)","('Labor_Practices', 0.003171088406816125)","('Employee_Engagement_Inclusion_And_Diversity', 0.0023974906653165817)","(['Operational Eco-Efficiency'], 0.9785354733467102)","('NON-ESG', 0.003171088406816125)","('NON-ESG', 0.0023974906653165817)"
Line 1396,"We do not count the date of injury  and date of return to full duty as restricted days.
","('Employee_Health_And_Safety', 0.9758795499801636)","('Critical_Incident_Risk_Management', 0.002585328882560134)","('Employee_Engagement_Inclusion_And_Diversity', 0.001864259596914053)","(['Operational Eco-Efficiency'], 0.9758795499801636)","('NON-ESG', 0.002585328882560134)","('NON-ESG', 0.001864259596914053)"
Line 1397,"13The regional breakdown of the data included in this section reflects the structure of the Environmental, Health, Safety and Sustainability  (EHS&S) organization and the categorization of data in the EHS&S global information management system through 2020.
","('Employee_Health_And_Safety', 0.8616876006126404)","('Product_Quality_And_Safety', 0.058338433504104614)","('Product_Design_And_Lifecycle_Management', 0.007632396183907986)","(['Operational Eco-Efficiency'], 0.8616876006126404)","('NON-ESG', 0.058338433504104614)","('NON-ESG', 0.007632396183907986)"
Line 1398,"Some data for  2018 and 2019 are updated from data reported in the Baxter 2019 Corporate Responsibility Report, to improve accuracy and in the case  of GHG emissions to reflect updated GHG emission factors.
","('GHG_Emissions', 0.9653488993644714)","('Air_Quality', 0.0062813181430101395)","('Ecological_Impacts', 0.0028354311361908913)","(['Climate Change'], 0.9653488993644714)","('NON-ESG', 0.0062813181430101395)","('NON-ESG', 0.0028354311361908913)"
Line 1399,"Some totals vary from sum of items in category, due to rounding.
","('Competitive_Behavior', 0.3871656358242035)","('Customer_Welfare', 0.140335813164711)","('Systemic_Risk_Management', 0.05544452369213104)","('NON-ESG', 0.3871656358242035)","('NON-ESG', 0.140335813164711)","('NON-ESG', 0.05544452369213104)"
Line 1400,"14 Values correspond to the U.S. Environmental Protection Agency Toxics Release Inventory (TRI) Program data reported for reporting  years 2018 and 2019.
","('Waste_And_Hazardous_Materials_Management', 0.9196291565895081)","('Ecological_Impacts', 0.013138732872903347)","('Water_And_Wastewater_Management', 0.012134220451116562)","(['Operational Eco-Efficiency'], 0.9196291565895081)","('NON-ESG', 0.013138732872903347)","('NON-ESG', 0.012134220451116562)"
Line 1401,"It includes facilities in the continental United States only.
","('Business_Model_Resilience', 0.2077588140964508)","('Competitive_Behavior', 0.12329400330781937)","('Customer_Welfare', 0.07788790762424469)","('NON-ESG', 0.2077588140964508)","('NON-ESG', 0.12329400330781937)","('NON-ESG', 0.07788790762424469)"
Line 1402,"15 Includes air emissions associated with on-site energy generation.
","('Air_Quality', 0.9780486822128296)","('Critical_Incident_Risk_Management', 0.0020579190459102392)","('Energy_Management', 0.0016226678853854537)","(['Operational Eco-Efficiency'], 0.9780486822128296)","('NON-ESG', 0.0020579190459102392)","('NON-ESG', 0.0016226678853854537)"
Line 1403,"Emission factors from the U.S. Environmental Protection Agency  publication “Compilation of Air Pollutant Emission Factors,” AP-42, Fifth Edition, Volume 1: “Stationary Point and Area Sources.” 16Excludes energy consumption associated with Baxter-operated mobile sources and renewable electricity generated on site.
","('Air_Quality', 0.9779546856880188)","('Critical_Incident_Risk_Management', 0.0027384471613913774)","('Energy_Management', 0.0020485459826886654)","(['Operational Eco-Efficiency'], 0.9779546856880188)","('NON-ESG', 0.0027384471613913774)","('NON-ESG', 0.0020485459826886654)"
Line 1404,"17 Baxter’s Lean Energy Program began in 2007.
","('Energy_Management', 0.6065260767936707)","('Business_Model_Resilience', 0.05937391147017479)","('Product_Design_And_Lifecycle_Management', 0.05251113325357437)","(['Operational Eco-Efficiency'], 0.6065260767936707)","('NON-ESG', 0.05937391147017479)","('NON-ESG', 0.05251113325357437)"
Line 1405,"Early in 2016, we introduced new Lean Energy Program requirements and updated  some existing ones to better align the program with ISO 50001 requirements for energy management.
","('Energy_Management', 0.9806616306304932)","('Management_Of_Legal_And_Regulatory_Framework', 0.0024665340315550566)","('Air_Quality', 0.0018407433526590466)","(['Operational Eco-Efficiency'], 0.9806616306304932)","('NON-ESG', 0.0024665340315550566)","('NON-ESG', 0.0018407433526590466)"
Line 1406,"18 Data differ slightly from the 2018 total stated in the Baxter Operations Total line of the Baxter Value Chain Energy Usage and GHG  Emissions table, due to rounding.
","('GHG_Emissions', 0.9626657962799072)","('Air_Quality', 0.0057125878520309925)","('Energy_Management', 0.0042345719411969185)","(['Climate Change'], 0.9626657962799072)","('NON-ESG', 0.0057125878520309925)","('NON-ESG', 0.0042345719411969185)"
Line 1407,"19 Excludes waste associated with U.S. Renal Home Care operations, since patients dispose of unused product rather than returning it to  Baxter for disposal.
","('Waste_And_Hazardous_Materials_Management', 0.9817310571670532)","('Product_Design_And_Lifecycle_Management', 0.0019223393173888326)","('Water_And_Wastewater_Management', 0.0014070890611037612)","(['Operational Eco-Efficiency'], 0.9817310571670532)","('NON-ESG', 0.0019223393173888326)","('NON-ESG', 0.0014070890611037612)"
Line 1408,"Also excludes construction and demolition debris, remediation waste and wastewater treatment sludge.
","('Waste_And_Hazardous_Materials_Management', 0.9801351428031921)","('Water_And_Wastewater_Management', 0.00342570710927248)","('Air_Quality', 0.0014437662903219461)","(['Operational Eco-Efficiency'], 0.9801351428031921)","('NON-ESG', 0.00342570710927248)","('NON-ESG', 0.0014437662903219461)"
Line 1409,"Removing  these waste categories from the company total allows for more consistent evaluation of facility performance and trends over time.
","('Waste_And_Hazardous_Materials_Management', 0.984226405620575)","('Water_And_Wastewater_Management', 0.0015397020615637302)","('Air_Quality', 0.0011582827428355813)","(['Operational Eco-Efficiency'], 0.984226405620575)","('NON-ESG', 0.0015397020615637302)","('NON-ESG', 0.0011582827428355813)"
Line 1410,"20 Excludes production by-products reused on-site, construction and demolition debris, and wastewater treatment sludge.
","('Waste_And_Hazardous_Materials_Management', 0.723360002040863)","('Water_And_Wastewater_Management', 0.20795539021492004)","('Air_Quality', 0.006356928497552872)","(['Operational Eco-Efficiency'], 0.723360002040863)","('NON-ESG', 0.20795539021492004)","('NON-ESG', 0.006356928497552872)"
Line 1411,"Includes  discarded/returned products (such as intravenous solution, dextrose solution, etc.) that are nonhazardous in nature but may be  classified as regulated in some countries.
","('Customer_Welfare', 0.2161732017993927)","('Product_Design_And_Lifecycle_Management', 0.204448863863945)","('Waste_And_Hazardous_Materials_Management', 0.15974849462509155)","('NON-ESG', 0.2161732017993927)","('NON-ESG', 0.204448863863945)","('NON-ESG', 0.15974849462509155)"
Line 1412,"Excludes waste associated with U.S. Renal Home Care operations, since patients dispose of  unused product rather than returning it to Baxter for disposal.
","('Waste_And_Hazardous_Materials_Management', 0.9819537401199341)","('Product_Design_And_Lifecycle_Management', 0.0018395755905658007)","('Water_And_Wastewater_Management', 0.0014105705777183175)","(['Operational Eco-Efficiency'], 0.9819537401199341)","('NON-ESG', 0.0018395755905658007)","('NON-ESG', 0.0014105705777183175)"
Line 1413,"21 Excludes waste recycled on-site, remediation waste, construction and demolition debris, and wastewater treatment sludge.
","('Waste_And_Hazardous_Materials_Management', 0.9833964705467224)","('Water_And_Wastewater_Management', 0.001966803101822734)","('Data_Security', 0.0013423257041722536)","(['Operational Eco-Efficiency'], 0.9833964705467224)","('NON-ESG', 0.001966803101822734)","('NON-ESG', 0.0013423257041722536)"
Line 1414,"Includes certain  waste streams (such as waste oils, batteries, fluorescent lamps, light ballasts and asbestos) not classified as regulated in some locations.
","('Waste_And_Hazardous_Materials_Management', 0.9844465851783752)","('Water_And_Wastewater_Management', 0.0013811965472996235)","('Data_Security', 0.001250161323696375)","(['Operational Eco-Efficiency'], 0.9844465851783752)","('NON-ESG', 0.0013811965472996235)","('NON-ESG', 0.001250161323696375)"
Line 1415,"22 Water usage from Baxter’s 55 sites with the greatest use, representing 97% of the company’s total annual water consumption.
","('Water_And_Wastewater_Management', 0.9752734899520874)","('Energy_Management', 0.0026668189093470573)","('GHG_Emissions', 0.002450904343277216)","(['Operational Eco-Efficiency'], 0.9752734899520874)","('NON-ESG', 0.0026668189093470573)","('NON-ESG', 0.002450904343277216)"
Line 1416,"The WRI water tool defines baseline water stress as the total annual water withdrawals (municipal, industrial and agricultural)  expressed as a percent of the total annual available flow.
","('Water_And_Wastewater_Management', 0.9778348803520203)","('GHG_Emissions', 0.002224958036094904)","('Energy_Management', 0.001649860292673111)","(['Operational Eco-Efficiency'], 0.9778348803520203)","('NON-ESG', 0.002224958036094904)","('NON-ESG', 0.001649860292673111)"
Line 1417,"Higher values indicate more competition among users.
","('Competitive_Behavior', 0.9603049159049988)","('Customer_Welfare', 0.0035217644181102514)","('Business_Model_Resilience', 0.0027055286336690187)","(['Business Ethics'], 0.9603049159049988)","('NON-ESG', 0.0035217644181102514)","('NON-ESG', 0.0027055286336690187)"
Line 1418,"Low—Less than 10% of the water available to agricultural, domestic and industrial users is withdrawn annually.
","('Water_And_Wastewater_Management', 0.9762775301933289)","('Energy_Management', 0.002365570981055498)","('GHG_Emissions', 0.002272964222356677)","(['Operational Eco-Efficiency'], 0.9762775301933289)","('NON-ESG', 0.002365570981055498)","('NON-ESG', 0.002272964222356677)"
Line 1419,"Low-Med—Between 10 and 20% of the water available to agricultural, domestic and industrial users is withdrawn annually.
","('Water_And_Wastewater_Management', 0.9754378199577332)","('Energy_Management', 0.0025902986526489258)","('GHG_Emissions', 0.0024030886124819517)","(['Operational Eco-Efficiency'], 0.9754378199577332)","('NON-ESG', 0.0025902986526489258)","('NON-ESG', 0.0024030886124819517)"
Line 1420,"Med-High—Between 20 and 40% of the water available to agricultural, domestic and industrial users is withdrawn annually.
","('Water_And_Wastewater_Management', 0.975695788860321)","('Energy_Management', 0.0025041955523192883)","('GHG_Emissions', 0.0022943594958633184)","(['Operational Eco-Efficiency'], 0.975695788860321)","('NON-ESG', 0.0025041955523192883)","('NON-ESG', 0.0022943594958633184)"
Line 1421,"High—Between 40 and 80% of the water available to agricultural, domestic and industrial users is withdrawn annually.
","('Water_And_Wastewater_Management', 0.9752585291862488)","('Energy_Management', 0.0025586653500795364)","('GHG_Emissions', 0.0024488552007824183)","(['Operational Eco-Efficiency'], 0.9752585291862488)","('NON-ESG', 0.0025586653500795364)","('NON-ESG', 0.0024488552007824183)"
Line 1422,"Extremely High—More than 80% of the water available to agricultural, domestic, and industrial users is withdrawn annually.
","('Water_And_Wastewater_Management', 0.9759336113929749)","('GHG_Emissions', 0.00234861858189106)","('Energy_Management', 0.0023033295292407274)","(['Operational Eco-Efficiency'], 0.9759336113929749)","('NON-ESG', 0.00234861858189106)","('NON-ESG', 0.0023033295292407274)"
Line 1423,"23 Estimated total water pollutant levels for treated wastewater discharged directly into waterways.
","('Water_And_Wastewater_Management', 0.9718424677848816)","('Waste_And_Hazardous_Materials_Management', 0.0034359300043433905)","('GHG_Emissions', 0.003252392401918769)","(['Operational Eco-Efficiency'], 0.9718424677848816)","('NON-ESG', 0.0034359300043433905)","('NON-ESG', 0.003252392401918769)"
Line 1424,"Data do not include one facility that  operates zero-discharge systems in accordance with local regulatory requirements.
","('Water_And_Wastewater_Management', 0.5598528385162354)","('Air_Quality', 0.10458852350711823)","('Waste_And_Hazardous_Materials_Management', 0.08377297222614288)","(['Operational Eco-Efficiency'], 0.5598528385162354)","('NON-ESG', 0.10458852350711823)","('NON-ESG', 0.08377297222614288)"
Line 1425,"BOD5 refers to five-day biological oxygen demand;  COD refers to chemical oxygen demand; TSS refers to total suspended solids.
","('Water_And_Wastewater_Management', 0.3513143062591553)","('Energy_Management', 0.18528497219085693)","('GHG_Emissions', 0.16660571098327637)","('NON-ESG', 0.3513143062591553)","('NON-ESG', 0.18528497219085693)","('NON-ESG', 0.16660571098327637)"
Line 1426,"When actual performance data were not available,  estimates are based on performance at similar facilities or on other measured performance indicators.
","('Systemic_Risk_Management', 0.317710280418396)","('Business_Model_Resilience', 0.19340196251869202)","('Human_Rights_And_Community_Relations', 0.07196922600269318)","('NON-ESG', 0.317710280418396)","('NON-ESG', 0.19340196251869202)","('NON-ESG', 0.07196922600269318)"
Line 1427,"24 Of the $79,500 in environmental fines Baxter paid in 2018, $75,000 was associated with three Notices of Violation received in 2016.
","('Management_Of_Legal_And_Regulatory_Framework', 0.44069838523864746)","('Business_Ethics', 0.43754538893699646)","('Access_And_Affordability', 0.009830066002905369)","('NON-ESG', 0.44069838523864746)","('NON-ESG', 0.43754538893699646)","('NON-ESG', 0.009830066002905369)"
Line 1428,"25 Fiscal year basis (October 1 through September 30 of the year noted).
","('Management_Of_Legal_And_Regulatory_Framework', 0.5060508847236633)","('Director_Removal', 0.1313180774450302)","('Physical_Impacts_Of_Climate_Change', 0.053948819637298584)","(['Corporate Governance'], 0.5060508847236633)","('NON-ESG', 0.1313180774450302)","('NON-ESG', 0.053948819637298584)"
Line 1429,"26 United States and Puerto Rico.
","('Management_Of_Legal_And_Regulatory_Framework', 0.49361762404441833)","('Competitive_Behavior', 0.1531187742948532)","('GHG_Emissions', 0.04016891494393349)","('NON-ESG', 0.49361762404441833)","('NON-ESG', 0.1531187742948532)","('NON-ESG', 0.04016891494393349)"
Line 1430,"Fiscal year basis (October 1 through September 30 of the year noted).
","('Management_Of_Legal_And_Regulatory_Framework', 0.5398755073547363)","('Director_Removal', 0.11901940405368805)","('Physical_Impacts_Of_Climate_Change', 0.043142687529325485)","(['Corporate Governance'], 0.5398755073547363)","('NON-ESG', 0.11901940405368805)","('NON-ESG', 0.043142687529325485)"
Line 1431,"Accounts payable data are  sent to a third party, which categorizes spending.
","('Customer_Privacy', 0.23201751708984375)","('Management_Of_Legal_And_Regulatory_Framework', 0.12583646178245544)","('Competitive_Behavior', 0.09121599048376083)","('NON-ESG', 0.23201751708984375)","('NON-ESG', 0.12583646178245544)","('NON-ESG', 0.09121599048376083)"
Line 1432,"Other categories include disability-owned, service-disabled-veteran-owned,  LGBT-owned, small disadvantaged and HUBZone-certified businesses.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9105871915817261)","('Employee_Health_And_Safety', 0.012117673642933369)","('Labor_Practices', 0.010720384307205677)","(['Human Capital Development'], 0.9105871915817261)","('NON-ESG', 0.012117673642933369)","('NON-ESG', 0.010720384307205677)"
Line 1433,"HUBZone is a U.S. Small Business Administration program  for small companies that operate and employ people in Historically Underutilized Business Zones.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7550653219223022)","('Labor_Practices', 0.04134450480341911)","('Employee_Health_And_Safety', 0.02305009588599205)","(['Human Capital Development'], 0.7550653219223022)","('NON-ESG', 0.04134450480341911)","('NON-ESG', 0.02305009588599205)"
Line 1434,"Spending with suppliers that  qualify for more than one category may be included in the totals for each of the relevant categories.
","('Supply_Chain_Management', 0.8324869275093079)","('Energy_Management', 0.020164934918284416)","('Management_Of_Legal_And_Regulatory_Framework', 0.015917478129267693)","(['Supply Chain Management'], 0.8324869275093079)","('NON-ESG', 0.020164934918284416)","('NON-ESG', 0.015917478129267693)"
Line 1435,"27 Data was restated for 2019 due to error in emission factor to calculate rail emissions for Canada.
","('Air_Quality', 0.9388976097106934)","('GHG_Emissions', 0.02270125411450863)","('Energy_Management', 0.005070027429610491)","(['Operational Eco-Efficiency'], 0.9388976097106934)","('NON-ESG', 0.02270125411450863)","('NON-ESG', 0.005070027429610491)"
Line 1436,"Number includes Scope 3 emissions  plus Scope 1 emissions for product transport.
","('GHG_Emissions', 0.41166022419929504)","('Air_Quality', 0.34731587767601013)","('Energy_Management', 0.08786945044994354)","('NON-ESG', 0.41166022419929504)","('NON-ESG', 0.34731587767601013)","('NON-ESG', 0.08786945044994354)"
Line 1437,"Some totals vary from sum of items in category, due to rounding.
","('Competitive_Behavior', 0.3871656358242035)","('Customer_Welfare', 0.140335813164711)","('Systemic_Risk_Management', 0.05544452369213104)","('NON-ESG', 0.3871656358242035)","('NON-ESG', 0.140335813164711)","('NON-ESG', 0.05544452369213104)"
Line 1438,"28Variations in Baxter’s annual product donations are due to fluctuations in community needs, the need and volume of disaster relief  response, the regulatory environment, manufacturing processes and changes in product mix and marketing.
","('Critical_Incident_Risk_Management', 0.9248612523078918)","('Physical_Impacts_Of_Climate_Change', 0.009398593567311764)","('Employee_Health_And_Safety', 0.008513815701007843)","(['Risk & Crisis Management'], 0.9248612523078918)","('NON-ESG', 0.009398593567311764)","('NON-ESG', 0.008513815701007843)"
Line 1439,"We identify opportunities  to donate and respond to community and humanitarian aid partner requests as appropriate.
","('Human_Rights_And_Community_Relations', 0.35134434700012207)","('Critical_Incident_Risk_Management', 0.32451900839805603)","('Access_And_Affordability', 0.09116479009389877)","('NON-ESG', 0.35134434700012207)","('NON-ESG', 0.32451900839805603)","('NON-ESG', 0.09116479009389877)"
Line 1440,"Value of products donated (provided at no  cost) is provided by partners based on wholesale acquisition cost at the time of donation.
","('Product_Design_And_Lifecycle_Management', 0.9040402770042419)","('Selling_Practices_And_Product_Labeling', 0.01703040301799774)","('Energy_Management', 0.011351626366376877)","(['Product Stewardship'], 0.9040402770042419)","('NON-ESG', 0.01703040301799774)","('NON-ESG', 0.011351626366376877)"
Line 1441,"This number may be greater or less than the  value of Baxter products distributed during the year by our relief partners.
","('Product_Design_And_Lifecycle_Management', 0.8909574747085571)","('Selling_Practices_And_Product_Labeling', 0.028602631762623787)","('Product_Quality_And_Safety', 0.017488844692707062)","(['Product Stewardship'], 0.8909574747085571)","('NON-ESG', 0.028602631762623787)","('NON-ESG', 0.017488844692707062)"
Line 1442,"See Innovation That Expands Access to Care.
","('Access_And_Affordability', 0.714725911617279)","('Customer_Welfare', 0.036916494369506836)","('Energy_Management', 0.03030308708548546)","(['Health Outcome Contribution'], 0.714725911617279)","('NON-ESG', 0.036916494369506836)","('NON-ESG', 0.03030308708548546)"
Line 1443,"29 Contributions to U.S.-based 501(c)(3) organizations for programs within and outside of the United States.BAXTER VALUE CHAIN ENERGY USAGE AND GHG EMISSIONS 1 Baxter used the World Resources Institute and World Business Council for Sustainable Development Greenhouse Gas Protocol  to calculate emissions data from fossil fuel use.
","('GHG_Emissions', 0.9690150022506714)","('Air_Quality', 0.004631426185369492)","('Ecological_Impacts', 0.0030137826688587666)","(['Climate Change'], 0.9690150022506714)","('NON-ESG', 0.004631426185369492)","('NON-ESG', 0.0030137826688587666)"
Line 1444,"We used country electricity emission factors published by the International  Energy Agency and the U.S. Environmental Protection Agency (EPA) E-Grid U.S. regional electricity emission factors to  calculate GHG emissions related to electricity consumption.
","('GHG_Emissions', 0.9187348484992981)","('Air_Quality', 0.03791417181491852)","('Management_Of_Legal_And_Regulatory_Framework', 0.004841055255383253)","(['Climate Change'], 0.9187348484992981)","('NON-ESG', 0.03791417181491852)","('NON-ESG', 0.004841055255383253)"
Line 1445,"2 Apex Companies LLC verified to a reasonable level Baxter’s 2018–2020 Scope 1 and Scope 2 GHG emissions.
","('GHG_Emissions', 0.9678693413734436)","('Air_Quality', 0.003747252281755209)","('Ecological_Impacts', 0.0030196402221918106)","(['Climate Change'], 0.9678693413734436)","('NON-ESG', 0.003747252281755209)","('NON-ESG', 0.0030196402221918106)"
Line 1446,"Apex Companies  LLC also verified to a limited level Baxter’s methodology for determining 2018–2020 Scope 3 GHG emissions.
","('GHG_Emissions', 0.9675452709197998)","('Air_Quality', 0.004389401525259018)","('Management_Of_Legal_And_Regulatory_Framework', 0.002979000099003315)","(['Climate Change'], 0.9675452709197998)","('NON-ESG', 0.004389401525259018)","('NON-ESG', 0.002979000099003315)"
Line 1447,"3 Some data for 2018 and 2019 are updated from data reported in the Baxter 2019 Corporate Responsibility Report for accuracy  and to reflect updated GHG emission factors.
","('GHG_Emissions', 0.9573462605476379)","('Air_Quality', 0.010827657766640186)","('Physical_Impacts_Of_Climate_Change', 0.003350921906530857)","(['Climate Change'], 0.9573462605476379)","('NON-ESG', 0.010827657766640186)","('NON-ESG', 0.003350921906530857)"
Line 1448,"4 We used the Greenhouse Gas Protocol: A Corporate Accounting and Reporting Standard, Revised Edition to determine GHG  emissions associated with using biomass fuel, principally wood/wood waste, as a boiler fuel at two Baxter locations.
","('GHG_Emissions', 0.9690560102462769)","('Air_Quality', 0.004155750386416912)","('Ecological_Impacts', 0.0030830020550638437)","(['Climate Change'], 0.9690560102462769)","('NON-ESG', 0.004155750386416912)","('NON-ESG', 0.0030830020550638437)"
Line 1449,"These  emissions were calculated as 145,000, 152,000 and 149,000 metric tons CO 2 in 2018, 2019 and 2020, respectively.
","('GHG_Emissions', 0.9236361980438232)","('Air_Quality', 0.019495896995067596)","('Management_Of_Legal_And_Regulatory_Framework', 0.008886746130883694)","(['Climate Change'], 0.9236361980438232)","('NON-ESG', 0.019495896995067596)","('NON-ESG', 0.008886746130883694)"
Line 1450,"CO 2e  emissions from CH 4 and N 2O components of biomass combustion are included in reported Scope 1 emissions.
","('GHG_Emissions', 0.9472004771232605)","('Air_Quality', 0.011033525690436363)","('Management_Of_Legal_And_Regulatory_Framework', 0.005526673514395952)","(['Climate Change'], 0.9472004771232605)","('NON-ESG', 0.011033525690436363)","('NON-ESG', 0.005526673514395952)"
Line 1451,"5 Baxter used the Greenhouse Gas Protocol to estimate GHG emissions associated with reported fuel usage by company- managed sales and distribution fleet vehicles and other vehicles.
","('GHG_Emissions', 0.9700208306312561)","('Ecological_Impacts', 0.0036547973286360502)","('Air_Quality', 0.002860523061826825)","(['Climate Change'], 0.9700208306312561)","('NON-ESG', 0.0036547973286360502)","('NON-ESG', 0.002860523061826825)"
Line 1452,"We estimated fuel usage for international sales and  distribution vehicles based on regional sales information.
","('Energy_Management', 0.9487900733947754)","('Product_Design_And_Lifecycle_Management', 0.012591260485351086)","('Selling_Practices_And_Product_Labeling', 0.0033941688016057014)","(['Operational Eco-Efficiency'], 0.9487900733947754)","('NON-ESG', 0.012591260485351086)","('NON-ESG', 0.0033941688016057014)"
Line 1453,"6 Refrigerant emissions represent reported CFC, HCFC and HFC refrigerant losses by each Baxter location.
","('Air_Quality', 0.5606803894042969)","('GHG_Emissions', 0.15719737112522125)","('Energy_Management', 0.14567434787750244)","(['Operational Eco-Efficiency'], 0.5606803894042969)","('NON-ESG', 0.15719737112522125)","('NON-ESG', 0.14567434787750244)"
Line 1454,"We calculated  associated GHG emissions using actual emission factors for each reported refrigerant.
","('GHG_Emissions', 0.9418894648551941)","('Air_Quality', 0.02082679234445095)","('Energy_Management', 0.005393648985773325)","(['Climate Change'], 0.9418894648551941)","('NON-ESG', 0.02082679234445095)","('NON-ESG', 0.005393648985773325)"
Line 1455,"7 Includes the purchase of electricity generated from 100% certified renewable electricity (Belgium, Brazil, France, Germany,  Ireland, Italy, Spain, Sweden, Switzerland, UK and United States).
","('Energy_Management', 0.9725874662399292)","('Management_Of_Legal_And_Regulatory_Framework', 0.004701853729784489)","('Water_And_Wastewater_Management', 0.0025907147210091352)","(['Operational Eco-Efficiency'], 0.9725874662399292)","('NON-ESG', 0.004701853729784489)","('NON-ESG', 0.0025907147210091352)"
Line 1456,"8 Estimated based on an environmentally extended input-output model from an independent third party and Baxter’s revenue and  sector of operation.
","('Energy_Management', 0.331123948097229)","('Supply_Chain_Management', 0.19401641190052032)","('Management_Of_Legal_And_Regulatory_Framework', 0.15221725404262543)","('NON-ESG', 0.331123948097229)","('NON-ESG', 0.19401641190052032)","('NON-ESG', 0.15221725404262543)"
Line 1457,"9 Estimated based on capital expenditures and an estimated emission factor per million dollars of capital expenditure from  benchmarking with industry.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5591254830360413)","('Business_Model_Resilience', 0.08395104110240936)","('Systemic_Risk_Management', 0.07069514691829681)","(['Corporate Governance'], 0.5591254830360413)","('NON-ESG', 0.08395104110240936)","('NON-ESG', 0.07069514691829681)"
Line 1458,"10 Estimated based on Baxter’s actual yearly energy usage by energy type and GHG emission factors for each energy type per GaBi  life cycle assessment software.
","('GHG_Emissions', 0.533709704875946)","('Energy_Management', 0.29400375485420227)","('Air_Quality', 0.07789597660303116)","(['Climate Change'], 0.533709704875946)","('NON-ESG', 0.29400375485420227)","('NON-ESG', 0.07789597660303116)"
Line 1459,"11 Estimated based on shipment of products to our customers using the EcoTransIT World Software that is compliant with the  GHG Protocol and the Global Logistics Emissions Council Framework.
","('GHG_Emissions', 0.9570292234420776)","('Ecological_Impacts', 0.00491905165836215)","('Management_Of_Legal_And_Regulatory_Framework', 0.004142075311392546)","(['Climate Change'], 0.9570292234420776)","('NON-ESG', 0.00491905165836215)","('NON-ESG', 0.004142075311392546)"
Line 1460,"12 Estimated emissions for wastewater treatment by municipalities and off-site waste recycling and disposal based on Baxter’s  waste generation by type, guidance provided by the Massachusetts Department of Environmental Protection (United States) and  the U.S. EPA WARM model.
","('Waste_And_Hazardous_Materials_Management', 0.9811729788780212)","('Water_And_Wastewater_Management', 0.0028293575160205364)","('Data_Security', 0.0012440194841474295)","(['Operational Eco-Efficiency'], 0.9811729788780212)","('NON-ESG', 0.0028293575160205364)","('NON-ESG', 0.0012440194841474295)"
Line 1461,"13 Estimated based on domestic and international air mileage, rental vehicle CO 2e emissions or mileage, and hotel room stays  provided by Baxter’s global travel providers, and using emission factors from UK Government GHG Conversion Factors for  Company Reporting, Greenhouse Gas Protocol Mobile Combustion GHG Emissions Calculation Tool, and Carbonfund.org  Business Travel Calculator.
","('GHG_Emissions', 0.9156056046485901)","('Air_Quality', 0.044424694031476974)","('Physical_Impacts_Of_Climate_Change', 0.004034987650811672)","(['Climate Change'], 0.9156056046485901)","('NON-ESG', 0.044424694031476974)","('NON-ESG', 0.004034987650811672)"
Line 1462,"14 Estimated based on the number of Baxter employees by country and statistics on commuting time and transport mode split into  public transport, passenger cars, taxi and motorcycle, and walking or bicycling.
","('Employee_Health_And_Safety', 0.6506164073944092)","('Labor_Practices', 0.04527408629655838)","('Employee_Engagement_Inclusion_And_Diversity', 0.02810024842619896)","(['Operational Eco-Efficiency'], 0.6506164073944092)","('NON-ESG', 0.04527408629655838)","('NON-ESG', 0.02810024842619896)"
Line 1463,"Emission factors for each mode were obtained  from Defra.
","('Air_Quality', 0.958206057548523)","('GHG_Emissions', 0.008318379521369934)","('Energy_Management', 0.0053237550891935825)","(['Operational Eco-Efficiency'], 0.958206057548523)","('NON-ESG', 0.008318379521369934)","('NON-ESG', 0.0053237550891935825)"
Line 1464,"15 Emissions associated with upstream leased assets are included in Baxter’s Scope 1 and 2 emissions.
","('GHG_Emissions', 0.926484227180481)","('Ecological_Impacts', 0.010043783113360405)","('Management_Of_Legal_And_Regulatory_Framework', 0.010041111148893833)","(['Climate Change'], 0.926484227180481)","('NON-ESG', 0.010043783113360405)","('NON-ESG', 0.010041111148893833)"
Line 1465,"16 Estimated based on previous Baxter product LCAs as well as the company’s revenue by product type.
","('Product_Design_And_Lifecycle_Management', 0.9221962690353394)","('Product_Quality_And_Safety', 0.012206574901938438)","('Customer_Welfare', 0.01022789441049099)","(['Product Stewardship'], 0.9221962690353394)","('NON-ESG', 0.012206574901938438)","('NON-ESG', 0.01022789441049099)"
Line 1466,"Category 1 emissions  were extrapolated to other categories depending on the product type.
","('Product_Design_And_Lifecycle_Management', 0.6412997841835022)","('Energy_Management', 0.1400202214717865)","('Customer_Welfare', 0.02870049513876438)","(['Product Stewardship'], 0.6412997841835022)","('NON-ESG', 0.1400202214717865)","('NON-ESG', 0.02870049513876438)"
Line 1467,"17 Estimated based on an environmentally extended input-output model from an independent third party and revenue from  Baxter’s contract services business.
","('Energy_Management', 0.3019673526287079)","('Supply_Chain_Management', 0.2365511953830719)","('Management_Of_Legal_And_Regulatory_Framework', 0.13591806590557098)","('NON-ESG', 0.3019673526287079)","('NON-ESG', 0.2365511953830719)","('NON-ESG', 0.13591806590557098)"
Line 1468,"18 Estimated based on production quantities and global warming potential information for certain types of products.
","('Product_Design_And_Lifecycle_Management', 0.950614333152771)","('Selling_Practices_And_Product_Labeling', 0.008905182592570782)","('Product_Quality_And_Safety', 0.005202125292271376)","(['Product Stewardship'], 0.950614333152771)","('NON-ESG', 0.008905182592570782)","('NON-ESG', 0.005202125292271376)"
Line 1469,"Emissions  for certain other products estimated based on previous Baxter product LCAs as well as the company’s revenue by product type.
","('Product_Design_And_Lifecycle_Management', 0.8536036610603333)","('Energy_Management', 0.043472662568092346)","('Product_Quality_And_Safety', 0.021220536902546883)","(['Product Stewardship'], 0.8536036610603333)","('NON-ESG', 0.043472662568092346)","('NON-ESG', 0.021220536902546883)"
Line 1470,"Category 1 emissions were extrapolated to other categories depending on the product type.
","('Product_Design_And_Lifecycle_Management', 0.6412997841835022)","('Energy_Management', 0.1400202214717865)","('Customer_Welfare', 0.02870049513876438)","(['Product Stewardship'], 0.6412997841835022)","('NON-ESG', 0.1400202214717865)","('NON-ESG', 0.02870049513876438)"
Line 1471,"19 Totals do not include CO 2 emissions from Baxter-owned wood-fired boilers.
","('Air_Quality', 0.5755411386489868)","('GHG_Emissions', 0.29440656304359436)","('Energy_Management', 0.04427190497517586)","(['Operational Eco-Efficiency'], 0.5755411386489868)","('NON-ESG', 0.29440656304359436)","('NON-ESG', 0.04427190497517586)"
Line 1472,"See endnote 4 above for detail.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6697463989257812)","('Data_Security', 0.03429609537124634)","('Systemic_Risk_Management', 0.03398953750729561)","(['Corporate Governance'], 0.6697463989257812)","('NON-ESG', 0.03429609537124634)","('NON-ESG', 0.03398953750729561)"
Line 1473,"BAXTER FACILITIES WITH ISO 14001, ISO 45001, ISO 50001   AND GREEN BUILDING CERTIFICATIONS   1 As of December 31, 2020.
","('Product_Quality_And_Safety', 0.35906121134757996)","('Product_Design_And_Lifecycle_Management', 0.19055034220218658)","('Management_Of_Legal_And_Regulatory_Framework', 0.07975345104932785)","('NON-ESG', 0.35906121134757996)","('NON-ESG', 0.19055034220218658)","('NON-ESG', 0.07975345104932785)"
Line 1474,"2 Facilities transitioned to ISO 45001 from OHSAS 18001.
","('Product_Quality_And_Safety', 0.4549112915992737)","('Management_Of_Legal_And_Regulatory_Framework', 0.13096338510513306)","('Product_Design_And_Lifecycle_Management', 0.08625326305627823)","('NON-ESG', 0.4549112915992737)","('NON-ESG', 0.13096338510513306)","('NON-ESG', 0.08625326305627823)"
Line 1475,"3 The building with green certification noted is one of several buildings at the designated location.
","('Ecological_Impacts', 0.2398844063282013)","('Product_Design_And_Lifecycle_Management', 0.17863118648529053)","('Supply_Chain_Management', 0.0650343969464302)","('NON-ESG', 0.2398844063282013)","('NON-ESG', 0.17863118648529053)","('NON-ESG', 0.0650343969464302)"
Line 1476,"SUSTAINABILITY ACCOUNTING STANDARDS BOARD INDEX 1 Differences compared with data on FDA websites may be due to timeframe (the date Baxter takes an action may differ from  the date FDA classifies that action), definition of ""recall"" (FDA data includes actions taken even if the product is not removed  or corrected), and classification by product group vs.
","('Product_Quality_And_Safety', 0.48065298795700073)","('Selling_Practices_And_Product_Labeling', 0.2500642240047455)","('Product_Design_And_Lifecycle_Management', 0.04938017204403877)","('NON-ESG', 0.48065298795700073)","('NON-ESG', 0.2500642240047455)","('NON-ESG', 0.04938017204403877)"
Line 1477,"product code (FDA counts each impacted product code within a product  family as a distinct recall).
","('Product_Quality_And_Safety', 0.6788889169692993)","('Selling_Practices_And_Product_Labeling', 0.11353560537099838)","('Product_Design_And_Lifecycle_Management', 0.024341657757759094)","(['Product Quality & Recall Management'], 0.6788889169692993)","('NON-ESG', 0.11353560537099838)","('NON-ESG', 0.024341657757759094)"
Line 1478,"2 This figure is lower than reported in 2019 due to a difference in the calculation methodology.APPENDIX:   Endnotes (continued)Baxter International Inc.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8686543703079224)","('Director_Removal', 0.010352417826652527)","('Access_And_Affordability', 0.008890300057828426)","(['Corporate Governance'], 0.8686543703079224)","('NON-ESG', 0.010352417826652527)","('NON-ESG', 0.008890300057828426)"
Line 1479,"One Baxter Parkway  Deerfield, Illinois 60015-USA www.baxter.com © Baxter International Inc., 2021.
","('Customer_Welfare', 0.1700282096862793)","('Systemic_Risk_Management', 0.09811700135469437)","('Selling_Practices_And_Product_Labeling', 0.09029637277126312)","('NON-ESG', 0.1700282096862793)","('NON-ESG', 0.09811700135469437)","('NON-ESG', 0.09029637277126312)"
Line 1480,"All rights reserved.
","('Customer_Privacy', 0.18397872149944305)","('Human_Rights_And_Community_Relations', 0.07860073447227478)","('Waste_And_Hazardous_Materials_Management', 0.07202215492725372)","('NON-ESG', 0.18397872149944305)","('NON-ESG', 0.07860073447227478)","('NON-ESG', 0.07202215492725372)"
Line 1481,"References in this report to Baxter are intended to refer collectively to Baxter International Inc.
","('Selling_Practices_And_Product_Labeling', 0.14480054378509521)","('Business_Ethics', 0.10583603382110596)","('Supply_Chain_Management', 0.10136048495769501)","('NON-ESG', 0.14480054378509521)","('NON-ESG', 0.10583603382110596)","('NON-ESG', 0.10136048495769501)"
Line 1482,"and its U.S.   and international subsidiaries.
","('Business_Model_Resilience', 0.21301601827144623)","('Customer_Privacy', 0.1562388688325882)","('Director_Removal', 0.09497018903493881)","('NON-ESG', 0.21301601827144623)","('NON-ESG', 0.1562388688325882)","('NON-ESG', 0.09497018903493881)"
Line 1483,"Baxter, Amia, Baxter Renal Care Services, Doxil, Evo IQ, Floseal, Kaguya, Multirate, Revaclear, Sharesource,  Sigma Spectrum, Spectrum IQ, Theranova, Twin Bag and Viaflo are trademarks of Baxter International Inc.,   or its subsidiaries.
","('Customer_Privacy', 0.14648760855197906)","('Business_Ethics', 0.13049940764904022)","('Competitive_Behavior', 0.10618904232978821)","('NON-ESG', 0.14648760855197906)","('NON-ESG', 0.13049940764904022)","('NON-ESG', 0.10618904232978821)"
Line 1484,"Contrafluran and Sensofluran are trademarks of ZeoSys GmbH.
","('Selling_Practices_And_Product_Labeling', 0.3110768795013428)","('Customer_Welfare', 0.1690160185098648)","('Competitive_Behavior', 0.1040712371468544)","('NON-ESG', 0.3110768795013428)","('NON-ESG', 0.1690160185098648)","('NON-ESG', 0.1040712371468544)"
Line 1485,"Matrix-M is a trademark of Novavax, Inc.
","('Competitive_Behavior', 0.29771971702575684)","('Customer_Welfare', 0.10879390686750412)","('Selling_Practices_And_Product_Labeling', 0.0721493661403656)","('NON-ESG', 0.29771971702575684)","('NON-ESG', 0.10879390686750412)","('NON-ESG', 0.0721493661403656)"
Line 1486,"Any other trademarks, products or brand images appearing herein are the property of their respective owners.
","('Customer_Privacy', 0.22507941722869873)","('Selling_Practices_And_Product_Labeling', 0.21917450428009033)","('Competitive_Behavior', 0.11944789439439774)","('NON-ESG', 0.22507941722869873)","('NON-ESG', 0.21917450428009033)","('NON-ESG', 0.11944789439439774)"
Line 1487,"Cover Photo:   In 2020, Baxter supported Americares global   response to the COVID-19 pandemic, which provided  critically needed protective gear, training and emotional  support for frontline health workers worldwide.
","('Employee_Health_And_Safety', 0.974910318851471)","('Critical_Incident_Risk_Management', 0.0039441282860934734)","('Labor_Practices', 0.0022780660074204206)","(['Operational Eco-Efficiency'], 0.974910318851471)","('NON-ESG', 0.0039441282860934734)","('NON-ESG', 0.0022780660074204206)"
Line 1488,"Americares  COVID-19 response spanned 31 countries in 2020, including  Perú, pictured here, where Americares provided mobile  health services in close coordination with the Peruvian  Ministry of Health, the United States Agency for International  Development and local partners, including VIDA Perú.
","('Critical_Incident_Risk_Management', 0.36179637908935547)","('Access_And_Affordability', 0.17398807406425476)","('Employee_Health_And_Safety', 0.13749614357948303)","('NON-ESG', 0.36179637908935547)","('NON-ESG', 0.17398807406425476)","('NON-ESG', 0.13749614357948303)"
Line 1489,"Baxter is a longtime supporter of  Americares, a health-focused relief and development organization that saves lives and  improves health for people affected by poverty or disaster.• 100 Best Corporate Citizens   3BL Media • Score: A-   CDP Climate Change and CDP Water • Best Place to Work for Disability Inclusion   (top 10% of all companies)   Disability Equality Index  • Dow Jones Sustainability Index • FTSE4Good Index Series • America's Best Employers for Diversity   Forbes • America's Best Employers for Women   Forbes • Corporate Equality Index for LGBTQ Equality   (100% score)   Human Rights Campaign Foundation  • America's Most Just Companies   JUST Capital • America's Most Responsible Companies   Newsweek • Global Inclusion Index (in 11 countries:   Brazil, China, France, Germany, India, Ireland,   Italy, Japan, Mexico, Singapore, UK)   Seramount • 100 Best Companies   Seramount  (formerly  Working Mother Media ) • Best Companies for Dads   Seramount  (formerly  Working Mother Media ) • Top Companies for Executive Women   Seramount  (formerly Working Mother Media 's  National Association for Female Executives) • Top 10% Inclusion Index Company   Seramount Inclusion IndexRECOGNITION HIGHLIGHTS (AS OF JUNE 2021 ) RECOGNITION Baxter is proud to be recognized by numerous  organizations and publications globally.
","('Employee_Health_And_Safety', 0.7032824158668518)","('Employee_Engagement_Inclusion_And_Diversity', 0.10098162293434143)","('Access_And_Affordability', 0.05210649594664574)","(['Operational Eco-Efficiency'], 0.7032824158668518)","('NON-ESG', 0.10098162293434143)","('NON-ESG', 0.05210649594664574)"
Line 1490,"Baxter is a longtime supporter of  Americares, a health-focused relief and development organization that saves lives and  improves health for people affected by poverty or disaster.• 100 Best Corporate Citizens   3BL Media • Score: A-   CDP Climate Change and CDP Water • Best Place to Work for Disability Inclusion   (top 10% of all companies)   Disability Equality Index  • Dow Jones Sustainability Index • FTSE4Good Index Series • America's Best Employers for Diversity   Forbes • America's Best Employers for Women   Forbes • Corporate Equality Index for LGBTQ Equality   (100% score)   Human Rights Campaign Foundation  • America's Most Just Companies   JUST Capital • America's Most Responsible Companies   Newsweek • Global Inclusion Index (in 11 countries:   Brazil, China, France, Germany, India, Ireland,   Italy, Japan, Mexico, Singapore, UK)   Seramount • 100 Best Companies   Seramount  (formerly  Working Mother Media ) • Best Companies for Dads   Seramount  (formerly  Working Mother Media ) • Top Companies for Executive Women   Seramount  (formerly Working Mother Media 's  National Association for Female Executives) • Top 10% Inclusion Index Company   Seramount Inclusion IndexRECOGNITION HIGHLIGHTS (AS OF JUNE 2021 ) RECOGNITION Baxter is proud to be recognized by numerous  organizations and publications globally.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8151910901069641)","('Human_Rights_And_Community_Relations', 0.04629853740334511)","('Employee_Health_And_Safety', 0.02381495200097561)","(['Human Capital Development'], 0.8151910901069641)","('NON-ESG', 0.04629853740334511)","('NON-ESG', 0.02381495200097561)"
Line 1491,"Baxter is a longtime supporter of  Americares, a health-focused relief and development organization that saves lives and  improves health for people affected by poverty or disaster.• 100 Best Corporate Citizens   3BL Media • Score: A-   CDP Climate Change and CDP Water • Best Place to Work for Disability Inclusion   (top 10% of all companies)   Disability Equality Index  • Dow Jones Sustainability Index • FTSE4Good Index Series • America's Best Employers for Diversity   Forbes • America's Best Employers for Women   Forbes • Corporate Equality Index for LGBTQ Equality   (100% score)   Human Rights Campaign Foundation  • America's Most Just Companies   JUST Capital • America's Most Responsible Companies   Newsweek • Global Inclusion Index (in 11 countries:   Brazil, China, France, Germany, India, Ireland,   Italy, Japan, Mexico, Singapore, UK)   Seramount • 100 Best Companies   Seramount  (formerly  Working Mother Media ) • Best Companies for Dads   Seramount  (formerly  Working Mother Media ) • Top Companies for Executive Women   Seramount  (formerly Working Mother Media 's  National Association for Female Executives) • Top 10% Inclusion Index Company   Seramount Inclusion IndexRECOGNITION HIGHLIGHTS (AS OF JUNE 2021 ) RECOGNITION Baxter is proud to be recognized by numerous  organizations and publications globally.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9536197781562805)","('Human_Rights_And_Community_Relations', 0.004848945885896683)","('Business_Model_Resilience', 0.0039004962891340256)","(['Human Capital Development'], 0.9536197781562805)","('NON-ESG', 0.004848945885896683)","('NON-ESG', 0.0039004962891340256)"
Line 1492,"These  examples of our recent accomplishments highlight  Baxter as an employer of choice, as a company  that works to nurture an inclusive and diverse  workplace, and as a socially and environmentally  responsible business.","('Employee_Engagement_Inclusion_And_Diversity', 0.948484480381012)","('Human_Rights_And_Community_Relations', 0.008862225338816643)","('Employee_Health_And_Safety', 0.005643343552947044)","(['Human Capital Development'], 0.948484480381012)","('NON-ESG', 0.008862225338816643)","('NON-ESG', 0.005643343552947044)"
